Citrus Sinensis ID: 046897
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 404 | 2.2.26 [Sep-21-2011] | |||||||
| Q06548 | 410 | Protein kinase APK1A, chl | yes | no | 0.980 | 0.965 | 0.724 | 1e-175 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.985 | 0.966 | 0.720 | 1e-172 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.952 | 0.989 | 0.667 | 1e-156 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.878 | 0.898 | 0.662 | 1e-139 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.782 | 0.741 | 0.707 | 1e-137 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.792 | 0.751 | 0.677 | 1e-133 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.863 | 0.897 | 0.636 | 1e-132 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.797 | 0.657 | 0.680 | 1e-130 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.841 | 0.689 | 0.641 | 1e-130 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.784 | 0.773 | 0.645 | 1e-119 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 613 bits (1582), Expect = e-175, Method: Compositional matrix adjust.
Identities = 303/418 (72%), Positives = 345/418 (82%), Gaps = 22/418 (5%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MGICLSA++KAES +G S+KY D D+ S GSK SS+SV P+PR+EGEIL+SPNLK
Sbjct: 1 MGICLSAQVKAES---SGASTKY---DAKDIGSLGSKASSVSVRPSPRTEGEILQSPNLK 54
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSF++LK+ATRNFRPDSVLGEGGFG VFKGWIDE S A++PGTG+VIAVK+LNQDG+Q
Sbjct: 55 SFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQ 114
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVNYLGQ H +LVKL+GYCLED+HRLLVYEFMPRGSLENHLFRRG YFQPLS
Sbjct: 115 GHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLS 174
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W LRLKVALGAAKG+AFLH +ET+VIYRDFKTSNILLD+ YNAKLSDFGLAKDGP GD+S
Sbjct: 175 WKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGT+GYAAPEYLATGHLT KSDVYSFGVVLLE+LSGRRAVDKNRPSGE NLVEW
Sbjct: 235 HVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEW 294
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYL +KRKIFR+IDNRL+ QY++E A K ATL+LRCL+TE K RP M+EVV+ LE +Q
Sbjct: 295 AKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDARSR--------------SVTAYPRPSASPLYA 404
S I N + R +D S+ +V AYPRPSASPLY
Sbjct: 355 --SLNAAIGGNMDKTDRRMRRRSDSVVSKKVNAGFARQTAVGSTVVAYPRPSASPLYV 410
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 603 bits (1555), Expect = e-172, Method: Compositional matrix adjust.
Identities = 301/418 (72%), Positives = 341/418 (81%), Gaps = 20/418 (4%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MGICLSA+IKA SP G S KY+SS+ ND + S S+ PR+EGEIL+SPNLK
Sbjct: 1 MGICLSAQIKAVSP---GASPKYMSSEANDSLGSKSSSVSIRT--NPRTEGEILQSPNLK 55
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SF+F++LK ATRNFRPDSVLGEGGFGSVFKGWIDE + A+KPGTG+VIAVK+LNQDG+Q
Sbjct: 56 SFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ 115
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVNYLGQ HPNLVKL+GYCLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 116 GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 175
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W LRLKVALGAAKG+AFLH AET VIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 176 WTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKS 235
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTR+MGTYGYAAPEYLATGHLT KSDVYS+GVVLLE+LSGRRAVDKNRP GE LVEW
Sbjct: 236 HVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEW 295
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
A+P LA+KRK+FR+IDNRL+ QY++E A K ATLALRCL+ E K RP M EVV+ LE +Q
Sbjct: 296 ARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQ 355
Query: 361 DSSETGNIRCNTHNRPKIRRHS----------ADDARSRSV----TAYPRPSASPLYA 404
+E G + R ++RR S A AR +V TAYPRPS SPL+
Sbjct: 356 TLNEAGGRNIDMVQR-RMRRRSDSVAINQKPNAGFARQTAVGVIATAYPRPSDSPLFV 412
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 551 bits (1419), Expect = e-156, Method: Compositional matrix adjust.
Identities = 267/400 (66%), Positives = 323/400 (80%), Gaps = 15/400 (3%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG C S RIK + +T +SSK++S DG S GS +S S PR+EGEIL++ NLK
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDG----SKGSSTASFSY--MPRTEGEILQNANLK 54
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
+FS S+LK+ATRNFRPDSV+GEGGFG VFKGWIDE S A +KPGTG+VIAVKRLNQ+GFQ
Sbjct: 55 NFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQ 114
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAE+NYLGQL HPNLVKL+GYCLE++HRLLVYEFM RGSLENHLFRRG+++QPLS
Sbjct: 115 GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLS 174
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
WN R+++ALGAA+G+AFLH A+ +VIYRDFK SNILLD+NYNAKLSDFGLA+DGP GD S
Sbjct: 175 WNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGT GYAAPEYLATGHL+ KSDVYSFGVVLLE+LSGRRA+DKN+P GEHNLV+W
Sbjct: 235 HVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDW 294
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
A+PYL +KR++ R++D RL+GQY+L A K A LAL C+S + K RP M E+V +E+L
Sbjct: 295 ARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELH 354
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDARSRSVTA--YPRPS 398
E + N P+I S D+ ++S A YPRPS
Sbjct: 355 IQKEASKEQQN----PQI---SIDNIINKSPQAVNYPRPS 387
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1278), Expect = e-139, Method: Compositional matrix adjust.
Identities = 240/362 (66%), Positives = 292/362 (80%), Gaps = 7/362 (1%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG C S+R+KA+ F+ G SS S S+ SS +V ++EGEIL S +K
Sbjct: 1 MGSCFSSRVKADI-FHNGKSSDLYGL------SLSSRKSSSTVAAAQKTEGEILSSTPVK 53
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SF+F++LK ATRNFRPDSV+GEGGFG VFKGW+DE + TKPGTG+VIAVK+LNQ+GFQ
Sbjct: 54 SFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQ 113
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWL E+NYLGQL HPNLVKL+GYCLED+HRLLVYEFM +GSLENHLFRRG+YF+PL
Sbjct: 114 GHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLP 173
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W LR+ VAL AAKG+AFLH KVIYRD K SNILLD +YNAKLSDFGLA+DGP GD S
Sbjct: 174 WFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLS 233
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
+VSTRVMGTYGYAAPEY+++GHL A+SDVYSFGV+LLE+LSG+RA+D NRP+ E NLV+W
Sbjct: 234 YVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDW 293
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
A+PYL SKRK+ I+DNRL+ QY E A + A++A++CLS E K RP M +VV L+QLQ
Sbjct: 294 ARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQ 353
Query: 361 DS 362
D+
Sbjct: 354 DN 355
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 490 bits (1261), Expect = e-137, Method: Compositional matrix adjust.
Identities = 225/318 (70%), Positives = 277/318 (87%), Gaps = 2/318 (0%)
Query: 45 PTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPG 104
PTPR+EGEIL SPNLK+F+F++LK ATRNFRPDS+LGEGGFG VFKGWID + A+KPG
Sbjct: 54 PTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPG 113
Query: 105 TGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGS 164
+G+V+AVK+L +G+QGHKEWL EVNYLGQL HPNLVKLVGYC+E ++RLLVYEFMP+GS
Sbjct: 114 SGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGS 173
Query: 165 LENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224
LENHLFRRG+ QPL+W +R+KVA+GAAKG+ FLH A+++VIYRDFK +NILLD +N+K
Sbjct: 174 LENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSK 231
Query: 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
LSDFGLAK GPTGD++HVST+VMGT+GYAAPEY+ATG LTAKSDVYSFGVVLLE+LSGRR
Sbjct: 232 LSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRR 291
Query: 285 AVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGK 344
AVDK++ E +LV+WA PYL KRK+FRI+D RL GQY +GAY AA+LAL+CL+ + K
Sbjct: 292 AVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAK 351
Query: 345 FRPMMAEVVTVLEQLQDS 362
RP M+EV+ L+QL+ +
Sbjct: 352 LRPKMSEVLAKLDQLEST 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-133, Method: Compositional matrix adjust.
Identities = 218/322 (67%), Positives = 274/322 (85%), Gaps = 2/322 (0%)
Query: 45 PTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPG 104
PT R+EGEIL SPNLK+F+F++LK AT+NFR D++LGEGGFG VFKGWID+ S A++PG
Sbjct: 57 PTLRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPG 116
Query: 105 TGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGS 164
+G+V+AVK+L +GFQGHKEWL EVNYLGQL HPNLV LVGYC E ++RLLVYEFMP+GS
Sbjct: 117 SGIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGS 176
Query: 165 LENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224
LENHLFRRG+ QPL+W +R+KVA+GAAKG+ FLH A+++VIYRDFK +NILLD ++NAK
Sbjct: 177 LENHLFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAK 234
Query: 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
LSDFGLAK GPTGD +HVST+V+GT+GYAAPEY+ATG LTAKSDVYSFGVVLLE++SGRR
Sbjct: 235 LSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRR 294
Query: 285 AVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGK 344
A+D + E++LV+WA PYL KRK+FRI+D +L GQY +GA+ AA LAL+CL+ + K
Sbjct: 295 AMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAK 354
Query: 345 FRPMMAEVVTVLEQLQDSSETG 366
RP M+EV+ LEQL+ ++ G
Sbjct: 355 LRPKMSEVLVTLEQLESVAKPG 376
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1212), Expect = e-132, Method: Compositional matrix adjust.
Identities = 231/363 (63%), Positives = 285/363 (78%), Gaps = 14/363 (3%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG CLS+R+ +S ++G+ ++SS + S+T K +EGEIL S +K
Sbjct: 1 MGSCLSSRVLNKS--SSGLDDLHLSSCKSSSSATAHK-----------TEGEILSSTTVK 47
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSF++LK ATRNFR DSV+GEGGFG VF+GW+DE + TK +G+VIAVKRLN DGFQ
Sbjct: 48 SFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDGFQ 107
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY-FQPL 179
GH+EWL E+NYLGQL HPNLVKL+GYCLED+ RLLVYEFM +GSLENHLF G+ F+PL
Sbjct: 108 GHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPL 167
Query: 180 SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
SW LR+KVAL AAKG+AFLH KVIYRD K SNILLD+++NAKLSDFGLA+DGP G+Q
Sbjct: 168 SWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQ 227
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299
S+VSTRVMGT+GYAAPEY++TGHL A+SDVYSFGVVLLE+L GR+A+D NRP+ E NLV+
Sbjct: 228 SYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQNLVD 287
Query: 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
WA+PYL S+RK+ I+D RL QY EGA + A++A++CLS E K RP M +VV L QL
Sbjct: 288 WARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQL 347
Query: 360 QDS 362
QDS
Sbjct: 348 QDS 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1195), Expect = e-130, Method: Compositional matrix adjust.
Identities = 224/329 (68%), Positives = 266/329 (80%), Gaps = 7/329 (2%)
Query: 32 SSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG 91
++T + SSLS TP E+ +LK FSF DLK ATRNFRP+S+LGEGGFG VFKG
Sbjct: 97 TTTSNAESSLS---TPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKG 153
Query: 92 WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151
W++E+ A KPGTG+ +AVK LN DG QGHKEWLAE+NYLG L HPNLVKLVGYC+EDD
Sbjct: 154 WVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDD 213
Query: 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK-VIYRDF 210
RLLVYEFMPRGSLENHLFRR PL W++R+K+ALGAAKG++FLH K VIYRDF
Sbjct: 214 QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDF 270
Query: 211 KTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVY 270
KTSNILLD YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVY
Sbjct: 271 KTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 330
Query: 271 SFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYK 330
SFGVVLLEML+GRR++DKNRP+GEHNLVEWA+P+L KR+ +R++D RLEG ++++GA K
Sbjct: 331 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQK 390
Query: 331 AATLALRCLSTEGKFRPMMAEVVTVLEQL 359
LA +CLS + K RP M+EVV VL+ L
Sbjct: 391 VTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1194), Expect = e-130, Method: Compositional matrix adjust.
Identities = 224/349 (64%), Positives = 275/349 (78%), Gaps = 9/349 (2%)
Query: 17 TGVSSKYVSSDGND-----MSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTAT 71
T + SK + ND +SST + ++ S TP E+ S +L+ F+F+DLK +T
Sbjct: 80 TTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLST 139
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
RNFRP+S+LGEGGFG VFKGWI+E+ A KPGTG+ +AVK LN DG QGHKEWLAE+N+
Sbjct: 140 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINF 199
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
LG L HPNLVKLVGYC+EDD RLLVYEFMPRGSLENHLFRR PL W++R+K+ALGA
Sbjct: 200 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGA 256
Query: 192 AKGVAFLHGAETK-VIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
AKG++FLH K VIYRDFKTSNILLD +YNAKLSDFGLAKD P ++HVSTRVMGTY
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 316
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
GYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR++DKNRP+GEHNLVEWA+P+L KR+
Sbjct: 317 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRR 376
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
+R++D RLEG ++++GA K LA +CLS + K RP M++VV L+ L
Sbjct: 377 FYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 211/327 (64%), Positives = 257/327 (78%), Gaps = 10/327 (3%)
Query: 38 VSSLSVPPTPRSEGEILRSP----NLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWI 93
VS LS P TPR + R+P + F+ +L+T T++FRPD +LGEGGFG+V+KG+I
Sbjct: 30 VSDLSDPSTPRFRDDS-RTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYI 88
Query: 94 DEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHR 153
D++ K + +AVK LN++G QGH+EWL EVN+LGQL HPNLVKL+GYC EDDHR
Sbjct: 89 DDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR 145
Query: 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTS 213
LLVYEFM RGSLENHLFR+ + PLSW+ R+ +ALGAAKG+AFLH AE VIYRDFKTS
Sbjct: 146 LLVYEFMLRGSLENHLFRKTT--APLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTS 203
Query: 214 NILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFG 273
NILLD++Y AKLSDFGLAK GP GD++HVSTRVMGTYGYAAPEY+ TGHLTA+SDVYSFG
Sbjct: 204 NILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFG 263
Query: 274 VVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAAT 333
VVLLEML+GR++VDK RPS E NLV+WA+P L KRK+ +IID RLE QY++ A KA +
Sbjct: 264 VVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACS 323
Query: 334 LALRCLSTEGKFRPMMAEVVTVLEQLQ 360
LA CLS K RP+M++VV LE LQ
Sbjct: 324 LAYYCLSQNPKARPLMSDVVETLEPLQ 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 404 | ||||||
| 224059486 | 405 | predicted protein [Populus trichocarpa] | 1.0 | 0.997 | 0.851 | 0.0 | |
| 297746068 | 404 | unnamed protein product [Vitis vinifera] | 0.995 | 0.995 | 0.839 | 0.0 | |
| 359478936 | 442 | PREDICTED: protein kinase APK1A, chlorop | 0.995 | 0.909 | 0.769 | 0.0 | |
| 224106475 | 391 | predicted protein [Populus trichocarpa] | 0.965 | 0.997 | 0.824 | 0.0 | |
| 359807309 | 419 | protein kinase APK1A, chloroplastic-like | 0.997 | 0.961 | 0.775 | 0.0 | |
| 449450736 | 404 | PREDICTED: protein kinase APK1A, chlorop | 0.995 | 0.995 | 0.797 | 0.0 | |
| 449517535 | 404 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.995 | 0.995 | 0.794 | 0.0 | |
| 363807636 | 422 | uncharacterized protein LOC100798404 [Gl | 0.997 | 0.954 | 0.769 | 0.0 | |
| 84468358 | 409 | putative protein kinase APK1A [Trifolium | 0.985 | 0.973 | 0.754 | 0.0 | |
| 350534672 | 401 | protein kinase 1b [Solanum lycopersicum] | 0.985 | 0.992 | 0.790 | 0.0 |
| >gi|224059486|ref|XP_002299870.1| predicted protein [Populus trichocarpa] gi|222847128|gb|EEE84675.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/405 (85%), Positives = 375/405 (92%), Gaps = 1/405 (0%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MGICLSA+IKAES NTG+SSKYVS+DGND+SSTGSKV S+SVPPTPRSEGEIL+S NLK
Sbjct: 1 MGICLSAQIKAESSCNTGLSSKYVSTDGNDLSSTGSKVLSVSVPPTPRSEGEILQSTNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSFSDLK ATR+FRPDSVLGEGGFGSVFKGWIDE SF+A KPGTG+VIAVKRLNQDGFQ
Sbjct: 61 SFSFSDLKMATRSFRPDSVLGEGGFGSVFKGWIDEQSFSAAKPGTGIVIAVKRLNQDGFQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GHKEWLAEVNYLGQ YHP+LVKL+GYCLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHKEWLAEVNYLGQFYHPHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
WNLRLKVALGAAKG+AFLH AET+VIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WNLRLKVALGAAKGLAFLHCAETQVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRV+GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA+DKNRPSGEHNLVEW
Sbjct: 241 HVSTRVIGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAIDKNRPSGEHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRKIFRI+DNRLEGQY+++ A+KA+TLALRCLS E KFRP M EVVT +EQLQ
Sbjct: 301 AKPYLANKRKIFRILDNRLEGQYSMDVAFKASTLALRCLSIETKFRPTMDEVVTAMEQLQ 360
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDARS-RSVTAYPRPSASPLYA 404
DS ETG+ + N P+IRR SADD S R+ AYPRPS SPLYA
Sbjct: 361 DSKETGSANGHASNAPRIRRRSADDTISGRNTAAYPRPSTSPLYA 405
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746068|emb|CBI16124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/404 (83%), Positives = 366/404 (90%), Gaps = 2/404 (0%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLSARIKAESP +TG SSKYVS+DGN+ +ST SKVS SVPPTPRSEG+IL+SPNLK
Sbjct: 1 MGVCLSARIKAESPCHTGGSSKYVSTDGNEQNSTSSKVSVASVPPTPRSEGDILQSPNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
+F+FS+LK ATRNFRPDSVLGEGGFGSVFKGWIDE SFAA +PGTGMVIAVKRLN + FQ
Sbjct: 61 NFTFSELKMATRNFRPDSVLGEGGFGSVFKGWIDEQSFAAARPGTGMVIAVKRLNLESFQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GHKEWLAEVNYLGQLYHP+LVKL+G+C ED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHKEWLAEVNYLGQLYHPHLVKLIGFCSEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
WNLRLKVALGAAKG+AFLH AETKVIYRDFKTSNILLD+NYNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WNLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNILLDSNYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTA+SDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTARSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRKIFRI+DNRLEGQY+LEGA+KA+ LALRCLSTE KFRP M EVVT LEQLQ
Sbjct: 301 AKPYLANKRKIFRILDNRLEGQYSLEGAHKASNLALRCLSTEAKFRPTMTEVVTALEQLQ 360
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDA-RSRSVTAYPRPSASPLY 403
D E I N K RR SADD + + AYPRPSASPLY
Sbjct: 361 DCKEP-EITNNRSGGMKHRRRSADDKEKPTTAIAYPRPSASPLY 403
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478936|ref|XP_002283646.2| PREDICTED: protein kinase APK1A, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/442 (76%), Positives = 367/442 (83%), Gaps = 40/442 (9%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLSARIKAESP +TG SSKYVS+DGN+ +ST SKVS SVPPTPRSEG+IL+SPNLK
Sbjct: 1 MGVCLSARIKAESPCHTGGSSKYVSTDGNEQNSTSSKVSVASVPPTPRSEGDILQSPNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
+F+FS+LK ATRNFRPDSVLGEGGFGSVFKGWIDE SFAA +PGTGMVIAVKRLN + FQ
Sbjct: 61 NFTFSELKMATRNFRPDSVLGEGGFGSVFKGWIDEQSFAAARPGTGMVIAVKRLNLESFQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GHKEWLAEVNYLGQLYHP+LVKL+G+C ED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHKEWLAEVNYLGQLYHPHLVKLIGFCSEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
WNLRLKVALGAAKG+AFLH AETKVIYRDFKTSNILLD+NYNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WNLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNILLDSNYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTA+SDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTARSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRKIFRI+DNRLEGQY+LEGA+KA+ LALRCLSTE KFRP M EVVT LEQLQ
Sbjct: 301 AKPYLANKRKIFRILDNRLEGQYSLEGAHKASNLALRCLSTEAKFRPTMTEVVTALEQLQ 360
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDARSR------------------------------- 389
D E I N K RR SADD R+
Sbjct: 361 DCKEP-EITNNRSGGMKHRRRSADDVRNEKPPIATPYPLSADDARKEKPVIPSAHPQSAD 419
Query: 390 --------SVTAYPRPSASPLY 403
+ AYPRPSASPLY
Sbjct: 420 YAKKEKPTTAIAYPRPSASPLY 441
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106475|ref|XP_002314178.1| predicted protein [Populus trichocarpa] gi|222850586|gb|EEE88133.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/405 (82%), Positives = 360/405 (88%), Gaps = 15/405 (3%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MGICLSA+IKAES +T T SKVSSLSVPPTPRSEGEIL+S NLK
Sbjct: 1 MGICLSAQIKAESSCST--------------VGTSSKVSSLSVPPTPRSEGEILQSSNLK 46
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSFSDLK ATRNFRPDSVLGEGGFGSVFKGWIDE +F+A KPGTGMVIAVKRLNQDGFQ
Sbjct: 47 SFSFSDLKMATRNFRPDSVLGEGGFGSVFKGWIDEQTFSAAKPGTGMVIAVKRLNQDGFQ 106
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GHKEWLAEVNYLGQLY+P+LVKL+GYCLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 107 GHKEWLAEVNYLGQLYNPHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 166
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
WNLR+KV+LGAAKG+AFLH AETKVIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 167 WNLRMKVSLGAAKGLAFLHSAETKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 226
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW
Sbjct: 227 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 286
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRKIFRI+D+RLEGQY+++ AYK +TLALRCLS E KFRP M EVVT LEQLQ
Sbjct: 287 AKPYLANKRKIFRILDSRLEGQYSMDVAYKVSTLALRCLSIETKFRPTMDEVVTALEQLQ 346
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDAR-SRSVTAYPRPSASPLYA 404
DS ETG + N+P+IRR SA+DA S+ AYPRPSASPLYA
Sbjct: 347 DSKETGTANGHVGNKPRIRRRSANDATGGGSIAAYPRPSASPLYA 391
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359807309|ref|NP_001240863.1| protein kinase APK1A, chloroplastic-like [Glycine max] gi|223452444|gb|ACM89549.1| putative protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/418 (77%), Positives = 362/418 (86%), Gaps = 15/418 (3%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLSA+IKAESPFNT +SKYVS+DGND+ ST KVS+ SVP TPRSEGEIL+S NLK
Sbjct: 1 MGVCLSAQIKAESPFNTVFNSKYVSTDGNDLGSTNDKVSANSVPQTPRSEGEILQSSNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SF+ S+LKTATRNFRPDSVLGEGGFGSVFKGWIDE+S ATKPGTG+VIAVKRLNQDG Q
Sbjct: 61 SFTLSELKTATRNFRPDSVLGEGGFGSVFKGWIDENSLTATKPGTGIVIAVKRLNQDGIQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVNYLGQL HP+LV+L+G+CLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNYLGQLSHPHLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W+LRLKVAL AAKG+AFLH AE KVIYRDFKTSN+LLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WSLRLKVALDAAKGLAFLHSAEAKVIYRDFKTSNVLLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG+RAVDKNRPSG+HNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGKRAVDKNRPSGQHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKP++A+KRKIFR++D RL+GQY+ + AYK ATLALRCLS E KFRP M +VVT LEQLQ
Sbjct: 301 AKPFMANKRKIFRVLDTRLQGQYSTDDAYKLATLALRCLSIESKFRPNMDQVVTTLEQLQ 360
Query: 361 DSSETGNIRCNT--------HNRP------KIRRHSADD-ARSRSVTAYPRPSASPLY 403
S+ G R H P ++RR SADD +R + AYPRPSASPLY
Sbjct: 361 LSNVNGGPRVRRRSADVNRGHQNPSSVNGSRVRRRSADDISRLETPNAYPRPSASPLY 418
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450736|ref|XP_004143118.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/404 (79%), Positives = 361/404 (89%), Gaps = 2/404 (0%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLS RIKAE+ NTGV+S VS+DGND+ ST SK++ LSVPPTPR+EGEIL+S NLK
Sbjct: 1 MGVCLSTRIKAENSCNTGVNSNGVSTDGNDIGSTNSKINLLSVPPTPRTEGEILQSSNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSF++LK ATRNFRPDSV+GEGGFGSVFKGWIDEHSFAA KPGTGMVIAVKRLNQDGFQ
Sbjct: 61 SFSFTELKAATRNFRPDSVVGEGGFGSVFKGWIDEHSFAAAKPGTGMVIAVKRLNQDGFQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVN+LGQL H +LV+LVGYCLED+HR+LVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNFLGQLSHCHLVRLVGYCLEDEHRMLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W+LRLKVALGAAKG+AFLH E KVIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WSLRLKVALGAAKGLAFLHSDERKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLT SDVYSFGVVLLE+L GRRA+DKNRP+ EHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTTWSDVYSFGVVLLEILCGRRAIDKNRPAREHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRKIFRIID+RLEGQY+L+GAYKA+ LALRC+S K RP+M +VV LEQLQ
Sbjct: 301 AKPYLANKRKIFRIIDSRLEGQYSLDGAYKASMLALRCISINPKLRPIMNDVVKELEQLQ 360
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDARS-RSVTAYPRPSASPLY 403
DS+ + R +T+NR + RRHSADDAR+ S AYPRP S LY
Sbjct: 361 DSTLPTSNRNSTNNR-RARRHSADDARNPNSAQAYPRPPVSALY 403
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449517535|ref|XP_004165801.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase APK1A, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 665 bits (1715), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/404 (79%), Positives = 360/404 (89%), Gaps = 2/404 (0%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLS RIKAE+ NTGV+S VS+DGND+ ST SK++ LSVPPTPR+EGEIL+S NLK
Sbjct: 1 MGVCLSTRIKAENSCNTGVNSNGVSTDGNDIGSTNSKINLLSVPPTPRTEGEILQSSNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSF++LK ATRNFRPDSV+GEGGFGSVFKGWIDEHSFAA KPGTGMVIAVKRLNQDGFQ
Sbjct: 61 SFSFTELKAATRNFRPDSVVGEGGFGSVFKGWIDEHSFAAAKPGTGMVIAVKRLNQDGFQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVN+LGQL H +LV+LVGYCLED+HR+LVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNFLGQLSHCHLVRLVGYCLEDEHRMLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W+LRLKVALGAAKG+AFLH E KVIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WSLRLKVALGAAKGLAFLHSDERKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLT SDVYSFGVVLLE+L GRRA+DKNRP+ EHNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTTWSDVYSFGVVLLEILCGRRAIDKNRPAREHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRK FRIID+RLEGQY+L+GAYKA+ LALRC+S K RP+M +VV LEQLQ
Sbjct: 301 AKPYLANKRKXFRIIDSRLEGQYSLDGAYKASMLALRCISINPKLRPIMNDVVKELEQLQ 360
Query: 361 DSSETGNIRCNTHNRPKIRRHSADDARS-RSVTAYPRPSASPLY 403
DS+ + R +T+NR + RRHSADDAR+ S AYPRP S LY
Sbjct: 361 DSTLPTSNRNSTNNR-RARRHSADDARNPNSAQAYPRPPVSALY 403
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807636|ref|NP_001242670.1| uncharacterized protein LOC100798404 [Glycine max] gi|255647315|gb|ACU24124.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/421 (76%), Positives = 358/421 (85%), Gaps = 18/421 (4%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLSA+IKAESP+NTG +SKYVS+DGND ST KVS+ S+P TPRSEGEILRS NLK
Sbjct: 1 MGVCLSAQIKAESPYNTGFNSKYVSTDGNDFGSTNDKVSANSIPQTPRSEGEILRSSNLK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SF S+LKTATRNFRPDSVLGEGGFGSVFKGWIDE+S ATKPGTG+VIAVKRLNQDG Q
Sbjct: 61 SFPLSELKTATRNFRPDSVLGEGGFGSVFKGWIDENSLTATKPGTGIVIAVKRLNQDGIQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVNYLGQL HP+LV+L+G+CLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNYLGQLSHPHLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W+LRLKVAL AAKG+AFLH E KVIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WSLRLKVALDAAKGLAFLHSTEAKVIYRDFKTSNILLDSKYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG+RAVDKNRPSG+HNLVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGKRAVDKNRPSGQHNLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRKIFR++D RLEGQY+ + A K ATLALRCLS E KFRP M EVVT LEQLQ
Sbjct: 301 AKPYLANKRKIFRVLDTRLEGQYSTDDACKLATLALRCLSIESKFRPNMDEVVTTLEQLQ 360
Query: 361 DSSETGNIRCNTH-----------------NRPKIRRHSADD-ARSRSVTAYPRPSASPL 402
+ G + + N ++RR SADD + + TAYPRPSASPL
Sbjct: 361 VPNVNGGHQNGSRVRRRSADVNRGYQNPSVNGSRVRRRSADDISPMETPTAYPRPSASPL 420
Query: 403 Y 403
Y
Sbjct: 421 Y 421
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|84468358|dbj|BAE71262.1| putative protein kinase APK1A [Trifolium pratense] | Back alignment and taxonomy information |
|---|
Score = 651 bits (1680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/415 (75%), Positives = 364/415 (87%), Gaps = 17/415 (4%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MG+CLSA+IKAESP+NTG++SK +S GND+SST SKVS+ SVP TPRSEGEIL+S N+K
Sbjct: 1 MGVCLSAQIKAESPYNTGLNSKNSNSAGNDLSSTNSKVSTGSVPQTPRSEGEILKSTNVK 60
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
S++ ++LK+ATRNFRPDSVLGEGGFGSVFKGWIDE+S A KPGTG+VIAVKRLNQ+ FQ
Sbjct: 61 SYTLAELKSATRNFRPDSVLGEGGFGSVFKGWIDENSLAPAKPGTGIVIAVKRLNQESFQ 120
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVNYLGQ HP+LV+L+GYCLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLS
Sbjct: 121 GHREWLAEVNYLGQFSHPHLVRLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W+LRLKVAL AAKG+AFLH +ETKVIYRDFKTSNILLD++YNAKLSDFGLAKDGPTGD+S
Sbjct: 181 WSLRLKVALDAAKGLAFLHSSETKVIYRDFKTSNILLDSDYNAKLSDFGLAKDGPTGDKS 240
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEYLATGHLT KSDVYS+GVVLLEMLSG+RAVDKNRPSG+H+LVEW
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEMLSGKRAVDKNRPSGQHSLVEW 300
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
AKPYLA+KRK+F ++D+RLEGQY+ + +Y+ ATLALRCLSTE K+RP M EVV +LEQL+
Sbjct: 301 AKPYLANKRKVFSVLDSRLEGQYSSDESYRVATLALRCLSTESKYRPNMDEVVRILEQLK 360
Query: 361 DSSETGNIRCNTHNRPKIRRHSADD-----------ARSRSVTAYPRPSASPLYA 404
N+ N N+ + RR SADD A +R+ T+YPRPSASPLYA
Sbjct: 361 ----VPNV--NVGNQRRYRRKSADDVTHARTHKKSCASARAHTSYPRPSASPLYA 409
|
Source: Trifolium pratense Species: Trifolium pratense Genus: Trifolium Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350534672|ref|NP_001234409.1| protein kinase 1b [Solanum lycopersicum] gi|189163920|gb|ACD77110.1| protein kinase 1b [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/406 (79%), Positives = 362/406 (89%), Gaps = 8/406 (1%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLK 60
MGICLSARIKAESPF+TG++S+ VS DG D +S S VP T RSEGEIL+SPNLK
Sbjct: 1 MGICLSARIKAESPFHTGLNSRSVSIDGGDSNS------SSRVPSTTRSEGEILQSPNLK 54
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDE++FAATKPGTG++IAVKRLNQ+GFQ
Sbjct: 55 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDENTFAATKPGTGVIIAVKRLNQEGFQ 114
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAEVNYLGQ HP+LVKL+GYCLED+HRLLVYEF+PRGSLENHLFRRGSYFQPLS
Sbjct: 115 GHREWLAEVNYLGQFSHPHLVKLIGYCLEDEHRLLVYEFVPRGSLENHLFRRGSYFQPLS 174
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W LRLKVALGAAKG+AFLH AETKVIYRDFKTSNILLD+NY AKLSDFGLAKDGPTGD+S
Sbjct: 175 WKLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNILLDSNYTAKLSDFGLAKDGPTGDKS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGTYGYAAPEY+ATGHLT+KSDVYSFGVVLLEMLSGRRA+DKNRPSGEHNLVEW
Sbjct: 235 HVSTRVMGTYGYAAPEYMATGHLTSKSDVYSFGVVLLEMLSGRRAIDKNRPSGEHNLVEW 294
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL- 359
AKPYL +KRK+FR++D RLEGQY++E A K A LALRCLS + +FRP M+++V +EQL
Sbjct: 295 AKPYLGNKRKVFRVLDTRLEGQYSMEVASKVANLALRCLSKDPRFRPSMSDIVKEMEQLY 354
Query: 360 QDSSETGNIRCNTHNRPKIRRHSADDARSRSVT-AYPRPSASPLYA 404
Q S E+GN R + NRP+ RR SA+D +R+ + AYPRPSASP YA
Sbjct: 355 QQSKESGNTRSHASNRPRPRRRSANDVANRNPSVAYPRPSASPPYA 400
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 404 | ||||||
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.950 | 0.907 | 0.709 | 3.9e-147 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.957 | 0.994 | 0.650 | 8.3e-138 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.878 | 0.898 | 0.651 | 1.8e-126 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.898 | 0.852 | 0.642 | 7e-125 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.900 | 0.854 | 0.616 | 1.1e-121 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.769 | 0.634 | 0.695 | 5.4e-118 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.871 | 0.854 | 0.616 | 2.3e-117 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.841 | 0.689 | 0.630 | 3e-117 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.779 | 0.813 | 0.667 | 4.9e-117 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.873 | 0.779 | 0.620 | 1.3e-116 |
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
Identities = 283/399 (70%), Positives = 318/399 (79%)
Query: 18 GVSSKYVSSDGNDMXXXXXXXXXXXVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPD 77
G S KY+SS+ ND + PR+EGEIL+SPNLKSF+F++LK ATRNFRPD
Sbjct: 26 GASPKYMSSEAND--SLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPD 83
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
SVLGEGGFGSVFKGWIDE + A+KPGTG+VIAVK+LNQDG+QGH+EWLAEVNYLGQ H
Sbjct: 84 SVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSH 143
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PNLVKL+GYCLED+HRLLVYEFMPRGSLENHLFRRGSYFQPLSW LRLKVALGAAKG+AF
Sbjct: 144 PNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAF 203
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
LH AET VIYRDFKTSNILLD+ YNAKLSDFGLAKDGPTGD+SHVSTR+MGTYGYAAPEY
Sbjct: 204 LHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEY 263
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDN 317
LATGHLT KSDVYS+GVVLLE+LSGRRAVDKNRP GE LVEWA+P LA+KRK+FR+IDN
Sbjct: 264 LATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDN 323
Query: 318 RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG--NI-----RC 370
RL+ QY++E A K ATLALRCL+ E K RP M EVV+ LE +Q +E G NI R
Sbjct: 324 RLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRM 383
Query: 371 NTH------NRPKIXXXXXXXXXXXXVTAYPRPSASPLY 403
N+ TAYPRPS SPL+
Sbjct: 384 RRRSDSVAINQKPNAGFARQTAVGVIATAYPRPSDSPLF 422
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
Identities = 259/398 (65%), Positives = 312/398 (78%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMXXXXXXXXXXXVPPTPRSEGEILRSPNLK 60
MG C S RIK + +T +SSK++S DG+ PR+EGEIL++ NLK
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYM------PRTEGEILQNANLK 54
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
+FS S+LK+ATRNFRPDSV+GEGGFG VFKGWIDE S A +KPGTG+VIAVKRLNQ+GFQ
Sbjct: 55 NFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQ 114
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWLAE+NYLGQL HPNLVKL+GYCLE++HRLLVYEFM RGSLENHLFRRG+++QPLS
Sbjct: 115 GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLS 174
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
WN R+++ALGAA+G+AFLH A+ +VIYRDFK SNILLD+NYNAKLSDFGLA+DGP GD S
Sbjct: 175 WNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNS 234
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
HVSTRVMGT GYAAPEYLATGHL+ KSDVYSFGVVLLE+LSGRRA+DKN+P GEHNLV+W
Sbjct: 235 HVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDW 294
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
A+PYL +KR++ R++D RL+GQY+L A K A LAL C+S + K RP M E+V +E+L
Sbjct: 295 ARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELH 354
Query: 361 DSSETGNIRCNTHNRPKIXXXXXXXXXXXXVTAYPRPS 398
E + N P+I V YPRPS
Sbjct: 355 IQKEASKEQQN----PQISIDNIINKSPQAVN-YPRPS 387
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1242 (442.3 bits), Expect = 1.8e-126, P = 1.8e-126
Identities = 236/362 (65%), Positives = 286/362 (79%)
Query: 1 MGICLSARIKAESPFNTGVSSKYVSSDGNDMXXXXXXXXXXXVPPTPRSEGEILRSPNLK 60
MG C S+R+KA+ F+ G SS V ++EGEIL S +K
Sbjct: 1 MGSCFSSRVKADI-FHNGKSSDLYG------LSLSSRKSSSTVAAAQKTEGEILSSTPVK 53
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ 120
SF+F++LK ATRNFRPDSV+GEGGFG VFKGW+DE + TKPGTG+VIAVK+LNQ+GFQ
Sbjct: 54 SFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQ 113
Query: 121 GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
GH+EWL E+NYLGQL HPNLVKL+GYCLED+HRLLVYEFM +GSLENHLFRRG+YF+PL
Sbjct: 114 GHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLP 173
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
W LR+ VAL AAKG+AFLH KVIYRD K SNILLD +YNAKLSDFGLA+DGP GD S
Sbjct: 174 WFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLS 233
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
+VSTRVMGTYGYAAPEY+++GHL A+SDVYSFGV+LLE+LSG+RA+D NRP+ E NLV+W
Sbjct: 234 YVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEENLVDW 293
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
A+PYL SKRK+ I+DNRL+ QY E A + A++A++CLS E K RP M +VV L+QLQ
Sbjct: 294 ARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQ 353
Query: 361 DS 362
D+
Sbjct: 354 DN 355
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1227 (437.0 bits), Expect = 7.0e-125, P = 7.0e-125
Identities = 241/375 (64%), Positives = 300/375 (80%)
Query: 1 MGICL--SARI--KAESPF-NTGVSSKYVSS--DGNDMXXXXXXXXXXXVP--PTPRSEG 51
MG CL SA++ + SP N+ S VSS + + V PTPR+EG
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 52 EILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAV 111
EIL SPNLK+F+F++LK ATRNFRPDS+LGEGGFG VFKGWID + A+KPG+G+V+AV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 112 KRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR 171
K+L +G+QGHKEWL EVNYLGQL HPNLVKLVGYC+E ++RLLVYEFMP+GSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 172 RGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
RG+ QPL+W +R+KVA+GAAKG+ FLH A+++VIYRDFK +NILLD +N+KLSDFGLA
Sbjct: 181 RGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLA 238
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291
K GPTGD++HVST+VMGT+GYAAPEY+ATG LTAKSDVYSFGVVLLE+LSGRRAVDK++
Sbjct: 239 KAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKV 298
Query: 292 SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351
E +LV+WA PYL KRK+FRI+D RL GQY +GAY AA+LAL+CL+ + K RP M+E
Sbjct: 299 GMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSE 358
Query: 352 VVTVLEQLQDSSETG 366
V+ L+QL+ S++ G
Sbjct: 359 VLAKLDQLE-STKPG 372
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
Identities = 233/378 (61%), Positives = 295/378 (78%)
Query: 1 MGICLSARIKAE----SPF----NTG--VSSKYVSSDG-NDMXXXXXXXXXXXVP-PTPR 48
MG CL + K + SP ++G VSSK S G + + P PT R
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 49 SEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV 108
+EGEIL SPNLK+F+F++LK AT+NFR D++LGEGGFG VFKGWID+ S A++PG+G+V
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 109 IAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENH 168
+AVK+L +GFQGHKEWL EVNYLGQL HPNLV LVGYC E ++RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 169 LFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228
LFRRG+ QPL+W +R+KVA+GAAKG+ FLH A+++VIYRDFK +NILLD ++NAKLSDF
Sbjct: 181 LFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDF 238
Query: 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288
GLAK GPTGD +HVST+V+GT+GYAAPEY+ATG LTAKSDVYSFGVVLLE++SGRRA+D
Sbjct: 239 GLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDN 298
Query: 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM 348
+ E++LV+WA PYL KRK+FRI+D +L GQY +GA+ AA LAL+CL+ + K RP
Sbjct: 299 SNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPK 358
Query: 349 MAEVVTVLEQLQDSSETG 366
M+EV+ LEQL+ ++ G
Sbjct: 359 MSEVLVTLEQLESVAKPG 376
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 5.4e-118, P = 5.4e-118
Identities = 219/315 (69%), Positives = 258/315 (81%)
Query: 46 TPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGT 105
TP E+ +LK FSF DLK ATRNFRP+S+LGEGGFG VFKGW++E+ A KPGT
Sbjct: 108 TPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 167
Query: 106 GMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSL 165
G+ +AVK LN DG QGHKEWLAE+NYLG L HPNLVKLVGYC+EDD RLLVYEFMPRGSL
Sbjct: 168 GLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 227
Query: 166 ENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK-VIYRDFKTSNILLDTNYNAK 224
ENHLFRR PL W++R+K+ALGAAKG++FLH K VIYRDFKTSNILLD YNAK
Sbjct: 228 ENHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAK 284
Query: 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
LSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR
Sbjct: 285 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
Query: 285 AVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGK 344
++DKNRP+GEHNLVEWA+P+L KR+ +R++D RLEG ++++GA K LA +CLS + K
Sbjct: 345 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSK 404
Query: 345 FRPMMAEVVTVLEQL 359
RP M+EVV VL+ L
Sbjct: 405 IRPKMSEVVEVLKPL 419
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
Identities = 225/365 (61%), Positives = 289/365 (79%)
Query: 6 SARIKAESPFNTGVSSKYV-SSDGNDMXXXXXXXXXXXVPPTPRSEGEILRSPNLKSFSF 64
S+RI A+ ++ +SS + SS ND TPRSEGE+L SP LK+F+F
Sbjct: 21 SSRISAKRSQSSRLSSLTIQSSSYNDDTSVASLQ-------TPRSEGELLASPTLKAFTF 73
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE 124
++LKTATRNFRPDSV+GEGGFG V+KGWIDE + + +KPG+GMV+AVK+L ++GFQGH++
Sbjct: 74 NELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVVAVKKLKEEGFQGHRQ 133
Query: 125 WLAEVNYLGQLYHPNLVKLVGYCLEDDH-RLLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
WLAEV+ LG+L+H NLVKL+GYC + DH RLLVYE+MP+GSLENHLFRRG+ +P+ W
Sbjct: 134 WLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHLFRRGA--EPIPWRT 191
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
R+KVA+GAA+G+AFLH E +VIYRDFK SNILLD+ +NAKLSDFGLAK GPTGD++HVS
Sbjct: 192 RIKVAIGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVS 249
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303
T+VMGT GYAAPEY+ATG +TAKSDVYSFGVVLLE+LSGR VDK + E NLV+WA P
Sbjct: 250 TQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGVERNLVDWAIP 309
Query: 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363
YL KRK+FRI+D +L GQY +GA A AL+CL+ E K RP M++V++ LE+L+ +
Sbjct: 310 YLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLSTLEELEMTL 369
Query: 364 ETGNI 368
++G+I
Sbjct: 370 KSGSI 374
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1155 (411.6 bits), Expect = 3.0e-117, P = 3.0e-117
Identities = 220/349 (63%), Positives = 268/349 (76%)
Query: 17 TGVSSKYVSSDGND-----MXXXXXXXXXXXVPPTPRSEGEILRSPNLKSFSFSDLKTAT 71
T + SK + ND + TP E+ S +L+ F+F+DLK +T
Sbjct: 80 TTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLST 139
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
RNFRP+S+LGEGGFG VFKGWI+E+ A KPGTG+ +AVK LN DG QGHKEWLAE+N+
Sbjct: 140 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINF 199
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
LG L HPNLVKLVGYC+EDD RLLVYEFMPRGSLENHLFRR PL W++R+K+ALGA
Sbjct: 200 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---PLPWSIRMKIALGA 256
Query: 192 AKGVAFLHGAETK-VIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
AKG++FLH K VIYRDFKTSNILLD +YNAKLSDFGLAKD P ++HVSTRVMGTY
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 316
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
GYAAPEY+ TGHLT+KSDVYSFGVVLLEML+GRR++DKNRP+GEHNLVEWA+P+L KR+
Sbjct: 317 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRR 376
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
+R++D RLEG ++++GA K LA +CLS + K RP M++VV L+ L
Sbjct: 377 FYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1153 (410.9 bits), Expect = 4.9e-117, P = 4.9e-117
Identities = 213/319 (66%), Positives = 270/319 (84%)
Query: 46 TPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGT 105
TPRSEGE+L SP LK+F+F++LKTATRNF+P+S++GEGGFG V+KGWI E S + +KPG+
Sbjct: 56 TPRSEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGS 115
Query: 106 GMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSL 165
GMV+AVK+L +GFQGHKEWL EV+YLG+L+H NLVKL+GYCLE + RLLVYE+MP+GSL
Sbjct: 116 GMVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSL 175
Query: 166 ENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225
ENHLFRRG+ +P+ W R+KVA AA+G++FLH E KVIYRDFK SNILLD ++NAKL
Sbjct: 176 ENHLFRRGA--EPIPWKTRMKVAFSAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKL 231
Query: 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA 285
SDFGLAK GPTGD++HV+T+V+GT GYAAPEY+ATG LT+KSDVYSFGVVLLE+LSGR
Sbjct: 232 SDFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPT 291
Query: 286 VDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKF 345
+DK++ E NLV+WA PYL +RK+FRI+D +L GQY +GA AA +ALRCL+TE K
Sbjct: 292 LDKSKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKL 351
Query: 346 RPMMAEVVTVLEQLQDSSE 364
RP MA+V++ L+QL+ SS+
Sbjct: 352 RPDMADVLSTLQQLETSSK 370
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 1.3e-116, P = 1.3e-116
Identities = 224/361 (62%), Positives = 271/361 (75%)
Query: 4 CLSARIKAESPFN-TGVSS---KYVSSDGNDMXXXXXXXXXXXVPPTPRSEGEILRSPNL 59
C+S+R K +S N T V + K + TP GE+ S L
Sbjct: 29 CISSRSKVDSSMNATAVIAEPKKVIEKLEGHPAPTKDTGCAESGSSTPLMSGELKYSSKL 88
Query: 60 KSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF 119
+ F F+DLK ATRNFRP+S+LGEGGFG VFKGWI+E+ A KPGTG+ +AVK LN DG
Sbjct: 89 RIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGL 148
Query: 120 QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL 179
QGHKEWLAE+N+LG L HP+LVKLVGYC+E+D RLLVYEFMPRGSLENHLFRR PL
Sbjct: 149 QGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTL---PL 205
Query: 180 SWNLRLKVALGAAKGVAFLHG-AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD 238
W++R+K+ALGAAKG+AFLH AE VIYRDFKTSNILLD YNAKLSDFGLAKD P
Sbjct: 206 PWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEK 265
Query: 239 QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298
+SHVSTRVMGTYGYAAPEY+ TGHLT KSDVYSFGVVLLE+L+GRR+VDK+RP+GE NLV
Sbjct: 266 KSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLV 325
Query: 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358
EW +P+L K++ +R++D RLEG Y+++GA KA +A +CL+ + K RP M+EVV L+
Sbjct: 326 EWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKP 385
Query: 359 L 359
L
Sbjct: 386 L 386
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P46573 | APK1B_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7200 | 0.9851 | 0.9660 | no | no |
| Q06548 | APK1A_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7248 | 0.9801 | 0.9658 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00011608 | hypothetical protein (405 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 404 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-55
Identities = 77/223 (34%), Positives = 114/223 (51%), Gaps = 26/223 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNYLGQLYHP 138
LGEGGFG+V+ A TG +A+K + ++ E L E+ L +L HP
Sbjct: 1 LGEGGFGTVYL---------ARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+VKL G +++H LV E+ GSL++ L LS + L++ L +G+ +L
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYL 108
Query: 199 HGAETKVIYRDFKTSNILLD-TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
H +I+RD K NILLD N KL+DFGL+K + ++GT Y APE
Sbjct: 109 H--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEV 164
Query: 258 L-ATGHLTAKSDVYSFGVVLLEMLSGRRAVDK-------NRPS 292
L G+ + KSD++S GV+L E+ + + K RPS
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPS 207
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 80/213 (37%), Positives = 113/213 (53%), Gaps = 20/213 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNY 131
+ LG G FG+V+K A GTG ++AVK L + + + E+
Sbjct: 1 YELLRKLGSGSFGTVYK---------AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L +L HPN+V+L+ + DH LV E+ G L ++L R G PLS + K+AL
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQI 107
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+G+ +LH +I+RD K NILLD N K++DFGLAK S ++T V GT
Sbjct: 108 LRGLEYLHSN--GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPW 163
Query: 252 YAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGR 283
Y APE L G K DV+S GV+L E+L+G+
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 8e-49
Identities = 74/206 (35%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL 135
LGEG FG V+KG + G + +AVK L +D Q +E+L E + +L
Sbjct: 4 GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HPN+VKL+G C E++ ++V E+MP G L ++L + LS + L AL A+G+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGM 116
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
+L I+RD N L+ N K+SDFGL++D D + + AP
Sbjct: 117 EYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAP 173
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLS 281
E L G T+KSDV+SFGV+L E+ +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 9e-49
Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 12/206 (5%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL 135
LGEG FG V+KG + + +AVK L +D Q +E+L E + +L
Sbjct: 4 GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HPN+VKL+G C E++ +V E+M G L ++L + LS + L AL A+G+
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGM 115
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
+L I+RD N L+ N K+SDFGL++D D + + AP
Sbjct: 116 EYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAP 172
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLS 281
E L G T+KSDV+SFGV+L E+ +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 72/211 (34%), Positives = 109/211 (51%), Gaps = 23/211 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
LGEG FG V+KG + GT +AVK L + + +E+L E + + +L H
Sbjct: 6 KLGEGAFGEVYKGTLKG-----DGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PN+V+L+G C + + +V E+MP G L + L + G + L+ L++AL AKG+ +
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEY 117
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST------RVMGTYG 251
L ++RD N L+ N K+SDFGL++D D + M
Sbjct: 118 LE--SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM---- 171
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE L G T+KSDV+SFGV+L E+ +
Sbjct: 172 --APESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNYL 132
+ LGEG FG V+ A TG ++A+K + + + +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYL---------ARDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+L HPN+V+L ++D LV E+ G L + L +RG LS +
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG----RLSEDEARFYLRQIL 107
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+ +LH +++RD K NILLD + + KL+DFGLA+ ++T V GT Y
Sbjct: 108 SALEYLHSK--GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEY 162
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L D++S GV+L E+L+G+
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 93/295 (31%), Positives = 136/295 (46%), Gaps = 50/295 (16%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYH 137
LGEG FG V+KG K G +AVK L +D + K++L E + +L H
Sbjct: 2 KLGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH 55
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-----FRRGSYFQPLSWNLRLKVALGAA 192
PN+V+L+G C E++ LV E+M G L ++L LS L A+ A
Sbjct: 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST------RV 246
KG+ +L K ++RD N L+ + K+SDFGL++D D T R
Sbjct: 116 KGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY-- 304
M APE L G T+KSDV+SFGV+L E+ + G A PY
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFTL----------G-------ATPYPG 210
Query: 305 LASKRKIFRIID-NRLE-GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357
L+++ + + RL +Y + Y+ L L C + + RP +E+V LE
Sbjct: 211 LSNEEVLEYLRKGYRLPKPEYCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-36
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
F +G+GGFG V+K TG +A+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
+ HPN+VK G L+ D +V EF GSL++ L + S Q L+ + V K
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLK--STNQTLTESQIAYVCKELLK 109
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ +LH +I+RD K +NILL ++ KL DFGL+ + ++GT +
Sbjct: 110 GLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWM 164
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE + K+D++S G+ +E+ G+
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLY 136
+LG G FGSV+ A TG ++AVK L+ D + + E+ L L
Sbjct: 7 LLGRGSFGSVY---------LALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 137 HPNLVKLVGYCL--EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
HPN+V+ G E + + E++ GSL + L + F L + K +G
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEG 113
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+A+LH +++RD K +NIL+D++ KL+DFG AK + + V GT + A
Sbjct: 114 LAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
PE + +D++S G ++EM +G+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 70/208 (33%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQLYHP 138
LGEG FG V D TG +AVK LN G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYD-----PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 139 NLVKLVGYCLEDDHR---LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
N+VK G C E L+ E++P GSL ++L + Q L L + KG+
Sbjct: 67 NIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRL-LLFSSQICKGM 122
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST--RVMGTYGYA 253
+L + I+RD NIL+++ K+SDFGLAK P + + Y
Sbjct: 123 DYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLS 281
APE L T ++ SDV+SFGV L E+ +
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 22/207 (10%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
+ +G+G FG V G + K +AVK L D + +LAE + + L H
Sbjct: 12 ATIGKGEFGDVMLG-----DYRGQK------VAVKCLKDDS-TAAQAFLAEASVMTTLRH 59
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PNLV+L+G L+ + +V E+M +GSL ++L RG ++ +L AL +G+ +
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEY 117
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
L E ++RD N+L+ + AK+SDFGLAK+ Q S ++ + APE
Sbjct: 118 LE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSGKL--PVKWTAPEA 170
Query: 258 LATGHLTAKSDVYSFGVVLLEMLS-GR 283
L + KSDV+SFG++L E+ S GR
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKR--LNQDGFQGHKEWLAEVNYLGQLY 136
++G G FG V+KG ++ TG +A+K+ L + + K + E++ L L
Sbjct: 7 LIGRGAFGVVYKG-LNLE--------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
HPN+VK +G D ++ E+ GSL + + F P +L +G+A
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLA 113
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+LH E VI+RD K +NIL + KL+DFG+A D S V+GT + APE
Sbjct: 114 YLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPE 169
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ + SD++S G ++E+L+G
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 74/214 (34%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVN 130
R + VLGEG FG V + + GTG ++AVK L ++ Q + W E+N
Sbjct: 4 RYLKKIRVLGEGHFGKVSL-----YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 131 YLGQLYHPNLVKLVGYCLE--DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L LYH N+VK G C E L+ E++P GSL ++L + L+ L A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFA 113
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSH-VSTRVM 247
+G+A+LH I+RD N+LLD + K+ DFGLAK P G + + V
Sbjct: 114 QQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ A E L + SDV+SFGV L E+L+
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 23/228 (10%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
VLG G FG+V+KG WI E + +A+K L ++ + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGVWIPE------GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSL----ENHLFRRGSYFQPLSWNLRLKVALGAA 192
HP++V+L+G CL L+ + MP G L NH GS L+W +++ A
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQ-YLLNWCVQI------A 119
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
KG+++L E ++++RD N+L+ T + K++DFGLAK ++ + + +
Sbjct: 120 KGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVE 299
A E + T KSDV+S+GV + E+++ G + + +L+E
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 84/342 (24%), Positives = 139/342 (40%), Gaps = 33/342 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
++R LGEG FG V+ + ++A+K L + KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 130 NYLGQLYHP-NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L L HP N+VKL + ++ LV E++ GSLE L ++ PLS + L +
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFIL 107
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-AKLSDFGLAK----DGPTGDQSHVS 243
+ +LH +I+RD K NILLD + KL DFGLAK G T +
Sbjct: 108 AQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 244 TRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
+ +GT GY APE L + ++ SD++S G+ L E+L+G + + S +
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-- 223
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV-LEQL 359
+ + L + A+ L + L+ + K R + ++ L
Sbjct: 224 ---LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 360 QDSSETGNIRCNTHNRPKIRRHSADDARSRSVTAYPRPSASP 401
E+ + R S + +++ + S
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISG 322
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKR--LNQDGFQGHKEWLAEVN 130
+ +G+G FG V+ + G + +K L+ + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYL---------VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS----WNLRLK 186
L +L HPN++K E +V E+ G L + ++ +P + ++
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+ L + +LH K+++RD K NI L +N KL DFG++K + T V
Sbjct: 112 LCLA----LKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV 164
Query: 247 MGTYGYAAPE------YLATGHLTAKSDVYSFGVVLLEMLSGRRA 285
GT Y +PE Y KSD++S G VL E+ + +
Sbjct: 165 -GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-28
Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 26/211 (12%)
Query: 80 LGEGGFGSVFKGW-IDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G FGSV++G +D+ F A K +++ Q G + K+ E+ L +L HP
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V+ +G E+D+ + E +P GSL L + GS+ +P+ ++ L G+ +L
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEYL 118
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-----GTYGYA 253
H T ++RD K +NIL+DTN KL+DFG+AK V G+ +
Sbjct: 119 HDRNT--VHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWM 168
Query: 254 APEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
APE +A G +D++S G +LEM +G+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-28
Identities = 73/210 (34%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY 136
LG+G FG V K TG + A+K L + KE L E N L ++
Sbjct: 1 LGKGSFGKVL---------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLRLKVALGAAK 193
HP +VKL Y + + +L LV E+ P G L +HL + G + + + + + +AL
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE--- 107
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+LH +IYRD K NILLD + + KL+DFGLAK+ + +T GT Y
Sbjct: 108 ---YLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC-GTPEYL 160
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L D +S GV+L EML+G+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYH 137
LGEG FG VF G + ++AVK L + K++ E L H
Sbjct: 12 ELGEGAFGKVFLG----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF----------QPLSWNLRLKV 187
N+VK G C E D ++V+E+M G L L G L+ + L++
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
A+ A G+ +L A ++RD T N L+ + K+ DFG+++D T D V M
Sbjct: 128 AVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ PE + T +SDV+SFGVVL E+ +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNYLGQLYHP 138
+G+G FG V+KG + +AVK K +L E L Q HP
Sbjct: 3 IGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+VKL+G C++ +V E +P GSL L ++ + L+ L+++L AA G+ +L
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYL 109
Query: 199 HGAETK-VIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
E+K I+RD N L+ N K+SDFG++++ G + + APE
Sbjct: 110 ---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSG 282
L G T++SDV+S+G++L E S
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 73/209 (34%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHP 138
LG G FGSV KG K G + +AVK L Q+ G KE+L E + + QL HP
Sbjct: 3 LGHGNFGSVVKGVY------LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV-ALGAAKGVAF 197
+V+L+G C + +LV E P G L +L +R LK A A G+A+
Sbjct: 57 CIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAY 110
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG-----Y 252
L ++RD N+LL + AK+SDFG+++ G + +T T G +
Sbjct: 111 LE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKW 164
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
APE + G ++KSDV+S+GV L E S
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LG+G FG V++G K +A+K +N++ + E+L E + + +
Sbjct: 14 LGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR------GSYFQPLSWNLRLKVALGAA 192
++V+L+G L+V E M +G L+++L R P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
G+A+L A K ++RD N ++ + K+ DFG+ +D D + + +
Sbjct: 130 DGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
APE L G T KSDV+SFGVVL EM +
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 74/238 (31%), Positives = 120/238 (50%), Gaps = 30/238 (12%)
Query: 80 LGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
+G G FG V+ G W+++ +A+K + ++G ++++ E + +L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQPLSWNLRLKVALGAAKGVAF 197
LV+L G C E LV+EFM G L ++L +RG S L + L +G+A+
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAY 115
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
L + VI+RD N L+ N K+SDFG+ + DQ ST +++PE
Sbjct: 116 LE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE-------WAKPYLASK 308
+ ++KSDV+SFGV++ E+ S + +NR + E +VE KP LAS+
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETINAGFRLYKPRLASQ 228
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 72/209 (34%), Positives = 112/209 (53%), Gaps = 25/209 (11%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
++GEG FG+V +G E+ TG +AVK + D + +L E + +L+H
Sbjct: 12 EIIGEGEFGAVLQG---EY--------TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
NLV+L+G L + +V E M +G+L N L RG + L+ +L A+G+ +
Sbjct: 59 KNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGMEY 115
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG-DQSHVSTRVMGTYGYAAPE 256
L K+++RD NIL+ + AK+SDFGLA+ G G D S + + + APE
Sbjct: 116 LE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE 167
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLSGRRA 285
L ++KSDV+S+GV+L E+ S RA
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 79/289 (27%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 80 LGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYH 137
LG+G FG V +G W +T G + +AVK L D ++L E + L H
Sbjct: 3 LGDGSFGVVRRGEW-------STSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS--WNLRLKVALGAAKGV 195
NL++L G L ++V E P GSL + L + +S + +++A G+
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGM 110
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST---RVMGTYGY 252
+L + I+RD NILL ++ K+ DFGL + P + +V +V + +
Sbjct: 111 RYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAW 166
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA-SKRKI 311
APE L T + SDV+ FGV L EM + GE +P+ S +I
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT----------YGE-------EPWAGLSGSQI 209
Query: 312 FRIIDNRLE----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356
+ ID E + + Y + L+C + RP A + L
Sbjct: 210 LKKIDKEGERLERPEACPQDIY---NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPG-TGMVIAVKRLNQDGFQGHKEW--LAEVNYLG 133
+ V+G G FG V +G + PG + +A+K L + G + L E + +G
Sbjct: 9 EKVIGGGEFGEVCRGRL-------KLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMG 60
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
Q HPN+++L G + +++ E+M GSL+ L F + + G A
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIAS 117
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG-- 251
G+ +L +E ++RD NIL+++N K+SDFGL S TY
Sbjct: 118 GMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGL---------SRRLEDSEATYTTK 166
Query: 252 -------YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE +A T+ SDV+SFG+V+ E++S
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 74 FRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
F + LG G FG V++G W + + +A+K L D +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+L H +L+ L C + ++ E M +GSL F R Q L + +A A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVA 114
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+G+A+L E I+RD NIL+ + K++DFGLA+ + ++S+ Y +
Sbjct: 115 EGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKW 170
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
APE + G + KSDV+SFG++L EM +
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHP 138
LGEG FG V+KG + + +A+K L ++ + +E+ E + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR------------GSYFQPLSWNLRLK 186
N+V L+G C ++ +++E++ G L L R + L + L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+A+ A G+ +L + ++RD N L+ K+SDFGL++D + D V ++
Sbjct: 129 IAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ + PE + G T +SD++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGT-----GMVIAVKRLNQDG-FQGHKEWLAEVNYLG 133
+G+G FG VF+ A PG ++AVK L ++ ++ E +
Sbjct: 13 IGQGAFGRVFQ---------ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQ---------------- 177
+ HPN+VKL+G C L++E+M G L L R Q
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 178 --PLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235
PLS +L +A A G+A+L +E K ++RD T N L+ N K++DFGL+++
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ D S + PE + T +SDV+++GVVL E+ S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 84/274 (30%), Positives = 126/274 (45%), Gaps = 41/274 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMV-IAVKRLNQDGF-QGHKEWLAEVNYLGQLYH 137
LG G FG V++G + PG+G + +AVK L + Q KE+L E + + H
Sbjct: 3 LGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR-RGSYFQP--LSWNLRLKVALGAAKG 194
PN+VKL+G CL ++ + ++ E M G L ++L R F P L+ L + L AKG
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 195 VAFLHGAETKVIYRDFKTSNILL-----DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
+L + I+RD N L+ D + K+ DFGLA+D D +
Sbjct: 119 CVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS---------------------GRRAVDK 288
+ APE L G T +SDV+SFGV++ E+L+ GR +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236
Query: 289 NRPSGEHNLVE--WAKPYLASKRKIFRIIDNRLE 320
N P + L+ WA+ S+R F I L+
Sbjct: 237 NCPDKIYQLMTNCWAQ--DPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 70/271 (25%), Positives = 119/271 (43%), Gaps = 36/271 (13%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYH 137
+G+G FG VFK + V A+K+++ +E + E L +L
Sbjct: 8 IGKGSFGVVFK---------VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQPLSWNLRLKVALGAAKGVA 196
+++ L+ +V E+ G L L +RG +PL + + + G+A
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLA 115
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
LH K+++RD K+ N+ LD N K+ D G+AK D ++ + ++GT Y +PE
Sbjct: 116 HLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPE 171
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316
KSDV++ GVVL E +G+ D N + L+ KI R +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKIIRGVF 218
Query: 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347
+ Y+ + A L +CL+ + + RP
Sbjct: 219 PPVSQMYSQQ----LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 87/309 (28%), Positives = 133/309 (43%), Gaps = 45/309 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNY 131
N LGEG FG V K + G V AVK L ++ ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR---LKGRAGYTTV-AVKMLKENASSSELRDLLSEFNL 56
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL---------------FRRGSYF 176
L Q+ HP+++KL G C +D LL+ E+ GSL + L R SY
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 177 -----QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
+ L+ + A ++G+ +L AE K+++RD N+L+ K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNR 290
+D D ++ + A E L T +SDV+SFGV+L E+++ G
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 291 PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350
P NL L + ++ R +N E Y L L C E RP A
Sbjct: 235 PERLFNL-------LKTGYRMER-PENCSEEMY---------NLMLTCWKQEPDKRPTFA 277
Query: 351 EVVTVLEQL 359
++ LE++
Sbjct: 278 DISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 69/215 (32%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-----NQDGFQGHKEWL-AEVNYL 132
VLG+G +G+V+ G + G +IAVK++ N + E L EV+ L
Sbjct: 7 VLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
L H N+V+ +G CL+D+ + EF+P GS+ + L R G +P+ ++
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----L 112
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD----GPTGDQSHVSTRVMG 248
GVA+LH V++RD K +N++L N KL DFG A+ G G S++ + G
Sbjct: 113 DGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T + APE + KSD++S G + EM +G+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 53/241 (21%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL---AEV 129
+F+ ++GEG F +V A + T A+K L+ K L +V
Sbjct: 2 DFKFGKIIGEGSFSTVVL---------AKEKETNKEYAIKILD-------KRQLIKEKKV 45
Query: 130 NY-------LGQL-YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS 180
Y L +L HP ++KL Y +D+ L V E+ P G L ++ + GS L
Sbjct: 46 KYVKIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LD 100
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD-- 238
A + +LH +I+RD K NILLD + + K++DFG AK
Sbjct: 101 EKCTRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158
Query: 239 ------------QSHVSTR----VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
Q + R +GT Y +PE L SD+++ G ++ +ML+G
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
Query: 283 R 283
+
Sbjct: 219 K 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 42/295 (14%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLY 136
+LGEG FGSV +G + + G+ + +AVK + D +E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLSQDD------GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 137 HPNLVKLVGYCLEDDHR------LLVYEFMPRGSLENHLFRRGSYFQPLSWNLR--LKVA 188
HPN++KL+G C E +++ FM G L + L P L+ LK
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD---QSHVSTR 245
+ A G+ +L + I+RD N +L + ++DFGL+K +GD Q ++
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305
+ + A E LA T+KSDV++FGV + E+ + R H + + YL
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYD----YL 228
Query: 306 ASKRKIFRIIDNRL-EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
NRL + + L+ Y L C + K RP ++ VLE +
Sbjct: 229 --------RHGNRLKQPEDCLDELYD---LMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 82/301 (27%), Positives = 141/301 (46%), Gaps = 43/301 (14%)
Query: 80 LGEGGFGSVFKGWID--------EHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVN 130
LGEG FG V + + F K G +++AVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRK-GRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR--------GSYFQP---- 178
L +L PN+++L+G C+++D ++ E+M G L L G+ P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 179 ---LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235
+S++ L VAL A G+ +L + ++RD T N L+ N K++DFG++++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE- 294
GD + R + + A E + G T SDV++FGV L E+L + K +P GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGEL 245
Query: 295 --HNLVEWAKPYLA-SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351
++E A + R+++ +G Y+ L L+C S + + RP ++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYE---LMLQCWSRDCRERPSFSD 297
Query: 352 V 352
+
Sbjct: 298 I 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 80 LGEGGFGSVF----KGWIDEHSFAATK-PGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLG 133
LGEG FG V +G + A + G +++AVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQ--------PLSWNLRL 185
+L +PN+++L+G C+ DD ++ E+M G L L +R +S L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
+A+ A G+ +L A ++RD T N L+ +Y K++DFG++++ +GD + R
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ + A E + G T SDV++FGV L EM +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 8e-24
Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 27/213 (12%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL--NQDGFQGHKEWLAEVNYLGQL 135
V+GEG +G V K TG ++A+K+ ++D K L EV L QL
Sbjct: 7 GVVGEGAYGVVLK---------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLEN-HLFRRG---SYFQPLSWNLRLKVALGA 191
H N+V L LV+E++ R LE G + W L
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL-------- 109
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+ +A+ H +I+RD K NIL+ + KL DFG A+ S ++ V T
Sbjct: 110 LQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW 166
Query: 252 YAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGR 283
Y APE L K DV++ G ++ E+L G
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
S LGEG GSV K + TGM+ A+K + D K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 137 HPNLVKLVGYCLEDDHRLL--VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
P +VK G L++ + E+ GSL++ + + + K+A KG
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+++LH K+I+RD K SNILL KL DFG++ + S T GT Y A
Sbjct: 118 LSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN---SLAGTFT-GTSFYMA 171
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
PE + + SDV+S G+ LLE+ R
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 77/288 (26%), Positives = 141/288 (48%), Gaps = 39/288 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMV-IAVKRLNQDGF--QGHKEWLAEVNYLGQL 135
V+G G FG VF+G + PG V +A+K L + G+ + +++L+E + +GQ
Sbjct: 12 VIGAGEFGEVFRGIL-------KMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASIMGQF 63
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
H N+++L G + +++ E+M G+L+ +L F L+ G A G+
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGM 120
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRVMGTYGY 252
+L ++ ++RD NIL+++N K+SDFGL++ D P G + ++ +
Sbjct: 121 KYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRW 176
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL-ASKRKI 311
APE +A T+ SDV+SFG+V+ E++S GE +PY S ++
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEV 219
Query: 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
+ I++ ++ L L+C + RP ++V +L++L
Sbjct: 220 MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA--EVNYLGQL 135
+GEG G V+K AT TG +A+K++ + + L E+ +
Sbjct: 25 EKIGEGASGEVYK---------ATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDC 72
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HPN+V L D +V E+M GSL + + + F ++ V +G+
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGL 129
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
+LH VI+RD K+ NILL + + KL+DFG A S V+GT + AP
Sbjct: 130 EYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAP 185
Query: 256 EYLATGHL-TAKSDVYSFGVVLLEMLSG 282
E + K D++S G++ +EM G
Sbjct: 186 E-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 88/290 (30%), Positives = 127/290 (43%), Gaps = 58/290 (20%)
Query: 80 LGEGGFGSVFKGW-IDEHSFAATKPGTGMVIAVKRLN-QDGFQG-HKEWLAEVNYLGQLY 136
+G G FG V+ +D TG ++AVK + QD KE E+ L L
Sbjct: 8 IGGGTFGKVYTAVNLD----------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV----ALGAA 192
HPNLVK G + + + E+ G+LE L G L V L
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGR-------ILDEHVIRVYTLQLL 109
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRVMGT 249
+G+A+LH +++RD K +NI LD N KL DFG A + T V + + GT
Sbjct: 110 EGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGT 166
Query: 250 YGYAAPEYL----ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP-SGEHNLVEWAKPY 304
Y APE + GH A +D++S G V+LEM +G+ RP S N E+ +
Sbjct: 167 PAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGK------RPWSELDN--EFQIMF 217
Query: 305 -LASKRK--IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351
+ + K I + EG+ L+ RCL ++ K RP +E
Sbjct: 218 HVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 80 LGEGGFGSV-------FKGWIDE-HSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVN 130
LGEG FG V + + ++ + +V AVK L D +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLV-AVKVLRPDASDNAREDFLKEVK 71
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR-------GSYFQPLSWNL 183
L +L PN+ +L+G C D ++ E+M G L L + + LS++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
L +A A G+ +L ++RD T N L+ NY K++DFG++++ + D V
Sbjct: 132 LLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
R + A E + G T KSDV++FGV L E+L+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 7e-23
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 47/222 (21%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW------LAEVNYLG 133
+GEG +G V+K A TG ++A+K++ + +++ + E+ L
Sbjct: 7 IGEGTYGQVYK---------ARNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQ 53
Query: 134 QLYHPNLVKLVGYCLEDDHR--LLVYEFMP---RGSLENHLFRRG-----SYFQPLSWNL 183
+L HPN+V+L +V+E+M G L++ + Y + L
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL---- 109
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
+G+ +LH +++RD K SNIL++ + KL+DFGLA+ T S
Sbjct: 110 --------LEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADY 158
Query: 244 TRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
T + T Y PE L AT + D++S G +L E+ G+
Sbjct: 159 TNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 9e-23
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNY 131
LG G G V K +P TG ++AVK RL + K+ L E++
Sbjct: 3 LEYLGELGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINE-AIQKQILRELDI 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF--QPLSWNLRLKVAL 189
L + P +V G + + E+M GSL+ L + L K+A+
Sbjct: 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAV 107
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-- 247
KG+ +LH + K+I+RD K SNIL+++ KL DFG VS +++
Sbjct: 108 AVLKGLTYLH-EKHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNS 154
Query: 248 ------GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GT Y APE + + KSD++S G+ L+E+ +GR
Sbjct: 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LGEG FG VF + ++ + TK M++AVK L K++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF------QPLSWN------LRLKV 187
+VK G C + D ++V+E+M G L L G QP L +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
A A G+ +L A ++RD T N L+ N K+ DFG+++D + D V M
Sbjct: 129 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ PE + T +SDV+SFGV+L E+ +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 69/205 (33%), Positives = 107/205 (52%), Gaps = 19/205 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYH 137
+LG+G FG VFKG + + + +AVK +D Q K ++L+E L Q H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PN+VKL+G C + +V E +P G + L ++ L +K AL AA G+A+
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAY 108
Query: 198 LHGAETK-VIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
L E+K I+RD N L+ N K+SDFG+++ G S + + + APE
Sbjct: 109 L---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPE 164
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS 281
L G +++SDV+S+G++L E S
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQLY 136
VLG+G G V+K KP TG + A+K+++ DG + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYK--------VRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
P +VK G + + +V E+M GSL + L + G + + +A KG+
Sbjct: 58 SPYVVKCYG-AFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGL 112
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
+LH + +I+RD K SN+L+++ K++DFG++K +T V GT Y +P
Sbjct: 113 DYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSP 169
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSGR 283
E + + +D++S G+ LLE G+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
+ + +G+G FG V G ++ G +AVK + D + +LAE +
Sbjct: 6 KELKLLQTIGKGEFGDVMLG---DYR--------GNKVAVKCIKNDATA--QAFLAEASV 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ QL H NLV+L+G +E+ L +V E+M +GSL ++L RG L + LK +L
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLD 110
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTRVMGT 249
+ + +L ++RD N+L+ + AK+SDFGL K+ T D + +
Sbjct: 111 VCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---- 164
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GR 283
+ APE L + KSDV+SFG++L E+ S GR
Sbjct: 165 --WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-22
Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN--QDGFQGHKEWLA--- 127
N+R +LG+G FG V+ TG +AVK++ D + KE A
Sbjct: 3 NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVY-EFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
E+ L L H +V+ G CL DD L ++ E+MP GS+++ L G L+ + K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRK 108
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR- 245
+GV +LH +++RD K +NIL D+ N KL DFG +K T S +
Sbjct: 109 YTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
V GT + +PE ++ K+DV+S G ++EML+
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 33/286 (11%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQ-DGFQGHKEWLAEVNYLGQLY 136
V+G+G FG V+ G ID G + AVK LN+ + +++L E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 137 HPNLVKLVGYCLEDDHR-LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HPN++ L+G CL + L+V +M G L N F R P +L + L AKG+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDL-IGFGLQVAKGM 111
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD--GPTGDQSHVSTRVMGTYGYA 253
+L A K ++RD N +LD ++ K++DFGLA+D H T +
Sbjct: 112 EYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313
A E L T T KSDV+SFGV+L E+++ R ++ YL R++
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITV----YLLQGRRL-- 221
Query: 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
L+ +Y + Y+ + L C + + RP +E+V+ +EQ+
Sbjct: 222 -----LQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-22
Identities = 81/296 (27%), Positives = 144/296 (48%), Gaps = 49/296 (16%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV-IAVKRLNQDGFQGH--KEWLAEVNYLG 133
+ V+G G FG V +G + PG + +A+K L + G+ +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKL-------PGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMG 60
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
Q HPN++ L G + +++ EFM G+L++ L + F + L+ G A
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAA 117
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTGDQSHVSTRVMG--- 248
G+ +L +E ++RD NIL+++N K+SDFGL++ + T D ++ S+ +G
Sbjct: 118 GMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKI 173
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL-AS 307
+ APE +A T+ SDV+S+G+V+ E++S GE +PY S
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWDMS 216
Query: 308 KRKIFRIIDNRLEGQYTLEGAYKAAT----LALRCLSTEGKFRPMMAEVVTVLEQL 359
+ + N +E Y L T L L C + RP ++V+ L+++
Sbjct: 217 NQDVI----NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ----DGFQGHKEWLAEVNYLGQL 135
+GEG +G V+K TG ++A+K++ +G K L E+ L +L
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIP--KTALREIKLLKEL 55
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLEN--HLFRRGSYFQPLSWNLRLKVALGAAK 193
HPN++KL+ LV+EFM + L + L +L +
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQR--GLPESLIKSYLYQLLQ 109
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTGDQSH-VSTRVMGTY 250
G+AF H +++RD K N+L++T KL+DFGLA+ P +H V TR
Sbjct: 110 GLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR----- 162
Query: 251 GYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L + D++S G + E+LS R
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-22
Identities = 89/321 (27%), Positives = 147/321 (45%), Gaps = 39/321 (12%)
Query: 50 EGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVI 109
E + S KS + +D+ ++ + ++V+ G G+ +KG GM
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKG---------KSIKNGMQF 718
Query: 110 AVKRLNQ-DGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENH 168
VK +N + +E+ +G+L HPN+VKL+G C + L++E++ +L
Sbjct: 719 VVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773
Query: 169 LFRRGSYFQPLSWNLRLKVALGAAKGVAFLH-GAETKVIYRDFKTSNILLDTNYNAKLSD 227
L + LSW R K+A+G AK + FLH V+ + I++D L
Sbjct: 774 L-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
L+ G T+ + Y APE T +T KSD+Y FG++L+E+L+G+ D
Sbjct: 826 --LSLPGLLC----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
Query: 288 KNRPSGEH-NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEG--AYKAATLALRCLSTEGK 344
G H ++VEWA+ Y S + ID + G ++ + LAL C +T+
Sbjct: 880 AE--FGVHGSIVEWAR-YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPT 936
Query: 345 FRPMMAEVVTVLEQLQDSSET 365
RP +V+ LE SS +
Sbjct: 937 ARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-22
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 63/297 (21%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ------DGFQGHKEWLAEVNYL 132
LG G F S + A TG ++AVK++ + + + E+ +
Sbjct: 7 QLGTGAFSSCY---------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM 57
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+L HP++++++G ED H L E+M GS+ + L S + + +
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLL 113
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLD-TNYNAKLSDFG----LAKDGPTGDQSHVSTRVM 247
+G+++LH E ++I+RD K +N+L+D T +++DFG LA G + +++
Sbjct: 114 RGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLL 169
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307
GT + APE L DV+S G V++EM + + P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK------PPWNAEK----------- 212
Query: 308 KRKIFRIIDNRLEGQYTLEGAYKAATL-----------ALRCLSTEGKFRPMMAEVV 353
N L + + A A ++ LRCL + + RP E++
Sbjct: 213 -------HSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 9e-22
Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYH 137
LG G FG V++G A + + +AVK L + Q ++L E + + H
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR-RGSYFQPLSWNLR--LKVALGAAKG 194
N+V+L+G E R ++ E M G L++ L R +P S ++ L A AKG
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 195 VAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+L E I+RD N LL AK++DFG+A+D R M
Sbjct: 129 CKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ PE G T+K+DV+SFGV+L E+ S
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG G FG V+ G T GT V AVK L G + +L E + +L H
Sbjct: 14 LGAGQFGEVWMG---------TWNGTTKV-AVKTLKP-GTMSPEAFLQEAQIMKKLRHDK 62
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
LV+L C E++ +V E+M +GSL + L L + +A A+G+A+L
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE 120
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLA---KDGPTGDQSHVSTRVMGT---YGYA 253
I+RD NIL+ N K++DFGLA +D + R G +
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARLIED------DEYTAR-EGAKFPIKWT 171
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLS-GR 283
APE G T KSDV+SFG++L E+++ GR
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 1e-21
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 34/220 (15%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQ--DGFQGHKEWLAEV 129
+ LGEG +G V+K D+ TG ++A+K RL+ +G L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKK--------TGEIVALKKIRLDNEEEGIP--STALREI 49
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMP---RGSLENHLFRRGSYFQPLSWNLRLK 186
+ L +L HPN+VKL+ + LV+E+ + L+ PLS NL
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR-------PGPLSPNLIKS 102
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTR 245
+ +G+A+ H ++++RD K NIL++ + KL+DFGLA+ G +
Sbjct: 103 IMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THE 158
Query: 246 VMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
V+ T Y APE L + + TA D++S G + EM++G+
Sbjct: 159 VV-TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKR--LNQDGFQGHKEWL--------AE 128
++G+G +G V+ A TG ++AVK+ L H +E
Sbjct: 8 LIGKGTYGRVY---------LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
+ L L H N+V+ +G+ +++ + E++P GS+ + L G + + L +V
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+G+A+LH +++RD K N+L+D + K+SDFG++K + + + G
Sbjct: 119 ----EGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 249 TYGYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGRR 284
+ + APE + + +AK D++S G V+LEM +GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG G +G V++G ++ + +AVK L +D + E+L E + ++ HPN
Sbjct: 14 LGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
LV+L+G C + ++ EFM G+L ++L Q ++ + L +A + + +L
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE 121
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
+ I+RD N L+ N+ K++DFGL++ TGD + APE LA
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 260 TGHLTAKSDVYSFGVVLLEM 279
+ KSDV++FGV+L E+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 80 LGEGGFGSV----FKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL 135
LG G FG V ++G ID +A+K + + G +++ E + +L
Sbjct: 12 LGSGQFGVVHLGKWRGKID--------------VAIKMIRE-GAMSEDDFIEEAKVMMKL 56
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HPNLV+L G C + +V E+M G L N+L R L + + +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAM 113
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRVMGTYGY 252
+L I+RD N L+ + K+SDFGLA+ D DQ S +
Sbjct: 114 EYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKW 167
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
A PE ++KSDV+SFGV++ E+ S
Sbjct: 168 APPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
F LGEG +GSV+K A TG V+A+K + + +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYK---------AIHKETGQVVAIKVVPVEE--DLQEIIKEISILK 53
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
Q P +VK G ++ +V E+ GS+ + + L L K
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL---K 110
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA-KDGPTGDQSHVSTRVMGTYGY 252
G+ +LH K I+RD K NILL+ AKL+DFG++ + T + + V+GT +
Sbjct: 111 GLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFW 165
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE + K+D++S G+ +EM G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 74/229 (32%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
R+ + LG+G FGSV D + TG V+AVK+L + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 132 LGQLYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L L H N+VK G C R LV E++P GSL ++L + L A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL---LLYAS 115
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG- 248
KG+ +L + ++RD T NIL+++ K+ DFGL K P D+ + R G
Sbjct: 116 QICKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGE 172
Query: 249 --TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR-PSGE 294
+ YA PE L + SDV+SFGVVL E+ + DK+ P E
Sbjct: 173 SPIFWYA-PESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LGEG FG VF + +++AVK L K++ E L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHL---------FRRGSYFQPLSWNLRLKVALG 190
+VK G C+E D ++V+E+M G L L G+ L+ + L +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
A G+ +L A ++RD T N L+ N K+ DFG+++D + D V M
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ PE + T +SDV+S GVVL E+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-21
Identities = 79/296 (26%), Positives = 142/296 (47%), Gaps = 43/296 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV-IAVKRLNQDGF--QGHKEWLAEV 129
+ + V+G G FG V G + PG + +A+K L + G+ + +++L+E
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRL-------KLPGKREIPVAIKTL-KAGYTEKQRRDFLSEA 56
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
+ +GQ HPN++ L G + ++V E+M GSL+ L + F + L+
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR--- 113
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRV 246
G A G+ +L ++ ++RD NIL+++N K+SDFGL++ D P + ++ +
Sbjct: 114 GIASGMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--EAAYTTRGG 169
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL- 305
+ APE +A T+ SDV+S+G+V+ E++S GE +PY
Sbjct: 170 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWE 212
Query: 306 ASKRKIFRIIDN--RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
S + + + I+ RL A L L C + RP ++V++L++L
Sbjct: 213 MSNQDVIKAIEEGYRLPAPMDCPAALH--QLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 71/223 (31%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAE 128
+F LG G FG V K +G A+K L++ K+ L E
Sbjct: 1 DDFEFIKTLGTGSFGRVM--------LVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNE 51
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
L + HP LV L G +DD L LV E++P G L +HL + G V
Sbjct: 52 KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSG--------RFPEPV 102
Query: 188 ALGAAKGVA----FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
A A V +LH + ++YRD K N+LLD++ K++DFG AK V
Sbjct: 103 ARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVK 152
Query: 244 TRVM---GTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSG 282
R GT Y APE L+ G+ A D ++ G+++ EML+G
Sbjct: 153 GRTYTLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-21
Identities = 70/215 (32%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---------QGHKEWLAEV 129
VLG+G FG V A GT + AVK L +D K LA
Sbjct: 2 VLGKGSFGKVL---------LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
HP L +L D V E++ G L H+ R G + +P + ++ L
Sbjct: 53 GK-----HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL 107
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-G 248
G + FLH E +IYRD K N+LLD+ + K++DFG+ K+G G V+T G
Sbjct: 108 G----LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCG 158
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T Y APE L+ D ++ GV+L EML+G+
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLY 136
LG+GGFG V A TG + A K+L++ +G + L E L ++
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK-- 193
+V L Y E D LV M G L+ H++ G P + + AA+
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA-----RAIFYAAQII 105
Query: 194 -GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
G+ LH + +++YRD K N+LLD + N ++SD GLA + G + GT GY
Sbjct: 106 CGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGY 160
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L D ++ G L EM++GR
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN----QDGFQGHKEWLAEVNYLGQL 135
+GEG G VFK A TG +A+K++ + G + L E+ L
Sbjct: 8 IGEGAHGIVFK---------AKDRETGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HP +VKL+ +LV E+MP L L +++ L KGV
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGV 112
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTGDQ-SH-VSTRVMGTYG 251
A++H +++RD K +N+L+ + K++DFGLA+ SH V+TR
Sbjct: 113 AYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----W 165
Query: 252 YAAPEYL-ATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L D+++ G + E+L+G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 80 LGEGGFGSV-------FKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNY 131
LGEG FG V + ++D+ +++AVK L +D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQP-------LSWNLR 184
+ +L PN+++L+ C+ D ++ E+M G L L R +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
+ +A A G+ +L + ++RD T N L+ NY K++DFG++++ +GD +
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
R + + + E + G T SDV++FGV L E+L+
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LGEG FG VF K M++AVK L + +++ E L L H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDK----MLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR------------RGSYFQPLSWNLRLKV 187
+V+ G C E L+V+E+M G L N R L+ L +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
A A G+ +L A ++RD T N L+ K+ DFG+++D + D V R M
Sbjct: 128 ASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ PE + T +SD++SFGVVL E+ +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-20
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 44/263 (16%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-----NQDGFQGHKEWLA----E 128
+++G G FGSV+ G +G ++AVK++ + + L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
+ L +L H N+V+ +G L+ DH + E++P GS+ L G++ + L N ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK----DGPTGDQSHVST 244
KG+ +LH +I+RD K +NIL+D K+SDFG++K + + +
Sbjct: 117 ----KGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR-------------RAVDKNRP 291
+ G+ + APE + T K+D++S G +++EML+G+ + + P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230
Query: 292 SGEHNLVEWAKPYLASKRKIFRI 314
N+ A +L K F I
Sbjct: 231 EIPSNISSEAIDFL---EKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWL-AEVNYLGQLY 136
+G+G FG+V K + G ++ K ++ K+ L +EVN L +L
Sbjct: 7 TIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 137 HPNLVKLVGYC----LEDDHRL-LVYEFMPRGSLEN---HLFRRGSYF-QPLSWNLRLKV 187
HPN+V+ Y + L +V E+ G L + Y + W + ++
Sbjct: 58 HPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
L A V++RD K +NI LD N N KL DFGLAK D S T V
Sbjct: 115 LL-ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYV- 171
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GT Y +PE L KSD++S G ++ E+ +
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAE----VNYLGQ 134
LG G FG V ++ ++ +K M +AVK L +E L +++LG
Sbjct: 42 TLGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
H N+V L+G C L++ E+ G L N L R+ F L+ L + AKG
Sbjct: 98 --HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKG 153
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV---STRVMGTYG 251
+AFL A I+RD N+LL K+ DFGLA+D D ++V + R+
Sbjct: 154 MAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVK 208
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE + T +SDV+S+G++L E+ S
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 71 TRNFRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAE 128
R +LG G FG+V KG WI E + +A+K + ++ G Q +E
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGD------SIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQP---LSWNLRL 185
+ +G L H +V+L+G C +L V + P GSL +H+ + P L+W +++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
AKG+ +L E ++++R+ NILL ++ +++DFG+A D+ + +
Sbjct: 119 ------AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ A E + G T +SDV+S+GV + EM+S
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA--EVN 130
+ V+G G FG V K +VI +K++ + + A E
Sbjct: 1 KYEKIRVVGRGAFGIVH--------LCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQ 51
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
L L HPN+++ LED ++V E+ P G+L ++ +R + L V +
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 191 AAKGVAFLHGAETKVI-YRDFKTSNILLDTNYNA-KLSDFGLAKDGPTGDQSHVSTRVMG 248
A LH TK+I +RD KT NILLD + K+ DFG++K +S T V+G
Sbjct: 112 LA-----LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVG 163
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD-KNRPS 292
T Y +PE KSD+++ G VL E+ S +RA + N P+
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 8e-20
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN-QDGFQGH--KEWLAEV 129
+F V+G+G FG V I + T + A+K +N Q + + L E
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQKR------DTKKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L +L HP LV L Y +D+ + LV + + G L HL ++ + + ++ +
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWIC 107
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+ +LH +I+RD K NILLD + ++DF +A + T G
Sbjct: 108 -EIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSG 161
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
T GY APE L + D +S GV E L G+R
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQL-Y 136
V+GEG FG V K I K G M A+KR+ + + H+++ E+ L +L +
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR------------GSYFQPLSWNLR 184
HPN++ L+G C + L E+ P G+L + L + S LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
L A A+G+ +L ++ + I+RD NIL+ NY AK++DFGL++ G + +V
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 245 RVMGTYG--YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ MG + A E L T SDV+S+GV+L E++S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 83 GGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQLYHPN 139
G +G VF A K TG + A+K + + + L E + L Q P
Sbjct: 4 GAYGRVF---------LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 140 LVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
+VKL Y + L LV E++P G L + L GS + ++ ++ L + +L
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYL 109
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS------TRVMGTYGY 252
H +I+RD K NIL+D+N + KL+DFGL+K G Q +++ R++GT Y
Sbjct: 110 H--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 253 AAPE-YLATGHLTAKSDVYSFGVVLLEMLSG 282
APE L GH + D +S G +L E L G
Sbjct: 168 IAPEVILGQGH-SKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQLYH 137
V+G G V+ A P +A+KR++ + Q E EV + Q H
Sbjct: 8 VIGVGATAVVYA--------AICLPN-NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PN+VK + D LV ++ GSL + + L + V KG+ +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGTYGYA 253
LH I+RD K NILL + + K++DFG LA G V +GT +
Sbjct: 118 LH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWM 173
Query: 254 APEYLATGH-LTAKSDVYSFGVVLLEMLSGR 283
APE + H K+D++SFG+ +E+ +G
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 22/207 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG G FG V+ G+ + H TK +A+K L Q G + +LAE N + QL HP
Sbjct: 14 LGAGQFGEVWMGYYNGH----TK------VAIKSLKQ-GSMSPEAFLAEANLMKQLQHPR 62
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
LV+L ++ ++ E+M GSL + L + L+ N + +A A+G+AF+
Sbjct: 63 LVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY--GYAAPEY 257
I+RD + +NIL+ K++DFGLA+ + + + R + + APE
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEA 174
Query: 258 LATGHLTAKSDVYSFGVVLLEMLS-GR 283
+ G T KSDV+SFG++L E+++ GR
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 30/221 (13%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQL 135
+ V+GEG FG V + I K G M A+K L + + H+++ E+ L +L
Sbjct: 7 EDVIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 136 -YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL------------FRRGSYFQPLSWN 182
+HPN++ L+G C + + E+ P G+L + L + L+
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
L+ A A G+ +L +E + I+RD N+L+ N +K++DFGL++ G++ +V
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173
Query: 243 STRVMGTYG--YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ MG + A E L T KSDV+SFGV+L E++S
Sbjct: 174 K-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 70/208 (33%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL-AEVNYLGQLYHP 138
LGEG FG V + + TG +AVK L + H L E+ L LYH
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 139 NLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLR--LKVALGAAKG 194
N+VK G C ED L+ EF+P GSL+ +L R + NL+ LK A+ KG
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI-----NLKQQLKYAVQICKG 121
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSH-VSTRVMGTYGYA 253
+ +L + ++RD N+L+++ + K+ DFGL K T + + V + +
Sbjct: 122 MDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLS 281
APE L SDV+SFGV L E+L+
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL---- 135
LGEG FG V K + P +AVK L D + K+ V+ + +
Sbjct: 20 LGEGAFGQVVKA----EAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIG 73
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR---GSYFQ-----PLSWNLRLK- 186
H N++ L+G C ++ +V E+ G+L + L R G Y P L K
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 187 ---VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
A A+G+ FL A K I+RD N+L+ ++ K++DFGLA+D D +
Sbjct: 134 LVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
T + APE L T +SDV+SFGV+L E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 5e-19
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 56/227 (24%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-----LAEVNYL 132
LG+G FGSV+ A TG ++A+K++ + W L EV L
Sbjct: 5 KQLGDGTFGSVYL---------ARNKETGELVAIKKMKKK----FYSWEECMNLREVKSL 51
Query: 133 GQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLF-----RRGSYFQPL---SWNL 183
+L HPN+VKL E+D V+E+M E +L+ R+G F S
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIY 106
Query: 184 RLKVALGAAKGVAFLHGAETKVIY--RDFKTSNILLDTNYNAKLSDFGLAKD----GPTG 237
++ +G+A +H K + RD K N+L+ K++DFGLA++ P
Sbjct: 107 QI------LQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156
Query: 238 DQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
D +VSTR Y APE L + ++ D+++ G ++ E+ + R
Sbjct: 157 D--YVSTR-----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 80 LGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G FG V++G W + T P +AVK L + G K++LAE + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNN------TTP-----VAVKTL-KPGTMDPKDFLAEAQIMKKLRHP 61
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
L++L C ++ +V E M GSL +L + L + +A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYL 119
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD-QSHVSTRVMGTYGYAAPEY 257
I+RD N+L+ N K++DFGLA+ ++ + + APE
Sbjct: 120 E--AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEA 175
Query: 258 LATGHLTAKSDVYSFGVVLLEMLS-GR 283
+ KSDV+SFG++L E+++ GR
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLY 136
LG+GGFG V A TG + A K+L++ + G K L E L ++
Sbjct: 1 LGKGGFGEVC---------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 137 HPNLVKLVGYCLEDD-HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
P +V L Y E H LV M G L+ H++ G + L + + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGI 108
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
LH ++YRD K N+LLD N +LSD GLA + G T+ GT GY AP
Sbjct: 109 LHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAP 163
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSGR 283
E L + D ++ G + EM++GR
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 70/219 (31%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQL-Y 136
V+GEG FG V K I K G M A+KR+ + + H+++ E+ L +L +
Sbjct: 2 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL------------FRRGSYFQPLSWNLR 184
HPN++ L+G C + L E+ P G+L + L S LS
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
L A A+G+ +L ++ + I+RD NIL+ NY AK++DFGL++ G + +V
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167
Query: 245 RVMGTYG--YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ MG + A E L T SDV+S+GV+L E++S
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGT--GMVIAVKRLNQ-DGFQGHKEWLAEVNYLGQLY 136
LGE FG ++KG H + PG ++A+K L + Q E+ E + + +L+
Sbjct: 13 LGECAFGKIYKG----HLYL---PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR-------------GSYFQPLSWNL 183
HPN+V L+G ++ +++E++ +G L L R G+ L
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
L +A+ A G+ +L + +++D NIL+ + K+SD GL+++ + D V
Sbjct: 126 FLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ + + PE + G ++ SD++SFGVVL E+ S
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 36/292 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLY 136
+LG+G FGSV + ++ G+ +AVK L D F +E+L E + +
Sbjct: 6 MLGKGEFGSV------REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 137 HPNLVKLVGYCLEDDHR------LLVYEFMPRGSLENHLF--RRGSYFQPLSWNLRLKVA 188
HPN++KL+G L + +++ FM G L L R G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+ A G+ +L + I+RD N +L+ N ++DFGL+K +GD
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308
+ A E LA T SDV++FGV + E+++ R + VE ++ Y
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENSEIY---- 225
Query: 309 RKIFRIIDNRL-EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
+ I NRL + LE Y+ L +C S E K RP + LE +
Sbjct: 226 --NYLIKGNRLKQPPDCLEDVYE---LMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY 136
+G G FG+V+ AT T V+AVK+++ G Q +++W + EV +L QL
Sbjct: 29 IGHGSFGAVY---------FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
HPN ++ G L++ LV E+ GS + L + +PL + GA +G+A
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLA 135
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+LH +I+RD K NILL KL+DFG A +S + +GT + APE
Sbjct: 136 YLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPE 187
Query: 257 YLAT---GHLTAKSDVYSFGVVLLEMLSGRRAV-DKNRPSGEHNLVEWAKPYLAS 307
+ G K DV+S G+ +E+ + + + N S +++ + P L S
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQS 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 31/245 (12%)
Query: 80 LGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G FG V G W ++ +A+K + ++G E++ E + +L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMKLSHE 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
LV+L G C + +V E+M G L N+L G FQP L++ +G+A+L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYL 116
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YGYAAP 255
+ I+RD N L+D K+SDFGL++ D + S+ +G+ ++ P
Sbjct: 117 ESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPP 170
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDK--NRPSGEH--NLVEWAKPYLASKRK 310
E L ++KSDV++FGV++ E+ S G+ ++ N + E + +P+LAS+ K
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE-K 229
Query: 311 IFRII 315
++ I+
Sbjct: 230 VYAIM 234
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 73 NFRPDSVLGEGGFGSVFK-GWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
+F+ LG+G +GSV+K + ++ F A K + + ++Q + ++ + E+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK-----EVDLGSMSQ---KEREDAVNEIRI 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L + HPN++ L+ + +V E+ P G L + +R + + ++ +
Sbjct: 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+G+ LH E K+++RD K++NILL N K+ D G++K + +++ +GT
Sbjct: 113 LRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPH 166
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE + KSD++S G +L EM +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN----QDGFQGHKE-------WLAE 128
LG G FG V+K K ++A+K +N G + +E ++E
Sbjct: 8 LGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFG-KDKRERDKSIGDIVSE 58
Query: 129 VNYLG-QLYHPNLVKLVGYCLEDDHRLLVYEFM---PRGSLENHLFRRGSYF-QPLSWNL 183
V + QL HPN+V+ LE+D +V + + P G N L + F + WN+
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
+++ L + +LH E ++++RD +NI+L + ++DFGLAK +S +
Sbjct: 119 FVQMVLA----LRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL- 170
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEM 279
T V+GT Y+ PE + K+DV++FG +L +M
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LGEG FGSV +G +++ M IA+ ++ +++L+E + + HPN
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE-----MEDFLSEAVCMKEFDHPN 61
Query: 140 LVKLVGYCLEDDHR------LLVYEFMPRGSLENHLF--RRGSYFQPLSWNLRLKVALGA 191
+++L+G CL+ +++ FM G L + L R G Q L + +K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
A G+ +L + I+RD N +L+ N N ++DFGL+K GD
Sbjct: 122 ASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEM 279
+ A E LA T KSDV+SFGV + E+
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHK-EWLAEVNYLGQLYH 137
LG G FG+V KG K +AVK L N + K E L E N + QL +
Sbjct: 3 LGSGNFGTVKKG------MYKMKKSE-KTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
P +V+++G C E + +LV E G L L + + L +V++G + +
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKY 110
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY--GYAAP 255
L ET ++RD N+LL T + AK+SDFGL+K D+++ + G + + AP
Sbjct: 111 LE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAP 167
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLS 281
E + ++KSDV+SFGV++ E S
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 82/259 (31%), Positives = 117/259 (45%), Gaps = 52/259 (20%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-------NQDGFQGHKEWLAEVN 130
VLG+GG+G VF+ T TG + A+K L NQ K AE N
Sbjct: 2 KVLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK---AERN 52
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLRLKV 187
L + HP +V L+ Y + +L L+ E++ G L HL R G + + + + + +
Sbjct: 53 ILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL 111
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
AL H + +IYRD K NILLD + KL+DFGL K+ V+
Sbjct: 112 ALE--------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFC 161
Query: 248 GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306
GT Y APE L +GH A D +S G ++ +ML+G A P+ A
Sbjct: 162 GTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTG------------------APPFTA 202
Query: 307 SKRKIFRIIDNRLEGQYTL 325
RK + ID L+G+ L
Sbjct: 203 ENRK--KTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 5e-18
Identities = 59/205 (28%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
VLG G FG+V+KG W+ E + +A+K LN+ G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVK------IPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
HP+LV+L+G CL +L V + MP G L +++ + + L L + AKG+
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMM 123
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+L E ++++RD N+L+ + + K++DFGLA+ ++ + + + A E
Sbjct: 124 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS 281
+ T +SDV+S+GV + E+++
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 64/221 (28%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HK 123
DL+T S LG G GSV K +H TG V+A K ++ K
Sbjct: 5 EDLETI-------SDLGAGNGGSVSKV---KHI------PTGTVMAKKVVHIGAKSSVRK 48
Query: 124 EWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
+ L E+ + + P +V G L +++ + EFM GSL+ ++++G P+ +
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG---PIPVEI 104
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ-SHV 242
K+A+ +G+ +L+ ++++RD K SNIL+++ KL DFG+ +G+ + +
Sbjct: 105 LGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSI 158
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ +GT Y +PE + G T KSDV+S G+ ++E+ G+
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----- 127
+ LGEG + V+K D+ TG ++A+K++ + K+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKA-RDKE--------TGRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
E+ L +L HPN++ L+ + LV+EFM LE + + S + L
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKS--------IVLTP 101
Query: 188 A------LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSH 241
A L +G+ +LH +++RD K +N+L+ ++ KL+DFGLA+ G +
Sbjct: 102 ADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNR 157
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKS-----DVYSFGVVLLEMLSGR 283
T + T Y APE L A+ D++S G + E+L
Sbjct: 158 KMTHQVVTRWYRAPELL----FGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 76 PDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNYLG 133
+GEG FG V++G ++ + +AVK +E +L E +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMS-------PENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL----KVAL 189
Q HP++VKL+G ++ +V E P G L SY Q ++L L +
Sbjct: 63 QFDHPHIVKLIGVI-TENPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSY 114
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV-STRVMG 248
+ +A+L + ++RD N+L+ + KL DFGL++ D+S+ +++
Sbjct: 115 QLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSR--YLEDESYYKASKGKL 170
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE + T+ SDV+ FGV + E+L
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 70/240 (29%), Positives = 103/240 (42%), Gaps = 45/240 (18%)
Query: 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ----DGFQGHKE 124
+ R++ LGEG FG V+K A + TG V+A+K++ DGF
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYK---------ARQIKTGRVVALKKILMHNEKDGF--PIT 53
Query: 125 WLAEVNYLGQLYHPNLVKLVGYCLE--DDH---RLLVYEFMP------RGSLENHLFRRG 173
L E+ L +L HPN+V L+ +E D R VY P G LEN +
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-- 111
Query: 174 SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK- 232
+ L +G+ +LH E +++RD K +NIL+D K++DFGLA+
Sbjct: 112 --LTESQIKCYMLQLL---EGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 233 --------DGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
G G + T ++ T Y PE L T D++ G V EM + R
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEV 129
+F VLG+G FG V A + GT + A+K L +D + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L P + + C + RL V E++ G L H+ + G + +P + +++
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM- 247
+G + FLH +IYRD K N++LD+ + K++DFG+ K+ V+TR
Sbjct: 112 VG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFC 162
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
GT Y APE +A D +++GV+L EML+G+ D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 71/212 (33%), Positives = 101/212 (47%), Gaps = 39/212 (18%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY 136
+G G FG+V+ A T V+A+K+++ G Q +++W + EV +L QL
Sbjct: 23 IGHGSFGAVY---------FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGS----LENHLFRRGSYFQPLSWNLRLKVALGAA 192
HPN ++ G L + LV E+ GS LE H +PL + GA
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHK-------KPLQEVEIAAICHGAL 125
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS--TRVMGTY 250
+G+A+LH E I+RD K NILL KL+DFG A S VS +GT
Sbjct: 126 QGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPANSFVGTP 175
Query: 251 GYAAPEY-LAT--GHLTAKSDVYSFGVVLLEM 279
+ APE LA G K DV+S G+ +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ-DGF 119
+F S+L+ T LG G FG VF + G ++ VK L +
Sbjct: 1 AFPRSNLQEIT-------TLGRGEFGEVFLAKAKG----IEEEGGETLVLVKALQKTKDE 49
Query: 120 QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLF-----RRGS 174
E+ E++ +L H N+V+L+G C E + ++ E+ G L+ L
Sbjct: 50 NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKL 109
Query: 175 YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234
PLS ++ + A G+ L + + ++RD N L+ + K+S L+KD
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHL--SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD- 166
Query: 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ + + + APE + + KSDV+SFGV++ E+ +
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 71/218 (32%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ---------DGFQGHKE 124
FR +VLG G FG V A K TG + A+K L + + K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 125 WLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR 184
N HP LV L +DH V E+ G L H+ + +P +
Sbjct: 52 IFETANSER---HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYA 107
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
V LG + +LH E K++YRD K N+LLDT K++DFGL K+G G ST
Sbjct: 108 ACVVLG----LQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST 160
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
GT + APE L T D + GV++ EML G
Sbjct: 161 -FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 68/233 (29%), Positives = 102/233 (43%), Gaps = 36/233 (15%)
Query: 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL 126
L T F V+GEG +G V+K + TG ++A+K ++ +E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIK 50
Query: 127 AEVNYLGQL-YHPNLVKLVGYCLEDDHRL------LVYEFMPRGS---LENHLFRRGSYF 176
E N L + HPN+ G ++ + LV E GS L L ++G
Sbjct: 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG--- 107
Query: 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
+ L + +G+A+LH E KVI+RD K NILL N KL DFG++
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-- 163
Query: 237 GDQSHVSTR--VMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSG 282
S + R +GT + APE +A A+SDV+S G+ +E+ G
Sbjct: 164 --DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG+G FG V+K A TG+ A K + + + ++++ E++ L + HPN
Sbjct: 13 LGDGAFGKVYK---------AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG-----SYFQPLSWNLRLKVALGAAKG 194
+V L ++ ++ EF G+L++ + + + + +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQM--------LEA 115
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+ FLH KVI+RD K NILL + + KL+DFG++ + Q + +GT + A
Sbjct: 116 LNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 255 PEYLATGHLT-----AKSDVYSFGVVLLEMLSGR 283
PE +A K+D++S G+ L+E+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 44/229 (19%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVN 130
NF+ +GEG +G V+K A TG V+A+K RL+ + + E++
Sbjct: 1 NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFM-----------PRGSLENHLFRRGSY-FQP 178
L +L HPN+VKL+ ++ LV+EF+ P + L + SY FQ
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQL 109
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD 238
L G+AF H +V++RD K N+L++T KL+DFGLA+ G
Sbjct: 110 LQ-------------GLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGV 152
Query: 239 QSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGRRAV 286
T + T Y APE L + + D++S G + EM++ RRA+
Sbjct: 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 24/197 (12%)
Query: 105 TGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLYHPNLVKLV--GYCLEDDHRLLVYEF 159
TG +A+K L D + + + E +LYHPN+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 160 MPRGSLENHLFRRGSYFQPLSWNLRLKV--ALGAAKGVAFLHGAETKVIYRDFKTSNILL 217
+P +L L G+ + L L+V AL A H +++RD K NI++
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ--GIVHRDLKPQNIMV 112
Query: 218 ---DTNYNAKLSDFGLAKDGP-TGD----QSHVSTRVMGTYGYAAPEYLATGHLTAKSDV 269
+AK+ DFG+ P D +T V+GT Y APE L +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 270 YSFGVVLLEMLSGRRAV 286
Y++G++ LE L+G+R V
Sbjct: 173 YAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 72/224 (32%), Positives = 99/224 (44%), Gaps = 56/224 (25%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL--NQDGFQGHKEWLAEVNYLGQLYH 137
+GEG +G VFK E TG ++A+K+ ++D K L E+ L QL H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 138 PNLVKLV-------------GYCLEDDHRLL-VYEFMPRGSLENHLFRRGSYFQPLSWNL 183
PNLV L+ YC DH +L E PRG + HL ++ + W
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRG-VPEHLIKK------IIWQT 109
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTGDQS- 240
+ V F H + I+RD K NIL+ KL DFG A+ GP D +
Sbjct: 110 --------LQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKS--DVYSFGVVLLEMLSG 282
+V+TR Y APE L G DV++ G V E+L+G
Sbjct: 160 YVATR-----WYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIA---VKRLNQDG-FQGHKEWLAEVNYLGQL 135
+G G FG V G GM A VK L +L EV +L
Sbjct: 3 IGNGWFGKVLLGEAH----------RGMSKARVVVKELRASATPDEQLLFLQEVQPYREL 52
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR-RGSYFQPLSWNLRLKVALGAAKG 194
HPN+++ +G C+E LLV EF P G L+N+L RG Q ++ ++A A G
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG------PTGDQSHVSTRVMG 248
+ +LH A+ I+ D N L + + K+ D+GLA + T D V R
Sbjct: 113 LLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--- 167
Query: 249 TYGYAAPEY-------LATGHLTAKSDVYSFGVVLLEM 279
+ APE L T KS+++S GV + E+
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 25/218 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL--NQDGFQGHKEWLA--- 127
N+R +LG G FG V+ + TG +AVK++ + D + KE A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCY---------DADTGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 128 EVNYLGQLYHPNLVKLVGYCLED--DHRLLVY-EFMPRGSLENHLFRRGSYFQPLSWNLR 184
E+ L L H +V+ G CL D + +L ++ E+MP GS+++ L G+ L+ N+
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVT 108
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
+ +GV++LH +++RD K +NIL D+ N KL DFG +K T S
Sbjct: 109 RRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 245 R-VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ V GT + +PE ++ K+DV+S ++EML+
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 22/214 (10%)
Query: 74 FRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQ-DGFQGHKEWLAEVNY 131
F+ VLG G FG+V+KG WI E + +A+K L + + +KE L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGE------KVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSL----ENHLFRRGSYFQPLSWNLRLKV 187
+ + +P++ +L+G CL +L + + MP G L H GS + L+W +++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI-- 118
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
AKG+ +L E ++++RD N+L+ T + K++DFGLAK ++ + +
Sbjct: 119 ----AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ A E + T +SDV+S+GV + E+++
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-17
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 80 LGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G FG V G W + +A+K +N+ G ++++ E + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-----------VAIKAINE-GAMSEEDFIEEAKVMMKLSHP 59
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
LV+L G C + +V EFM G L N+L +R ++ L + +G+ +L
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYL 116
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRVMGTYGYAAP 255
I+RD N L+ + K+SDFG+ + D D+ S+ ++ P
Sbjct: 117 E--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKWSPP 170
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLS 281
E ++KSDV+SFGV++ E+ +
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 71/209 (33%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQ- 134
V+G+G FG V A G AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLL---------AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN 52
Query: 135 LYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
+ HP LV L Y + +L V +++ G L HL R S+ +P + R A A
Sbjct: 53 VKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA---RFYAA-EIAS 107
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+ +LH +IYRD K NILLD+ + L+DFGL K+G + S ++ GT Y
Sbjct: 108 ALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCGTPEYL 163
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE L D + G VL EML G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 38/213 (17%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+GEG G V AT TG +AVK+++ Q + EV + HPN
Sbjct: 27 IGEGSTGIVC---------IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK------VALGAAK 193
+V++ L D +V EF+ G+L + + + R+ V L K
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLAVLK 126
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGT 249
++FLH VI+RD K+ +ILL ++ KLSDFG ++K+ P ++GT
Sbjct: 127 ALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR------RKSLVGT 178
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ APE ++ + D++S G++++EM+ G
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 9e-17
Identities = 82/292 (28%), Positives = 136/292 (46%), Gaps = 44/292 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGW-IDEHSFAATKPGTGMVIAVKRL--NQDGFQGHKEWLA-- 127
N+R +LG+G FG V+ + +D TG +A K++ + + + KE A
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAAKQVQFDPESPETSKEVSALE 52
Query: 128 -EVNYLGQLYHPNLVKLVGYCLED--DHRLLVY-EFMPRGSLENHLFRRGSYFQPLSWNL 183
E+ L L H +V+ G CL D + L ++ E+MP GS+++ L G+ L+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESV 107
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
K +G+++LH +++RD K +NIL D+ N KL DFG +K T S
Sbjct: 108 TRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 244 TR-VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302
R V GT + +PE ++ K+DV+S G ++EML+ +P WA+
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-------EKPP-------WAE 211
Query: 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354
+ IF+I Q + A L C+ E + RP E++
Sbjct: 212 --YEAMAAIFKIATQPTNPQLPSHISEHARDF-LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQ 134
VLG+G FG V A + GT + A+K L +D + + E L
Sbjct: 6 MVLGKGSFGKVM---------LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 135 LYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
P + + C + RL V E++ G L H+ + G + +P + + A A
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA----VFYAAEIAI 112
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGY 252
G+ FLH +IYRD K N++LD + K++DFG+ K+ G +TR GT Y
Sbjct: 113 GLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDY 167
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
APE +A D ++FGV+L EML+G+ D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LG+G FG V++G +P T +A+K +N+ + E+L E + + +
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHL------FRRGSYFQPLSWNLRLKVALGAA 192
++V+L+G + L++ E M RG L+++L P S +++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
G+A+L+ K ++RD N ++ ++ K+ DFG+ +D D + + +
Sbjct: 130 DGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEM 279
+PE L G T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 73/247 (29%), Positives = 96/247 (38%), Gaps = 59/247 (23%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN-----QDGFQGHKEWLA 127
+F V+G G FG V+ TG V A+K L + H A
Sbjct: 2 DFEVIKVIGRGAFGEVW---------LVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRA 50
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWN---- 182
E + L P +VKL Y +D+ L LV E+MP G L N L R+ + P
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF--PEETARFYI 107
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS-- 240
L +AL + + F+H RD K NIL+D + + KL+DFGL K
Sbjct: 108 AELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 241 --------------------HVSTRVM-----GTYGYAAPEYLATGHLTAKSDVYSFGVV 275
H RV GT Y APE L + D +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 276 LLEMLSG 282
L EML G
Sbjct: 220 LYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
+LG G G+V+K A T ++AVK + D + K+ ++E+ L +
Sbjct: 8 ILGHGNGGTVYK---------AYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
P ++ G ++ + EFM GSL+ ++R+ + ++ ++A+ KG+ +
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTY 110
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
L K+++RD K SN+L++T KL DFG++ T + ++ +GT Y APE
Sbjct: 111 LWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPER 164
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGR 283
++ SDV+S G+ +E+ GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 25/220 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL--NQDGFQGHKEWLA--- 127
N+R +LG+G FG V+ + TG +AVK++ + + + KE A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCY---------DADTGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 128 EVNYLGQLYHPNLVKLVGYCLED--DHRLLVY-EFMPRGSLENHLFRRGSYFQPLSWNLR 184
E+ L L H +V+ G CL D + L ++ E MP GS+++ L G+ L+ N+
Sbjct: 54 EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGA----LTENVT 108
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
K +GV++LH +++RD K +NIL D+ N KL DFG +K T S
Sbjct: 109 RKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 245 R-VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ V GT + +PE ++ K+D++S G ++EML+ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 50/225 (22%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-----EVNYLGQ 134
LG+G +G V+K A T V+A+K++ D F+ + A E+ +L +
Sbjct: 15 LGKGAYGIVWK---------AIDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62
Query: 135 LY-HPNLVKLVG-YCLEDDHRL-LVYEFMP--------RGSLEN-HLFRRGSYFQPLSWN 182
L HPN+VKL+ E+D + LV+E+M LE+ H +R +Q L
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQLL--- 117
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQ 239
K + ++H VI+RD K SNILL+++ KL+DFGLA+ + +
Sbjct: 118 ----------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGR 283
+ V T + T Y APE L K D++S G +L EML G+
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 32/282 (11%)
Query: 73 NFRPDSVLGEGGFGS-VFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
++ P VLG+G FG ++ S K + + RL++ + ++ L E+
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKE-----VNLTRLSE---KERRDALNEIVI 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L L HPN++ + ++D+ L+ E+ G+L + + R+ Q + L
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQI 110
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
V+++H + +++RD KT NI L KL DFG++K G + ++ V+GT
Sbjct: 111 VSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPY 166
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311
Y +PE KSD+++ G VL E+L+ +R D P NLV KI
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV----------KI 213
Query: 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353
+ + Y+ E +L L + + RP EV+
Sbjct: 214 VQGNYTPVVSVYSSE----LISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 59/229 (25%), Positives = 88/229 (38%), Gaps = 30/229 (13%)
Query: 83 GGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL---NQDGFQGHKEWLAE-VNYLGQLYHP 138
G FGSV+ A K TG A+K L + AE + Q P
Sbjct: 7 GAFGSVY---------LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
+ KL D+ LV E++ G + + G L + + GV L
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDL 113
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
H +I+RD K N+L+D + KL+DFGL+++G + + +GT Y APE +
Sbjct: 114 HQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETI 165
Query: 259 ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG-----EHNLVEWAK 302
SD +S G V+ E L G P + W +
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 73 NFRPDSVLGEGGFGSVF--KGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130
+ +G G FG V + I EH +A VI +K+ K L EV+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVS 59
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLL--VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
HP +++L + E D R L + E++P G L ++L G + S + L A
Sbjct: 60 ------HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF----SNSTGLFYA 107
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR--- 245
+ +LH E ++YRD K NILLD + KL+DFG AK + R
Sbjct: 108 SEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--------LRDRTWT 157
Query: 246 VMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSG 282
+ GT Y APE + GH A D ++ G+++ EML G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ R + LG+G FG V+ G T GT V A+K L + G + +L E +
Sbjct: 7 SLRLEVKLGQGCFGEVWMG---------TWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVM 55
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+L H LV+L + ++ +V E+M +GSL + F +G + L + +A A
Sbjct: 56 KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIA 112
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY-- 250
G+A++ ++RD + +NIL+ N K++DFGLA+ + + + R +
Sbjct: 113 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPI 167
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+ APE G T KSDV+SFG++L E+ + R
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 40/289 (13%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
+G+G FG VFKG ID T V+A+K ++ + + E + E+ L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNR--------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
+ K G L+D ++ E++ GS + L G PL + KG+ +L
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG----PLDETQIATILREILKGLDYL 117
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
H K I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 118 H--SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 259 ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNR 318
+K+D++S G+ +E+ G P E L + +F I N
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGE------PPHSE----------LHPMKVLFLIPKNN 217
Query: 319 LEGQYTLEGAYKA--ATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365
TLEG Y CL+ E FRP E++ ++ + +T
Sbjct: 218 PP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 82 EGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL----NQDGFQGHKEWLAEVNYLGQLYH 137
EG +G V++ A TG ++A+K+L ++GF L E+N L +L H
Sbjct: 15 EGTYGVVYR---------ARDKKTGEIVALKKLKMEKEKEGFP--ITSLREINILLKLQH 63
Query: 138 PNLVKL----VGYCLEDDHRLLVYEFMP---RGSLENHLFRRGSYFQPLSWNLRLKVALG 190
PN+V + VG L D +V E++ + +E + + Q L L++ G
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSG 118
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
VA LH + +++RD KTSN+LL+ K+ DFGLA+ G T+++ T
Sbjct: 119 ----VAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTL 170
Query: 251 GYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L + D++S G + E+L+ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
+G G FG VF G + A P +AVK + K ++L E L Q HP
Sbjct: 3 IGRGNFGEVFSGRLR----ADNTP-----VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V+L+G C + +V E + G L G L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYL 110
Query: 199 HGAETK-VIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
E+K I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 111 ---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 258 LATGHLTAKSDVYSFGVVLLEMLS 281
L G +++SDV+SFG++L E S
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
+LG+G FG VF A GT A+K L +D + + E L
Sbjct: 2 MLGKGSFGKVF---------LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 136 Y-HPNLVKLVGYCL--EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+ HP L L YC ++ V E++ G L H+ + P + ++ G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+ FLH ++YRD K NILLDT+ + K++DFG+ K+ GD + GT Y
Sbjct: 109 --LQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L D +SFGV+L EML G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQL-YH 137
LGEG FG V + KP + +AVK L D + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG------SY------FQPLSWNLRL 185
N++ L+G C +D ++ E+ +G+L +L R SY + +++ +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
A+G+ +L A K I+RD N+L+ N K++DFGLA+D D +T
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE L T +SDV+SFGV++ E+ +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATK---PGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
+ LG G FG V+ ++H+ A K PG+ V A +LAE N +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--------------FLAEANVMK 56
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
L H LVKL + + ++ EFM +GSL + L QPL + + A+
Sbjct: 57 TLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AE 113
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY--G 251
G+AF+ + I+RD + +NIL+ + K++DFGLA+ + + + R +
Sbjct: 114 GMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIK 168
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA-SKRK 310
+ APE + G T KSDV+SFG++L+E+++ R PY S +
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-----------------PYPGMSNPE 211
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357
+ R ++ + + +RC + RP + +VL+
Sbjct: 212 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 72/209 (34%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVN-YLGQ 134
V+G+G FG V A + G AVK L + KE +AE N L
Sbjct: 2 VIGKGSFGKVL---------LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 135 LYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
+ HP LV L Y + +L V +F+ G L HL R S+ +P + R A A
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RFYAA-EIAS 107
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+ +LH ++YRD K NILLD+ + L+DFGL K+G QS +T GT Y
Sbjct: 108 ALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYL 163
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE + D + G VL EML G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 66/214 (30%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN-----QDGFQGH----KEWLAEVN 130
LG GGFG V A+K + + G Q H KE L E N
Sbjct: 1 LGVGGFGRVEL---------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
HP +VKL + + ++ E+ G L L RG + + + R +A
Sbjct: 52 ------HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA---RFYIA-C 101
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+LH +IYRD K N+LLD+N KL DFG AK +G ++ GT
Sbjct: 102 VVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTP 156
Query: 251 GYAAPEY-LATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L G+ + D +S G++L E+L+GR
Sbjct: 157 EYVAPEIILNKGYDFS-VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
VLG+G +G V+ AA T + IA+K + + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA--KGVA 196
N+V+ +G E+ + E +P GSL L R S + PL N + + +G+
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLR--SKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFG----LAKDGPTGDQSHVSTRVMGTY 250
+LH + ++++RD K N+L++T Y+ K+SDFG LA P + GT
Sbjct: 123 YLH--DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTL 173
Query: 251 GYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGR 283
Y APE + G A +D++S G ++EM +G+
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLYH 137
+GEG +G V+KG TG ++A+K RL + + E++ L +L H
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLRLKVALGAAKGV 195
PN+V L +++ L++EF+ L+ +L +G Y L L +G+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL---QGI 114
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
F H +V++RD K N+L+D KL+DFGLA+ G V T + T Y AP
Sbjct: 115 LFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAP 170
Query: 256 EYL-ATGHLTAKSDVYSFGVVLLEMLSGR 283
E L + + D++S G + EM + +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQL-YH 137
LGEG FG V + KP +AVK L D + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG------SY------FQPLSWNLRL 185
N++ L+G C +D ++ E+ +G+L +L R Y + LS+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
A A+G+ +L A K I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE L T +SDV+SFGV+L E+ +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 61/237 (25%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN---QDGFQGHKEWLAEVN 130
+ +G G +G V +A TG +A+K+++ D K L E+
Sbjct: 2 YELLKPIGSGAYGVVC---------SAVDKRTGRKVAIKKISNVFDDLIDA-KRILREIK 51
Query: 131 YLGQLYHPNLVKL-------VGYCLEDDHRLLVYEFMP---------RGSLEN-HLFRRG 173
L L H N++ L D + +V E M L + H+
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVY--IVTELMETDLHKVIKSPQPLTDDHI---- 105
Query: 174 SYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
YF Q L +G+ +LH A VI+RD K SNIL+++N + K+ DFGLA
Sbjct: 106 QYFLYQIL-------------RGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLA 150
Query: 232 KDGPTGDQSHVSTRVMGTY----GYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ D + Y Y APE L++ T D++S G + E+L+ +
Sbjct: 151 R---GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
VLG+G FG V + G G AVK L +D + + E L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 136 Y-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK- 193
+ +P L L +H V EF+ G L H+ +G + +L A
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF------DLYRATFYAAEIV 106
Query: 194 -GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
G+ FLH +IYRD K N++LD + + K++DFG+ K+ GD ++ GT Y
Sbjct: 107 CGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L T D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
VLG G FG+V+KG WI + + +A+K L ++ + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGE------NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLF----RRGSYFQPLSWNLRLKVALGAA 192
P + +L+G CL +L V + MP G L +++ R GS L+W +++ A
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQI------A 119
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
KG+++L E ++++RD N+L+ + + K++DFGLA+ + + + +
Sbjct: 120 KGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
A E + T +SDV+S+GV + E+++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-LAEVNY 131
NF+ LGEG + +V+KG TG ++A+K ++ D +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+ +L H N+V+L ++ +LV+E+M L+ ++ G L N
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVR-GALDPNTVKSFTYQL 109
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG--PTGDQSHVSTRVMGT 249
KG+AF H E +V++RD K N+L++ KL+DFGLA+ P + S V+ T
Sbjct: 110 LKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-T 163
Query: 250 YGYAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGR 283
Y AP+ L + S D++S G ++ EM++GR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 68/210 (32%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLG-Q 134
VLG+G FG V A GT V A+K L +D + + E L
Sbjct: 2 VLGKGSFGKVM---------LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 135 LYHPNLVKLVGYCLEDDHRLL-VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
HP L L C + RL V E++ G L + R + +P S +V L
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--- 108
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+ FLH VIYRD K NILLD + KL+DFG+ K+G +T GT Y
Sbjct: 109 -LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYI 163
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L D ++ GV++ EM++G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYH 137
LGE FG V+KG H F +A+K L +D +G +E+ E +L H
Sbjct: 13 LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQH 67
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG---------------SYFQPLSWN 182
PN+V L+G ++ +++ + L L R S +P +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+ + A G+ FL + V+++D T N+L+ N K+SD GL ++ D +
Sbjct: 127 --VHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ + +PE + G + SD++S+GVVL E+ S
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 64/217 (29%), Positives = 92/217 (42%), Gaps = 36/217 (16%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ------DGFQG---HKEWLAEVN 130
LG+GGFG V A TG + A K+LN+ G++G K LA+V
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
H + + Y + L LV M G L H++
Sbjct: 51 ------HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA 104
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA---KDGPTGDQSHVSTRV 246
G+ LH + ++IYRD K N+LLD + N ++SD GLA KDG + + +
Sbjct: 105 QIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---- 158
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GT G+ APE L D ++ GV L EM++ R
Sbjct: 159 -GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YH 137
LGEG FG V + KP + +AVK L D + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR---GSYF---------QPLSWNLRL 185
N++ L+G C +D ++ E+ +G+L +L R G + + L++ +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
A A+G+ +L A K I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE L T +SDV+SFGV+L E+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
+G+G FG VFKG ID T V+A+K ++ + + E + E+ L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNR--------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
+ K G L+ ++ E++ GS + L R F LK L KG+ +L
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLDYL 117
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
H K I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 118 H--SEKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 259 ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDN- 317
+K+D++S G+ +E+ G P R +F I N
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----------------MRVLFLIPKNN 217
Query: 318 --RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353
L G+++ +K A CL+ + FRP E++
Sbjct: 218 PPTLTGEFS--KPFKEFIDA--CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATK---PGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY 136
LG G FG V+ G+ + + A K PGT V A +L E N + L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA--------------FLEEANLMKTLQ 59
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQ-PLSWNLRLKVALGAAKG 194
H LV+L +++ ++ E+M +GSL + L G P + ++A +G
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA----EG 115
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY--GY 252
+A++ I+RD + +N+L+ + K++DFGLA+ + + + R + +
Sbjct: 116 MAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKW 170
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
APE + G T KSDV+SFG++L E+++
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
+G+G G+V+ A TG +A+K++N Q KE + E+ + + HP
Sbjct: 27 IGQGASGTVY---------TAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHP 76
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V + L D +V E++ GSL + + + V + + FL
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL 131
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
H +VI+RD K+ NILL + + KL+DFG T +QS ST V GT + APE +
Sbjct: 132 HS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVV 187
Query: 259 ATGHLTAKSDVYSFGVVLLEMLSG 282
K D++S G++ +EM+ G
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
+LG+G FG V + TG A+K L ++ E L E L
Sbjct: 2 LLGKGTFGKVI---------LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLRLKVALGAA 192
HP L L Y + RL V E+ G L HL R + + + + + ALG
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG-- 109
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+LH V+YRD K N++LD + + K++DFGL K+G + D + + T GT Y
Sbjct: 110 ----YLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEY 161
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L D + GVV+ EM+ GR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY-------L 132
+G+GG+G VF A K TG ++A+KR+ + L EV + L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 133 GQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
LVKL+ Y +DD L L E++P G L G LS +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGV----LSEDHARFYMAEM 110
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+ V LH E I+RD K N L+D + + KL+DFGL+K T S V+G+
Sbjct: 111 FEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPD 163
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
Y APE L D +S G +L E L G
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYL 132
F +G+G FG V+K ID+ T V+A+K ++ + + E + E+ +L
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKR--------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
Q P + K G L+ ++ E+ GS L + G L +
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG----KLDETYIAFILREVL 108
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR---VMGT 249
G+ +LH E I+RD K +NILL + KL+DFG++ G + ++ +GT
Sbjct: 109 LGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ APE + K+D++S G+ +E+ G
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
VLG+G FG V A GT A+K L +D + + E L
Sbjct: 2 VLGKGSFGKVM---------LAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 136 Y-HPNLVKLVGYCL--EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+ HP L L +C +H V E++ G L H+ G + + + AA
Sbjct: 53 WEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-------RARFYAA 103
Query: 193 K---GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
+ G+ FLH + +IYRD K N+LLD + + K++DFG+ K+ G+ ++ GT
Sbjct: 104 EIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGT 159
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L D +SFGV+L EML G+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 32/271 (11%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKP 103
P T R+ L+ P + F + + F +G G FG+V+ A
Sbjct: 1 PSTSRAGS--LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVY---------FARDV 47
Query: 104 GTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFM 160
T V+A+K+++ G Q +++W + EV +L ++ HPN ++ G L + LV E+
Sbjct: 48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC 107
Query: 161 PRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220
GS + L + +PL + GA +G+A+LH +I+RD K NILL
Sbjct: 108 -LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEP 161
Query: 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLL 277
KL+DFG A + + +GT + APE + G K DV+S G+ +
Sbjct: 162 GQVKLADFGSAS------IASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 215
Query: 278 EMLSGRRAV-DKNRPSGEHNLVEWAKPYLAS 307
E+ + + + N S +++ + P L S
Sbjct: 216 ELAERKPPLFNMNAMSALYHIAQNESPTLQS 246
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
FR VLG+GGFG V A TG + A K+L + + K +N
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 134 QLYHPN--LVKLVGYCLE-DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
L N V + Y E D LV M G L+ H++ G +
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFY 107
Query: 191 AAK---GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
AA+ G+ LH + +++YRD K NILLD + + ++SD GLA P G + RV
Sbjct: 108 AAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV- 162
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GT GY APE + T D ++ G +L EM++G+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 73 NFRPDSVLGEGGFGSVF--KGWID-EHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEV 129
+ +GEG FG ++ K D EH T M + K ++ EV
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----------EV 50
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR-RGSYF---QPLSWNLRL 185
L ++ HPN+V E+ +V E+ G L + R RG F Q LSW +++
Sbjct: 51 ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLSDFGLAKDGPTGDQSHVST 244
+ L H + K+++RD K+ NI L N AKL DFG+A+ D ++
Sbjct: 111 SLGLK--------HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKN 289
+GT Y +PE K+D++S G VL E+ + + + N
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ R D LG+G FG V+ G T GT V A+K L + G + +L E +
Sbjct: 7 SLRLDVKLGQGCFGEVWMG---------TWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIM 55
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR-RGSYFQPLSWNLRLKVALGA 191
+L H LV L + ++ +V EFM +GSL + L G Y L + +A
Sbjct: 56 KKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQI 111
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY- 250
A G+A++ I+RD + +NIL+ N K++DFGLA+ + + + R +
Sbjct: 112 ADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFP 166
Query: 251 -GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+ APE G T KSDV+SFG++L E+++ R
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG+G FG V+K A TG++ A K ++ + ++++ E++ L HPN
Sbjct: 13 LGDGAFGKVYK---------AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+VKL+ +++ ++ EF G+++ + +PL+ V + + +LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLH 120
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
E K+I+RD K NIL + + KL+DFG++ Q S +GT + APE +
Sbjct: 121 --ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 176
Query: 260 TGH-----LTAKSDVYSFGVVLLEM 279
K+DV+S G+ L+EM
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL--NQDGFQGHKEWLAEVNYLGQLY 136
++GEG +G V K E TG ++A+K+ ++D K + E+ L QL
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLEN-HLFRRGSYFQPLSWNLRLKVALGAAKGV 195
H NLV L+ LV+EF+ L++ + G L + K +G+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGI 113
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
F H +I+RD K NIL+ + KL DFG A+ + + T + T Y AP
Sbjct: 114 EFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAP 169
Query: 256 EYLATGHLTAKS-DVYSFGVVLLEMLSG 282
E L ++ D+++ G ++ EML+G
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 69/217 (31%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVN 130
FR VLG+GGFG V A TG + A KRL + + G L E
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY-FQPLSWNLRLKVAL 189
L ++ +V L D LV M G L+ H++ G+ F+ +
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERALF 106
Query: 190 GAAK---GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
AA+ G+ LH +YRD K NILLD + ++SD GLA P G+ + RV
Sbjct: 107 YAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV 162
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GT GY APE L T D + G ++ EM+ G+
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-15
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG G FG V KG + K + I V + + E + E + QL +P
Sbjct: 3 LGSGNFGCVKKG-----VYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPY 56
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V+++G C E + +LV E G L + F G + N+ +++ + G+ +L
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNV-VELMHQVSMGMKYLE 112
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY--GYAAPEY 257
G ++RD N+LL + AK+SDFGL+K D S+ R G + + APE
Sbjct: 113 G--KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 258 LATGHLTAKSDVYSFGVVLLEMLS 281
+ +++SDV+S+G+ + E S
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 46/280 (16%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
+G+G FG V+KG ID T V+A+K ++ + + E + E+ L Q P
Sbjct: 12 IGKGSFGEVYKG-IDNR--------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
+ + G L+ ++ E++ GS + L + G PL + KG+ +L
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG----PLEETYIATILREILKGLDYL 117
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
H +E K I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 118 H-SERK-IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 259 ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY--LASKRKIFRIID 316
K+D++S G+ +E+ G P L R +F I
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGE------------------PPNSDLHPMRVLFLIPK 215
Query: 317 NR---LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353
N LEGQY+ +K A CL+ + +FRP E++
Sbjct: 216 NSPPTLEGQYS--KPFKEFVEA--CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 65/212 (30%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
VLG+G FG V + E +G + AVK L +D + + E L
Sbjct: 2 VLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 136 Y-HPNLVKLVGYCLEDDHRLL-VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
HP L +L C + RL V EF+ G L H+ + + + + AA+
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-------RARFYAAE 104
Query: 194 ---GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+ FLH + +IYRD K N+LLD + KL+DFG+ K+G ++ GT
Sbjct: 105 ITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTP 160
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
Y APE L D ++ GV+L EML G
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 74/220 (33%), Positives = 104/220 (47%), Gaps = 44/220 (20%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--------GHKEWLAEVN 130
VLG+G FG VF T P G + A+K L + + ++ LAEVN
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLR----- 184
HP +VKL Y + + +L L+ +F+ R G F LS +
Sbjct: 57 ------HPFIVKL-HYAFQTEGKLYLILDFL----------RGGDLFTRLSKEVMFTEED 99
Query: 185 LKVALGA-AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
+K L A + LH +IYRD K NILLD + KL+DFGL+K+ ++ S
Sbjct: 100 VKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 244 TRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVLLEMLSG 282
GT Y APE + GH T +D +SFGV++ EML+G
Sbjct: 158 --FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 47/225 (20%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQ 134
S +GEG +G V +AT TG+ +A+K+++ F+ + L E+ L +
Sbjct: 11 SYIGEGAYGMVC---------SATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRR 59
Query: 135 LYHPNLVKLVGY----CLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWN------- 182
H N++ ++ E + + +V E M E L++ Q LS +
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKL-IKTQHLSNDHIQYFLY 113
Query: 183 --LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK-DGPTGDQ 239
LR G+ ++H A V++RD K SN+LL+TN + K+ DFGLA+ P D
Sbjct: 114 QILR---------GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGR 283
+ T + T Y APE + K+ D++S G +L EMLS R
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 70/209 (33%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVN-YLGQ 134
V+G+G FG V A + G AVK L + KE +AE N L
Sbjct: 2 VIGKGSFGKVL---------LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 135 LYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
L HP LV L Y + +L V +++ G L HL R + +P + R A A
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA---RFYAA-EVAS 107
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+ +LH +IYRD K NILLD+ + L+DFGL K+G +++ ++ GT Y
Sbjct: 108 AIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYL 163
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE L D + G VL EML G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
VLG+G FG V A + GT + A+K L +D + + E L
Sbjct: 7 VLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
P + + C + RL V E++ G L + + G + +P + ++A+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK----DGPTGDQSHVSTRVM-GT 249
+ FLH +IYRD K N++LD+ + K++DFG+ K DG V+T+ GT
Sbjct: 114 LFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-------VTTKTFCGT 164
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE +A D ++FGV+L EML+G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN----QDGFQGHKEWL 126
NF+ + +G+G F V+K A G V+A+K++ D + ++ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYK---------AICLLDGRVVALKKVQIFEMMDA-KARQDCL 50
Query: 127 AEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLE---NHLFRRGSYF-QPLSWN 182
E++ L QL HPN++K + +E++ +V E G L H ++ + W
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQ 239
+++ + +H ++++RD K +N+ + KL D GL + T
Sbjct: 111 YFVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEM 279
S V GT Y +PE + KSD++S G +L EM
Sbjct: 165 SLV-----GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+G+G G+VF A TG +A+K++N + + E+ + +L +PN
Sbjct: 27 IGQGASGTVF---------TAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V + L D +V E++ GSL + + ++ V + + FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH 132
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
+VI+RD K+ N+LL + + KL+DFG T +QS ST V GT + APE +
Sbjct: 133 A--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 260 TGHLTAKSDVYSFGVVLLEMLSG 282
K D++S G++ +EM+ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 72 RNFRPDSV------LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW 125
R+ P+ V LG+G FG V+K A TG + A K + + +++
Sbjct: 6 RDLDPNEVWEIIGELGDGAFGKVYK---------AKNKETGALAAAKVIETKSEEELEDY 56
Query: 126 LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
+ E+ L HP +VKL+G D ++ EF P G+++ + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
+ L A + +LH K+I+RD K N+LL + + KL+DFG++ Q S
Sbjct: 117 RQMLEA---LQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-- 169
Query: 246 VMGTYGYAAPEYLATGHLTA-----KSDVYSFGVVLLEM 279
+GT + APE + + K+D++S G+ L+EM
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
+G G +G V+K D TG ++A+K + + + E++ L + H
Sbjct: 9 QRIGSGTYGDVYKA-RDIA--------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLEN--HLFRRGSYFQPLSWNLRLKVALGAAKGV 195
PN+V G L D +V E+ GSL++ + R PLS V KG+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGL 114
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR---VMGTYGY 252
A+LH ET I+RD K +NILL + + KL+DFG++ + + +GT +
Sbjct: 115 AYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYW 167
Query: 253 AAPEYLA---TGHLTAKSDVYSFGVVLLEM 279
APE A G K D+++ G+ +E+
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLA--EVN 130
FR VLG+GGFG V A TG + A K+L + + K E +A E
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 131 YLGQLYHPNLVKLVGYCLE-DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L ++ +V L Y E D LV M G L+ H++ G ++ V
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMG----NPGFDEERAVFY 107
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
A +++YRD K NILLD + ++SD GLA + P G+ + RV GT
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GT 164
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GY APE + T D + G ++ EM+ G+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNY 131
+F S LG G G VFK + KP +G+++A K ++ + + + E+
Sbjct: 6 DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQIIRELQV 56
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L + P +V G D + E M GSL+ L + G + + KV++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAV 112
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
KG+ +L + K+++RD K SNIL+++ KL DFG++ G D ++ +GT
Sbjct: 113 IKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y +PE L H + +SD++S G+ L+EM GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTG-MVIAVKRLNQDGFQGHKE--WLAEVNYLG 133
+ +LG G FG + +G + P + +A+ L + G + +LAE LG
Sbjct: 10 ERILGTGRFGELCRGCLK-------LPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLG 61
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
Q H N+V+L G + ++V E+M G+L++ L + L + + G A
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLAS 118
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG-- 251
G+ +L +E +++ +L++++ K+S F ++ D+S M
Sbjct: 119 GMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIYTTMSGKSPV 172
Query: 252 -YAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
+AAPE + H ++ SDV+SFG+V+ E++S G R
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYL 132
++ ++G G +G+V++G TG V+A+K +N D + EV L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 133 GQLYH---PNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQP-LSWNLR-LK 186
QL PN+ K G RL ++ E+ GS+ L + G + +S +R +
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
VAL ++H VI+RD K +NIL+ N KL DFG+A S ST V
Sbjct: 112 VAL------KYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFV 162
Query: 247 MGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSG 282
GT + APE + G K+D++S G+ + EM +G
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 47/295 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHP 138
LG+G FG V++G + + T +AVK +N+ + E+L E + +
Sbjct: 14 LGQGSFGMVYEG--NARDIIKGEAETR--VAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQP--LSWNLRLKVALGA--A 192
++V+L+G + L+V E M G L+++L R + P L+ + + A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
G+A+L+ K ++RD N ++ ++ K+ DFG+ +D D + + +
Sbjct: 130 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312
APE L G T SD++SFGVVL E+ S L E +PY
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAE--QPYQG------ 224
Query: 313 RIIDNRLEGQYTLEGAY---------KAATLALRCLSTEGKFRPMMAEVVTVLEQ 358
+ N ++ ++G Y + L C K RP E+V +L+
Sbjct: 225 --LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-LAEVNYLGQLY 136
+L EG FG +F G IDE KPG + VK + + L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSY-----FQPLSWNLRLKVALG 190
H N++ ++ C+ED + ++Y +M G+L+ L ++ Q LS + +A+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPT-----GDQSHVST 244
A G+++LH VI++D N ++D K++D L++D P GD +
Sbjct: 126 IACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ M A E L ++ SDV+SFGV+L E+++
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 32/238 (13%)
Query: 49 SEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV 108
+ P+ S+ SD + LG G FG V A GTG
Sbjct: 2 KAAYMFTKPDTSSWKLSDFEMG-------ETLGTGSFGRVR---------IAKHKGTGEY 45
Query: 109 IAVKRLNQDGFQGHKE---WLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSL 165
A+K L + K+ E + L +L HP +V ++ +++ + EF+ G L
Sbjct: 46 YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105
Query: 166 ENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225
HL + G + ++ ++ L AF + +IYRD K N+LLD + K+
Sbjct: 106 FTHLRKAGRFPNDVAKFYHAELVL------AFEYLHSKDIIYRDLKPENLLLDNKGHVKV 159
Query: 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSG 282
+DFG AK P D++ + GT Y APE + + GH A D ++ GV+L E ++G
Sbjct: 160 TDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNY 131
+F LG G G V K +P +G+++A K ++ + + + E+
Sbjct: 2 DFEKLGELGAGNGGVVTK--------VLHRP-SGLIMARKLIHLEIKPAIRNQIIRELKV 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L + P +V G D + E M GSL+ L + G + N+ K+++
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPENILGKISIAV 108
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+G+ +L + K+++RD K SNIL+++ KL DFG++ G D S ++ V GT
Sbjct: 109 LRGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRS 163
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y +PE L H T +SD++S G+ L+EM GR
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LG G FG V+ G T G V AVK L + G + +L E + +L H
Sbjct: 14 LGNGQFGEVWMG---------TWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
LV+L + ++ +V E+M +GSL + F + + L + +A A G+A++
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY--GYAAPEY 257
I+RD +++NIL+ K++DFGLA+ + + + R + + APE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEA 174
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGRR 284
G T KSDV+SFG++L E+++ R
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 54/225 (24%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQ--DGFQGHKEWLAEVNYLGQL 135
+GEG +G V++ A +G ++A+K R++ DG L E+ L L
Sbjct: 15 IGEGTYGIVYR---------ARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNL 63
Query: 136 YHPNLVKL---------------VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
HPN+V+L + YC +D LL + MP P S
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------------PFS 106
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
+ + L +G+ +LH E +I+RD K SN+LL K++DFGLA+ G +
Sbjct: 107 ESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPA 162
Query: 241 HVSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
T + T Y APE L T + TA D+++ G +L E+L+ +
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 43/219 (19%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLYH 137
+GEG +G V+K A TG ++A+K RL + + E++ L +L H
Sbjct: 7 IGEGTYGVVYK---------ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH 57
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFM-----------PRGSLENHLFRRGSYFQPLSWNLRL 185
PN+V+L+ + +++L LV+EF+ P L+ L + Y Q L
Sbjct: 58 PNIVRLLD-VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY-QLL------ 109
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
+G+A+ H +V++RD K N+L+D KL+DFGLA+ G T
Sbjct: 110 -------QGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTH 158
Query: 246 VMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ T Y APE L + + D++S G + EM++ R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 67/237 (28%), Positives = 108/237 (45%), Gaps = 28/237 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY 136
+G G FG+V+ A V+A+K+++ G Q +++W + EV +L +L
Sbjct: 23 IGHGSFGAVY---------FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
HPN ++ G L + LV E+ GS + L + +PL V GA +G+A
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+LH +I+RD K NILL KL DFG A + +GT + APE
Sbjct: 130 YLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPE 181
Query: 257 YLAT---GHLTAKSDVYSFGVVLLEMLSGRRAV-DKNRPSGEHNLVEWAKPYLASKR 309
+ G K DV+S G+ +E+ + + + N S +++ + P L S
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLYH 137
+G G FG+V K +G ++AVK R D + K L +++ + +
Sbjct: 12 IGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSD 61
Query: 138 -PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR--GSYFQPLSWNLRLKVALGAAKG 194
P +VK G + + E M SL+ ++ + + K+A+ K
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+ +L E K+I+RD K SNILLD N N KL DFG++ G D S TR G Y A
Sbjct: 120 LNYLK-EELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKTRDAGCRPYMA 175
Query: 255 PEYLATGHLTA---KSDVYSFGVVLLEMLSGR 283
PE + +SDV+S G+ L E+ +G+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 69/231 (29%), Positives = 97/231 (41%), Gaps = 41/231 (17%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVN 130
FR VLG+GGFG V A TG + A K+L + + G L E
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 131 YLGQLYHPNLVKLVGYCLE-DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L ++ +V L Y E D LV M G L+ H++ G+
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-------------- 97
Query: 190 GAAKGVAFLHGAE----------TKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
G + A + AE +++YRD K NILLD + ++SD GLA P G+
Sbjct: 98 GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290
V RV GT GY APE + T D + G ++ EM+ G+ K +
Sbjct: 158 --VRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 73 NFRPDSVLGEGGFGSVF----KGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAE 128
NF VLG G +G VF G D A K I K + + ++ L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
V P LV L Y + D +L L+ +++ G L HL++R + + ++V
Sbjct: 61 VRR-----CPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRV 109
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD--GPTGDQSHVSTR 245
+ +A H + +IYRD K NILLD+ + L+DFGL+K+ ++++
Sbjct: 110 YIAEIV-LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---S 165
Query: 246 VMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSG 282
GT Y APE + GH A D +S GV+ E+L+G
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 53/216 (24%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YH 137
LGEG FG V + + + ++P + +AVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR------------GSYFQPLSWNLRL 185
N++ L+G C ++ ++ E+ +G+L L R + LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
A A+G+ +L + I+RD N+L+ + K++DFGLA+ D ++
Sbjct: 138 SCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE L T +SDV+SFG+++ E+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HP LV L C + + RL V EF+ G L H+ R+ + + +++L +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 109
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG-PTGDQSHVSTRVMGTYGYAA 254
FLH E +IYRD K N+LLD + KL+D+G+ K+G GD ++ GT Y A
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIA 164
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
PE L D ++ GV++ EM++GR D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYH- 137
+G G G V+K TG V+AVK++ + G + +K L +++ + H
Sbjct: 23 IGSGTCGQVYK---------MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHD 72
Query: 138 -PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
P +VK GY + D + E M + + L +R P+ ++ K+ + K +
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELM--STCLDKLLKR--IQGPIPEDILGKMTVAIVKALH 128
Query: 197 FL---HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+L HG VI+RD K SNILLD + N KL DFG++ G D S TR G Y
Sbjct: 129 YLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYM 181
Query: 254 APEYL----ATGHLTAKSDVYSFGVVLLEMLSGR 283
APE + ++DV+S G+ L+E+ +G+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLYH 137
+GEG +G V+K D T IA+K RL Q+ + E++ L ++ H
Sbjct: 10 IGEGTYGVVYKAR-DRV--------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL-KVAL-GAAKGV 195
N+V+L + LV+E++ L+ H+ + + N RL K L +G+
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDF----AKNPRLIKTYLYQILRGI 115
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNA-KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
A+ H +V++RD K N+L+D NA KL+DFGLA+ G T + T Y A
Sbjct: 116 AYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRA 171
Query: 255 PE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
PE L + H + D++S G + EM++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL 135
++G GGFG V+ K TG + A+K L++ QG L E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 136 YH---PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
P +V + D + + M G L HL + G + + ++ LG
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE 111
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
H V+YRD K +NILLD + + ++SD GLA D + + H S +GT+GY
Sbjct: 112 ------HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 253 AAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297
APE L G + +D +S G +L ++L G +++ +H +
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 137 HPNLVKLVGYCLEDDHRLL-VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HP LV L C + + RL V E++ G L H+ R+ + + +++L +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----L 109
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG-PTGDQSHVSTRVMGTYGYAA 254
+LH E +IYRD K N+LLD+ + KL+D+G+ K+G GD ++ GT Y A
Sbjct: 110 NYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIA 164
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
PE L D ++ GV++ EM++GR D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
+LG+G FG V + TG A+K L ++ E + E L
Sbjct: 2 LLGKGTFGKVI---------LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SA 107
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+ +LH + V+YRD K N++LD + + K++DFGL K+G + D + + T GT Y A
Sbjct: 108 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLA 163
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
PE L D + GVV+ EM+ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+GEG FG + + G VI +++ + +E EV L + HPN
Sbjct: 8 IGEGSFGKAI-------LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYF---QPLSWNLRLKVALGAAKGV 195
+V+ E+ + +V ++ G L + +RG F Q L W +++ +AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
H + K+++RD K+ NI L + KL DFG+A+ ++ +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSP 170
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSGRRA 285
E KSD+++ G VL EM + + A
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
+LG+G FG V + +G A+K L ++ E L E L
Sbjct: 2 LLGKGTFGKVI---------LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
HP L L Y + RL V E++ G L HL R + + + ++
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SA 107
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+ +LH K++YRD K N++LD + + K++DFGL K+G T D + + T GT Y A
Sbjct: 108 LDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT-FCGTPEYLA 163
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
PE L D + GVV+ EM+ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 65/207 (31%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLY 136
+G+G FG V + K T + A+K + + E LAE L Q+
Sbjct: 1 IGKGSFGKVMQ---------VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN 51
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
P +V L + + +L LV F+ G L +HL R G + +L A
Sbjct: 52 CPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRF------DLSRARFYTAELLC 104
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
A + + VIYRD K NILLD + L DFGL K D + GT Y AP
Sbjct: 105 ALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAP 162
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSG 282
E L T D ++ GV+L EML+G
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL 135
++G GGFG V+ K TG + A+K L++ QG L E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 136 YHPN--LVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+ + + Y +L + + M G L HL + G + + ++ LG
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
H V+YRD K +NILLD + + ++SD GLA D + + H S +GT+GY
Sbjct: 112 ------HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 253 AAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297
APE L G + +D +S G +L ++L G +++ +H +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN----QDGFQGHKEWLAE 128
NFR + +G G F V++ AT G+ +A+K++ D + + + E
Sbjct: 3 NFRIEKKIGRGQFSEVYR---------ATCLLDGVPVALKKVQIFDLMDA-KARADCIKE 52
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLRLK 186
++ L QL HPN++K +ED+ +V E G L + F++ P +
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
V L + A H +V++RD K +N+ + KL D GL + + ++ + +
Sbjct: 113 VQLCS----ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEM 279
+GT Y +PE + KSD++S G +L EM
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+G+G G+V+ A TG +A+K++N + + E+ + + +PN
Sbjct: 27 IGQGASGTVY---------TAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V + L D +V E++ GSL + + + V + + FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLH 132
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
+VI+RD K+ NILL + + KL+DFG T +QS ST V GT + APE +
Sbjct: 133 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 260 TGHLTAKSDVYSFGVVLLEMLSG 282
K D++S G++ +EM+ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
+LG+G FG V + TG A+K L ++ E L E L
Sbjct: 2 LLGKGTFGKVI---------LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SA 107
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+ +LH +E V+YRD K N++LD + + K++DFGL K+G D + + T GT Y A
Sbjct: 108 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLA 164
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
PE L D + GVV+ EM+ GR
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 46/221 (20%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKR--LNQDGFQGHKEWLAEVNYLGQLYH 137
+GEG +G+VFK E T ++A+KR L+ D L E+ L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMP----------RGSLENHLFRRGSY-FQPLSWNLRL 185
N+V+L L D +L LV+E+ G ++ + + S+ FQ L
Sbjct: 59 KNIVRLYD-VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--SFMFQLL------ 109
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
KG+AF H V++RD K N+L++ N KL+DFGLA+ + + S
Sbjct: 110 -------KGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAE 159
Query: 246 VMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGRR 284
V+ T Y P+ L A + T+ D++S G + E+ + R
Sbjct: 160 VV-TLWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 49/259 (18%)
Query: 41 LSVPPTPRSEGEILRSPNLKSF-----SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDE 95
L +PP S S S S S+L+ R +G G G+V+K
Sbjct: 45 LPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYK----- 92
Query: 96 HSFAATKPGTGMVIAVKRLNQDGFQGHKEWL-----AEVNYLGQLYHPNLVKLVGYCLED 150
TG + A+K + + H++ + E+ L + HPN+VK +
Sbjct: 93 ----VIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144
Query: 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDF 210
++ EFM GSLE + VA G+A+LH +++RD
Sbjct: 145 GEIQVLLEFMDGGSLEGTHIADEQFLA--------DVARQILSGIAYLH--RRHIVHRDI 194
Query: 211 KTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAK--- 266
K SN+L+++ N K++DFG+++ T D + S +GT Y +PE + T
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDG 251
Query: 267 --SDVYSFGVVLLEMLSGR 283
D++S GV +LE GR
Sbjct: 252 YAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 67/237 (28%), Positives = 101/237 (42%), Gaps = 44/237 (18%)
Query: 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH 122
+ L+ +F V+G G FG V + H + V A+K L++
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHK------SSKQVYAMKLLSKFEMIKR 84
Query: 123 KE----WLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQ 177
+ W E + + +V+L Y +DD L +V E+MP G L N + +Y
Sbjct: 85 SDSAFFW-EERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM---SNYDI 139
Query: 178 PLSW----NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG---- 229
P W + +AL A + F+H RD K N+LLD + + KL+DFG
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDVYSFGVVLLEMLSG 282
+ +G T V GT Y +PE L + G+ + D +S GV L EML G
Sbjct: 192 MDANG----MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 50/153 (32%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
+P LV L C + RL LV E++ G L H+ R+ + + ++ + +
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----L 109
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG-PTGDQSHVSTRVMGTYGYAA 254
FLH E +IYRD K N+LLD + + KL+D+G+ K+G GD ++ GT Y A
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIA 164
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
PE L D ++ GV++ EM++GR D
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLYH 137
LG+G +GSV+K +P TG+ +A+K RL D + + + E++ L +
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESK-FNQIIMELDILHKAVS 58
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
P +V G + + E+M GSL+ L+ G + + ++ ++ KG+ F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD-QSHVSTRVMGTYGYAAPE 256
L E +I+RD K +N+L++ N KL DFG+ +G+ + ++ +G Y APE
Sbjct: 118 LK-EEHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSYMAPE 171
Query: 257 YLATGHLTA------KSDVYSFGVVLLEMLSGR 283
+ +G +SDV+S G+ +LEM GR
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 77/273 (28%), Positives = 107/273 (39%), Gaps = 82/273 (30%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL---- 135
LG G FG V I+ +F K T +AVK L + H E A ++ L L
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIG 68
Query: 136 YHPNLVKLVGYCLEDDHRLLV-YEFMPRGSLENHL----------------FRRGS---- 174
+H N+V L+G C + L+V EF G+L N+L FR+G
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYG 128
Query: 175 -------------------------------------------YFQPLSWNLRLKVALGA 191
Y + L+ + +
Sbjct: 129 DISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQV 188
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV---STRVMG 248
AKG+ FL A K I+RD NILL N K+ DFGLA+D D +V R+
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARL-- 243
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE + T +SDV+SFGV+L E+ S
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+GEG G V AT+ TG +AVK+++ Q + EV + +H N
Sbjct: 30 IGEGSTGIVC---------IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V + L D +V EF+ G+L + + + ++ V L + +++LH
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH 135
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGTYGYAAP 255
VI+RD K+ +ILL ++ KLSDFG ++K+ P ++GT + AP
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAP 187
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSG 282
E ++ + D++S G++++EM+ G
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNY 131
+F S LG G G V K KP +G+++A K ++ + + + E+
Sbjct: 6 DFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQIIRELQV 56
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L + P +V G D + E M GSL+ L + + + KV++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAV 112
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+G+A+L + ++++RD K SNIL+++ KL DFG++ G D ++ +GT
Sbjct: 113 LRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y +PE L H + +SD++S G+ L+E+ GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLY 136
+G+G FG V++ K T + A+K L++ KE + E N L +
Sbjct: 1 IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51
Query: 137 HPNLVKLVG--YCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
+VG + + D L LV ++M G L HL + G + + R K + A
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYI-AEL 105
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+A H + ++YRD K NILLD + L DFGL+K T +++ + GT Y
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 254 APEYL--ATGHLTAKSDVYSFGVVLLEMLSG 282
APE L G+ T D +S GV++ EM G
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+GEG G V AT +G ++AVK+++ Q + EV + H N
Sbjct: 28 IGEGSTGIVC---------IATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V++ L D +V EF+ G+L + + + ++ V L K ++ LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
VI+RD K+ +ILL + KLSDFG + ++GT + APE ++
Sbjct: 134 A--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELIS 189
Query: 260 TGHLTAKSDVYSFGVVLLEMLSG 282
+ D++S G++++EM+ G
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 24/235 (10%)
Query: 49 SEGEILRSPNLKSF-SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGM 107
S+ EIL L+S S D K F +G+G G+V+ A TG
Sbjct: 1 SDEEILE--KLRSIVSVGDPKKKYTRFEK---IGQGASGTVY---------TAMDVATGQ 46
Query: 108 VIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLEN 167
+A++++N + + E+ + + +PN+V + L D +V E++ GSL +
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 168 HLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227
+ + V + + FLH +VI+RD K+ NILL + + KL+D
Sbjct: 107 VVTE-----TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
FG T +QS ST V GT + APE + K D++S G++ +EM+ G
Sbjct: 160 FGFCAQ-ITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 51/245 (20%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-----LAEVNYL 132
+GEG +G V+K D+ TG ++A+K++ D KE + E+ L
Sbjct: 13 GQIGEGTYGQVYKA-RDKD--------TGELVALKKVRLDN---EKEGFPITAIREIKIL 60
Query: 133 GQLYHPNLVKLVGYCLEDDHRL----------LVYEFMPR---GSLENHL--FRR---GS 174
QL H N+V L + L LV+E+M G LE+ L F S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 175 YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234
+ + L +G+ + H + ++RD K SNILL+ KL+DFGLA+
Sbjct: 121 FMKQL------------LEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 235 PTGDQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293
+ + + +V+ T Y PE L DV+S G +L E+ + + N+
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
Query: 294 EHNLV 298
+ L+
Sbjct: 226 QLELI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKG--WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130
NF+ + +G G F V++ +D A K V+ + ++ + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--------VQIFEMMDAKARQDCVKEID 54
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLRLKVA 188
L QL HPN++K + +ED+ +V E G L + F++ P + V
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
L +A V +H +V++RD K +N+ + KL D GL + + ++ + ++G
Sbjct: 115 LCSA--VEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVG 168
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEM 279
T Y +PE + KSD++S G +L EM
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVN 130
PD +G G FG V W + T P G +A+K++ + FQ K E+
Sbjct: 2 VEPDRPIGYGAFGVV---W------SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELK 51
Query: 131 YLGQLYHPNLVKLVGY-------CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
L H N++ + E +V E M + L + QPLS +
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFE--EIYVVTELM-QSDLHKIIVSP----QPLSSD- 103
Query: 184 RLKVAL-GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+KV L +G+ +LH A +++RD K N+L+++N K+ DFGLA+ + H+
Sbjct: 104 HVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM 161
Query: 243 STRVMGTYGYAAPEYLATG--HLTAKSDVYSFGVVLLEMLSGR 283
+ V+ Y Y APE L G H T+ D++S G + E+L R
Sbjct: 162 TQEVVTQY-YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 8/102 (7%)
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
K+A+ K + +LH ++ VI+RD K SN+L++ N KL DFG++ G D S T
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKTI 162
Query: 246 VMGTYGYAAPEY----LATGHLTAKSDVYSFGVVLLEMLSGR 283
G Y APE L KSDV+S G+ ++E+ +GR
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 43/269 (15%)
Query: 27 DGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFG 86
+D +S + PT + E++ S ++ +KT T G G
Sbjct: 36 SDDDSASESDDDDDDGLIPTKQKAREVV-----ASLGYTVIKTLT----------PGSEG 80
Query: 87 SVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGY 146
VF ATKPG + +K + Q G L E L + HP+++++
Sbjct: 81 RVF---------VATKPGQPDPVVLK-IGQKGTT-----LIEAMLLQNVNHPSVIRMKDT 125
Query: 147 CLEDDHRLLVYEFMP--RGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK 204
+ +V +P L +L +R +PL + L + +G+ +LH +
Sbjct: 126 LVSGAITCMV---LPHYSSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA--QR 177
Query: 205 VIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLT 264
+I+RD KT NI ++ + D G A+ P + + + GT APE LA
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYN 234
Query: 265 AKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293
+K+D++S G+VL EML+ + ++ PS
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 73 NFRPDSVLGEGGFGSVF----KGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAE 128
NF VLG G +G VF D A K I K + + ++ L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
+ P LV L Y + D +L L+ +++ G L HL +R + + +V
Sbjct: 61 IRQ-----SPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-------EV 107
Query: 188 ALGAAKGV-AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+ + + V A H + +IYRD K NILLD+N + L+DFGL+K+ D+ +
Sbjct: 108 QIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSF 166
Query: 247 MGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSG 282
GT Y AP+ + GH A D +S GV++ E+L+G
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--H-KEWLAEVN 130
++ S +G G +G V A TG +A+K+L++ FQ H K E+
Sbjct: 17 YQNLSPVGSGAYGQVCS---------AFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELR 66
Query: 131 YLGQLYHPNLVKLVGYCLEDDHR------LLVYEFMPRGSLENHLFRRGSYFQPLSWNLR 184
L + H N++ L+ LV M G+ N++ + Q LS +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC----QKLSDDHI 120
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSH 241
+ +G+ ++H A +I+RD K SNI ++ + K+ DFGLA+ D TG +
Sbjct: 121 QFLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG---Y 175
Query: 242 VSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
V+TR Y APE L H D++S G ++ E+L+G+
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/210 (30%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVN-YLGQ 134
V+G+G FG V A AVK L + KE ++E N L
Sbjct: 2 VIGKGSFGKVL---------LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 52
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
+ HP LV L D V +++ G L HL R + +P + R A A
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAA-EIASA 108
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG--PTGDQSHVSTRVMGTYGY 252
+ +LH ++YRD K NILLD+ + L+DFGL K+ G ++ GT Y
Sbjct: 109 LGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEY 162
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE L D + G VL EML G
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 56/238 (23%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ--DGFQGHKEWLAEVN 130
++P +G G +G V A +G +A+K++ D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCS---------AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 131 YLGQLYHPNLVKLVGYCLED---------DHRLLVYEFM---------PRGSLENHLFRR 172
L H N++ + D +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR- 110
Query: 173 GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
YF L LR G+ ++H A VI+RD K SN+L++ + ++ DFG+A+
Sbjct: 111 --YF--LYQLLR---------GLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
Query: 233 ---DGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LTAKSDVYSFGVVLLEMLSGRRAV 286
PT + + T + T Y APE L + T D++S G + EML GRR +
Sbjct: 156 GLSSSPT-EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 80 LGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG+G F +++KG + PG + + +K L D + + + + QL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
+LVKL G C+ D++ ++V E++ G L+ L R + L W +L VA A + +L
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNV-SLHW--KLDVAKQLASALHYL 117
Query: 199 HGAETKVIYRDFKTSNILL-----DTNYN--AKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+ K+++ + NIL+ + Y KLSD G+ + R+
Sbjct: 118 E--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 252 YAAPEYLATGH--LTAKSDVYSFGVVLLEMLSG 282
+ APE + G LT +D +SFG LLE+ S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 69/235 (29%), Positives = 97/235 (41%), Gaps = 38/235 (16%)
Query: 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-- 125
K +F LG G FG V A K +A+KR + K+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 126 -LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR 184
+E L + HP V L G ++ + LV EF+ G +F L N R
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGE----------FFTFLRRNKR 127
Query: 185 LKVALG---AAKGV-AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
+G AA+ V F + ++YRD K N+LLD + K++DFG AK
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------- 180
Query: 241 HVSTR---VMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291
V TR + GT Y APE L GH A +D ++ G+ + E+L G N P
Sbjct: 181 -VDTRTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 53/223 (23%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKR----LNQDGFQGHKEWLAEVNYLGQL 135
+GEG +G+V+K A TG +A+K+ L+++G L E+ L QL
Sbjct: 7 IGEGAYGTVYK---------ARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQL 55
Query: 136 Y---HPNLVKLVGYCL--EDDHRL---LVYEFM-----------PRGSLENHLFRRGSYF 176
HPN+V+L+ C D L LV+E + P+ L +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR- 114
Query: 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
Q L GV FLH ++++RD K NIL+ ++ K++DFGLA+
Sbjct: 115 QLLR-------------GVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---I 156
Query: 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEM 279
T V+ T Y APE L D++S G + E+
Sbjct: 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEV 129
+ +P +G G FG V +A TG +A+K++ F K E+
Sbjct: 14 DLQP---VGMGAFGLVC---------SARDQLTGQNVAIKKI-MKPFSTPVLAKRTYREL 60
Query: 130 NYLGQLYHPNLVKLVGYC---LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
L L H N++ L LED + V E + G+ + L PL
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSR----PLEKQFIQY 112
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+G+ ++H A V++RD K SNIL++ N + K+ DFGLA+ +VSTR
Sbjct: 113 FLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY 170
Query: 247 MGTYGYAAPEYLATGH-LTAKSDVYSFGVVLLEMLSGR 283
Y APE + T + D++S G + EML G+
Sbjct: 171 -----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF------QGHKEWL 126
NF VLG G +G VF T TG + A+K L + H
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 127 AEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
E N L + + + Y + + +L L+ +++ G + HL++R ++ + +
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EV 107
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
+ G +A H + ++YRD K NILLD+ + L+DFGL+K+ + ++ +
Sbjct: 108 RFYSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165
Query: 246 VMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSG 282
GT Y APE + GH A D +S G+++ E+L+G
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 48/223 (21%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL----NQDGFQGHKEWLAEVNYLGQL 135
+G+G FG VFK A T ++A+K++ ++GF L E+ L L
Sbjct: 20 IGQGTFGEVFK---------ARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLL 68
Query: 136 YHPNLVKLVGYC-----LEDDHR---LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
H N+V L+ C + ++ LV+EF E+ L L N +K
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAG-------LLSNKNVKF 116
Query: 188 ALGAAK--------GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTG 237
L K G+ ++H K+++RD K +NIL+ + KL+DFGLA+
Sbjct: 117 TLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 238 DQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEM 279
+ + T + T Y PE L D++ G ++ EM
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 54/240 (22%), Positives = 102/240 (42%), Gaps = 38/240 (15%)
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG------SYFQPLSW 181
E+ L ++ N++K+ G+ ++ + + +PR SL RG + LS+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIID------IVDDLPRLSLILEYCTRGYLREVLDKEKDLSF 121
Query: 182 NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSH 241
+L +A+ KG+ L+ T Y++ + + L+ NY K+ GL K + +
Sbjct: 122 KTKLDMAIDCCKGLYNLY-KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 242 VSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299
V+ V Y + + L T K D+YS GVVL E+ +G+ + ++L
Sbjct: 181 VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL-- 233
Query: 300 WAKPYLASKRKIFRI-IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358
+ +K ++ +D LE + +E C S + RP + E++ L
Sbjct: 234 -----IINKNNSLKLPLDCPLEIKCIVE----------ACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL---- 135
+GEG F V K + K TG A+K + + F+ L +VN L ++
Sbjct: 7 IGEGTFSEVLKA-------QSRK--TGKYYAIKCMKKH-FKS----LEQVNNLREIQALR 52
Query: 136 ---YHPNLVKLVGYCLEDDH-RL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
HPN+++L+ + RL LV+E M +L + R + L
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL- 110
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
K + +H + +RD K NIL+ + KL+DFG + T + T
Sbjct: 111 --KSLDHMHR--NGIFHRDIKPENILIK-DDILKLADFGSCR---GIYSKPPYTEYISTR 162
Query: 251 GYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLS 281
Y APE L T G+ K D+++ G V E+LS
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 60/249 (24%), Positives = 99/249 (39%), Gaps = 52/249 (20%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLY 136
+G+GG G V+ + P +A+K++ +D + K +L E L
Sbjct: 10 IGKGGMGEVYLAY---------DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMP--RGSLENHLFRRGSYFQPLSWNLRLKVALGA--- 191
HP +V + C + D VY MP G L + + LS L K ++GA
Sbjct: 61 HPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 192 -----AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA--KDGPTGDQSHVST 244
+ ++H V++RD K NILL + D+G A K D +
Sbjct: 118 IFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 245 --------------RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS--------- 281
+++GT Y APE L + +D+Y+ GV+L +ML+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 282 GRRAVDKNR 290
GR+ ++
Sbjct: 236 GRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHP 138
+G G FG V G ++ A + VK L Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQ-------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLRLKVALGAAKGVA 196
NL++ +G C E LLV EF P G L+ +L R+ P L+ ++A A G+
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLL 114
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG------PTGDQSHVSTRVMGTY 250
LH + I+ D N LL + K+ D+GL+ + T DQ V R
Sbjct: 115 HLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----- 167
Query: 251 GYAAPEYLATGH-------LTAKSDVYSFGVVLLEML 280
+ APE + H T +S+V+S GV + E+
Sbjct: 168 -WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIA---VKRLNQDGFQGH 122
DL+ ++ V+G G FG V + H ++ +KR + F
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEV---QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 123 KEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSW 181
++ +A N P +V+L Y +DD L +V E+MP G L N + +Y P W
Sbjct: 94 RDIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKW 143
Query: 182 ----NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG----LAKD 233
+ +AL A + F+H RD K N+LLD + + KL+DFG + K+
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195
Query: 234 GPTGDQSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDVYSFGVVLLEMLSG 282
G + V GT Y +PE L + G+ + D +S GV L EML G
Sbjct: 196 GMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LGEG + +VFKG T ++A+K + + +G + EV+ L L H
Sbjct: 14 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V L D LV+E++ + L+ ++ G+ + + L L +G+A+
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE-Y 257
H KV++RD K N+L++ KL+DFGLA+ +++ + V T Y P+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGR 283
L + + + D++ G + EM SGR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 58/231 (25%), Positives = 88/231 (38%), Gaps = 58/231 (25%)
Query: 81 GEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA--------EVNYL 132
G G +G V+K G A+K F+G KE E+ L
Sbjct: 9 GRGTYGRVYKAKRKN-------GKDGKEYAIK-----KFKGDKEQYTGISQSACREIALL 56
Query: 133 GQLYHPNLVKLVGYCLEDDHRL--LVYEFMPRGSLE---NHLFRRGSYFQP-----LSWN 182
+L H N+V LV LE + L++++ + H + P L W
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA----KLSDFGLAK--DGP- 235
+ GV +LH V++RD K +NIL+ K+ D GLA+ + P
Sbjct: 117 I--------LNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 236 ----TGDQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLS 281
D V+ T Y APE L H T D+++ G + E+L+
Sbjct: 167 KPLADLD------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 71/231 (30%), Positives = 100/231 (43%), Gaps = 31/231 (13%)
Query: 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW 125
L T + +G+G +G V+K T G + AVK L+ +E
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYK---------VTNKKDGSLAAVKILDPIS-DVDEEI 65
Query: 126 LAEVNYLGQL-YHPNLVKLVGYCLEDDHRL-----LVYEFMPRGS---LENHLFRRGSYF 176
AE N L L HPN+VK G + D + LV E GS L L G
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG--- 122
Query: 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
Q L + + GA G+ LH ++I+RD K +NILL T KL DFG++ T
Sbjct: 123 QRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LT 179
Query: 237 GDQSHVSTRVMGTYGYAAPEYLATGH-----LTAKSDVYSFGVVLLEMLSG 282
+ +T V GT + APE +A A+ DV+S G+ +E+ G
Sbjct: 180 STRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 80 LGEGGFGSVF----KGWIDEHSFAATKPGTGMVIAVKRLN-QDGFQGHKEWLAEVNYLGQ 134
LG+G FG+V+ K + E K I V LN + Q ++E L +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKE-----IPVGELNPNETVQANQE----AQLLSK 58
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLE---NHLFRRGSYF---QPLSWNLRLKVA 188
L HP +VK LE D ++ E+ L+ L G Q W ++L +
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
GV ++H + ++++RD K NI L N K+ DFG+++ ++T G
Sbjct: 118 -----GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFTG 167
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEM 279
T Y +PE L +KSD++S G +L EM
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 66/233 (28%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+ P +G G +G V +A T +A+K++ + F K L
Sbjct: 4 DTKYVPIKPIGRGAYGIVC---------SAKNSETNEKVAIKKIA-NAFDNRIDAKRTLR 53
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHR------LLVYEFMPRGSLENHLFRRGSYFQPLSW 181
E+ L L H N++ + + HR +VYE M + H R S Q LS
Sbjct: 54 EIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSS--QTLSD 107
Query: 182 N---------LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
+ LR G+ ++H A V++RD K SN+LL+ N + K+ DFGLA+
Sbjct: 108 DHCQYFLYQLLR---------GLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR 156
Query: 233 DGPTGDQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGRR 284
T ++ T + T Y APE L T DV+S G + E+L GR+
Sbjct: 157 --TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL----NQDGFQ-GHKEWLAE 128
+ P + +G G +G+V+K A P +G +A+K + N+DG +A
Sbjct: 2 YEPVAEIGVGAYGTVYK---------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL 52
Query: 129 VNYLGQLYHPNLVKLVGYC--LEDDHRL---LVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
+ L HPN+V+L+ C D LV+E + + L +L + P
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK 111
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
L +G+ FLH +++RD K NIL+ + KL+DFGLA+
Sbjct: 112 DLMRQF--LRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMAL 164
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280
T V+ T Y APE L D++S G + EM
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-10
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YH 137
++G G +G V+KG TG + A+K ++ G + +E E+N L + +H
Sbjct: 13 LVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHH 62
Query: 138 PNLVKLVGYCLE------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
N+ G ++ DD LV EF GS+ + + + + L +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREI 120
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTGDQSHVSTRVMGT 249
+G++ LH + KVI+RD K N+LL N KL DFG++ D G ++ +GT
Sbjct: 121 LRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TFIGT 174
Query: 250 YGYAAPEYLATGH-----LTAKSDVYSFGVVLLEMLSG 282
+ APE +A KSD++S G+ +EM G
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 40/121 (33%), Positives = 54/121 (44%), Gaps = 3/121 (2%)
Query: 178 PLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237
PL + + + +A+LHG +I+RD KT NI LD NA L DFG A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 238 DQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAV-DKNRPSGEHN 296
+ GT +PE LA AK+D++S G+VL EM + K S
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ 298
Query: 297 L 297
L
Sbjct: 299 L 299
|
Length = 392 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ--DGFQGHKEWLAEVNY 131
++ V+G+G +G V ID H TG +A+K++N + L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTH--------TGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHR-----LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
L L HP++V++ L R +V+E M S + + + P L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK----DGPTGD--QS 240
L + + ++H A V +RD K NIL + + K+ DFGLA+ D PT
Sbjct: 111 QLL---RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 241 HVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGR 283
+V+TR Y APE + T D++S G + E+L+G+
Sbjct: 166 YVATR-----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
V+GEG FG + + +H + K + RL + ++ E L ++ HP
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQK----YAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHP 58
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQP---LSWNLRLKVALGAAKG 194
N+V D H +V E+ G L + +RG F L W +++ + G
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------G 112
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
V +H E +V++RD K+ NI L N KL DFG A+ T ++ T V GT Y
Sbjct: 113 VQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYVP 168
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKN 289
PE KSD++S G +L E+ + + N
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 71/267 (26%), Positives = 104/267 (38%), Gaps = 73/267 (27%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQL-Y 136
VLG G FG V ++ +F K + +AVK L + HK ++E+ L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 137 HPNLVKLVGYCLEDDHRLLV-YEF------------------------------------ 159
H N+V L+G C + + L+V EF
Sbjct: 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129
Query: 160 ------MPRGSLENHLFRRGS----------------YFQPLSWNLRLKVALGAAKGVAF 197
+ LF R + PL+ + + A+G+ F
Sbjct: 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEF 189
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV---STRVMGTYGYAA 254
L A K I+RD NILL N K+ DFGLA+D D +V S R+ + A
Sbjct: 190 L--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGSARL--PLKWMA 244
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLS 281
PE + T +SDV+SFGV+L E+ S
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 62/253 (24%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ-DGFQGHKEWLAEV-- 129
+F V+G G FG V K TG + A+K+L + + + KE +A V
Sbjct: 2 DFESIKVIGRGAFGEVR---------LVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 130 --NYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
+ L + +P +VKL Y +D++ L L+ E++P G + L ++ ++ + + R
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---RFY 106
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL---------------- 230
+A + +H + I+RD K N+LLD + KLSDFGL
Sbjct: 107 IA-ETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163
Query: 231 AKDGPTGDQSHVST---------------RVM-----GTYGYAAPE-YLATGHLTAKSDV 269
+ P+ +S R + GT Y APE +L TG+ + D
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDW 222
Query: 270 YSFGVVLLEMLSG 282
+S GV++ EML G
Sbjct: 223 WSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 26/180 (14%)
Query: 111 VKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLF 170
+KR + F ++ +A N P +V+L +D + +V E+MP G L N +
Sbjct: 82 IKRSDSAFFWEERDIMAFAN------SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM- 134
Query: 171 RRGSYFQPLSW----NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226
+Y P W + +AL A + +H RD K N+LLD + + KL+
Sbjct: 135 --SNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLA 184
Query: 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDVYSFGVVLLEMLSG 282
DFG T V GT Y +PE L + G+ + D +S GV L EML G
Sbjct: 185 DFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 71/280 (25%), Positives = 110/280 (39%), Gaps = 72/280 (25%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ-DGFQ----GHKEWLAE 128
F +G G FG V + K T + A+K L + D H + AE
Sbjct: 3 FVKIKTIGIGAFGEV---CL------VRKVDTNALYAMKTLRKADVLMRNQAAHVK--AE 51
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLRL 185
+ L + + +VKL Y +D L V +++P G + + L R G + + L+ + L
Sbjct: 52 RDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAEL 110
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL---------AKDGPT 236
A+ + + F+H RD K NIL+D + + KL+DFGL +K
Sbjct: 111 TCAIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162
Query: 237 GDQSHVS---------------------------TRVM-----GTYGYAAPEYLA-TGHL 263
GD R + GT Y APE L TG+
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY- 221
Query: 264 TAKSDVYSFGVVLLEMLSGRRAVDKNRPSG-EHNLVEWAK 302
T D +S GV+L EML G+ + P+ + ++ W
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 32/239 (13%)
Query: 58 NLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD 117
+L S L+ F V+G G +G V+KG H K G I V + +D
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKG---RH----VKTGQLAAIKVMDVTED 54
Query: 118 GFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE------DDHRLLVYEFMPRGSLENHLF 170
+E E+N L + +H N+ G ++ DD LV EF GS+ + +
Sbjct: 55 E---EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV- 110
Query: 171 RRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230
+ + L + + +G+A LH KVI+RD K N+LL N KL DFG+
Sbjct: 111 -KNTKGNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTENAEVKLVDFGV 167
Query: 231 AK--DGPTGDQSHVSTRVMGTYGYAAPEYLATGH-----LTAKSDVYSFGVVLLEMLSG 282
+ D G ++ +GT + APE +A +SD++S G+ +EM G
Sbjct: 168 SAQLDRTVGRRN----TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 69/249 (27%), Positives = 101/249 (40%), Gaps = 57/249 (22%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAE 128
++F+ +LG+G G VF GTG + A+K L++ + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF---------LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L L HP L L + + LV ++ P G L L +R QP L +VA
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR----QPGKC-LSEEVA 105
Query: 189 -LGAAKGVA---FLH--GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK-----DGPTG 237
AA+ + +LH G ++YRD K NILL + + LSDF L+K P
Sbjct: 106 RFYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 238 DQSHVSTRVM----------------------GTYGYAAPEYLA-TGHLTAKSDVYSFGV 274
+R GT Y APE ++ GH + D ++ G+
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGI 220
Query: 275 VLLEMLSGR 283
+L EML G
Sbjct: 221 LLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE 124
DL + + RP LG G G VF +D +AVK++ Q K
Sbjct: 1 FDLGSRYMDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKH 48
Query: 125 WLAEVNYLGQLYHPNLVKLV------GYCLEDDHRLL--------VYEFMPRGSLENHLF 170
L E+ + +L H N+VK+ G L +D L V E+M E L
Sbjct: 49 ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL- 102
Query: 171 RRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLSDFG 229
PLS +G+ ++H A V++RD K +N+ ++T + K+ DFG
Sbjct: 103 ANVLEQGPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFG 160
Query: 230 LAK--DGPTGDQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
LA+ D + ++S ++ + Y +P L+ + T D+++ G + EML+G+
Sbjct: 161 LARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 39/268 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+GEG G V A + +G +AVK ++ Q + EV + H N
Sbjct: 29 IGEGSTGIVC---------IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK------VALGAAK 193
+V++ L + ++ EF+ G+L + + RL V +
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTD-----------IVSQTRLNEEQIATVCESVLQ 128
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGT 249
+ +LH VI+RD K+ +ILL + KLSDFG ++KD P ++GT
Sbjct: 129 ALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGT 180
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP-SGEHNLVEWAKPYLASK 308
+ APE ++ + D++S G++++EM+ G + P L + P L +
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNA 240
Query: 309 RKIFRIIDNRLEGQYTLEGAYKAATLAL 336
KI ++ + LE T E +A L
Sbjct: 241 HKISPVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 26/222 (11%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN-QDGFQGHK-EWLAEV 129
+ + + +GEG +G VFK A G +A+KR+ Q G +G + EV
Sbjct: 1 QQYECVAEIGEGAYGKVFK--------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 52
Query: 130 NYLGQLY---HPNLVKLVGYCL-----EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSW 181
L L HPN+V+L C + LV+E + + L +L + P
Sbjct: 53 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 111
Query: 182 NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSH 241
+ L +G+ FLH +V++RD K NIL+ ++ KL+DFGLA+
Sbjct: 112 IKDMMFQL--LRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 164
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T V+ T Y APE L D++S G + EM +
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 16/187 (8%)
Query: 128 EVNYLGQLYHPNLVKLV-GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQP----LSWN 182
E L QL HPN+V + ED +V F G L + L + P + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+++ +AL +LH E +++RD KT N+ L K+ D G+A+ +Q +
Sbjct: 109 VQIAMAL------QYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDM 158
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD-KNRPSGEHNLVEWA 301
++ ++GT Y +PE + KSDV++ G + EM + + A + K+ S + ++E
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218
Query: 302 KPYLASK 308
P +
Sbjct: 219 LPPMPKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 34/93 (36%), Positives = 49/93 (52%)
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+A H +I+RD K++NILL +N KL DFG +K V GT Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
PE + K+D++S GV+L E+L+ +R D
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHP 138
+G G FG V I T G V+ VK L + + E+L + + L HP
Sbjct: 3 IGNGWFGKVLLSEI------YTDTGVARVV-VKELKANASSKEQNEFLQQGDPYRILQHP 55
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+++ +G C+E LLV+E+ G L+++L + + + L ++A A GV +
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
H + ++ D N L ++ K+ D+G+ D + APE +
Sbjct: 116 H--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 259 ATGH---LTAK----SDVYSFGVVLLEML 280
H +TA+ S+V++ GV L E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 18/159 (11%)
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLRLKVALGAAKGV 195
PN+V L Y + +D LV + G L +H+ F W + VAL A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTRVMGTYGYAA 254
LH ++ RD +NILLD + +L+ F + + D V Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293
PE T D +S G +L E+L+G + + + PSG
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 73/237 (30%), Positives = 99/237 (41%), Gaps = 31/237 (13%)
Query: 60 KSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF 119
K+ F + + +G+G +G VFK G AVK L+
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFK---------VLNKKNGSKAAVKILDPI-H 55
Query: 120 QGHKEWLAEVNYLGQLY-HPNLVKLVG-YCLED----DHRLLVYEFMPRGS---LENHLF 170
+E AE N L L HPN+VK G Y +D D LV E GS L
Sbjct: 56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 171 RRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230
+RG + L AL G+ LH K I+RD K +NILL T KL DFG+
Sbjct: 116 KRGERMEEPIIAYILHEAL---MGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-----LTAKSDVYSFGVVLLEMLSG 282
+ T + +T V GT + APE +A A+ DV+S G+ +E+ G
Sbjct: 171 SAQ-LTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LGEG + +VFKG T ++A+K + + +G + EV+ L L H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V L + LV+E++ L+ +L G+ + + + L +G+++
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYC 119
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE-Y 257
H + K+++RD K N+L++ KL+DFGLA+ +++ + V T Y P+
Sbjct: 120 H--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGR 283
L + + D++ G +L EM +GR
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHK-EWLAEVNYLGQL 135
LGEG + +V+KG + TG ++A+K RL + +G + E + L L
Sbjct: 12 KLGEGSYATVYKG-RSKL--------TGQLVALKEIRLEHE--EGAPFTAIREASLLKDL 60
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
H N+V L LV+E++ L+ ++ G + L L L +G+
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGL 116
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL--AKDGPTGDQSHVSTRVMGTYGYA 253
A+ H +V++RD K N+L+ KL+DFGL AK P+ S+ V+ T Y
Sbjct: 117 AYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---EVV-TLWYR 170
Query: 254 APE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
P+ L + + D++ G + EM +GR
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 69/261 (26%), Positives = 127/261 (48%), Gaps = 60/261 (22%)
Query: 50 EGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVI 109
+ +I RSPN ++++ +++G G FG V++ A T +
Sbjct: 57 DNDINRSPN-------------KSYKLGNIIGNGSFGVVYE---------AICIDTSEKV 94
Query: 110 AVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGY----CLEDDHRLL----VYEFMP 161
A+K++ QD ++E L N L H N++ L Y C + + + + V EF+P
Sbjct: 95 AIKKVLQDPQYKNRELLIMKN----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150
Query: 162 RGSLENHL--FRRGSYFQPLSWNLRLKV-ALGAAKGVAFLHGAETKVI-YRDFKTSNILL 217
+ ++ ++ + R ++ PL +K+ + + +A++H +K I +RD K N+L+
Sbjct: 151 Q-TVHKYMKHYARNNHALPL---FLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLI 203
Query: 218 DTN-YNAKLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFG 273
D N + KL DFG AK+ G + S++ +R Y APE L + T D++S G
Sbjct: 204 DPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLG 258
Query: 274 VVLLEML------SGRRAVDK 288
++ EM+ SG+ +VD+
Sbjct: 259 CIIAEMILGYPIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA---- 127
++F S++G G FG V + TG + A+K + + +E ++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ---------VVREKATGDIYAMKVMKKSVL-LAQETVSFFEE 50
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNL--- 183
E + L P + +L Y +D L LV E+ P G L + L R Y ++
Sbjct: 51 ERDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQF 106
Query: 184 ---RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
L +A+ + + ++H RD K N+L+D + KL+DFG A T ++
Sbjct: 107 YLAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSAA-RLTANKM 157
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKS------DVYSFGVVLLEMLSGR 283
S +GT Y APE L T + K D +S GV+ EM+ GR
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LGEG + +V+KG T ++A+K + + +G + EV+ L L H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V L + LV+E++ + L+ +L G+ + L L L +G+ +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYC 120
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE-Y 257
H KV++RD K N+L++ KL+DFGLA+ +++ + V T Y P+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGR 283
L + + + D++ G + EM +GR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 41/110 (37%), Positives = 58/110 (52%), Gaps = 8/110 (7%)
Query: 175 YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234
Y +PL+ + + A+G+ FL A K I+RD NILL N K+ DFGLA+D
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD- 222
Query: 235 PTGDQSHV---STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
D +V R+ + APE + T +SDV+SFGV+L E+ S
Sbjct: 223 IYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LGEG + +V+KG G ++A+K ++ +G + E + L L H
Sbjct: 13 LGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V L + V+E+M L ++ + P +N+RL +G+A++
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHP--YNVRL-FMFQLLRGLAYI 119
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
HG +++RD K N+L+ KL+DFGLA+ Q++ S V T Y P+ L
Sbjct: 120 HG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 259 --ATGHLTAKSDVYSFGVVLLEMLSGR 283
AT + +A D++ G + +EML G+
Sbjct: 176 LGATDYSSA-LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+G G +G V+K A TG + A+K + + + E+ + H N
Sbjct: 17 IGSGTYGDVYK---------ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V G L D + EF GSL++ G PLS + V+ +G+ +LH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLH 123
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
++RD K +NILL N + KL+DFG++ S +GT + APE A
Sbjct: 124 SKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAA 179
Query: 260 T---GHLTAKSDVYSFGVVLLEM 279
G D+++ G+ +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQ 134
S +G G +GSV AA TG+ +AVK+L++ FQ K E+ L
Sbjct: 23 SPVGSGAYGSVC---------AAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 72
Query: 135 LYHPNLVKLV-----GYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
+ H N++ L+ LE+ + LV M G+ N++ + Q L+ + +
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK----CQKLTDDHVQFLI 126
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+G+ ++H A+ +I+RD K SN+ ++ + K+ DFGLA+ +V+TR
Sbjct: 127 YQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 181
Query: 249 TYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGR 283
Y APE + H D++S G ++ E+L+GR
Sbjct: 182 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQLY 136
+G G +G+V +A TG +A+K+L + FQ K E+ L +
Sbjct: 23 VGSGAYGTVC---------SALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMK 72
Query: 137 HPNLVKLVGY-----CLEDDHRL-LVYEFMPR--GSLENHLFRRGSYFQPLSWNLRLKVA 188
H N++ L+ L+ H LV FM G L H Q L + +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM----- 127
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
KG+ ++H A +I+RD K N+ ++ + K+ DFGLA+ + +V TR
Sbjct: 128 ---LKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR--- 179
Query: 249 TYGYAAPEY-LATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L H T D++S G ++ EML+G+
Sbjct: 180 --WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
PL + L+ + A+G+ FL A I+RD N+LL AK+ DFGLA+D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IM 263
Query: 237 GDQSHVSTRVMGT----YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
D ++V V G + APE + T +SDV+S+G++L E+ S
Sbjct: 264 NDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 53/245 (21%), Positives = 96/245 (39%), Gaps = 52/245 (21%)
Query: 71 TRNFRP-DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-------- 121
+ + + LGEG +G V K A TG ++A+K++
Sbjct: 7 SERYIQKGAHLGEGTYGKVEK---------AYDTLTGKIVAIKKVKIIEISNDVTKDRQL 57
Query: 122 ------HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMP---RGSLENHLFRR 172
H L E+ + ++ H N++ LV +E D LV + M + ++ +
Sbjct: 58 VGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLT 117
Query: 173 GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
S + + + G+ LH + ++RD +NI +++ K++DFGLA+
Sbjct: 118 ESQVKCILLQI--------LNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
Query: 233 -------DGPTGDQSHVSTRVMGTYG-----YAAPEYL--ATGHLTAKSDVYSFGVVLLE 278
+ R T Y APE L A + A D++S G + E
Sbjct: 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAE 226
Query: 279 MLSGR 283
+L+G+
Sbjct: 227 LLTGK 231
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQLY 136
+G G +GSV ID+ TG +A+K+L++ FQ K E+ L +
Sbjct: 23 VGSGAYGSVCSA-IDKR--------TGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQ 72
Query: 137 HPNLVKL--------VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
H N++ L G +D + ++ Y + H Q L + +
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK-VQYLVYQM----- 126
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
G+ ++H A +I+RD K N+ ++ + K+ DFGLA+ +V TR
Sbjct: 127 ---LCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 178
Query: 249 TYGYAAPEY-LATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L H D++S G ++ EML+G+
Sbjct: 179 --WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
AKG++FL A I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ APE + T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVNYLGQLYH 137
+GEG +G V+K A TG ++A+K RL D L E++ L L
Sbjct: 9 IGEGTYGKVYK---------ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 138 -PNLVKL--VGYCLEDDHRL---LVYEFMPRGSLENHLFR-RGSYFQPLSWNLRLKVALG 190
+V+L V + E + + LV+E++ L+ + +PL
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA-KLSDFGLAKDG--PTGDQSHVSTRVM 247
KGVA H V++RD K N+L+D K++D GL + P +H +
Sbjct: 119 LLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EI 172
Query: 248 GTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSG 282
T Y APE L + H + D++S G + EM
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 4/159 (2%)
Query: 127 AEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
+E++ L H +VK DD LL+ E+ G L + +R P +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYE 170
Query: 187 VALGAAKGVAFLHGAET-KVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
V L + V L + K+++RD K++NI L KL DFG +K V++
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
GT Y APE + K+D++S GV+L E+L+ R
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 8/106 (7%)
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRVMGTY 250
G+ ++H A V++RD K N+L++ + K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173
Query: 251 GYAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGRRAVDKNRPSGEH 295
Y APE + + K+ DV+S G +L E+L GR+ V K + +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 80 LGEGGFGSVFKG----WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL 135
LG+G F +FKG D T+ + +K L++ + + + + QL
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTE------VLLKVLDKSHRNYSESFFEAASMMSQL 56
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
H +LV G C+ D ++V E++ GSL+ +L + + +SW +L+VA A +
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI-NISW--KLEVAKQLAWAL 113
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT--YGYA 253
FL + + + + N+LL + K + K G V + + +
Sbjct: 114 HFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 254 APEYLATG-HLTAKSDVYSFGVVLLEMLSG 282
PE + +L+ +D +SFG L E+ SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 66/263 (25%), Positives = 100/263 (38%), Gaps = 73/263 (27%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEV-- 129
+F V+G+G FG V K TG + A+K L + F+ K+ LA V
Sbjct: 2 DFHTVKVIGKGAFGEVR---------LVQKKDTGKIYAMKTLLKSEMFK--KDQLAHVKA 50
Query: 130 --NYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLR 184
+ L + P +V L Y +D L L+ EF+P G L L + ++ + ++ +
Sbjct: 51 ERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE 109
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL-------------- 230
+A+ A + F+H RD K NIL+D + KLSDFGL
Sbjct: 110 CVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 231 -------AKDGPTGDQSHV-------------------STRVM-----GTYGYAAPEYLA 259
K+ S + R+M GT Y APE
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 260 TGHLTAKSDVYSFGVVLLEMLSG 282
+ D +S G ++ E L G
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216
Y+ ++N L G + L+ L A+G+ FL A ++RD N+L
Sbjct: 214 YKGSNDSEVKNLLSDDG--SEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVL 269
Query: 217 LDTNYNAKLSDFGLAKDGPTGDQSHVST-RVMGTYGYAAPEYLATGHLTAKSDVYSFGVV 275
L K+ DFGLA+D D ++VS + APE + T SDV+S+G++
Sbjct: 270 LAQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 276 LLEMLS 281
L E+ S
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHP 138
LGEG + +V+KG G ++A+K + +G + E + L L H
Sbjct: 13 LGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V L + LV+E++ L ++ + P + L L L +G++++
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYI 119
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE-Y 257
H + +++RD K N+L+ KL+DFGLA+ SH + + T Y P+
Sbjct: 120 H--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVL 175
Query: 258 LATGHLTAKSDVYSFGVVLLEMLSGRRA 285
L + + D++ G + +EM+ G A
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+G G +G V+K A TG + AVK + + E+ + + H N
Sbjct: 17 VGSGTYGDVYK---------ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+V G L + + E+ GSL++ G PLS V +G+A+LH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLH 123
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA 259
++RD K +NILL N + KL+DFG+A S +GT + APE A
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAA 179
Query: 260 ---TGHLTAKSDVYSFGVVLLEM 279
G D+++ G+ +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 33/86 (38%), Positives = 46/86 (53%), Gaps = 14/86 (16%)
Query: 206 IYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGTYGYAAPEYL--- 258
++RD K N+LLD N + +L+DFG L DG QS+V+ +GT Y +PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNVA---VGTPDYISPEILQAM 178
Query: 259 --ATGHLTAKSDVYSFGVVLLEMLSG 282
G + D +S GV + EML G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEW-LAEVNYLGQLY 136
V+GEG +G V K E T ++A+K+ + + + KE L E+ L L
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 137 HPNLVKLVGYCLEDDHRLLVYEF-----------MPRGSLENHLFRRGSYFQPLSWNLRL 185
N+V+L LV+E+ MP G + R +Q +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV--RSYIYQLI------ 110
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
K + + H + +++RD K N+L+ N KL DFG A++ G ++ T
Sbjct: 111 -------KAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TE 160
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ T Y +PE L D++S G +L E+ G+
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 51/201 (25%), Positives = 78/201 (38%), Gaps = 41/201 (20%)
Query: 105 TGMVIAVKRLNQDGFQGHKEWL---AEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFM 160
T ++AVK++N D ++ E+ QL HPN++ V D L +V M
Sbjct: 24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDSELYVVSPLM 81
Query: 161 PRGS----LENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216
GS L+ H F G L+ LK L + ++H I+R K S+IL
Sbjct: 82 AYGSCEDLLKTH-FPEG--LPELAIAFILKDVL---NALDYIH--SKGFIHRSVKASHIL 133
Query: 217 LDTNYNAKLSDF----GLAKDG---------PTGDQSHVSTRVMGTYGYAAPEYLATGHL 263
L + LS + K G P ++ + +PE L
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--------WLSPEVLQQNLQ 185
Query: 264 --TAKSDVYSFGVVLLEMLSG 282
KSD+YS G+ E+ +G
Sbjct: 186 GYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 61/251 (24%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----E 128
+F V+G G FG V K TG + A+K L + KE +A E
Sbjct: 2 DFESLKVIGRGAFGEVR---------LVQKKDTGHIYAMKILRKADML-EKEQVAHIRAE 51
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLRL 185
+ L + +VK+ Y +D L L+ EF+P G + L ++ + + + +
Sbjct: 52 RDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA-------------- 231
+A+ A + F+H RD K N+LLD + KLSDFGL
Sbjct: 111 VLAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 232 -KDGPTGDQS------------------HVSTRVMGTYGYAAPE-YLATGHLTAKSDVYS 271
P D S ++ +GT Y APE ++ TG+ D +S
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWS 221
Query: 272 FGVVLLEMLSG 282
GV++ EML G
Sbjct: 222 LGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T S + T + T Y
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 254 APEY-LATGHLTAKSDVYSFGVVLLEMLSGR 283
APE L G+ D++S G ++ EM+ G
Sbjct: 185 APEVILGMGY-KENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 65/255 (25%), Positives = 102/255 (40%), Gaps = 69/255 (27%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL---AEVNYLGQLY 136
LG G FG V A K T + A+K L + + AE + L +
Sbjct: 9 LGIGAFGEVC---------LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD 59
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLS--WNLRLKVALGAAK 193
+ +V+L Y +D D+ V +++P G + + L R G + + L+ + L A+ +
Sbjct: 60 NEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL---------AKDGPTGD------ 238
+ F+H RD K NIL+D + + KL+DFGL +K +GD
Sbjct: 119 KMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 239 ------------------------------QSHVSTRVMGTYGYAAPEYLATGHLTAKSD 268
Q ++ ++GT Y APE L T D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230
Query: 269 VYSFGVVLLEMLSGR 283
+S GV+L EML G+
Sbjct: 231 WWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAE 128
+N P +G G +GSV +A +AVK+L++ FQ + E
Sbjct: 18 QNLTP---VGSGAYGSVC---------SAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRE 64
Query: 129 VNYLGQLYHPNLVKLV-----GYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWN 182
+ L + H N++ L+ +E+ + + LV M G+ N++ + Q LS
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVK----CQKLSDE 118
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+ +G+ ++H A +I+RD K SN+ ++ + ++ DFGLA+ +V
Sbjct: 119 HVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV 176
Query: 243 STRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
+TR Y APE L H D++S G ++ E+L G+
Sbjct: 177 ATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 69/255 (27%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL---AEVNYLGQLY 136
LG G FG V A K T + A+K L + + AE + L +
Sbjct: 9 LGIGAFGEVC---------LACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 137 HPNLVKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLS--WNLRLKVALGAAK 193
+ +VKL Y +D D+ V +++P G + + L R + + L+ + L +A+ +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL----------------------- 230
+ F+H RD K NIL+D + + KL+DFGL
Sbjct: 119 KMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 231 ---------AKDGPTGD-------------QSHVSTRVMGTYGYAAPEYLATGHLTAKSD 268
+ GD Q ++ ++GT Y APE L T D
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 269 VYSFGVVLLEMLSGR 283
+S GV+L EML G+
Sbjct: 231 WWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T S + T + T Y
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
APE + D++S G ++ EM+ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T + + T + T Y
Sbjct: 135 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE + D++S G ++ E++ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 32/86 (37%), Positives = 46/86 (53%), Gaps = 14/86 (16%)
Query: 206 IYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGTYGYAAPEYL--- 258
++RD K N+LLD N + +L+DFG + +DG QS V+ +GT Y +PE L
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSVA---VGTPDYISPEILQAM 178
Query: 259 --ATGHLTAKSDVYSFGVVLLEMLSG 282
G + D +S GV + EML G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T S + T + T Y
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLS------GRRAVDK 288
APE + D++S G ++ EM+ GR +D+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 46/147 (31%), Positives = 66/147 (44%), Gaps = 20/147 (13%)
Query: 146 YCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK 204
Y +D++ L LV ++ G L L + L + A V LH
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH----- 122
Query: 205 VIYRDFKTSNILLDTNYNAKLSDFG----LAKDGPTGDQSHVSTRVMGTYGYAAPEYL-- 258
++RD K NIL+D N + +L+DFG L +DG QS V+ +GT Y +PE L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVA---VGTPDYISPEILQA 177
Query: 259 ---ATGHLTAKSDVYSFGVVLLEMLSG 282
G + D +S GV + EML G
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 35/170 (20%)
Query: 128 EVNYLGQLYHPNLVKL--------VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL 179
E+ LG+L H N++K+ Y + + +Y FM + + +PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-------DRPL 265
Query: 180 SWNLR--LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237
R +K L A V ++H + K+I+RD K NI L+ + L DFG A
Sbjct: 266 LKQTRAIMKQLLCA---VEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTA------ 314
Query: 238 DQSHVSTRVMGTYGYA------APEYLATGHLTAKSDVYSFGVVLLEMLS 281
R YG+ +PE LA +D++S G++LL+MLS
Sbjct: 315 -MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 5e-06
Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 29/187 (15%)
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLL--VYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
EVN + +L H N+V+ + L ++ L + EF G L ++ + F + + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 186 KVALGAAKGVAFLHGAE-----TKVIYRDFKTSNILLDT-------------NYN----A 223
+ +A+ H + +V++RD K NI L T N N A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLS 281
K+ DFGL+K+ +H +GT Y +PE L T KSD+++ G ++ E+ S
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238
Query: 282 GRRAVDK 288
G+ K
Sbjct: 239 GKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 64/255 (25%), Positives = 99/255 (38%), Gaps = 69/255 (27%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ-DGFQ----GHKEWLA 127
+F V+G G FG V K TG V A+K L + D + GH A
Sbjct: 2 DFESLKVIGRGAFGEVR---------LVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS--WNLR 184
E + L + +VK+ Y +D L L+ EF+P G + L ++ + + + +
Sbjct: 51 ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG------- 237
+A+ + + F+H RD K N+LLD+ + KLSDFGL TG
Sbjct: 110 TVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLC----TGLKKAHRT 157
Query: 238 ------------------------------DQSHVSTRVMGTYGYAAPEYLATGHLTAKS 267
++ ++ +GT Y APE
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC 217
Query: 268 DVYSFGVVLLEMLSG 282
D +S GV++ EML G
Sbjct: 218 DWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 35/117 (29%), Positives = 51/117 (43%), Gaps = 5/117 (4%)
Query: 162 RGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221
R L +L R PL VA + ++HG +I+RD KT N+L++
Sbjct: 243 RSDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPE 297
Query: 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLE 278
+ L DFG A + + GT APE LA T D++S G+V+ E
Sbjct: 298 DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
E + L + HP++++L G + L+ +PR + + + + L ++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
++ + + +LH E ++I+RD K NI ++ + L DFG A P ++
Sbjct: 190 SV--LRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAV 286
GT APE LA D++S G+VL EM + ++
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD 238
LS+ + + A G+ FL A ++RD N+L+ K+ DFGLA+D D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARD-IMRD 292
Query: 239 QSHVST-RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+++S + APE + T SDV+SFG++L E+ +
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 80 LGEGGFGSVFKG----WIDEHSFAATK-PGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ 134
+G G +G V+K DE +A + GTG+ ++ R E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 135 LYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYF--QPLSWNLRLKVAL- 189
L HPN++ L L R L++++ F R S +P+ + +L
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114
Query: 190 -GAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAK--DGPTGDQSHV 242
G+ +LH V++RD K +NIL+ K++D G A+ + P + +
Sbjct: 115 YQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 243 STRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVLLEMLS 281
V+ T+ Y APE L H T D+++ G + E+L+
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 10/102 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAE----VNYLGQ 134
LG G FG V ++ ++ K M +AVK L +E L ++YLG
Sbjct: 42 TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF 176
H N+V L+G C L++ E+ G L N L R+ F
Sbjct: 98 --HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 23/156 (14%)
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
Q+ H ++V L G C+ D ++V EF+ G L+ + R+ L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLAS 116
Query: 194 GVAFLHGAETKVIYRDFKTSNILL-----DTNYNA--KLSDFGLAKDGPTGDQSHVSTR- 245
+++L + +++ + T NILL D KLSD G+ V +R
Sbjct: 117 ALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT--------VLSRQ 166
Query: 246 -VMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEM 279
+ + APE + + +L+ +D +SFG L E+
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 35/220 (15%)
Query: 80 LGEGGFGSVFKG----WIDEHSFAATK-PGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ 134
+G G +G V+K D+ +A + GTG+ ++ R E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 135 LYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQP----LSWNLRLKVA 188
L HPN++ L L R L++++ F R S L + +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAK--DGPTGDQSHV 242
G+ +LH V++RD K +NIL+ K++D G A+ + P + +
Sbjct: 115 YQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 243 STRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVLLEMLS 281
V+ T+ Y APE L H T D+++ G + E+L+
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 13/91 (14%)
Query: 205 VIYRDFKTSNILLDTNYNAKLSDFGLAKDG-------------PTGDQSHVSTRVMGTYG 251
+++RD K N+L+ + + KL+DFGL+K G + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
Y APE + D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 6/107 (5%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL-AEVNYLGQL-Y 136
LG G FG V ++ +F K + +AVK L +E L +E+ L L
Sbjct: 45 TLGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQ 100
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
H N+V L+G C L++ E+ G L N L ++ F L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMAL 147
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF-QPLSWNLRLKVALGAAKGV 195
HPN++ ++ FM GS N L + +YF + +S L + GA +G+
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLLK--TYFPEGMSEALIGNILFGALRGL 114
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSD----FGLAKDGPTG----DQSHVSTRVM 247
+LH + I+R+ K S+IL+ + LS + L ++G D ST V+
Sbjct: 115 NYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL 172
Query: 248 GTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGR 283
+ +PE L G+ KSD+YS G+ E+ +GR
Sbjct: 173 P---WLSPELLRQDLYGY-NVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 404 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.33 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.21 | |
| PLN02236 | 344 | choline kinase | 97.07 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.91 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.77 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.51 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.51 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.34 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.85 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.74 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.73 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.72 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.67 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.26 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.2 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=380.74 Aligned_cols=290 Identities=57% Similarity=0.971 Sum_probs=250.9
Q ss_pred CCCccCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC
Q 046897 58 NLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137 (404)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 137 (404)
....|++.++..++++|...++||+|+||.||+|.+.+ +..||||++.........+|..|+.+|.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56789999999999999999999999999999998764 47899998877543314569999999999999
Q ss_pred CCcceEEEEEEeCC-eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCceecCCCCCcE
Q 046897 138 PNLVKLVGYCLEDD-HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA-ETKVIYRDFKTSNI 215 (404)
Q Consensus 138 p~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~i~H~Dlkp~NI 215 (404)
||+|+++|||.+.+ +.+||+||+++|+|.++++..... +++|..+++|+.++|+||+|||.. ...|+|||||++||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999999999998 599999999999999999876532 789999999999999999999953 23699999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCCCcceeec-cccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV-MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~ 294 (404)
|+|+++..||+|||+|...+.. .. ..... .||.+|++||.+..+..+.++||||||+++.||++|+.+.+...+...
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~-~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEG-DT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred eECCCCCEEccCccCcccCCcc-cc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 9999999999999999765431 11 11222 799999999999888999999999999999999999999987766666
Q ss_pred cchhhhhhhhhhhccccchhhccccc-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLE-GQYTL-EGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
..++.|..+.+.+. .+.+++|+.+. ..+.. .....+..++.+|++.+|++||+|.+|++.|+.+...
T Consensus 287 ~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 287 LSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 77899997776655 89999999987 66665 5778899999999999999999999999999766544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=368.14 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=211.5
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.+.++.||+|..|+||+ +.+..+++.+|+|++... +....+++.+|+++++..+||+||.+|+.|+.+.
T Consensus 80 dle~~~~lG~G~gG~V~k---------v~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYK---------VRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEE---------EEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 455678999999999999 677779999999999543 3344577999999999999999999999999999
Q ss_pred -eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 152 -HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 152 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
.++|+||||++|+|++++...+ .+++..+..++.+|++||.|||. ..+|+||||||+||||+..|.|||||||.
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 4999999999999999998663 58999999999999999999993 38999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+...... .....+||..|||||.+.+..|+.++||||||+.++||.+|+.||....+. .. .|+. .
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~---~~~~-------L 290 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL---DIFE-------L 290 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC---CHHH-------H
Confidence 9876543 456789999999999999999999999999999999999999999764211 11 1111 1
Q ss_pred cchhhcccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLE-GAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+..+++... ..++.+ ++.+++.++..||++||.+||++.++++.
T Consensus 291 l~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 291 LCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112222111 233443 77889999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=386.48 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=213.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD---GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+|...++||+|+|+.||. +++..+|..||+|++.+. .....+.+.+|+++.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe---------~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYE---------ARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEE---------EEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 5799999999999999999 455568999999999874 3344577899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+.+++|||.|+|..++|..++.++ +++++..++.+++||+.||.||| +.+|+|||||..|+|++++.+|||+||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEeccc
Confidence 999999999999999999999854 57999999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+|+......+ ...+.+|||.|.|||++....++..+||||+||+||.|+.|++||+...-
T Consensus 163 GLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------------- 223 (592)
T KOG0575|consen 163 GLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------------- 223 (592)
T ss_pred ceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----------------
Confidence 99998764433 35568999999999999999999999999999999999999999986431
Q ss_pred cccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..+.... ...+...+.+..+||..+|+.||.+|||+.+|+..
T Consensus 224 ---kety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 224 ---KETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---HHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122222211 23344566678899999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=359.06 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEE-EEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVG-YCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~ 148 (404)
.+|++++.||.|.||.||+ +.+..+|..+|.|.+.-... .....+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vyk---------v~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYK---------VQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEE---------eeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 4588889999999999999 66677899999999875433 22356889999999999999999999 555
Q ss_pred eCCe-eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEcCCCcEEE
Q 046897 149 EDDH-RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 149 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~~~~~vkl 225 (404)
++.. ++||||||.+|+|..+|+...+..+.+++..+|.++.|++.||..+|+.-.+ |+||||||.||||+.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 8999999999999999987666667899999999999999999999952144 999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+|||+++...... ......+|||.||+||.+.+.+|+.++|||||||++|||+.-.+||.+.+-
T Consensus 170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------------- 233 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------------- 233 (375)
T ss_pred ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------------
Confidence 9999999764432 234568999999999999999999999999999999999999999987521
Q ss_pred hhccccchhhcccccCCC---C-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQY---T-LEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~---~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
..+..+.-.+++ + ...+.++..||..|+..||+.||+...++..+.
T Consensus 234 ------~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 234 ------LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ------HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 111111112222 3 567889999999999999999998655544443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=369.28 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=208.3
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-------HHHHHHHHHHHhcCCCCCcce
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-------HKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~ 142 (404)
..+.|.+.+.||+|+||.|-+ +.+..+|+.||+|++++..... ...+.+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkl---------a~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKL---------AYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEE---------EEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 456789999999999999998 6677789999999997642221 233579999999999999999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC--
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-- 220 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-- 220 (404)
++++|...+..||||||++||+|.+.+-.++ .+.+...+.+++|++.|+.||| +.||+||||||+|||++.+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAE 314 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCc
Confidence 9999999999999999999999999998775 4777888999999999999999 8999999999999999766
Q ss_pred -CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCC---CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 221 -YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL---TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 221 -~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
..+||+|||+|...... ..+.+.|||+.|.|||++.+..+ ..++|+|||||+||-+++|.+||........
T Consensus 315 ~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-- 389 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-- 389 (475)
T ss_pred ceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--
Confidence 77999999999986533 35677999999999999976543 3478999999999999999999986443220
Q ss_pred hhhhhhhhhhhccccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+++...+.. ........++..+||.+||..||++|||+.|+|+.
T Consensus 390 -------------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 -------------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -------------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 01112222111 12334567789999999999999999999999865
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=364.63 Aligned_cols=204 Identities=31% Similarity=0.516 Sum_probs=183.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..+|.+.+.||.|+||+||+|+++ .++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~---------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK---------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEec---------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 457888999999999999996554 46789999999887 3444566889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC------Cc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN------YN 222 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~------~~ 222 (404)
.++.+|+|||||+||+|.++|+.++ .+++..+..++.||+.||++|| +++||||||||+||||+.. -.
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCce
Confidence 9999999999999999999999875 5899999999999999999999 8999999999999999765 45
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
+||+|||+|+...++. ...+.+|++.|||||++..+.|+.|+|+||+|+++|+|++|+.||+..++.
T Consensus 154 LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred EEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 8999999999876544 456789999999999999999999999999999999999999999865543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=368.47 Aligned_cols=258 Identities=34% Similarity=0.562 Sum_probs=214.6
Q ss_pred CCCCcccccCcccEEEEEecCcccccccCCCCcE-EEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 75 RPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV-IAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.+.+.||.|+||+||+|.++ |.. ||+|.+....... .+.|.+|+.+|.+++|||||+++|++.+..
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred hhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 33455999999999999885 344 9999997654333 458999999999999999999999999887
Q ss_pred -eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC-ceecCCCCCcEEEcCCC-cEEEecc
Q 046897 152 -HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK-VIYRDFKTSNILLDTNY-NAKLSDF 228 (404)
Q Consensus 152 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-i~H~Dlkp~NIll~~~~-~vkl~Df 228 (404)
.++|||||+++|+|.++++.. ....+++..++.++.||+.||.||| +.+ ||||||||+|||++.++ ++||+||
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 799999999999999999884 1257999999999999999999999 677 99999999999999998 9999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc--cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA--TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|+++...... .......||+.|||||++. ...|+.++||||||+++|||+||+.||....+..
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------------- 253 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------------- 253 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-------------
Confidence 9998654321 1233368999999999998 5689999999999999999999999998754311
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
....+.....+...+..+...+..++.+||..||..||++.+|+..|+.+......
T Consensus 254 ---~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 254 ---VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11223333344455555778899999999999999999999999999998774443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=358.44 Aligned_cols=243 Identities=29% Similarity=0.411 Sum_probs=204.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|+++++||+|+||+||. +++..+++.||+|++++..... .+....|..+|..++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~---------Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQ---------VRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEE---------EEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 46799999999999999998 5555789999999998764333 35578999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
++.+.+|+|+||+.||.|...|++.+ .+++..+..++.+|+.||.||| +++|+||||||+|||++.+|+++|+|
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEec
Confidence 99999999999999999999998765 4899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||+++..-... .....++||+.|||||++.+..|+.++|+||||+++|||++|.+||...+.. .+..
T Consensus 169 FgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~----- 235 (357)
T KOG0598|consen 169 FGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYD----- 235 (357)
T ss_pred cccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHH-----
Confidence 99998543322 2345589999999999999999999999999999999999999999864421 1111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 347 (404)
.+.... ....+.-...+.++++.++|..||++|.
T Consensus 236 -----~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 236 -----KILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----HHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111111 1122333566788999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=356.97 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=213.6
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCcceE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL-YHPNLVKL 143 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~ 143 (404)
.....+|.+++.||.|+|++|++ |++..+++.||||++.+.-. .+.+.+.+|-..|.+| .||.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~---------A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVL---------AREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEE---------eeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 34457899999999999999999 66667899999999976532 2334567888899999 79999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
+..|+++..+|+|+||+++|+|.++|.+.+ .+++.....++.+|+.||+||| +.|||||||||+|||++.+|++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHI 213 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcE
Confidence 999999999999999999999999999886 4899999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCC---------cc--eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 224 KLSDFGLAKDGPTGDQS---------HV--STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
+|+|||.|..+...... .. ...++||-.|.+||++.....++.+|||+|||++|+|+.|.+||...++.
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 99999999865433211 11 24589999999999999999999999999999999999999999875532
Q ss_pred CCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
-. ..++++ +...++...++...+|+.+.|..||.+|++..+|.+.
T Consensus 294 li----------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 LI----------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH----------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 111221 1224455556778899999999999999999888765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=339.67 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+.|+.+..+|+|+||.||+ |+++.+|+.||||.+..... ...+-.++|+++|++|+|+|+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~K---------Crnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMK---------CRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEE---------eccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 3578889999999999999 77778999999999865432 223457899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
...+++|||||+. ++.+-+.... ..++...+..++.|++.|+.|+| +++++||||||+||||+.+|.+||||||
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccch
Confidence 9999999999965 5556665554 57899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh-------
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA------- 301 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~------- 301 (404)
.|+.... .....+..+.|.+|+|||++.+ ..|+..+|||++||++.||++|.+.|.+..+.+....+...
T Consensus 147 FAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 147 FARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred hhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 9998653 2224567889999999999887 68999999999999999999999999876654332222111
Q ss_pred -hhhhhhccccchhhcccccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 -KPYLASKRKIFRIIDNRLEG-----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 -~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...+....-...+.-+.... ..-+....-+.+++..||+.||.+|++-++++..
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111111111111 1112334578899999999999999999998853
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=355.34 Aligned_cols=257 Identities=30% Similarity=0.438 Sum_probs=214.2
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCee
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
+.+.+.||+|.||.||.|+++. ...||+|.++... ...+.|.+|+.+|++|+|+|||++++++..++.+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC----------CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3446789999999999999864 2368999887753 4557899999999999999999999999998899
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
||||||++.|+|.++|..... ..+.....+.++.||++||+||+ ++++|||||...||||++++.+||+|||+|+.
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999999999987332 56889999999999999999999 89999999999999999999999999999995
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
..+. .........-...|.|||.+..+.++.++||||||++||||+| |+.||..... ..+.
T Consensus 353 ~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~ 414 (468)
T KOG0197|consen 353 IGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVL 414 (468)
T ss_pred cCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHH
Confidence 3332 2222222334567999999999999999999999999999999 8888876432 1222
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
+.++...+-..+..++..+.+++..||..+|++|||++.+...|+.+....
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 334444444566778899999999999999999999999999999876543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=355.75 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=215.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
..|.....||+|+.|.||. +.+..++..||+|++........+-++.|+.+|+..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~---------A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYV---------ARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceee---------eeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 4677788999999999998 6677788999999999887677777899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
.+|+||||++||+|.+.+... .+++.++..|+.++++||+||| .++|+|||||.+|||++.+|.+||+|||++
T Consensus 344 eLWVVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeee
Confidence 999999999999999999765 3899999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ .....+|||+|||||++....|++++||||||++++||+.|.+||-..++.....++.
T Consensus 417 aqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------ 482 (550)
T KOG0578|consen 417 AQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------ 482 (550)
T ss_pred eccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------------
Confidence 87655332 4566899999999999999999999999999999999999999997644322111110
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. +.......+...+..+.+++.+||+.|+++|+++.|+|+.
T Consensus 483 -~--ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 -T--NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -h--cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0 1112223445567789999999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=353.78 Aligned_cols=264 Identities=26% Similarity=0.365 Sum_probs=212.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhcCC-CCCcceEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE--WLAEVNYLGQLY-HPNLVKLVGY 146 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hp~iv~~~~~ 146 (404)
.-++|.+.+.||.|+||.||+| +...+|..||||.++..-.. .++ -++|+.-|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 3468899999999999999994 55557888999998775433 333 378999999998 9999999999
Q ss_pred EEeCC-eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 147 CLEDD-HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 147 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
+.+.+ .+|+||||| ..+|++++..+. ..+++..++.|+.||++||+|+| .+|+.|||+||+|||+..+..+||
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEe
Confidence 99988 999999999 669999998874 68999999999999999999999 999999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
+|||+|+...... -.+..+.|.+|+|||++. ...|+.+.|||++||+++|+.+-++.|.+.++.+....+ ..+
T Consensus 152 aDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~V 225 (538)
T KOG0661|consen 152 ADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEV 225 (538)
T ss_pred cccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHH
Confidence 9999999765433 356688999999999875 567999999999999999999999999876553322211 111
Q ss_pred hhh--------ccccchhhccccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LAS--------KRKIFRIIDNRLE-------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.. ...+...++-++. ..+-+.+..++.+++.+||..||.+|||+.++++.
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 1111111221111 11223467789999999999999999999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=327.68 Aligned_cols=237 Identities=28% Similarity=0.398 Sum_probs=205.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||.|+||+|.+ ++++.+|..+|+|++.+...... +....|.++|+.+.||+++++++.|.
T Consensus 44 ~dfe~~~tlGtGSFGrV~L---------Vr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHL---------VREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEE---------EEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 5788899999999999999 45555789999999987654443 44678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+...+|+||||++||.|..++++.+ ++++..++.++.||+.||+||| +.+|++|||||+|||+|.+|.+||+||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999998875 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|.|..... ...+.||||.|+|||++...+|+.++|.|+||+++|||+.|.+||...++...
T Consensus 189 GFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-------------- 249 (355)
T KOG0616|consen 189 GFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-------------- 249 (355)
T ss_pred cceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH--------------
Confidence 99987543 35568999999999999999999999999999999999999999987654211
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFR 346 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 346 (404)
..+|+...+ .++.....++.+|+.++|+.|-.+|
T Consensus 250 --Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 --YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 112222222 4566677788999999999999999
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=321.62 Aligned_cols=266 Identities=24% Similarity=0.315 Sum_probs=209.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.+|...+.||+|.||.||+ +++..+|+.||+|.++..+..+ ....++|++.|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyk---------a~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYK---------ARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEE---------EEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 4688899999999999999 5566689999999998764432 2457899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.+.+.+|+||+ ..+|+..+.... ..++...+..++.++++||+||| .+.|+||||||.|+||+.+|.+||+|||
T Consensus 73 ~~~l~lVfEfm-~tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 73 KSNLSLVFEFM-PTDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred CCceEEEEEec-cccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeeccc
Confidence 99999999999 559999998765 57899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh--hhhh-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA--KPYL- 305 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~--~~~~- 305 (404)
+|+.....+.. ....+-|.+|+|||++.| ..|+..+||||.||++.||+-|.+-|.+.++.+....+-.+ .+..
T Consensus 147 LAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 147 LARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred chhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 99986554432 333478999999998765 67999999999999999999999988776543322222100 0000
Q ss_pred --hhccccch------hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 --ASKRKIFR------IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 --~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+...+.+ ...+.+ ..+-..+..+..+++.+|+..||.+|++++++++.
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCccccccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00001111 111111 11223456677999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.30 Aligned_cols=258 Identities=29% Similarity=0.430 Sum_probs=206.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|...+.||+|+||.||++.. ..+|...|||.+........+.+.+|+.+|.+++|||||++++.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~---------~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATN---------KKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEEEe---------cCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 34577789999999999999554 345888999988766433356789999999999999999999975544
Q ss_pred C--eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CCcEEEec
Q 046897 151 D--HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLSD 227 (404)
Q Consensus 151 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~~vkl~D 227 (404)
+ .++++|||+.+|+|.+++...+. .+++..+..+.+||+.||.||| +++|+|+||||+|||++. ++.+||+|
T Consensus 87 ~~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 87 ENDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred cCeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEecc
Confidence 4 68999999999999999987652 5999999999999999999999 899999999999999999 79999999
Q ss_pred ccCCCCCCC-CCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 228 FGLAKDGPT-GDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
||++..... ...........||+.|||||++.++ ....++|||||||++.||+||+.||... .....
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~------ 230 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAE------ 230 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHH------
Confidence 999986543 1112223457899999999999853 3345999999999999999999999763 00011
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+..+........++...+.+..+++.+|+..||++|||+.++|+..-
T Consensus 231 ----~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 231 ----ALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----HHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111122222223555567778889999999999999999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=345.03 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=207.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
...|+.++.||+|+||.||+ |++..+|+.||+|.+..+.. ....-..+||.+|++|+||||+++.+...
T Consensus 116 ~~~feki~kIGeGTyg~VYk---------Ar~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYK---------ARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred hHHHHHHHHhcCcchhheeE---------eeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 35677889999999999999 66777899999999987653 33355789999999999999999999998
Q ss_pred eC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 149 ED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+. ..+|||||||+. +|..++.... -.|++.++..+++||+.||.|+| .++|+|||||.+|||||.+|.+||+
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEec
Confidence 77 689999999955 8988887643 46899999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh-hh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK-PY 304 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~-~~ 304 (404)
|||+|+....... ...+..+.|.+|+|||++.| ..|+.++|+||.||||.||+.|++.|.+..+......+-... ..
T Consensus 261 DFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 261 DFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred cccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 9999997544332 23566789999999999876 579999999999999999999999998765432222111000 00
Q ss_pred hhhccccchhhc---ccccCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LASKRKIFRIID---NRLEGQYTL-------EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~---~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+.+...++.. ......+.. ..+....+|+..+|..||.+|.|+.++|+
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000000111110 000111111 12346779999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=349.72 Aligned_cols=271 Identities=25% Similarity=0.399 Sum_probs=220.0
Q ss_pred cCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCC
Q 046897 62 FSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPN 139 (404)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~ 139 (404)
.+..+..+..++..+...||+|.||+||+|.|.. .||||+++.+... ..+.|+.|+.+|++-+|.|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 4446666677788889999999999999998864 4999999876543 4477999999999999999
Q ss_pred cceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 140 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
|+-+.|++..+.. .||+.+|+|.+|+.+++... ..+.......|++||++|+.||| .++|||||||..|||+.+
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHE 523 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEcc
Confidence 9999999998877 99999999999999998765 46899999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
+++|||+|||++................|...|||||++. ..+|++.+||||||+++|||++|..||..........
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif 603 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF 603 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE
Confidence 9999999999998654443333344456888999999985 3579999999999999999999999998433221111
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
.+ .+ ..+.+++ ......++.++.+|+..||.+++++||.+.+|+..|+.+....
T Consensus 604 mV--Gr----------G~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 604 MV--GR----------GYLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred Ee--cc----------cccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 10 00 0001111 1223456778999999999999999999999999999877653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=337.31 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=211.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.+.|++..+||.|..+.||+ |+....+..||||+++.+..... +.+.+|+..++.++||||++++..|..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~---------A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYL---------ARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccceeEEEEEeccceeEeee---------eeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 57899999999999999999 55556789999999988765554 788999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..+|+||+||.+|++.+++...-. ..+.+..+..+++++++||.||| .+|.||||||+.||||+.+|.|||+|||
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCce
Confidence 9999999999999999999986543 56999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCc-ce-eeccccccccCccccc--cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 230 LAKDGPTGDQSH-VS-TRVMGTYGYAAPEYLA--TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 230 ~a~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
.+.......... .. ...+||++|||||++. ...|+.|+||||||++..||.+|..||....+....-.. .
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----L- 245 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----L- 245 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----h-
Confidence 887554433221 12 4578999999999964 357999999999999999999999999865442110000 0
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...........+..+........+.+++..||+.||.+|||++++++.
T Consensus 246 --qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 --QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred --cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000000001111111122234478899999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=349.47 Aligned_cols=269 Identities=29% Similarity=0.414 Sum_probs=208.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+.. ..+..++..||+|++..... ...+.+.+|+.+|..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFG----IDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEec----cCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4689999999999999999986532 12234567899999875422 2335688999999999 8999999999887
Q ss_pred eCC-eeEEEEeccCCCChHHHHhhcCCC----------------------------------------------------
Q 046897 149 EDD-HRLLVYEFMPRGSLENHLFRRGSY---------------------------------------------------- 175 (404)
Q Consensus 149 ~~~-~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 175 (404)
..+ .++++|||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 644 588999999999999999754211
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeecccc
Q 046897 176 ------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249 (404)
Q Consensus 176 ------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt 249 (404)
..++++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...............++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 135788889999999999999999 899999999999999999999999999999864332221122234466
Q ss_pred ccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHH
Q 046897 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGA 328 (404)
Q Consensus 250 ~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (404)
..|+|||++.+..++.++|||||||++|||++ |..||....... .... .. .+. .....+...+
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~-~~---------~~~-~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQ-RL---------KDG-TRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHH-HH---------hcC-CCCCCCCCCC
Confidence 78999999988899999999999999999997 999997543211 0000 00 000 0011222345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 329 YKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 329 ~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=349.94 Aligned_cols=256 Identities=27% Similarity=0.382 Sum_probs=211.3
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC----Cc-ccHHHHHHHHHHHhcCC-CCCcceE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD----GF-QGHKEWLAEVNYLGQLY-HPNLVKL 143 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hp~iv~~ 143 (404)
..++|.+.+.||+|+||+|++| .+..++..||+|++... .. ...+.+.+|+.+++.+. ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a---------~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLA---------KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEe---------eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 4578999999999999999995 44556799999987664 22 23355678999999998 9999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-Cc
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YN 222 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~ 222 (404)
++++.....+|+||||+.||+|.+++...+ ++.+..+..+++|++.|++||| +++|+||||||+|||++.+ ++
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCC
Confidence 999999999999999999999999998853 5888999999999999999999 8999999999999999999 99
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCC-CC-cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LT-AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
+||+|||++.... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..+... .
T Consensus 160 ~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~------l 231 (370)
T KOG0583|consen 160 LKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN------L 231 (370)
T ss_pred EEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH------H
Confidence 9999999999763 2223456789999999999999877 86 68999999999999999999998733211 0
Q ss_pred hhhhhhhccccchhhcccccCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEG-AYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
.. .+..... .++... +.++..++.+||..||.+|+++.+|+ .-..++.
T Consensus 232 ~~----------ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 232 YR----------KIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HH----------HHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 00 1111111 222233 77889999999999999999999999 6666665
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=347.52 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=205.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|+++++||+|+||.||+ |++..+|..+|+|++++..... .+.++.|-.+|....+|.||+++..|+
T Consensus 141 ~DFe~Lk~IgkGAfGeVrL---------arKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRL---------ARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ 211 (550)
T ss_pred ccchhheeeccccceeEEE---------EEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence 5899999999999999998 7778899999999998865433 345788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+.+++||||||++||++..+|...+ .|++..+..++.+++.|+..|| +.|+|||||||+|+|||..|++||+||
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeeccc
Confidence 9999999999999999999998875 6999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCC----------------------CCCC------cc-----------------eeeccccccccCccccccCCC
Q 046897 229 GLAKDGPT----------------------GDQS------HV-----------------STRVMGTYGYAAPEYLATGHL 263 (404)
Q Consensus 229 g~a~~~~~----------------------~~~~------~~-----------------~~~~~gt~~y~aPE~~~~~~~ 263 (404)
|++.-... .+.. .. ....+|||.|+|||++.+..|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 99952110 0000 00 013689999999999999999
Q ss_pred CcccchhhhhHHHHHHHhCCCCcCCCCCCCC-cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCC
Q 046897 264 TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE-HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTE 342 (404)
Q Consensus 264 ~~~~DiwslG~ll~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 342 (404)
+..+|+||||||+||||.|.+||...++... ..++.|... +..........+..+||.+||. |
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-C
Confidence 9999999999999999999999987665322 111122111 1111122234678899999999 9
Q ss_pred CCCCCC---HHHHHH
Q 046897 343 GKFRPM---MAEVVT 354 (404)
Q Consensus 343 P~~RPs---~~eil~ 354 (404)
|++|.- +.||.+
T Consensus 430 ~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKK 444 (550)
T ss_pred HHHhcCcccHHHHhc
Confidence 999975 555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=346.27 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=210.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|.+.+.||+|.||.||+| +.+.+.+.||+|.+.+... +..+.+.+|+++++.++||||+.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 47888999999999999995 5566889999999977543 334668999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
..++|+|.||+.| +|..++...+ .++++.+..++.+++.||.||| +++|+|||+||.|||++.+|++|++|||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhh
Confidence 9999999999965 9999998775 4899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+|+.... .........|||.|||||+..+.+|+..+|+|||||++|||++|++||-... +...+..
T Consensus 146 ~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~------ 211 (808)
T KOG0597|consen 146 LARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKS------ 211 (808)
T ss_pred hhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHH------
Confidence 9997554 3335667889999999999999999999999999999999999999996421 1111111
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
|+.... ..+......+..+++..|.+||.+|.+..+++..
T Consensus 212 ----I~~d~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 212 ----ILKDPV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----HhcCCC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111111 2344667789999999999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.31 Aligned_cols=246 Identities=29% Similarity=0.421 Sum_probs=205.8
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhcCC-CCCcceE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQLY-HPNLVKL 143 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~-hp~iv~~ 143 (404)
....++|.++++||+|.||+|+++ ...++++.+|||+++++..... +..+.|.+++...+ ||+++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~la---------e~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLA---------ELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEE---------EEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 334578999999999999999994 5556788999999998755433 45678888888774 9999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
++.|+..+++|+||||+.||++..+++. ..+++..+..++..|+.||+||| +++||+||||.+|||+|.+|.+
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~ 507 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHV 507 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcE
Confidence 9999999999999999999995544432 35899999999999999999999 9999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||+|||+++.... ......+++|||.|||||++.+..|+.++|+|+|||+||||+.|..||.+.++.+..+
T Consensus 508 kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd------- 578 (694)
T KOG0694|consen 508 KIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD------- 578 (694)
T ss_pred EecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------
Confidence 9999999987432 2225677999999999999999999999999999999999999999998755432111
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
.|+... ..++...+.+...+++++|..||++|.-+
T Consensus 579 ---------sI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 ---------SIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------HHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 122211 24566677888999999999999999855
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.42 Aligned_cols=271 Identities=30% Similarity=0.438 Sum_probs=229.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+....+.||+|+||+||+|..... .-....+.||||.++..... ...+|.+|+++|..++|||||+++|+|.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 3455678899999999999865431 12234578999999887655 567899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSY----------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+-+++|+|||..|+|.++|..+... ..+++..+.+.|+.||+.||.||- ++.+|||||..+|+||.++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhceeccc
Confidence 9999999999999999999864321 223889999999999999999999 7889999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~ 299 (404)
..|||+|||+++.....++........-..+||+||.+..+.|+.++|||||||+|||+++ |+.||.+...
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------- 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------- 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence 9999999999998877776665555567789999999999999999999999999999998 8889977543
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
.+.+..+.+..+ ...+..++.++++|+..||+.+|.+||+++||-..|+..-..++.
T Consensus 712 --------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 712 --------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred --------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 233434444444 577888999999999999999999999999999999987766543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=319.44 Aligned_cols=268 Identities=22% Similarity=0.280 Sum_probs=208.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++++.|++|+||.||+ +++..+++.||+|+++.+....- -..++|+.+|.+.+|||||.+.++..
T Consensus 75 v~efe~lnrI~EGtyGiVYR---------akdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYR---------AKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEE---------eccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 45788899999999999999 66777899999999987642211 23589999999999999999999887
Q ss_pred eC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 149 ED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
.. +.+|||||||+. +|..++.... +++....+..++.|++.|++||| ++.|+|||||++|+|+++.|.+||+
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEec
Confidence 54 479999999965 9999998765 68999999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh--
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP-- 303 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~-- 303 (404)
|||+|+..... ....+..+.|.+|+|||++.+ ..|+.+.|+||+|||+.||+++++.|.+.......+.+-..-.
T Consensus 220 DFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 220 DFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred ccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 99999976543 234566889999999998876 5799999999999999999999999987655433222210000
Q ss_pred ---hhhhcccc--------chhhcccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 304 ---YLASKRKI--------FRIIDNRLEGQYTLE-GAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 304 ---~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..-..+ .......++..+... ..+.-++|+..+|..||.+|.|+.+.|+.
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00000000 000011111111111 34567799999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=338.34 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=211.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..|...+.||+|.||.||+| .+..+++.||+|++..+.... .+++.+|+.+|.+++++||.++|+.|..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~---------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKA---------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeee---------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 45777789999999999995 555688999999998765443 47788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
..++++||||.||++.+.+.... .+.+..+..++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEecce
Confidence 99999999999999999997653 3578888899999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ....++||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+.....++.
T Consensus 158 a~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp----------- 224 (467)
T KOG0201|consen 158 AGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP----------- 224 (467)
T ss_pred eeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-----------
Confidence 987655433 2367899999999999998899999999999999999999999998876643322211
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.....+.......+.+++..||+.||+.||++.++|+.
T Consensus 225 ------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 ------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111122333566778999999999999999999998864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=344.72 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=212.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.-|++++.||.|+-|.|-+ |++..+|+..|||++.+.... ....+.+|+-+|+.+.||||+.+|++++
T Consensus 12 GpwkLgkTLG~Gstg~vrl---------akh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRL---------AKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehh---------hhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 4588899999999999987 777789999999999776221 1245789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++.++|+|.||+++|.|.+++-.++ ++++..+..+++||+.|+.|+| ..+|+||||||+|+|++..+.+||+||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeecc
Confidence 9999999999999999999998886 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCC-cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLT-AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|+|..-.++. ...+-||.|.|.+||++.|.+|+ .++||||.|+|||.|++|+.||++.+
T Consensus 157 GMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----------------- 216 (786)
T KOG0588|consen 157 GMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----------------- 216 (786)
T ss_pred ceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----------------
Confidence 9998754433 45667999999999999998885 68999999999999999999998532
Q ss_pred ccccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+..++.+... .+++...+.++.+|+.+||..||++|.|++||++.
T Consensus 217 ---ir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 217 ---IRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---HHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2333333332 24556677788999999999999999999999886
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=336.52 Aligned_cols=252 Identities=27% Similarity=0.361 Sum_probs=217.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|..++++|+|+||.+++ +.+...+..|++|.+....... .+...+|+.++.++.|||||.+++.|.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~l---------vrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALL---------VRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhh---------hhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 5788999999999999997 6677778899999987654322 3457899999999999999999999999
Q ss_pred CCe-eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 150 DDH-RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 150 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++. ++|||+||+||+|.+.|.+.. ...++++.+..|+.|++.|+.||| .++|+|||||+.|||++.++.|+|+||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecch
Confidence 988 999999999999999998765 356899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+|+...... ......+||+.||+||++.+.+|+.++|||||||++|||++-+++|...+....
T Consensus 151 GlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------------- 214 (426)
T KOG0589|consen 151 GLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------------- 214 (426)
T ss_pred hhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--------------
Confidence 9999865543 235568899999999999999999999999999999999999999986543211
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.++.... ....+.....++..++..||..+|+.||++.++|..
T Consensus 215 --i~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 --ILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --HHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11122111 235667788899999999999999999999999987
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.68 Aligned_cols=277 Identities=25% Similarity=0.305 Sum_probs=214.5
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEec--CCCcccHHHHHHHHHHHhcCCCCCcceEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN--QDGFQGHKEWLAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 145 (404)
......|...+.||.|+||.|.. +.+..+|..||+|.+. .+.....++..+|+++|+.++|+||+.+++
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcs---------A~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~d 88 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCS---------AKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLD 88 (359)
T ss_pred EeccceecccccccCcceeeEEE---------EEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEe
Confidence 33456777789999999999998 5666788999999987 455566788999999999999999999999
Q ss_pred EEEe-----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 146 YCLE-----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 146 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
++.. -+.+|+|+|+| +.+|...+... +.++...+..++.|+++||.|+| +.+|+||||||.|+|++.+
T Consensus 89 i~~p~~~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiH--SAnViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 89 IFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIH--SANVIHRDLKPSNLLLNAD 161 (359)
T ss_pred ecccccccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhh--cccccccccchhheeeccC
Confidence 9875 24689999999 77999988765 45999999999999999999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
..+||+|||+|+...........+..+-|.+|+|||++. ...|+.+.||||+|||+.||++|++.|.+.+......++.
T Consensus 162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 999999999999865433333456788999999999875 5789999999999999999999999998765433222221
Q ss_pred hhhhhhhhccccchh--------hccc-ccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHh
Q 046897 300 WAKPYLASKRKIFRI--------IDNR-LEGQ-----YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQD 361 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~--------~~~~-~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 361 (404)
..-... ....+..+ +... .... .-+.......+|+.+||..||.+|+|++|.|+. |..+.+
T Consensus 242 ~~lGtP-~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 242 ELLGTP-SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HhcCCC-CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 110000 00000000 0000 0001 112345678899999999999999999999876 665543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=342.88 Aligned_cols=267 Identities=26% Similarity=0.364 Sum_probs=207.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+.. .....++..||+|++.... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYG----LFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEec----cccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3478999999999999999986532 2234567789999987543 22335688999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC-----------------------------------------------------
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY----------------------------------------------------- 175 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------------- 175 (404)
..+..++||||+++|+|.+++......
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999999999753210
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCC
Q 046897 176 ------------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237 (404)
Q Consensus 176 ------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~ 237 (404)
...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999 899999999999999999999999999999865432
Q ss_pred CCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 238 DQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
..........++..|+|||++.+..++.++|||||||++|||++ |..||....... ... ..+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~--------------~~~~ 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY--------------KMIK 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH--------------HHHH
Confidence 22112222345667999999998899999999999999999998 888886532211 000 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.......+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111111222345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.44 Aligned_cols=260 Identities=25% Similarity=0.326 Sum_probs=207.5
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--------------ccHHHHHHHHHHHh
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--------------QGHKEWLAEVNYLG 133 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~ 133 (404)
....++|++.+.||+|.||+|-+ +++..+++.||+|++.+... ...+.+.+|+.+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkL---------ar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKL---------ARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEE---------EeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 44457899999999999999998 56666899999999965322 11246889999999
Q ss_pred cCCCCCcceEEEEEEeC--CeeEEEEeccCCCChHHHHhhcCCCCCC-CCHHHHHHHHHHHHHHHHHhHcCCCCceecCC
Q 046897 134 QLYHPNLVKLVGYCLED--DHRLLVYEFMPRGSLENHLFRRGSYFQP-LSWNLRLKVALGAAKGVAFLHGAETKVIYRDF 210 (404)
Q Consensus 134 ~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dl 210 (404)
+++|||||+++++..+. +.+|||+|||..|.+...-- .++ +++.+++.++.+++.||.||| .++|+||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDI 236 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDI 236 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHH--hcCeecccc
Confidence 99999999999998764 58999999998887643221 133 899999999999999999999 899999999
Q ss_pred CCCcEEEcCCCcEEEecccCCCCCCCCC---CCcceeeccccccccCccccccCC----CCcccchhhhhHHHHHHHhCC
Q 046897 211 KTSNILLDTNYNAKLSDFGLAKDGPTGD---QSHVSTRVMGTYGYAAPEYLATGH----LTAKSDVYSFGVVLLEMLSGR 283 (404)
Q Consensus 211 kp~NIll~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~ll~ell~g~ 283 (404)
||+|+||+.+|+|||+|||.+.....+. ........+|||.|+|||.+.++. .+.+.||||+|++||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 9999999999999999999998653332 112233478999999999887632 356899999999999999999
Q ss_pred CCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 284 RAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.||-..... ....+|++..+.-...++..+.+.+||.+||++||+.|.++.+|....--.
T Consensus 317 ~PF~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 317 LPFFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred CCcccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 999754321 112245555554444456778899999999999999999999998775543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.98 Aligned_cols=275 Identities=26% Similarity=0.427 Sum_probs=208.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccc-------cccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcce
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFA-------ATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~ 142 (404)
.++|++.+.||+|+||.||++.+.+.... ..+...+..||+|.+...... ....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 45789999999999999999876542210 123345668999998765322 2356889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCcee
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGS---------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIY 207 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H 207 (404)
+++++.+.+..++||||+.+++|.+++..... ....+++..++.++.||+.||.||| +.+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence 99999999999999999999999999865321 1134678889999999999999999 889999
Q ss_pred cCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh--CCCC
Q 046897 208 RDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS--GRRA 285 (404)
Q Consensus 208 ~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~--g~~p 285 (404)
|||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544332222333456788999999988889999999999999999987 5567
Q ss_pred cCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 286 VDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
|...... .............. .......+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7653321 11111111111000 00001112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.49 Aligned_cols=255 Identities=27% Similarity=0.338 Sum_probs=212.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.+.|++++.||+|.-|+||++ ...+++..+|+|++.+...... .++..|-+||..++||.+..+|..|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~---------~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLV---------ELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEE---------EecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 356777899999999999995 4455678999999987654433 4567899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..+...|++||||.||+|..+++++.. ..+++..+..++.+|+.||+||| ..|||.|||||+||||-++|+|.|.|
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsD 222 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSD 222 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeee
Confidence 999999999999999999999988764 67999999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCC---------------------------------CCCC---------------------cceeecccccccc
Q 046897 228 FGLAKDGPT---------------------------------GDQS---------------------HVSTRVMGTYGYA 253 (404)
Q Consensus 228 fg~a~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~ 253 (404)
|.++..... .... .....++||-.|+
T Consensus 223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl 302 (459)
T KOG0610|consen 223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL 302 (459)
T ss_pred ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence 998853210 0000 0122468999999
Q ss_pred CccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHH
Q 046897 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAAT 333 (404)
Q Consensus 254 aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 333 (404)
|||++.|...+.++|+|.||+++|||+.|..||.+.+.. ..+..++.+.+.-...+.....+.+
T Consensus 303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akD 366 (459)
T KOG0610|consen 303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKD 366 (459)
T ss_pred cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHH
Confidence 999999999999999999999999999999999876532 3344455555544444466788999
Q ss_pred HHHHcccCCCCCCCC----HHHHHH
Q 046897 334 LALRCLSTEGKFRPM----MAEVVT 354 (404)
Q Consensus 334 li~~cl~~dP~~RPs----~~eil~ 354 (404)
||+++|.+||.+|.- +.||.+
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhc
Confidence 999999999999987 677654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=340.82 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=207.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|+... .....++..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFG----LGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEec----CCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3579999999999999999976532 11233456899999975432 2335678999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------------------------------------------------
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------------------------------------------------ 174 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 174 (404)
.....++||||+.+|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999865321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcc
Q 046897 175 ------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242 (404)
Q Consensus 175 ------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~ 242 (404)
...++++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++...........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 0124788899999999999999999 89999999999999999999999999999976433222111
Q ss_pred eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccC
Q 046897 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEG 321 (404)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (404)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||........ ...........
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----------------~~~~~~~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----------------FYKMVKRGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----------------HHHHHHcccCc
Confidence 222345668999999988899999999999999999997 9999975332110 00111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 322 QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 322 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
..+...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112223467889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.24 Aligned_cols=240 Identities=28% Similarity=0.444 Sum_probs=207.9
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
++.||.|+-|.||+|+++ ++.||||.++.-. ..+|+.|++|+||||+.+.++|.....+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 567999999999999875 5779999775321 2578999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
||||..|-|...|... .++.......|..+|+.|+.||| .+.|||||||.-||||+.+..|||+|||.++....
T Consensus 191 MEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH--~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLH--LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHH--HhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999765 46899999999999999999999 78899999999999999999999999999986543
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
. ...-.++||..|||||++.+.+.+.|+||||||++||||+||..||.+-.. ...|...-.
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------------sAIIwGVGs 325 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------------SAIIWGVGS 325 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------------heeEEeccC
Confidence 3 234458899999999999999999999999999999999999999975322 122334444
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
..+....+..++..+.-|++.||+-.|.+||++++|+..|+-.
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 5555677888899999999999999999999999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=326.87 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=210.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..+|++.+.||+|+||+|-+ |++...|+.||||.++++...+... +.+|++||..|+||||+.++++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~---------A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKL---------AYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceee---------hhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 45789999999999999998 6677789999999998876555543 67899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
...+.+.|||||..+|.|++|+.+++ .+++..+..+++||+.|+.|+| .++++|||||.+|||+|.++++||+|
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeec
Confidence 99999999999999999999999875 5999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++....... ....++|.|.|.+||++.|.+| ++.+|-||||++||.|+.|..||++.+...
T Consensus 197 FGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~------------- 260 (668)
T KOG0611|consen 197 FGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR------------- 260 (668)
T ss_pred cchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------------
Confidence 99998764433 4566899999999999999888 578999999999999999999998754311
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.++-.... ..+..+.+..-||+|||-.||++|.|+.+|...
T Consensus 261 ---lvrQIs~GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 261 ---LVRQISRGAY---REPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---HHHHhhcccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1111111111 112223455679999999999999999998765
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=305.75 Aligned_cols=270 Identities=24% Similarity=0.332 Sum_probs=216.9
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
....++|++.+.||+|||+-||+ +....++..||+|++......+.+..++|++..++++|||+++++++.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~L---------V~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDL---------VKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred EEcCceEEEeeeecCCCceeeee---------ecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 34568999999999999999998 455567889999999888777788899999999999999999998876
Q ss_pred EeCC-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 148 LEDD-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 148 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
..+. ..||+++|+..|+|.+.+.........+++..++.|+.+|++||.+||.....++||||||.|||++..+.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 5443 48999999999999999998776667899999999999999999999944444999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcc-------eeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 223 AKLSDFGLAKDGPTGDQSHV-------STRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
++|.|||.++...-...... ......|..|+|||++. +...+.++|||||||++|+|+.|..||+..-..
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 99999999986432221110 11235778899999885 456788999999999999999999999753221
Q ss_pred CCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
+. + .-..+.+..+...-....++.+.+++.+||+.||.+||++.+++..++.++
T Consensus 248 Gg-S-------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GG-S-------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CC-e-------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 1 111222222222223336788999999999999999999999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=324.19 Aligned_cols=247 Identities=22% Similarity=0.321 Sum_probs=199.4
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEEe----C
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCLE----D 150 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 150 (404)
..||+|++|.||+|.+ +|+.||+|.+....... .+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 6799999999999865 36789999987654333 3567799999999999999999999877 3
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++|+|.+++... ..+++.....++.|++.||.|||. ..+++||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 4688999999999999999764 357889999999999999999993 24889999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+....... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~------ 232 (283)
T PHA02988 170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYD------ 232 (283)
T ss_pred Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHH------
Confidence 87543221 23457889999999876 68999999999999999999999999754321 0000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
.+.........+...+..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 233 ----~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 ----LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111122333456789999999999999999999999999998764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.61 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=214.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEE-EE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGY-CL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~-~~ 148 (404)
..++++.++|.+|||+.||++ ...+.|..||+|++-..+....+.+.+|+++|+.|. |+|||.+++. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla---------~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLA---------QDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEE---------EecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 456788899999999999994 444556899999988777788889999999999996 9999999993 22
Q ss_pred eC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 ED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
.. -+++|+||||.||.|-+++..+.. ..|++..+++|+.|+++|+++||.....|||||||-+||||+.+|.
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 11 256899999999999999987654 3499999999999999999999977788999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcc-------eeeccccccccCcccc---ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 223 AKLSDFGLAKDGPTGDQSHV-------STRVMGTYGYAAPEYL---ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
.||||||.+........... .-...-|+.|+|||.+ .+...++|+|||+|||+||-|+....||+....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~- 263 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK- 263 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence 99999999975332221100 1124578999999976 477899999999999999999999999986432
Q ss_pred CCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
..|++....-.-.+.....+.+||..||+.||++||++-+++..+..+...
T Consensus 264 -------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 234444443334457888999999999999999999999999999988753
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=324.04 Aligned_cols=271 Identities=28% Similarity=0.426 Sum_probs=213.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|.+.+.||+|+||+||++.... .....++..+++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~----~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYN----LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEecc----CCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4578899999999999999976432 123345677999988766545556789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGS---------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
+..+++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCC
Confidence 999999999999999999975431 1235899999999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~ 300 (404)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~-- 232 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI-- 232 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--
Confidence 999999999986533222212223345778999999988889999999999999999998 899986543211 00
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
..+..... ...+...+..+.+++.+||+.||.+|||+.++++.|+++...+.
T Consensus 233 -----------~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 233 -----------ECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred -----------HHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 01111100 01112234568999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.44 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=201.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.|+..+.||+|+||.||++. ...++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQ---------VRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEE---------EecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 37778999999999999954 4446889999998754322 22357789999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 35889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ ..
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~------- 215 (285)
T cd05631 148 LAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV--DR------- 215 (285)
T ss_pred CcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH--HH-------
Confidence 997643222 123456899999999999999999999999999999999999999864432111000 00
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.+.. ....++...+..+.+|+.+||+.||++||+ ++++++
T Consensus 216 ---~~~~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 216 ---RVKE--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---Hhhc--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0000 111233344567889999999999999997 677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=323.10 Aligned_cols=265 Identities=26% Similarity=0.446 Sum_probs=210.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||+|+||.||+|..... ........|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGP----NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecC----CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4688899999999999999876431 1223457899998875432 2235688999999999999999999999988
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSY------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
...+++|||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEc
Confidence 8999999999999999999764221 135788999999999999999999 89999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcch
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNL 297 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~ 297 (404)
.++.++|+|||++......+.........+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---- 234 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---- 234 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999999976543332223334457888999999988889999999999999999998 999997543211
Q ss_pred hhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+...+........+...+..+.+|+.+||+.||.+||++.+|++.|+++
T Consensus 235 -------------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 -------------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -------------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111111233445667899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=331.38 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVR---------DRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEE---------EcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368899999999999999954 445688999999865422 23356788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++...|+||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEec
Confidence 9999999999999999999997653 5889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~------ 208 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYE------ 208 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH------
Confidence 998764321 223568999999999998889999999999999999999999997543211 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 355 (404)
.+.... ..++......+.+++.+||+.||.+||+ +.++++.
T Consensus 209 ----~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 209 ----KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111 1222333557889999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.90 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=200.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+|.+.+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAK---------HKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEE---------ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 568889999999999999954 445688999999875422 23356789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..|+||||+.+++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997653 5788999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....+. ..
T Consensus 163 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~-------- 223 (329)
T PTZ00263 163 GFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RI-------- 223 (329)
T ss_pred cCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HH--------
Confidence 999865332 22357999999999999888999999999999999999999999653321 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~ 355 (404)
...+..... .++......+.+++.+||+.||.+||+ +.++++.
T Consensus 224 --~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 224 --YEKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --HHHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011111111 122223456789999999999999996 5666644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=303.20 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=210.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++++.||+|-||.||+|+ ...++-.||+|++.+.... ....+.+|+++-..|+||||+++|++|
T Consensus 21 l~dfeigr~LgkgkFG~vYlar---------ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAR---------EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred hhhccccccccCCccccEeEee---------eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3579999999999999999955 4456778999998765332 235688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.++...|+++||..+|.|...+..... ..+++...+.++.|++.||.|+| .++|+||||||+|+|++..+.+||+|
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccC
Confidence 999999999999999999999985443 46889999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||.+...+. ......+||..|.+||...+..++..+|+|++|++.||++.|.+||........
T Consensus 168 fGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------------- 230 (281)
T KOG0580|consen 168 FGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------------- 230 (281)
T ss_pred CCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------------
Confidence 999987542 235568999999999999999999999999999999999999999986542111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..++..-++ .++...+.+..++|.+|+..+|.+|.+..++++.
T Consensus 231 ---YkrI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 231 ---YKRIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---HHHHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111221111 3445566778899999999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.94 Aligned_cols=243 Identities=27% Similarity=0.354 Sum_probs=196.7
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
++||+|+||.||++ .+..+|..||+|++..... .....+.+|+.+++.++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILV---------REKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 46999999999994 4455788999999875421 22345778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
+||||+++++|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 72 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999999999999987653 5899999999999999999999 899999999999999999999999999998753
Q ss_pred CCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .... .+
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~----------~~ 207 (323)
T cd05571 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFE----------LI 207 (323)
T ss_pred ccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHH----------HH
Confidence 2211 1233467999999999999889999999999999999999999999653211 0000 01
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
.... ..++......+.+++.+||+.||++|| ++.++++.
T Consensus 208 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 208 LMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1111 122334456788999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=347.16 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=204.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCC-CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGT-GMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.|.+.+.||+|+||.||+|.. ..+ +..|++|.+..........+.+|+.+|+.++||||+++++++..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~---------~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATR---------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEE---------cCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 488999999999999999643 333 6778889876655455566788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..|+||||+++|+|.+++........++++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 999999999999999988754333356899999999999999999999 889999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
...............+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~--------- 281 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQ--------- 281 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH---------
Confidence 8654332222334567999999999998889999999999999999999999999653211 1011
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..... ...+...+..+.+++.+||+.||++||++.+++.
T Consensus 282 -~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 282 -QVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -HHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111110 1122234567889999999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=330.58 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||++ .+..++..+++|.+..... ...+.+.+|+++|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKV---------QHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEE---------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 468999999999999999995 4455788999999876422 233568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 999999999999999999997653 58899999999999999999993 2469999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK- 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 308 (404)
++...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||............ ..+.....
T Consensus 150 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~ 223 (331)
T cd06649 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF--GRPVVDGEE 223 (331)
T ss_pred cccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--ccccccccc
Confidence 98764322 123456899999999999889999999999999999999999999643221000000 00000000
Q ss_pred ---------------------------cccch----hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 ---------------------------RKIFR----IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ---------------------------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... +...............++.+++.+||+.||++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 001000111111245678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.35 Aligned_cols=270 Identities=27% Similarity=0.434 Sum_probs=214.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|.+.+.||+|+||.||+|.... .....++..+++|.+........+.+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYN----LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeec----cCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 468888999999999999976533 1223456678999987766555577899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
..++||||+++++|.+++..... ....+++..++.++.||+.||+||| +++|+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEcc
Confidence 99999999999999999976431 1134789999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~ 298 (404)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~ 235 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI 235 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 99999999999976543322222233456788999999988889999999999999999998 999986543211 11
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
. .+..... .......+..+.+++.+||+.||++||++.+|++.|+++....+
T Consensus 236 ~-------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 236 E-------------CITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred H-------------HHhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 0 0111111 11122345678899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=319.02 Aligned_cols=260 Identities=22% Similarity=0.393 Sum_probs=206.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|++.. ....+..|++|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKL------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEec------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 3568899999999999999987642 234567899999876532 223568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.++++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCc
Confidence 999999999999999999997643 35889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
.+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~--------- 219 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK--------- 219 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---------
Confidence 8765322111 11112335678999999988899999999999999999775 999997543211 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+. .......+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ----~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 ----AVE-DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----HHH-CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 0011122334566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=321.18 Aligned_cols=265 Identities=28% Similarity=0.430 Sum_probs=209.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.... .....++..|++|.+...... ..+.+.+|+++|+.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYH----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeecc----ccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 3568889999999999999986543 122345678999998765443 34678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGS----------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
....+++|||+++++|.+++...+. ....+++..+..++.|++.||.||| +.+++|+||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGY 157 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcC
Confidence 9999999999999999999976431 1245788899999999999999999 889999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~ 298 (404)
++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI 234 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH
Confidence 99999999999875433222112223446788999999998899999999999999999998 999986543211 11
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.. +.... ....+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 235 ~~-------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 EC-------------ITQGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH-------------HHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 10 11111 111222345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=335.57 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=209.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLY-HPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 148 (404)
.++|++.++||+|+||.||+|.+.. ......+..||+|++..... ...+.+.+|+.+|+.+. ||||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYG----LSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcc----cCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 5689999999999999999987532 22333456799999975432 22356889999999996 999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------------------------------------------------
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------------------------------------------------ 174 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 174 (404)
+.+..|+||||+++|+|.+++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999875321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 175 --------------------------------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 175 --------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
....+++..+..++.|++.||+||| +.+|+|+||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Nil 269 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhEE
Confidence 0124778888999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 99999999999999986433222222223456788999999988889999999999999999997 9999865321100
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
. . ..+........+...+..+.+++.+||+.||++||++.+|.+.|+++..
T Consensus 349 -~----~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 -F----Y----------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -H----H----------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 0 0000011112223445678899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=353.79 Aligned_cols=273 Identities=29% Similarity=0.412 Sum_probs=223.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+-.+.+.||+|+||.||.|.+.+.. .......||+|.+... +.....+|++|..+|+.++|||||+++|++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 34556789999999999999876521 1112567999988764 445567899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGS---YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
...+|++|||++|+|..+|++.+. ....++....+.++.||++|+.||+ .+++|||||..+|+|++....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999987621 1246889999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||+|+.....+.........-...|||||.+..+.++.++||||||+++||+++ |..||...+....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------------ 913 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------------ 913 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------------
Confidence 999997666555444443345578999999999999999999999999999999 8889876442211
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCC
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGN 367 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 367 (404)
+...+... +-+.+..++..+.+++..||+.+|++||+++.|++.+..+.+......
T Consensus 914 ----~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 914 ----LLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred ----HHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 11111111 346677788999999999999999999999999999998887555443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=330.83 Aligned_cols=254 Identities=26% Similarity=0.333 Sum_probs=203.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+..|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAK---------KKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEE---------ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368899999999999999954 44467899999987542 223356788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..|+||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999997653 5889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ..
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~-- 212 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL------KY-- 212 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH------Hh--
Confidence 99976433 223457999999999999889999999999999999999999999764322110000 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....+............+.++.+++.+||..+|.+||++.++++.
T Consensus 213 --~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 --WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000000112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=327.99 Aligned_cols=269 Identities=27% Similarity=0.383 Sum_probs=207.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||.|+||.||+|.... ..+..+++.|++|++..... ...+.+.+|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~----~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFG----IEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccc----cccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4689999999999999999975432 12234568899999875432 2235678899999999 7999999999887
Q ss_pred eC-CeeEEEEeccCCCChHHHHhhcCCC----------------------------------------------------
Q 046897 149 ED-DHRLLVYEFMPRGSLENHLFRRGSY---------------------------------------------------- 175 (404)
Q Consensus 149 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 175 (404)
.. ..++++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5688999999999999998653211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccc
Q 046897 176 -----FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250 (404)
Q Consensus 176 -----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~ 250 (404)
..++++..+..++.||+.||+||| +.+|+||||||+|||++.++.++|+|||++................++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 136889999999999999999999 8999999999999999999999999999998654332222223345667
Q ss_pred cccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHH
Q 046897 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329 (404)
Q Consensus 251 ~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (404)
.|+|||++.+..++.++|||||||++|||++ |..||........ .. ..+........+.....
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----~~-----------~~~~~~~~~~~~~~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FC-----------RRLKEGTRMRAPEYATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----HH-----------HHHhccCCCCCCccCCH
Confidence 8999999999999999999999999999998 9999965322110 00 00011011111223446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 330 KAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 330 ~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
.+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 78899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=324.05 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=207.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|++.+.||+|+||.||+|.+... ....+..|++|.+.... ....+++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 35699999999999999999875421 12224468999987543 2334678899999999999999999999876
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
. ..++++||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccc
Confidence 4 5789999999999999998653 35788999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------------- 219 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------- 219 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------------
Confidence 9986543322212222334678999999988899999999999999999998 999997532110
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
+..++........+..+...+..++.+||..||.+||++.+++..|..+.....
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 220 --ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 011111111111222344568899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=319.10 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=206.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||.||+|.+.. ......+..|++|.+..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~----~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEecc----CCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 45789999999999999999987643 22334567899998865322 23356889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
.+...++||||+.+++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCC
Confidence 999999999999999999999764321 134678889999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~ 301 (404)
++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~- 233 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF- 233 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-
Confidence 99999999875433322212222345778999999988889999999999999999999 78888653221 00000
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
+.+... ...+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 234 ------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 ------------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000000 1122234457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=325.89 Aligned_cols=256 Identities=26% Similarity=0.343 Sum_probs=200.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG----FQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
+|++.+.||+|+||.||+++. +....++..||+|++.... ....+.+..|+.+++.+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRK------VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEE------cccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 478899999999999999764 2334568899999986532 12234577899999999 599999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..++..++||||+.+|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999999999997653 5889999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ....
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~---- 221 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSR---- 221 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHH----
Confidence 9999764332211 22345799999999998764 47889999999999999999999997543221111 0000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
.+.. .....+......+.+++.+||+.||++|| ++.++++.
T Consensus 222 ------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 ------RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ------HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111 01122233456678999999999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=318.81 Aligned_cols=266 Identities=29% Similarity=0.403 Sum_probs=208.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+|++.+.||+|+||.||+|.... .........+++|.+..... .....+.+|+.+++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFR----LKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEec----CCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47888999999999999987643 22233456788998865432 23356889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGS--------------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFK 211 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlk 211 (404)
..+++|||+.+++|.+++..... ...++++..++.++.|++.||.||| +.+++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence 99999999999999999875321 1135788999999999999999999 8999999999
Q ss_pred CCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCC
Q 046897 212 TSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNR 290 (404)
Q Consensus 212 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~ 290 (404)
|+|||++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999976433222112223345678999999988889999999999999999998 999996543
Q ss_pred CCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 291 PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
+.. . ............+......+.+++.+||+.+|++||++.++++.|+++..
T Consensus 235 ~~~---~--------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PER---L--------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH---H--------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 211 0 01111111112223345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=321.48 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=217.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..-|.+.+.||+|.|+.|-+ |++..+|..||||++.+...... ..+.+|++.|+.++|||||++|++..
T Consensus 17 AGLYDLekTlG~GHFAVVKL---------ArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKL---------ARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhh---------hhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 45688899999999999987 77888999999999987654433 45789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc-CCCcEEEec
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD-TNYNAKLSD 227 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~-~~~~vkl~D 227 (404)
.+..+|+|+|.-++|+|.+||.++. ..+.+..+.+++.||+.|+.|+| +..+|||||||+||++. .-|-|||.|
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999999999876 57999999999999999999999 99999999999998875 568899999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCc-ccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTA-KSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++....++. .....+|...|-|||++.|..|+. ++||||||+|||.|++|++||+..++.+
T Consensus 163 FGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------- 226 (864)
T KOG4717|consen 163 FGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------- 226 (864)
T ss_pred ccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------
Confidence 99998776654 456689999999999999999874 7899999999999999999998766542
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..|+|-. ...+.....++.+||..||..||.+|.++++|...
T Consensus 227 ---TLTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 ---TLTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---hhhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 233344432 35677888999999999999999999999998654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=322.97 Aligned_cols=267 Identities=21% Similarity=0.258 Sum_probs=199.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+++ +..++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCR---------HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEE---------ECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 368999999999999999954 445688999999875422 233567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||++++.+..+... . ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~-~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEM-P---NGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhc-C---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 9999999999988766554432 2 35889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh-hhh----
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA-KPY---- 304 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~-~~~---- 304 (404)
++......... ......|++.|+|||++.+..++.++|||||||++|||++|+.||............... .+.
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 146 FARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred Ccccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 99865332211 223456899999999998888999999999999999999999999754321111000000 000
Q ss_pred ---hhhccccchhhccccc------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 ---LASKRKIFRIIDNRLE------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
............+... .......+..+.+++.+||+.||++|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000 0111123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=320.86 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=198.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||.|+||.||+|. +..++..||+|++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGR---------SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEE---------ECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 568999999999999999954 445688999999875432 2234678999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999999996 59999887553 35788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh-------
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK------- 302 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~------- 302 (404)
+........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 150 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred eeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 875432221 2233568899999998865 568999999999999999999999997543221111000000
Q ss_pred -hhhhhccccchhhcccccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 -PYLASKRKIFRIIDNRLEG----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+.............+.... ........++.+++.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000000000 001122456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.68 Aligned_cols=240 Identities=29% Similarity=0.333 Sum_probs=192.6
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||+|+||.||+++ +..++..||+|++.... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 1 lg~G~~g~Vy~~~---------~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVR---------KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999954 44568899999986532 22335678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 72 LAFINGGELFHHLQREG----RFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred EcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99999999999997653 5889999999999999999999 89999999999999999999999999999875322
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... +..
T Consensus 146 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~----------~~~ 207 (312)
T cd05585 146 DD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRK----------ILQ 207 (312)
T ss_pred CC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHH----------HHc
Confidence 21 1233467999999999999989999999999999999999999999753211 11111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. ..++......+.+++.+||+.||++||++..+.+
T Consensus 208 ~~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 208 EP--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred CC--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 11 1223334567889999999999999986543333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=328.27 Aligned_cols=243 Identities=27% Similarity=0.358 Sum_probs=196.3
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
+.||+|+||.||++ .+..++..||+|++..... .....+.+|+++++.++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILV---------REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 46999999999994 4555788999999875422 23356788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
+||||+++++|..++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 999999999999888764 35889999999999999999999 899999999999999999999999999998753
Q ss_pred CCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... +
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~----------~ 207 (328)
T cd05593 146 ITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFEL----------I 207 (328)
T ss_pred CCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHH----------h
Confidence 2211 1223457999999999998889999999999999999999999999753321 00000 0
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
... ...++.....++.+++.+||+.||++|+ ++.++++.
T Consensus 208 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 208 LME--DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ccC--CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 000 0122233456788999999999999997 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=312.53 Aligned_cols=261 Identities=25% Similarity=0.446 Sum_probs=207.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+.. .......|++|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKL------PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEcc------CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 3578999999999999999987642 1223567999988754322 23568889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.+..+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccc
Confidence 999999999999999999997643 35889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~--------- 219 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIK--------- 219 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHH---------
Confidence 9987642222212222345678999999988889999999999999999998 99998653211 0000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+.+ ......+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 220 ----~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 ----AVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 001112223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=322.62 Aligned_cols=247 Identities=30% Similarity=0.380 Sum_probs=196.8
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG----FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
.+.||+|+||.||+++.. ....++..||+|++.... ......+..|+.+|+.++||||+++++++..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKV------TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEc------ccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 367999999999997642 223568899999987532 1223456789999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.|+||||+.+++|.+++.... .+.+..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 999999999999999987653 4788889999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ..
T Consensus 149 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~----------~~ 210 (323)
T cd05584 149 ESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KT----------ID 210 (323)
T ss_pred ecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HH----------HH
Confidence 432221 1223357999999999998888999999999999999999999999754321 00 11
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
.+..... ..+......+.+++.+||+.||++|| ++.++++.
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 211 KILKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111111 22333456788999999999999999 77777663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=327.30 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=192.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|+..+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+++++.++|+||+++++++..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVI---------HRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEE---------ECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 456678899999999999954 444678999999865432 2235688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+.+++||||+++++|.+.. ...+..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred CeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999999986432 3467788899999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+........ ......||..|+|||++.. ...+.++|||||||++|||++|+.||............ ..
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~-- 287 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CA-- 287 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HH--
Confidence 976432211 1234579999999998743 23456899999999999999999999743221110000 00
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+. ..............+.+++.+||+.||++||++.|+++.
T Consensus 288 --------~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 --------IC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --------Hh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000112223445678899999999999999999999874
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=327.95 Aligned_cols=243 Identities=27% Similarity=0.340 Sum_probs=195.5
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
+.||+|+||.||++ .+..+|..||+|++..... .....+.+|+++++.++||||+++++.+..++..|
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 46999999999995 4455788999999875421 22345678999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
+||||+++++|..++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 72 FVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9999999999998887653 5889999999999999999999 899999999999999999999999999998753
Q ss_pred CCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
.... .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~----------~~ 207 (323)
T cd05595 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FE----------LI 207 (323)
T ss_pred cCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HH----------HH
Confidence 2211 122345799999999999888999999999999999999999999975432110 00 01
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
.... ..++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 208 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 208 LMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1111 112233456788999999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.99 Aligned_cols=259 Identities=25% Similarity=0.302 Sum_probs=206.9
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
...++|++.+.||+|+||.||++. +..++..||+|++..... .....+.+|+.++..++|+||+++.+.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~---------~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAK---------RVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEE---------EcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 345789999999999999999954 445688999999876532 233567889999999999999999887
Q ss_pred EEeCC--------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 147 CLEDD--------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 147 ~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
+...+ .+++||||+++|+|.+++.........+++..+..++.|++.||.||| +.+|+||||||+|||++
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLC 177 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEe
Confidence 75432 368999999999999999765544567899999999999999999999 89999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~ 298 (404)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------ 251 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------ 251 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence 99999999999997654332222334567999999999999889999999999999999999999999753211
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... +.... ....+...+..+.+++.+||+.||.+||++.++++.
T Consensus 252 ~~~~~----------~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHK----------TLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHH----------HhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111 11100 112333455678899999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=330.47 Aligned_cols=266 Identities=29% Similarity=0.413 Sum_probs=214.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++-.+.+.||+|+||.||+|.+... .......||+|....+. .....++++|+++++.++|||||++||+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~-----~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLK-----NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEec-----CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4555668999999999999987532 11112238999887533 455578999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+.-+++|||+|.||+|.++|.+... .++......++.+.+.||+||| .++++||||..+|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999998763 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|+++....-. .......-...|+|||.+....|+.++|||||||++||+++ |..||.+......
T Consensus 307 GLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------------- 371 (474)
T KOG0194|consen 307 GLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------------- 371 (474)
T ss_pred ccccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------------
Confidence 9988653111 11111235678999999999999999999999999999999 8889976543211
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
...+.........+...+..+..++.+|+..||++||+|.++.+.|+.+......
T Consensus 372 ---~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 372 ---KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1112122222344445677888999999999999999999999999998876554
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=312.55 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=208.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||.|+||.||+|+. ..++..|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATC---------LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEE---------eCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 5789999999999999999654 3467889999876432 222345788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+..+++|||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988654333346889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++........ ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... ...+...
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~----- 219 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK----- 219 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-----
Confidence 99876433211 122346888999999998888999999999999999999999998643211 0111100
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
+.............+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 -----IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000111122344567899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.23 Aligned_cols=264 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|++.+.||+|+||.||+|.+... .......+++|.+..... ....++..|+..++.+.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4688899999999999999865321 111223578888754322 22356778888999999999999999875 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++++||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 56788999999999999997654 35899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++...............++..|++||.+.+..++.++||||||+++|||++ |..||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--------------- 220 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV--------------- 220 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---------------
Confidence 986543332222333457778999999988889999999999999999998 9999975432110
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
.+++........+..+...+..++.+||..||++|||+.++++.|..+..+.
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 221 --PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred --HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0111111111111123446788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=333.46 Aligned_cols=200 Identities=28% Similarity=0.385 Sum_probs=174.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-C-----CCcceEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-H-----PNLVKLVG 145 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~iv~~~~ 145 (404)
.+|.++++||+|+||+|-+ |.+..+++.||||+++... ........|+++|..|+ | -|+|++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk---------~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVK---------AYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEE---------EEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 3678899999999999999 5566789999999997753 33455678999999996 4 38999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC--CcE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN--YNA 223 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~--~~v 223 (404)
+|...+++|||+|.+ ..+|.+++..+. +.+++...+..++.||+.||.+|| ..+|||+||||+||||..- ..|
T Consensus 256 ~F~fr~HlciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred ccccccceeeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCce
Confidence 999999999999999 779999998764 478999999999999999999999 8999999999999999643 469
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCC
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~ 291 (404)
||+|||.+...... ......+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++
T Consensus 331 KVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 331 KVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred eEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 99999999875432 2256788899999999999999999999999999999999999876544
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=315.73 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|++.+.||+|+||.||+|.+.. .....+..+++|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 467888999999999999987532 2334567899999875432 2235688899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGS-------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll 217 (404)
...|++|||+++++|.+++..... ....+++..+..++.|++.||+||| +.+++|+||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEE
Confidence 999999999999999999864321 1134788899999999999999999 8899999999999999
Q ss_pred cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcc
Q 046897 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHN 296 (404)
Q Consensus 218 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~ 296 (404)
+.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~ 234 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E 234 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986543332222333446678999999988889999999999999999998 88898653211 0
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.. ..+........+...+..+.+++.+||+.||.+||++.+|++.|..
T Consensus 235 ~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VI--------------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 01 1111111111222345678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.83 Aligned_cols=245 Identities=29% Similarity=0.410 Sum_probs=193.1
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHH---hcCCCCCcceEEEEE
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYL---GQLYHPNLVKLVGYC 147 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hp~iv~~~~~~ 147 (404)
|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+.+|++++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAE---------YKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6778999999999999954 44568899999987542 12234566666554 566899999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
...+..|+||||+++++|..++.. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCc
Confidence 999999999999999999988754 35899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++....... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ....
T Consensus 145 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~----- 211 (324)
T cd05589 145 FGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFD----- 211 (324)
T ss_pred ccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHH-----
Confidence 99987532211 1233467999999999999889999999999999999999999999754321 0000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.+..... .++...+..+.+++.+||+.||.+||+ +.++++
T Consensus 212 -----~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 -----SIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----HHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111111 122334566789999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=329.61 Aligned_cols=260 Identities=20% Similarity=0.244 Sum_probs=196.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.+|.+.+.||+|+||.||+ +.+..+++.||+|.... ..+.+|+++|+.++||||++++++|..+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~---------~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFA---------CIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred CCcEEEEEEcCCCCeEEEE---------EEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 5799999999999999999 45556788999996532 34678999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++|||++ +++|..++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 157 ~~~lv~e~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 157 FTCLILPRY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred eeEEEEecC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 999999999 57888888654 35789999999999999999999 889999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc-c---hhhhhhhhhh-
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH-N---LVEWAKPYLA- 306 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~-~---~~~~~~~~~~- 306 (404)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..||......... . ..........
T Consensus 230 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 75322111 1223457999999999999889999999999999999999999887543221110 0 0000000000
Q ss_pred --------hccccchhh----cccc-c-C-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 --------SKRKIFRII----DNRL-E-G-----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 --------~~~~~~~~~----~~~~-~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
....+..+. .... . . ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0000 0 0 001123557889999999999999999999985
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=318.35 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=209.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||++..... ........+++|.+..... .....+.+|+.++..+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 45788899999999999999876431 1124457899998875422 2335678899999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRG------------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.+...+++|||+++++|..++.... .....+++..++.++.|++.||.||| +.+|+|+||||+|||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Nil 164 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeEE
Confidence 9999999999999999999997532 12346889999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~- 243 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL- 243 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-
Confidence 99999999999999986543322212222335677999999988899999999999999999997 8889865332110
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
...+........+......+.+++.+||..||++|||+.++++.|+.+.
T Consensus 244 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0111111111223344567889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=324.73 Aligned_cols=267 Identities=25% Similarity=0.364 Sum_probs=201.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||.|+||.||++ .+..++..+++|.+..... ...+.+.+|+++++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKV---------SHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEE---------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 468999999999999999995 4455688899998876422 233568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+|+||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 999999999999999999997643 57899999999999999999993 2479999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh------h---
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE------W--- 300 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~------~--- 300 (404)
++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. +
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 98754321 1233568999999999988889999999999999999999999997533211000000 0
Q ss_pred ------------hhhhhhh---ccccchhhccccc---CCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 ------------AKPYLAS---KRKIFRIIDNRLE---GQYT-LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 ------------~~~~~~~---~~~~~~~~~~~~~---~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...+... ......+.+.... ...+ .....++.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 0000000000000 0000 1124568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=303.17 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=207.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|.+.++||+|.|+.||+ +.+..+|+.+++|+++...+ ...+++.+|++|-+.|+||||+++.+.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrR---------c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHH---------HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 346788889999999999998 88888999999998875433 3457889999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCcEE
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAK 224 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~vk 224 (404)
.+....|+|+|+++|++|..-|-.+ .-+++..+-..++||+.+|.|+| .++|+|||+||+|+++.. ..-+|
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCcee
Confidence 9999999999999999998777655 24678888899999999999999 899999999999999954 34599
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||+|.....+ .......|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+......
T Consensus 154 L~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl---------- 220 (355)
T KOG0033|consen 154 LADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---------- 220 (355)
T ss_pred ecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH----------
Confidence 9999999987632 245567899999999999999999999999999999999999999986432111
Q ss_pred hhhccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LASKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+++.... .....-+...++..+|+++||..||.+|.|+.|.|+
T Consensus 221 ------ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 221 ------YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ------HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111111 112233445677889999999999999999988764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=311.68 Aligned_cols=271 Identities=23% Similarity=0.283 Sum_probs=205.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCC-cceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPN-LVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~ 148 (404)
..|...+.||+|+||+||+|+ ...+|..||+|++..+.. ..-....+|+.+|+.|+|+| |+.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar---------~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKAR---------SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEE---------EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 345566779999999999954 455789999999976533 23355789999999999999 999999999
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
..+ .+++||||+ ..+|..++.........++...++.++.||+.||+||| +++|+||||||.||||+.+|.
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCCc
Confidence 877 789999999 66999999876643346777899999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||+|+...... ...+..++|..|+|||++.+. .|+...||||+|||++||++++..|.+..+... ...+
T Consensus 159 lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~I 233 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRI 233 (323)
T ss_pred EeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHH
Confidence 9999999999644222 234556799999999998876 799999999999999999999999987654211 1111
Q ss_pred hhhhhhc--cccch---hhcccc-------cCCCCHHH---HHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 046897 302 KPYLASK--RKIFR---IIDNRL-------EGQYTLEG---AYKAATLALRCLSTEGKFRPMMAEVVTV--LEQL 359 (404)
Q Consensus 302 ~~~~~~~--~~~~~---~~~~~~-------~~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 359 (404)
...+... ..+.. +.+-.. ...+.... ..+..+++.+||+.+|.+|.|+..+++. |..+
T Consensus 234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111000 00000 000000 00011111 1367899999999999999999999886 5543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=319.26 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=197.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGK---------SKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEE---------ECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 4689999999999999999954 4446889999998754322 23457789999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++||||+ .++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCC
Confidence 99999999999 568888876543 35788999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .............
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 224 (303)
T cd07869 149 LARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTP 224 (303)
T ss_pred cceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCC
Confidence 987532221 12233568899999998865 458889999999999999999999997543210 0000000000000
Q ss_pred --c------ccchhhcccccCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 --R------KIFRIIDNRLEGQYT---------LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 --~------~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ..............+ ......+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 000000000000000 001246779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.48 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=196.4
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|.. ..++..+++|.+..... .....+.+|+++++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~---------~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRL---------RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEE---------ecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 4699999999999544 44678899998765432 2335688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 72 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 72 MELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred EeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccccc
Confidence 99999999999987543 35789999999999999999999 89999999999999999999999999999875432
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
............+..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~ 209 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAI 209 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHH
Confidence 211111111223457999999988889999999999999999998 888886432210 00111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 210 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111111223334567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=313.09 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=208.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|.+.+.||.|+||.||+|... . +..+++|.+..........+..|+.+++.++|+||+++++++...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~---------~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWK---------N-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEec---------C-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 456889999999999999996543 2 678999999877665667889999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999999976432 45889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+........ ......++..|++||.+.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~---------- 215 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD---------- 215 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH----------
Confidence 976533221 1223346678999999988889999999999999999998 89999654311 0000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
. .........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 216 ---~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 216 ---Q-ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---H-HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 111111122334456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=323.70 Aligned_cols=251 Identities=27% Similarity=0.334 Sum_probs=214.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCC-CCCcceEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLY-HPNLVKLVG 145 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~ 145 (404)
....|.+.+.||.|.||.||+ |.+..+|..+|+|.+.+..... .+.+.+|+.+|+++. |||||.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~---------~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYL---------CREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEE---------EEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 356789999999999999999 6677789999999998765433 357899999999998 999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC----C
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN----Y 221 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~----~ 221 (404)
+|.+...+++|||++.||.|.+.+... .+++..+..++.|++.++.||| ..+|+||||||+|+|+... +
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCC
Confidence 999999999999999999999999876 2899999999999999999999 8999999999999999543 5
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||..........
T Consensus 177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----- 248 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----- 248 (382)
T ss_pred cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----
Confidence 799999999998655 335667899999999999988999999999999999999999999998765432211
Q ss_pred hhhhhhccccchhhcc--cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDN--RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+... .............+.+++.+||..||.+|+|+.++|+.
T Consensus 249 -----------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 -----------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 22334445567788999999999999999999999995
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.81 Aligned_cols=248 Identities=25% Similarity=0.292 Sum_probs=200.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|.+.+.||+|+||.||+|.+.. ..+..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKN--------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEEC--------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 3568889999999999999975432 124689999886432 22335678899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..|+||||+.+|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEec
Confidence 99999999999999999999997653 5889999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.. ..
T Consensus 175 FG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~------ 237 (340)
T PTZ00426 175 FGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IY------ 237 (340)
T ss_pred CCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HH------
Confidence 9999764321 234579999999999988889999999999999999999999997543210 00
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
..+..... .++......+.+++.+||+.||++|+ ++.++++.
T Consensus 238 ----~~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 238 ----QKILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----HHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111111 12233445678999999999999995 78887764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.84 Aligned_cols=273 Identities=31% Similarity=0.468 Sum_probs=206.3
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED-- 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 150 (404)
|.+.+.||+|+||+||++.++ +.....+..|++|.+..... .....+.+|+++|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEc-----cccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 488999999999999987543 23445678899999876532 2345678999999999999999999988654
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...+++|||+++++|.+++... .+++..++.++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeeccc
Confidence 4688999999999999999753 4899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+.......... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ........ .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~~ 231 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQG-QMTVV 231 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccc-ccchh
Confidence 98654332211 11223456679999999888899999999999999999999999864322100 00000000 00000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.+....+.......+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111111222223344568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=316.48 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=205.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+|++.+.||+|+||.||+|..... .....+..||+|++...... ..+.+.+|+.++..++||||+++++++....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 467788999999999999876431 12334678999998765322 2356788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRG------------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
..++++||+.+++|.+++.... .....+++..++.++.|++.||+||| +.+|+||||||+||+++.
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEecC
Confidence 9999999999999999986321 11235788889999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~ 298 (404)
++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------ 233 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------ 233 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999886543332222233456788999999988889999999999999999998 88888653221
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.+.. .+.+. .....+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 234 ~~~~----------~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIE----------MIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHH----------HHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1110 11111 1112334456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=329.66 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=196.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||++ .+..++..||+|++.... ....+.+.+|+++++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLV---------QKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 36889999999999999995 445578899999986532 122355788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++...|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999764 35889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCC---------------------------------------------cceeeccccccccCccccccCCC
Q 046897 229 GLAKDGPTGDQS---------------------------------------------HVSTRVMGTYGYAAPEYLATGHL 263 (404)
Q Consensus 229 g~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 263 (404)
|+++........ ......+||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998632110000 00012469999999999998899
Q ss_pred CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCC
Q 046897 264 TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEG 343 (404)
Q Consensus 264 ~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 343 (404)
+.++|||||||++|||++|..||........ ........ ..+...........+.+++.+||. +|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~--------~~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSENSHET------YRKIINWR--------ETLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCCCHHHH------HHHHHccC--------CccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999999999999999999975432110 00000000 000000111234567899999997 77
Q ss_pred CCC---CCHHHHHHH
Q 046897 344 KFR---PMMAEVVTV 355 (404)
Q Consensus 344 ~~R---Ps~~eil~~ 355 (404)
.+| +++.+++..
T Consensus 291 ~~r~~r~~~~~~l~h 305 (377)
T cd05629 291 ENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCHHHHhcC
Confidence 665 589888875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.61 Aligned_cols=268 Identities=23% Similarity=0.356 Sum_probs=208.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLY-HPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+|++.. ......+..||+|++....... .+.+.+|+.+|..+. ||||+++++++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~----~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHG----LSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcC----CCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4568889999999999999988754 2233456789999997653222 346889999999997 999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------------------------------------------------
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------------------------------------------------ 174 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 174 (404)
.....++||||+.+|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 175 ----------------------------------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 175 ----------------------------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
....+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcce
Confidence 1124667788899999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSG 293 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~ 293 (404)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999975432221111223456788999999988889999999999999999998 888986432110
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
. ....+........+......+.+++.+||+.+|++||++++|++.|+++.
T Consensus 350 ~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q----------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 00111111111222334567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.92 Aligned_cols=265 Identities=26% Similarity=0.380 Sum_probs=208.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||++.... ......+..+|+|.+..... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYG----LSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEec----CCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4579999999999999999986532 22344567899998875432 2235688999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+..+++|||+.+++|.+++..... ..+++..++.++.|++.||+||| +.+|+|+||||+|||++.++.++|+||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999975432 34899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------------- 252 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------------- 252 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-------------
Confidence 99986543222111222346778999999988889999999999999999998 9999865332110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.............+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 253 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 ---FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011111111111222345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=313.58 Aligned_cols=264 Identities=26% Similarity=0.397 Sum_probs=207.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|...+.||+|+||.||++.... ......+..+++|.+..........+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEec----CCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3568889999999999999976432 223445678999988776655567789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGS-----------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
...+++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcC
Confidence 999999999999999999976431 1134788999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~ 298 (404)
++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I 234 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H
Confidence 99999999999875433222112222345678999999988889999999999999999998 8999864332110 0
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
..+.. ......+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 235 -------------~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 -------------ECITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------------HHHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000 0011112234456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.12 Aligned_cols=254 Identities=33% Similarity=0.529 Sum_probs=196.7
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 155 (404)
.+.||.|.||.||+|.+.. .....+..|+||.++.... ...+.+.+|++.+++++||||+++++++...+..++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred eeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccc
Confidence 4689999999999998762 3445678899999965432 235789999999999999999999999998888999
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
||||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+++|+||+++||+++.++.+||+|||++....
T Consensus 79 v~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 9999999999999988621 46899999999999999999999 7899999999999999999999999999998753
Q ss_pred CCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
................|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~----------~~~~ 218 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EI----------IEKL 218 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HH----------HHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cc----------cccc
Confidence 3222222233457778999999988889999999999999999999 67887653211 11 1111
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
.+ ......+..++..+.+++..||..||++||++.+|++.|
T Consensus 219 ~~-~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQ-GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HT-TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc-cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 111223334566788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=325.63 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=195.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||+||++ .+..+++.||+|++..... .....+..|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLV---------QKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 46889999999999999994 4555788999999875321 22345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++..+|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeec
Confidence 999999999999999999999765 35899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCC---------------------------------cceeeccccccccCccccccCCCCcccchhhhhHH
Q 046897 229 GLAKDGPTGDQS---------------------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVV 275 (404)
Q Consensus 229 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~l 275 (404)
|++......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998754221100 00123579999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCC--HHHHHHHHHHHHHccc--CCCCCCCCHHH
Q 046897 276 LLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYT--LEGAYKAATLALRCLS--TEGKFRPMMAE 351 (404)
Q Consensus 276 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~--~dP~~RPs~~e 351 (404)
+|||++|+.||......... . .+........++ ......+.+++.+++. .++..||++.+
T Consensus 226 l~ell~G~~Pf~~~~~~~~~------~----------~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 226 MYEMLIGYPPFCSETPQETY------K----------KVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred HHHHHhCCCCCCCCCHHHHH------H----------HHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 99999999999754321100 0 011000000011 1123456778877654 23334689999
Q ss_pred HHHH
Q 046897 352 VVTV 355 (404)
Q Consensus 352 il~~ 355 (404)
|++.
T Consensus 290 i~~h 293 (363)
T cd05628 290 IKTN 293 (363)
T ss_pred HhCC
Confidence 9875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.26 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=205.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.+|.+.+.||.|+||.||+|.+. ..+..+++|.+..+. .....+.+|+++++.++|+||+++++++..+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEe---------cCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 45778899999999999996543 357889999887543 33467889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999976432 45889999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~--------- 215 (263)
T cd05052 152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVY--------- 215 (263)
T ss_pred cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH---------
Confidence 765432211 1111234567999999988899999999999999999998 89998653211 110
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
..+........+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 216 --~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 --ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111111122333456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=310.19 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=203.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
|.+.+.||+|+||.||+|.... +...+..||+|.+..+... ....+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678999999999999986532 2234578999998764322 2356889999999999999999999887655
Q ss_pred e------eEEEEeccCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 152 H------RLLVYEFMPRGSLENHLFRRG--SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 152 ~------~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
. .+++|||+++++|..++.... .....+++..+..++.|++.||.||| +.+++|+||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeE
Confidence 4 789999999999999986542 22246899999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~-- 227 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDY-- 227 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--
Confidence 9999999986543332212222335678999999988889999999999999999999 88888653321 11110
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+.. ......+......+.+++.+||+.||++||++.++++.|+++
T Consensus 228 -----------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -----------LRH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----------HHc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 011122334456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.66 Aligned_cols=272 Identities=25% Similarity=0.352 Sum_probs=209.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||++...... -....+...+++|.+.... ......+..|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999997653210 0111234679999987542 22335678899999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.++..|+||||+.+++|.+++...... ...+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheE
Confidence 999999999999999999999765321 134888999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 99999999999999876433221111122234568999999988889999999999999999998 88888643211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
... ..+........+......+.+++.+||..+|++||++.++++.|+++....
T Consensus 250 ---~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ---ELF-----------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ---HHH-----------HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 100 011111111223344567889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.60 Aligned_cols=252 Identities=29% Similarity=0.346 Sum_probs=203.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||+|. +..++..||+|++..... .....+..|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEE---------ECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 368899999999999999954 445788999999875422 23356788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..|+||||+.+++|.+++... ..+++..++.++.||+.||+||| ..+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecC
Confidence 999999999999999999999865 35899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCC---------------------------CCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh
Q 046897 229 GLAKDGPTGD---------------------------QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281 (404)
Q Consensus 229 g~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~ 281 (404)
|++....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9998644322 0012234569999999999999999999999999999999999
Q ss_pred CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc--ccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 046897 282 GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID--NRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-MAEVVTV 355 (404)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~ 355 (404)
|+.||........ ...+.. ..+........+..+.+++.+||. ||.+||+ +.++++.
T Consensus 226 g~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 226 GFPPFYSDTLQET----------------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCCHHHH----------------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999976442100 001111 011111111145678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.67 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=207.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.... ......+..|++|.+..... .....+.+|+.++..++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKG----VVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEec----cCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4578899999999999999987653 12234567899999865432 333567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSY------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
....++||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCE
Confidence 99999999999999999999754321 124688899999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~-- 233 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF-- 233 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH--
Confidence 9999999876543322222233456788999999988889999999999999999998 999986533211 0100
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 ------------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000111222234667889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.96 Aligned_cols=243 Identities=27% Similarity=0.349 Sum_probs=195.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
+.||+|+||.||++ .+..++..||+|++..... .....+..|++++..++||||+++++++..++..|
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 46999999999984 4555788999999875422 22345678999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
+||||+++++|..++... ..+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+|||++..
T Consensus 72 lv~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH--~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 999999999999888764 35899999999999999999999 5 7999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~----------~ 207 (325)
T cd05594 146 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE----------L 207 (325)
T ss_pred cCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHH----------H
Confidence 32211 12234579999999999988899999999999999999999999996533210 000 0
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
+.... ..++.....++.+++.+||+.||++|+ ++.++++.
T Consensus 208 i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 208 ILMEE--IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HhcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 00000 112223455788999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=330.63 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=198.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||++ .+..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLV---------QKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 46889999999999999995 445578899999987532 123345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..|+||||+.+|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeec
Confidence 9999999999999999999997653 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCc------------------------------------ceeeccccccccCccccccCCCCcccchhhh
Q 046897 229 GLAKDGPTGDQSH------------------------------------VSTRVMGTYGYAAPEYLATGHLTAKSDVYSF 272 (404)
Q Consensus 229 g~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 272 (404)
|++.......... .....+||+.|+|||++.+..++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987532211000 0112469999999999988899999999999
Q ss_pred hHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC---H
Q 046897 273 GVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM---M 349 (404)
Q Consensus 273 G~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~ 349 (404)
||++|||++|..||........ ........ ..+...........+.+++.+||. +|.+|++ +
T Consensus 226 G~il~el~~G~~Pf~~~~~~~~------~~~i~~~~--------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQET------YRKIINWK--------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHHHH------HHHHHcCC--------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999999999999975432110 00000000 000000111234567799999996 9999998 8
Q ss_pred HHHHHH
Q 046897 350 AEVVTV 355 (404)
Q Consensus 350 ~eil~~ 355 (404)
.++++.
T Consensus 291 ~~ll~h 296 (364)
T cd05599 291 NEIKSH 296 (364)
T ss_pred HHHhcC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=323.25 Aligned_cols=243 Identities=28% Similarity=0.341 Sum_probs=195.0
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
++.||+|+||.||+++. .....++..||+|++..... .....+..|+++|++++||||+++++++..++..|
T Consensus 1 l~~lg~G~~g~Vy~~~~------~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 1 LKVLGQGSFGKVFLVRK------ITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred CceeeeCCCEEEEEEEE------eccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence 36799999999998754 23345688999999875432 22345678999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
+||||+++++|.+++.+. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 75 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 75 LILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 999999999999998764 35899999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
.... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... .+
T Consensus 149 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~----------~i 210 (318)
T cd05582 149 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMT----------MI 210 (318)
T ss_pred CCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHH----------HH
Confidence 3321 1233467999999999998888999999999999999999999999754321 0000 11
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 351 (404)
.... ...+...+..+.+++.+||+.||++||++.+
T Consensus 211 ~~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 LKAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111 1222334567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=325.22 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=195.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||+|+||.||+|+ +..++..||+|.+.... ......+.+|+++++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAI---------DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEE---------ECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 58889999999999999954 44568899999986432 22335688999999999999999999988643
Q ss_pred C-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 151 D-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 151 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
. ..|+||||+ +++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEE
Confidence 2 479999999 57899888754 35899999999999999999999 899999999999999999999999
Q ss_pred ecccCCCCCCCCCCC-cceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh---
Q 046897 226 SDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE--- 299 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~--- 299 (404)
+|||+++........ .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999999754322211 12234579999999999865 678999999999999999999999997543211000000
Q ss_pred ------hhhhhhhhccccchhhc---ccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 300 ------WAKPYLASKRKIFRIID---NRLEGQY---TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 300 ------~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... .......+. ....... .......+.+++.+||+.||++|||+.++++.
T Consensus 225 ~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVR--NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhh--hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 000000000 0000000 01123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=314.50 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=195.7
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||+|+||+||++ .+..+++.||+|.+....... .+.+..|+++++.++|+||+++.+++..+...++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSAC---------QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEE---------EEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 799999999984 445578899999987543222 24567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++|+|.+++.........+++..++.++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999999888654433456899999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ... ..+..
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~----------~~~~~ 215 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELK----------QRILN 215 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHH----------Hhhcc
Confidence 221 2233578999999999999999999999999999999999999997543211100 000 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
.. ...+...+..+.+++.+||+.||++|| +++++++
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11 122334556788999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=329.14 Aligned_cols=252 Identities=26% Similarity=0.307 Sum_probs=196.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.|.+.+.||+|+||+||+| .+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLA---------CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 5888999999999999995 4455788999999976432 223567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++.+|+||||+++|+|.+++.... .+++..+..++.||+.||.||| ..+|+||||||+||||+.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence 999999999999999999997653 5889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCC---------------------------------------------CcceeeccccccccCccccccCCCC
Q 046897 230 LAKDGPTGDQ---------------------------------------------SHVSTRVMGTYGYAAPEYLATGHLT 264 (404)
Q Consensus 230 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 264 (404)
++........ ........||+.|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 9753210000 0001235799999999999888999
Q ss_pred cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc--ccccCCCCHHHHHHHHHHHHHc--cc
Q 046897 265 AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID--NRLEGQYTLEGAYKAATLALRC--LS 340 (404)
Q Consensus 265 ~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~c--l~ 340 (404)
.++|||||||++|||++|..||....+.... ..+.+ ..+..........++.+++.+| +.
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTETQ----------------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHHH----------------HHHHccccccCCCCCCCCCHHHHHHHHHHccCc
Confidence 9999999999999999999999764321100 00110 0010011112345677888884 45
Q ss_pred CCCCCCCCHHHHHHH
Q 046897 341 TEGKFRPMMAEVVTV 355 (404)
Q Consensus 341 ~dP~~RPs~~eil~~ 355 (404)
.++..||++.+++..
T Consensus 291 ~~~~~R~~~~~~l~h 305 (381)
T cd05626 291 EERLGRNGADDIKAH 305 (381)
T ss_pred ccccCCCCHHHHhcC
Confidence 566669999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=312.90 Aligned_cols=268 Identities=25% Similarity=0.363 Sum_probs=207.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||.||+|..++. .....+..|++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 356899999999999999999876531 2223456899998865432 22345788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
..+..++||||+.+|+|.+++...... ....+...+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCc
Confidence 999999999999999999999764311 234567788999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~ 301 (404)
++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~ 231 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVL 231 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence 99999999886433322222222345678999999988889999999999999999998 78888653221 111
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.. +.+. .....+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 232 ~~----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KF----------VMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HH----------HHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00 0000 001112233467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=315.05 Aligned_cols=272 Identities=24% Similarity=0.357 Sum_probs=210.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
..+|.+.+.||+|+||.||++...... ......+..+++|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 567889999999999999997643210 0122345679999886542 23346788999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.....+++|||+.+++|.+++..... ....+++..++.++.||+.||.||| +.+++|+||||+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEE
Confidence 99999999999999999999976432 1235788899999999999999999 889999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 99999999999999986543332222223446678999999988889999999999999999998 78888543211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
..... +........+......+.+++.+||..+|.+||++.++++.|+++....
T Consensus 247 ---~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 ---ELFKL-----------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHHH-----------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11110 1111111122344567889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=312.18 Aligned_cols=275 Identities=27% Similarity=0.391 Sum_probs=210.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccc-------cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcce
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFA-------ATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~ 142 (404)
..+|++.+.||+|+||.||++........ ......+..|++|.+..... ...+.+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35799999999999999999876543211 22334557899999876532 23456889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGS-------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
+++++..+...+++|||+.+++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhce
Confidence 99999999999999999999999999976541 1235899999999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh--CCCCcCCCCCCC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS--GRRAVDKNRPSG 293 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~--g~~p~~~~~~~~ 293 (404)
+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999876543332222334456778999999988889999999999999999998 67777543211
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
........... ..........+...+.++.+++.+||+.||++|||+.+|++.|+
T Consensus 241 --~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 --QVIENAGHFFR-------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHhccc-------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111110000 00111111122234467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=307.67 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=204.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||.|++|.||+|.+. .+..|++|.+.... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 456889999999999999997542 24679999987654 3456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+.+++|.+++.... ...+++..+..++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcce
Confidence 99999999999999999997643 246899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+......... .......+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----------- 214 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL----------- 214 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-----------
Confidence 9865422111 1111223457999999988889999999999999999999 999996532110 00
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
..+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 215 ---QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---HHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00011111122233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=312.16 Aligned_cols=277 Identities=26% Similarity=0.353 Sum_probs=206.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-- 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 149 (404)
.+|++.+.||+|+||.||++... ..+..++..|++|.+........+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEec-----CCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 57889999999999999997653 23445688999999887665556778999999999999999999998754
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCc
Confidence 346889999999999999997543 35889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcce-eeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVS-TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++............ ....++..|+|||.+.+..++.++||||||+++|||++|..++......-....... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIV 232 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccch
Confidence 99865433221111 112234569999999888899999999999999999998876543211000000000 0000000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
..+...+............+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000011111111112233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=311.45 Aligned_cols=269 Identities=25% Similarity=0.320 Sum_probs=204.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD- 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 151 (404)
.|...+++|.|+||.||+|...+ ++..||||..-.+..- -.+|+.+|+.+.|||||++.-+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 46778999999999999976544 4788999988665322 237999999999999999999887532
Q ss_pred ----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcEEEe
Q 046897 152 ----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLS 226 (404)
Q Consensus 152 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~vkl~ 226 (404)
...+||||++ .+|.+.+.......+.++...++-+..||++||.||| ..+|+||||||.|+|+|.+ |.+||+
T Consensus 92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEec
Confidence 3468999995 5999999865444567888899999999999999999 7999999999999999976 999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|||.|+....+... .....+..|+|||++.| ..|+.+.||||.||++.||+-|++.|.+.+.. .++...++-+-
T Consensus 169 DFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG 243 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLG 243 (364)
T ss_pred cCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhC
Confidence 99999987665533 44668889999998876 57999999999999999999999999874332 22222111110
Q ss_pred -hhccccch------------hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHhc
Q 046897 306 -ASKRKIFR------------IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQDS 362 (404)
Q Consensus 306 -~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~~ 362 (404)
...+.+.. +.......-+......++.+++.++|..+|.+|.++.+++.. ++.+++.
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00111111 111111111333456688999999999999999999999854 7777655
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.46 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=194.6
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||.||++. +..++..||+|++..... ...+.+..|..++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~~---------~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVE---------LKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 469999999999954 445688999999975422 2234577899999888 799999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9999999999999988765 35899999999999999999999 89999999999999999999999999999874
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC--Ccchhhhhhhhhhhcccc
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG--EHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 311 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+...
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-------- 215 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ-------- 215 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--------
Confidence 22111 12334679999999999999899999999999999999999999997433221 1111111111
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM------MAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~ 354 (404)
.+..... ..+......+.+++.+||+.||.+|++ +.++++
T Consensus 216 -~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 216 -VILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -HHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1111111 122234556889999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=316.24 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCCcceEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQL---YHPNLVKLVGY 146 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hp~iv~~~~~ 146 (404)
++|++.+.||+|+||.||+|... ..++..||+|.+..... .....+.+|+.+++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEc--------CCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 47999999999999999996432 12467899998865422 2223456677776665 69999999998
Q ss_pred EEe-----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 147 CLE-----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 147 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
+.. ....++||||+. ++|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 147 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCC
Confidence 863 346899999995 699999876432 45889999999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|||++|++||......... ...
T Consensus 148 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i 221 (290)
T cd07862 148 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKI 221 (290)
T ss_pred CEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHH
Confidence 99999999997643321 233456899999999998889999999999999999999999999865432111 000
Q ss_pred hhhhh--hccccc-------hhhcccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 302 KPYLA--SKRKIF-------RIIDNRL---EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 302 ~~~~~--~~~~~~-------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..... ...... ..+.... ........+..+.+++.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000 0000000 00011223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.67 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=203.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|... .+..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN----------NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec----------CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 457889999999999999997543 24569999876543 3356788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999999999976432 45788899999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~-------- 217 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL-------- 217 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH--------
Confidence 9865332211 1122345678999999988889999999999999999998 999996532211 01000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
... .........+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 218 -----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 -----QRG-YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----HcC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 000 00011122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.55 Aligned_cols=265 Identities=21% Similarity=0.331 Sum_probs=191.6
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC------CCCcc
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY------HPNLV 141 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv 141 (404)
....++|++.++||+|+||+||+|+ +..++..||||++.... ........|+.+++.++ |.+++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~---------~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAW---------DRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEE---------EcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCccee
Confidence 3446789999999999999999954 44467889999986432 22234556666666654 45688
Q ss_pred eEEEEEEeC-CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcC
Q 046897 142 KLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDT 219 (404)
Q Consensus 142 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~ 219 (404)
+++++|..+ .+.|+|||++ +++|.+++.+.. .+++..+..++.||+.||.||| . .+|+||||||+|||++.
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH--~~~gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMET 267 (467)
T ss_pred eeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCHHHEEEec
Confidence 999988765 5789999998 788999887653 5899999999999999999999 5 59999999999999987
Q ss_pred CC----------------cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCC
Q 046897 220 NY----------------NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283 (404)
Q Consensus 220 ~~----------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~ 283 (404)
++ .+||+|||.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 65 499999998764322 223467999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCCcchhh---------hhh--------hhhhhccccchhhccc-----ccCC--CCHHHHHHHHHHHHHcc
Q 046897 284 RAVDKNRPSGEHNLVE---------WAK--------PYLASKRKIFRIIDNR-----LEGQ--YTLEGAYKAATLALRCL 339 (404)
Q Consensus 284 ~p~~~~~~~~~~~~~~---------~~~--------~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~l~~li~~cl 339 (404)
.||...........+. |.. .+......+....++. .... ........+.+||.+||
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 422 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence 9997644321111110 000 0000000000000000 0000 00012346789999999
Q ss_pred cCCCCCCCCHHHHHH
Q 046897 340 STEGKFRPMMAEVVT 354 (404)
Q Consensus 340 ~~dP~~RPs~~eil~ 354 (404)
+.||++|||+.|+++
T Consensus 423 ~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 423 HYDRQKRLNARQMTT 437 (467)
T ss_pred CcChhhCCCHHHHhc
Confidence 999999999999997
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=306.66 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=199.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||+|+||.||++.++. +..+++|.+.... .....+.+|+.+|+.++||||+++++++..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 457888999999999999976542 3568999876543 33467889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCc
Confidence 9999999999999999987543 24789999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i--------- 214 (256)
T cd05114 148 RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI--------- 214 (256)
T ss_pred cccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---------
Confidence 764322211 1112235568999999988889999999999999999999 89999654321 111110
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
.... ....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 215 ----~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 215 ----SRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----HCCC-CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0000 0011112345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.77 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=200.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+|++.++||+|+||.||++. +..++..||+|.+...... ....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQ---------VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEE---------EcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47888999999999999954 4446789999998654322 22446789999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 45899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~--------- 212 (285)
T cd05605 148 LAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---E--------- 212 (285)
T ss_pred CceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---H---------
Confidence 987643222 1223468999999999988889999999999999999999999997543211100 0
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
+...+.. ....++...+..+.+++.+||..||.+|| ++.++++.
T Consensus 213 -~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 -VERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -HHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0000100 11123334566788999999999999999 77777554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.38 Aligned_cols=238 Identities=27% Similarity=0.387 Sum_probs=190.8
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||.||+|+ +..++..||+|++.... ....+.+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLAR---------LKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEE---------EcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999954 44468899999987532 22335567888888876 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999999999999887653 5889999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~----------~ 207 (320)
T cd05590 146 GIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFE----------A 207 (320)
T ss_pred cCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHH----------H
Confidence 32211 1233457999999999998889999999999999999999999999754321 1001 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
+..... ..+.....++.+++.+||+.||++||++.
T Consensus 208 i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 208 ILNDEV--VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HhcCCC--CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 111111 12223456788999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=314.68 Aligned_cols=274 Identities=22% Similarity=0.362 Sum_probs=210.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
..+|.+.+.||+|+||.||++...... .........+++|.+..... .....+..|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 357889999999999999997643210 11223456789998875422 2345678899999999 6999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.+...+++|||+++++|.+++..... ....+++..+..++.|++.||.||| +.+++|+||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEE
Confidence 98899999999999999999976431 1235888999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999986543222111222234567999999988889999999999999999999 888886432211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
... .+........+...+..+.+++.+||..||++||++.++++.|+++......
T Consensus 245 -~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 245 -LFK--------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred -HHH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 000 0001111122333455788999999999999999999999999998775544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=320.28 Aligned_cols=242 Identities=28% Similarity=0.396 Sum_probs=191.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||.||+|. ...++..||+|++.... ....+.+..|..++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAE---------LKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999954 44467889999987532 12234456677777654 899999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 99999999999999987653 5889999999999999999999 89999999999999999999999999999975
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~----------~ 207 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFD----------S 207 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHH----------H
Confidence 43222 1233467999999999998888999999999999999999999999754321 0000 0
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA-EVVT 354 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 354 (404)
+... ...++.....++.+++.+||+.||++||++. ++++
T Consensus 208 i~~~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 208 ILND--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1110 1122233455678999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=325.29 Aligned_cols=252 Identities=24% Similarity=0.282 Sum_probs=200.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||++ .+..++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVV---------REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 46889999999999999995 4455788999999876422 23355788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccC
Confidence 9999999999999999999997753 36899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc------cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA------TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|++......... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... ...
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~ 219 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYN 219 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHH
Confidence 999765332211 223357899999999986 4567889999999999999999999997543211 000
Q ss_pred hhhhhccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.... +........+..+.+++..||. +|.+||++.++++.
T Consensus 220 ----------~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 220 ----------NIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----------HHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111100 1111112245668899999998 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.08 Aligned_cols=242 Identities=29% Similarity=0.384 Sum_probs=193.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCC-CCcceEEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYH-PNLVKLVGYCL 148 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 148 (404)
+|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+..|.+++..+.| ++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAE---------RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 47889999999999999954 44567899999987532 2233567789999999976 56888999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+..|+||||+++++|.+++.... .+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeec
Confidence 9999999999999999999987653 4789999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~------- 210 (324)
T cd05587 146 GMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELF------- 210 (324)
T ss_pred CcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH-------
Confidence 9987432211 1233467999999999999989999999999999999999999999754321 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
..+.... ..++......+.+++.+||..||.+|++.
T Consensus 211 ---~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 211 ---QSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---HHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111111 12223345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=328.88 Aligned_cols=250 Identities=26% Similarity=0.316 Sum_probs=194.4
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+|.+.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.+++.++|+||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLA---------RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEE---------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 5888999999999999995 4455788999999875422 223467889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..|+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECC
Confidence 999999999999999999987653 5789999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCC---------------------------------------------CCcceeeccccccccCccccccCCCC
Q 046897 230 LAKDGPTGD---------------------------------------------QSHVSTRVMGTYGYAAPEYLATGHLT 264 (404)
Q Consensus 230 ~a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 264 (404)
++....... ........+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 975321000 00001234699999999999988999
Q ss_pred cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc--ccccCCCCHHHHHHHHHHHHHcccCC
Q 046897 265 AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID--NRLEGQYTLEGAYKAATLALRCLSTE 342 (404)
Q Consensus 265 ~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~d 342 (404)
.++|||||||++|||++|+.||....+... ...+.. ..+...........+.+++.+|+ .+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~ 289 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLET----------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RG 289 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHH----------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cC
Confidence 999999999999999999999976432110 000110 00110111123456678888865 59
Q ss_pred CCCCCC---HHHHHH
Q 046897 343 GKFRPM---MAEVVT 354 (404)
Q Consensus 343 P~~RPs---~~eil~ 354 (404)
|++|++ +.++++
T Consensus 290 p~~R~~~~~~~ei~~ 304 (382)
T cd05625 290 PEDRLGKNGADEIKA 304 (382)
T ss_pred HhHcCCCCCHHHHhc
Confidence 999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=308.17 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=207.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+|.+.+.||.|+||.||++. ...++..+++|.+..... ....++.+|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~---------~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRAT---------CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEe---------ecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468889999999999999954 344678899998765322 23356788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..+++|||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998754333356899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ......
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~------ 218 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK------ 218 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh------
Confidence 99876433221 122346888999999998888999999999999999999999999643221 001100
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.+................+.+++.+||..||++|||+.+|++.++++.
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 ----KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000000011111235567889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=308.75 Aligned_cols=265 Identities=23% Similarity=0.378 Sum_probs=204.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|++.+.||+|+||.||+|.+... .......||+|.+..... ...+.+.+|+.++..++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 45788899999999999999865421 111234589998875432 234568899999999999999999999875
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCC
Confidence 45789999999999999987643 35889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++................++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----------- 220 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I----------- 220 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-----------
Confidence 9986543222111122335678999999988889999999999999999998 899986432110 0
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
...+........+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 221 ---PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0111111111122334567889999999999999999999999998875544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=322.18 Aligned_cols=267 Identities=22% Similarity=0.253 Sum_probs=201.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
...+|.+.+.||+|+||.||++... ....+..|++|.+... +...+|+++|+.++||||+++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~-------~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKH-------GDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEc-------CCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 3467999999999999999996532 2335678999987653 234689999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....|++||++ +++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||
T Consensus 158 ~~~~~lv~e~~-~~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 158 KSTVCMVMPKY-KCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred CCEEEEEehhc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence 99999999999 56888888543 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK- 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 308 (404)
++................||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...+...
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 9976544333323334679999999999998899999999999999999999999997654432111111110000000
Q ss_pred --------cccch---hhcccccCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 --------RKIFR---IIDNRLEGQYT-------LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 --------~~~~~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+.. .........+. .....++.++|.+||..||++||++.+++..
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000000 1123467889999999999999999999875
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.77 Aligned_cols=243 Identities=27% Similarity=0.363 Sum_probs=193.4
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||.||+|. +..++..||+|++.... ....+.+..|.+++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAE---------LKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEE---------ECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 469999999999954 44568899999987542 12234567788888866 799999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 99999999999999887653 5889999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~----------~ 207 (321)
T cd05591 146 GILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFE----------S 207 (321)
T ss_pred cccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHH----------H
Confidence 32221 12334578999999999988899999999999999999999999997543211 000 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-------MMAEVVTV 355 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~ 355 (404)
+..... ..+.....++.+++.+||+.||++|| ++.++++.
T Consensus 208 i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 208 ILHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111111 12222345788999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=334.57 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=197.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~---------~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAI---------CIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEE---------ECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4679999999999999999954 44467899999886542 2345799999999999999999987542
Q ss_pred --------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-
Q 046897 151 --------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY- 221 (404)
Q Consensus 151 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~- 221 (404)
..+++||||++ ++|.+++.........+++..++.++.||+.||+||| +.+|+||||||+|||++.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCCC
Confidence 24678999995 5788877654333457899999999999999999999 89999999999999998665
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh-h
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV-E 299 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~-~ 299 (404)
.+||+|||+++...... ......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...........+ .
T Consensus 209 ~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred ceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 69999999998654322 1223568999999998765 46899999999999999999999999764332110000 0
Q ss_pred hh-hhhhhh----cc-----ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHh
Q 046897 300 WA-KPYLAS----KR-----KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQD 361 (404)
Q Consensus 300 ~~-~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 361 (404)
.. .+.... .. ....+....+...++...+.++.+|+.+||+.||.+|||+.++++. |+.+.+
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00 000000 00 0000000111111222334678899999999999999999999854 555543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=310.45 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=204.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.+... .....+..|++|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 46789999999999999999766431 11125678999988654322 23468899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---cE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGS---YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY---NA 223 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~---~v 223 (404)
.+..++||||+++++|.+++..... ....+++..+..++.||+.||.||| +.+++|+||||+||+++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcce
Confidence 9999999999999999999976532 1135889999999999999999999 88999999999999998765 58
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||++.................+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----- 230 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----- 230 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-----
Confidence 9999999986532221111122234567999999988899999999999999999997 999997543211 0
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
...+........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ---------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ---------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111111111223334567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=302.28 Aligned_cols=249 Identities=29% Similarity=0.381 Sum_probs=215.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
-|.+++.||+|+||.||+ +.++.+|..+|+|.+..+ .+.+++.+|+.++.+...|++|++|+.|.....
T Consensus 34 VFDi~~KLGEGSYGSV~K---------AIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHK---------AIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHhcCCcchHHHH---------HHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 366678899999999998 778889999999998776 466889999999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
+|||||||..|++.+.+..+. +++.+..+..+++..+.||+||| ...-+|||||..|||++.+|..||+|||.+.
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999999998765 68999999999999999999999 8889999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
.+.... ...+...|||.|||||++..-.|+.++||||||++..||..|++||....+... ++
T Consensus 178 QLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IF 239 (502)
T KOG0574|consen 178 QLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IF 239 (502)
T ss_pred hhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eE
Confidence 754432 234568899999999999999999999999999999999999999987554322 22
Q ss_pred hhhc-ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 313 RIID-NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 313 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
-+.. +...-..+..++.++.++++.||-.+|++|-|+.++++.
T Consensus 240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2211 112234566788899999999999999999999888764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=318.86 Aligned_cols=270 Identities=27% Similarity=0.359 Sum_probs=205.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.... .....+++.||+|.+..... .....+.+|+.+|..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeecc----CCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4679999999999999999986532 22344678899999876432 2235678999999999 6899999999886
Q ss_pred eC-CeeEEEEeccCCCChHHHHhhcCCC----------------------------------------------------
Q 046897 149 ED-DHRLLVYEFMPRGSLENHLFRRGSY---------------------------------------------------- 175 (404)
Q Consensus 149 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 175 (404)
.. ...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4678999999999999998753210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCccee
Q 046897 176 -----------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244 (404)
Q Consensus 176 -----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 244 (404)
...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 123678888999999999999999 8999999999999999999999999999987643322211122
Q ss_pred eccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCC
Q 046897 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQY 323 (404)
Q Consensus 245 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (404)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... .+........
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~-----------~~~~~~~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCR-----------RLKEGTRMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHH-----------HHhccCCCCC
Confidence 2345678999999988889999999999999999997 899986532210 0000 0000000011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 324 TLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 324 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
+......+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 112335688999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=311.76 Aligned_cols=276 Identities=26% Similarity=0.426 Sum_probs=205.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCccc-----ccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSF-----AATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
.++|++.+.||+|+||.||+++...... .....+....|++|.+..... .....+.+|+++++.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999976543210 011223345689999876432 2235688999999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGS--------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
+++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+||+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEE
Confidence 999999999999999999999999865421 1124688899999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh--CCCCcCCCCCCCC
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS--GRRAVDKNRPSGE 294 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~--g~~p~~~~~~~~~ 294 (404)
++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999976543322222223345678999999988889999999999999999998 56677643321
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
........+.... ........+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 240 -~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENTGEFFRNQ-------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHhhhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111000 0000011122234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.04 Aligned_cols=252 Identities=24% Similarity=0.281 Sum_probs=199.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||++ .+..++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLV---------RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 467999999999999999995 445578899999986532 12234467899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..|+||||+++|+|.+++... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999999999998653 4788899999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccC----CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG----HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------- 255 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--------- 255 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---------
Confidence 999876432211 112345799999999988643 478899999999999999999999976432100
Q ss_pred hhhhccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 304 YLASKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
...+.+.. +........+..+.+++.+||+.+|.+ |+++.++++.
T Consensus 256 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 -------YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01111111 111111124567889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=306.21 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=202.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-----GHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
++|.+.+.||+|++|.||++. +..++..+++|.+...... ....+.+|+++++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~---------~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCY---------DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEE---------EcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 478999999999999999954 4456789999988654221 22457889999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+++..++++||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999998765 35788999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcc-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHV-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~------ 215 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A------ 215 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H------
Confidence 9999875433211111 123457889999999988889999999999999999999999996532110 0
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.............+......+.+++.+||..+|++||++.++++.
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 -----IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111111123334456678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.02 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=209.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||+|.. ..++..|++|.+.... ....+.+.+|+++++.++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAIC---------LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEE---------cCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 5789999999999999999654 3467889999886432 223457889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..+++|||+++++|.+++.........+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999998764443456899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~------ 218 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK------ 218 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh------
Confidence 99875433221 122346888999999998888999999999999999999999998643211 111000
Q ss_pred cccchhhcccccCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 309 RKIFRIIDNRLEGQYTL-EGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.+.. ......+. .....+.+++.+||..+|++||++.+|++.|+++.
T Consensus 219 ----~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 ----KIEK-CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----hhhc-CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000 01111222 44567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=329.83 Aligned_cols=254 Identities=26% Similarity=0.304 Sum_probs=196.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+|++.+.||+|+||.||++ .+..++..||+|++..... .....+.+|+++|+.++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLV---------RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEE---------EECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 36899999999999999995 4445688999999865321 22355788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999997653 5788999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCC-----------------------------------------CCcceeeccccccccCccccccCCCCccc
Q 046897 229 GLAKDGPTGD-----------------------------------------QSHVSTRVMGTYGYAAPEYLATGHLTAKS 267 (404)
Q Consensus 229 g~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 267 (404)
|++....... .........||+.|+|||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 9975321000 00001134799999999999998999999
Q ss_pred chhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 046897 268 DVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347 (404)
Q Consensus 268 DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 347 (404)
|||||||++|||++|+.||....+..... .... . ...............+.+++.+|+ .+|.+|+
T Consensus 226 DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~----~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLADTPAETQL------KVIN----W----ETTLHIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeeeccceeeehhhCCCCCCCCCHHHHHH------HHhc----c----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 99999999999999999997644321100 0000 0 000000111123455678888876 5999999
Q ss_pred ---CHHHHHHH
Q 046897 348 ---MMAEVVTV 355 (404)
Q Consensus 348 ---s~~eil~~ 355 (404)
++.++++.
T Consensus 291 ~~~t~~ell~h 301 (376)
T cd05598 291 GKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHhCC
Confidence 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=328.60 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=209.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.|.|+..||.|+||+||++. ...++...|.|++........+.++-|+.||....||+||++++.|+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~---------nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAV---------NKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhh---------cccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 346677889999999999954 44456667888888877777888999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
.++|+.|||.||-....+-..+ ..+.+.++..+++|++.||.||| +++|||||||..|||++-+|.++|+|||.+
T Consensus 103 kLwiliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeeccccc
Confidence 9999999999999988887765 57999999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCcccc-----ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYL-----ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
..... .......+.|||+|||||+. ...+|+.++||||||++|.||..+.+|....++..
T Consensus 178 AKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------------- 242 (1187)
T KOG0579|consen 178 AKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------------- 242 (1187)
T ss_pred ccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------------
Confidence 75322 22345568999999999986 35789999999999999999999999987644321
Q ss_pred hccccchhhccc-ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNR-LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..+-... ...-.+..+...+.+++.+||..||+.||+++++++
T Consensus 243 ---VllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 243 ---VLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---HHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111111 111345567788999999999999999999999875
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=318.25 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=191.2
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
+.||+|+||.||++. +..++..||+|++.... ....+.+..|+.++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVR---------LKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 469999999999954 44568899999987642 22334567888888776 799999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|..++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 9999999999999888664 35899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC--cchhhhhhhhhhhcccc
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE--HNLVEWAKPYLASKRKI 311 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 311 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+...
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-------- 215 (329)
T cd05618 146 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------- 215 (329)
T ss_pred ccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH--------
Confidence 32211 122346799999999999999999999999999999999999999964322111 111111111
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
.+..... .++......+.+++.+||+.||++||++
T Consensus 216 -~i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 216 -VILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -HHhcCCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1111111 2333445678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=309.38 Aligned_cols=268 Identities=23% Similarity=0.354 Sum_probs=209.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.++||+|+||.||+|.+.+. ....+..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356899999999999999999876431 12346789999886542 233456789999999999999999999877
Q ss_pred e-CCeeEEEEeccCCCChHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 149 E-DDHRLLVYEFMPRGSLENHLFRRGSY----FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
. +...+++++|+.+++|.+++...... ...+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcE
Confidence 6 46789999999999999999765322 145899999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||....+. ....+.
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~- 232 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYL- 232 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHH-
Confidence 9999999986543332222223346678999999988889999999999999999999 99999754321 111110
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
. ...........+..+.+++.+||..||++|||+.++++.|+.+..
T Consensus 233 ---~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 ---K----------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---H----------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 011111122235678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=317.34 Aligned_cols=238 Identities=30% Similarity=0.395 Sum_probs=188.5
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVN-YLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
+.||+|+||+||+|. +..+++.||+|++..... .....+..|.. +++.++||||+++++.+..++..
T Consensus 1 ~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAK---------HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 469999999999954 445788999999865422 12234455544 56788999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|..++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 9999999999999998764 35889999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~----------~ 207 (323)
T cd05575 146 GIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYD----------N 207 (323)
T ss_pred cccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHH----------H
Confidence 32211 1233457999999999999889999999999999999999999999753311 1000 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
+..... .........+.+++.+||+.||.+||++.
T Consensus 208 i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 208 ILNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111111 12223356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.43 Aligned_cols=241 Identities=29% Similarity=0.394 Sum_probs=191.3
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||.||+|. +..++..||+|.+.... ....+....|..++..+ +||||+++++++.++++.
T Consensus 1 ~~lg~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAE---------LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999954 44578899999987542 12334566788888754 899999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+.+++|..++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999999999999987653 5789999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~----------~ 207 (316)
T cd05620 146 NVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFE----------S 207 (316)
T ss_pred cccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHH----------H
Confidence 32221 1234467999999999999889999999999999999999999999754321 0000 0
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA-EVV 353 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 353 (404)
+... ...++.....++.+++.+||+.||++||++. +++
T Consensus 208 ~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 208 IRVD--TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHhC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000 0112222455678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.15 Aligned_cols=252 Identities=24% Similarity=0.285 Sum_probs=198.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||++. +..++..+|+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVR---------HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF 112 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4689999999999999999954 44578899999986422 12234577899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..++..|+||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999998653 4788999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccC----CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG----HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .
T Consensus 186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~--- 255 (370)
T cd05621 186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------T--- 255 (370)
T ss_pred cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------H---
Confidence 999986532221 122346799999999998653 37889999999999999999999997543210 0
Q ss_pred hhhhccccchhhcccccCCC--CHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQY--TLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
...+.+......+ .......+.+++.+||..++.+ |+++.++++.
T Consensus 256 -------~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 -------YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111111111 1233566788999999865544 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=310.91 Aligned_cols=276 Identities=24% Similarity=0.400 Sum_probs=206.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccc-------cccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcce
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFA-------ATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~ 142 (404)
.++|++.+.||+|+||.||++........ .....++..+++|.+..... .....+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 35799999999999999999754432110 02233456799999875432 23357889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY-------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
+++++..++..+++|||+.+++|.+++...... ...+++..++.++.|++.||+||| +.+++|+||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheE
Confidence 999999999999999999999999999764321 124778899999999999999999 88999999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh--CCCCcCCCCCCC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS--GRRAVDKNRPSG 293 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~--g~~p~~~~~~~~ 293 (404)
|++.++.++|+|||++................++..|++||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876533322112222345678999998888889999999999999999998 778886533211
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.......+..... .......+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 242 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111110000 000011122344678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=310.87 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=203.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 149 (404)
++|++.++||+|+||.||+|+... .+....+++|.+... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-------DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-------CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 478899999999999999976532 122345788877642 223345688999999999 79999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll 217 (404)
.+..+++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence 9999999999999999999976431 1135888999999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcc
Q 046897 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHN 296 (404)
Q Consensus 218 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~ 296 (404)
+.++.+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--- 226 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--- 226 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 999999999999986422111 1111223457999999988889999999999999999997 999996543211
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
... . +........+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 227 ---~~~----------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 227 ---LYE----------K-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---HHH----------H-HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 0 1111111222234567889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.72 Aligned_cols=242 Identities=28% Similarity=0.386 Sum_probs=191.4
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhc-CCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQ-LYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~ 153 (404)
+.||+|+||.||+|. +..++..||+|++.... ....+....|..++.. ++||||+++++++.+++..
T Consensus 1 ~~lG~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAE---------LKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999954 44567889999987542 1223456677788875 4899999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 9999999999999998764 35789999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ....
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~i--------- 208 (316)
T cd05619 146 NMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---FQSI--------- 208 (316)
T ss_pred CCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---HHHH---------
Confidence 322211 2334679999999999988899999999999999999999999997543210 0 0000
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA-EVVT 354 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 354 (404)
... ...++......+.+++.+||+.||++||++. ++++
T Consensus 209 -~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 209 -RMD--NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -HhC--CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000 0112223445678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=314.65 Aligned_cols=275 Identities=25% Similarity=0.361 Sum_probs=210.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
..+|.+.+.||+|+||.||++...... -........|++|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 357899999999999999998653210 0111234578999887542 22346788999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.++..+++|||+.+++|.+++..... ....+++..+..++.|++.||.||| +.+++||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil 166 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVL 166 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEE
Confidence 99999999999999999999976431 1235788899999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 243 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 99999999999999876433222111222334567999999988899999999999999999998 88888653211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
.... .+........+......+.+++.+||+.+|++||++.++++.|+++.......
T Consensus 244 ---~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~ 300 (334)
T cd05100 244 ---ELFK-----------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300 (334)
T ss_pred ---HHHH-----------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCC
Confidence 1111 01111111222334567889999999999999999999999999998665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.53 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=197.0
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
.||+|+||.||+|.++ ...++..+++|++..... ...+.+..|+.+++.+.||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~-------~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYK-------MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEe-------cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 5899999999998643 234567899998865432 23456889999999999999999999875 4567899
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||.||+++.++.+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 74 MELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999999999999754 35889999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCCcc-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 237 GDQSHV-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 237 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~--------------~~ 210 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT--------------QM 210 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH--------------HH
Confidence 322111 112234578999999988889999999999999999998 99999754321 111 11
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+........+...+.++.+++.+||+.||++||++.+|.+.|+++
T Consensus 211 i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 211 IESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111111223334556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=318.23 Aligned_cols=242 Identities=26% Similarity=0.360 Sum_probs=193.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
+|.+.+.||+|+||.||+|. +..++..||+|++..... ...+.+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAE---------RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 47889999999999999954 445678999999875422 2223466788888777 5899999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+..|+||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccC
Confidence 9999999999999999999987653 4889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 146 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~------- 210 (323)
T cd05616 146 GMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LF------- 210 (323)
T ss_pred CCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HH-------
Confidence 9987532211 12334679999999999999999999999999999999999999997543210 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
..+.... ..++.....++.+++.+||+.||.+|++.
T Consensus 211 ---~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 211 ---QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---HHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111111 12233445678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=304.91 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=200.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|.+.+.||+|+||.||+|.+.. +..+++|.+.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468888999999999999975432 3459999887543 34467899999999999999999999999888
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+.+++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999999999997643 35899999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
........ .......++..|++||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~----------- 212 (256)
T cd05113 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE----------- 212 (256)
T ss_pred eecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH-----------
Confidence 75433221 11112235567999999988889999999999999999998 999986543211 000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+.+.. ....+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 213 --~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 213 --KVSQGL-RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --HHhcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011100 00111123567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=308.86 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=194.3
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||+|+||.||++. ...+|..|++|.+...... ....+..|+++++.++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~---------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQ---------VKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEE---------EccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999954 4456889999998653221 223456799999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred EecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 999999999988865432 45889999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .... .....
T Consensus 148 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~----------~~~~~ 212 (277)
T cd05607 148 GK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELK----------RRTLE 212 (277)
T ss_pred Cc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHH----------HHhhc
Confidence 22 223356899999999998888999999999999999999999999753321110 0100 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.... ......+.++.+++.+||+.||++||+++|+++.+.
T Consensus 213 ~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 213 DEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1110 001123556889999999999999999988764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=316.68 Aligned_cols=242 Identities=29% Similarity=0.422 Sum_probs=193.6
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
+.||+|+||+||++. +..++..||+|++.... ......+..|.+++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAE---------LKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999954 44567889999987542 22334567888888887 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99999999999999887653 5899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .
T Consensus 146 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~----------~ 207 (318)
T cd05570 146 GILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQ----------S 207 (318)
T ss_pred cCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHH----------H
Confidence 322111 223356899999999999999999999999999999999999999753311 1100 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM-----AEVVT 354 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~ 354 (404)
+..... .++...+..+.+++.+||+.||++||++ .++++
T Consensus 208 i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 ILEDEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHcCCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111111 1222345678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.01 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=197.9
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED- 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 150 (404)
|.+.+.||+|+||.||+|.+... .....+++|.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 35678999999999999765431 122468999886542 23345688899999999999999999987532
Q ss_pred -----CeeEEEEeccCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 151 -----DHRLLVYEFMPRGSLENHLFRRG--SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 151 -----~~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
...+++|||+.+++|.+++.... .....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCE
Confidence 24689999999999999885432 12245889999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+|+|||++................+++.|++||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---- 224 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY---- 224 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----
Confidence 9999999986543322111222346678999999988889999999999999999999 78898653221 000
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
....... ....+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 225 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 DYLRQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011000 0011223455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=303.86 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=199.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.+|++.+.||+|+||.||+|.+. .+..+++|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 45888999999999999997543 24568999886543 33456888999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999999999997654 35889999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ..
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----------- 212 (256)
T cd05059 148 RYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VE----------- 212 (256)
T ss_pred eeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HH-----------
Confidence 764322111 1111223457999999988899999999999999999999 8999975432110 00
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
. +........+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 213 --~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 213 --S-VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --H-HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 000111112223466788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=304.39 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=202.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+|++.+.||.|+||.||++ .+..++..+++|.+.... ....+.+..|+.+++.++|+||+++++.+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLV---------QHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEE---------EEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 4788899999999999985 445568899999886432 233466788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..|++|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCcc
Confidence 99999999999999998865332 45789999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~--------- 210 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLIL--------- 210 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHH---------
Confidence 76433221 223456889999999998888999999999999999999999999753211 0000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+... .....+...+..+.+++.+||+.||++||++.+++..
T Consensus 211 -~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 -KVCQG-SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHhcC-CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00000 0111223345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=317.08 Aligned_cols=243 Identities=27% Similarity=0.339 Sum_probs=190.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHH-HHHhcCCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEV-NYLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
+.||+|+||.||++. +..++..||+|++..... .....+..|. .+++.++||||+++++++..++..
T Consensus 1 ~~lg~G~fg~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLAR---------HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 469999999999954 445678899999875321 1123344444 356788999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+.+++|.+++.... .+.+..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 99999999999999997643 4788889999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~----------~ 207 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYD----------N 207 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHH----------H
Confidence 32211 12334679999999999999899999999999999999999999997533210 000 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+..... .........+.+++.+||+.||.+||++.+.+..
T Consensus 208 i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 208 ILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 111111 1223345678899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.60 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=203.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|++.+.||+|+||.||+|..... ...+..|++|.+... ......++..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecC------CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 3578899999999999999765431 122457999998754 223346789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCcc
Confidence 99999999999999999987643 35789999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceee-cc--ccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTR-VM--GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 231 a~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
+.............. .. .+..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----- 224 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----- 224 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH-----
Confidence 875433221111111 11 2357999999988899999999999999999886 99999654321 111111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
........+.+.+..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ---------EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---------HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011112233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.30 Aligned_cols=260 Identities=26% Similarity=0.450 Sum_probs=204.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|...+.||+|+||.||+|.... .......+++|.+.... ....+.+..|+++++.++|+||+++.+++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKM------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 467888999999999999976532 11224579999887542 23345688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 99999999999999999987643 35889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcce-eeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 231 AKDGPTGDQSHVS-TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 231 a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+............ .....+..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~----- 222 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKA----- 222 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHH-----
Confidence 8765432211111 11223457999999988889999999999999999997 99999653321 11110
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+............+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 ------i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 ------INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001111122223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=293.07 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=207.8
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----ccH----HHHHHHHHHHhcC-CCCC
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGH----KEWLAEVNYLGQL-YHPN 139 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~hp~ 139 (404)
.....|...+.||.|..+.|.+ |.+..+|..+++|++..... ... +.-.+|+.+|+++ .||+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrR---------ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~ 84 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRR---------CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPY 84 (411)
T ss_pred hHHhhcChHHHhcccchhhhhh---------hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCc
Confidence 3456788889999999999987 77888899999998854211 111 3456899999998 6999
Q ss_pred cceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 140 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
|+++.++|+.+..+|+|+|.|+.|.|.|++...- .++++....+++|++.|+.||| .++|+||||||+|||+++
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDD 158 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeecc
Confidence 9999999999999999999999999999998764 6899999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccc------cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA------TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
+.++||+|||.++....+. .....+|||+|+|||.+. ...|+..+|+|++|+++|.|+.|.+||......
T Consensus 159 n~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm- 234 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM- 234 (411)
T ss_pred ccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-
Confidence 9999999999999887765 456689999999999874 346888999999999999999999999642210
Q ss_pred Ccchhhhhhhhhhhccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+. +.-+.... .......+.+....+||.+||+.||.+|.|+.|+|+.
T Consensus 235 -----------lM----LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 235 -----------LM----LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -----------HH----HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 00 01111111 1112234556688899999999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=314.75 Aligned_cols=194 Identities=26% Similarity=0.369 Sum_probs=165.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
...+|++.+.||+|+||.||+|. +..++..||+|+.... ....|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVAT---------KPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEE---------ECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34579999999999999999954 4456788999975432 23568999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....++|||++ .++|.+++.... ..+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCc
Confidence 99999999999 568888886543 46899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
++....... ......||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 203 AAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 987532211 1234568999999999998899999999999999999998666553
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=315.44 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=193.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 153 (404)
+.||+|+||.||++. ...++..||+|++..... ...+.+.+|+.++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVR---------LKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEE---------ECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 469999999999954 444678999999976422 2234577899998888 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|..++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 9999999999999888754 35899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+.....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------- 215 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-------- 215 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------
Confidence 32211 12334679999999999999999999999999999999999999997543322222221111111
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
..... ..+...+..+.+++.+||+.||++|+++.
T Consensus 216 -~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 216 -LEKPI--RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -HhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11111 12223445678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.01 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=204.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|++.+.||+|+||.||+|.... ....+..+++|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKL------PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEec------CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3578899999999999999976432 112345799998865432 223568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..+++|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCC
Confidence 999999999999999999997653 35789999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcc-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHV-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++........... .....++..|++||.+.+..++.++|+||||+++||+++ |..||....... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~------ 222 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI------ 222 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH------
Confidence 9986543321111 111223567999999988889999999999999999886 999997543211 11100
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+. .........+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 223 -------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 -------EEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------hCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 01111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=314.77 Aligned_cols=238 Identities=30% Similarity=0.396 Sum_probs=187.9
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVN-YLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||.||+|+ +..++..||+|++..... .....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAK---------RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 469999999999954 445688999999865322 12234455554 67889999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+++++|...+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999888654 35788999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~----------~ 207 (321)
T cd05603 146 GVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYD----------N 207 (321)
T ss_pred CCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHH----------H
Confidence 32211 1233457899999999998888999999999999999999999999754211 1111 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
+..... ..+......+.+++.+||+.||.+||++.
T Consensus 208 i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 208 ILHKPL--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HhcCCC--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111 22233455788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.09 Aligned_cols=265 Identities=28% Similarity=0.388 Sum_probs=204.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||.|+||.||++.... .....++..+++|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~----~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPG----LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcc----cCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 4578999999999999999976532 11233567899998875432 223568889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCC
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGS------------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFK 211 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlk 211 (404)
+...+++|||+++++|.+++..... ....+++..++.++.|++.||.||| +.+++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccccc
Confidence 9999999999999999999975321 1134788899999999999999999 8999999999
Q ss_pred CCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCC
Q 046897 212 TSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNR 290 (404)
Q Consensus 212 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~ 290 (404)
|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875432221111222334567999999988889999999999999999997 888886432
Q ss_pred CCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 291 PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.. .... .+.+... ...+...+..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 238 ~~------~~~~----------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HE------EVIY----------YVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH------HHHH----------HHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 21 1110 1111111 01122345678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=302.00 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=201.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|++.+.||+|+||.||+|.+.. ...|++|.+.... ...+.+.+|+.+++.++||||+++++.+. +
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 3569999999999999999975432 2358999987643 23467889999999999999999999874 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCc
Confidence 568999999999999999975422 35788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+......... ......++..|+|||...+..++.++||||||+++|+|++ |..||....... .. .
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~---~------- 214 (262)
T cd05071 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---D------- 214 (262)
T ss_pred eeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH---H-------
Confidence 9765332211 1122346678999999988889999999999999999999 888886532210 00 0
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+.. ..........+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 215 ---~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 215 ---QVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---HHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0000 011122334566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.65 Aligned_cols=251 Identities=29% Similarity=0.484 Sum_probs=204.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||.|+||.||+|.. .++.|++|.+..... ..+++.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 45788999999999999999643 367899999977643 457789999999999999999999999988
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999999999976542 35899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+........ ....+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----------- 209 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----------- 209 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-----------
Confidence 986532211 2234567999999988889999999999999999997 999986432110 00
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
..+........+...+..+.+++.+||..+|++||++.+++++|+++
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 210 ---PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00111111122233456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.16 Aligned_cols=256 Identities=24% Similarity=0.308 Sum_probs=201.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|. ...++..|++|++..........+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKAR---------NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEE---------ECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 4579999999999999999964 3446789999998765444456678899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++... .++++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999988754 35889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+........ ......++..|+|||.+. ...++.++|||||||++|||++|+.||....+....... .
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~------ 222 (267)
T cd06646 153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--S------ 222 (267)
T ss_pred ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--e------
Confidence 976432211 122346888999999874 345788999999999999999999998644322110000 0
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
.. ....+.. ......+..+.+++.+||..+|++||+++++++.|
T Consensus 223 ~~---~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 223 KS---NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cC---CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0000001 01122346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=302.42 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=200.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|... .+..+++|.+..... ..+.+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 357899999999999999996543 245689998876543 3467889999999999999999999875 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCcee
Confidence 568999999999999999976432 45889999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~--------- 215 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ--------- 215 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---------
Confidence 9764332211 1112335567999999888889999999999999999999 88999653211 00100
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
+........+...+..+.+++.+||..+|.+|||+.++++.|++
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 -----VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111112233445678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.02 Aligned_cols=276 Identities=27% Similarity=0.374 Sum_probs=205.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+.|.+.+.||+|+||.||++.+. .....++..|++|.+.... ......+.+|+.+++.++||||+++.+++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEc-----cCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45788999999999999997653 2344567899999987543 23346788999999999999999999998875
Q ss_pred --CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 151 --DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
...++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCC
Confidence 56899999999999999987643 35789999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++......... .......++..|+|||.+.+..++.++||||||+++|||++++.|+................. ...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~-~~~ 232 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ-MTV 232 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc-ccH
Confidence 999865432221 111234567789999999888899999999999999999998776532111000000000000 000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
...+ ..+............+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLV-RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHH-HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 00111111112223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.18 Aligned_cols=255 Identities=33% Similarity=0.465 Sum_probs=205.1
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|..... ...+..+++|.+....... .+.+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4699999999999765431 1347889999987764433 56788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 157 YEFMPRGSLENHLFRRGSY-----FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
|||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999875211 256899999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~-------- 218 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLE-------- 218 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHH--------
Confidence 87654332222334567889999999988889999999999999999999 69999764221 0000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+.+ ......+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 219 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 --YLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --HHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111 1111233344678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.74 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=196.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|++.+.||+|+||.||++ .+..++..||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAA---------FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEE---------EEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4578999999999999999995 44557889999998653 223345678999999999999999999998
Q ss_pred EeCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 148 LEDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 148 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
.... ..|+||||++ ++|...+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~ 160 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 160 (359)
T ss_pred ccCCCccccceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCC
Confidence 6543 4799999995 467666642 3788899999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc-----
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN----- 296 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~----- 296 (404)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 161 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 161 TLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred CEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999997532211 2233568999999999999999999999999999999999999997543211000
Q ss_pred -------hhh----hhhhhhhhccccc-----hhhcccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 297 -------LVE----WAKPYLASKRKIF-----RIIDNRL---EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 297 -------~~~----~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ....+........ ....... ...........+.+++.+||..||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000000000 0000000 000111124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=323.24 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=197.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||+|+||.||++. +..++..||+|.+... .....+++.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVT---------DPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEE---------ECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 47889999999999999954 4456889999988653 223346788999999999999999999999877
Q ss_pred C-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 151 D-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 151 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
+ ..|+||||+. ++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEe
Confidence 6 7899999995 6888877543 35899999999999999999999 899999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh--
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK-- 302 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~-- 302 (404)
+|||+++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+....
T Consensus 145 ~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~ 223 (372)
T cd07853 145 CDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223 (372)
T ss_pred ccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999976433221 122334678999999998764 57899999999999999999999997654321111110000
Q ss_pred hhhh----hccccchhh-ccccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLA----SKRKIFRII-DNRLE-------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~----~~~~~~~~~-~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+... ........+ ..... ..........+.+++.+||+.||++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000000 00000 01111235578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=308.84 Aligned_cols=252 Identities=29% Similarity=0.411 Sum_probs=199.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.|+..++||+|+||.||++ .+..+++.||+|.+....... ...+..|+.+++.++|++|+++++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEE---------EEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 3677889999999999984 445578899999886543222 2346789999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+.+++|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999998865432 45889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~----------- 213 (285)
T cd05630 148 LAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV----------- 213 (285)
T ss_pred ceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-----------
Confidence 987543222 122346899999999998889999999999999999999999999754321110000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
..+... ....+.......+.+++.+||+.||++||| +.++++
T Consensus 214 --~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 214 --ERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --Hhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000000 001122234456889999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.83 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=204.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|.+.+.||.|+||.||+|. +..++..|++|.+........+.+.+|+.+++.+.|+||+++++.+..+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEE---------ECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 3579999999999999999964 3446788999999876666667788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...|+||||+++++|.+++... .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~ 162 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECcccc
Confidence 9999999999999999998643 4788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ....
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~---------- 228 (296)
T cd06654 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLI---------- 228 (296)
T ss_pred chhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHH----------
Confidence 876433221 12234688999999999888899999999999999999999999975432110 0000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..........+......+.+++.+||..||++||++.++++.
T Consensus 229 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 229 ---ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ---hcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000000111223345678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.66 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=203.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.+.+.||+|++|.||++.. ..++..|++|.+.... ......+.+|+++++.++||||+++++++.++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVR---------KADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEE---------cCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 477889999999999999544 4467899999886542 23346688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEccccc
Confidence 999999999999999999976522 46889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...... .. ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~-------- 211 (256)
T cd08529 148 AKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---AL---IL-------- 211 (256)
T ss_pred ceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HH--------
Confidence 876543221 223356888999999998888999999999999999999999999754311 00 00
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.... ....+......+.+++.+||+.+|++||++.++++.
T Consensus 212 --~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 --KIIRGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HHHcCC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111111 112222445678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.97 Aligned_cols=253 Identities=30% Similarity=0.456 Sum_probs=198.5
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|.+.. ...++..+++|.+...... ..+.+.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 469999999999986532 2224578999998766442 3456889999999999999999999876 4568999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++.... .+++..++.++.|++.+|+||| ..+++|+||||+|||++.++.+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 74 MELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999999999997653 5789999999999999999999 88999999999999999999999999999986533
Q ss_pred CCCCcc-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 237 GDQSHV-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 237 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .......
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~------------ 212 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE------------ 212 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH------------
Confidence 322111 111223467999999988889999999999999999998 99999654321 1111110
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.......+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 213 --~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 --SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00011222234467889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.87 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=202.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|... ++..|++|.+.... .....+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 467899999999999999997532 35779999987654 34467889999999999999999999874 5
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+.+++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCcc
Confidence 678999999999999999865432 46889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---------- 214 (260)
T cd05067 149 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQ---------- 214 (260)
T ss_pred eeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHH----------
Confidence 876442221 11122345678999999988889999999999999999999 999997543211 000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+........+...+..+.+++.+||+.+|++||++++++..|+.+
T Consensus 215 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 215 ----NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 0011111112223345789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=304.08 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|++.+.||+|+||.||+|.+... .......+++|.+..... .....+.+|+.++..++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 5688899999999999999875431 112234689998876543 233568899999999999999999999887
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...+++|||+.+++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 78899999999999999997653 35899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+................++..|+|||.+.+..++.++|+||||+++||+++ |+.||....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~-------- 221 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IP-------- 221 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HH--------
Confidence 986543322211112224567999999988889999999999999999998 999997543211 10
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
..+........+......+..++.+||..||.+||++.++++.|+++...
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 ---DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111111112222345678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.60 Aligned_cols=264 Identities=28% Similarity=0.418 Sum_probs=202.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+|.+.. .+....+++|.+.... ......+.+|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKK-------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEcc-------CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 478889999999999999976432 1122356777765432 22335678899999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll 217 (404)
++..|+||||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEe
Confidence 9999999999999999999976532 1135789999999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcc
Q 046897 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHN 296 (404)
Q Consensus 218 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~ 296 (404)
+.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 231 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--- 231 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---
Confidence 999999999999986422111 1111234567999999988889999999999999999998 999996433210
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.... .........+...+..+.+++.+||+.+|++||++.+++..|+.+.....
T Consensus 232 ---~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 ---LYEK-----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ---HHHH-----------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0000 00001111122234568899999999999999999999999998765544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=300.59 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=201.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
++||+|++|.||+|.+.. ..+....+++|.+..... ...+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST------SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEec------CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 468999999999986532 123345799999987765 455678999999999999999999999988 889999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999999999987542 46899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 237 GDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 237 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ........
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~-------- 215 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDK-------- 215 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh--------
Confidence 22111 1123456788999999988889999999999999999998 99999643221 10000000
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 --EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00011122234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.22 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=199.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEE-eC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL-ED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~ 150 (404)
++|.+.+.||+|+||.||++.. .+..+++|.+..+. ..+.+.+|+.+++.++|+|++++++++. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 5788899999999999999643 25678999886543 3467889999999999999999999765 45
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCcc
Confidence 678999999999999999976542 35789999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .....
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~~~~------ 211 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPR------ 211 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH------
Confidence 87543221 12234567999999988889999999999999999997 99998643211 11000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+............+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 212 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 -----VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 001111122233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.73 Aligned_cols=243 Identities=29% Similarity=0.371 Sum_probs=190.4
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVN-YLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
++||+|+||+||++ .+..+|..+|+|++..... .....+..|.. +++.++||||+++++++..++..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 46999999999995 4445788999999865421 22234555554 56778999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+.+++|..++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999999999999888754 35899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...... .... .
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~----------~ 207 (325)
T cd05604 146 GIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYD----------N 207 (325)
T ss_pred CCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHH----------H
Confidence 32211 1233467999999999999989999999999999999999999999754321 0000 1
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+....+ ...+.....+.+++.+||+.+|.+||++++.++.
T Consensus 208 ~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 208 ILHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred HHcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 111111 1122344567899999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=300.31 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=196.6
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEE
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVY 157 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 157 (404)
.||+|+||.||+|.+.. ...+..|++|++...... ..+.+.+|+.+++.++||||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~-------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKM-------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEec-------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 38999999999976532 234567999988765322 2356889999999999999999999875 45789999
Q ss_pred eccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCC
Q 046897 158 EFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237 (404)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~ 237 (404)
||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 74 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 74 EMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999999987543 36899999999999999999999 889999999999999999999999999999754332
Q ss_pred CCCcc-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 238 DQSHV-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 238 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ...+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~--------------~~~~ 211 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---V--------------MSFI 211 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---H--------------HHHH
Confidence 21111 111233578999999988889999999999999999996 999997543211 0 0111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
........+.....++.+++.+||..||++||++.+|.+.|+.+
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 212 EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11111233344567888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.98 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=201.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||+|+||.||++ .+..++..+++|.+..... .....+.+|+++++.++||||+++++.+..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKV---------LHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEE---------EEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 36889999999999999995 4445678899998875422 2235688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.++|+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCC
Confidence 9999999999999999999765 358899999999999999999993 25899999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK-- 308 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 308 (404)
+....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......................
T Consensus 147 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
T cd06615 147 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES 222 (308)
T ss_pred cccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCC
Confidence 87543221 233568899999999988889999999999999999999999996433211110000000000000
Q ss_pred --------------cccchhhccccc---CCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 --------------RKIFRIIDNRLE---GQYT-LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 --------------~~~~~~~~~~~~---~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....+..+.... ...+ .....++.+++.+||..||++||++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 0000 1134568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=319.91 Aligned_cols=245 Identities=29% Similarity=0.410 Sum_probs=205.5
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.|.-++.||.|+||.||- +++..+...||||.+...+.. +..++++|++.|++++|||+|.+.+.|..
T Consensus 27 lf~dLrEIGHGSFGAVYf---------Ard~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYF---------ARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEE---------eeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 455678899999999997 666778899999999766543 34678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...|+||||| -|+-.|++.... +++-+..+..|..+.+.||+||| +.+.||||||..|||+++.|.|||+|||
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLH--S~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHH--HhhHHhhhccccceEecCCCeeeecccc
Confidence 99999999999 678888887765 58999999999999999999999 7889999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
.|....+ .+.++|||+|||||++. .+.|+-++||||||++..||...++|+...+..
T Consensus 172 SAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------------- 231 (948)
T KOG0577|consen 172 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------- 231 (948)
T ss_pred chhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--------------
Confidence 9876544 34589999999999985 578999999999999999999999998654321
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.-+..|-...-.--...+++..+++++..||+.-|.+|||..++++
T Consensus 232 --SALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 232 --SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --HHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111221111111225678889999999999999999999988875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=319.23 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=197.3
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
...++|++.+.||+|+||.||++ .+..++..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 84 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEE---------EecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence 34578999999999999999995 444567889999987542 2233567889999999999999999998
Q ss_pred EEeC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 147 CLED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 147 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+... ...|+||||++ ++|.+.+.. .+++..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~ 155 (355)
T cd07874 85 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSD 155 (355)
T ss_pred eeccccccccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCC
Confidence 8644 35799999995 577776643 3788899999999999999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh--
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV-- 298 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~-- 298 (404)
+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 156 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999997643221 223457899999999999889999999999999999999999999754321100000
Q ss_pred --------------hhhhhhhhhccccchhhcc-----c-c--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 --------------EWAKPYLASKRKIFRIIDN-----R-L--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 --------------~~~~~~~~~~~~~~~~~~~-----~-~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.....+.........+..+ . . ...........+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000000000 0 0 001111234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.83 Aligned_cols=264 Identities=23% Similarity=0.259 Sum_probs=195.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
...|.+.+.||+|+||.||++. +...+..|++|.... ..+.+|+++|++++|+||+++++++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~---------~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESS---------HPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEE---------ECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999954 445678899996432 3356899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++|||++ .++|..++.... ..+++..++.++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence 9999999999 578988886543 36899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC-CCc----chhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS-GEH----NLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~-~~~----~~~~~~~~~~ 305 (404)
++...............||..|+|||++.+..++.++|||||||++|||++|..++...... ... .+...+....
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~ 386 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence 97653322222223457999999999999989999999999999999999988765332211 110 0111110000
Q ss_pred hhccccc---------hhhc-----cccc---CCCC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIF---------RIID-----NRLE---GQYT--LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~---------~~~~-----~~~~---~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....... .... .... ..+. ......+.+|+.+||+.||++|||+.|+|+.
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 0000 0000 0000 0123467899999999999999999999874
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=314.34 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=193.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLY-HPNLVKLVGYCL 148 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 148 (404)
+|...+.||+|+||.||++ .+..++..||+|++.... ....+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 4778899999999999994 455578899999987542 122345678888888885 578888999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEecc
Confidence 9999999999999999999987653 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~-------- 209 (323)
T cd05615 146 GMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------EL-------- 209 (323)
T ss_pred ccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HH--------
Confidence 9987532211 1223456899999999998889999999999999999999999999754321 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
...+.... ..++...+..+.+++.+||+.+|.+|++.
T Consensus 210 --~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 --FQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --HHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01111111 12233345677899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=321.12 Aligned_cols=259 Identities=24% Similarity=0.272 Sum_probs=200.3
Q ss_pred HHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcc
Q 046897 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv 141 (404)
.++....++|++.+.||+|+||.||++ .+..++..+|+|++..... .....+.+|+.+++.++||||+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv 106 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEE---------EECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 334445689999999999999999995 4555788999999864321 2234567899999999999999
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
++++.+..+...|+||||+++|+|.+++... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred eEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCC
Confidence 9999999999999999999999999998653 4788899999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccC----CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG----HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----- 253 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----- 253 (371)
T ss_pred CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----
Confidence 999999999976533221 122346799999999998653 3788999999999999999999999754321
Q ss_pred hhhhhhhhhhccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTVL 356 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L 356 (404)
... ..+.... +........+..+.+++.+||..++.+ |+++.++++..
T Consensus 254 -~~~----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 -GTY----------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHH----------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 1111110 111111234566789999999844433 77888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.79 Aligned_cols=276 Identities=28% Similarity=0.374 Sum_probs=208.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE- 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 149 (404)
+.|.+.+.||+|+||.||++.+.. ....++..+++|.+...... ..+.+.+|+.+++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 467788999999999999987643 12446789999999766543 45678999999999999999999999887
Q ss_pred -CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 150 -DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 150 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
....+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence 557899999999999999997654 25899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++.......... ......++..|++||.+.+..++.++||||||+++|||++|..|+............. .. ....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~-~~~~ 231 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQ-GQMI 231 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-cc-cccc
Confidence 9998754322111 1112345567999999988889999999999999999999999986432211000000 00 0000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
...+...+........+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0001111111111122233456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.11 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=198.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|.+.+.||+|+||.||+|+ +..++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGR---------SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEE---------ecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 568999999999999999954 444678899999875432 2234577899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||++ ++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcccc
Confidence 99999999996 58888886553 35788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh-------
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK------- 302 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~------- 302 (404)
+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 875432221 1223467899999998764 568899999999999999999999997654321111110000
Q ss_pred -hhhhhccccchhhccccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 -PYLASKRKIFRIIDNRLE----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 -~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+.............+... .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000000000 0011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=301.13 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=204.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|.+.+.||.|+||.||+|... .+..+++|.+.... ...+++.+|+.+++.++|+||+++++++..+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~----------~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN----------GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc----------CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 468999999999999999996543 24678999887654 3456789999999999999999999999988
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred CceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECcccc
Confidence 899999999999999999976432 45889999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---------- 215 (261)
T cd05034 150 ARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE---------- 215 (261)
T ss_pred ceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence 876533111 11112234567999999988889999999999999999998 999996532110 000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+. .......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 216 ---~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 216 ---QVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred ---HHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 000 0011111222356788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.72 Aligned_cols=256 Identities=23% Similarity=0.245 Sum_probs=195.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||+++ ...++..||+|++.... ....+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVK---------MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEE---------ECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 468999999999999999954 44568899999986421 122345788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++++.|+||||+++++|.+++.+.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999999997643 35889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
|++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 147 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~ 219 (331)
T cd05597 147 GSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGK 219 (331)
T ss_pred CceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHH
Confidence 99875433221 11223469999999999863 45788999999999999999999999753221 10000
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
.... ..... + .......+..+.+++.+||..++++ |+++.++++.
T Consensus 220 i~~~-~~~~~-----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 220 IMNH-KEHFQ-----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHcC-CCccc-----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 00000 0 0111124556788999988654443 7899888877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=304.92 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=197.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.++||+|+||.||+|. +..++..|++|.+.... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAY---------HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEE---------EcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 367888999999999999954 44568899999986542 22335688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|..+. .+++..+..++.|++.||+||| +.+|+|+||||+|||++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred CEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999999999986542 3678889999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc-hhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN-LVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 309 (404)
+....... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ......
T Consensus 142 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 210 (279)
T cd06619 142 STQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ------- 210 (279)
T ss_pred ceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-------
Confidence 87543321 233578999999999988889999999999999999999999997533221110 000000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.+..............+.+++.+||+.||++||++.++++.
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 211 ---CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111111001111234568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=321.48 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=195.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||++ .+..++..||+|++.... ......+..|+.++..++|+||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLV---------QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36888999999999999995 444578899999986532 223356778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..|+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997653 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCC---------------------------------cceeeccccccccCccccccCCCCcccchhhhhHH
Q 046897 229 GLAKDGPTGDQS---------------------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVV 275 (404)
Q Consensus 229 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~l 275 (404)
|++......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 998743221100 00113479999999999999999999999999999
Q ss_pred HHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCC--HHHHHHHHHHHHHcccCCCCCCCC---HH
Q 046897 276 LLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYT--LEGAYKAATLALRCLSTEGKFRPM---MA 350 (404)
Q Consensus 276 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~ 350 (404)
+|||++|+.||....+.... . .+........++ ......+.+++.+|+ .||.+|++ +.
T Consensus 226 lyel~tG~~Pf~~~~~~~~~------~----------~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 288 (360)
T cd05627 226 MYEMLIGYPPFCSETPQETY------R----------KVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVE 288 (360)
T ss_pred eeecccCCCCCCCCCHHHHH------H----------HHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHH
Confidence 99999999999764432110 0 011100000011 113456778888876 59999986 55
Q ss_pred HHHHH
Q 046897 351 EVVTV 355 (404)
Q Consensus 351 eil~~ 355 (404)
++++.
T Consensus 289 ei~~h 293 (360)
T cd05627 289 EIKSH 293 (360)
T ss_pred HHhcC
Confidence 55543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.18 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||+|+ +..+++.||+|++..... ...+++.+|+++++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~---------d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAY---------DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEE---------ECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 579999999999999999954 445688999999875422 22356889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS-------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
+++..+++|||++|++|.+++..... ....++...++.++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCC
Confidence 99999999999999999999864211 1134566788999999999999999 88999999999999999999
Q ss_pred cEEEecccCCCCCCCCCC----------------CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCC
Q 046897 222 NAKLSDFGLAKDGPTGDQ----------------SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA 285 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p 285 (404)
.++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999976421110 0011235699999999999999999999999999999999999999
Q ss_pred cCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhHhccc
Q 046897 286 VDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-MMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~~ 364 (404)
|.......... . . .+..+.. .......+..+.+++.+||..||++|| ++.++++.|+.+....+
T Consensus 231 F~~~~~~ki~~----~-------~---~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 231 YRRKKGRKISY----R-------D---VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred CCCcchhhhhh----h-------h---hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 97532211000 0 0 0000000 000113345678999999999999996 67888888888766433
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=307.02 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=205.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|.+.+.||.|+||.||++. +..++..|++|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAI---------DIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEE---------ECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999999999954 4446889999999776555567788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++... .+++..+..++.|++.+|.||| +.+++|+||||+|||++.++.++|+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999998653 4788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+.......
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------------ 227 (297)
T cd06656 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------ 227 (297)
T ss_pred ceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------------
Confidence 876433221 123356888999999998888999999999999999999999999754332110000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..........+......+.+++.+||..||++||++.++++.
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 228 ---ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111223345567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.24 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=206.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||.|+||.||+|+.+.. ........+++|.+...... ....+.+|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 5788999999999999999887542 23445678999988664433 346788999999999999999999999998
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSY-----FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
+..++||||+++++|.+++...... ...+++..++.++.|++.||+||| +.+|+|+||||+||+++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEE
Confidence 9999999999999999999765421 125899999999999999999999 889999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 159 ~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----- 229 (275)
T cd05046 159 SLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----- 229 (275)
T ss_pred cccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH-----
Confidence 9999987542221 112223356778999999888888999999999999999998 788886432211 110
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
...............+..+.+++.+||+.+|++||++.++++.|.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 --------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111111122234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=305.23 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=201.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+.|++.+.||.|+||.||+|.. ..++..+++|.+........+.+.+|+.+++.++|+||+++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKN---------KETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEE---------CCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 46799999999999999999644 446788999999877656667788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|..++.... ..+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999988876543 35899999999999999999999 89999999999999999999999999998
Q ss_pred CCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+....... .......+++.|+|||++. ...++.++|||||||++|+|++|..||....... ......
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~ 228 (292)
T cd06644 157 SAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIA 228 (292)
T ss_pred ceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHh
Confidence 87532211 1223456888999999884 3457889999999999999999999996543210 000000
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ...+ ....+.....++.+++.+||+.||++||++.++++
T Consensus 229 ~-------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 229 K-------SEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred c-------CCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000 01112234456889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=312.15 Aligned_cols=253 Identities=22% Similarity=0.235 Sum_probs=195.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||+++ +..++..||+|++.... ......+.+|..++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVK---------MKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478899999999999999954 44567889999986532 122244678899999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..|+||||+.+|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEec
Confidence 9999999999999999999997643 35889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
|++........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ....
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~- 218 (331)
T cd05624 147 GSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYG- 218 (331)
T ss_pred cceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHH-
Confidence 99876433221 12233569999999998865 46788999999999999999999999753321 0000
Q ss_pred hhhhccccchhhccccc---CCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLE---GQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
.+...... .......+..+.+++.+||..++.+ |++++++++.
T Consensus 219 ---------~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 ---------KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---------HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111000 0111223567889999999876554 4578887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=298.52 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=193.7
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeeEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-DDHRLL 155 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 155 (404)
+.||+|+||.||+|.+.+ ....+..+++|.+... .....+.+.+|+.+++.++||||+++++++.. +...++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999987532 2234567999988543 22334678889999999999999999997764 556889
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
+|||+.+++|.+++.... ....+..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 75 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999997643 23577788899999999999999 8999999999999999999999999999987543
Q ss_pred CCCCCc--ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhC-CCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 236 TGDQSH--VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG-RRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 236 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
...... ......++..|+|||.+.+..++.++||||||+++|||++| .+||...... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~--------- 214 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVY--------- 214 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH---------
Confidence 221110 11123456789999999888899999999999999999995 5556432211 11000
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
+... .....+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 215 -~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 -LLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -HhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0000 0001112234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=300.17 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=200.4
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhcCCCCCcceE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---------HKEWLAEVNYLGQLYHPNLVKL 143 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~ 143 (404)
+|.+.+.||.|+||.||+|. +..++..+++|.+....... .+.+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGM---------NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEE---------ecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 47889999999999999954 34467889999886543221 1457789999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGI 145 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCE
Confidence 999999999999999999999999997653 5788999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCC----CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 224 KLSDFGLAKDGPTGDQ----SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
+|+|||.+........ ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~ 219 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------Q 219 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------H
Confidence 9999999886542111 11122345888999999998888999999999999999999999999753211 0
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..+.. ......+...+..+.+++.+||+.||++||++.++++
T Consensus 220 ----------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 220 ----------AIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----------HHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0001111 1112233345667889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=301.64 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=200.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|...+.. .....+..+++|.+.... ......+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 46999999999998765421 112334678999876543 23346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-----cEEEecc
Q 046897 157 YEFMPRGSLENHLFRRGS---YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-----NAKLSDF 228 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-----~vkl~Df 228 (404)
|||+++++|.+++..... ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999999975422 1234788999999999999999999 88999999999999999887 8999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~------- 225 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH------- 225 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH-------
Confidence 99876543322222223345678999999988899999999999999999998 99998643211 00000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
+........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 -------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000111223344567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=313.88 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=202.4
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCC-CCCcceEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLY-HPNLVKLVGY 146 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 146 (404)
..+.|++++.||+||.+.||++... ....||+|.+... +.....-+..|+.+|.+|+ |.+||++++|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s----------~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS----------DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC----------CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 4568999999999999999995432 2345677765433 3344566899999999995 9999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
-..++.+||||||- ..+|..+|.++.. -.+.-.++.+..|++.++.++| ..+|||.||||.|+|+ -.|.+||+
T Consensus 429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLl-VkG~LKLI 501 (677)
T KOG0596|consen 429 EVTDGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLL-VKGRLKLI 501 (677)
T ss_pred eccCceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEE-EeeeEEee
Confidence 99999999999987 5699999988764 2333388899999999999999 8999999999999998 56799999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccC-----------CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-----------HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
|||+|...............+||+.||+||.+... ..+.++||||||||||+|+.|++||...
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------ 575 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------ 575 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------
Confidence 99999988776666667788999999999988432 2467899999999999999999999742
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEG-AYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
......+..+.++.-.-+++.-- ..++.++++.||..||++||++.++|+.
T Consensus 576 ---------~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 ---------INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---------HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11222344555554433333222 2238999999999999999999999874
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=306.37 Aligned_cols=265 Identities=23% Similarity=0.404 Sum_probs=203.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|+..+.||+|+||.||+|.+... .......+++|.+....... ..++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 35688899999999999999765431 11112467899887543322 2467889999999999999999999875
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
. ..++++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEcccc
Confidence 4 5678999999999999987653 35789999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~--------- 222 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD--------- 222 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---------
Confidence 9986543222111222345678999999988889999999999999999997 899986532111 111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
++........+......+..++.+||..+|++||++.++++.|+.+....
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 223 -----LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 11111111111223457889999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.37 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=192.5
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQL---YHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~ 147 (404)
+|++.+.||+|+||.||+| .+..++..||+|.+...... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEE---------EECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 5888999999999999995 44557889999988754221 223455677666655 799999999988
Q ss_pred EeC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 148 LED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 148 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
... ...+++|||+. ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCC
Confidence 642 45799999996 589888876432 45899999999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+||+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|++||......... ....
T Consensus 147 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~ 220 (288)
T cd07863 147 VKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIF 220 (288)
T ss_pred EEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHH
Confidence 9999999997643221 122356889999999998889999999999999999999999999654321110 0000
Q ss_pred hhhhh--ccccch-------hhccc---ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 PYLAS--KRKIFR-------IIDNR---LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 ~~~~~--~~~~~~-------~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..... ...... ..... ............+.+++.+||+.||++|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000000 00000 000111234557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=297.38 Aligned_cols=248 Identities=29% Similarity=0.447 Sum_probs=197.1
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
++||.|+||.||++. ... +..|++|.+...... ....+.+|+++++.+.|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~---------~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGV---------LKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEE---------EeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 469999999999954 333 788999988765443 446788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+.+++|.+++.... ..+++..+..++.+++.+|.||| +++++|+||+|+||+++.++.++|+|||++.....
T Consensus 71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG 145 (251)
T ss_pred EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence 99999999999987643 35789999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~ 208 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERI 208 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHH
Confidence 221111112234567999999988889999999999999999999 88888654321100 001
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
........+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 209 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 111111122234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=312.76 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=217.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
..+.+.||.|.||.||.|.+.+. +.+....||||..+.+ ...+.+.|+.|..+++.++||||++++|++.+. -
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 34457899999999999988652 2455677999998874 445567899999999999999999999999764 6
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.|||||.++-|.|..+++... ..++......++.||+.||+||| +.++|||||...|||+.....|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 899999999999999998876 46888999999999999999999 8999999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........... ...-...|||||.+.-..++.++|||.||+.+||++. |..||.+-...+. +
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I 602 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------I 602 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------E
Confidence 87766544333 4456678999999988899999999999999999876 8899986443221 1
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
..++..-+...++.++..+..|..+||..+|.+||.+.++...|..+..
T Consensus 603 -~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 -GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1122223346778889999999999999999999999999999988765
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=300.26 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=192.1
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|.+. ...++..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~-------~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVN-------SGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEc-------CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 46999999999998643 223456799998876542 2234678899999999999999999999998899999
Q ss_pred EeccCCCChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGS-YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
|||+++++|.+++..... .....++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999976432 1234567788899999999999999 8999999999999999999999999999987543
Q ss_pred CCCCCcceeeccccccccCccccccC-------CCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 236 TGDQSHVSTRVMGTYGYAAPEYLATG-------HLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
............++..|+|||++.+. .++.++||||||+++|||++ |+.||........ .... .
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~-----~ 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT-----V 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH-----h
Confidence 32221122234577889999988532 35789999999999999996 9999965432110 0000 0
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
......+..+. ........+.+++..|+ .+|++|||+.+|+..|+
T Consensus 224 ~~~~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00011111111 11123445778999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=300.12 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=195.2
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeeEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 155 (404)
++||+|+||.||+|.+.. .+....+++|.+.... ....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcC-------CCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 469999999999976532 1122357888876432 23345688999999999 79999999999999999999
Q ss_pred EEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 156 VYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
+|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence 9999999999999976431 1134789999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||....... ...
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~ 222 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 222 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHH
Confidence 999999986322111 1111234567999999988889999999999999999997 999996532110 000
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
. +........+......+.+++.+||..||.+|||+.++++.|+++.
T Consensus 223 ~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 K-----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred H-----------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0000111122233456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.17 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=191.0
Q ss_pred cccccCcccEEEEEecCcc---------------cccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceE
Q 046897 79 VLGEGGFGSVFKGWIDEHS---------------FAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKL 143 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~---------------~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 143 (404)
.||+|+||.||+|.+.... ...........|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999764211 0011223345789998876544444678889999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC--
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-- 221 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-- 221 (404)
++++..+...++||||+++++|..++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886533 35789999999999999999999 89999999999999997644
Q ss_pred -----cEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHH-hCCCCcCCCCCCCC
Q 046897 222 -----NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEML-SGRRAVDKNRPSGE 294 (404)
Q Consensus 222 -----~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell-~g~~p~~~~~~~~~ 294 (404)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643221 12356788999998865 56899999999999999995 69999875433211
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
. . +. .... ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ~---~----~~----------~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E---R----FY----------EKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---H----HH----------Hhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 0 00 0000 111112346789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=304.45 Aligned_cols=251 Identities=32% Similarity=0.518 Sum_probs=199.9
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHH--HHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK--EWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
|++.+.||+|+||+||+ +.+..++..+|+|++......... ...+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~---------~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYK---------AKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEE---------EEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEE---------EEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 56788999999999999 455567889999999887544433 2356999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+++++|.+++... ..+++..++.++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccccc----ccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 999999999888999999843 35899999999999999999999 789999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
... ...........++..|+|||++. +..++.++||||||+++|+|++|..||...... +.....
T Consensus 146 ~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~--------- 211 (260)
T PF00069_consen 146 VKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEII--------- 211 (260)
T ss_dssp EES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHH---------
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhh---------
Confidence 753 11122344567899999999998 788999999999999999999999999864110 000000
Q ss_pred cchhhcccccCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 311 IFRIIDNRLEGQY--TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 311 ~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
............ .......+.+++.+||+.||++||++.++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 212 -EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -hhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001100000000 0011278899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=303.87 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=199.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
.|++.+.||.|+||.||+|. +..++..+++|.+........+.+.+|+++++.++||||+++++++..++.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQ---------NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEE---------ECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 36778899999999999954 444678899999877655556778899999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++||||+++++|..++.... .++++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEccccccc
Confidence 999999999999998876533 46899999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
...... .......++..|+|||++. +..++.++|||||||++|+|++|+.||........ .......
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~ 223 (282)
T cd06643 152 KNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS 223 (282)
T ss_pred cccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc
Confidence 543221 1223356889999999873 34578899999999999999999999865332100 0000000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ....+...+..+.+++.+||+.||.+||++.++++.
T Consensus 224 -------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 224 -------EPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -------CCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 001122345678899999999999999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=298.10 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=204.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||.|+||.||+|. ...++..+++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKAR---------DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEeE---------ecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 3578899999999999999954 3446778999999876555667889999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..|++|||+.+++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECcccc
Confidence 99999999999999999887652 35889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccC---CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATG---HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....+.... .. ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~--~~ 217 (262)
T cd06613 148 SAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FL--IS 217 (262)
T ss_pred chhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH--HH
Confidence 876433211 12335688899999998766 7889999999999999999999999754321100 00 00
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .. ..........+..+.+++.+||..+|.+||++.+|+.
T Consensus 218 ~~~---~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 218 KSN---FP--PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hcc---CC--CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 0001123345667899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=297.75 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=199.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||.|+||.||+|.... +..+++|.+.... ...+.+.+|+++++.++|+|++++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 568889999999999999975432 2358999876543 33467889999999999999999998875 45
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+.+++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccc
Confidence 68999999999999999976432 45789999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----------- 214 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE----------- 214 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----------
Confidence 764332211 1122345678999999988889999999999999999999 899987533211 000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.+.. ......+...+..+.+++.+||..||++||++.++++.|++
T Consensus 215 --~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 215 --QVER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --HHHc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000 01112223445678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.10 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=196.7
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|.+.+.||+|+||.||+++ +...+..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAY---------DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEE---------ECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 35789999999999999999954 44567889999987532 23345678999999999999999999987
Q ss_pred EeC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 148 LED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 148 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
... ...|+||||++ ++|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 163 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCC
Confidence 643 35799999995 577777743 3788899999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh---
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV--- 298 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~--- 298 (404)
.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 164 ~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 164 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred cEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999997643221 223456899999999999999999999999999999999999999754321110000
Q ss_pred ---------hhh----hhhhhhcccc-----chhhcccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 ---------EWA----KPYLASKRKI-----FRIIDNRL---EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ---------~~~----~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ..+....... ..+..... ...........+.+++.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000000000 00000000 000111123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=317.76 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=205.1
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEe
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYE 158 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 158 (404)
+||+|+||+||-| ++..+...+|||.+...+-...+-+..|+.+.++|+|.|||+++|.+.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~---------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAA---------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEee---------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 6999999999984 5556788999999988766666778999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc-CCCcEEEecccCCCCCC
Q 046897 159 FMPRGSLENHLFRRGSYFQPL--SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD-TNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 159 ~~~~~~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~-~~~~vkl~Dfg~a~~~~ 235 (404)
-++||+|.+++..... ++ .+..+-.+.+||+.||.||| ++.|||||||-+||||+ -.|.+||.|||.++...
T Consensus 653 qVPGGSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred cCCCCcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 9999999999987653 45 77888999999999999999 89999999999999996 46889999999998754
Q ss_pred CCCCCcceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 236 TGDQSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..+ .....+.||..|||||++.. ..|+.++|||||||++.||.||++||-........ .++
T Consensus 728 gin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFk 790 (1226)
T KOG4279|consen 728 GIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFK 790 (1226)
T ss_pred cCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhh
Confidence 332 24556789999999999964 46899999999999999999999999754332110 011
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.---......+.+...+...+|.+|+++||.+||++.++|+
T Consensus 791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11112234667778889999999999999999999999986
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=305.84 Aligned_cols=251 Identities=29% Similarity=0.416 Sum_probs=197.8
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
|+..+.||+|+||+||++. ...+++.+|+|.+...... ....+.+|+.+++.++|+||+++.+.+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQ---------VRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 6677899999999999954 4446889999998654322 223467899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+.+++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCc
Confidence 999999999999999988875432 36899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...
T Consensus 149 ~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~--~~~-------- 215 (285)
T cd05632 149 AVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE--VDR-------- 215 (285)
T ss_pred ceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHH--------
Confidence 87543221 12234689999999999888999999999999999999999999975432110000 000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.+... ...+.......+.+++.+||+.||++||+ +.++++
T Consensus 216 --~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 216 --RVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --hhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00000 01122334556789999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=302.23 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=199.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|.+.+.||+|+||.||+| .+..++..|++|.+..........+.+|+.+++.++||||+++++.+..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEE---------EEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 47888899999999999995 444568899999987665444566788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999999987653 5899999999999999999999 889999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
....... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+....... ..
T Consensus 154 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--------~~ 223 (267)
T cd06645 154 AQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------TK 223 (267)
T ss_pred eEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--------hc
Confidence 7543211 1223457899999999874 456888999999999999999999998654321110000 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. ....... .....+..+.+++.+||+.+|++||++.+|++
T Consensus 224 ~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 SN---FQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cC---CCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0000000 01123456789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=309.89 Aligned_cols=253 Identities=22% Similarity=0.253 Sum_probs=195.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||++.. ..++..+|+|++..... .....+..|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKL---------KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEE---------CCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 3688999999999999999544 44678899999864221 22234778899999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997643 35889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
|++....... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ....
T Consensus 147 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~- 218 (332)
T cd05623 147 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYG- 218 (332)
T ss_pred chheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHH-
Confidence 9987543221 11223357999999999885 346889999999999999999999999754321 1111
Q ss_pred hhhhccccchhhccccc---CCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLE---GQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
.+...... ..........+.+++.+||..++.+ |+++.++++.
T Consensus 219 ---------~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 ---------KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---------HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111100 0111234567889999988765544 6889998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=299.75 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=204.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|.+.+.||+|+||.||+|.+.+. ......+++|...... ....+.+.+|+.+++.+.||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 35688899999999999999875431 1234568999887654 3344678899999999999999999998865
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCc
Confidence 56789999999999999997643 35899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........ ....
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~------- 221 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI------- 221 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH-------
Confidence 98764332211 1122334567999999888889999999999999999986 9999975432111 0000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
. .......+...+..+.+++.+|+..+|.+|||+.++++.|+.+.+.
T Consensus 222 ------~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 222 ------E-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------H-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0000112233456788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=299.18 Aligned_cols=240 Identities=29% Similarity=0.400 Sum_probs=204.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|..+++||+|.||+|.+ |+.+.+++.||+|+++++......+ -+.|-++|...+||.+..+.-.|+
T Consensus 168 ~dFdfLKvLGkGTFGKVIL---------~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVIL---------CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred chhhHHHHhcCCccceEEE---------EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 5788899999999999998 7778899999999998876555444 367899999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+++|+||||.+||.|.-++.+. ..+++.....+-..|+.||.||| +++||.||||.+|.|+|.+|++||+||
T Consensus 239 t~drlCFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEeeec
Confidence 999999999999999999888765 35888999999999999999999 799999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...- ........++|||.|+|||++....|+.++|+|.+|+++|||++|+.||...+...
T Consensus 313 GLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------------- 375 (516)
T KOG0690|consen 313 GLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------------- 375 (516)
T ss_pred ccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------
Confidence 9998532 23335677999999999999999999999999999999999999999997654332
Q ss_pred cccchhh-cccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 046897 309 RKIFRII-DNRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347 (404)
Q Consensus 309 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 347 (404)
+++++ -..+ .++.....+...|+..+|..||.+|.
T Consensus 376 --LFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 --LFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --HHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 22221 1111 34555566778999999999999995
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.38 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=192.2
Q ss_pred CcccccCcccEEEEEecCcccc---cccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFA---ATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
+.||+|+||.||+|++...... .........+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999976432100 1112345578999887665445567888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc-------EEEec
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-------AKLSD 227 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~-------vkl~D 227 (404)
++|||+++++|..++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998886543 35899999999999999999999 899999999999999987664 89999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHH-hCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEML-SGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell-~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
||++..... .....++..|+|||.+. +..++.++|||||||++|||+ .|..||........ .
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~--- 219 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------E--- 219 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------H---
Confidence 999865422 12245778899999886 467899999999999999998 58888764322110 0
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+..... .........+.+++.+||+.||++||++.+|++.|+
T Consensus 220 -------~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 -------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -------HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000000 011112356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=301.92 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=197.8
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
+...|.+.+.||+|+||.||+|.. ..+++.+++|.+.... .....+..|+.++..+ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~---------~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRH---------VKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEE---------cCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 456788899999999999999644 4467899999987653 3446788899999998 6999999999987
Q ss_pred eC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 ED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
.. ...|++|||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAE 149 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCC
Confidence 53 468999999999999999876432 45889999999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
++|+|||++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....+...
T Consensus 150 ~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--- 224 (272)
T cd06637 150 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--- 224 (272)
T ss_pred EEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---
Confidence 9999999987543221 1223456889999999885 34588899999999999999999999964322100
Q ss_pred hhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. . ..............+..+.+++.+||..||.+|||+.++++
T Consensus 225 --~~---~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 --LF---L--------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --HH---H--------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0 00000000111223456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=307.57 Aligned_cols=264 Identities=27% Similarity=0.425 Sum_probs=217.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+...+.+.||+|-||.|.++... .+..||+|.++.+..... ++|.+|+++|.+|+||||+.++++|..+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve----------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE----------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hheehhhhhcCcccceeEEEEec----------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 45678899999999999985443 268899999987655444 7899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+.+++++||++.|+|.+++..+.. ..+.......|+.||+.||+||. +.++|||||.+.|+|++.++++||+|||+
T Consensus 608 ePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLe--s~nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLE--SLNFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHH--hhchhhccccccceeecCcccEEecCccc
Confidence 999999999999999999988753 12455667789999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh--CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS--GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++....++........+-..+|||+|.+..+.++.++|+|+||+++||+++ ...||........ ++-...++..
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~- 759 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRD- 759 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCC-
Confidence 998877777777777788899999999999999999999999999999855 7778876543221 1111111111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.-.......+.-++..+.+++.+||..|-++||+++++...|.+.
T Consensus 760 ------~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 ------QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111122244566788899999999999999999999999998864
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=307.01 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=162.2
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE--DDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 154 (404)
.+.||+|+||.||+|... ...++..||+|.+.... ....+.+|+.+|+.++||||+++++++.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~-------~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRK-------DGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEc-------cCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 468999999999997643 22356789999987553 23457789999999999999999999864 45689
Q ss_pred EEEeccCCCChHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE----cCCCcEEE
Q 046897 155 LVYEFMPRGSLENHLFRRGS-----YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKL 225 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll----~~~~~vkl 225 (404)
++|||+ +++|.+++..... ....+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999999 5688888764321 1235889999999999999999999 8999999999999999 45678999
Q ss_pred ecccCCCCCCCCCCC-cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 226 SDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 999999764332211 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.50 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=198.2
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
....+|.+.+.||.|+||.||+++ +..++..+++|.+..... .....+..|+.+|+.|+||||++++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAk---------dk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVK---------HKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEE---------ECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 345689999999999999999954 445678899998875432 233568899999999999999999999
Q ss_pred EEeC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----CCceecCCCCCcEEEcC
Q 046897 147 CLED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-----TKVIYRDFKTSNILLDT 219 (404)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~i~H~Dlkp~NIll~~ 219 (404)
|... ..+||||||+.+++|.++|.........+++..++.|+.||+.||+|||... .+|+||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8654 5689999999999999999765433356999999999999999999999321 45999999999999964
Q ss_pred -----------------CCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHH
Q 046897 220 -----------------NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEML 280 (404)
Q Consensus 220 -----------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell 280 (404)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 3348999999997643322 2234579999999999854 45889999999999999999
Q ss_pred hCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 281 SGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 281 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+|..||...... ...... +..... ......+..+.+||..||..+|.+||++.++|.
T Consensus 238 TGk~PF~~~~~~-----~qli~~-----------lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 SGKTPFHKANNF-----SQLISE-----------LKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HCCCCCCcCCcH-----HHHHHH-----------HhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999643211 111100 000000 000123457889999999999999999999984
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=303.24 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=203.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||.|+||.||+|.. ..++..+++|.+........+.+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQH---------KETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEE---------cCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 35688999999999999999654 336788999999776655667788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...|+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCcc
Confidence 99999999999999999987654 36899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+........ ......+++.|++||.+. ...++.++||||||+++|+|++|+.||....... ...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~--- 218 (280)
T cd06611 150 SAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLL--- 218 (280)
T ss_pred chhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHH---
Confidence 875433221 223456889999999874 3457789999999999999999999997543211 000
Q ss_pred hhccccchhhccc-ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNR-LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.... .....+......+.+++.+||+.+|.+||++.++++.
T Consensus 219 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 219 -------KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -------HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000000 0001122344578899999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.72 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=203.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||.|+||.||+|... .++..+++|.+..... .+.+.+|+++++.++|+||+++++.+..+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK---------ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc---------CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 57899999999999999996543 3578899999876532 577899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..|+++||+.+++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999999987543 46899999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+...... +
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~ 211 (256)
T cd06612 147 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------I 211 (256)
T ss_pred hhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------h
Confidence 86543321 22334578899999999888899999999999999999999999975432211000 0
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.... ......+......+.+++.+||+.||++|||+.++++
T Consensus 212 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 212 PNKP--PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ccCC--CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000 0011122334567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.62 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=203.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|+..++||.|+||.||.+ ....++..+++|.+.... .....++.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLY---------RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEE---------EEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 5888999999999999984 444578889999886543 33346688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+++++|.+++.... ...+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcc
Confidence 99999999999999999997653 245889999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~-------- 211 (256)
T cd08221 148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVV-------- 211 (256)
T ss_pred eEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHH--------
Confidence 876533221 223456899999999998888899999999999999999999999653321 0000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+...... ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 212 --~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 212 --KIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --HHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11111111 1123345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=304.68 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=203.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||.|+||.||+|. +..++..|++|.+........+.+.+|+.+++.++||||+++++++..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAI---------DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEE---------EcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468999999999999999954 44568899999987765556677889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++|+||+++++|..++... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999988643 4789999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+... ......
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~----- 229 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIAT----- 229 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-----
Confidence 76433221 12334688899999999888899999999999999999999999976432110 000000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
........+......+.+++.+||..||++||++.+++..
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 230 ----NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ----cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000011222345568899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=300.20 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=202.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|.+.+.||.|+||.||+|.. ..++..+++|.+.... ......+.+|+.+++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAID---------KRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEE---------CCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 3688899999999999999644 4468899999987653 23345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++|+||+.+++|.+++... ++++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998753 5899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+... ..
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~----------- 208 (274)
T cd06609 145 SGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF----------- 208 (274)
T ss_pred ceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH-----------
Confidence 98654332 122345688899999999888899999999999999999999999975432110 00
Q ss_pred cchhhcccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLE-GAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+. .......... .+..+.+++.+||..+|++||+++++++.
T Consensus 209 --~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 209 --LIP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --Hhh-hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 0001111111 45568899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=297.84 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=200.3
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
|.+.++||+|+||.||+|.+.. ...++..+++|++..+. ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6678899999999999986532 33467899999887543 223456889999999999999999999886542
Q ss_pred ------eeEEEEeccCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 152 ------HRLLVYEFMPRGSLENHLFRRG--SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 152 ------~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
..+++++|+.+++|.+++.... .....++...++.++.|++.||+||| +.+|+|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCE
Confidence 2378899999999998875432 11124788999999999999999999 8899999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |+.||...... ....+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~- 228 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL- 228 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH-
Confidence 9999999886543322212223345678999999988889999999999999999999 88888643221 111100
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.... . ...+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 229 ---~~~~--------~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 ---IKGN--------R--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---HcCC--------c--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0 011123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.77 Aligned_cols=247 Identities=30% Similarity=0.447 Sum_probs=194.7
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
++||+|+||.||+|... .+..+++|.+....... ...+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 46999999999996532 35689999887654322 34678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++.... ..+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence 99999999999986543 35789999999999999999999 89999999999999999999999999999875332
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ ... .
T Consensus 146 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~----~---------- 207 (250)
T cd05085 146 GIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQ----V---------- 207 (250)
T ss_pred cccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHH----H----------
Confidence 2111 1112234567999999988889999999999999999998 9999965432110 000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
........+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 000111222234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=281.95 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=196.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 151 (404)
...+..||.|+.|+|++ ++...+|..+|||.+...+ ....++++..+.++..-+ +|+||+++++|..+.
T Consensus 94 l~~l~dlGsGtcG~V~k---------~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWK---------MRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred hhhHHhhcCCCccceEE---------EEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 34456799999999999 5555688999999997653 333466777777776654 899999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++.||.| ...++.++.+.. .++++..+-.+...++.||.||.. .++|+|||+||+|||+|..|.+||||||++
T Consensus 165 dV~IcMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeeccccc
Confidence 999999998 556666665543 579999999999999999999985 788999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
....... ..+...|.+.|||||.+. ...|+.++||||||++++||.||+.||.+.... .
T Consensus 240 GrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F------------- 301 (391)
T KOG0983|consen 240 GRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F------------- 301 (391)
T ss_pred ceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H-------------
Confidence 8765433 344567999999999985 357899999999999999999999999875432 1
Q ss_pred cccchhhcccccCCCC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYT--LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+..+++... ..++ ...+..+.+++..||..|+.+||...++++.
T Consensus 302 e~ltkvln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 302 EVLTKVLNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11112222111 1111 1146678999999999999999999998864
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.41 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=190.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|.... ......+++|.+...... ....+.+|+.+++.++|+||+++++.+......++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHR-------GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEec-------CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 359999999999985432 123457889987654322 234578899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSY-FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
|||+++|+|.+++...... ....++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999999765421 233567888999999999999999 8999999999999999999999999999987533
Q ss_pred CCCCCcceeeccccccccCccccc-------cCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 236 TGDQSHVSTRVMGTYGYAAPEYLA-------TGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
............++..|+|||++. ...++.++|||||||++|||++ |..||....+... ......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~- 224 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVR- 224 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhh-
Confidence 322111122334567899999864 2356789999999999999999 7888865432110 000000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.....+.. ..........+..++..|+ .||++||++.+|++.|.
T Consensus 225 -~~~~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 -EQDIKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -ccCccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00001111 1222334556678888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.41 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=195.5
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~ 145 (404)
....++|.+.+.||.|+||.||+| .+..++..||+|.+..... ...+.+.+|+.+|+.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSA---------YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEE---------EECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhh
Confidence 345678999999999999999995 4445678999999875422 23355778999999999999999999
Q ss_pred EEEeC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 146 YCLED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 146 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
++... ...|++++++ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~ 153 (343)
T cd07878 82 VFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNE 153 (343)
T ss_pred hhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECC
Confidence 87543 3468999998 7899887753 35899999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~ 298 (404)
++.+||+|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .
T Consensus 154 ~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~ 225 (343)
T cd07878 154 DCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---L 225 (343)
T ss_pred CCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---H
Confidence 999999999999864321 233568999999999876 5688999999999999999999999965432110 0
Q ss_pred hhhhhhhhh----------ccccchhhcccccCCCC--------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 EWAKPYLAS----------KRKIFRIIDNRLEGQYT--------LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
......... .......... +. ..+ ......+.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 226 KRIMEVVGTPSPEVLKKISSEHARKYIQS-LP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHhCCCCHHHHHhcchhhHHHHhhc-cc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0000000000 00 000 0122357799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.46 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=199.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE- 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 149 (404)
+|++.+.||+|++|.||++. +..+++.+++|.+..... ...+.+.+|+.+++.++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVR---------HRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEE---------EcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48889999999999999954 444678899999865432 233567889999999999999999998764
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...|++|||+++++|.+++..... ..+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEeccc
Confidence 4467999999999999999976432 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~------ 213 (257)
T cd08223 148 IARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR------ 213 (257)
T ss_pred ceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH------
Confidence 987543221 1233456889999999998888999999999999999999999998743211 11111
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.... ....+......+.+++.+||+.||++||++.++++.
T Consensus 214 ----~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 214 ----IIEGK-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----HHhcC-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11100 112233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.05 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=201.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||++... .+..+++|.+.... ...+.+.+|+.+++.++|+||+++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec----------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 467899999999999999997543 24568999887543 334678899999999999999999999887
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcc
Confidence 778999999999999999976432 45788899999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... ...+
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~--------- 215 (260)
T cd05073 149 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA--------- 215 (260)
T ss_pred eeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH---------
Confidence 8764332211 1122345677999999988889999999999999999998 899997532210 0100
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+............+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 216 -----LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -----HhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 000011112223456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=304.55 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=197.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|.+.+.||.|+||.||+|. +..++..|++|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGR---------SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEE---------EcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 578999999999999999954 444678899999875432 2234577899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+. ++|..++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999999995 68988887643 35789999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS-- 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 307 (404)
+........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..........
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~ 225 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPT 225 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 875432221 1223457889999998765 4578899999999999999999999975432111 1000000000
Q ss_pred ccccchhhc---------ccccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIID---------NRLEG----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
......+.. +.... .........+.+++.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00000 011123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=295.97 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=190.7
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|.... ......+++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYT-------DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred CcCCCCcCceEEEEEEEc-------CCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence 359999999999975422 1223456777776543 23346789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++..........+...++.++.||+.||+||| +.+++|+||||+|||++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999999865433345677888999999999999999 89999999999999999999999999999864322
Q ss_pred CCCCcceeeccccccccCcccccc-------CCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLAT-------GHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
...........++..|+|||++.. ..++.++||||||+++|||++ |..||....+. ........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh--
Confidence 221112234567889999998743 245779999999999999997 56677543221 11111110
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.....+.++.+. ......+.+++..|| .+|++||++.+|++.|.
T Consensus 224 ~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 DQQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hcccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111112222222 223456778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=297.20 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=199.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+++.....||+|+||.||+|. +..++..|++|.+........+.+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~---------~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAAR---------DLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred ccccCCceEEEecCCceEEEEeE---------ecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 34455566789999999999964 344678899999887765666788999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPL--SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~~vkl~ 226 (404)
++..++++||+++++|.+++.... ..+ ++..+..++.|++.||+||| +.+|+|+||||+||+++. ++.++|+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEe
Confidence 999999999999999999997643 234 78888999999999999999 899999999999999976 6799999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccC--CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG--HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ..+.
T Consensus 152 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~--- 223 (268)
T cd06624 152 DFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFK--- 223 (268)
T ss_pred cchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhh---
Confidence 9999875432221 12234578899999998654 378899999999999999999999964322100 0000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..........+......+.+++.+||+.+|.+|||+.++++
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 224 ---------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---------hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00001112233345567889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=302.66 Aligned_cols=263 Identities=26% Similarity=0.316 Sum_probs=201.5
Q ss_pred HHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcce
Q 046897 64 FSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVK 142 (404)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 142 (404)
+..+....++|++.+.||+|+||.||++. +..++..+++|++.... .....+..|+.+++.+ +||||++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~---------~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVL---------NKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEE---------ECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence 34445567899999999999999999954 44567889999876532 2235677899999999 6999999
Q ss_pred EEEEEE-----eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE
Q 046897 143 LVGYCL-----EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217 (404)
Q Consensus 143 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll 217 (404)
+++++. .++..++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++||||||+||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili 157 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILL 157 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEE
Confidence 999884 345689999999999999988654333356889999999999999999999 8899999999999999
Q ss_pred cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 218 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
+.++.++|+|||++........ ......|++.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 9999999999999876433221 123346889999999874 345788999999999999999999999754321
Q ss_pred CCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ... ....... ...+......+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~--~~~-----------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 RAL--FKI-----------PRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHH--hhc-----------cccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 100 000 0000000 01111234568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.37 Aligned_cols=254 Identities=27% Similarity=0.345 Sum_probs=201.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||++ ....++..+++|.+...... ..+.+..|+++++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLV---------RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEE---------EEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 36888999999999999995 44446889999999765433 3356788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.....|++|||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeec
Confidence 99999999999999999999875432 46899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCC---------------------------cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh
Q 046897 229 GLAKDGPTGDQS---------------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281 (404)
Q Consensus 229 g~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~ 281 (404)
|++......... .......|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754222110 01113468889999999988889999999999999999999
Q ss_pred CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 046897 282 GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM----MAEVVT 354 (404)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 354 (404)
|..||........ ...+.+...........+..+.+++.+||+.||++||+ +.++++
T Consensus 228 g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 228 GTTPFKGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999975432110 11111111111111124678899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.24 Aligned_cols=247 Identities=32% Similarity=0.478 Sum_probs=197.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|.+.+.||+|+||.||++.. ++..+++|.+.... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5688999999999999998532 46679999886542 346788999999999999999999998754
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+.+++|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccc
Confidence 57999999999999999976532 35789999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... ...
T Consensus 148 ~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~-------- 208 (254)
T cd05083 148 RVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKE-------- 208 (254)
T ss_pred eeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHH--------
Confidence 7543211 12234567999999988889999999999999999997 999997543211 000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
..............+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 ---CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---HHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011111112223345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.49 Aligned_cols=270 Identities=20% Similarity=0.239 Sum_probs=196.3
Q ss_pred CCCccccc--CcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 76 PDSVLGEG--GFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 76 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.++||+| +|++||+ +....+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~---------~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNL---------ARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEE---------EeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 6789998 45556789999999876532 22345778999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+++.||+..
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999999999999975432 35889999999999999999999 899999999999999999999999999865
Q ss_pred CCCCCCCCC-----cceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 232 KDGPTGDQS-----HVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 232 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 226 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGT 226 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCC
Confidence 432211100 01112346778999999875 4689999999999999999999999974322110 00000000
Q ss_pred hh---h-----ccc-------------cch---------hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LA---S-----KRK-------------IFR---------IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~---~-----~~~-------------~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. + ... ... .................+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 227 VPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0 000 000 00000000112234567889999999999999999999987
Q ss_pred H--HHhhH
Q 046897 355 V--LEQLQ 360 (404)
Q Consensus 355 ~--L~~~~ 360 (404)
. +.++.
T Consensus 307 ~p~f~~~~ 314 (327)
T cd08227 307 HSFFKQIK 314 (327)
T ss_pred Chhhhhcc
Confidence 3 55443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.11 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=196.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.+.+.||.|++|.||+|. +..++..|++|.+..... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGR---------NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEE---------ECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 47888999999999999964 444678999998865422 2335678899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...|+||||+. ++|.+++..... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 688888865332 246899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh-----
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY----- 304 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~----- 304 (404)
+....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~ 223 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTE 223 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 87543221 11223457889999998765 4578899999999999999999999975432110 00000000
Q ss_pred --hhhccccch---hhccccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 --LASKRKIFR---IIDNRLE---GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 --~~~~~~~~~---~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
......+.. ....... .......+.++.+++.+||+.||.+|||+.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 0000000 0011123457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=295.28 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=195.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-----QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.+|...+.||+|+||.||+| .+..++..|++|.+..... ...+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLC---------YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEE---------EEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 36889999999999999995 4445688999998864321 223457889999999999999999998
Q ss_pred EEeC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 147 CLED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
+... ...+++|||+++++|.+++.... .+++...+.++.|++.||+||| +.+|+|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEE
Confidence 8753 57889999999999999997643 4788999999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCC-CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQ-SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
|+|||++........ ........++..|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~---- 216 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------A---- 216 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------H----
Confidence 999999875432111 11122345888999999998888999999999999999999999999753211 0
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+............+......+..++ +||..+|++||++.+|++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 217 ------AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00111111111233334455666777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=296.02 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=202.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..|...+.||.|+||.||+|.. ..++..|++|.+.... ......+.+|+.+++.+.|+||+++++.+.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGID---------NRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEE---------ccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 4577788999999999999543 4467889999887543 23346688899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++... ++++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEccccc
Confidence 9999999999999999988642 4788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......++..|+|||.+.+..++.++|+||||+++|||++|..||....+.....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------------- 211 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------------- 211 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--------------
Confidence 976533221 1223467889999999988889999999999999999999999997543221100
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..............+..+.+++.+||+.+|++||++.+++..
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 ---LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001111123344566788999999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=295.47 Aligned_cols=250 Identities=30% Similarity=0.444 Sum_probs=198.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF------QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
+|.+.+.||.|+||.||+|.. .++..+++|.+..... .....+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~----------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT----------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEE----------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 478899999999999999643 2467899998865321 112457889999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+....+++|||+++++|.+++.... ++++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.++|+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEec
Confidence 999999999999999999999997643 5789999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCC----CCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 227 DFGLAKDGPTGD----QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 227 Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|||++....... .........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.....
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------- 217 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------- 217 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-------
Confidence 999987532111 111223356889999999998888999999999999999999999999653221100
Q ss_pred hhhhhccccchhhcc-cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 PYLASKRKIFRIIDN-RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+... ......+......+.+++.+||+.+|.+||++.+++.
T Consensus 218 ---------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 ---------FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---------HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0111223334567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=293.02 Aligned_cols=256 Identities=32% Similarity=0.491 Sum_probs=201.6
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
+.+.+.||.|+||.||++..... ....+..+++|.+...... ..+.+..|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 45678999999999999766431 1123588999999765433 45678899999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.+++|||+++++|.+++..... ..+++..++.++.|++.||++|| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCce
Confidence 9999999999999999976532 12899999999999999999999 8899999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
.......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 152 ~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~----------- 216 (258)
T smart00219 152 DLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEY----------- 216 (258)
T ss_pred eccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-----------
Confidence 6544322111 12336789999999988889999999999999999998 78888652211 00000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
+.. ..........+..+.+++.+||..||++|||+.++++.|
T Consensus 217 --~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 --LKK-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --Hhc-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 001112223456788999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=293.75 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=198.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.+|++.+.||.|+||.||++.+. .+..+++|.+.... .....+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 46788899999999999997543 24579999886543 33467889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+++++|.+++.... ..+++..++.++.|++.+|+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999999987643 35789999999999999999999 889999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~------- 213 (256)
T cd05112 148 RFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVET------- 213 (256)
T ss_pred eecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHH-------
Confidence 754322111 1112234568999999988889999999999999999998 99998653211 00000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
+........+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 214 ----INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----HhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000000011111346788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=298.87 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=191.5
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVY 157 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 157 (404)
+.||.|+||.||+|...... .........+++|.+........+.+..|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~--~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVG--DYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccc--cccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46999999999998664311 0001234568888876654444567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc--------EEEeccc
Q 046897 158 EFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN--------AKLSDFG 229 (404)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~--------vkl~Dfg 229 (404)
||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999997654 35789999999999999999999 899999999999999987765 6999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCC-CCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGR-RAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++..... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||....... .. ...
T Consensus 154 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~-- 218 (258)
T cd05078 154 ISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFY-- 218 (258)
T ss_pred cccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHH--
Confidence 8865432 122457888999999876 45789999999999999999995 5554322110 00 000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
... ...+.....++.+++.+||+.||++|||++++++.|+
T Consensus 219 --------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 --------EDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------Hcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 1122223356889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=311.45 Aligned_cols=241 Identities=26% Similarity=0.323 Sum_probs=184.7
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCee
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQL---YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~ 153 (404)
||+|+||+||+|+ +..++..||+|++...... .......|..++..+ .||||+++++++..++..
T Consensus 1 lG~G~~g~Vy~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVR---------KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEE---------ECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999954 4456889999998653222 122345566666655 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|+||||+.+++|..++.... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999999999999887653 5899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~--------- 208 (330)
T cd05586 146 NLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRN--------- 208 (330)
T ss_pred CCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHH---------
Confidence 32222 123346799999999998654 5889999999999999999999999753321 00000
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM----MAEVVT 354 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 354 (404)
+...... .........+.+++.+||+.||.+||+ +.++++
T Consensus 209 -i~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 209 -IAFGKVR-FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -HHcCCCC-CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0000000 000123456789999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=293.88 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=203.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE- 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 149 (404)
+|++.+.||.|+||.||++ .+..++..+++|.+..... ...+.+..|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKV---------RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEe---------eecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 4788899999999999995 4445678899998875432 233567889999999999999999998764
Q ss_pred -CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC---CCCceecCCCCCcEEEcCCCcEEE
Q 046897 150 -DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA---ETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 150 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
+...+++|||+++++|.+++........++++..++.++.|++.||.|||.. +.+++|+||+|+||+++.++.+||
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 3567999999999999999977544446789999999999999999999943 577999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . ...
T Consensus 152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~---~~~--- 220 (265)
T cd08217 152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---Q---LAS--- 220 (265)
T ss_pred ecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---H---HHH---
Confidence 99999987544321 123356899999999998888999999999999999999999999754311 1 110
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..........+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 --------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011111123334456788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.55 Aligned_cols=259 Identities=27% Similarity=0.362 Sum_probs=200.5
Q ss_pred HHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcce
Q 046897 64 FSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVK 142 (404)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 142 (404)
..++....+.|++.+.||.|+||.||+|.. ..++..+++|++.... .....+..|+.++..+ +|+||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~ 77 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRH---------VKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIAT 77 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEE---------cCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEE
Confidence 344445567899999999999999999654 3467889999886653 2335678899999988 6999999
Q ss_pred EEEEEEe------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 143 LVGYCLE------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 143 ~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
+++++.. ....|++|||+.+++|.+++..... ..+++..++.++.||+.||.||| +.+|+|+||+|+||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nil 153 (282)
T cd06636 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVL 153 (282)
T ss_pred EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEE
Confidence 9999853 4578999999999999999876432 45788889999999999999999 889999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCC
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~ 291 (404)
++.++.++|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|..||....+
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 99999999999999875432111 123356889999999875 34678899999999999999999999965432
Q ss_pred CCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 292 SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..... .+.............+..+.+++.+||..||.+||++.++++
T Consensus 232 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 MRALF----------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred Hhhhh----------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11110 001110111111234567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.37 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=198.4
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC----CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD----GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.+...+||+|+|-+||+| .+..+|..||.-.++.+ .....+++..|+.+|+.|+||||+++|++|.+
T Consensus 42 ~k~~evLGrGafKtVYka---------~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKA---------FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred eehhhhcccccceeeeec---------cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 356788999999999995 45557888887666543 23344779999999999999999999999997
Q ss_pred CCe--eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcEEEe
Q 046897 150 DDH--RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLS 226 (404)
Q Consensus 150 ~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~vkl~ 226 (404)
... +.+|+|.+..|+|..|+.+.+ .+..+.++.|++||+.||.|||+++..|+|||||.+||||+.+ |.|||+
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 765 778999999999999998875 4889999999999999999999999999999999999999864 889999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|+|+|+...... .....|||.|||||... ..|+..+||||||+.++||+|+..||........
T Consensus 189 DLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------------ 251 (632)
T KOG0584|consen 189 DLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------------ 251 (632)
T ss_pred chhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------------
Confidence 999998754432 23378999999999985 7899999999999999999999999976543210
Q ss_pred hccccchhhcc-cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDN-RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
|.+-+-. .....+..-...++.++|.+||.. ..+|||+.|+|+-
T Consensus 252 ----IYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 252 ----IYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----HHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 0000000 000111112245788999999999 9999999999863
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=295.31 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=200.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----------ccHHHHHHHHHHHhc-CCCCCcc
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----------QGHKEWLAEVNYLGQ-LYHPNLV 141 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~hp~iv 141 (404)
.|.+.+.||+|+||.||+|.... ..+..+++|.+..... ....++.+|+.++.. ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 47888999999999999976532 1467899998754321 122456778888875 6999999
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
++++++..++..+++|||+++++|.+++.........+++..++.++.|++.+|.|||. ..+++|+||+|+||+++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence 99999999999999999999999999886543333568999999999999999999993 36799999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.++|+|||++....... ......|+..|++||.+.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~ 222 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLA 222 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHH
Confidence 99999999998644322 233456888999999998888999999999999999999999998643211 000
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
. .+.+..............+.+++.+||+.||++||++.|+.+.++
T Consensus 223 ~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 T----------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred H----------HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 111111111111123467889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.61 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=203.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||++.. ..++..|++|++.... ....+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~---------~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKH---------IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEE---------cCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 35688889999999999999544 4467889999876543 2334678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....++||||+++++|.+++... .++++..+..++.+++.+|.|||. ..+++|+||+|+||+++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 99999999999999999988764 358999999999999999999993 3589999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ... .
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~--~~~---~ 220 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM--GIL---D 220 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh--HHH---H
Confidence 986542211 2235689999999999888899999999999999999999999975443211000000 000 0
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+..+.............+..+.+++.+||+.||++||++.|+++..-
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 001111111110111124567889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=294.59 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=202.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF------QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
+|+..+.||+|++|.||+|. +..++..+++|++..... ...+.+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~---------~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQAR---------DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEE---------EcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999854 445678899999865321 123568899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEE
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKL 225 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl 225 (404)
+.+.+..++||||+.+++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999999764 35889999999999999999999 89999999999999998776 5999
Q ss_pred ecccCCCCCCCCCCC--cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 226 SDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
+|||.+......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------ 219 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------ 219 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH------
Confidence 999998765432111 112234678899999999888899999999999999999999999964332111110
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+............+......+.+++.+||..+|.+||++.++++
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 -------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111111122344456678889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=300.19 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=200.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||+|+||.||++. ...++..|++|.+.... ......+.+|+.+++.++|+||+++++.+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~---------~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVL---------HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEE---------EcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368889999999999999954 44467899999886542 22345788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|..++.... ....+++..+..++.|++.||.|||. ..+|+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 99999999999999998886532 12368999999999999999999993 35899999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccC------CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATG------HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
+...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||..........
T Consensus 150 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------- 217 (286)
T cd06622 150 SGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-------- 217 (286)
T ss_pred cccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH--------
Confidence 8754322 12234578899999988543 35789999999999999999999996532211000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..+... .....+.....++.+++.+||+.+|++||++.++++.
T Consensus 218 -----~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 218 -----QLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----HHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00111111 1112334466778899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.30 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=194.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHH-HhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNY-LGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||++ .+..+|..||+|++..... .....+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKM---------RHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEE---------EEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 36888999999999999995 4455789999999876532 223445566665 566789999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCcEEEcCCCcEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+...|++|||++ ++|.+++.........+++..++.++.|++.||+||| ++ +++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999995 6898888764433357899999999999999999999 65 8999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .. .
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~--~----- 216 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQ--Q----- 216 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HH--H-----
Confidence 9987643221 1223467889999998854 45688999999999999999999999642211 00 0
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+................+..+.+++.+||..+|.+||++.++++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 ------LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ------HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111100000011124567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=302.25 Aligned_cols=202 Identities=23% Similarity=0.339 Sum_probs=161.5
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe--CCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE--DDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 154 (404)
...||+|+||.||+|...+ ..++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~-------~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKD-------GKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecC-------CCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 3579999999999976432 2356789999887653 23467889999999999999999998854 45789
Q ss_pred EEEeccCCCChHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE----cCCCcEEE
Q 046897 155 LVYEFMPRGSLENHLFRRG-----SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKL 225 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll----~~~~~vkl 225 (404)
++|||+. ++|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9999995 58888775321 11235889999999999999999999 8899999999999999 56778999
Q ss_pred ecccCCCCCCCCCCC-cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 226 SDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 999999865332211 11233568999999999866 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.36 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=199.5
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.|...+.||+|+||.||+|.. ..++..|++|.+.... ....+.+.+|+.+++.++||||+++++.+..+.
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGID---------NRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEE---------cCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 456678899999999999654 3457789999887543 233356889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999998854 35789999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||....+....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------- 210 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------------- 210 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----------------
Confidence 76433221 122346788999999998888999999999999999999999998643321100
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+............+..+.+++.+||+.+|++||++.++++.
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 211 -FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0001111112223345678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=295.33 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=197.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc----------cHHHHHHHHHHHhcCCCCCcce
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ----------GHKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~ 142 (404)
+|.+.+.||.|+||.||+|. ...++..+++|.+...... ..+.+.+|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~---------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLAL---------NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEe---------ecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 57888999999999999964 3346788999987542111 1235678999999999999999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
+++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGI 146 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCe
Confidence 999999999999999999999999999765 35888999999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCC--CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
++|+|||++................++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... ...
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~ 221 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAM 221 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHH
Confidence 9999999997643322222223356888999999987654 788999999999999999999999643211 000
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. . .... .............+..+.+++.+||..+|++||++.+|++
T Consensus 222 ~~-~--~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 222 FK-L--GNKR----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HH-h--hccc----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 0 0000 0001111122234567889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=293.53 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=196.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-----QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.+|.+.+.||+|+||.||+|. +..++..|++|.+..... ...+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~---------~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCY---------DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEE---------EcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 478899999999999999954 444688999998754321 223467889999999999999999998
Q ss_pred EEeC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 147 CLED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
+.+. ..++++|||+++++|.+++.... .+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEE
Confidence 8764 46789999999999999987653 4788889999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------- 216 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---------- 216 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----------
Confidence 9999998754322111 11223468889999999988889999999999999999999999996432110
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+............+......+.+++.+|+. +|++||++++|++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 217 ------AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ------HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011111111223344556678899999985 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=296.39 Aligned_cols=255 Identities=29% Similarity=0.394 Sum_probs=200.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
..++|++.+.||.|+||.||+|. +..++..+++|++..... ..+.+.+|+.+++.+ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKAR---------HKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEE---------ECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 35789999999999999999954 344678899999876543 346788999999999 6999999999997
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
... ..++||||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCe
Confidence 644 489999999999999998764433356899999999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
++|+|||++....... .......|+..|+|||.+.. ..++.++||||||+++|+|++|..||........
T Consensus 152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--- 226 (275)
T cd06608 152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--- 226 (275)
T ss_pred EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---
Confidence 9999999987543221 12233568889999998753 3467899999999999999999999964322100
Q ss_pred hhhhhhhhhhccccchhhcccc-cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDNRL-EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+..+..... ...........+.+++.+||..||++|||+.++++
T Consensus 227 -------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 -------------LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -------------HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 001111101 01112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.82 Aligned_cols=269 Identities=25% Similarity=0.430 Sum_probs=223.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
....+.++||.|.||.|++|+++-. ......||||.++.... ....+|+.|+.||.++.||||+++.++....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~p------gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLP------GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCC------CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 3456789999999999999987642 13356899999987543 3446799999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
.-..||.|||++|+|+.+|..+.. .+...++..+++.|+.|+.||- +.++|||||...||||+.+..+|++|||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999988763 4888899999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceee--ccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTR--VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++...+.... ..+. ..-..+|.|||.+....++.++||||+|++|||.++ |..||.+....
T Consensus 778 SRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------------- 841 (996)
T KOG0196|consen 778 SRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------- 841 (996)
T ss_pred eeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---------------
Confidence 9976443321 1111 223468999999999999999999999999999877 99999875432
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCcc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNIR 369 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~ 369 (404)
++-.-++...+..-+.+++..|.+|+++||++|-.+||.+.+|+..|++++.+...-...
T Consensus 842 --dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~ 901 (996)
T KOG0196|consen 842 --DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI 901 (996)
T ss_pred --HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence 111223334444667789999999999999999999999999999999998766555443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.21 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=194.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||+|+||.||+|. +..+|..+++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~---------~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEE---------ECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 57888999999999999954 444688999999865422 2224577899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++++||+. ++|.+++.... ..+++..++.++.||+.||.||| ..+|+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccch
Confidence 99999999995 58888776543 35899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS-- 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 307 (404)
+........ ......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+....... ............
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~ 221 (284)
T cd07839 146 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPT 221 (284)
T ss_pred hhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCC
Confidence 875432211 12234578899999988664 47899999999999999999999864322210 000000000000
Q ss_pred c---cccchhhcccc----c-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 K---RKIFRIIDNRL----E-----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~---~~~~~~~~~~~----~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ..+....+... . ..........+.+++.+||+.||.+|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 00000000000 0 0111223567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.93 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=201.4
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||+|+||.||++. ...++..|++|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVK---------SKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEE---------EcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 58889999999999999854 44467899999986542 23345788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+.+++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999999999999998876432 35788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...... ....
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~-------- 211 (256)
T cd08218 148 ARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVL-------- 211 (256)
T ss_pred eeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHH--------
Confidence 876433221 122345788999999998888999999999999999999999998643211 0000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.++... ....+......+.+++.+||+.+|.+||++.+|++.
T Consensus 212 --~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 --KIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111 011223345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=291.72 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=200.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||+|+||.||++. ...++..+++|.+..... ...+.+.+|+.+++.++||||+++++.+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCR---------RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEE---------EcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 58889999999999999954 344678899999876532 2345788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcEEEeccc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLSDFG 229 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~vkl~Dfg 229 (404)
+..++||||+++++|.+++..... ..+++..++.++.|++.+|.||| +.+++|+||+|+||+++.+ +.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence 999999999999999999976432 45889999999999999999999 8999999999999999865 457999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ...
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~---------- 211 (256)
T cd08220 148 ISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL---------- 211 (256)
T ss_pred CceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH----------
Confidence 998654322 1223568889999999988888999999999999999999999996543211 000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+... .....+......+.+++.+||..+|.+|||+.+++.
T Consensus 212 ---~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 212 ---KIMSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---HHHhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00000 011122234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=291.85 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=199.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-----QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
+|+..+.||+|+||+||+|.. ..++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLN---------LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEE---------cCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 477889999999999999654 33578899998865432 2335688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..+...++++||+++++|.+++... ..+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.+||+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999999999764 35789999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCC-CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++....... ......++..|++||.+.... ++.++|+||||+++|+|++|+.||...... ....
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~---- 212 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVF---- 212 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHH----
Confidence 99987643322 223456888999999987666 899999999999999999999999754311 0000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...........+......+.+++.+||+.+|.+||++.+++.
T Consensus 213 ------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 213 ------KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000011223334567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=319.48 Aligned_cols=282 Identities=21% Similarity=0.278 Sum_probs=190.3
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccc--c----CCCCcE----EEEEEecCCCcccHHHHHHHHHHHhcCCCC
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAAT--K----PGTGMV----IAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~--~----~~~~~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~hp 138 (404)
....+|++.+.||+|+||+||++.++....... . ...+.. ++.|.+.. .......+.+|+.+|+.++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999976543211000 0 000111 11122211 112235578999999999999
Q ss_pred CcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE
Q 046897 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGS-YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217 (404)
Q Consensus 139 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll 217 (404)
||+++++++...+..|++++++ +++|..++..... .........+..++.||+.||.||| +++|+||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence 9999999999999999999999 5678777754321 1122345677889999999999999 8899999999999999
Q ss_pred cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCC-cCCCCCCCCcc
Q 046897 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA-VDKNRPSGEHN 296 (404)
Q Consensus 218 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p-~~~~~~~~~~~ 296 (404)
+.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999986533221 122335799999999999999999999999999999999998864 43322211111
Q ss_pred hhhhhhhhhhhc-------cccchhhcccccC----CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 297 LVEWAKPYLASK-------RKIFRIIDNRLEG----QYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 297 ~~~~~~~~~~~~-------~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+........... ..+...++..... ..+ .....++.+++.+||+.||++|||+.|+++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111000000 0001111000000 000 0123456788999999999999999999864
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=295.80 Aligned_cols=266 Identities=25% Similarity=0.304 Sum_probs=198.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+|. ...++..|++|++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCR---------NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEE---------ECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 468899999999999999954 344678999998865422 223557889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++||||+++++|..++... ..+++..++.++.|++.+|.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccc
Confidence 99999999999988887766443 35899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh-hhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE-WAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 307 (404)
++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............. ........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 146 FARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred cceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9986544321 1223457888999998865 567889999999999999999999997544321111000 00000000
Q ss_pred -------ccccchhhcccccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 -------KRKIFRIIDNRLEGQY-----TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 -------~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..-...+..+...... ....+..+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000000 0123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=298.56 Aligned_cols=264 Identities=24% Similarity=0.287 Sum_probs=200.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||.|+||.||+|. +..++..|++|++..... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAK---------DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEE---------ECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 58889999999999999954 344688999999876542 2346788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+ +++|.+++.... .++++..++.++.||+.+|+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence 9999999999 999999987644 46899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh---
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA--- 306 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--- 306 (404)
+........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|.++|........ .........
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~ 221 (286)
T cd07832 146 ARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPN 221 (286)
T ss_pred cccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCC
Confidence 886543321 12233568899999998865 4468899999999999999999888865432110 000000000
Q ss_pred --------hccccchhhcccc----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 --------SKRKIFRIIDNRL----EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 --------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.......+..... ...........+.+++.+||..||++||++++++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 000111234788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.23 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=219.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
+......||.|.||.||.|+|+.. .-.||||.++.+. ...++|+.|+.+|+.++|||+|+++++|..+.-
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred heeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 344567899999999999998764 3569999987764 556899999999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
+|||+|||..|+|.+|+.+..+ ..++...+++++.||..|+.||. .+++|||||...|+||.++..||++|||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999988654 56788889999999999999999 8999999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ ......-...|.|||-+.-..++.++|||+||++|||+.| |-.||.+.+ ...+
T Consensus 414 lMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqV 475 (1157)
T KOG4278|consen 414 LMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQV 475 (1157)
T ss_pred hhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHH
Confidence 86443221 1111122457999999998999999999999999999988 777876532 2234
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
..++++..+-+.+..|+..+.+|++.||+.+|.+||+++|+-+.|+.+...+.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 56666666667777889999999999999999999999999999998776544
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.02 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=206.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+|++.+.||.|++|.||++ .+..++..|++|++..... .....+.+|+..+..++|+||+++++++..+.
T Consensus 2 ~~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred cceeeeeeeecCCeEEEEE---------EEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 6888999999999999995 4445788999999877654 34567889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
..+++|||+++++|.+++... ..+++..++.++.|++.+|+||| + .+++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999999765 45899999999999999999999 8 9999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~------------ 212 (264)
T cd06623 147 SKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM------------ 212 (264)
T ss_pred ceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH------------
Confidence 8865433221 12346788999999998888999999999999999999999999765431111111
Q ss_pred cchhhcccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLE-GAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+... .....+.. .+..+.+++.+||..+|++||++.++++.
T Consensus 213 -~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 213 -QAICDG-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -HHHhcC-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111 11122223 56688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=298.01 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=199.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||++.. ..+++.+++|++..... ...+.+.+|+++++.++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRH---------KGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEE---------cCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 3688899999999999999654 34678899999865422 23456788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+...++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999999999765 35899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~------- 207 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIY------- 207 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHH-------
Confidence 998865432 23346889999999998888899999999999999999999999754311 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
..+.... ..++......+.+++.+||+.||.+|+ +++++++
T Consensus 208 ---~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 208 ---EKILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---HHHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0011111 122233356788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=298.22 Aligned_cols=261 Identities=28% Similarity=0.342 Sum_probs=201.2
Q ss_pred HHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceE
Q 046897 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKL 143 (404)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~ 143 (404)
.++....++|.+.+.||+|+||.||++. ...++..+++|++.... .....+.+|+.+++.+ +|||++++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~---------~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~ 84 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVT---------NKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF 84 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEE---------ECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 4444557889999999999999999954 44468899999986542 2235677899999998 79999999
Q ss_pred EEEEEeC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 144 VGYCLED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 144 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
++++... ...++||||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~ 162 (291)
T cd06639 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEc
Confidence 9998754 3589999999999999988754333356899999999999999999999 88999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC-----CCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-----HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
.++.++|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||....+..
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 999999999999876433221 12234688899999987543 36889999999999999999999997543211
Q ss_pred Ccchhhhhhhhhhhccccchhhccc-ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNR-LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. . ..+.... .....+......+.+++.+||+.+|++||++.++++.
T Consensus 241 ~--~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 T--L--------------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H--H--------------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 0000000 0001122334568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=291.26 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=191.6
Q ss_pred CcccccCcccEEEEEecCccccc-ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAA-TKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
+.||+|+||.||+|.+....... ........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999998876422110 01222346788877655433 5778899999999999999999999988 778999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-------cEEEeccc
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-------NAKLSDFG 229 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-------~vkl~Dfg 229 (404)
|||+++++|.+++..... .+++..++.++.||+.||+||| +.+|+|+||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999987542 5889999999999999999999 89999999999999999888 79999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccC--CCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG--HLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||........ .. .+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~---~~~- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER---FYQ- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH---HHh-
Confidence 9886433 1223466789999998766 78999999999999999999 5777765432110 00 000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.. . ..+......+.+++.+||..+|.+||++.++++.|+
T Consensus 221 ~~---------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ---------H---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC---------C---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 001111267889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.33 Aligned_cols=260 Identities=27% Similarity=0.329 Sum_probs=201.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED- 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 150 (404)
+|...+.||.|++|.||++.. ..++..+++|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEE---------CCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 577889999999999999654 34678899999875433 3346688999999999999999999998654
Q ss_pred -CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 -DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
..+++||||+++++|.+++.........++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeecc
Confidence 4689999999999999987654333356889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC--CCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS--GEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 307 (404)
++....... .....++..|++||.+.+..++.++||||||+++|+|++|..||...... ...+...+...
T Consensus 151 ~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 222 (287)
T cd06621 151 VSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---- 222 (287)
T ss_pred ccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----
Confidence 987543222 12345788899999998889999999999999999999999999765331 11111111110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.....+.+ .. .........+.+++.+||..+|.+|||+.|+++.
T Consensus 223 -~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 223 -MPNPELKD-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CCchhhcc-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00000000 00 1111245678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=296.61 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=203.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|.+.+.||.|+||.||++. +..++..+++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAI---------DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEE---------EcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 3689999999999999999964 3345778999998765555556788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..|+|+||+++++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~ 161 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999999999998653 4788899999999999999999 89999999999999999999999999998
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.........
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~----------- 228 (293)
T cd06647 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------- 228 (293)
T ss_pred eeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-----------
Confidence 875433221 2233468889999999988889999999999999999999999997543321100000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
................+.+++.+||..+|++||++.+++..
T Consensus 229 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 ----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111122345568899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=293.93 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=202.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|+..+.||.|+||.||++. +..++..+++|.+..... ...+.+.+|+.+++.+.||||+++++.+..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVL---------HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEE---------EcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 357788999999999999954 444678899998876532 3345688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
...++++||+.+++|.+++.... ..+++..+..++.|++.+|.||| + .+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d~g 146 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFG 146 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997653 46889999999999999999999 7 899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
.+....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 147 ~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~------- 214 (265)
T cd06605 147 VSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQ------- 214 (265)
T ss_pred cchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHH-------
Confidence 987543221 1125688899999999888999999999999999999999999975432111 1111111
Q ss_pred ccchhhcccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLE-GAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..... ...+.. ....+.+++.+||..||++|||+.+++..
T Consensus 215 ---~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 215 ---YIVNEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---HHhcCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111111 112222 56678899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=300.46 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=200.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+|.+.+.||+|+||.||++. +..++..|++|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~---------~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVR---------HKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEE---------ECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368889999999999999954 445678999998876532 22346778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeC
Confidence 9999999999999999999997653 5889999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCC-------------CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 229 GLAKDGPTGDQ-------------SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 229 g~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
|+++....... ........++..|+|||.+.+..++.++||||||+++|||++|..||......
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--- 222 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--- 222 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 98863211100 00111245788899999998888999999999999999999999999653221
Q ss_pred chhhhhhhhhhhccccchhhccccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLE-GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.... ........ .......+..+.+++.+||+.||++||++.++++.|+.
T Consensus 223 ---~~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 ---ELFG----------QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---HHHH----------HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000 00000000 01111245567899999999999999998777777664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=296.55 Aligned_cols=264 Identities=24% Similarity=0.333 Sum_probs=195.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||.|++|.||+|.. ..++..|++|.+...... ....+.+|+.+++.++|+||+++++++..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRS---------KLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEE---------cCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 5788999999999999999643 346788999998654322 224567899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECcccc
Confidence 99999999996 59999887654 36789999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS-- 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 307 (404)
++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ............
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 225 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPT 225 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCC
Confidence 875422111 1122346788999998865 568899999999999999999999996543110 000000000000
Q ss_pred cccc------chh-------h-cccccCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKI------FRI-------I-DNRLEGQY-TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~------~~~-------~-~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.... ... . ...+.... .......+.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 000 0 00000000 0011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.17 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=198.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
.|.....||+|+||.||++. +..++..|++|.+........+.+.+|+.+++.++|+||+++++.+..++.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIAT---------EKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEE---------ECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 34445679999999999954 444678899999876555555678899999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 9999999999999998854 24788999999999999999999 8899999999999999999999999999987
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .. . +.
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~---~-------~~ 231 (292)
T cd06658 167 QVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MR---R-------IR 231 (292)
T ss_pred hcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---H-------HH
Confidence 5432221 12335688999999999888899999999999999999999999975332110 00 0 00
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
........ ........+..++.+||..||.+|||+.++++.
T Consensus 232 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 111234567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.12 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=203.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||.|+||.||+|.. ..++..+++|++..... .....+.+|+.+++.++|+||+++++.+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAIC---------LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEE---------cCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 4789999999999999999653 33578899999875432 2446788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++||++++++|.+++..... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccch
Confidence 999999999999999999976421 135889999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCc--ceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQSH--VSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+.......... ......|+..|++||.+... .++.++|+||||+++|+|++|+.||........ ...... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----~ 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----N 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc----C
Confidence 87654433221 22335688999999998766 788999999999999999999999975433211 000000 0
Q ss_pred ccccchhhcccccCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQY-TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
......... ....+..+.+++.+||+.||++||++.++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000010000 1234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.65 Aligned_cols=249 Identities=28% Similarity=0.399 Sum_probs=207.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
+.|+.-++||+|+||.||- |....+|+.||.|.+.+..... ....+.|-.+|.+++.++||.+--.|.
T Consensus 185 n~F~~~RvlGkGGFGEV~a---------cqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCA---------CQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred cceeeeEEEecccccceeE---------EEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 5678889999999999997 6666789999999886643322 234688999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+.+|+|+..|+||+|.-+|...++ ..+++..+..++.+|+.||++|| +.+||.|||||+|||+|+.|+++|+|+
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999988775 67999999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+|.....+.. ....+||.+|||||++.+..|+...|+|||||++|||+.|+.||.........
T Consensus 332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------- 395 (591)
T KOG0986|consen 332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------- 395 (591)
T ss_pred ceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------
Confidence 99998766543 33358999999999999999999999999999999999999999754322111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
+++.+.... -...++...+++..++.+..|..||++|.--+
T Consensus 396 eEvdrr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 EEVDRRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 111111111 11245566777889999999999999997543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=298.13 Aligned_cols=267 Identities=26% Similarity=0.338 Sum_probs=199.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+|. +..++..|++|.+.... ....+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~---------~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCR---------NKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEE---------eCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368889999999999999954 44467899999886542 2234678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..+++|||++++.+..+.... ..+++..++.++.||+.||.||| ..+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeee
Confidence 99999999999876666555432 34889999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh-hhhhh-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA-KPYLA- 306 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~- 306 (404)
++........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||............... .....
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 146 FARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224 (288)
T ss_pred cccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9886544332 122335678899999999877 8899999999999999999999999754321100000000 00000
Q ss_pred ------hccccc--hhhccc----ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 ------SKRKIF--RIIDNR----LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ------~~~~~~--~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...... ...+.. ....++...+..+.+++++||..+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000000 000112223677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=296.34 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=198.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-----GHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
+|.+.+.||.|+||.||+|.. ..++..|++|.+...... ....+..|+.+++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARD---------KETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEE---------CCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 478889999999999999643 445789999998765433 234567899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEcc
Confidence 9999999999999 899999997643 35899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.++|....+... .........
T Consensus 146 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~ 220 (298)
T cd07841 146 FGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALG 220 (298)
T ss_pred ceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcC
Confidence 999986543321 1222356788999998754 4678899999999999999999888865433211 000000000
Q ss_pred --------hccccchhhcccccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 --------SKRKIFRIIDNRLEG-----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 --------~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
............... .........+.+++.+||..||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000 111233567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=289.13 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=200.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.+.+.||+|+||.||+|.. ..++..|++|.+...... ..+.+..|+.+++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVN---------LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEE---------CCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 588899999999999999643 345788999998766443 456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++|+||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999987642 4788999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcc--eeeccccccccCccccccCC---CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 231 AKDGPTGDQSHV--STRVMGTYGYAAPEYLATGH---LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+........... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +...+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~ 218 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFH 218 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHH
Confidence 886543322111 12356788999999987665 888999999999999999999999753211 000000
Q ss_pred hhccccchhhcccccCCCCH--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTL--EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... ......+. .....+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VGA---------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred Hhc---------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00111111 23566789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=300.01 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=198.3
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCee
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
|.....||.|+||.||++. +..++..|++|.+........+.+.+|+.+++.++||||+++++.+..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAR---------EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEE---------EcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 4445679999999999954 4446788999998765555556788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
+++|||+++++|..++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~ 166 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence 999999999999987754 24789999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ..... .
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~------ 231 (297)
T cd06659 167 ISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLR----D------ 231 (297)
T ss_pred cccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh----c------
Confidence 432211 12335688999999999888899999999999999999999999975332110 00000 0
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... ..........+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 232 SPPPK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 01111234567899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.45 Aligned_cols=272 Identities=21% Similarity=0.239 Sum_probs=198.4
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+|.+.+.||+|+||.||+|.... ...+..||+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecC-------CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 47888999999999999975432 1267899999987732 3334667889999999999999999999998
Q ss_pred C--CeeEEEEeccCCCChHHHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC----CCc
Q 046897 150 D--DHRLLVYEFMPRGSLENHLFRRGSYF-QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT----NYN 222 (404)
Q Consensus 150 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~----~~~ 222 (404)
. ...++||||++ ++|.+++....... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccce
Confidence 8 78999999995 57777775443322 36899999999999999999999 899999999999999999 999
Q ss_pred EEEecccCCCCCCCCCC-CcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh--
Q 046897 223 AKLSDFGLAKDGPTGDQ-SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV-- 298 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~-- 298 (404)
+||+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999886533222 111233467889999998765 45889999999999999999999999765443210000
Q ss_pred ----hhhhhhh-----------hhccccchhhcccccCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHH
Q 046897 299 ----EWAKPYL-----------ASKRKIFRIIDNRLEGQYT---------L--EGAYKAATLALRCLSTEGKFRPMMAEV 352 (404)
Q Consensus 299 ----~~~~~~~-----------~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~ei 352 (404)
......+ ..........+.......+ . .....+.+++.+||+.||++|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0000000 0000000000000000111 0 233468899999999999999999999
Q ss_pred HH
Q 046897 353 VT 354 (404)
Q Consensus 353 l~ 354 (404)
++
T Consensus 311 l~ 312 (316)
T cd07842 311 LE 312 (316)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=293.44 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=201.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+|++.+.||.|+||.||++. +..++..+++|.+..... ...+.+.+|++++++++||||+++++.+.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQ---------KRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEE---------EccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 57888999999999999954 444688999999876432 234678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++|+||+.+++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeecc
Confidence 99999999999999999999765 36889999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ..
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~------- 211 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IR------- 211 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HH-------
Confidence 988654332 1233568889999999988889999999999999999999999998654321100 00
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM--AEVV 353 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil 353 (404)
..... .....+...+..+.+++.+||+.||.+||++ .+++
T Consensus 212 ---~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 ---AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00000 1123334455788899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=294.96 Aligned_cols=247 Identities=28% Similarity=0.393 Sum_probs=196.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
+.|.+.+.||.|+||.||+|.. ..++..|++|.+...... ..+.+.+|+.+++.++||||+++.+++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARD---------VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEE---------cCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 5688899999999999999644 346789999988654322 2346789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..++||||+. |+|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeec
Confidence 9999999999995 67777776443 35899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++...... ....++..|+|||++. ...++.++||||||+++|||++|..||........ .
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~---- 223 (307)
T cd06607 160 GSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L---- 223 (307)
T ss_pred CcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------H----
Confidence 998754322 2345788999999874 45688899999999999999999999865332110 0
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+.............+..+.+++.+||+.||++||++.+|+..
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 224 ------YHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ------HHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000001122345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=308.65 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=213.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
...+.++||+|.||.|++|.|.. -.++-..||||.+..+... ....|++|+.+|.+|+|+|++++|++..+ .
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~------psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQ------PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccC------CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34456889999999999998864 2344567999999887655 55789999999999999999999999987 6
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
.+.+|||.++.|+|.+.|.+.. ...|....+..++.||+.||.||. .+++|||||...|+|+.....|||+|||+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeeeecccce
Confidence 7889999999999999998832 256888889999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCccee-eccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 232 KDGPTGDQSHVST-RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 232 ~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+.+...+....+. .......|+|||.+....++.++|||+||+++|||++ |..||-+....
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------- 322 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------- 322 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------------
Confidence 9876655443332 3445678999999999999999999999999999999 77798765421
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
.|.+.+|..-+...+..+++++++++..||..+|.+||++..|.+.+
T Consensus 323 qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 323 QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 23333444444456777899999999999999999999999997443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=297.28 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=197.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+|.. ..+++.|++|++...... ..+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKH---------KETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEE---------CCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 3688899999999999999544 446789999987654322 23567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++||||++++.|..+.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeee
Confidence 99999999999988888776543 34899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc-chhhhhh-----
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH-NLVEWAK----- 302 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~-~~~~~~~----- 302 (404)
++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|++||......... ....+..
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 146 FARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223 (286)
T ss_pred eeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence 9876433221 2233467889999998865 45788999999999999999999999643321000 0000000
Q ss_pred --hhhhhccccchhhccccc-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 --PYLASKRKIFRIIDNRLE-----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...........+..+... .......+..+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000000000 0011133567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=287.00 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=205.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.+.+.||.|+||.||++.. ..++..+++|++..... .....+.+|+++++.++|+|++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRR---------KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEE---------cCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 578889999999999999543 44678999999876543 3446788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++++||+++++|.+++.........+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999999875433357899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~-------- 213 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELAL-------- 213 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHH--------
Confidence 97654432 1233456889999999988888999999999999999999999999654311 0000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.... ......+......+.+++.+||..+|++||++.++++
T Consensus 214 --~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 214 --KILK-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --HHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0010 1111223344567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=289.76 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=199.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
-|+..+.||.|+||.||+|.. ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGID---------NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEE---------CCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 477788999999999999643 34578999998865432 23356788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+++++|.+++... .+++..+..++.|++.++.+|| ..+++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence 999999999999999988642 4789999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-------- 212 (277)
T cd06641 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-------- 212 (277)
T ss_pred eecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH--------
Confidence 75433221 1223467889999999988888999999999999999999999996532210 0000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+............+..+.+++.+||+.+|.+||++.++++.
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 ---IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001112223345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=334.29 Aligned_cols=253 Identities=28% Similarity=0.377 Sum_probs=204.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
-++.....||.|.||.||. +....+|...|+|.++...- ...+.+.+|..+|..++|||+|+++++-.+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYt---------avN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYT---------AVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred eeeccccccCCcceeeeEE---------eecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 4677788999999999998 56667899999998865432 223557889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.+..+|.||||.+|+|.+.+...+ ..++.....+..|++.|++||| +.+||||||||+|||++.+|-+|++|||
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeeccc
Confidence 999999999999999999997654 3667777788899999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCC--CcceeeccccccccCcccccc---CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 230 LAKDGPTGDQ--SHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 230 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
.|........ ........||+.|||||++.+ .....+.|||||||++.||+||+.||...+.. |+.-|
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy 1452 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMY 1452 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHh
Confidence 9987544321 122345789999999999965 45677999999999999999999999764432 22222
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
-... .-..+.+...+.+-.+++.+||+.||++|+++.++++.
T Consensus 1453 ~V~~---------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAA---------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhc---------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2111 22234555566777899999999999999999877764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=288.15 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=204.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||.|+||.||++. +..++..+++|.+..... .....+.+|+++++.++|+||+++.+++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVK---------RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEE---------ECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 47888999999999999953 445678899999875432 2335678899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++.........+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999998774433356899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||....... ..
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~--------- 210 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LR--------- 210 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH---------
Confidence 9865443 1223457889999999988889999999999999999999999997543210 00
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...........+.....++.+++.+||+.+|++||++.++++
T Consensus 211 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 211 --YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000111112233456677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=283.71 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=203.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
+|...+.||+|++|.||++.. ..++..+++|++........+.+.+|+.+++.++|+||+++++.+..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARH---------KRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEE---------CCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 477889999999999999544 34678899999987655456788999999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++++||+++++|.+++.... ..+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 999999999999999987653 46899999999999999999999 8999999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
....... .....++..|++||.+.+..++.++|+||||+++|+|++|+.||........ .... ......
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~~~ 215 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKI-----ATNGPP 215 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHH-----HhcCCC
Confidence 7544332 2345688899999999888889999999999999999999999975431100 0000 000000
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ..........+.+++.+||+.||++|||+.++++
T Consensus 216 ~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 216 G-------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred C-------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0111112567889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.02 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=199.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
+|...+.||+|++|.||++. +..++..+++|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIAT---------DKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEE---------ECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 45556899999999999954 344678899999876555555678899999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++++||+.+++|.+++... .+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+.
T Consensus 91 ~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEEEEeccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence 99999999999999998762 4788999999999999999999 8999999999999999999999999999887
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...++. .......
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~------- 228 (285)
T cd06648 164 QVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR------- 228 (285)
T ss_pred hhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-------
Confidence 5432211 123356889999999998888999999999999999999999999653321 1000000
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
....... ......+..+.+++.+||..+|++||++.++++
T Consensus 229 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 229 DNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred hcCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0000000 111124467889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=285.46 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=205.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|...+.||+|++|.||+|.. ..++..+++|++..... ...+.+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALD---------KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEE---------CCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 477889999999999999644 44678999999876543 3356788999999999999999999999988
Q ss_pred --CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 151 --DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
...++++||+++++|.+++.... .+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 88999999999999999997653 6899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|.+................++..|++||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~--------- 211 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MA--------- 211 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HH---------
Confidence 9988654433211133456888999999998888999999999999999999999999764410 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
....+.........+......+.+++.+||+.||++||++.++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 212 -ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 001111111122334444678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=292.63 Aligned_cols=267 Identities=23% Similarity=0.279 Sum_probs=194.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|++.+.||+|+||.||+|. +..++..|++|++....... ...+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGI---------SRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEE---------EcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4679999999999999999954 44467889999986543222 2456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...|+||||+. ++|.+++.... ..+.+..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEeccc
Confidence 999999999995 68877775433 34778888999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh---h--
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK---P-- 303 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~---~-- 303 (404)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.............|.. +
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 149 LARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred cccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 9875432211 1233457889999999865 457889999999999999999999997543211000000000 0
Q ss_pred -----hhhhccccchhhcccccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 -----YLASKRKIFRIIDNRLEGQY-----TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.................... .......+.+++.+||..||.+|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000000 0012456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=289.21 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=197.5
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCC---CCCcceEEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLY---HPNLVKLVGYCL 148 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~ 148 (404)
.|+..+.||.|+||.||+|. +..++..+++|.+.... ......+.+|+.+++.+. |||++++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGK---------HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEE---------EcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47788999999999999954 44467899999987542 233456788999999886 999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+...+++|||+++++|.+++... .+++..++.++.|++.+|.||| +.+|+|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccC
Confidence 999999999999999999988643 5889999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----------- 212 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----------- 212 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----------
Confidence 99886543321 2233468889999998764 457889999999999999999999997543211100
Q ss_pred ccccchhhcccccCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTL-EGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.....+ .... .....+.+++.+||+.||++||++.++++.
T Consensus 213 --~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 --LIPKSKPP----RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --ccccCCCC----CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00000001 1111 134578899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=293.38 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=197.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.|...+.||+|+||.||++.. ..++..+++|.+..... .....+.+|+.+++.++|||++++++++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~---------~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARD---------VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEE---------cCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 377788999999999999644 34678899999875432 223467889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+. |+|.+.+.... .++++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCC
Confidence 999999999996 57877776543 45899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
++..... .....++..|+|||.+. +..++.++|||||||++|+|++|+.||........
T Consensus 171 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------------ 232 (317)
T cd06635 171 SASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------ 232 (317)
T ss_pred CccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------------
Confidence 9875432 22346888999999873 45688899999999999999999999865321100
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
+..+................+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus 233 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 233 ----LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01111111111122234557889999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=293.98 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=197.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|.+.+.||.|+||.||+|. ...++..+++|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRAR---------DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEE---------ECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 578889999999999999954 4446788999998754322 22356789999999999999999999987
Q ss_pred C--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 150 D--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 150 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
. ...|+||||+. ++|.+++.... ..+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEee
Confidence 7 88999999996 59999887654 35899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh-------
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE------- 299 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~------- 299 (404)
||++........ ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.............
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 150 FGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred cCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 999886543221 12234578899999988654 46889999999999999999999997543221110000
Q ss_pred ---hhh--hhhh-hccccchhhcccccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 300 ---WAK--PYLA-SKRKIFRIIDNRLEGQYTLE-GAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 300 ---~~~--~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
|.. .... ............+...++.. ....+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0000 00000000001111112211 3566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=289.67 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=203.6
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+.|...+.||+|++|.||+|... ..+..+++|++..... ..+.+.+|+++++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDR---------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEc---------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 3567888899999999999996543 3578899999876543 45678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++++||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999999999999998754 36899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||....+... . .
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~---~---~------- 226 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA---L---F------- 226 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH---H---H-------
Confidence 8875433221 12234578899999999888899999999999999999999999864322100 0 0
Q ss_pred ccchhhccccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 310 KIFRIIDNRLE-GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+...... .......+..+.+++.+||+.+|.+||++.++++
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 227 ---LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00000010 0111224567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=291.71 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=195.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||.|+||.||+|. +..++..|++|.+..... .....+.+|++++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEE---------ECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 48889999999999999954 444678999998875432 2235688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+. ++|..++..... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999995 689888865432 46889999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS-- 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 307 (404)
+........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .........-..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~ 222 (284)
T cd07860 147 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDE 222 (284)
T ss_pred hhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 875432221 12233568889999987654 46889999999999999999999996543211 000000000000
Q ss_pred ------------ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 ------------KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
............. .........+.+++.+||+.||.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 223 VVWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.49 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=208.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
...|.+.+.||+|.|++|.+ +++..++..||+|.+.+.... ....+.+|++++..|+|||||+++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~L---------a~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKL---------ARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEe---------eEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 46799999999999999998 566668999999999876332 2345789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
....+|+||||+.+|.+.+++.+.+. ..+..+..++.|++.|++||| ++.|+|||||.+|||++.+..+||+||
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeecc
Confidence 99999999999999999999998864 556888999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++.....+ ......+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||++......
T Consensus 200 gfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------- 263 (596)
T KOG0586|consen 200 GFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------- 263 (596)
T ss_pred ccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------
Confidence 999876533 35667899999999999988776 5689999999999999999999987543222
Q ss_pred ccccchhhcccccC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEG--QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..+.+ ..+.....++.++|+++|..+|.+|+++.++.+.
T Consensus 264 -------r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 -------RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -------cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1112211 2223345577899999999999999999988765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=286.03 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=195.8
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||.|+||.||++. ...++..+++|++..... ...+.+.+|+.+++.++||||+++++.+.++...+++
T Consensus 1 lg~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVK---------VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEE---------ECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 7999999999954 444678999999875432 2335688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++.+.. .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 72 MEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred EecCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 99999999999997653 4889999999999999999999 89999999999999999999999999999987544
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. ......++..|++||.+.+..++.++|+||||+++|+|++|..||...... ..... ..+..
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----------~~~~~ 208 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIY----------NDILK 208 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHH----------HHHhc
Confidence 32 123346888999999988888999999999999999999999999765421 01111 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.......+......+.+++.+||+.+|++||+ +.|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 209 GNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11112333334678899999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.31 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=197.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|++.+.||+|+||.||+| .+..++..|++|.+... .......+.+|+.+++.++|+||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAA---------YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEE---------EECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 4578999999999999999995 44557889999998643 223345677899999999999999999988
Q ss_pred EeC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 148 LED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 148 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
... ...|+||||+ .++|.+.+... ++...+..++.|++.||+||| ..+|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~ 155 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELM-DANLCQVIQMD------LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 155 (353)
T ss_pred ccCCCccccCcEEEEEecc-CCCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCC
Confidence 644 3579999999 45888877532 788899999999999999999 88999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh---
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV--- 298 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~--- 298 (404)
.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 156 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 156 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred CEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999999998643321 122346788999999999999999999999999999999999999654321100000
Q ss_pred ------hh-------hhhhhhhcc-----ccchhhccccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 ------EW-------AKPYLASKR-----KIFRIIDNRLE----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ------~~-------~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+ ...+..... ....+...... ..........+.+++.+||+.||++|||+.++|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000000 00000000000 00011235567899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=288.95 Aligned_cols=242 Identities=28% Similarity=0.404 Sum_probs=190.4
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||+|+||+||++ .+..++..|++|.+..... .....+..|+++++.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCAC---------QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEE---------EEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 689999999984 4445688999998865322 2234467899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred EecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999999999999976542 46899999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. ......++..|++||.+.+..++.++||||||+++|+|++|+.||............. . ....
T Consensus 148 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~----------~~~~ 212 (277)
T cd05577 148 GK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--R----------RTLE 212 (277)
T ss_pred CC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--h----------cccc
Confidence 11 1223457788999999988889999999999999999999999997544321111000 0 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 351 (404)
.....+...+..+.+++.+||+.||.+||+.++
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 011223334667889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=278.24 Aligned_cols=253 Identities=26% Similarity=0.266 Sum_probs=199.5
Q ss_pred HhcCCCCC-CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 70 ATRNFRPD-SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
.+++|.+. ++||-|-.|+|.. |.++.+++.+|+|++... ....+|+++.-.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~---------C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQ---------CVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEE---------EEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 45667664 6899999999987 777789999999988654 4456777765444 699999999998
Q ss_pred EeC----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---C
Q 046897 148 LED----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---N 220 (404)
Q Consensus 148 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~ 220 (404)
... ..+.+|||.++||.|...++.++. ..+++..+..|++||..|+.||| +.+|.||||||+|+|.+. |
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCC
Confidence 643 467899999999999999998875 67999999999999999999999 899999999999999964 5
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
..+||+|||+|..... .......+-||.|.|||++....|+..+|+||+|+++|-|++|.+||........ ...
T Consensus 201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spg 274 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPG 274 (400)
T ss_pred cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---Chh
Confidence 5699999999987543 2234567899999999999999999999999999999999999999965432110 000
Q ss_pred hhhhhhhccccchhhcccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRL--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. -.++..... ........++...++|+.+|..+|.+|.|+.++++.
T Consensus 275 M---------k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 275 M---------KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred H---------HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 001111111 112224567788999999999999999999998764
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=286.51 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=199.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.+.+.||.|+||.||+|.. ..++..+++|.+..... ...+.+.+|+.+++.++|+||+++++.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKA---------KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEE---------cCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 478889999999999999654 44678899999865422 2345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc-EEEeccc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-AKLSDFG 229 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~-vkl~Dfg 229 (404)
...++++||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++. ++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccc
Confidence 999999999999999999976432 35789999999999999999999 889999999999999998865 6999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
.+........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~------- 212 (257)
T cd08225 148 IARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL------- 212 (257)
T ss_pred cchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH-------
Confidence 9876543221 222346888999999998888999999999999999999999998643211 1111
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....... ..........+.+++.+||..+|++|||+.++++.
T Consensus 213 ---~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 213 ---KICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---HHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111 11122334578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=292.22 Aligned_cols=267 Identities=22% Similarity=0.256 Sum_probs=194.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLY-HPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||+|. +..++..|++|.+..... .....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKAR---------DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEE---------ECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368899999999999999954 444688999998765422 22356788999999995 699999999998
Q ss_pred eCCe-----eEEEEeccCCCChHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CC
Q 046897 149 EDDH-----RLLVYEFMPRGSLENHLFRRGSY-FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NY 221 (404)
Q Consensus 149 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~ 221 (404)
..+. .|++|||+++ +|.+++...... ...+++..++.++.||+.||.||| +.+|+||||+|+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCC
Confidence 7665 8999999965 898888654322 346899999999999999999999 899999999999999998 89
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... ...
T Consensus 149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~ 224 (295)
T cd07837 149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHI 224 (295)
T ss_pred eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH
Confidence 999999999875432211 1122356788999998754 46789999999999999999999999754321100 000
Q ss_pred hhhhhhh-ccccchh---hc----cccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLAS-KRKIFRI---ID----NRLE----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~-~~~~~~~---~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
....... ....... .. +... ..........+.++|.+||..||.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000000 00 0000 0011224567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=291.98 Aligned_cols=257 Identities=26% Similarity=0.334 Sum_probs=193.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLY-HPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 150 (404)
+|...+.||+|+||.||++ .+..++..+++|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKM---------LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEE---------EECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 4556788999999999995 4445688999999875432 23456788999999996 99999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRR-GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
...+++|||+. ++|.++.... ......+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 99999999984 4665543221 1112468999999999999999999993 3589999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccC---CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG---HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
++....... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ........
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~-- 223 (288)
T cd06616 154 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQV-- 223 (288)
T ss_pred hhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhh--
Confidence 987543222 11234578899999998765 688999999999999999999999975321 00000000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.....+.+........+..+.+++.+||+.||++|||+.+|++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 -----VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111112222355678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=288.28 Aligned_cols=243 Identities=27% Similarity=0.353 Sum_probs=186.7
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHH---hcCCCCCcceEEEEEEeCCe
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYL---GQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l---~~l~hp~iv~~~~~~~~~~~ 152 (404)
+||+|+||.||++. +..++..+|+|.+....... ...+.+|..++ ...+||||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEE---------ECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999954 44568899999886543211 12234444333 34479999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+|+||||+|||++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 999999999999999887653 5899999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
...... .....|+..|+|||.+. +..++.++|||||||++|+|++|..||............
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~------------- 208 (279)
T cd05633 146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------- 208 (279)
T ss_pred eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH-------------
Confidence 543221 12346899999999886 456899999999999999999999999754322111000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
... .......+...+..+.+++.+||..||.+|| ++.++++.
T Consensus 209 -~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 -RMT-LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -HHh-hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 0111123344566788999999999999999 58887664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.16 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=198.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+|++.+.||.|++|.||+|. +..++..|++|++...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGR---------NRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEE---------ECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 58889999999999999954 4446889999998765332 3356778999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+. ++|.+++..... ...+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999996 588888865442 245899999999999999999999 889999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh-hhh-hhhh---
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV-EWA-KPYL--- 305 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~-~~~-~~~~--- 305 (404)
....... .......++..|++||.+.+ ..++.++||||||+++|+|++|+.||............ ... .+..
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 7543221 11223457889999998755 45788999999999999999999999754332110000 000 0000
Q ss_pred hhccccchhhcccc------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRL------EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.............. ........+..+.+++.+||+.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 00111233567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=287.79 Aligned_cols=268 Identities=22% Similarity=0.280 Sum_probs=204.0
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--CC----Ccc
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY--HP----NLV 141 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp----~iv 141 (404)
.....+|.+...+|+|+||+|-.++. ..++..||+|+++... ...+..+-|+++|.++. .| -++
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D---------~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWD---------RETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred cccccceehhhhhcCCcccceEEEee---------cCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 34478999999999999999998554 4457899999987643 33456778999999994 23 378
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC--
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-- 219 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-- 219 (404)
++.++|...++.|||+|.+ |-++.+++..+. ..+++...+..+++|++.++++|| +.+++|.||||+|||+..
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccc
Confidence 8889999999999999999 779999997644 478999999999999999999999 899999999999999832
Q ss_pred ------------------CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh
Q 046897 220 ------------------NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281 (404)
Q Consensus 220 ------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~ 281 (404)
+..|+|+|||.|+..... ....+.|..|+|||++.+-+|+.++||||+||||+|+.+
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 335899999999864321 255788999999999999999999999999999999999
Q ss_pred CCCCcCCCCCCCCcchhhhhh--------------hhhhhc----------cccchhhcccc----cCCCCHHHHHHHHH
Q 046897 282 GRRAVDKNRPSGEHNLVEWAK--------------PYLASK----------RKIFRIIDNRL----EGQYTLEGAYKAAT 333 (404)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~----------~~~~~~~~~~~----~~~~~~~~~~~l~~ 333 (404)
|...|...+..+...+++.+. .++... +......+... .-.....+...|++
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999998765332222221111 000000 00000000000 00122345668999
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 046897 334 LALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 334 li~~cl~~dP~~RPs~~eil~~ 355 (404)
|+++||..||.+|+|+.|+|..
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=303.14 Aligned_cols=275 Identities=24% Similarity=0.340 Sum_probs=209.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC-
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD- 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 151 (404)
|...+.||+|+||.||+|+ ++.+|+.||||.++... ....++..+|+++|++|+|+|||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgr---------nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGR---------NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeec---------ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4556789999999999965 44589999999998753 334467789999999999999999998866543
Q ss_pred -----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc--CCCc--
Q 046897 152 -----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD--TNYN-- 222 (404)
Q Consensus 152 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~--~~~~-- 222 (404)
...+|||||.+|+|...+.+-. +...+++...+.++.++..||.||| .++|+||||||.||++. .+|+
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceE
Confidence 4579999999999999997644 4467999999999999999999999 89999999999999994 3344
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.||+|||.|+...... .....+||+.|++||+.. .+.|+..+|.|||||++|+++||..||...........+.|.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 6999999999875544 577789999999999998 488999999999999999999999999765443322222221
Q ss_pred hhhhhhccccc---hhhccc--------ccCCCCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHhhHhcc
Q 046897 302 KPYLASKRKIF---RIIDNR--------LEGQYTLEGAYKAATLALRCLSTEGKFRP--MMAEVVTVLEQLQDSS 363 (404)
Q Consensus 302 ~~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~eil~~L~~~~~~~ 363 (404)
...-.....+- .-.+.. ....+.......+..++..+|+.+|++|. ...++...+..|....
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 11100000000 000000 11223345566788999999999999999 7777777777666543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=287.94 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=191.8
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC-
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLY-HPNLVKLVGYCLED- 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~- 150 (404)
|++.+.||+|+||.||+|. +..++..+++|.+..... .......+|+.++.++. |+||+++++++.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~---------~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQ---------SRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEE---------EcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6678899999999999954 444678899998875421 22234457888898885 99999999999987
Q ss_pred -CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 -DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..++||||+. ++|.+.+.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 88999999996 58888876543 35899999999999999999999 899999999999999999 999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++........ .....++..|+|||.+. +..++.++|||||||++|||++|..||...+... ............
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~ 218 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTP 218 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCC
Confidence 9986533221 12345788999999764 4557889999999999999999999997643311 111111000000
Q ss_pred -cccchh------hccccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 -RKIFRI------IDNRLE-------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 -~~~~~~------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+... .+.... .......+..+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 000000 0011234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.55 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=191.3
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.....+|+.+++||+||||.||++ +.+-+|+.||||++.... ......+.+|++.|.+|+|||||+++..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysA 545 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSA 545 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehh
Confidence 345567888999999999999994 555579999999997763 2333568999999999999999999754
Q ss_pred EEe-----------------------------------------------------------------------------
Q 046897 147 CLE----------------------------------------------------------------------------- 149 (404)
Q Consensus 147 ~~~----------------------------------------------------------------------------- 149 (404)
|.+
T Consensus 546 WVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~de 625 (1351)
T KOG1035|consen 546 WVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDE 625 (1351)
T ss_pred hhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccc
Confidence 321
Q ss_pred ----------------------------------C--------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHH
Q 046897 150 ----------------------------------D--------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187 (404)
Q Consensus 150 ----------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i 187 (404)
+ ..+||.||||+..+|.+++...... -.....|.+
T Consensus 626 dg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrL 702 (1351)
T KOG1035|consen 626 DGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRL 702 (1351)
T ss_pred cccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHH
Confidence 0 1247899999887777777654311 146788999
Q ss_pred HHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC----------------CCCCCcceeecccccc
Q 046897 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP----------------TGDQSHVSTRVMGTYG 251 (404)
Q Consensus 188 ~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~ 251 (404)
+++|+.||+|+| +.+||||||||.|||+++++.|||+|||+|.... .+......+..+||..
T Consensus 703 FreIlEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTal 780 (1351)
T KOG1035|consen 703 FREILEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTAL 780 (1351)
T ss_pred HHHHHHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceee
Confidence 999999999999 8999999999999999999999999999998611 0011113445789999
Q ss_pred ccCccccccC---CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhccccc--CCCCHH
Q 046897 252 YAAPEYLATG---HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLE--GQYTLE 326 (404)
Q Consensus 252 y~aPE~~~~~---~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 326 (404)
|+|||++.+. .|+.|+|+||||++++||+. ||....+ ....+..+.+..+. ..+...
T Consensus 781 YvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME---------------Ra~iL~~LR~g~iP~~~~f~~~ 842 (1351)
T KOG1035|consen 781 YVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME---------------RASILTNLRKGSIPEPADFFDP 842 (1351)
T ss_pred eecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH---------------HHHHHHhcccCCCCCCcccccc
Confidence 9999999764 49999999999999999986 4543211 01111122222221 122333
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 327 GAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 327 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
....-..+|++||+.||.+|||+.|+|+
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 4445668999999999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=283.15 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=194.1
Q ss_pred HHHHHHHhcCCCCCCcc--cccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCc
Q 046897 64 FSDLKTATRNFRPDSVL--GEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNL 140 (404)
Q Consensus 64 ~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 140 (404)
+.+.....++|.+.+.+ |.|+||.||++ .+..++..+++|.+........ |+.....+ +||||
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~i 71 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVL---------KHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNF 71 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEE---------EEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCE
Confidence 34455556778887776 99999999984 4555788999999876432221 22222222 69999
Q ss_pred ceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 141 VKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 141 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+++++.+..++..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRA 145 (267)
T ss_pred EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCC
Confidence 999999999999999999999999999997653 6899999999999999999999 8899999999999999999
Q ss_pred C-cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 221 Y-NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~-~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
+ .++|+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|+.||....... .....
T Consensus 146 ~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~ 218 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES 218 (267)
T ss_pred CCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH
Confidence 8 9999999998754321 22458889999999988889999999999999999999999997443221 11111
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-MAEVVT 354 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 354 (404)
+... .... .......+..+.+++.+||+.+|.+||+ +.++++
T Consensus 219 ~~~~-----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 219 LLKR-----------QQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHh-----------hccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1110 0000 1122245667889999999999999995 688874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=329.43 Aligned_cols=265 Identities=30% Similarity=0.495 Sum_probs=208.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
...|...++||+|+||.||+|.. ..++..||+|.+...... ...|++++++++||||+++++++.++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKS---------IKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEE---------CCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 35677888999999999999654 345788999988654322 13468889999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA-ETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..|+||||+++|+|.+++. .+++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 99999999999999999995 278999999999999999999953 5689999999999999999888775 66
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
....... .....+++.|+|||++.+..++.++|||||||++|||++|+.||+... ........|.+.... ..
T Consensus 828 ~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~-~~ 899 (968)
T PLN00113 828 LPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYS-DC 899 (968)
T ss_pred ccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcC-cc
Confidence 5443211 112367899999999998899999999999999999999999995432 223445555543322 22
Q ss_pred ccchhhcccccC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 310 KIFRIIDNRLEG--QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 310 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
....++++.+.. ........++.+++.+||+.||++||++.++++.|+++....+
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 233444544432 2344556678899999999999999999999999998866444
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.17 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=195.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
|++.+.||.|++|.||+|.. ..+|..|++|++..... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARD---------KLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEE---------cCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 67788999999999999543 44688999999875432 22356788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+ +++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~iv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 72 KLYLVFEFL-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred eEEEEEecc-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 999999999 4689998876542 35899999999999999999999 889999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc--
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK-- 308 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 308 (404)
........ ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........ ............
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 222 (283)
T cd07835 147 RAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDED 222 (283)
T ss_pred cccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChH
Confidence 75432211 1222356889999998765 4578899999999999999999999975432110 000000000000
Q ss_pred -----cccchhhcccc------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 -----RKIFRIIDNRL------EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 -----~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+.+...... ........+..+.+++.+||+.||.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 00111223357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=292.54 Aligned_cols=268 Identities=23% Similarity=0.295 Sum_probs=193.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+| .+..++..|++|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKA---------RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEE---------EECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 357999999999999999995 44557889999988654322 2234578999999999999999999987
Q ss_pred eCC--------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 149 EDD--------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 149 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
... ..++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKD 155 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCC
Confidence 654 3599999995 58888876543 35899999999999999999999 8899999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCC--cceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 221 YNAKLSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
+.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~ 235 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999764332211 112234578889999987654 478899999999999999999999975443211111
Q ss_pred hhhhhh-----hhhhccccchhhccc-ccCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 298 VEWAKP-----YLASKRKIFRIIDNR-LEGQY---------TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 298 ~~~~~~-----~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...... ........ ...+.. ..... .......+.+++.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKL-ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccch-hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 110000 00000000 000000 00000 0001345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=282.59 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=198.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-----FQGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.+|++.+.||+|+||.||+|. +..++..|++|.+.... ......+.+|+.+++.++|+||+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCY---------DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEE---------EcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 478999999999999999954 44568899999875321 2233567889999999999999999999
Q ss_pred EEeC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 147 CLED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
+... ...+++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEE
Confidence 8764 46889999999999999987643 4788999999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCC-CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQ-SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------- 215 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------- 215 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----------
Confidence 999999986432111 11122356889999999998888999999999999999999999999643211
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+..+.........+......+.+++.+||. +|..||++.+++.
T Consensus 216 -----~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 216 -----AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00111111111223445566778899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.00 Aligned_cols=269 Identities=21% Similarity=0.269 Sum_probs=195.1
Q ss_pred Cccccc--CcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEG--GFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
..||.| +||+||+ +.+..+++.||+|++..... ...+.+.+|+.+++.++||||++++++|..++..
T Consensus 4 ~~ig~g~~~~~~v~~---------a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYL---------ARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEE---------EEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 456766 8999998 45555789999999875432 2235678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
++||||+.+++|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++||+.+..
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999999999999876532 45889999999999999999999 89999999999999999999999999986543
Q ss_pred CCCCCCCc-----ceeeccccccccCccccccC--CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh---
Q 046897 234 GPTGDQSH-----VSTRVMGTYGYAAPEYLATG--HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP--- 303 (404)
Q Consensus 234 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~--- 303 (404)
........ ......++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~ 228 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPY 228 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCC
Confidence 21111000 01112345679999998763 478899999999999999999999975422100 0000000
Q ss_pred ------hhh-------------h---------ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 304 ------YLA-------------S---------KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 304 ------~~~-------------~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... . ......+....+...........+.+++.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0 000000111111222233456788999999999999999999999754
Q ss_pred --HHhhHh
Q 046897 356 --LEQLQD 361 (404)
Q Consensus 356 --L~~~~~ 361 (404)
+..++.
T Consensus 309 ~~~~~~~~ 316 (328)
T cd08226 309 AFFKQVKE 316 (328)
T ss_pred HHHHHHHH
Confidence 555554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=297.81 Aligned_cols=271 Identities=26% Similarity=0.328 Sum_probs=198.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+++|.+.+.||+|+||.||+|. +..++..|++|.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSAT---------HKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEE---------EcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999954 44568899999986432 2233567889999999999999999988765
Q ss_pred C-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 150 D-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 150 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
. ...|+++||+. ++|.+++.. ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEE
Confidence 4 35799999995 588877754 35899999999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCCC-cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 225 LSDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~ 223 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLIL 223 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 9999998764332211 11233568899999998654 568899999999999999999999996532110 000000
Q ss_pred hhhhh--ccccchhhccc---------ccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHh
Q 046897 303 PYLAS--KRKIFRIIDNR---------LEGQ-----YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQD 361 (404)
Q Consensus 303 ~~~~~--~~~~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 361 (404)
..+.. ......+.... .... ........+.+++.+||+.||++||++.++++. |++..+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 00000000000 0000 011234568899999999999999999999887 655433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=292.77 Aligned_cols=268 Identities=25% Similarity=0.311 Sum_probs=195.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||.|+||.||+|. +..+|..||+|.+....... ...+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRAR---------DTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEE---------ECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 4679999999999999999954 44568899999986543222 234568999999999999999999987
Q ss_pred eC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 149 ED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
.. +..++||||+. ++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEC
Confidence 65 46899999995 58888887543 46899999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh-h--
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA-K-- 302 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~-~-- 302 (404)
|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.-. .
T Consensus 151 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 151 DFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred ccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999986543221 1222345788999998865 56889999999999999999999999754332111000000 0
Q ss_pred -----hhhhhcc--ccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 -----PYLASKR--KIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 -----~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+...... ....+...... ..........+.+++.+||+.||++|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 00000000000 00001124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.44 Aligned_cols=248 Identities=27% Similarity=0.471 Sum_probs=202.4
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.+.+.||+|++|.||++. +...+..|++|.+..... .....+.+|+++++.++|+|++++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGL---------NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEE---------EcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 47889999999999999954 444678899999877654 3446788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||+++++|.+++... ..+++..++.++.|++.+|.+|| +.+|+|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEecccc
Confidence 9999999999999999998765 35899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+......... .....++..|+|||.+.+..++.++|||+||+++|+|++|..||...... ... .
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~----~----- 209 (254)
T cd06627 146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AAL----F----- 209 (254)
T ss_pred ceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHH----H-----
Confidence 9865443321 23356888999999988777899999999999999999999999743311 000 0
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .......+......+.+++.+||..+|++||++.+++.
T Consensus 210 --~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 --RIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --HHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000 00111223334567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=287.15 Aligned_cols=264 Identities=16% Similarity=0.162 Sum_probs=187.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhcCCCC
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-----------KEWLAEVNYLGQLYHP 138 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hp 138 (404)
..++|.+.++||+|+||.||+|..... ...+..+++|.......... .....++..+..+.|+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~------~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASD------HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCC------cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 346899999999999999999765431 11145567776443322111 1122334556677899
Q ss_pred CcceEEEEEEeCC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 139 NLVKLVGYCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 139 ~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
||+++++.+.... ..+++++++ ..++.+.+.... ..++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~N 156 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPEN 156 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHH
Confidence 9999998766543 347788887 457766665432 3577888999999999999999 8899999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKN 289 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~ 289 (404)
||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999764322111 1112346999999999999999999999999999999999999999765
Q ss_pred CCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 290 RPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
...... ...... .-+..+..... .....+..+.+++..|+..+|++||++.++++.|
T Consensus 237 ~~~~~~--~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNL--IHAAKC-----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHH--HHHhHH-----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 322111 100000 00111111111 1112356788999999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=296.59 Aligned_cols=266 Identities=21% Similarity=0.319 Sum_probs=197.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||.|+||.||+| .+..++..|++|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEE---------EEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 478999999999999999995 444568899999987542 233456788999999999999999998876
Q ss_pred e----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 149 E----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
. ....++||||+ +++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 75 PPGADFKDVYVVMDLM-ESDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred ccCCCCceEEEEEehh-hhhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEE
Confidence 3 34689999999 46898888654 34899999999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCCC--cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 225 LSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
|+|||++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ....
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~ 224 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLI 224 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHH
Confidence 9999998754332211 11233578899999998765 4688999999999999999999999965432111 0000
Q ss_pred hhhhhh----------ccccchhhcc-cccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLAS----------KRKIFRIIDN-RLEGQY-----TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~----------~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... ...+....+. ...... ....+..+.+++.+||+.+|++||++.+++..
T Consensus 225 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 225 LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 0000000000 000011 12235678999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.31 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=195.6
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
...||+|+||.||++.. ..++..|++|.+..........+.+|+.+++.++|+||+++++.+..++..+++
T Consensus 25 ~~~lg~g~~g~v~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATV---------KSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEE---------cCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 46799999999999544 346889999998665544556788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+++++|.+++... .+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999999887542 4788999999999999999999 88999999999999999999999999998875433
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. .......|+..|++||.+.+..++.++|+||||+++|+|++|..||........ .... .....
T Consensus 169 ~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~----------~~~~~ 233 (292)
T cd06657 169 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMI----------RDNLP 233 (292)
T ss_pred cc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----------HhhCC
Confidence 21 112335688999999999888889999999999999999999999965322100 0000 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+ .........+.+++.+||..||.+||++.++++.
T Consensus 234 ~~~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 234 PKL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccc--CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111 0112234567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.36 Aligned_cols=273 Identities=25% Similarity=0.315 Sum_probs=199.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
..++|.+.+.||.|+||.||+|.. ..++..+++|.+... .......+.+|+.+++.+ +||||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAID---------RRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEE---------cCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 456899999999999999999654 345788999988542 223335577899999999 99999999999
Q ss_pred EEeC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 147 CLED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 147 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
+... ...|+||||+. ++|..++... .+.+..++.++.|++.||+||| +.+|+|+||+|+||+++.++.+|
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEE
Confidence 8654 36899999995 5998888653 4788899999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCCC---cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 225 LSDFGLAKDGPTGDQS---HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
|+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~ 227 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999865433221 12234568899999998754 5678899999999999999999999965332211000000
Q ss_pred hhhhhh-------hccccchhhccccc------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 046897 301 AKPYLA-------SKRKIFRIIDNRLE------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQL 359 (404)
Q Consensus 301 ~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 359 (404)
...... .......+++.... .......+..+.+++.+||+.||.+|||+.++++. +.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000 00000001110000 01111235678999999999999999999999975 5554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=295.72 Aligned_cols=274 Identities=24% Similarity=0.328 Sum_probs=201.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||++ .+..++..|++|.+... .......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSA---------KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEE---------EecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 467999999999999999995 44557889999988653 2233456778999999999999999999876
Q ss_pred eC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 149 ED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
.. ...|++|||+ +++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCE
Confidence 54 3579999999 57898888654 35899999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh-hh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE-WA 301 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~-~~ 301 (404)
||+|||++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............. ..
T Consensus 148 kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 225 (337)
T cd07858 148 KICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225 (337)
T ss_pred EECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999999998653322 12233467889999998764 468899999999999999999999996542110000000 00
Q ss_pred hhh------hhhccccchhhccc---cc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHhc
Q 046897 302 KPY------LASKRKIFRIIDNR---LE---GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQDS 362 (404)
Q Consensus 302 ~~~------~~~~~~~~~~~~~~---~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~~ 362 (404)
... .............. .. .......+..+.+++.+||+.+|++|||+.++++. |+.+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 00000000000000 00 01112345678899999999999999999999987 6655433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=284.70 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=195.2
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||.|+||.||++. +..++..+++|.+..... ...+.+.+|+++++.++||||+++++.+..+...|++
T Consensus 1 lg~g~~~~vy~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAK---------KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEE---------ECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999954 444688999999876543 3345688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+.+++|.+++.... .+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 72 MEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99999999999997653 5899999999999999999999 89999999999999999999999999999875433
Q ss_pred CCC------CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 237 GDQ------SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 237 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
... ........++..|++||.+.+..++.++||||||+++|+|++|..||....... ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~-------- 211 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQ-------- 211 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHH--------
Confidence 211 112233567889999999988888999999999999999999999997543210 000
Q ss_pred cchhhcccccCCCCHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLE--GAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+..... ..+.. .+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus 212 --~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 212 --NILNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --HHhcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0111011 11111 2567889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=287.57 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=193.0
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
|...+.||+|+||.||+|. +..++..|++|.+..... .....+.+|+.+++.++|||++++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~---------~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFAT---------NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEE---------ECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6667889999999999954 444688999999865432 2234678899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...|+||||+. ++|.+++.... .++++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 99999999995 68888776543 46899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+..... .....|+..|+|||.+. +..++.++||||||+++|+|++|..||........ . .
T Consensus 168 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~---~----- 230 (313)
T cd06633 168 ASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---Y----- 230 (313)
T ss_pred CcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---H---H-----
Confidence 864322 22356888999999874 45688899999999999999999999865432110 0 0
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+................+.+++.+||+.+|.+||++.+++..
T Consensus 231 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 -----HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001111112234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=286.24 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=196.2
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED- 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 150 (404)
|.+.+.||.|+||.||+|.. ..++..+++|.+.... ......+.+|+.+++.++|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~---------~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARN---------KKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEE---------CCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 56788999999999999644 3457889999997653 23345678899999999999999999999988
Q ss_pred -CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 -DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
...++||||++ ++|.+++.... ..+++..++.++.||+.||+||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 78999999996 58888886543 36899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS- 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (404)
++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ........
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~ 221 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSP 221 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCC
Confidence 9986544321 11223456788999997754 467899999999999999999999997544321100 00000000
Q ss_pred ----ccccchh-----------hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 ----KRKIFRI-----------IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ----~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
......+ ....+...+....+..+.+++.+||..+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0000000011112567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=283.57 Aligned_cols=245 Identities=26% Similarity=0.296 Sum_probs=188.3
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHH-hcCCCCCcceEEEEEEeCCee
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYL-GQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~ 153 (404)
+.||.|+||.||+| .+..++..|++|.+....... ...+..|..++ ...+|+||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLA---------KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEE---------EecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 57999999999995 444567899999987543221 12334454443 455899999999999999999
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|++|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 99999999999999997653 5889999999999999999999 88999999999999999999999999999875
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
... .....++..|++||.+.+..++.++||||||+++|+|++|..||....... ........
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~------ 208 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSR------ 208 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhc------
Confidence 322 223468889999999988888999999999999999999999996533210 00000000
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
............+..+.+++.+||+.||++||++.++.+.|.
T Consensus 209 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 209 --RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 000011112234567889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=287.37 Aligned_cols=268 Identities=21% Similarity=0.279 Sum_probs=194.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||.|++|.||+|. +..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKAR---------DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEE---------ecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 468889999999999999954 444688899998865432 223567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CCcEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~~vkl~Df 228 (404)
+...|+||||++ ++|.+++..... ..+++..++.++.||+.||+||| +.+++|+||+|+||+++. ++.+||+||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEccc
Confidence 999999999995 588888765432 24678889999999999999999 889999999999999985 567999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh-hhh-hhh-
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV-EWA-KPY- 304 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~-~~~-~~~- 304 (404)
|++....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ... .+.
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (294)
T PLN00009 148 GLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE 225 (294)
T ss_pred ccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9997543221 11223457889999998865 45789999999999999999999999754321110000 000 000
Q ss_pred --hhhccccchhhcc--ccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 --LASKRKIFRIIDN--RLE----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 --~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.....+...... ... .......+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 000 00112234567899999999999999999999863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.93 Aligned_cols=242 Identities=29% Similarity=0.405 Sum_probs=202.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHH---HHHHHHHHhcC-CCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
..+|..+.+||+|+||+|.+ +...++.+.||||+++++...+... -+.|-++|... +-|.++++...
T Consensus 348 ~tDFnFl~VlGKGSFGKVlL---------aerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLL---------AERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ecccceEEEeccCccceeee---------ecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 45788899999999999998 6677788999999998875444332 35677788776 47899999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
|+.-+.+|+||||++||+|...|+.-++ +.+..+..++.+|+-||-+|| +++|+.||||.+|||++.+|++||+
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEee
Confidence 9999999999999999999999998765 667788899999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++...-... .....++|||.|+|||++..++|+..+|+||+|++||||+.|++||++.++...
T Consensus 493 DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------------ 558 (683)
T KOG0696|consen 493 DFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------------ 558 (683)
T ss_pred ecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------------
Confidence 999998643333 245678999999999999999999999999999999999999999987543211
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 347 (404)
...+.+.. -.++...+.+...++...|..+|.+|.
T Consensus 559 ----F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 ----FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11222222 256666777888999999999999995
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=283.20 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=186.8
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHH---HHHHhcCCCCCcceEEEEEEeCCe
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAE---VNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E---~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
+||+|+||.||++ .+..+++.||+|.+....... ...+..| +..++...||||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEE---------EEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999985 444568899999887643221 1123333 344455679999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++||||+.+++|..++... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 99999999999999988654 35899999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
...... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||............
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~------------- 208 (278)
T cd05606 146 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------- 208 (278)
T ss_pred ccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-------------
Confidence 543221 2234689999999998744 6899999999999999999999999764322111000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
... .......+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 209 -~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 209 -RMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -HHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000 0011122333456788999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=284.87 Aligned_cols=264 Identities=25% Similarity=0.300 Sum_probs=198.7
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
|.+.+.||.|++|.||++ ....++..+++|.+...... ....+.+|+.+++.++|+||+++++++..+.
T Consensus 1 y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKA---------RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEE---------EcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 567789999999999995 44456889999998765332 3456788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..+++|||+. ++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 72 DLYLVFEFMD-TDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CEEEEEeccC-CCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence 9999999996 58888887643 36899999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh-h-hhhhhhhc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE-W-AKPYLASK 308 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~-~-~~~~~~~~ 308 (404)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......... . ..+.....
T Consensus 146 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 146 RSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred EecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence 7654432 112234578889999998766 78899999999999999999999996543211100000 0 00000000
Q ss_pred cccch--------hhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFR--------IIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~--------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..... ..... .........+..+.+++.+||+.||.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 00000 001122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.02 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=194.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
+.|...+.||+|+||.||+|.. ..++..+++|.+..... ....++.+|+++++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEE---------cCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 3477778899999999999654 34678899998864322 22346788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+...++||||+. ++|.+.+.... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999995 68887775443 45889999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++..... .....++..|+|||.+. ...++.++|||||||++|+|++|..||....... ..
T Consensus 160 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~---- 223 (308)
T cd06634 160 GSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL---- 223 (308)
T ss_pred ccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HH----
Confidence 99875432 12345788999999874 3567889999999999999999999986432110 00
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
..+................+.+++.+||..+|++||++.++++...
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 224 ------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ------HHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0000000111112234566889999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.95 Aligned_cols=277 Identities=20% Similarity=0.247 Sum_probs=199.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
...|+..+.||+|++|.||++.-.+.. ..-...+|+|.++.+. ..-.....+|+.+++.++||||+.+..+|.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n-----~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTN-----DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCC-----cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 356899999999999999997432210 0113478999887542 122245789999999999999999999988
Q ss_pred e-CCeeEEEEeccCCCChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC----Cc
Q 046897 149 E-DDHRLLVYEFMPRGSLENHLFRRGS-YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN----YN 222 (404)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~----~~ 222 (404)
. +..+++++||.+. +|...|+-... ..+.++...+..++.||+.|+.||| ++=|+||||||.||||..+ |.
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEeccCCccCe
Confidence 7 7789999999965 88888865432 2246889999999999999999999 7889999999999999877 99
Q ss_pred EEEecccCCCCCCCCCCCc-ceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc----
Q 046897 223 AKLSDFGLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN---- 296 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~---- 296 (404)
|||+|||+++.....-... .....+.|..|+|||++.| ..|+.+.|||++|||+.||++-.+.|.+.+......
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999754432221 2345778999999999876 569999999999999999999999997543321111
Q ss_pred --hhhhhhhhhhh--ccccch---h------hcccccCCCCH----H-------HHHHHHHHHHHcccCCCCCCCCHHHH
Q 046897 297 --LVEWAKPYLAS--KRKIFR---I------IDNRLEGQYTL----E-------GAYKAATLALRCLSTEGKFRPMMAEV 352 (404)
Q Consensus 297 --~~~~~~~~~~~--~~~~~~---~------~~~~~~~~~~~----~-------~~~~l~~li~~cl~~dP~~RPs~~ei 352 (404)
..+.+...+.. ...+.. + +.......+.. . .+....+|+.++|+.||.+|.|+.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11111000000 000000 0 00000000000 0 11236789999999999999999998
Q ss_pred HHH
Q 046897 353 VTV 355 (404)
Q Consensus 353 l~~ 355 (404)
++.
T Consensus 335 leh 337 (438)
T KOG0666|consen 335 LEH 337 (438)
T ss_pred hcc
Confidence 875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=284.71 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=200.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
+|.+.+.||+|+||.||++... ....++..|++|.+..... ...+.+..|+.++..+ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~------~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKV------GGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEe------ccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4778899999999999997642 2334578899998865321 2234577899999999 599999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..+...++||||+.+++|.+++... ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEE
Confidence 9999999999999999999998754 35789999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCC--CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
||++........ .......|+..|++||.+.+.. .+.++||||||+++|+|++|..||....... .........
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~- 224 (288)
T cd05583 149 FGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRI- 224 (288)
T ss_pred Cccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHH-
Confidence 999876433221 1122346888999999986654 7889999999999999999999996432211 111111110
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
... ....+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 225 ---------~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 225 ---------LKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---------Hcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 110 012222344567899999999999999999888877764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=286.13 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=201.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLY-HPNLVKLVGYC 147 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 147 (404)
++|.+.+.||.|+||.||++.. ..++..+++|++..... ...+.+..|+.+++.+. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKE---------KETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEE---------cCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 4688999999999999999644 34688999999875322 22356788999999998 99999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..++..+++|||+.+++|.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecC
Confidence 99999999999999999999997653 5899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCC------------------cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCC
Q 046897 228 FGLAKDGPTGDQS------------------HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKN 289 (404)
Q Consensus 228 fg~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~ 289 (404)
||++......... .......++..|++||.+.+..++.++||||||+++++|++|+.||...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998864332210 1223346788999999988888999999999999999999999999754
Q ss_pred CCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 046897 290 RPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM----AEVVT 354 (404)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~ 354 (404)
..... ...+. ......+...+..+.+++.+||+.+|.+||++ .++++
T Consensus 226 ~~~~~----------------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 226 NEYLT----------------FQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cHHHH----------------HHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 31100 00111 11123333446678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=282.50 Aligned_cols=255 Identities=27% Similarity=0.347 Sum_probs=195.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
+|++.+.||.|+||.||+++.. ....+|..|++|++..... ...+.+.+|+.+++.+ +|+||+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~------~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKV------SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEec------cCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 4788899999999999997642 2234678899999875322 2235678899999999 599999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..+...++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+|||++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999999765 35788999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
||++........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ........
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~- 224 (290)
T cd05613 149 FGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRI- 224 (290)
T ss_pred Cccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHh-
Confidence 999876433221 11223568889999999865 3467899999999999999999999964322111 11111110
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
... ...++......+.+++.+||+.||++|| ++.++++
T Consensus 225 ---------~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 ---------LKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------hcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000 0122333456778999999999999997 5566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=285.51 Aligned_cols=247 Identities=21% Similarity=0.251 Sum_probs=183.9
Q ss_pred CCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCC
Q 046897 103 PGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180 (404)
Q Consensus 103 ~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 180 (404)
..++..||+|++... .....+.+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++..... ..++
T Consensus 22 ~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~--~~~~ 99 (314)
T cd08216 22 KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLP 99 (314)
T ss_pred cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc--cCCC
Confidence 337889999998765 233446789999999999999999999999999999999999999999999976432 3588
Q ss_pred HHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCC-----CcceeeccccccccCc
Q 046897 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ-----SHVSTRVMGTYGYAAP 255 (404)
Q Consensus 181 ~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aP 255 (404)
+..+..++.|++.||+||| +.+|+|+||||+||+++.++.++|+|||.+........ ........++..|+||
T Consensus 100 ~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 100 ELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177 (314)
T ss_pred HHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence 9999999999999999999 88999999999999999999999999998875432211 1112234577789999
Q ss_pred ccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh----------hhhhccccch----hhc---
Q 046897 256 EYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP----------YLASKRKIFR----IID--- 316 (404)
Q Consensus 256 E~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~----~~~--- 316 (404)
|.+.+ ..++.++|||||||++|||++|..||....... ........ .......... ..+
T Consensus 178 E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
T cd08216 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNN 255 (314)
T ss_pred HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccch
Confidence 99865 358899999999999999999999997543211 00000000 0000000000 000
Q ss_pred -ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 317 -NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 317 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.............++.+++.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 256 RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 001112233445678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=274.81 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=193.1
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 154 (404)
+..||.|+||+|++ ..++.+|+.+|||++...+. ...++++.|.+...+- ++||||++||....++..|
T Consensus 69 lg~iG~G~fG~V~K---------M~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNK---------MLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred HHHhcCCcchhhhh---------hhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 46699999999998 78888999999999987654 4456788888766554 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 155 LVYEFMPRGSLENHLFRR-GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
|.||.| ..+|..+...- ......+++..+-.|....+.||.||-. ..+|+|||+||+|||++..|.|||||||++..
T Consensus 140 iCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 999999 55665543211 1111468899999999999999999985 78899999999999999999999999999876
Q ss_pred CCCCCCCcceeeccccccccCccccc--cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLA--TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
+...- ..+.-.|..-|||||.+. +..|+.++||||||++|||+.||+.|+.+.... .+ .+
T Consensus 218 Lv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----fe----------ql 279 (361)
T KOG1006|consen 218 LVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FE----------QL 279 (361)
T ss_pred HHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HH----------HH
Confidence 53322 234456888899999985 346999999999999999999999999764321 00 01
Q ss_pred chhhcc---ccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 312 FRIIDN---RLE-GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 312 ~~~~~~---~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..++.. .+. ..........+..+|.-||-+|-.+||...+++++
T Consensus 280 ~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111 111 11223456688999999999999999999998764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=271.38 Aligned_cols=268 Identities=26% Similarity=0.375 Sum_probs=206.2
Q ss_pred ccCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCC
Q 046897 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPN 139 (404)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~ 139 (404)
.-.|.++...+. ++||+|+++.|-. |....+|..||||++.+..-....++.+|++++.+.+ |+|
T Consensus 72 ~g~F~d~YkLt~-----e~LGeGAyasVqt---------cv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~n 137 (463)
T KOG0607|consen 72 SGKFEDMYKLTS-----ELLGEGAYASVQT---------CVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKN 137 (463)
T ss_pred cchHHHHHHhHH-----HHhcCccceeeee---------eeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCcc
Confidence 345666666655 6799999999986 6677789999999998886677788999999999985 999
Q ss_pred cceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 140 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
|++++++|+++..+|+|||-+.||.|...|+++. .+++..+.++.++|+.||.||| +++|.||||||+|||-..
T Consensus 138 ilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 138 ILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCES 211 (463)
T ss_pred HHHHHHHhcccceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecC
Confidence 9999999999999999999999999999998874 5899999999999999999999 999999999999999966
Q ss_pred CCc---EEEecccCCCCCCCCC-----CCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCc
Q 046897 220 NYN---AKLSDFGLAKDGPTGD-----QSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAV 286 (404)
Q Consensus 220 ~~~---vkl~Dfg~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~ 286 (404)
... |||+||.+..-..... ........+|+..|||||+.. ...|+.++|.||||+|+|-|++|.+||
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 544 8999998875321111 111223468999999999752 246889999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhhh--hccccc-hhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 287 DKNRPSGEHNLVEWAKPYLA--SKRKIF-RIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.=..+ ..|.+.-.. -...++ .|.+... +++ ...+.+..+++..+|..|+.+|.++..++.
T Consensus 292 vG~Cg~d----CGWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 292 VGHCGAD----CGWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCccCCc----CCccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 7532211 112111000 001111 1111111 122 245667889999999999999999998887
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.68 Aligned_cols=258 Identities=24% Similarity=0.281 Sum_probs=205.2
Q ss_pred HHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcc
Q 046897 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv 141 (404)
.++....++|.++++||+|+||.|.. +++..+++.||.|++++-... ...-|..|-.+|..-+.+-|+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~l---------Vr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVAL---------VRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEE---------EEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 33444567999999999999999998 566678999999999874332 223467788888888899999
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
.+.-.|.++.++|+|||||+||+|..++.+.. ++++..+..++..|+.||.-|| +.|+|||||||+|||||..|
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccC
Confidence 99999999999999999999999999997653 6999999999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccc----c-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA----T-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
++||+|||.+-.... +..-.....+|||.|.+||++. + +.|+..+|+||+|+++|||+.|..||......+
T Consensus 213 HikLADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--- 288 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--- 288 (1317)
T ss_pred cEeeccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH---
Confidence 999999999876543 2233455678999999999984 3 579999999999999999999999996432110
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCC--HHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYT--LEGAYKAATLALRCLSTEGKFRPM---MAEVVTV 355 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~ 355 (404)
...+|++-.-.-.+| ...+....+||.+.+ .+|+.|.. +.++-..
T Consensus 289 -------------TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 289 -------------TYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -------------HHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 111122211111233 346778889999887 57888887 7777543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=290.41 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=194.3
Q ss_pred hcCCC-CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--------------HHHHHHHHHHHhcC
Q 046897 71 TRNFR-PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--------------HKEWLAEVNYLGQL 135 (404)
Q Consensus 71 ~~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l 135 (404)
.++|. +.+.||.|+||.||+|. +...+..||+|.+....... ...+.+|+.+++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAY---------DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEE---------ECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 35665 45789999999999964 34467899999886543222 12467899999999
Q ss_pred CCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 136 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
+|+||+++++++..++..+++|||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~ni 150 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANI 150 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHe
Confidence 99999999999999999999999995 6999988654 35889999999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCC------------CCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGD------------QSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSG 282 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g 282 (404)
+++.++.++|+|||++....... .........++..|+|||.+.+. .++.++|||||||++|+|++|
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999987543111 00111223467889999988654 468899999999999999999
Q ss_pred CCCcCCCCCCCCcchhhhhhhhhhhc--cccchhh--------cccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 283 RRAVDKNRPSGEHNLVEWAKPYLASK--RKIFRII--------DNRL---EGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 283 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--------~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
..||........ ...+....... ....... .... ...........+.+++.+||+.+|++||++
T Consensus 231 ~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~ 307 (335)
T PTZ00024 231 KPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307 (335)
T ss_pred CCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence 999975543211 00000000000 0000000 0000 000011234568899999999999999999
Q ss_pred HHHHH
Q 046897 350 AEVVT 354 (404)
Q Consensus 350 ~eil~ 354 (404)
.+++.
T Consensus 308 ~~~l~ 312 (335)
T PTZ00024 308 KEALK 312 (335)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=280.37 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=193.1
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCCcceEEEEEE
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQL---YHPNLVKLVGYCL 148 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~~ 148 (404)
|++.+.||+|+||.||+|... .++..|++|.+...... ....+.+|+.+++.+ +|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL---------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEEC---------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 567889999999999996543 35788999998754322 123456677766655 6999999999998
Q ss_pred eCCe-----eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 149 EDDH-----RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
..+. .+++|||+. ++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCE
Confidence 8776 899999996 589888876432 35899999999999999999999 8899999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
+|+|||++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||........ .......
T Consensus 147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~ 221 (287)
T cd07838 147 KIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDV 221 (287)
T ss_pred EEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHH
Confidence 9999999876533221 1223578889999999888899999999999999999999999975433211 0000000
Q ss_pred hhh---hcc--cc---chhhccccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLA---SKR--KI---FRIIDNRLE---GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~---~~~--~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... ... .. ......... ..........+.+++.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000 00 000000000 1112234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=284.47 Aligned_cols=269 Identities=25% Similarity=0.293 Sum_probs=195.7
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
...++|++.+.||+|+||.||+|.. ..++..|++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARD---------KDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEE---------CCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 3457899999999999999999654 34578899999875432 222456789999999999999999999
Q ss_pred EEeCC----------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 147 CLEDD----------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 147 ~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
+.+.. ..++++||+++ +|...+.... ..+++..++.++.|++.||+||| +.+|+|+||+|+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nil 148 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNIL 148 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence 87654 78999999965 7777776542 36899999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 149 i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred ECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999865433221 1122346778999998754 45788999999999999999999999754321111
Q ss_pred chhhhhh--hhhhhccccchh-----hcc------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 296 NLVEWAK--PYLASKRKIFRI-----IDN------RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 296 ~~~~~~~--~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+.... +.......+... .+. ... ......+..+.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 000000000000 000 000 000112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=291.31 Aligned_cols=273 Identities=25% Similarity=0.318 Sum_probs=203.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|++.+.||.|+||.||+|. ...++..+++|.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAV---------DKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEE---------eCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58889999999999999954 44468899999887643 33446788999999999999999999998877
Q ss_pred C-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 151 D-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 151 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
. ..|++|||+. ++|.+++... ..+++..++.++.|++.||.||| +.+|+|+||||+|||++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEE
Confidence 5 7899999996 5888888654 26899999999999999999999 889999999999999999999999
Q ss_pred ecccCCCCCCCCCCC-cceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh-hh
Q 046897 226 SDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW-AK 302 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~-~~ 302 (404)
+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.. ..
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 224 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence 999999865443210 112334678899999999877 789999999999999999999999975542110000000 00
Q ss_pred hhh------hhccccchhhcccc------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHh
Q 046897 303 PYL------ASKRKIFRIIDNRL------EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQD 361 (404)
Q Consensus 303 ~~~------~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 361 (404)
... .........+.... ...........+.+++.+||+.+|++||++.+++.. |++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000 00000000000000 000112235678899999999999999999999985 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=292.70 Aligned_cols=268 Identities=22% Similarity=0.269 Sum_probs=194.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|.+.+.||.|+||.||+| .+..++..|++|.+........+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~---------~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSA---------VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEE---------EECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 468999999999999999995 44457889999998776656667788999999999999999999776543
Q ss_pred --------------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 151 --------------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 151 --------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
...|+||||+. ++|.+++... .+++..++.++.||+.||.||| +.+|+||||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nil 146 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVF 146 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEE
Confidence 35789999995 6888887542 4789999999999999999999 899999999999999
Q ss_pred EcC-CCcEEEecccCCCCCCCCCCC-cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 217 LDT-NYNAKLSDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 217 l~~-~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
++. ++.++|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 974 567899999998754322111 11122357889999997654 568889999999999999999999997543311
Q ss_pred Ccchhhhhhhhhh--hcc----ccchhhc-ccccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAKPYLA--SKR----KIFRIID-NRLEGQ-----YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~~~~~--~~~----~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.........+... ... .+..... ...... .......++.+++.+||+.||++|||+.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 1000000000000 000 0000000 000000 011234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.19 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=221.1
Q ss_pred CCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCee
Q 046897 75 RPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 153 (404)
+..++||.|+||+||+|.|-- ....-..+||+|++... ......++++|+-+|.++.|||++++++++.... +
T Consensus 699 kk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 346789999999999997742 23334678999988654 4455678999999999999999999999998765 8
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
.||++|++.|+|.++++..+ ..+..+..+.|..||++||.||| +++++||||..+||||..-..+||.|||+++.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 89999999999999998865 57889999999999999999999 89999999999999999999999999999998
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
..............-.+-|||-|.+....|+.++||||||+++||++| |..|+++.. .+++.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------~~eI~ 910 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------AEEIP 910 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------HHHhh
Confidence 766554444444445678999999999999999999999999999998 888887643 23345
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
+++...-+...++-+..++..++.+||..|+..||+++++...+.++....
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 555555555777888999999999999999999999999999999876644
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=283.61 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=192.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+|.+ ..++..|++|.+..... .....+..|+.++..+ .|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRF---------KKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEE---------CCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 46788899999999999999654 34578899999875432 2334566777767666 4999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+...|++|||+ +++|.+++.... ..+++..+..++.|++.||+|||+ ..+|+||||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 999999999998 557877776543 368999999999999999999993 258999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCC----CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH----LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .....
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~-- 229 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLT-- 229 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHH--
Confidence 99875433221 12235778899999986543 788999999999999999999999643211 00000
Q ss_pred hhhccccchhhcccc-cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LASKRKIFRIIDNRL-EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..... ...........+.+++.+||..||++||++.++++.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 230 --------KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --------HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111100 000111234578899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=288.10 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=197.2
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEE
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
+....++|.+.+.||.|+||.||++ .+..++..|++|.+.... ....+.+..|+.+++.++||||+++.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 75 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSA---------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEE---------EECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEe
Confidence 3445788999999999999999995 445578899999876432 22345678899999999999999999
Q ss_pred EEEEe-CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 145 GYCLE-DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 145 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
+++.. ....+++|||+ +++|..++... ++++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.+
T Consensus 76 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~ 147 (328)
T cd07856 76 DIFISPLEDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDL 147 (328)
T ss_pred eeEecCCCcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCE
Confidence 99876 45789999999 67898887642 4788888999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh----
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV---- 298 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~---- 298 (404)
+|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 148 ~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~ 222 (328)
T cd07856 148 KICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL 222 (328)
T ss_pred EeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999998754221 123457888999998765 57899999999999999999999999654321100000
Q ss_pred -----hhhhhhhhhccccchhhcc-cccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 -----EWAKPYLASKRKIFRIIDN-RLEGQYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 -----~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
++....... ...+.... ......+ ......+.+++.+||+.+|++||++.+++..
T Consensus 223 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 223 GTPPDDVINTICSE--NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCCCHHHHHhccch--hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000000 0001111 1234678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=290.74 Aligned_cols=273 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..+|.+.+.||+|+||.||+|. +..++..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAI---------DKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEE---------eCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 5789999999999999999954 34468899999886532 122345789999999999999999999987
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
... ..++|+||+. .+|..++. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCC
Confidence 543 4689999995 47766542 24789999999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............
T Consensus 156 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 156 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred EEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998764321 123457888999998865 46888999999999999999999999754321100000000
Q ss_pred h----hhhhhc---cccchhhc---ccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHhccccC
Q 046897 302 K----PYLASK---RKIFRIID---NRLEGQY---TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQDSSETG 366 (404)
Q Consensus 302 ~----~~~~~~---~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~~~~~~ 366 (404)
. +.+... ........ ....... .+.....+.+++.+||+.||++||++.+++.. ++.+++..+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 0 000000 00000000 0000000 01234567899999999999999999999954 77776544333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=274.74 Aligned_cols=277 Identities=23% Similarity=0.329 Sum_probs=230.6
Q ss_pred CHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcc
Q 046897 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv 141 (404)
...++.....+++...++.+|+||.||+|.|.+. ....+.+.+.+|.++.. ...+...++.|...|..+.|||+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 4456666677899999999999999999988753 23334456777766543 334456789999999999999999
Q ss_pred eEEEEEEeC-CeeEEEEeccCCCChHHHHhhc----CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 142 KLVGYCLED-DHRLLVYEFMPRGSLENHLFRR----GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 142 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
++.+++.++ ...++++.++..|+|..++... .+..+.++..+...++.|++.|++||| +.+|+|.||..+|.+
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCV 428 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcce
Confidence 999998765 4678889999999999999832 234466888899999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
|++..+|||+|=.+++...+++.++..........||+||.+.+..|+.++|+||||+++|||+| |+.|+..-++.
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf--- 505 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF--- 505 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH---
Confidence 99999999999999999999998888887888899999999999999999999999999999998 88898764432
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
+....+....+-..+..++++++.++.-||..+|++||+++++..-|.++...
T Consensus 506 --------------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 506 --------------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --------------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 22233333334466778899999999999999999999999999999887543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=278.93 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=193.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecC---CC--cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ---DG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
+|.+.+.||+|+||.||++.... .+..+++|.++. .. ......+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58889999999999999965432 233344444432 21 12233566789999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+....++||||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999998764433457899999999999999999999 899999999999999975 5799999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .....
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~----- 215 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL----- 215 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH-----
Confidence 999876433221 22335678899999998888889999999999999999999999864221 11000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.. ......+...+..+.+++.+||..||++||++.++++
T Consensus 216 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 216 -----RIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----HHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 1111233455668889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=287.39 Aligned_cols=271 Identities=22% Similarity=0.305 Sum_probs=198.5
Q ss_pred CHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCc
Q 046897 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNL 140 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~i 140 (404)
...++....++|.+.+.||+|+||.||+|. +..++..||+|++.... ....+.+.+|+.+++.++||||
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i 78 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEE---------EcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc
Confidence 345566678999999999999999999954 34468899999987532 2234567889999999999999
Q ss_pred ceEEEEEEeC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 141 VKLVGYCLED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 141 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
+++++++... ...+++++++ +++|.+++... .+++..++.++.|++.||+||| +.+|+||||||+|
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~N 150 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSN 150 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHH
Confidence 9999988643 3467888887 78998887542 4889999999999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
|+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999998764321 223467889999998765 568889999999999999999999996533211
Q ss_pred Ccchhhhhh----hhhhh---ccccchh---hcccccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAK----PYLAS---KRKIFRI---IDNRLEGQY---TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~----~~~~~---~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
......... +.... ....... +.......+ .......+.+++.+||+.||.+||++.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100000000 00000 0000000 000000000 00124567899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=287.44 Aligned_cols=269 Identities=22% Similarity=0.256 Sum_probs=191.3
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 149 (404)
+|.+.+.||+|+||.||++.... ...+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAE-------TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCC-------CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 47788999999999999965432 1127789999886432 12245678899999999 59999999987543
Q ss_pred C----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 150 D----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 150 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
. ...+++++|+ +++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.++|
T Consensus 74 ~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 74 FPGNFNELYLYEELM-EADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred ccccCCcEEEEEecc-cCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEe
Confidence 2 4578899998 46898888654 35899999999999999999999 899999999999999999999999
Q ss_pred ecccCCCCCCCCCCC--cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh----
Q 046897 226 SDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV---- 298 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~---- 298 (404)
+|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||............
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 999999764332211 11223568999999998755 56899999999999999999999999754321100000
Q ss_pred -----hhhhhhhhhc-cccchhhcccccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 -----EWAKPYLASK-RKIFRIIDNRLEG---QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 -----~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.......... ............. .........+.+++.+||+.||++|||+.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0000000000000 0011124578899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=285.89 Aligned_cols=269 Identities=25% Similarity=0.306 Sum_probs=192.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||.|+||.||+|. +..++..+++|++....... ...+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKAR---------QIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEE---------ECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999954 44467889999886543222 245678999999999999999999875
Q ss_pred eCC--------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 149 EDD--------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 149 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
... .+++||||+. ++|...+.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.+
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQ 151 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence 443 4699999995 57777776432 36899999999999999999999 8899999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCc---------ceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 221 YNAKLSDFGLAKDGPTGDQSH---------VSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
+.++|+|||++.......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997543322111 1123457888999998764 458899999999999999999999997544
Q ss_pred CCCCcchhhhh-hh----hhhhccccchhhcccccCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 291 PSGEHNLVEWA-KP----YLASKRKIFRIIDNRLEGQYT-------LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 291 ~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.......+... .. .......+....+.......+ ......+.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 232 DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 32111100000 00 000000000000000000000 112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=286.40 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=197.8
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~ 145 (404)
....++|.+.+.||+|+||.||++. +..++..||+|++.... ......+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 81 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSAL---------DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEE---------ECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceee
Confidence 3456789999999999999999954 44568899999886432 222356789999999999999999999
Q ss_pred EEEeCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 146 YCLEDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 146 ~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
++..+. ..++||||+ +++|.+++.. ..+++..++.++.|++.||+||| +.+|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~ 153 (343)
T cd07880 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNE 153 (343)
T ss_pred eecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcC
Confidence 987654 358999999 7799888754 35899999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch-
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL- 297 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~- 297 (404)
++.++|+|||++...... .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...........
T Consensus 154 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 154 DCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred CCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999998764321 123457889999998865 4588899999999999999999999975432100000
Q ss_pred hh--------hhhhhhhhccccchhhccc--cc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhH
Q 046897 298 VE--------WAKPYLASKRKIFRIIDNR--LE----GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT--VLEQLQ 360 (404)
Q Consensus 298 ~~--------~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~~ 360 (404)
.. +...... .......... .. ..........+.+++.+||+.||++|||+.++++ .++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 229 MKVTGTPSKEFVQKLQS--EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHhcCCCCHHHHHhhcc--hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 0000000 0000000000 00 0011123446889999999999999999999984 355443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.06 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=197.7
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
.++||.|.||+||- ++++.+|+.||||++.+-.+.. ...+..|+.||..+.||.||.+...|+..+.+|
T Consensus 569 devLGSGQFG~VYg---------g~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYG---------GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeec---------ceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 58999999999998 5666789999999998754433 356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC---CcEEEecccCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN---YNAKLSDFGLA 231 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~---~~vkl~Dfg~a 231 (404)
+|||-+ .|+..++|-...+ ..+++.....++.||+.||.||| .++|+|+||||+|||+... -.+||||||.|
T Consensus 640 VVMEKl-~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhh-cchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccce
Confidence 999999 5566565544333 46899999999999999999999 8999999999999999654 56999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
+...... .....+|||.|+|||++.++.|...-|+||+|+|+|--++|..||...++. .+.++-+...+.
T Consensus 715 RiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyP----- 784 (888)
T KOG4236|consen 715 RIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYP----- 784 (888)
T ss_pred eecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccC-----
Confidence 9876543 345588999999999999999999999999999999999999999764332 111111111000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..-..+......+||..+|+..-++|.|+...+.
T Consensus 785 ---------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 ---------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1112344567789999999999999999876654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=279.59 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=194.4
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 151 (404)
|.+.+.||.|+||.||+|.. ..++..|++|.+..... .......+|+..++.++ |+||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARN---------KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEE---------CCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 66788999999999999654 33578899998865432 12234567899999998 999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+ +++|.+++.... ...+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecccc
Confidence 999999999 789999887653 146899999999999999999999 899999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh-hhhhhh----h
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV-EWAKPY----L 305 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~-~~~~~~----~ 305 (404)
....... ......++..|+|||.+. +..++.++|+||||+++++|++|+.||............ ...... .
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 7643322 122345788999999874 456789999999999999999999999654321110000 000000 0
Q ss_pred hhccccchhhccccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRLE-------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+........+.... ..........+.+++.+||+.||++||++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000000 0011112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=291.17 Aligned_cols=242 Identities=26% Similarity=0.280 Sum_probs=198.4
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
....|.+...+|.|+|+.|-. +.+..+++..++|++..... ...+|+.++... +||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~---------~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKY---------CESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceee---------eeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceec
Confidence 356788888899999999987 66777889999999977622 223466555544 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE-cCCCcEEEec
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL-DTNYNAKLSD 227 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll-~~~~~vkl~D 227 (404)
++.+.|+|||.+.|+-|.+.+.... .....+..|+.+|+.|+.||| .++++||||||+|||+ +..++++|+|
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEE
Confidence 9999999999999998888876653 233777889999999999999 8999999999999999 6899999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||.+...... ....+-|..|.|||++....|++++||||||++||+|++|+.||......
T Consensus 460 FG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------------- 519 (612)
T KOG0603|consen 460 FGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------------- 519 (612)
T ss_pred echhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------
Confidence 9999876543 23456788999999999999999999999999999999999999764322
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.++........+....+....+|+.+||+.||.+||++.+++..
T Consensus 520 ----~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 ----IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12222223334446667788999999999999999999999765
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=277.38 Aligned_cols=261 Identities=26% Similarity=0.350 Sum_probs=196.9
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
|+..+.||.|++|.||+| ....++..+++|.+.... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKA---------RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEe---------eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 566788999999999995 445568899999987653 233456788999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+||| +.+|+|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcc
Confidence 9999999996 59999998653 35899999999999999999999 889999999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh----
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA---- 306 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---- 306 (404)
........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .........
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 220 (282)
T cd07829 146 RAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTE 220 (282)
T ss_pred cccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcH
Confidence 76533221 12233467789999998765 789999999999999999999999965432110 000000000
Q ss_pred ----hcccc---chhhcc---cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 ----SKRKI---FRIIDN---RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ----~~~~~---~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
....+ ...... .......+.....+.+++.+||+.||++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 000000 0000001122557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.65 Aligned_cols=257 Identities=27% Similarity=0.351 Sum_probs=210.7
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEE
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVG 145 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~ 145 (404)
+.....-|++.++||.|.+|.||++ ++..+++..|+|++..+.. ..+++..|.++|+.+ .|||++.+++
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg 83 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYG 83 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEE
Confidence 3344567899999999999999995 4555778888998876643 346778899999988 6999999999
Q ss_pred EEEe-----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 146 YCLE-----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 146 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+|.. ++.+|||||||.+|+..|++.... ...+.|..+..|++.++.|+.+|| ++.++|||||-.|||++.+
T Consensus 84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred EEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEecc
Confidence 9874 468999999999999999998765 577999999999999999999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
+.|||+|||.+....... .......|||.|||||++.. ..|+..+|+||||++..||--|.+|+-...+....
T Consensus 160 ~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred CcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 999999999998754432 23456789999999999853 35778999999999999999999999765543211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. -..++......+..+...+.++|..||..|-++||++.++++
T Consensus 238 F~---------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FL---------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cc---------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11 112233333446678889999999999999999999998875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=271.64 Aligned_cols=237 Identities=31% Similarity=0.401 Sum_probs=191.9
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
||.|+||.||++. +..++..+++|.+...... ....+..|+.+++.++|+||+++++.+..+...+++
T Consensus 1 lg~G~~~~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVR---------KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEE---------ECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999954 3446789999998765432 335688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|||+.+++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 72 LEYAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99999999999997653 5899999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. .......++..|++||.+.+..++.++|+||||+++|+|++|..||...... .... .+..
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~----------~~~~ 207 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYE----------KILK 207 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHH----------HHhc
Confidence 22 1223456788999999998888899999999999999999999999654320 0000 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 351 (404)
. ....+...+..+.+++.+||..||++||++.+
T Consensus 208 ~--~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 D--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 11223333567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=275.54 Aligned_cols=271 Identities=26% Similarity=0.383 Sum_probs=203.5
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ--LYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~ 150 (404)
...+.++||+|.||.||+|.++ ++.||||++... ....+..|-+|.+. ++|+||++++++-...
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-----------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 3445678999999999998764 478999999764 33556677777665 4799999999987655
Q ss_pred C----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHc-------CCCCceecCCCCCcEEEcC
Q 046897 151 D----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHG-------AETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 151 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------~~~~i~H~Dlkp~NIll~~ 219 (404)
. .++||++|.+.|+|.+++..+ .++|....+++..+++||+|||. ++..|+|||||..||||..
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 5 789999999999999999876 48999999999999999999994 3677999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCC-CC-----cccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LT-----AKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
|++..|+|||+|.....+.........+||.+|||||++.+.. +. .+.||||+|.++|||++...-+.. .+..
T Consensus 352 DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp 430 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVP 430 (534)
T ss_pred CCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCC
Confidence 9999999999999877665554455589999999999996632 22 268999999999999997665532 1111
Q ss_pred Ccchhhhhhhhhhhccccchh----hcccccCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 294 EHNLVEWAKPYLASKRKIFRI----IDNRLEGQYTL-----EGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.... -....+.....+.++ +.++.+..++. .....+.+.+..||..||+.|.|+.=+-+++.++....+
T Consensus 431 ~Yql--pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 431 EYQL--PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cccC--chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1000 000000111111111 12222223332 234578899999999999999999999999999887666
Q ss_pred c
Q 046897 365 T 365 (404)
Q Consensus 365 ~ 365 (404)
.
T Consensus 509 ~ 509 (534)
T KOG3653|consen 509 D 509 (534)
T ss_pred c
Confidence 4
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.99 Aligned_cols=146 Identities=26% Similarity=0.370 Sum_probs=129.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|.+.+.||+|+||.||+|+. ..++..||+|++....... ...+..|+.++..++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~---------~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRK---------KNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 5789999999999999999654 4467899999987543222 356788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
...+.|+||||+.+++|.+++.... .+++..++.++.||+.||.||| ..+|+||||||+||||+.++.+||+||
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeC
Confidence 9999999999999999999997643 4788999999999999999999 789999999999999999999999999
Q ss_pred cCCC
Q 046897 229 GLAK 232 (404)
Q Consensus 229 g~a~ 232 (404)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.55 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=195.4
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|.+.+.||.|+||.||+|.. ..++..|++|++.... ....+.+.+|+.+++.++|+||+++.+++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFD---------TKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEE---------CCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 467899999999999999999654 4467889999886532 22335677899999999999999999887
Q ss_pred EeCCe------eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 148 LEDDH------RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 148 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
...+. .++|+||+ +++|.+++.. ..+++..++.++.|++.||+||| +.+|+|+||+|+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~ 155 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDC 155 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCC
Confidence 76554 89999999 7799998864 35899999999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...
T Consensus 156 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~ 227 (343)
T cd07851 156 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKR 227 (343)
T ss_pred CEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHH
Confidence 9999999999864332 223457888999998765 4678899999999999999999999965432110 000
Q ss_pred hhhhhh-------hc---cccchhhcc---cccCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 AKPYLA-------SK---RKIFRIIDN---RLEGQY---TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 ~~~~~~-------~~---~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... .. ......+.. .....+ ....+..+.+++.+||+.||++|||+.+|++.
T Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000 00 000000000 000000 01125678899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=244.56 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=197.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+|.-.+.||+|++|+||+| +...+++.||+|.+..++ ...-...++|+.+|+.++|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 4555678999999999994 555578999999887643 23336689999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
..+.+|+||| ..+|..+..... ..++.+.+..++.|+++||.++| ++++.||||||.|.||+.+|.+||+|||+
T Consensus 74 kkltlvfe~c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fch--shnvlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCH--SHNVLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhh--hhhhhhccCCcceEEeccCCcEEecccch
Confidence 9999999999 568888876544 35889999999999999999999 78899999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhh--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-- 306 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~-- 306 (404)
++...- .-......+.|..|++|.++.+ .-|+...|+||-||++.|+.. |++.|.+.+..+....+-|.-....
T Consensus 148 arafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 148 ARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED 225 (292)
T ss_pred hhhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc
Confidence 986432 2223445678999999999876 468999999999999999987 6666655432211111111000000
Q ss_pred hccccchhhcccccCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYT---------LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.-..+.++.|-.....++ +.....=++++++.|..+|..|.++++.++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 001112222222222222 112224468999999999999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.94 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=203.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----C---CCcceE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-----H---PNLVKL 143 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~iv~~ 143 (404)
.+|.+.+.||.|.|++||++| +....+.||+|+.+... ...+..+.||++|++++ | .+||++
T Consensus 78 gRY~v~rKLGWGHFSTVWLaw---------Dtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAW---------DTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEe---------eccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999954 55577899999987643 34467789999999883 2 469999
Q ss_pred EEEEEe----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 144 VGYCLE----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 144 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
++.|.. +.++|||+|++ |.+|..+|....- +.++...+++|++||+.||.|||. ..+|||.||||+|||+..
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCS 223 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeec
Confidence 999975 45899999999 8899999987543 679999999999999999999997 789999999999999832
Q ss_pred --------------------------------------------------------------------------------
Q 046897 220 -------------------------------------------------------------------------------- 219 (404)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (404)
T Consensus 224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~ 303 (590)
T KOG1290|consen 224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY 303 (590)
T ss_pred cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 046897 220 -------------------------------------------------------------------------------- 219 (404)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (404)
T Consensus 304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~ 383 (590)
T KOG1290|consen 304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD 383 (590)
T ss_pred ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence
Q ss_pred ------CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 220 ------NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 220 ------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
+-++||+|||-|+.... ..+.-..|..|+|||++.+..|+..+||||++|++|||+||...|+...-..
T Consensus 384 ~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 384 IPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 00256666666554221 2334467889999999999999999999999999999999999998654433
Q ss_pred Ccchhhh---------------------hhhhhhhccccchhhccc-------c--cCCCCHHHHHHHHHHHHHcccCCC
Q 046897 294 EHNLVEW---------------------AKPYLASKRKIFRIIDNR-------L--EGQYTLEGAYKAATLALRCLSTEG 343 (404)
Q Consensus 294 ~~~~~~~---------------------~~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~l~~li~~cl~~dP 343 (404)
.....+. .+.++...+.+..|-.-. + ...++.+.+.++.+++.-||+.+|
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 2222211 122333333332222111 0 134667888899999999999999
Q ss_pred CCCCCHHHHHHH
Q 046897 344 KFRPMMAEVVTV 355 (404)
Q Consensus 344 ~~RPs~~eil~~ 355 (404)
++|||+.++|+.
T Consensus 539 eKR~tA~~cl~h 550 (590)
T KOG1290|consen 539 EKRPTAAQCLKH 550 (590)
T ss_pred cccccHHHHhcC
Confidence 999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.56 Aligned_cols=272 Identities=28% Similarity=0.418 Sum_probs=214.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++..+.+.||.|.||+|++|......... ......||||.++.... ...+.+..|+.+|+.+ .|+||+.+++.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344566779999999999999865421100 12357899999876432 3456789999999999 5999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcC---CC-------C--CCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRG---SY-------F--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
..+.+++|+||+..|+|.+++...+ .. . ..++....+.++.||+.|++||+ +.+++||||..+|||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAARNVL 450 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhhhEE
Confidence 9999999999999999999998776 11 1 23889999999999999999999 889999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeec-cccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCC
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRV-MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGE 294 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~ 294 (404)
++.+..+||+|||+++.............. .-...|||||.+....|+.++||||||++|||+++ |..||.+...
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--- 527 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--- 527 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---
Confidence 999999999999999976554433211111 13456999999999999999999999999999999 7888865211
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
..++.+.+....+...+..+..++.++++.||+.+|++||++.++.+.|+.....
T Consensus 528 -------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 -------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred -------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 0111122333333456666788899999999999999999999999999986443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=268.28 Aligned_cols=221 Identities=21% Similarity=0.210 Sum_probs=176.6
Q ss_pred cCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEeccCC
Q 046897 83 GGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPR 162 (404)
Q Consensus 83 G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 162 (404)
|.+|.||+ +.+..+++.|++|.+.... ....|...+....||||+++++++...+..+++|||+++
T Consensus 4 g~~~~v~~---------~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLL---------VMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEE---------EEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 89999998 4556678899999987653 223445555556799999999999999999999999999
Q ss_pred CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcc
Q 046897 163 GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242 (404)
Q Consensus 163 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~ 242 (404)
++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+......
T Consensus 70 ~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 70 GKLWSHISKFL----NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred CCHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 99999987653 4899999999999999999999 899999999999999999999999999987654332
Q ss_pred eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCC
Q 046897 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQ 322 (404)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (404)
.....++..|+|||.+.+..++.++||||+|+++|||++|..|+........ . .....
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~----~~~~~ 196 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------T----HTTLN 196 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------c----ccccC
Confidence 1223456789999999888899999999999999999999988753211000 0 00001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 323 YTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 323 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
.+......+.+++.+||+.||++||++.
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 2223455688999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=276.24 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=199.8
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-Cccc------HHHHHHHHHHHhcCCCCC
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQG------HKEWLAEVNYLGQLYHPN 139 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~------~~~~~~E~~~l~~l~hp~ 139 (404)
.....++|.++.+||+|+|+.||++ .+....+.||+|+-... ++.+ .+...+|.+|.+.|.||.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKA---------FDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpR 528 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKA---------FDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPR 528 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHh---------cccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcce
Confidence 3344567888999999999999994 45556788999975332 1221 234678999999999999
Q ss_pred cceEEEEEEeC-CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 140 LVKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 140 iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
||++|++|.-+ +.+|-|+|||+|.+|.-++.... .+++..+..|+.||+.||.||......|||-||||.|||+.
T Consensus 529 IVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv 604 (775)
T KOG1151|consen 529 IVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLV 604 (775)
T ss_pred eeeeeeeeeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEe
Confidence 99999999755 56788999999999999998764 58999999999999999999997788999999999999994
Q ss_pred ---CCCcEEEecccCCCCCCCCCCC-----cceeeccccccccCcccccc----CCCCcccchhhhhHHHHHHHhCCCCc
Q 046897 219 ---TNYNAKLSDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLAT----GHLTAKSDVYSFGVVLLEMLSGRRAV 286 (404)
Q Consensus 219 ---~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~ll~ell~g~~p~ 286 (404)
.-|.+||.|||++......... .......||.+|++||.+.- ...+.++||||+|+|+|+++.|+.||
T Consensus 605 ~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF 684 (775)
T KOG1151|consen 605 NGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF 684 (775)
T ss_pred cCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence 4578999999999976544332 23455789999999998753 34678999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhhhhccccchhhcc-cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046897 287 DKNRPSGEHNLVEWAKPYLASKRKIFRIIDN-RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353 (404)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 353 (404)
....... ++.+ .. .++.. ......-+....+...+|++||++--++|..+.++.
T Consensus 685 GhnqsQQ--dILq-------eN----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 685 GHNQSQQ--DILQ-------EN----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCchhHH--HHHh-------hh----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 7643211 1110 00 01111 111122234556778999999999999999887763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=282.90 Aligned_cols=206 Identities=29% Similarity=0.404 Sum_probs=175.2
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHH---HHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---EWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
|..++.||-|+||.|.+ +.+..+...||.|.+.+.+..... .++.|-.||..-..+-||++|-.|.++
T Consensus 631 Fvkik~iGvGAFGeV~L---------v~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCL---------VRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred eEEEeeecccccceeEE---------EeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 44567899999999998 455556788999999876544333 357789999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+.+|+||+|++||++..+|.+.+ -+.+..+..++.++.+|+++.| +.|+|||||||+|||||.+|++||+|||+
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeeccc
Confidence 99999999999999999998876 4789999999999999999999 99999999999999999999999999999
Q ss_pred CCCC---------CCCCCCc-------------------------------ceeeccccccccCccccccCCCCcccchh
Q 046897 231 AKDG---------PTGDQSH-------------------------------VSTRVMGTYGYAAPEYLATGHLTAKSDVY 270 (404)
Q Consensus 231 a~~~---------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 270 (404)
++-. ..++... .....+||+.|+|||++....|+..+|+|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 9621 1111100 01135899999999999999999999999
Q ss_pred hhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 271 SFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 271 slG~ll~ell~g~~p~~~~~~~~~ 294 (404)
|.|+|||||+.|+.||-...+.+.
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcc
Confidence 999999999999999987776544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=266.01 Aligned_cols=270 Identities=26% Similarity=0.355 Sum_probs=204.6
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCcceEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ--LYHPNLVKLVG 145 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~ 145 (404)
.+..++..+.+.||+|.||.||+|.|+ |..||||++...++ ..+.+|.+++.. |+|+||+.+++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhh
Confidence 455678888999999999999999885 67899999976543 456778888875 49999999998
Q ss_pred EEEeCC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHc------CCCCceecCCCCCcE
Q 046897 146 YCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHG------AETKVIYRDFKTSNI 215 (404)
Q Consensus 146 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~------~~~~i~H~Dlkp~NI 215 (404)
.-..++ .++||.+|.+.|+|.|+|... .++.+..++++..++.||++||. -+..|.|||||..||
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 876554 689999999999999999874 58999999999999999999993 156699999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCC--CcceeeccccccccCccccccCC----C--CcccchhhhhHHHHHHHhC-----
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPEYLATGH----L--TAKSDVYSFGVVLLEMLSG----- 282 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~ll~ell~g----- 282 (404)
||..+|..-|+|+|+|........ ....+..+||.+|||||++...- + -..+||||||.++||+...
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 999999999999999986544321 12234578999999999985421 1 1268999999999999763
Q ss_pred -----CCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 283 -----RRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 283 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
++||.+.-+.+..... +.+.-.+.++.-..............+.++++.||..||.-|-|+-.|.+.|.
T Consensus 428 i~eey~~Pyyd~Vp~DPs~ee------MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEE------MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred EehhhcCCcccCCCCCCCHHH------HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 3566543332221100 00111111111111122334456678889999999999999999999999999
Q ss_pred hhHhc
Q 046897 358 QLQDS 362 (404)
Q Consensus 358 ~~~~~ 362 (404)
++.+.
T Consensus 502 ~l~~~ 506 (513)
T KOG2052|consen 502 KLSNS 506 (513)
T ss_pred HHhcC
Confidence 98753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=263.31 Aligned_cols=269 Identities=25% Similarity=0.336 Sum_probs=198.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..|.-...||+|.||.||+ |....+|+.|++|.+..+++ .--...++|+++|..|+|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFk---------Ar~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFK---------ARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHH---------HhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 4566677899999999998 66777888899987654322 222557899999999999999999887753
Q ss_pred C--------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 150 D--------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 150 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
. ..+|+||.+|+. +|..++.... ..++...+..++.++..||.|+| ...|+|||+|++|+||+.+|
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDG 161 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCc
Confidence 2 358999999965 8888886543 56899999999999999999999 89999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCC--cceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh
Q 046897 222 NAKLSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~ 298 (404)
.+||+|||+++.....+.. ...+..+.|..|++||.+.| ..|+++.|||.-||++.||++|.+.|.+.........+
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 9999999999754433321 22345677999999998875 67999999999999999999999999876554332222
Q ss_pred hhh-----hhhhhhccc--cchhh--cccccCCCC--------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 EWA-----KPYLASKRK--IFRII--DNRLEGQYT--------LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ~~~-----~~~~~~~~~--~~~~~--~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ...+....+ +..-+ .+...+.+. .....+..+|+..+|..||.+|+++.+++..
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110 000000000 00000 000111111 1113367799999999999999999998865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=283.69 Aligned_cols=243 Identities=23% Similarity=0.276 Sum_probs=201.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++..+..||.|+||.|=++..+. ....+|+|.+++... ...+.+..|-++|...+.|.||++|..|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~---------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNS---------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecc---------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 345566789999999998865432 222478888876533 33455788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++.++|++||-|-||.|+..+.+++ .++......++..++.|++||| .++||.|||||+|.+++.+|.+||.||
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEeeh
Confidence 9999999999999999999999886 4788889999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|.|.....+. ...+++|||.|.|||++.+...+.++|.|+||+++|||++|.+||...++....+++..
T Consensus 565 GFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk-------- 633 (732)
T KOG0614|consen 565 GFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK-------- 633 (732)
T ss_pred hhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--------
Confidence 9999876554 46678999999999999999999999999999999999999999998665433222211
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM 348 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 348 (404)
..-.-.++........+|++++...+|.+|.-
T Consensus 634 --------Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 634 --------GIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --------hhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11112445555667779999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.48 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=197.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcC-CCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
-.+|.++++||+|+|++|.+ +....+.+.||+|+++++-... ...+..|-.+..+- +||.+|-+...
T Consensus 249 l~df~ll~vigrgsyakvl~---------~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLL---------VRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccceeeeeecCcchhhhhh---------eehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 35799999999999999987 5556678999999987753333 33455666666655 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
|..+..+|+|.||++||+|.-.+++.. .++++.+..+...|+.||.||| ..+|+.||||.+|+|++..|++||.
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeec
Confidence 999999999999999999998887764 5999999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC-CCcchhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS-GEHNLVEWAKPYL 305 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~-~~~~~~~~~~~~~ 305 (404)
|+|++...-. .......++|||.|.|||++.+..|+..+|+|+||++++||+.|+.||+.-... ...+..++..
T Consensus 394 dygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf--- 468 (593)
T KOG0695|consen 394 DYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF--- 468 (593)
T ss_pred ccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH---
Confidence 9999986322 223466789999999999999999999999999999999999999999743221 1111111111
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 347 (404)
.-++.+.+ ..+...+-....+++..|++||.+|.
T Consensus 469 ------qvilekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 ------QVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------HHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11222222 22223334456889999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=262.41 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=203.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.+.+..+.||-|+||.||. ++++.+|+.|++|.+... +....+++.+|+++|..++|.|++..+++..-
T Consensus 53 ~Di~PDRPIGYGAFGVVWs---------VTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWS---------VTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred ccCCCCCcccccceeEEEe---------ccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 3456678999999999997 788889999999988653 33445788999999999999999999887764
Q ss_pred CC-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 150 DD-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 150 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
.+ ++|+++|.+ ..+|...|-.- ++++...++-++.||++||.||| +.+|.||||||.|.|++.+..+|
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvLK 196 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCILK 196 (449)
T ss_pred CCchHHHHHHHHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceEE
Confidence 43 467888988 56787766543 67899999999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh--
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA-- 301 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~-- 301 (404)
|+|||+++.... +....++..+.|..|+|||++.| ..|+.+.||||+||++.||+..+..|...++....+++.-.
T Consensus 197 ICDFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 197 ICDFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred ecccccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 999999997543 33334556678999999999876 57999999999999999999999999877665444333110
Q ss_pred hh------hhhhccccchhhccccc-CC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 302 KP------YLASKRKIFRIIDNRLE-GQ--------YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 302 ~~------~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
.+ +..+. ....++..... .. -+.....+...++..++.+||++|.+..+.+..+.
T Consensus 276 TPs~EaMr~ACEG-Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 276 TPSQEAMKYACEG-AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CCcHHHHHHHhhh-hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00 00111 11111111111 01 11123345667888999999999999999887654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=243.64 Aligned_cols=204 Identities=26% Similarity=0.345 Sum_probs=168.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 149 (404)
+...-+..||+|++|.|=+ .++..+|...|+|.+...-. ...+++++|+.+..+. .+|++|.+|+.+..
T Consensus 46 d~L~~i~elGrGayG~vek---------mrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEK---------MRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred hhhhhhhhhcCCccchhhh---------eeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 3344456799999999976 56777899999999976533 3335678888877665 69999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....+|.||.| ..+|..+-.+--.....+++..+-+|+..++.||.|||+ ...++|||+||+||||+.+|+||+||||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999999 568877766544445789999999999999999999997 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccc----cCCCCcccchhhhhHHHHHHHhCCCCcCCC
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLA----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKN 289 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~ll~ell~g~~p~~~~ 289 (404)
++..+.+.- ..+-..|...|||||.+. ...|+.++||||||++++||.+++.||+..
T Consensus 195 IsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 195 ISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 998754432 222245778899999874 347899999999999999999999999753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.93 Aligned_cols=237 Identities=31% Similarity=0.427 Sum_probs=191.5
Q ss_pred CcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEeccCC
Q 046897 84 GFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPR 162 (404)
Q Consensus 84 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 162 (404)
+||.||+|.. ..++..+++|++....... .+.+.+|++.++.++|+||+++++.+......+++|||+.+
T Consensus 1 ~~g~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARD---------KKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEE---------CCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 5899999654 3467899999998765544 67889999999999999999999999999999999999988
Q ss_pred CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcc
Q 046897 163 GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242 (404)
Q Consensus 163 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~ 242 (404)
++|..++.... .+++..++.++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 72 ~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 72 GDLFDLLKKRG----RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 89999987643 2789999999999999999999 8899999999999999999999999999998754432 2
Q ss_pred eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCC
Q 046897 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQ 322 (404)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (404)
.....++..|++||.+.+..++.++|||+||+++++|++|..||...... ... ...+.......
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~--------------~~~~~~~~~~~ 206 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL--------------FKKIGKPKPPF 206 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH--------------HHHHhccCCCC
Confidence 33456788999999998888899999999999999999999999653111 000 01011000000
Q ss_pred CCHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 323 YTLE--GAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 323 ~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.... .+..+.+++.+||..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000 4567889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=281.33 Aligned_cols=267 Identities=19% Similarity=0.246 Sum_probs=169.8
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEE---
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGY--- 146 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~--- 146 (404)
..++|.+.+.||+|+||.||+|++.... ...+..||+|.+...... +....+ .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~-----~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ-----SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCc-----cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 3568999999999999999997664311 123788999987654321 111111 1222222222222221
Q ss_pred ---EEeCCeeEEEEeccCCCChHHHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCcee
Q 046897 147 ---CLEDDHRLLVYEFMPRGSLENHLFRRGSY----------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIY 207 (404)
Q Consensus 147 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H 207 (404)
...+...++||||+.+++|.+++...... ........+..++.||+.||.||| +.+|+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 23456789999999999999998754210 001123456789999999999999 889999
Q ss_pred cCCCCCcEEEcC-CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC----------------------CCC
Q 046897 208 RDFKTSNILLDT-NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG----------------------HLT 264 (404)
Q Consensus 208 ~Dlkp~NIll~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 264 (404)
|||||+|||++. ++.+||+|||++........ .......+++.|+|||.+... .+.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 68999999999986433221 223456789999999965322 234
Q ss_pred cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc---chhhcccccCC------CCHHHHHHHHHHH
Q 046897 265 AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI---FRIIDNRLEGQ------YTLEGAYKAATLA 335 (404)
Q Consensus 265 ~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~l~~li 335 (404)
.++|||||||++|||+++..+++.. ...+...+....... ..........+ ..........+|+
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence 5679999999999999977664321 111111000000000 00111110000 0001122455899
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 046897 336 LRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 336 ~~cl~~dP~~RPs~~eil~~ 355 (404)
.+||+.||++|||+.++++.
T Consensus 431 ~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHccCCcccCCCHHHHhCC
Confidence 99999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.44 Aligned_cols=277 Identities=20% Similarity=0.226 Sum_probs=183.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCccc-------ccccCCCCcEEEEEEecCCCcccHHH--------------HHHHH
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSF-------AATKPGTGMVIAVKRLNQDGFQGHKE--------------WLAEV 129 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 129 (404)
.++|.+.++||+|+||.||+|....... .......++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 4689999999999999999997532110 01233456789999987543222222 33466
Q ss_pred HHHhcCCCCCc-----ceEEEEEEe--------CCeeEEEEeccCCCChHHHHhhcCCC--------------------C
Q 046897 130 NYLGQLYHPNL-----VKLVGYCLE--------DDHRLLVYEFMPRGSLENHLFRRGSY--------------------F 176 (404)
Q Consensus 130 ~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~ 176 (404)
.++.+++|.++ ++++++|.. ++..++||||+.+++|.+++...... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766543 667776653 35689999999999999998753210 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcc
Q 046897 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256 (404)
Q Consensus 177 ~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 256 (404)
..+++..++.++.|++.+|.||| +.+|+||||||+|||++.++.+||+|||++......... ......+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 23467788999999999999999 889999999999999999999999999999754332211 111234578999999
Q ss_pred ccccCC--------------------CC--cccchhhhhHHHHHHHhCCC-CcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 257 YLATGH--------------------LT--AKSDVYSFGVVLLEMLSGRR-AVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 257 ~~~~~~--------------------~~--~~~DiwslG~ll~ell~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
.+.... |+ .+.||||+||++|+|++|.. ||........ ....+ ..+...+..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~----~~~~~~~r~ 455 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQY----DNDLNRWRM 455 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhc----cchHHHHHh
Confidence 875322 11 24799999999999999886 6643211100 00000 000000000
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEG---KFRPMMAEVVTV 355 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~~ 355 (404)
...................+++.+||..+| .+|+|+.|+|+.
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 001111111222345678899999999866 689999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=276.96 Aligned_cols=262 Identities=28% Similarity=0.399 Sum_probs=195.2
Q ss_pred CCCCCcccccCccc-EEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGS-VFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 151 (404)
|.-.+++|.|+.|+ ||+|.+. |+.||||++-.+. ..-..+|+..|+.- .|||||++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44567899999876 7888774 6789999886543 23457899999988 5999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---C--CcEEEe
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---N--YNAKLS 226 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~--~~vkl~ 226 (404)
..||+.|.| ..+|.+++...............+.++.|++.||++|| +.+|+||||||.||||+. + .+++|+
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--sl~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--SLKIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--hcccccccCCCceEEEEccCCCcceeEEec
Confidence 999999999 67999999874211111222456788999999999999 799999999999999975 3 468999
Q ss_pred cccCCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhC-CCCcCCCCCCCCcchhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG-RRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g-~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|||++.....+...- ......||.+|+|||++....-..++|||||||++|+.++| .+||...-..+.. +
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------I 725 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------I 725 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------h
Confidence 999999876554332 23456799999999999988888899999999999999996 8899754221110 0
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH---------HHHhhHhccccCCcc
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT---------VLEQLQDSSETGNIR 369 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~---------~L~~~~~~~~~~~~~ 369 (404)
+.....+..+ .-..++ ...+||.+|++++|..||++.+|+. +|.=+++.+..-++.
T Consensus 726 l~~~~~L~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e 790 (903)
T KOG1027|consen 726 LTGNYTLVHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKE 790 (903)
T ss_pred hcCccceeee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhh
Confidence 0011111110 011111 6779999999999999999999984 455555555444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=263.66 Aligned_cols=211 Identities=23% Similarity=0.269 Sum_probs=178.2
Q ss_pred cCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC----
Q 046897 62 FSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH---- 137 (404)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---- 137 (404)
|.+........+|.+....|+|-|++|.+ |.+...|..||||+|.... ...+.=++|+++|++|+.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvr---------a~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVR---------ARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPE 491 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeee---------ccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCch
Confidence 44555566678999999999999999988 5666677899999998764 334666889999999952
Q ss_pred --CCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 138 --PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 138 --p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
-|++.++..|...+++|||||-+ ..+|.+++.+.+.. ..|....+..++.|+..||..|- ..+|+|.||||+||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNI 567 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccce
Confidence 48999999999999999999999 77999999887643 56888899999999999999999 89999999999999
Q ss_pred EEcCC-CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 216 LLDTN-YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 216 ll~~~-~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
||++. ..+||||||.|-...... .+.+..+..|.|||++.|-+|+...|+||+||+||||.||+..|.+..
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred EeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99875 457999999997654332 223445667999999999999999999999999999999999997654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=261.38 Aligned_cols=197 Identities=24% Similarity=0.343 Sum_probs=169.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH--------HHHHHHHHHHhcCC---CCCc
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--------KEWLAEVNYLGQLY---HPNL 140 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---hp~i 140 (404)
.+|...+.+|.|+||.|++ |.++.+...|++|.+.++..-.. -.+-.|+.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~l---------ai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNL---------AIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEE---------eeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 4688999999999999999 55555678899999876422111 12356999999997 9999
Q ss_pred ceEEEEEEeCCeeEEEEecc-CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 141 VKLVGYCLEDDHRLLVYEFM-PRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 141 v~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
++++++|++++++||+||-. ++-+|.++|..+. .+++..+..|+.||+.|+++|| +.+|+|||||-+|+.++.
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDS 705 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEec
Confidence 99999999999999999976 5679999998764 5899999999999999999999 899999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcC
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
+|-+||+|||.+.....+. ...++||..|.|||++.|..| +..-|||+||++||.++....||.
T Consensus 706 ~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999998754432 456789999999999998877 557899999999999999988875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=240.44 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=196.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..+|.-++.+|.|.- .|-. +.+.-.++.|++|.+... +....++..+|+.++..++|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~---------a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVA---------AFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEe---------cchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 457888888999988 4443 566667889999987543 3344577889999999999999999999987
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
-.. ..|+|||++ ..+|...+.. .++-+.+..++.|+++|+.||| +.+|+||||||+||++..++.
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchhh
Confidence 443 579999999 6799998873 3688899999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+||.|||+|+..... -..+..+.|..|.|||++.+-.|...+||||+||++.||++|+..|.+... +-+|.+
T Consensus 157 lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~k 228 (369)
T KOG0665|consen 157 LKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNK 228 (369)
T ss_pred eeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHH
Confidence 999999999864332 245667899999999999988899999999999999999999999974322 222221
Q ss_pred hhh--------------hhccccc------------h-hhcccccC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046897 303 PYL--------------ASKRKIF------------R-IIDNRLEG--QYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353 (404)
Q Consensus 303 ~~~--------------~~~~~~~------------~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 353 (404)
..- ...+... + +.|..... +.+.-....+.+++.+||..||++|.|++++|
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 110 0000000 0 01111110 11112344678999999999999999999998
Q ss_pred HH
Q 046897 354 TV 355 (404)
Q Consensus 354 ~~ 355 (404)
..
T Consensus 309 ~H 310 (369)
T KOG0665|consen 309 RH 310 (369)
T ss_pred cC
Confidence 64
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=226.78 Aligned_cols=260 Identities=19% Similarity=0.256 Sum_probs=194.4
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 148 (404)
.+++|++.+.+|+|-++.||.|. ...++..+++|+++.. ..+.+.+|+.+|..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~---------~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGI---------NITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccc---------ccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 46789999999999999999854 4446788999999764 4467889999999996 999999999998
Q ss_pred eCC--eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcEEE
Q 046897 149 EDD--HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKL 225 (404)
Q Consensus 149 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~vkl 225 (404)
+.. ...+++||+++.+...+. +.++...+...+.+++.||.|+| +.||.|||+||.|++|+.. -.++|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred CccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeee
Confidence 764 467999999887665544 35788889999999999999999 8999999999999999865 46999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
+|||+|....++.. .+-.+.+..|.-||++.. ..|+..-|+|||||++..|+..+.||-..... ..+++..+ ..
T Consensus 175 IDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIa-kV 249 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIA-KV 249 (338)
T ss_pred eecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHH-HH
Confidence 99999987655443 233456778999998864 57899999999999999999999999643322 12222211 11
Q ss_pred hhh--------------ccccchhhcccccC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LAS--------------KRKIFRIIDNRLEG--------QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~--------------~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.. ......++..-.+. +-..-...+..+++.++|..|-.+|+|+.|....
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 110 00111111110000 0011124578899999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=227.13 Aligned_cols=211 Identities=36% Similarity=0.548 Sum_probs=181.3
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEe
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYE 158 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 158 (404)
||+|.+|.||++.. ..++..+++|++...... ..+.+.+|++.++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~---------~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARD---------KKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEe---------cCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 68999999999644 336788999998876433 34678899999999999999999999999899999999
Q ss_pred ccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CCcEEEecccCCCCCCCC
Q 046897 159 FMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLSDFGLAKDGPTG 237 (404)
Q Consensus 159 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~~vkl~Dfg~a~~~~~~ 237 (404)
++.+++|.+++.... ..++...++.++.+++.++.+|| ..+++|+||+|.||+++. ++.++|+|||.+......
T Consensus 72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 999899999987653 35789999999999999999999 789999999999999999 899999999999865433
Q ss_pred CCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhc
Q 046897 238 DQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIID 316 (404)
Q Consensus 238 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (404)
.. ......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 21 12334577889999998776 788999999999999999
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 317 NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+.+++.+|++.||++||++.++++.
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346689999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=230.51 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=187.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEE-E
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGY-C 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~-~ 147 (404)
..+.|.+.+.||+|.||.+.+ +.++++...+++|.+.... ....+|.+|...--.| .|.||+.-|++ |
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL---------~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILL---------AEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred hhhhhhHHHHhcccceeeEEe---------eeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 346788999999999999998 7788889999999887653 4567899998776666 58999998875 5
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc--CCCcEEE
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD--TNYNAKL 225 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~--~~~~vkl 225 (404)
+..+.+++++||++.|+|...+... .+.+.....++.|++.||.|+| ++++||||||.+||||- ...+|||
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEEEe
Confidence 5667788999999999999888764 4788999999999999999999 89999999999999993 3457999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCcccccc---C--CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT---G--HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
||||+.+..... ......+..|.+||++.. + ...+.+|||.||+++|.+++|+.||+.. .........|
T Consensus 165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~ 238 (378)
T KOG1345|consen 165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEW 238 (378)
T ss_pred eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHH
Confidence 999998864331 222334567999997642 2 2466899999999999999999999843 2333333333
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+-. .+... .+...+ ......+..+.++-|..++++|=-..++.+
T Consensus 239 ~~w~---~rk~~-----~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 239 EQWL---KRKNP-----ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HHHh---cccCc-----cCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 3211 11111 111011 122445678899999999999944444433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=259.85 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=205.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|.+...+|.|++|.||+ +++..++...|+|+++.+--.+..-+.+|+-+++..+||||+.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyK---------aRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYK---------ARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhh---------hcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 56799999999999999999 677778999999999887666666778899999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+.++++||||.+|+|.+.-+..+ ++++.++..+++..++||+||| +.+-+|||||-.||+++..|.+|++|||.
T Consensus 85 dklwicMEycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCc
Confidence 99999999999999998776553 6999999999999999999999 88899999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccc---ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYL---ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+......- .....+.||+.|||||+. ..+.|...+|||++|++..|+---.+|.....+.....+ ..
T Consensus 159 saqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--------mT 228 (829)
T KOG0576|consen 159 SAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--------MT 228 (829)
T ss_pred hhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--------hh
Confidence 87654322 234457899999999975 356899999999999999999887777654333222111 11
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .++.. ..-...+...+.++++.||-.+|++||+++.+|.
T Consensus 229 kS~----~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 KSG----FQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccC----CCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 100 01100 1112345667889999999999999999977654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=222.50 Aligned_cols=200 Identities=34% Similarity=0.470 Sum_probs=171.6
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
|.+.+.||.|++|.||++.. ..++..+++|.+...... ..+.+.+|++.++.++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARD---------KGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEE---------cCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 56778999999999999654 335788999999876554 56788899999999999999999999999899
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.++++|++++++|.+++..... .+++..++.++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999976531 1789999999999999999999 7899999999999999999999999999988
Q ss_pred CCCCCCCCcceeeccccccccCcccc-ccCCCCcccchhhhhHHHHHHHhCCCCcCC
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~ll~ell~g~~p~~~ 288 (404)
........ ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 75443211 22335678889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=231.23 Aligned_cols=272 Identities=24% Similarity=0.299 Sum_probs=198.0
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEE
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVG 145 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~ 145 (404)
+....+.|..++.||.|+|+.||++.+.. ....+..||+|.+.... .-.++..|+++|..+ .+.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchh
Confidence 44456789999999999999999975533 13367889999987763 346788999999999 5999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CCcEE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAK 224 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~~vk 224 (404)
.+..++...+|+||++.....++... ++...+..+++.++.||.++| .+||+||||||.|+|.+. .+.-.
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCce
Confidence 99999999999999999888887753 678899999999999999999 899999999999999974 57789
Q ss_pred EecccCCCC-----------------CCC--CC---------------C--------CcceeeccccccccCcccccc-C
Q 046897 225 LSDFGLAKD-----------------GPT--GD---------------Q--------SHVSTRVMGTYGYAAPEYLAT-G 261 (404)
Q Consensus 225 l~Dfg~a~~-----------------~~~--~~---------------~--------~~~~~~~~gt~~y~aPE~~~~-~ 261 (404)
|+|||+|.. ... +. . ........||++|+|||++.. .
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 999999971 000 00 0 000113579999999999865 4
Q ss_pred CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc--chh---------hhhhh--h--hhhccccchh---------h--
Q 046897 262 HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH--NLV---------EWAKP--Y--LASKRKIFRI---------I-- 315 (404)
Q Consensus 262 ~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~--~~~---------~~~~~--~--~~~~~~~~~~---------~-- 315 (404)
..+.++||||.|+|+.-+++++.||-.....-.. .++ +.+.. . +.+...+..+ +
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 5788999999999999999999999654332110 000 00000 0 0000000000 0
Q ss_pred ccccc--------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 316 DNRLE--------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 316 ~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... .......+..+.+++.+||+.||.+|.|+++.|+.
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00000 11111223478899999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=260.52 Aligned_cols=196 Identities=20% Similarity=0.233 Sum_probs=137.2
Q ss_pred cCCC-CCcceEEEEE-------EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc
Q 046897 134 QLYH-PNLVKLVGYC-------LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKV 205 (404)
Q Consensus 134 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i 205 (404)
.+.| .||+.++++| .....++++|||+ +++|.+++.... ..+++..++.++.||+.||.||| +++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAH--SQGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHH--hCCe
Confidence 3345 5777788877 2334567788988 679999997532 46899999999999999999999 8999
Q ss_pred eecCCCCCcEEEcCCCc-------------------EEEecccCCCCCCCCCC--------------Ccceeeccccccc
Q 046897 206 IYRDFKTSNILLDTNYN-------------------AKLSDFGLAKDGPTGDQ--------------SHVSTRVMGTYGY 252 (404)
Q Consensus 206 ~H~Dlkp~NIll~~~~~-------------------vkl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y 252 (404)
+||||||+||||+..+. +|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55555555543110000 0001123588899
Q ss_pred cCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHH
Q 046897 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAA 332 (404)
Q Consensus 253 ~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 332 (404)
||||++.+..|+.++|||||||+||||++|..|+..... ...... ...+.+. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--------~~~~~~------~~~~~~~-----~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--------TMSSLR------HRVLPPQ-----ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--------HHHHHH------HhhcChh-----hhhcCHHHH
Confidence 999999999999999999999999999999887653110 000000 0000000 011123456
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 046897 333 TLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 333 ~li~~cl~~dP~~RPs~~eil~ 354 (404)
.++.+||+.+|.+||++.++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=203.36 Aligned_cols=168 Identities=23% Similarity=0.188 Sum_probs=126.6
Q ss_pred CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcc
Q 046897 163 GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242 (404)
Q Consensus 163 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~ 242 (404)
|+|.+++.... .++++..++.++.|++.||.||| +.+ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997643 46999999999999999999999 555 999999999999999 99987643321
Q ss_pred eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccC-
Q 046897 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEG- 321 (404)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 321 (404)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ........
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~------~~~~~~~~~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNG------MPADDPRDR 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHH------hccCCcccc
Confidence 258899999999999999999999999999999999999996532211 000000000 00000000
Q ss_pred CCCHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 322 QYTLEGAY--KAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 322 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
........ .+.+++.+||..||++||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11122222 68999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=209.78 Aligned_cols=265 Identities=21% Similarity=0.198 Sum_probs=198.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC----CCCcceEEEEE-
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY----HPNLVKLVGYC- 147 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~~~~~~- 147 (404)
+|.+.+.||+|+||.||++..... ....+|+|............+..|..++..+. .+++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~--------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE--------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC--------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 799999999999999999754321 14678999877653333336778888888886 26899999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-----Cc
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-----YN 222 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-----~~ 222 (404)
..+...|+||+.+ |.+|.++..... ...++...+..++.|++.+|.+|| +.+++||||||+|+++... ..
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccce
Confidence 4777899999999 889999886655 367999999999999999999999 8999999999999999755 46
Q ss_pred EEEecccCCCCCC--CCCCC---c--c-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 223 AKLSDFGLAKDGP--TGDQS---H--V-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 223 vkl~Dfg~a~~~~--~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~ 294 (404)
++|.|||+++... ..... . . .....||..|.++.+..+...+.+.|+||++.++.+++.|..||........
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 9999999998322 11110 0 1 1235699999999999999999999999999999999999999965443222
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
..... ...............+..+..+...+-..+...+|....+...|.+.....
T Consensus 246 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 KSKFE-------------KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHH-------------HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11100 000001100012223345666666777789999999999999988876654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=196.85 Aligned_cols=268 Identities=18% Similarity=0.196 Sum_probs=206.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 149 (404)
+-.|++++.||+|.||..+.|. ..-+++.||||.-.... ..-.+..|.+..+.|. .++|..++-+..+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~---------Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGK---------NLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred cccceeccccccCcceeeeccc---------ccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 4579999999999999999864 34468999999876542 3356778888888884 7999999988888
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-----CcEE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-----YNAK 224 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-----~~vk 224 (404)
+-+-.||||.+ |-+|+|+..-.+ ..++.+.+..++.|++.-++|+| .+++|.|||||+|+||..- ..+.
T Consensus 96 G~~NiLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 96 GKYNILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred cchhhhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEE
Confidence 88889999999 889999998776 57999999999999999999999 8999999999999999543 3489
Q ss_pred EecccCCCCCCCCCCCc-----ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 225 LSDFGLAKDGPTGDQSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
++|||+|....+..... ......||.+||+=....|.+.+.+-|+-|||-++++++-|..||.+.........-
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY- 248 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY- 248 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-
Confidence 99999999765544321 233467999999999888999999999999999999999999999876543332211
Q ss_pred hhhhhhhhccccchhhccccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCc
Q 046897 300 WAKPYLASKRKIFRIIDNRLE---GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNI 368 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 368 (404)
++|-+.... ..+....+.++..-+.-.=..+-.+-|...-+...|..+.+.......
T Consensus 249 ------------eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 249 ------------EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred ------------HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 112121111 112222344555555555556667779999988888888775555444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=191.94 Aligned_cols=272 Identities=19% Similarity=0.192 Sum_probs=208.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH-PNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 148 (404)
....|.+++.||.|+||.+|.| ....+|..||+|+-... .....+..|.++.+.|++ ..|..+..++.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeee---------eeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3578999999999999999994 45567999999987654 334567789999999975 56777777888
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc---CCCcEEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD---TNYNAKL 225 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~---~~~~vkl 225 (404)
+..+-.+||+.+ |.+|+++..-.. ..++..+++-++-|++.-++|+| .++++||||||+|+|.. ....+.|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEE
Confidence 888999999999 889999988765 46899999999999999999999 89999999999999995 3456999
Q ss_pred ecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 226 SDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
+|||++......... .......||.+|.+--...+...+.+.|+-|+|.++.++.-|..||++.......+.-
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-- 233 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-- 233 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH--
Confidence 999999865433322 1233467999999888777778889999999999999999999999876543322211
Q ss_pred hhhhhhhccccchhhcccc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCcccc
Q 046897 301 AKPYLASKRKIFRIIDNRL---EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNIRCN 371 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~~~ 371 (404)
+.+.++.. ...+....+.++.-.+.-|=..--++-|...-+-+.+.-+..+......+.+
T Consensus 234 -----------EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iy 296 (341)
T KOG1163|consen 234 -----------EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIY 296 (341)
T ss_pred -----------HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEe
Confidence 12222211 1122233345666777788777778889988888888887777766665444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=208.80 Aligned_cols=179 Identities=18% Similarity=0.126 Sum_probs=132.0
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCCcce
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-----FQGHKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~ 142 (404)
.....+|.+.+.||+|+||+||+|++.. .++..+|+|++.... ....+.+.+|+++|+.++|+|+++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~ 85 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAG--------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVP 85 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcC--------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCc
Confidence 3456789999999999999999965432 146678999865321 112356889999999999999985
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCC-CCCcEEEcCCC
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDF-KTSNILLDTNY 221 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dl-kp~NIll~~~~ 221 (404)
.+.. .+..|+||||++|++|.. +.. .. ...++.|++.+|.||| +.+|+|||| ||+|||++.++
T Consensus 86 ~l~~---~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 86 QLLA---TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred EEEE---cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCC
Confidence 3322 245799999999999962 211 11 1467889999999999 899999999 99999999999
Q ss_pred cEEEecccCCCCCCCCCCCcc------eeeccccccccCccccccC------CCCcccchh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHV------STRVMGTYGYAAPEYLATG------HLTAKSDVY 270 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Diw 270 (404)
.+||+|||+++.......... .....+++.|++||.+... ..+..+|-|
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999999986544321111 1346788899999988532 233446666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=227.81 Aligned_cols=256 Identities=22% Similarity=0.219 Sum_probs=185.1
Q ss_pred CCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEec-----CCCcccH-HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 75 RPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN-----QDGFQGH-KEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
...+++|.|++|.|+.... .........|... ....... ..+..|+.+-..+.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~---------~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKR---------RSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEe---------cCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 4578899999997776332 2222222333221 1111111 22566777778889999988877776
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+.....-.||||++ +|..++.... .+....+..++.|++.|+.||| ..+|.|||||++|++++.+|.+||+||
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Df 464 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDF 464 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeec
Confidence 66555556999988 9999987652 4778889999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCC--cceeeccccccccCccccccCCCCc-ccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATGHLTA-KSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|.+......... ......+|...|+|||++.+..|++ ..||||.|++++.|++|+.||...........
T Consensus 465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------- 536 (601)
T KOG0590|consen 465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------- 536 (601)
T ss_pred CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--------
Confidence 999865544443 4556688999999999999999987 68999999999999999999976554433210
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
........-...-........+...+.++.+||+.||.+|.|+.+|++-
T Consensus 537 -~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 537 -TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000000000000112223445567799999999999999999999763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=193.59 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=192.1
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 154 (404)
...|.+...|..|+|+|.. ..++.|+++.... ...+.|..|.-.|+-+.||||+.+++.|....++.
T Consensus 195 ~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 4458889999999998864 3466777765433 23367888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
++..|++.|+|+..++.... --.+..++..++.++++|++|||+.+.-|.---|....++||++.+.+|. .+-++..
T Consensus 264 ~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS 340 (448)
T ss_pred EeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee
Confidence 99999999999999987654 34667789999999999999999766666667789999999999887764 1111110
Q ss_pred CCCCCCcceeeccccccccCccccccCCCC---cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLT---AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
. ......-.|.||+||.+...+-+ .++|+|||++++|||.|...||....+.+..
T Consensus 341 -f-----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------- 398 (448)
T KOG0195|consen 341 -F-----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------- 398 (448)
T ss_pred -e-----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------
Confidence 0 11113356889999999765443 4799999999999999999999876553221
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.++--..++-..++..+..+..|+.-|++.||.+||.+..|+-.|++++
T Consensus 399 mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1222233444666777788889999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-23 Score=193.73 Aligned_cols=261 Identities=30% Similarity=0.410 Sum_probs=195.0
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCC-CcceEEEEEEe
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHP-NLVKLVGYCLE 149 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp-~iv~~~~~~~~ 149 (404)
|.+.+.||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +|+++.+.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667888999999999996543 568899887654433 56789999999999988 79999999977
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl~Df 228 (404)
....+++++++.++++.+++...... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEecc
Confidence 77789999999999999766654311 25889999999999999999999 88899999999999999998 7999999
Q ss_pred cCCCCCCCCCCCc----ceeeccccccccCcccccc---CCCCcccchhhhhHHHHHHHhCCCCcCCCCCC-CCcchhhh
Q 046897 229 GLAKDGPTGDQSH----VSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS-GEHNLVEW 300 (404)
Q Consensus 229 g~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~-~~~~~~~~ 300 (404)
|.+.......... ......|+..|++||.+.+ ..+....|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998544333221 2356789999999999977 57888999999999999999999997654321 00000000
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. ...... .................+.+++..|+..+|..|.+..+....
T Consensus 227 ~---~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 I---LELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred H---HhcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000 000000000002223567899999999999999998877764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=213.73 Aligned_cols=247 Identities=20% Similarity=0.240 Sum_probs=177.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHH---HHHHHHHhcCCCCCcceEEEEEE
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEW---LAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
+|...+.||.+.|=+|.++..++ |. |++|++-+.. ....+.+ +.|++ ...++|||.+++..+-.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 67778999999999999865443 44 8899875543 2333333 44555 55668999999988877
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+...|||-+|.. -+|+|.+..+. -+.....+.|+.|++.||..+| ..+|+|||||.+||||+.-.-+.|+||
T Consensus 92 t~kAAylvRqyvk-hnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVK-HNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hhHHHHHHHHHHh-hhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcc
Confidence 7778899999994 59999887653 4777888999999999999999 999999999999999999999999999
Q ss_pred cCCCCC--CCCC---CCcceeeccccccccCccccccC----------C-CCcccchhhhhHHHHHHHh-CCCCcCCCCC
Q 046897 229 GLAKDG--PTGD---QSHVSTRVMGTYGYAAPEYLATG----------H-LTAKSDVYSFGVVLLEMLS-GRRAVDKNRP 291 (404)
Q Consensus 229 g~a~~~--~~~~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~ll~ell~-g~~p~~~~~~ 291 (404)
..-+.. +..+ ......+-..-.+|.|||.+... . .+++.||||+||++.||++ |++||...+.
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL 244 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL 244 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH
Confidence 876532 1111 11222233445689999987431 1 5678999999999999988 6888863211
Q ss_pred CCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 292 SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. .+... ........+++ + ....+++++..|++.||.+|.++++.|+.
T Consensus 245 ~------aYr~~---~~~~~e~~Le~-I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 L------AYRSG---NADDPEQLLEK-I-------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred H------hHhcc---CccCHHHHHHh-C-------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 00000 00001111111 0 11256799999999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=183.27 Aligned_cols=172 Identities=13% Similarity=0.070 Sum_probs=132.0
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHH---------HHHHHHHHhcCCCCC
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---------WLAEVNYLGQLYHPN 139 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hp~ 139 (404)
....+|+..++||.|+||.||++. . ++..+++|++.......... +.+|++.+.++.|++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~---------~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLID---------T--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEe---------c--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 357899999999999999999732 2 24569999997654333222 578999999999999
Q ss_pred cceEEEEEEeC--------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCC
Q 046897 140 LVKLVGYCLED--------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFK 211 (404)
Q Consensus 140 iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlk 211 (404)
|..+.+++... ...+++|||++|.+|.++.. ++. ....+++.+|..+| ..+++|||++
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH--~~gi~H~Dik 162 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH--QHGMVSGDPH 162 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH--HcCCccCCCC
Confidence 99999886643 35789999999999987632 222 24568999999999 8999999999
Q ss_pred CCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHH
Q 046897 212 TSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280 (404)
Q Consensus 212 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell 280 (404)
|+||+++.+| ++|+|||.......... .. ..+....|+.++|+|+||+++..+.
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a---~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKA---KD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhh---HH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999988 99999998865422110 00 0233456778999999999987664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-23 Score=183.42 Aligned_cols=235 Identities=21% Similarity=0.267 Sum_probs=148.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCC----------CCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLY----------HPN 139 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------hp~ 139 (404)
.+...+.||.|+|+.||. +++..+++.+++|+...... ...+.+.+|.-....+. |-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~---------v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFE---------VTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEE---------EEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEE---------EEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 345568899999999998 66777899999998754432 22345556554444432 212
Q ss_pred cceEEEEEE---------eC---C-----eeEEEEeccCCCChHHHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 046897 140 LVKLVGYCL---------ED---D-----HRLLVYEFMPRGSLENHLFR---RGSYFQPLSWNLRLKVALGAAKGVAFLH 199 (404)
Q Consensus 140 iv~~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH 199 (404)
++..++... .. . +.+++|+-+ .++|.+++.. .......+.....+.+..|+++.+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 222222222 11 1 236788888 6688887643 2221123445556677799999999999
Q ss_pred cCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc--------CCCCcccchhh
Q 046897 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--------GHLTAKSDVYS 271 (404)
Q Consensus 200 ~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diws 271 (404)
..+++|+||+|+|+|++.+|.++|+||+....... .......+..|.+||.... -.++.+.|.|+
T Consensus 163 --~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 --SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp --HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred --hcceEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 89999999999999999999999999988765322 1111345577999997633 24688999999
Q ss_pred hhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 046897 272 FGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFR 346 (404)
Q Consensus 272 lG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 346 (404)
||+++|.|++|+.||+...+...... .+ .... +.++.+..||..+|+.||++|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999986543222111 11 1233 678889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=200.48 Aligned_cols=229 Identities=28% Similarity=0.337 Sum_probs=182.2
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH--HHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEE
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 155 (404)
++|+|+||.|+++.- +.....+..++.|++.+...... .....|-.++...+ ||.++++...++.+...++
T Consensus 1 vlg~g~~gkvfLvrk------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 479999999997421 34445677888888865432211 13345777888886 9999999999999999999
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
++++..+|.|...+.... .+.+.....+...++-+++++| ..+|+|||+|++||+++.+|++++.|||+++..-
T Consensus 75 ~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence 999999999988876654 4677778888889999999999 9999999999999999999999999999998643
Q ss_pred CCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
.... .+||..|||||++. ....++|.||||++++||++|..||.. +. ...|+
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~-------------~~~Il 200 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DT-------------MKRIL 200 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HH-------------HHHHh
Confidence 3221 28999999999986 678899999999999999999999975 00 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
. .....+.+......+++..++..+|.+|.-.
T Consensus 201 ~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 K--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 1235666777788899999999999999754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=172.23 Aligned_cols=139 Identities=16% Similarity=0.179 Sum_probs=105.8
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--c-------H-----------------HHHHHHHH
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--G-------H-----------------KEWLAEVN 130 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~ 130 (404)
...||+|+||.||+|. .. +|+.||+|+++..... . . .....|++
T Consensus 2 ~~~ig~G~~~~Vy~a~---------~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHAT---------TA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEE---------CC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 5689999999999953 33 6889999998754211 1 0 11235999
Q ss_pred HHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCCceecC
Q 046897 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL-HGAETKVIYRD 209 (404)
Q Consensus 131 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~i~H~D 209 (404)
.+..+.++++.....+... ..+|||||++++++...+... .+++...+..++.|++.+|.+| | ..+|+|||
T Consensus 72 ~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrD 143 (190)
T cd05147 72 NLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQ--DCRLVHAD 143 (190)
T ss_pred HHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCC
Confidence 9999987776443333222 238999999887776543322 3578899999999999999999 7 78999999
Q ss_pred CCCCcEEEcCCCcEEEecccCCCCC
Q 046897 210 FKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 210 lkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
|||+|||++ ++.++|+|||++...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=163.56 Aligned_cols=190 Identities=17% Similarity=0.116 Sum_probs=138.7
Q ss_pred CCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH----HHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 046897 75 RPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH----KEWLAEVNYLGQLY-HPNLVKLVGYCLE 149 (404)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 149 (404)
.+...|+.|+||+||.+ .. .+..++.+.+.....-.. ..+.+|+++|++|. |++|.+++++
T Consensus 5 ~~~~~l~~~~f~~v~~~---------~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLV---------RG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEe---------ec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 35678999999999963 22 456777777766543211 24788999999995 5889999886
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCC-CCCcEEEcCCCcEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDF-KTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dl-kp~NIll~~~~~vkl~Df 228 (404)
+..+++|||+.|.+|...+.. . ...++.|++.+|.++| ..+|+|||| ||+|||++.++.++|+||
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR----------G-DLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh----------h-hHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence 346899999999888654311 1 1346789999999999 899999999 799999999999999999
Q ss_pred cCCCCCCCCCCC----cc-------eeeccccccccCccccc--cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 229 GLAKDGPTGDQS----HV-------STRVMGTYGYAAPEYLA--TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 229 g~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
|++......... .. ......++.|+.|+.-. ...--.+.+.++.|+-+|.++|++.++...++.
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 999854332210 00 00123577788887432 222225789999999999999999987655443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=165.03 Aligned_cols=141 Identities=17% Similarity=0.164 Sum_probs=108.2
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--c------------------------HHHHHHHH
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--G------------------------HKEWLAEV 129 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~ 129 (404)
+.+.||+|+||.||+|. +. +|+.||+|+++..... . ...+..|.
T Consensus 1 ~~~~ig~G~~~~Vy~a~---------~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05145 1 INGCISTGKEANVYHAR---------TG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF 70 (190)
T ss_pred CCceeecCCCcEEEEEE---------cC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence 35789999999999954 33 6889999998765211 0 11235788
Q ss_pred HHHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceec
Q 046897 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYR 208 (404)
Q Consensus 130 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~ 208 (404)
+.+.++.|++|.....+... ..++||||++++++....... ..++......++.|++.++.+|| . .+|+||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH--~~~givHr 142 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLY--QEAGLVHG 142 (190)
T ss_pred HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHH--HhCCEecC
Confidence 99999999887554444333 248999999887554332222 24678889999999999999999 7 899999
Q ss_pred CCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 209 DFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 209 Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
||||+||+++ ++.++|+|||++....
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999999 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=198.33 Aligned_cols=248 Identities=19% Similarity=0.198 Sum_probs=179.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY---HPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~ 147 (404)
...|.|.+.||+|+||+||+|. +.. |+.||+|+-...+.... .--.+++.+|+ -+.|..+...+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~---------~~~-~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVAT---------HSN-GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ceeEEEEeeeccccceEEEEee---------cCC-CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHH
Confidence 4567788899999999999953 333 89999998876543321 11112223333 34466666666
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc-------CC
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD-------TN 220 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~-------~~ 220 (404)
...+.-++|+||.+.|+|.++++.. +.+++..++.++.|++..+++|| ..+|||+||||+|+||. ..
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCcc
Confidence 6677788999999999999999843 46899999999999999999999 89999999999999993 23
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
..++|+|||.+.....-..........+|-.+-.+|...|.+|++.+|.|.|+.+++-|+.|+..=..
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~------------ 905 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVK------------ 905 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhc------------
Confidence 45899999999875544444456667899999999999999999999999999999999999853100
Q ss_pred hhhhhhhccccchhhcccccCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEG-AYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
. +.. ..++. .++... .+-+.++...+|+.|-..=|...++...|+.+..
T Consensus 906 ------~-g~~-~~~~~----~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 ------N-GSS-WMVKT----NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ------C-Ccc-eeccc----cchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 0 000 00000 011111 1234467777888444444778888877776554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=181.80 Aligned_cols=219 Identities=26% Similarity=0.368 Sum_probs=163.9
Q ss_pred HhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCc-eecCC
Q 046897 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKV-IYRDF 210 (404)
Q Consensus 132 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i-~H~Dl 210 (404)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.... ..+++.....++++++.||.|||. ..| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHN--SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeee
Confidence 457889999999999999999999999999999999998743 568999999999999999999994 444 99999
Q ss_pred CCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCC-------CCcccchhhhhHHHHHHHhCC
Q 046897 211 KTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-------LTAKSDVYSFGVVLLEMLSGR 283 (404)
Q Consensus 211 kp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~ll~ell~g~ 283 (404)
+..|.+++....+||.|||+.................-...|.|||.+.+.. .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999988754211111111122445699999986531 356799999999999999999
Q ss_pred CCcCCCCCCCCc-chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 284 RAVDKNRPSGEH-NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 284 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.||......... .++..... .....+.+.+... .+....+..++.+||..+|++||++..|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999864433221 22222111 0011111111111 13344788999999999999999999999999887665
Q ss_pred c
Q 046897 363 S 363 (404)
Q Consensus 363 ~ 363 (404)
.
T Consensus 228 ~ 228 (484)
T KOG1023|consen 228 G 228 (484)
T ss_pred c
Confidence 4
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=161.73 Aligned_cols=135 Identities=19% Similarity=0.232 Sum_probs=104.7
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-----CCCCcceEEEEEEeC
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-----YHPNLVKLVGYCLED 150 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~ 150 (404)
-.++||+|+||.||. ++.++.. ++|++........+.+.+|+.+++.+ .||||+++++++.++
T Consensus 6 ~~~~LG~G~~~~Vy~-----------hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-----------HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE-----------CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 357899999999994 2233444 68988765445567789999999999 579999999999987
Q ss_pred C---eeE-EEEec--cCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhHcCCCCceecCCCCCcEEEcC----
Q 046897 151 D---HRL-LVYEF--MPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV-AFLHGAETKVIYRDFKTSNILLDT---- 219 (404)
Q Consensus 151 ~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~i~H~Dlkp~NIll~~---- 219 (404)
. ..+ +|+|| +.+++|.+++... .+++. ..++.+++.++ +||| +.+|+||||||+|||++.
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISES 144 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCC
Confidence 4 334 78999 4478999999653 24444 35577888777 9999 899999999999999974
Q ss_pred CCcEEEecccCC
Q 046897 220 NYNAKLSDFGLA 231 (404)
Q Consensus 220 ~~~vkl~Dfg~a 231 (404)
++.++|+||+-+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 347999995433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.7e-20 Score=165.53 Aligned_cols=198 Identities=21% Similarity=0.217 Sum_probs=142.7
Q ss_pred CCCCcceEEEEEEe---------------------------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHH
Q 046897 136 YHPNLVKLVGYCLE---------------------------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188 (404)
Q Consensus 136 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~ 188 (404)
+|||||.+..+|.+ +..+|+||..+ ..+|..++..+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887753 22468999988 559999997653 5777888899
Q ss_pred HHHHHHHHHhHcCCCCceecCCCCCcEEE--cCC--CcEEEecccCCCCCCCCC----CCcceeeccccccccCcccccc
Q 046897 189 LGAAKGVAFLHGAETKVIYRDFKTSNILL--DTN--YNAKLSDFGLAKDGPTGD----QSHVSTRVMGTYGYAAPEYLAT 260 (404)
Q Consensus 189 ~qi~~~l~~LH~~~~~i~H~Dlkp~NIll--~~~--~~vkl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 260 (404)
.|+++|+.||| .++|.|||+|.+|||| +.+ -.+.|+|||++-....-. .....-...|.-..||||+...
T Consensus 348 aQlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 8999999999999999 333 347999999875321110 1111123457788999998743
Q ss_pred C--C----CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHH
Q 046897 261 G--H----LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATL 334 (404)
Q Consensus 261 ~--~----~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 334 (404)
. + .-.++|.|+.|.+.||++....||...... ..+... ........++..++..+.++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~---------------Yqe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT---------------YQESQLPALPSRVPPVARQL 489 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh---------------hhhhhCCCCcccCChHHHHH
Confidence 1 1 124899999999999999999999763221 111000 11122234566677888999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHH
Q 046897 335 ALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 335 i~~cl~~dP~~RPs~~eil~~L~ 357 (404)
+...|+.||.+|++..-....|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999998765555544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=176.14 Aligned_cols=175 Identities=26% Similarity=0.362 Sum_probs=129.7
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
.++||.|++|...+|.+||..+.. ....++...+.++.|++.++.| ++.+|+|+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999975442 3557788999999999999998 6799999999999999999999999999
Q ss_pred CCCCCCCC----CCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhh
Q 046897 231 AKDGPTGD----QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
........ .....+...||..||+||.+.+..|+.++|||+||++|+||+. -..+|+-.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------------- 466 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------------- 466 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------------
Confidence 98654433 1223455789999999999999999999999999999999998 33333210
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 351 (404)
....++.+..+...+ ......-..|+++++...|.+||++.+
T Consensus 467 ---~t~~d~r~g~ip~~~-~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 ---ATLTDIRDGIIPPEF-LQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---HhhhhhhcCCCChHH-hhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 001111111111000 011112347999999999999994433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=188.33 Aligned_cols=210 Identities=25% Similarity=0.347 Sum_probs=144.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|..++.|..|++|.||. ++++.+.+.+|.| +++++.. ++- +|.....|.+|
T Consensus 82 e~df~~IklisngAygavyl---------vrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYL---------VRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceee---------eeccccccchhhc-ccccchh-----hhc--cccccCCccee---------
Confidence 46788899999999999998 4555567778884 4443211 111 23333344443
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
|+-...+...+ +++.. ++.+++||| +.+|+|||+||+|.+|+.-|++|++|||+
T Consensus 136 ------------gDc~tllk~~g----~lPvd--------mvla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIG----PLPVD--------MVLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGL 189 (1205)
T ss_pred ------------chhhhhcccCC----CCcch--------hhHHhHhhc--cCCeecCCCCCCcceeeecccccccchhh
Confidence 34444443322 23322 267899999 89999999999999999999999999999
Q ss_pred CCCCCCCCC------------Cc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 231 AKDGPTGDQ------------SH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 231 a~~~~~~~~------------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
+........ .. .....+||+.|.|||++....|+..+|+|++|+|+||++.|..||.+..++.....
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~ 269 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 269 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence 874211110 00 12246899999999999999999999999999999999999999998765433221
Q ss_pred hhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 046897 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP 347 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 347 (404)
+ +.+...+. +.......+..+++.++|+.+|..|-
T Consensus 270 v------isd~i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 V------ISDDIEWP---------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h------hhhhcccc---------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 11111110 11222344677899999999999995
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=159.06 Aligned_cols=145 Identities=16% Similarity=0.134 Sum_probs=109.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------------------------cHHHHH
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------------------------GHKEWL 126 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~ 126 (404)
+.-|.+.+.||+|+||.||+|+. +..+|..||+|++...... ....+.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE 98 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence 34588999999999999999541 3346889999998754211 002246
Q ss_pred HHHHHHhcCCCC--CcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC
Q 046897 127 AEVNYLGQLYHP--NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK 204 (404)
Q Consensus 127 ~E~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 204 (404)
.|+..+..+.+. .+.+++++ ...++||||+++.+|....... ..+....+..++.|++.++.+|| +.+
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~g 168 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLY--KEG 168 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHH--hcC
Confidence 799999999753 33444432 2358999999888876654322 23556667899999999999999 888
Q ss_pred -ceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 205 -VIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 205 -i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
|+|+||||+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=151.74 Aligned_cols=134 Identities=19% Similarity=0.298 Sum_probs=111.2
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--------HHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--------HKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|++|.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 6799999999999754 35668889765432211 1346789999999999998877777777
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....+++|||++|++|.+++.... . ....++.+++.+|.+|| ..+++|+|++|.|||++ ++.++|+|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 788899999999999999986432 2 77889999999999999 89999999999999999 7899999999
Q ss_pred CCCC
Q 046897 230 LAKD 233 (404)
Q Consensus 230 ~a~~ 233 (404)
++..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=149.12 Aligned_cols=130 Identities=20% Similarity=0.308 Sum_probs=104.8
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--------GHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.||+|+||.||+|.+ .+..+++|........ ..+++.+|++++..+.|+++....-++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999753 3567889986543211 124567899999999888766555556667
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..+++|||++|++|.+++.... . .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||+
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-------~----~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-------D----ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-------H----HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence 77899999999999998875421 0 78899999999999 89999999999999999 88999999999
Q ss_pred CCC
Q 046897 231 AKD 233 (404)
Q Consensus 231 a~~ 233 (404)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=169.67 Aligned_cols=138 Identities=23% Similarity=0.270 Sum_probs=109.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--------cccHHHHHHHHHHHhcCCCCCcc
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--------FQGHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv 141 (404)
....|...+.||+|+||.||+|.+.. ..+++|+..... ....+++.+|+++++.++|++++
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 399 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVP 399 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCC
Confidence 34556778999999999999976532 123333221110 01124578999999999999999
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
....++......++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+|||+ .++
T Consensus 400 ~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 400 TPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDD 464 (535)
T ss_pred eeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECC
Confidence 88888777778899999999999998874 24678899999999999 8999999999999999 678
Q ss_pred cEEEecccCCCC
Q 046897 222 NAKLSDFGLAKD 233 (404)
Q Consensus 222 ~vkl~Dfg~a~~ 233 (404)
.++|+|||+++.
T Consensus 465 ~~~liDFGla~~ 476 (535)
T PRK09605 465 RLYLIDFGLGKY 476 (535)
T ss_pred cEEEEeCccccc
Confidence 999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=145.16 Aligned_cols=144 Identities=16% Similarity=0.079 Sum_probs=108.6
Q ss_pred HHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc----------------------cHH
Q 046897 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ----------------------GHK 123 (404)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~ 123 (404)
++......|.+.+.||+|+||.||++... +|..+++|++...... ...
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL 78 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence 33444445888999999999999996432 5788999987643210 011
Q ss_pred HHHHHHHHHhcCCCC--CcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 046897 124 EWLAEVNYLGQLYHP--NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA 201 (404)
Q Consensus 124 ~~~~E~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 201 (404)
....|+.++..+.|+ .+..+++ ....+++|||+++++|...... .....++.+++.++.++|
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh-- 142 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY-- 142 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH--
Confidence 256788888888777 4444443 2355899999999988765321 234678889999999999
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
..+|+|+||+|+||+++.++.++|+|||++....
T Consensus 143 ~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 143 KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred HCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 8999999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.1e-18 Score=170.35 Aligned_cols=258 Identities=23% Similarity=0.244 Sum_probs=188.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLE 149 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 149 (404)
.|.+.+.||+|+|+.|-+... .......++.|.+.... ....+....|..+-..+. |.|++.+++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~--------~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASN--------SRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhh--------cCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 466667799999999976321 12334556666665443 222233445777767776 9999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl~Df 228 (404)
.+..++.++|..++++.+.+.... ....+......++.|+..++.|+|. ..++.|+||||+|.+++..+ .+++.||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCc
Confidence 999999999999999988873211 1246667788899999999999995 57899999999999999999 9999999
Q ss_pred cCCCCCCC-CCCCcceeeccc-cccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPT-GDQSHVSTRVMG-TYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|+|..... ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||........ ....|...
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~-- 246 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSN-- 246 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeeccc--
Confidence 99997766 444444556778 9999999998774 456789999999999999999999976544321 11111110
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. .................++.+++..+|..|.+.+++..
T Consensus 247 --~--------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 --K--------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --c--------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00001111223345668899999999999999988743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-15 Score=136.71 Aligned_cols=135 Identities=23% Similarity=0.260 Sum_probs=100.6
Q ss_pred Cccc-ccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCCCCCc--c
Q 046897 78 SVLG-EGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-------------QGHKEWLAEVNYLGQLYHPNL--V 141 (404)
Q Consensus 78 ~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~i--v 141 (404)
.+|| .|+.|+||.+.. .+..+++|.+...+. ....++.+|++++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~-----------~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----------PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEe-----------CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4576 778888887543 256788887753211 222457889999999988775 6
Q ss_pred eEEEEEEeCCe----eEEEEeccCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 142 KLVGYCLEDDH----RLLVYEFMPR-GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 142 ~~~~~~~~~~~----~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
..+++...... .++|||+++| .+|.+++... +++.. .+.+++.+|.+|| +.+|+|+||||.|||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NIL 174 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNIL 174 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEE
Confidence 66766443322 2599999987 6898887542 34443 3568899999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCC
Q 046897 217 LDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~ 234 (404)
++.++.++|+|||.+...
T Consensus 175 v~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EcCCCCEEEEECCCcccC
Confidence 999999999999998763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=133.74 Aligned_cols=135 Identities=20% Similarity=0.173 Sum_probs=94.7
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHH----------------------HHHHHHHH
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKE----------------------WLAEVNYL 132 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l 132 (404)
.+.||+|+||.||+|.. . ++..||+|++....... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~---------~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALD---------G-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEEC---------C-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 57899999999999643 2 57889999886532211 111 13455556
Q ss_pred hcCCCC--CcceEEEEEEeCCeeEEEEeccCCCChHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceec
Q 046897 133 GQLYHP--NLVKLVGYCLEDDHRLLVYEFMPRGSLEN-HLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYR 208 (404)
Q Consensus 133 ~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~ 208 (404)
..+.+. .+.++++. ...+++|||++++.+.. .+.... . ...+..++.+++.++.++| . .+|+|+
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh--~~~~ivH~ 139 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLY--REAGLVHG 139 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHh--hccCcCcC
Confidence 555433 24444443 24689999998854322 111111 0 1567888999999999999 6 899999
Q ss_pred CCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 209 DFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 209 Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
||||+||+++ ++.++|+|||.+...
T Consensus 140 Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 140 DLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-16 Score=128.11 Aligned_cols=134 Identities=19% Similarity=0.102 Sum_probs=109.0
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CCcceEEEEEEeCCee
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH--PNLVKLVGYCLEDDHR 153 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~ 153 (404)
+.+.||.|.++.||++... +..+++|....... ...+.+|+..++.+.| .++.+++.++...+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4578999999999996542 25689998866543 4568889999999976 5899999988887889
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
+++|||+.++.+..+ +......++.+++.+|++||... .+++|+|++|+||+++..+.++++|||.+.
T Consensus 69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999999988766543 44566778899999999999321 469999999999999999999999999886
Q ss_pred C
Q 046897 233 D 233 (404)
Q Consensus 233 ~ 233 (404)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 5
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.9e-15 Score=143.69 Aligned_cols=254 Identities=24% Similarity=0.290 Sum_probs=186.3
Q ss_pred hcCCCCCCcccc--cCcccEEEEEecCcccccccCCCCcEEEEEEec--CCCcccHHHHHHHHHHHhcCC-CCCcceEEE
Q 046897 71 TRNFRPDSVLGE--GGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN--QDGFQGHKEWLAEVNYLGQLY-HPNLVKLVG 145 (404)
Q Consensus 71 ~~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 145 (404)
...|.+.+.+|. |.+|.||.+.. .....+..+++|.-+ .........=.+|+...+.++ |+|.++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~-------~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRC-------TNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhcccccccccCCCCCceeecccC-------CcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 345777889999 99999998543 225567788888733 232233333456776666774 999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhHcCCCCceecCCCCCcEEEcCC-
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK----GVAFLHGAETKVIYRDFKTSNILLDTN- 220 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~i~H~Dlkp~NIll~~~- 220 (404)
.+...+..|+-+|++ +.+|..+..... ..++...++..+.+... ||.++| ..+++|.|+||+||++..+
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheeccccc
Confidence 999999999999999 678888776554 34777888888888888 999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcc---eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHV---STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
...+++|||+......+..... ..+..|...|++||.+ ++.++...|||+||.++.+..+|-.+....-.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------ 332 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------ 332 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------
Confidence 8899999999987766553222 2233678889999987 55789999999999999999998776543210
Q ss_pred hhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..|. .+....+..++.......+...+..|++.+|..|++.+.+.+.
T Consensus 333 ~~W~-----------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 333 SSWS-----------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred CCcc-----------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0111 1111112223333334455668999999999999998877653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.1e-16 Score=136.54 Aligned_cols=207 Identities=22% Similarity=0.271 Sum_probs=144.2
Q ss_pred HHHHhcCCCCCcceEEEEEEeCC-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC
Q 046897 129 VNYLGQLYHPNLVKLVGYCLEDD-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET 203 (404)
Q Consensus 129 ~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 203 (404)
+.-|-++.|.|||++..|+.+.. ...++.||+..|+|..+|++.......+......+|+-||+.||.|||+++.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455567999999998886543 4678999999999999999887777888999999999999999999999999
Q ss_pred CceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCC--CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh
Q 046897 204 KVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281 (404)
Q Consensus 204 ~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~ 281 (404)
.|+|+++..+.|++..+|-+|++--.-......... ......-.+.++|.+||.-...+.+-++|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999998752211110000000 000112245678999997555566779999999999999998
Q ss_pred CCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 282 GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
|...-........ .... ....+..+-+.. -+.++..|++..|..||++++++..
T Consensus 278 lEiq~tnseS~~~-~ee~-------ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVE-VEEN-------IANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceee-hhhh-------hhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 8764221111000 0000 000111111111 1257889999999999999988654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.7e-13 Score=132.92 Aligned_cols=168 Identities=16% Similarity=0.193 Sum_probs=128.9
Q ss_pred ccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCC
Q 046897 101 TKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180 (404)
Q Consensus 101 ~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 180 (404)
....++.+|.|...............+-++.|+.++||||+++++.+..+..+|||+|.+. -|..++... .
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~ 102 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------G 102 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------H
Confidence 3445677888888877655334556788899999999999999999999999999999983 677777653 3
Q ss_pred HHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc
Q 046897 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT 260 (404)
Q Consensus 181 ~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 260 (404)
......-+.||+.||.|||. +.+++|++|.-+.|+|+..|..||++|.++........ ......--..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 56677788999999999985 78999999999999999999999999998865432221 0111112224666665432
Q ss_pred CCCCcccchhhhhHHHHHHHhC
Q 046897 261 GHLTAKSDVYSFGVVLLEMLSG 282 (404)
Q Consensus 261 ~~~~~~~DiwslG~ll~ell~g 282 (404)
.. -..|.|.|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 456999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-13 Score=133.29 Aligned_cols=141 Identities=17% Similarity=0.138 Sum_probs=95.3
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHH---------------------------------
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK--------------------------------- 123 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--------------------------------- 123 (404)
.+.||.|++|+||+|+++ +|+.||||+..........
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 468999999999998654 4789999998653211100
Q ss_pred -------HHHHHHHHHhcC----CCCCcceEEEEEE-eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 046897 124 -------EWLAEVNYLGQL----YHPNLVKLVGYCL-EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191 (404)
Q Consensus 124 -------~~~~E~~~l~~l----~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 191 (404)
++.+|++.+..+ .|.+-+.+-.++. .....++||||++|++|.++...... ... ...++..+
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~ 265 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENL 265 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHH
Confidence 123444444444 2333333333332 23457899999999999887653211 122 23455555
Q ss_pred HH-HHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 192 AK-GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 192 ~~-~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
+. .+..+| ..+++|+|++|.||+++.++.++|+|||++....
T Consensus 266 ~~~~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 55 467888 7899999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-13 Score=135.46 Aligned_cols=146 Identities=16% Similarity=0.130 Sum_probs=94.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc------------------------------
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG------------------------------ 121 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 121 (404)
..|.. +.||.|++|+||+|+++ .+|+.||||++.......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~---------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLK---------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEEC---------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 35665 78999999999996654 358899999987542110
Q ss_pred ----HHH------HHHHHHHHhcC----CCCCcceEEEEEEe-CCeeEEEEeccCCCChHHHH--hhcCCCCCCCCHHHH
Q 046897 122 ----HKE------WLAEVNYLGQL----YHPNLVKLVGYCLE-DDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLR 184 (404)
Q Consensus 122 ----~~~------~~~E~~~l~~l----~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~l~~~~~ 184 (404)
.+. +.+|+..+.++ .+.+.+.+-.++.+ ....++||||++|+.+.++- ...+.....+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 011 23344444333 24444444444432 45678999999999998743 222211112333333
Q ss_pred HHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC----cEEEecccCCCCCCC
Q 046897 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY----NAKLSDFGLAKDGPT 236 (404)
Q Consensus 185 ~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~----~vkl~Dfg~a~~~~~ 236 (404)
..++.|+ . ..+++|+|+||.||+++.+| .++++|||++.....
T Consensus 270 ~~~~~Qi-------f--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQV-------F--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------H--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4444444 3 57899999999999999888 999999999986544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-12 Score=110.65 Aligned_cols=128 Identities=18% Similarity=0.069 Sum_probs=92.3
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLV-KLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~l 155 (404)
.+.|+.|.++.||++.. .+..+++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++
T Consensus 3 ~~~l~~G~~~~vy~~~~-----------~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-----------ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEE-----------CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 35688999999998543 256799998765431 123456788888888655544 444433 334589
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC-----ceecCCCCCcEEEcCCCcEEEecccC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK-----VIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-----i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
||||++|.++... . . ....++.+++.+|+.|| ..+ ++|+|++|.||+++ ++.++++|||.
T Consensus 69 v~e~i~G~~l~~~--~-------~---~~~~~~~~l~~~l~~LH--~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 69 ITEFIEGSELLTE--D-------F---SDPENLEKIAKLLKKLH--SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred EEEecCCCccccc--c-------c---cCHHHHHHHHHHHHHHh--CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9999999877543 0 0 11235678999999999 565 59999999999999 67899999998
Q ss_pred CCC
Q 046897 231 AKD 233 (404)
Q Consensus 231 a~~ 233 (404)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.2e-13 Score=128.93 Aligned_cols=249 Identities=21% Similarity=0.197 Sum_probs=175.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHH--HHHHHHHHhcC-CCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE--WLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
..+|..+..||.|.|+.|+.. .....++..|++|.+...-.....+ -+.|+-+...+ .|.+++.++..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~--------~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKV--------SKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceee--------eecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 346778889999999999974 2233567789999876653333322 35566666665 488899988888
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcEEEe
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLS 226 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~vkl~ 226 (404)
....+.|+--|||+++++...+.-. .-+.+...+.+..|++.++.++| ...++|+|++|+||++..+ +..+++
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhcc
Confidence 8888888999999998887766322 34677788999999999999999 8999999999999999886 778999
Q ss_pred cccCCCCCCCCCCCcceeecccccccc--CccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYA--APEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|||+........ ....+..+++ +++......+..+.|+++||..+.+.++|...-.....
T Consensus 410 ~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------- 471 (524)
T KOG0601|consen 410 DFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------- 471 (524)
T ss_pred ccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------
Confidence 999986422211 1112233344 45555566788899999999999999998763322110
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
...+...... ..+ .....+..+...++..++..||.+.++....+-.
T Consensus 472 ------~~~i~~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 ------SLTIRSGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------ceeeeccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111111110 111 1125667888899999999999998887665543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-11 Score=105.88 Aligned_cols=145 Identities=14% Similarity=0.122 Sum_probs=98.3
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-------------C--cc------c-HHH----HHHHHH
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-------------G--FQ------G-HKE----WLAEVN 130 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-------------~--~~------~-~~~----~~~E~~ 130 (404)
...||.|--+.||.|...+. ......+..+|+|+.+.. . +. . .+. ..+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~---~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSN---ETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcc---cccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 46799999999999753211 001124578999987421 0 00 0 111 247999
Q ss_pred HHhcCCC--CCcceEEEEEEeCCeeEEEEeccCCCChHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCCce
Q 046897 131 YLGQLYH--PNLVKLVGYCLEDDHRLLVYEFMPRGSLEN-HLFRRGSYFQPLSWNLRLKVALGAAKGVAFL-HGAETKVI 206 (404)
Q Consensus 131 ~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~i~ 206 (404)
.|.++.. -++..++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| | ..+|+
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H--~~glV 147 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYK--ECNLV 147 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHH--hCCee
Confidence 9998853 355566654 45689999996543321 2221 1244556677889999999988 8 88999
Q ss_pred ecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 207 YRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 207 H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
|+||++.||++. ++.++|+|||.+....+
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999999997 56899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.6e-11 Score=99.06 Aligned_cols=131 Identities=21% Similarity=0.278 Sum_probs=96.8
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--------GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++++|+-+.+|.+.+. |..+++|.=...... ..++..+|+++|..+.--.|.-.+-++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 46889999999986442 344666643222111 11345789999998865555555556667
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.....|+|||++|..|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||++..++ +.++|||
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECC
Confidence 77888999999998888888654 2455666777788999 89999999999999997765 9999999
Q ss_pred CCCC
Q 046897 230 LAKD 233 (404)
Q Consensus 230 ~a~~ 233 (404)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.9e-11 Score=98.43 Aligned_cols=143 Identities=19% Similarity=0.205 Sum_probs=105.1
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--------QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
...+|-+|+-+.|+++.+ .|+.++||.-..... ....+.++|++.|.++.--.|.-..-++
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 567888999999998765 467777775322211 1224568899999988654554444466
Q ss_pred EeCCeeEEEEeccCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc---E
Q 046897 148 LEDDHRLLVYEFMPR-GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN---A 223 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~---v 223 (404)
.+...-+|+|||++| .++.+++..... ..........++..|-..+.-|| ..+|+|+||..+||++..++. +
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCce
Confidence 677777899999966 488888876543 23333444788888999999999 899999999999999965543 5
Q ss_pred EEecccCCCC
Q 046897 224 KLSDFGLAKD 233 (404)
Q Consensus 224 kl~Dfg~a~~ 233 (404)
.++|||++..
T Consensus 156 ~lIdfgls~~ 165 (229)
T KOG3087|consen 156 ILIDFGLSSV 165 (229)
T ss_pred EEEeecchhc
Confidence 8999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-12 Score=131.69 Aligned_cols=249 Identities=23% Similarity=0.250 Sum_probs=168.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.+.+.+.+-+..|.++.++. +.....|...+.|+...... ...+....+-.++-...+|.++...-.+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p---------~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~ 873 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFP---------ASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF 873 (1205)
T ss_pred CccceecccccCCCCccccc---------CCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence 34566677888999999986 55555565555554433211 1112222222222223456666555445
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
......+++++|+.+++|...++..+ ..+.+.....+..+..++++|| ...+.|+|++|.|+++..++..++.|
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccc--cchhhcccccccchhhcccCCcccCc
Confidence 55667899999999999999888765 3455556666777889999999 66799999999999999999999999
Q ss_pred ccCCCCCCCC----------------C-------------CCcceeeccccccccCccccccCCCCcccchhhhhHHHHH
Q 046897 228 FGLAKDGPTG----------------D-------------QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLE 278 (404)
Q Consensus 228 fg~a~~~~~~----------------~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~e 278 (404)
||........ . .........+|+.|.+||.+.+......+|+|++|++++|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9843311000 0 0011223578999999999999999999999999999999
Q ss_pred HHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhccccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 046897 279 MLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLE-GQYTLEGAYKAATLALRCLSTEGKFRPMMA 350 (404)
Q Consensus 279 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 350 (404)
.++|.+||....+....+ .++..... ..-+...+....+++.+.+..+|.+|-.+.
T Consensus 1028 ~l~g~pp~na~tpq~~f~----------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQIFE----------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhhhhh----------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999998765543221 11221111 112233455667889999999999997665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.8e-10 Score=108.88 Aligned_cols=164 Identities=20% Similarity=0.265 Sum_probs=124.3
Q ss_pred cccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEE----eCCeeEEEEeccCC-CChHHHHhhcCC
Q 046897 100 ATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL----EDDHRLLVYEFMPR-GSLENHLFRRGS 174 (404)
Q Consensus 100 ~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~~~ 174 (404)
+....+|..|++|++..+..........-++.++++.|+|||++.++|. .+..+++|++|+++ ++|.++-.....
T Consensus 295 ~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~ 374 (655)
T KOG3741|consen 295 ATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPP 374 (655)
T ss_pred eeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCc
Confidence 5566679999999995443233223345578889999999999999887 34578999999975 578776654322
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcce
Q 046897 175 Y-----------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243 (404)
Q Consensus 175 ~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~ 243 (404)
. ....++..+|.++.|+..||.++| +.|+.-+-|.|.+|+++.+.+++|...|..........
T Consensus 375 ~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---- 448 (655)
T KOG3741|consen 375 FTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---- 448 (655)
T ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC----
Confidence 1 234678999999999999999999 78899999999999999999999998888765433210
Q ss_pred eeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCC
Q 046897 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284 (404)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~ 284 (404)
|.+ .--.+-|.=.||.++..|.||..
T Consensus 449 ------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 449 ------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 111 11245789999999999999964
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-09 Score=100.70 Aligned_cols=266 Identities=16% Similarity=0.172 Sum_probs=161.1
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcce----EEEEEE--
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVK----LVGYCL-- 148 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~----~~~~~~-- 148 (404)
..+.||+|+-+.+|.. . .-.-.+-|+........... .+..|... .||-+-. -.....
T Consensus 15 ~gr~LgqGgea~ly~l----------~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 15 PGRPLGQGGEADLYTL----------G--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred CCccccCCccceeeec----------c--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 4577999999999951 1 11123456665543322222 22333333 4553322 111111
Q ss_pred e-CCeeEEEEeccCCCChHHHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 149 E-DDHRLLVYEFMPRGSLENHLFR---RGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
. ....-++|+.+.+..--..+.. +........|..++++++.++.+.+.|| ..|.+-+|+.++|+|+++++.|.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEE
Confidence 1 1225678888866422222221 2223456889999999999999999999 88899999999999999999999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhC-CCCcCCCCCC-----C
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSG-RRAVDKNRPS-----G 293 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g-~~p~~~~~~~-----~ 293 (404)
|.|=.......++ ......+|...|.+||... +-.-+...|.|.||+++++++.| ++||.+.... .
T Consensus 158 LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 158 LVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred EEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 9987655443222 2334467899999999753 33456689999999999999887 9999753221 1
Q ss_pred Cc-chhhhhhhhhhhccccchhhcccccCCCC-HHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHhhHhcccc
Q 046897 294 EH-NLVEWAKPYLASKRKIFRIIDNRLEGQYT-LEGAYKAATLALRCLSTE--GKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 294 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~d--P~~RPs~~eil~~L~~~~~~~~~ 365 (404)
.. ++...-..+..+. .. . ..+.. ...+ ...+.++..+..+|+... +.-|||++.++..|..+.+....
T Consensus 235 ~E~~Ia~g~f~ya~~~-~~-g-~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 235 LETDIAHGRFAYASDQ-RR-G-LKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred chhhhhcceeeechhc-cC-C-CCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 11 1111000000000 00 0 00000 0111 123456778888887643 67899999999999988775443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=100.75 Aligned_cols=141 Identities=20% Similarity=0.230 Sum_probs=102.5
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCC--CCcceEEEEEEeCC---
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYH--PNLVKLVGYCLEDD--- 151 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~--- 151 (404)
+.|+.|..+.||++... +|..+++|....... .....+..|++++..+.+ .++.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999996432 256799998765432 134567889999999865 34567777766532
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------------------------------
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA------------------------------ 201 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------------ 201 (404)
..++||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 56899999998887765421 1355666667777777777777731
Q ss_pred ------------------------CCCceecCCCCCcEEEcC--CCcEEEecccCCCC
Q 046897 202 ------------------------ETKVIYRDFKTSNILLDT--NYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ------------------------~~~i~H~Dlkp~NIll~~--~~~vkl~Dfg~a~~ 233 (404)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234699999999999998 66789999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.4e-09 Score=95.28 Aligned_cols=125 Identities=17% Similarity=0.113 Sum_probs=89.4
Q ss_pred CCcEEEEEEecCCCccc-H----------HHHHHHHHHHhcCCCCC--cceEEEEEEe-----CCeeEEEEeccCCC-Ch
Q 046897 105 TGMVIAVKRLNQDGFQG-H----------KEWLAEVNYLGQLYHPN--LVKLVGYCLE-----DDHRLLVYEFMPRG-SL 165 (404)
Q Consensus 105 ~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~hp~--iv~~~~~~~~-----~~~~~lv~e~~~~~-~L 165 (404)
.|+.|.||......... . ..+.+|.+.+..+..-+ +..++.++.. ....++|+|++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 35678999775443211 1 13678888887774322 2334444432 23468999999875 79
Q ss_pred HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-------CCcEEEecccCCCC
Q 046897 166 ENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-------NYNAKLSDFGLAKD 233 (404)
Q Consensus 166 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-------~~~vkl~Dfg~a~~ 233 (404)
.+++..... .+.+......++.+++..+.-|| +.||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWAT--NPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 888854321 34566777899999999999999 899999999999999975 46899999998854
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-10 Score=112.99 Aligned_cols=150 Identities=22% Similarity=0.295 Sum_probs=104.9
Q ss_pred HHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcc-------eeeccccccccCccccccC
Q 046897 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV-------STRVMGTYGYAAPEYLATG 261 (404)
Q Consensus 189 ~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 261 (404)
.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+.+........... .........|.|||.+.+.
T Consensus 106 ~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 445599999997 78999999999999999999999999998876444221111 1112345689999999888
Q ss_pred CCCcccchhhhhHHHHHHH-hCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHccc
Q 046897 262 HLTAKSDVYSFGVVLLEML-SGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLS 340 (404)
Q Consensus 262 ~~~~~~DiwslG~ll~ell-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 340 (404)
..+.++|+||||+++|.+. .|+..+......... ......+......+....+.++.+-+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999 455555433211100 0111111112223345566788888999999
Q ss_pred CCCCCCCCHHHHH
Q 046897 341 TEGKFRPMMAEVV 353 (404)
Q Consensus 341 ~dP~~RPs~~eil 353 (404)
.++.-||++.+++
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999766654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.4e-09 Score=88.90 Aligned_cols=99 Identities=23% Similarity=0.249 Sum_probs=64.3
Q ss_pred HHHHHHHHHhcCCCC--CcceEEEEEEeCCeeEEEEeccC--CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-h
Q 046897 124 EWLAEVNYLGQLYHP--NLVKLVGYCLEDDHRLLVYEFMP--RGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF-L 198 (404)
Q Consensus 124 ~~~~E~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~-L 198 (404)
...+|++.|..+..- ++.+++++. ..+|||||++ |..+..+.... ++......++.+++..+.. +
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHH
Confidence 357899999999765 455665442 3479999997 54454433221 1133455666777775444 5
Q ss_pred HcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 199 H~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
| ..+|+|+||.+.||+++.+ .+.|+|||.+....
T Consensus 124 ~--~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 124 H--KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp H--CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred H--hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 8 8999999999999999887 99999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.7e-08 Score=87.67 Aligned_cols=138 Identities=17% Similarity=0.135 Sum_probs=94.9
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--Ccc--------------------cHHHHHHHHH
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQ--------------------GHKEWLAEVN 130 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~--------------------~~~~~~~E~~ 130 (404)
-..+...||-|--+.||.|... +|..+++|.=+.. .+. ......+|.+
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 3566789999999999986543 5788999964211 110 0123578999
Q ss_pred HHhcCCCC--CcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceec
Q 046897 131 YLGQLYHP--NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYR 208 (404)
Q Consensus 131 ~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~ 208 (404)
.|..|... .+.+.+++ +.-.+|||+++|-.|...- +.....-.++..|+.-+..+- ..|++|+
T Consensus 162 ~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~--~~GiVHG 226 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY--RRGIVHG 226 (304)
T ss_pred HHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH--HcCcccc
Confidence 99988644 56666554 4567999999886654322 122333444555555555555 5789999
Q ss_pred CCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 209 DFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 209 Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
|+++-||+++++|.++++||-.+....
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCchheEEEecCCCEEEEeCcccccCC
Confidence 999999999999999999997776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.1e-08 Score=85.39 Aligned_cols=106 Identities=23% Similarity=0.215 Sum_probs=81.9
Q ss_pred HHHHHHHHHHhcCCCC--CcceEEEEEEeCC----eeEEEEeccCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 046897 123 KEWLAEVNYLGQLYHP--NLVKLVGYCLEDD----HRLLVYEFMPRG-SLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195 (404)
Q Consensus 123 ~~~~~E~~~l~~l~hp--~iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l 195 (404)
.+..+|...+..|..- .+.+.+.+..... ..++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 4577888877777432 2445555554422 458999999874 79988876432 55667888999999999
Q ss_pred HHhHcCCCCceecCCCCCcEEEcCCC---cEEEecccCCCCC
Q 046897 196 AFLHGAETKVIYRDFKTSNILLDTNY---NAKLSDFGLAKDG 234 (404)
Q Consensus 196 ~~LH~~~~~i~H~Dlkp~NIll~~~~---~vkl~Dfg~a~~~ 234 (404)
.-|| ..+|+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 132 ~~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 89999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-08 Score=98.81 Aligned_cols=143 Identities=14% Similarity=0.113 Sum_probs=90.0
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHH----------------------------------
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---------------------------------- 123 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------- 123 (404)
+.|+.++-|+||+|++++ |+.||||+....-....+
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 679999999999988753 899999997643211110
Q ss_pred ------HHHHHHHHHhcC----CCCCcceEEEEE-EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 046897 124 ------EWLAEVNYLGQL----YHPNLVKLVGYC-LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192 (404)
Q Consensus 124 ------~~~~E~~~l~~l----~hp~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 192 (404)
++.+|..-+.++ +...-+.+-.+| .......++|||++|-.+.+...... ..++...+.....++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f 277 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 123344444433 222223333333 23456789999999988888743222 2234333322222211
Q ss_pred HHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCC
Q 046897 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237 (404)
Q Consensus 193 ~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~ 237 (404)
+..+- ..+++|.|.+|.||+++.+|++.+.|||+.......
T Consensus 278 --~~q~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 278 --LRQLL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --HHHHH--hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 22222 367999999999999999999999999999865443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-07 Score=81.10 Aligned_cols=138 Identities=20% Similarity=0.148 Sum_probs=98.6
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC------cccHHHHHHHHHHHhcCCCC--CcceEEEEEE-e-
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG------FQGHKEWLAEVNYLGQLYHP--NLVKLVGYCL-E- 149 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--~iv~~~~~~~-~- 149 (404)
-|.||.+.|++..+. |..+-+|.-.... +.....+.+|+..|..|..- .+.++. ++. .
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 466899999885432 2357777654211 22346788999998888532 244444 332 1
Q ss_pred ---CCeeEEEEeccCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc--E
Q 046897 150 ---DDHRLLVYEFMPR-GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN--A 223 (404)
Q Consensus 150 ---~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~--v 223 (404)
....+||+|-+.+ -+|.+++..... .+.+......++.+++.++.-|| +.++.|+|+.+.||+++.++. +
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeE
Confidence 1246799998753 588888865432 34577778899999999999999 899999999999999986677 9
Q ss_pred EEecccCCCC
Q 046897 224 KLSDFGLAKD 233 (404)
Q Consensus 224 kl~Dfg~a~~ 233 (404)
+++||.-++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-06 Score=78.11 Aligned_cols=140 Identities=14% Similarity=0.146 Sum_probs=83.3
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--cceEEEEEEeCCeeEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN--LVKLVGYCLEDDHRLL 155 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~l 155 (404)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+++.+....+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 56899999999972 13457788776532 3355788999998885332 4667777777777889
Q ss_pred EEeccCCCC-hHHHHh--------------h-----cCCCCCCCCHHHHH-HHHH----------HHHHH-HHHhH--cC
Q 046897 156 VYEFMPRGS-LENHLF--------------R-----RGSYFQPLSWNLRL-KVAL----------GAAKG-VAFLH--GA 201 (404)
Q Consensus 156 v~e~~~~~~-L~~~l~--------------~-----~~~~~~~l~~~~~~-~i~~----------qi~~~-l~~LH--~~ 201 (404)
|||+++|.+ +...+. . +.-........... .+.. .+... ..+|. ..
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998853 211110 0 00000011111100 0000 00011 11221 12
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
...++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 34578999999999999888 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.8e-06 Score=74.76 Aligned_cols=137 Identities=12% Similarity=0.058 Sum_probs=86.8
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHH---------HHHHHHHhcC---CC
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---------LAEVNYLGQL---YH 137 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l---~h 137 (404)
...+|.+.+++-......|.+.. -+|..+++|..........+.+ .+++..+..+ .-
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe-----------i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE-----------IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE-----------ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 45677777777777666665532 2467899998876543322222 2333333333 22
Q ss_pred CCcceEEEEEE-----eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCC
Q 046897 138 PNLVKLVGYCL-----EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKT 212 (404)
Q Consensus 138 p~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp 212 (404)
..+..++.+.. .....+++|||++|..|.+... +++ .+...+.+++..|| ..|++|+|++|
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hp 163 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHP 163 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH--HcCCccCCCCc
Confidence 23333222222 2234568999999987766432 222 23455677889999 89999999999
Q ss_pred CcEEEcCCCcEEEecccCCC
Q 046897 213 SNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 213 ~NIll~~~~~vkl~Dfg~a~ 232 (404)
.|++++.+ .++++||+..+
T Consensus 164 gNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CcEEEECC-cEEEEECcccc
Confidence 99999855 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-08 Score=96.82 Aligned_cols=184 Identities=18% Similarity=0.136 Sum_probs=128.2
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeeE
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN-LVKLVGYCLEDDHRL 154 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~ 154 (404)
...-+++|+.+++++. +...+.. ...+.+... ....-++++|.+++||| .+..++-+..+...+
T Consensus 246 ~fh~fvK~altknpKk---------Rptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKK---------RPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred HHHHHHHHHhcCCCcc---------CCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 3455789999999973 2222222 224444332 33445788999999999 777777777778899
Q ss_pred EEEeccCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 155 LVYEFMPRG-SLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 155 lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
+.++++.++ +-...+.... ..+..-+...+.+.-++++++|| +..=+|+| ||+.++ +..+.+||+....
T Consensus 311 i~~~i~s~~rs~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~--~~~~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSE---IALEQYQFAYPLRKETRPLAELH--SSYKVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhhhcCCccccccCChhh---Hhhhhhhhhhhhhhhcccccccc--cccccCcc----cccccc-cccccccccCCcc
Confidence 999999665 2211111110 12333344455666678899999 54457888 777655 6889999999887
Q ss_pred CCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 234 GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
..... ......+++.|+|||+.....+....|+|++|.-..+|.-|-+|-.
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 65543 3445679999999999999999999999999998888888877754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.4e-06 Score=74.67 Aligned_cols=140 Identities=19% Similarity=0.098 Sum_probs=81.4
Q ss_pred ccccCc-ccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEEEE
Q 046897 80 LGEGGF-GSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLLVY 157 (404)
Q Consensus 80 lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 157 (404)
|..|.. ..||+. .. .+..+++|...... ...+.+|+++++.+. +--+.+++++...++..++||
T Consensus 6 ~~~g~~~~~v~~~---------~~--~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRL---------DG--KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEE---------cC--CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444554 778873 22 12568888776543 334667888888874 444667777776666789999
Q ss_pred eccCCCChHHHHh-------------------hcCCCCCCCCHH--HHHHHHH--------------------HHHHHHH
Q 046897 158 EFMPRGSLENHLF-------------------RRGSYFQPLSWN--LRLKVAL--------------------GAAKGVA 196 (404)
Q Consensus 158 e~~~~~~L~~~l~-------------------~~~~~~~~l~~~--~~~~i~~--------------------qi~~~l~ 196 (404)
|+++|.+|..... .......++... ....... .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9998877764321 000000011100 0000000 0111112
Q ss_pred HhH-----cCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 197 FLH-----GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 197 ~LH-----~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
.|- .....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 221 0134589999999999999987788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.4e-06 Score=71.45 Aligned_cols=155 Identities=17% Similarity=0.154 Sum_probs=99.2
Q ss_pred ccCHHHHHHHhcCCCCCCccc---ccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--cc--------------
Q 046897 61 SFSFSDLKTATRNFRPDSVLG---EGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QG-------------- 121 (404)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~-------------- 121 (404)
..+...+.....+..+..+.| +|--++||+|.. +.+..+|+|+...... ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~ 103 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNS 103 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcC
Confidence 344555666667776666555 566677888532 3477899998754211 11
Q ss_pred ---HH-----HHHHHHHHHhcCC--CCCcceEEEEEEeCCeeEEEEeccCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHH
Q 046897 122 ---HK-----EWLAEVNYLGQLY--HPNLVKLVGYCLEDDHRLLVYEFMPRG-SLENHLFRRGSYFQPLSWNLRLKVALG 190 (404)
Q Consensus 122 ---~~-----~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q 190 (404)
.+ ...+|+.-|.++. +=.+.+.+.+. ...|||||+... .-.-.|.. -++.......+..+
T Consensus 104 ~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~ 174 (268)
T COG1718 104 RSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYED 174 (268)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHH
Confidence 01 1356788787774 33444455443 346999999432 10001111 12333356677788
Q ss_pred HHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 191 i~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
+++.+.-|-. ..++||+||+.-|||+. ++.+.|+|||.+....+
T Consensus 175 ~v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 175 VVEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred HHHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 8888887762 48999999999999998 88999999999986543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=2e-05 Score=68.00 Aligned_cols=129 Identities=19% Similarity=0.245 Sum_probs=89.5
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC----------------cccHHHHHHHHHHHhcCC----
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG----------------FQGHKEWLAEVNYLGQLY---- 136 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 136 (404)
...||+|+.-.||. ++. .....||+..... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~-----------HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ-----------HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEE-----------CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 45799999999996 222 3346788887665 122355667776666555
Q ss_pred --CCCcceEEEEEEeCCeeEEEEeccCC------CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceec
Q 046897 137 --HPNLVKLVGYCLEDDHRLLVYEFMPR------GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYR 208 (404)
Q Consensus 137 --hp~iv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~ 208 (404)
+.+|.+++|+..++....+|+|.+.+ -+|.+++... .++. .....+.++ ..||- +.+|+.+
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~--~~~Iv~~ 142 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLL--DHHIVIR 142 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHH--HcCCeec
Confidence 78999999999999999999998732 3688888543 2444 444444444 34555 6779999
Q ss_pred CCCCCcEEEcCC--C--cEEEecc
Q 046897 209 DFKTSNILLDTN--Y--NAKLSDF 228 (404)
Q Consensus 209 Dlkp~NIll~~~--~--~vkl~Df 228 (404)
|++|.||++... + .+.|+|-
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDG 166 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeC
Confidence 999999999533 2 4777763
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.7e-06 Score=67.51 Aligned_cols=129 Identities=16% Similarity=0.141 Sum_probs=88.2
Q ss_pred CCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcce-EEEEEEeCCee
Q 046897 75 RPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVK-LVGYCLEDDHR 153 (404)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-~~~~~~~~~~~ 153 (404)
+..+.||+|++|.||+|.+. |..+++|+-..+. ....+..|+++|..+.--++.+ ++.|. ..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~ 87 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----ED 87 (201)
T ss_pred hhhhhhhcccccEEEEeecc-----------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence 34578999999999998774 4579999877664 3467889999999887655543 34332 23
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCC-CCcEEEcCCCcEEEecccCCC
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFK-TSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlk-p~NIll~~~~~vkl~Dfg~a~ 232 (404)
++.|||+.|-.|.++-... +..++ ..++..---|- ..+|-|+.|+ |..++|..++.+.|+||..|.
T Consensus 88 ~i~me~i~G~~L~~~~~~~-------~rk~l----~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-------DRKHL----LRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-------cHHHH----HHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 4669999887887665321 22222 33344433444 6778899885 555555566699999999887
Q ss_pred C
Q 046897 233 D 233 (404)
Q Consensus 233 ~ 233 (404)
.
T Consensus 155 ~ 155 (201)
T COG2112 155 F 155 (201)
T ss_pred h
Confidence 4
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=8.4e-06 Score=80.04 Aligned_cols=143 Identities=16% Similarity=0.106 Sum_probs=86.0
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-------------------------------H--
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-------------------------------K-- 123 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------~-- 123 (404)
.+.||..+.|+||+|+.++ |..||||+-+..-.... +
T Consensus 166 ~~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred cchhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 4679999999999987653 88999998654311110 0
Q ss_pred ----HHHHHHHHHh----cCCCCC---cceEEEEEE-eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 046897 124 ----EWLAEVNYLG----QLYHPN---LVKLVGYCL-EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191 (404)
Q Consensus 124 ----~~~~E~~~l~----~l~hp~---iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 191 (404)
+|.+|.+-.. .+.|-+ -|.+-.++. ......|+|||++|..+.+.-.-.. ..++...+..-+.+.
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEA 312 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHH
Confidence 1223332222 223444 122222222 2345789999999986666433222 234555444433333
Q ss_pred HHHHHHhHcCCCCceecCCCCCcEEEcC----CCcEEEecccCCCCCCC
Q 046897 192 AKGVAFLHGAETKVIYRDFKTSNILLDT----NYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 192 ~~~l~~LH~~~~~i~H~Dlkp~NIll~~----~~~vkl~Dfg~a~~~~~ 236 (404)
..-+ -+ ..|++|+|-+|.||++.. ++.+.+.|||+.....+
T Consensus 313 ~~~q-If---~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 313 YLEQ-IF---KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHH-HH---hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2222 22 356999999999999983 67899999999886544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=71.59 Aligned_cols=142 Identities=18% Similarity=0.168 Sum_probs=79.1
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CcceEEEEEEe---CCe
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP--NLVKLVGYCLE---DDH 152 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~~~~---~~~ 152 (404)
+.|+.|..+.||+.... + ..+++|..... .....+..|..+++.+... .+..++..... ...
T Consensus 3 ~~l~~G~~n~~~~v~~~----------~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD----------D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEET----------T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEEC----------C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 56889999999985332 1 47999987654 3446677888888877432 35566654432 335
Q ss_pred eEEEEeccCCCChHH----------------HHh---hcCCCCCCCCHHH---------HHHH------------HHHHH
Q 046897 153 RLLVYEFMPRGSLEN----------------HLF---RRGSYFQPLSWNL---------RLKV------------ALGAA 192 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~ 192 (404)
.+++|++++|..+.. .+. .......+..... .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 689999998887777 111 1100001111100 0000 01111
Q ss_pred H-HHHHhH-----cCCCCceecCCCCCcEEEc-CCCcEEEecccCCC
Q 046897 193 K-GVAFLH-----GAETKVIYRDFKTSNILLD-TNYNAKLSDFGLAK 232 (404)
Q Consensus 193 ~-~l~~LH-----~~~~~i~H~Dlkp~NIll~-~~~~vkl~Dfg~a~ 232 (404)
. .+..++ .....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 222222 1256699999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.1e-05 Score=70.40 Aligned_cols=32 Identities=19% Similarity=0.222 Sum_probs=26.5
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
...++|+|+.+.||+++.++..-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34589999999999998765567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.5e-05 Score=82.59 Aligned_cols=81 Identities=16% Similarity=0.211 Sum_probs=54.4
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCCc--ceEEEEEEeC--
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLY-HPNL--VKLVGYCLED-- 150 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hp~i--v~~~~~~~~~-- 150 (404)
.+.|+.|.+..+|+..... ......+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~-------~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGN-------GGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECC-------CCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 5668899999999854321 1111457778765432 223356789999999995 6654 7777777654
Q ss_pred -CeeEEEEeccCCCC
Q 046897 151 -DHRLLVYEFMPRGS 164 (404)
Q Consensus 151 -~~~~lv~e~~~~~~ 164 (404)
+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 36789999998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=9.8e-05 Score=63.32 Aligned_cols=125 Identities=29% Similarity=0.393 Sum_probs=85.4
Q ss_pred cCCCCCCcccccCc-ccEEEEEecCcccccccCCCCcEEEEEEecC---CCc------------------ccHHHHHHHH
Q 046897 72 RNFRPDSVLGEGGF-GSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ---DGF------------------QGHKEWLAEV 129 (404)
Q Consensus 72 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~ 129 (404)
.+++.++.||.|.- |.||++.. .|..||+|++.. ... ....-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 78889999999999 99999766 367899999321 100 1112366777
Q ss_pred HHHhcC---CCCCc--ceEEEEEEeCC------------------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHH
Q 046897 130 NYLGQL---YHPNL--VKLVGYCLEDD------------------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186 (404)
Q Consensus 130 ~~l~~l---~hp~i--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 186 (404)
+...+| .+.++ +++++|..-.. ...||.||..... .+.. .
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~ 168 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----R 168 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----h
Confidence 776666 45566 89999885331 1246777665432 1222 2
Q ss_pred HHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 187 i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
-+.+|.+-|..+| ..+|+-+|+++.|.. .-+|+|||.+
T Consensus 169 ~~~~~~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence 3455666778899 899999999999975 3478899864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.6e-05 Score=66.95 Aligned_cols=102 Identities=25% Similarity=0.216 Sum_probs=77.2
Q ss_pred HHHHHHhcCCC-CCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCC
Q 046897 127 AEVNYLGQLYH-PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA-ETK 204 (404)
Q Consensus 127 ~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~ 204 (404)
.|.-+++.+++ +++.+++|+|- .+++.||...+.+........ ..-..+|..+.+++.++++.+.+|+.. ...
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47778888865 69999999983 367899997665542200000 002358999999999999999999821 144
Q ss_pred ceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 205 VIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 205 i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
+.-.|++++|+-++.+|++|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 78899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.7e-05 Score=80.28 Aligned_cols=196 Identities=20% Similarity=0.214 Sum_probs=133.9
Q ss_pred HHHHHHHHhcCCCCCcceEEEEEEeCCeeE----EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 046897 125 WLAEVNYLGQLYHPNLVKLVGYCLEDDHRL----LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHG 200 (404)
Q Consensus 125 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 200 (404)
...|+..+..+.|+|++.++.|..+....- +..+++...++...++... .++....+.+..++..||.++|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHH-
Confidence 356777888889999999999887654332 3457777778888777653 5788899999999999999999
Q ss_pred CCCCceecCCCCC---cEEEcCCCcEEEe--cccCCCCCCCCCCCcceeeccccccccCccccccCCCCc--ccchhhhh
Q 046897 201 AETKVIYRDFKTS---NILLDTNYNAKLS--DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTA--KSDVYSFG 273 (404)
Q Consensus 201 ~~~~i~H~Dlkp~---NIll~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG 273 (404)
.....|.-|... +.-++..+.+.+. ||+........... .....+..|.++|......+.. ..|+|.+|
T Consensus 304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 444445444443 4444556677777 88888765443321 1223455678888776655554 47999999
Q ss_pred HHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046897 274 VVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353 (404)
Q Consensus 274 ~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 353 (404)
.++..+..|..+-.... ....+++. .....+.....+|+..++++|+++.+++
T Consensus 380 ll~~~~~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 99999999876432211 01111110 0111456788899999999999999998
Q ss_pred HHH
Q 046897 354 TVL 356 (404)
Q Consensus 354 ~~L 356 (404)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00011 Score=66.76 Aligned_cols=138 Identities=16% Similarity=0.088 Sum_probs=74.6
Q ss_pred ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeeEEEEe
Q 046897 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNL-VKLVGYCLEDDHRLLVYE 158 (404)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e 158 (404)
+..|-...+|+.. ..+..+++|........-.-...+|.++++.+....+ .+++... . -++|||
T Consensus 4 ~~~G~tn~~y~~~-----------~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIE-----------HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEE-----------eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence 4567778899742 2355788887654321110124678888888854333 3333332 2 368999
Q ss_pred ccCCCChHHH--------------Hh---hcCCCCCCCCHHH-HHHHHHHH---------HHHHHHhHc------CCCCc
Q 046897 159 FMPRGSLENH--------------LF---RRGSYFQPLSWNL-RLKVALGA---------AKGVAFLHG------AETKV 205 (404)
Q Consensus 159 ~~~~~~L~~~--------------l~---~~~~~~~~l~~~~-~~~i~~qi---------~~~l~~LH~------~~~~i 205 (404)
|++|..+... +. .......+++... +..+..++ ...+..+-. ....+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9988655321 11 1111111222211 11111111 111111210 12358
Q ss_pred eecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 206 IYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 206 ~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
+|+|+.|.||+++.++ +.|+||+.+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00018 Score=64.32 Aligned_cols=32 Identities=19% Similarity=0.260 Sum_probs=27.5
Q ss_pred CCCceecCCCCCcEEEcC-CCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDT-NYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~-~~~vkl~Dfg~a~~ 233 (404)
...++|+|+.+.|||++. ++.+.|+||..+..
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 356899999999999998 57899999987754
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0008 Score=64.46 Aligned_cols=76 Identities=17% Similarity=0.144 Sum_probs=50.9
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecC------CC-cccHHHHHHHHHHHhcCC---CCCcceEEEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ------DG-FQGHKEWLAEVNYLGQLY---HPNLVKLVGYC 147 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~ 147 (404)
+.||.|.+..||++... ..++.++||.-.. +. ....++...|.+.|+.+. ..++.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~---------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT---------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeC---------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 57999999999995432 2224789997532 11 224466777888888763 2456677766
Q ss_pred EeCCeeEEEEeccCCCC
Q 046897 148 LEDDHRLLVYEFMPRGS 164 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~ 164 (404)
+.+..++||||+++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 4456789999997643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00072 Score=62.67 Aligned_cols=143 Identities=16% Similarity=0.089 Sum_probs=79.7
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--cceEEEE------EE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN--LVKLVGY------CL 148 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~------~~ 148 (404)
.+.|..|....+|+... .+..+++|+... .....+..|++++..+.+.+ +.+++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~-----------~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----------DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEe-----------CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 44577777788997422 123588898764 22345667777777774322 4444331 22
Q ss_pred eCCeeEEEEeccCCCChHH----HHh----------hcC-CCCC------CCCHHHHH----------HHHHHHHHHHHH
Q 046897 149 EDDHRLLVYEFMPRGSLEN----HLF----------RRG-SYFQ------PLSWNLRL----------KVALGAAKGVAF 197 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~----~l~----------~~~-~~~~------~l~~~~~~----------~i~~qi~~~l~~ 197 (404)
.++..+++++|++|..+.. ... ... .... ...+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456689999998865422 111 000 0000 01111100 011112223333
Q ss_pred hHc-----CCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 198 LHG-----AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 198 LH~-----~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
+.. ....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 331 135699999999999999887789999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.001 Score=61.61 Aligned_cols=76 Identities=12% Similarity=0.024 Sum_probs=52.2
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC---CCcceEEEEEEe---C
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH---PNLVKLVGYCLE---D 150 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~~~~~~~~---~ 150 (404)
.+.||.|..+.||+... .++ .+++|..+.. .....+..|...|+.|.- -.+.++++++.. .
T Consensus 19 ~~~i~~G~~~~vy~~~~----------~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYD----------SQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEc----------CCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 45799999999997321 123 4667764331 123567889999988842 357788877654 3
Q ss_pred CeeEEEEeccCCCCh
Q 046897 151 DHRLLVYEFMPRGSL 165 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L 165 (404)
+..++|||++++.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 568999999988654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00075 Score=62.79 Aligned_cols=81 Identities=20% Similarity=0.201 Sum_probs=46.7
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNL-VKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv 156 (404)
+.|..|-...||+....... .....+..+++|+..... .......+|++++..+...++ .+++.++. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 34556667788885432210 012345788999865542 222345678888887753333 34555443 2 358
Q ss_pred EeccCCCChH
Q 046897 157 YEFMPRGSLE 166 (404)
Q Consensus 157 ~e~~~~~~L~ 166 (404)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9998876654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=9.1e-06 Score=86.61 Aligned_cols=160 Identities=14% Similarity=-0.007 Sum_probs=118.1
Q ss_pred HHHHHHHhcCCCCCcceEEEEEEe--CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC--
Q 046897 126 LAEVNYLGQLYHPNLVKLVGYCLE--DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA-- 201 (404)
Q Consensus 126 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-- 201 (404)
+.|...++...|+++...+.-... ....+..++|+.+|.+.+.|.+....++++....+.....+.+....-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445555678887766554432 3356889999999999999988776666666665555555545666665532
Q ss_pred -CCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHH
Q 046897 202 -ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280 (404)
Q Consensus 202 -~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell 280 (404)
..-.+|++||+.|.+|..+..+|++++|+.+...+. ........+++.|+.|++...-.++.++|+|..|+.+|++.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 233689999999999999999999999999832221 11233456888999999887778888899999999999999
Q ss_pred hCCCCcC
Q 046897 281 SGRRAVD 287 (404)
Q Consensus 281 ~g~~p~~ 287 (404)
-|..+|.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 9988774
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0047 Score=57.89 Aligned_cols=32 Identities=25% Similarity=0.315 Sum_probs=27.0
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
..++||+|+.|.||+++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 35799999999999998665568999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0024 Score=59.54 Aligned_cols=156 Identities=17% Similarity=0.158 Sum_probs=83.2
Q ss_pred HHHHHHhcCCCC-----CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC
Q 046897 65 SDLKTATRNFRP-----DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139 (404)
Q Consensus 65 ~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~ 139 (404)
..+...-++|.+ .+.++.|....+|+.. ..++ .+++|+..... ....+..|++++..|....
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~----------t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g 76 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLT----------TDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARG 76 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEE----------eCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCC
Confidence 344444445544 3557777778899742 1223 57788765421 2344556677776663222
Q ss_pred --cceEEEE------EEeCCeeEEEEeccCCCChH----HHH----------hhcCC-CCCC------C-CHHHHH----
Q 046897 140 --LVKLVGY------CLEDDHRLLVYEFMPRGSLE----NHL----------FRRGS-YFQP------L-SWNLRL---- 185 (404)
Q Consensus 140 --iv~~~~~------~~~~~~~~lv~e~~~~~~L~----~~l----------~~~~~-~~~~------l-~~~~~~---- 185 (404)
+.+++.. ...++..+++|+|++|..+. ... +.... +..+ . .|....
T Consensus 77 ~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~ 156 (307)
T TIGR00938 77 LPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCF 156 (307)
T ss_pred CCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhh
Confidence 3343332 11245678999999875431 111 11000 0000 0 010000
Q ss_pred --------HHHHHHHHHHHHhH-----cCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 186 --------KVALGAAKGVAFLH-----GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 186 --------~i~~qi~~~l~~LH-----~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
.....+...++++. ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 157 ~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 157 EAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 00112233444443 1247899999999999999888778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0026 Score=58.22 Aligned_cols=31 Identities=29% Similarity=0.388 Sum_probs=26.0
Q ss_pred CCceecCCCCCcEEEcCCCc-EEEecccCCCC
Q 046897 203 TKVIYRDFKTSNILLDTNYN-AKLSDFGLAKD 233 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll~~~~~-vkl~Dfg~a~~ 233 (404)
..++|+|++|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997565 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00047 Score=62.90 Aligned_cols=139 Identities=14% Similarity=0.085 Sum_probs=90.0
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecC--CCc------------------ccHH--HHHHHHH
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ--DGF------------------QGHK--EWLAEVN 130 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~--~~~------------------~~~~--~~~~E~~ 130 (404)
-+.+++.||-|--+.||.+-.. .|.+.++|.-.. ..+ .... ...+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 3567889999999999986443 356677774221 111 1111 2356888
Q ss_pred HHhcCC-CC-CcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceec
Q 046897 131 YLGQLY-HP-NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYR 208 (404)
Q Consensus 131 ~l~~l~-hp-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~ 208 (404)
.|+.|. |. -+.+.+++ +..++|||++.+..|...-+- .....+. ..+..-+.-|. +.|+||+
T Consensus 163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly---~~lm~~Iv~la--~~GlIHg 226 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLY---DDLMGLIVRLA--NHGLIHG 226 (465)
T ss_pred HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHH---HHHHHHHHHHH--HcCceec
Confidence 888774 32 23444443 356789999988777654322 1223333 33334445566 7899999
Q ss_pred CCCCCcEEEcCCCcEEEecccCCCCCCCC
Q 046897 209 DFKTSNILLDTNYNAKLSDFGLAKDGPTG 237 (404)
Q Consensus 209 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~ 237 (404)
|..--||+|..++.++++||-.+....+.
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS~sh~ 255 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVSTSHP 255 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhccCCC
Confidence 99999999999999999999876654443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0041 Score=57.61 Aligned_cols=34 Identities=21% Similarity=0.423 Sum_probs=29.4
Q ss_pred CCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
..++|+|+.+.|++++.++-+-++||+++....+
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 3479999999999999998899999999986433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0068 Score=57.45 Aligned_cols=146 Identities=16% Similarity=0.101 Sum_probs=78.4
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNL-VKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv 156 (404)
+.|-.|-.-.+|+..+... ....+..|++|+.......... ..+|..+++.+..-++ .++++.+... .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 3454577788888543211 1123467889987654322222 2578888888754333 3455555322 57
Q ss_pred EeccCCCChHHH-------H----------hhcCCCCC--CCCHHHHHHHHHHH-----------------HHHHHH---
Q 046897 157 YEFMPRGSLENH-------L----------FRRGSYFQ--PLSWNLRLKVALGA-----------------AKGVAF--- 197 (404)
Q Consensus 157 ~e~~~~~~L~~~-------l----------~~~~~~~~--~l~~~~~~~i~~qi-----------------~~~l~~--- 197 (404)
.+|+++.+|... + +....... ...+..+..++.++ ...+..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888877665421 0 01000000 11122222332211 111111
Q ss_pred -hH--cCCCCceecCCCCCcEEEcC-CCcEEEecccCCCC
Q 046897 198 -LH--GAETKVIYRDFKTSNILLDT-NYNAKLSDFGLAKD 233 (404)
Q Consensus 198 -LH--~~~~~i~H~Dlkp~NIll~~-~~~vkl~Dfg~a~~ 233 (404)
+. .....++|+|+++.|||++. ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 11446899999999999976 47899999988754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.015 Score=54.67 Aligned_cols=80 Identities=15% Similarity=0.100 Sum_probs=48.4
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecC-------CCcccHHHHHHHHHHHhcCC--CC-CcceEEEEEE
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ-------DGFQGHKEWLAEVNYLGQLY--HP-NLVKLVGYCL 148 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-~iv~~~~~~~ 148 (404)
.||.|...-||++.. ...+..++||.-.. .-....++..-|...|+... .| ++.+++.+
T Consensus 2 EigdGnlN~VfrV~~---------~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-- 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYD---------QEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-- 70 (370)
T ss_pred cCCCCceEEEEEEEc---------CCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--
Confidence 579999999999653 22235788887431 12344456667888887663 34 34444433
Q ss_pred eCCeeEEEEeccCCC-ChHHHH
Q 046897 149 EDDHRLLVYEFMPRG-SLENHL 169 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~-~L~~~l 169 (404)
+++...+|||+++.. .|...+
T Consensus 71 D~e~~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 71 DTEMAVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ccccceehHhhCccchHHHHHH
Confidence 445567899998542 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0022 Score=62.13 Aligned_cols=165 Identities=25% Similarity=0.357 Sum_probs=92.8
Q ss_pred HHHHHHHHHHHhcCCCCCcceEEEEEEeC-CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 046897 122 HKEWLAEVNYLGQLYHPNLVKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHG 200 (404)
Q Consensus 122 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 200 (404)
...++-...+++.+.|+|...++++.... ....+|||++ +.+|++.+..+.. ... ++ + -|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l--~~~----------s~---~--~~- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL--KDE----------SL---L--AH- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc--chh----------hh---c--cc-
Confidence 35667778899999999999999887654 3577899999 6799998865431 000 00 0 12
Q ss_pred CCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHH
Q 046897 201 AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280 (404)
Q Consensus 201 ~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell 280 (404)
++.|- |+ ++.+| -++.. | |- ...+++|||++|.++.++.
T Consensus 87 ---~~~~~-----~~-------~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 87 ---GVLHL-----NI-------IYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELY 125 (725)
T ss_pred ---cccee-----hh-------hhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHH
Confidence 12221 12 22222 01000 0 11 1124999999999999999
Q ss_pred hCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 046897 281 SGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352 (404)
Q Consensus 281 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 352 (404)
-|...+...... ........+.........+.. ......++...+.++...|+-..|..||...++
T Consensus 126 L~~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 126 LGISLEAELTES---EYLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HhhHHHHHHHHH---HHHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 998766432211 111111111111111111000 012233456677889999999999988855443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0074 Score=56.28 Aligned_cols=142 Identities=15% Similarity=0.103 Sum_probs=87.9
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccH------------------------HHHHHHHH
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGH------------------------KEWLAEVN 130 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~------------------------~~~~~E~~ 130 (404)
...|..|--+.||.+.- .+|..+|||+++..- +.+. -....|++
T Consensus 149 nGCiSTGKEANVYHat~----------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~R 218 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE----------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMR 218 (520)
T ss_pred ccccccCccceeEeeec----------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHH
Confidence 45677888999998532 246679999875320 0000 12356788
Q ss_pred HHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCC
Q 046897 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDF 210 (404)
Q Consensus 131 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dl 210 (404)
-|.+|+...|.-.--+.. . ...|||+|+. .+= +-...- ....++...+..+-.+++.-+.-|.. ..++||.||
T Consensus 219 NLkRl~~aGIP~PePIlL-k-~hVLVM~FlG-rdg--w~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADL 291 (520)
T KOG2270|consen 219 NLKRLNNAGIPCPEPILL-K-NHVLVMEFLG-RDG--WAAPKL-KDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADL 291 (520)
T ss_pred HHHHHHhcCCCCCCceee-e-cceEeeeecc-CCC--CcCccc-ccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccch
Confidence 888876544321111111 1 2368999993 221 111110 01245666677777777777776642 678999999
Q ss_pred CCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 211 KTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 211 kp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
.--|+|+ .+|.++|+|-+.+....+
T Consensus 292 SEfN~Ly-hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 292 SEFNLLY-HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred hhhhheE-ECCEEEEEEccccccCCC
Confidence 9999998 677999999998876443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0077 Score=56.04 Aligned_cols=73 Identities=18% Similarity=0.139 Sum_probs=56.5
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
.+.|++|++- |+.+.. + +...+.++..++++.+..++-+.. +..+-|||+.-.||||+ +|.|.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeee
Confidence 4567788876 555532 2 124577888888888877777763 67789999999999999 99999999999
Q ss_pred CCCC
Q 046897 231 AKDG 234 (404)
Q Consensus 231 a~~~ 234 (404)
++..
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.017 Score=54.53 Aligned_cols=30 Identities=17% Similarity=0.235 Sum_probs=25.8
Q ss_pred CceecCCCCCcEEEcC-CCcEEEecccCCCC
Q 046897 204 KVIYRDFKTSNILLDT-NYNAKLSDFGLAKD 233 (404)
Q Consensus 204 ~i~H~Dlkp~NIll~~-~~~vkl~Dfg~a~~ 233 (404)
-++|+|+.+.|||++. ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 57899999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.057 Score=50.31 Aligned_cols=31 Identities=23% Similarity=0.260 Sum_probs=26.5
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 367899999999999987 6789999987653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.04 Score=52.91 Aligned_cols=80 Identities=13% Similarity=0.074 Sum_probs=50.1
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC----C---cccHHHHHHHHHHHhcCC---CCCcceEEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD----G---FQGHKEWLAEVNYLGQLY---HPNLVKLVGY 146 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 146 (404)
.+.||.|....||+... .+..++||+-... . .....+...|++.|+.+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~-----------~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-----------SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEc-----------CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 45789999999998432 1235888875421 1 123345556677776653 2467778877
Q ss_pred EEeCCeeEEEEeccCC--CChHHHH
Q 046897 147 CLEDDHRLLVYEFMPR--GSLENHL 169 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~--~~L~~~l 169 (404)
+. +..+++||++++ ..+.+.+
T Consensus 106 de--d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 106 DR--TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CC--CCCEEEEeecCCcceehhhhh
Confidence 76 446789999966 2344444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0077 Score=52.80 Aligned_cols=30 Identities=30% Similarity=0.399 Sum_probs=21.3
Q ss_pred CCceecCCCCCcEEE-cCCCcEEEecccCCC
Q 046897 203 TKVIYRDFKTSNILL-DTNYNAKLSDFGLAK 232 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll-~~~~~vkl~Dfg~a~ 232 (404)
.-++|+|+.+.|||+ +.++.++|+||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 457899999999999 889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0081 Score=52.05 Aligned_cols=102 Identities=13% Similarity=0.124 Sum_probs=65.5
Q ss_pred EEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHH
Q 046897 109 IAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187 (404)
Q Consensus 109 vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i 187 (404)
..+|++..-... ...-+..+.+++++++ .|+++..- ....+-++.|+|..... .. ..+
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------------~~-~N~ 146 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------------NF-SNF 146 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------------ch-hHH
Confidence 344544433222 3345677788887764 36666622 23345688898843111 01 111
Q ss_pred HHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 188 ~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
+..=+.+|.-.|+.+.+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus 147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11114667888987899999999999999999999999997654
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.026 Score=53.91 Aligned_cols=75 Identities=17% Similarity=0.213 Sum_probs=47.8
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecC------CCcccHHHHHHHHHHHhcCC--CC-CcceEEEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ------DGFQGHKEWLAEVNYLGQLY--HP-NLVKLVGYC 147 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-~iv~~~~~~ 147 (404)
.+.||.|.-.-||++... ..+..|+||.-.. +-....++..-|.+.|+... .| ++.+++.+
T Consensus 34 ~~eigdGnlN~VfrV~~~---------~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDE---------QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEeeC---------CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 457899999999996542 1234688886421 22344567777888888763 34 44555543
Q ss_pred EeCCeeEEEEeccCC
Q 046897 148 LEDDHRLLVYEFMPR 162 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~ 162 (404)
+++...+|||+++.
T Consensus 104 -D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 -DSVMNCCVMEDLSD 117 (409)
T ss_pred -CcHHhhHHHHhCcc
Confidence 44556789998854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.025 Score=52.02 Aligned_cols=73 Identities=21% Similarity=0.251 Sum_probs=44.6
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCee
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL---YHPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~ 153 (404)
.+.++.|....+|+.. ..+..+.+|+-.. .....+..|..-|+.| ..-.+.+++.+...++..
T Consensus 22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEE-----------CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 3568888889998732 3567899997762 2234567787777777 345677888888877778
Q ss_pred EEEEeccCCC
Q 046897 154 LLVYEFMPRG 163 (404)
Q Consensus 154 ~lv~e~~~~~ 163 (404)
||+|||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.025 Score=53.58 Aligned_cols=59 Identities=17% Similarity=0.100 Sum_probs=41.7
Q ss_pred EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
.++=+|..|-.+..++.... .++.....++.-.++|+..+-- -.+++|.|+.|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence 35556777888888886543 4556667777666666544432 46799999999999994
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.14 Score=49.18 Aligned_cols=30 Identities=23% Similarity=0.092 Sum_probs=24.6
Q ss_pred CCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
..++|.|+.+.||+.+. +.++++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 56799999999998754 4699999987653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.17 Score=47.27 Aligned_cols=32 Identities=19% Similarity=0.202 Sum_probs=28.7
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
..+++|+|+.+.||+++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.26 Score=48.34 Aligned_cols=29 Identities=21% Similarity=0.295 Sum_probs=24.2
Q ss_pred CCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
.-++|+|+.+.|||.+.+ .++|+||..|.
T Consensus 284 ~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCC-CEEEEeecccc
Confidence 457999999999988655 49999998764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.028 Score=47.88 Aligned_cols=30 Identities=20% Similarity=0.263 Sum_probs=26.2
Q ss_pred CCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
.-.+|+|+.|.||+++.++ ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 4569999999999998877 99999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.086 Score=48.02 Aligned_cols=49 Identities=16% Similarity=0.077 Sum_probs=36.5
Q ss_pred HHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 185 ~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
...+..+-.++.-++....-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3344555555555552114589999999999999999999999988764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.20 E-value=1 Score=39.71 Aligned_cols=58 Identities=26% Similarity=0.331 Sum_probs=40.2
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcC---CCCCcceEEEEEEeCCeeEEEEeccCCCChH
Q 046897 106 GMVIAVKRLNQDGFQGHKEWLAEVNYLGQL---YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLE 166 (404)
Q Consensus 106 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 166 (404)
...+.+|+-... ....|..|+.-|+.| +.-.+.+++.+.....+.|+||||++-+.+.
T Consensus 39 ~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 356778864332 234566676655555 4556888888888899999999999875544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 404 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-47 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-46 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 528 bits (1363), Expect = 0.0
Identities = 113/325 (34%), Positives = 177/325 (54%), Gaps = 30/325 (9%)
Query: 50 EGEILR--SPNLKSFSFSDLKTATRNFRP------DSVLGEGGFGSVFKGWIDEHSFAAT 101
E + L SFSF +LK T NF + +GEGGFG V+KG+++
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------- 53
Query: 102 KPGTGMVIAVKRL----NQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVY 157
+AVK+L + + +++ E+ + + H NLV+L+G+ + D LVY
Sbjct: 54 ----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109
Query: 158 EFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217
+MP GSL + L PLSW++R K+A GAA G+ FLH E I+RD K++NILL
Sbjct: 110 VYMPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILL 166
Query: 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLL 277
D + AK+SDFGLA+ Q+ +++R++GT Y APE L G +T KSD+YSFGVVLL
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLL 225
Query: 278 EMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALR 337
E+++G AVD++R L++ + ++ I ID ++ ++A +
Sbjct: 226 EIITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQ 282
Query: 338 CLSTEGKFRPMMAEVVTVLEQLQDS 362
CL + RP + +V +L+++ S
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 526 bits (1357), Expect = 0.0
Identities = 122/331 (36%), Positives = 181/331 (54%), Gaps = 16/331 (4%)
Query: 35 GSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWID 94
GSK S + L DL+ AT NF ++G G FG V+KG +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 95 EHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL 154
+ G +A+KR + QG +E+ E+ L HP+LV L+G+C E + +
Sbjct: 62 D----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111
Query: 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214
L+Y++M G+L+ HL+ +SW RL++ +GAA+G+ +LH +I+RD K+ N
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSIN 169
Query: 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGV 274
ILLD N+ K++DFG++K G DQ+H+ST V GT GY PEY G LT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 275 VLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATL 334
VL E+L R A+ ++ P NL EWA + ++ +I+D L + E K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 335 ALRCLSTEGKFRPMMAEVVTVLE---QLQDS 362
A++CL+ + RP M +V+ LE +LQ+S
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 432 bits (1113), Expect = e-152
Identities = 123/316 (38%), Positives = 186/316 (58%), Gaps = 16/316 (5%)
Query: 46 TPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGT 105
P E + LK FS +L+ A+ NF ++LG GGFG V+KG +
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------D 53
Query: 106 GMVIAVKRLNQDGFQGHK-EWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGS 164
G ++AVKRL ++ QG + ++ EV + H NL++L G+C+ RLLVY +M GS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 165 LENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH-GAETKVIYRDFKTSNILLDTNYNA 223
+ + L R PL W R ++ALG+A+G+A+LH + K+I+RD K +NILLD + A
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ DFGLAK D +HV+T V GT G+ APEYL+TG + K+DV+ +GV+LLE+++G+
Sbjct: 174 VVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 284 RAVDKNRPSGEH--NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLST 341
RA D R + + L++W K L ++K+ ++D L+G Y E + +AL C +
Sbjct: 233 RAFDLARLANDDDVMLLDWVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291
Query: 342 EGKFRPMMAEVVTVLE 357
RP M+EVV +LE
Sbjct: 292 SPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-82
Identities = 73/326 (22%), Positives = 118/326 (36%), Gaps = 43/326 (13%)
Query: 62 FSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG 121
+L + + V G FG V+K + +AVK Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPI---QD 59
Query: 122 HKEWLAE--VNYLGQLYHPNLVKLVGYCLEDDH----RLLVYEFMPRGSLENHLFRRGSY 175
+ W E V L + H N+++ +G L+ F +GSL + L
Sbjct: 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---- 115
Query: 176 FQPLSWNLRLKVALGAAKGVAFLH--------GAETKVIYRDFKTSNILLDTNYNAKLSD 227
+SWN +A A+G+A+LH G + + +RD K+ N+LL N A ++D
Sbjct: 116 -NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-----TAKSDVYSFGVVLLEMLSG 282
FGLA G + + +GT Y APE L + D+Y+ G+VL E+ S
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 283 RRAVDKNRPSGEHNLVE--WAKPYLASKRKI--FRIIDNRLEGQYTLEGAYKA-ATLALR 337
A D E P L +++ + L +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 338 CLSTEGKFRPMMAEVVTVLEQLQDSS 363
C + + R V + Q+Q +
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-64
Identities = 59/339 (17%), Positives = 116/339 (34%), Gaps = 54/339 (15%)
Query: 62 FSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG 121
+ S+ N + ++G G +G+V+KG +D +AVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSF---AN 48
Query: 122 HKEWLAEVN--YLGQLYHPNLVKLVGYCLEDD-----HRLLVYEFMPRGSLENHLFRRGS 174
+ ++ E N + + H N+ + + LLV E+ P GSL +L
Sbjct: 49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--- 105
Query: 175 YFQPLSWNLRLKVALGAAKGVAFLH-------GAETKVIYRDFKTSNILLDTNYNAKLSD 227
W ++A +G+A+LH + + +RD + N+L+ + +SD
Sbjct: 106 --HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 228 FGLAK------DGPTGDQSHVSTRVMGTYGYAAPEYL-------ATGHLTAKSDVYSFGV 274
FGL+ G++ + + +GT Y APE L + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 275 VLLEMLSGRRAVDKNRPSGEHNL----VEWAKPYLASKRKIFRIIDNRLE----GQYTLE 326
+ E+ + E+ + P + + R + +
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283
Query: 327 GAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365
C + + R + +L E
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-62
Identities = 89/335 (26%), Positives = 142/335 (42%), Gaps = 49/335 (14%)
Query: 36 SKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG-WID 94
+S +P T + + + DL + +G G FG+V + W
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK-------IGAGSFGTVHRAEW-- 58
Query: 95 EHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152
G +AVK L + F E+L EV + +L HPN+V +G + +
Sbjct: 59 ----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKT 212
+V E++ RGSL L + G+ L RL +A AKG+ +LH +++R+ K+
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167
Query: 213 SNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSF 272
N+L+D Y K+ DFGL++ + S S GT + APE L KSDVYSF
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 273 GVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY--LASKRKIFRIIDN--RLEGQYTLEGA 328
GV+L E+ + + +P+ L + + + RLE L
Sbjct: 226 GVILWELATLQ------------------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 329 YKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363
A + C + E RP A ++ +L L S+
Sbjct: 268 V--AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 40/287 (13%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
V+G G FG V K W +A+K++ + + K ++ E+ L ++ H
Sbjct: 15 VVGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNH 60
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PN+VKL G CL + LV E+ GSL N L + + L ++GVA+
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 117
Query: 198 LHGAETK-VIYRDFKTSNILLDTNYN-AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
LH + K +I+RD K N+LL K+ DFG A D T G+ + AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAP 172
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315
E + + K DV+S+G++L E+++ R +P E + +
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHN------- 219
Query: 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362
R L + +L RC S + RP M E+V ++ L
Sbjct: 220 GTRPPLIKNLPKPIE--SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-60
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 49/296 (16%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-------KEWLAEVN 130
+G+GGFG V KG + V+A+K L +G +E+ EV
Sbjct: 26 QIGKGGFGLVHKGRLV----------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ L HPN+VKL G +V EF+P G L + L + P+ W+++L++ L
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLD 130
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDT-----NYNAKLSDFGLAKDGPTGDQSHVSTR 245
A G+ ++ +++RD ++ NI L + AK++DFGL++ H +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSG 185
Query: 246 VMGTYGYAAPEYLATGHL--TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303
++G + + APE + T K+D YSF ++L +L+G P E++ +
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFI 239
Query: 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
+ + + R + C S + K RP + +V L +L
Sbjct: 240 NMIREEGL------RPTIPEDCPPRL--RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 70/301 (23%), Positives = 114/301 (37%), Gaps = 43/301 (14%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
VLG+G FG K T TG V+ +K L + + + +L EV + L HP
Sbjct: 17 VLGKGCFGQAIKV---------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N++K +G +D + E++ G+L + S W+ R+ A A G+A+L
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK------------DGPTGDQSHVSTRV 246
H +I+RD + N L+ N N ++DFGLA+ V
Sbjct: 125 H--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306
+G + APE + K DV+SFG+VL E++ A P +
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-- 240
Query: 307 SKRKIFRIIDNRLE-GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365
+ + +RC + + RP ++ LE L+
Sbjct: 241 -----------DRYCPPNCPPSFFP---ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286
Query: 366 G 366
Sbjct: 287 H 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 60/310 (19%)
Query: 64 FSDLKTATRNFRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGH 122
F L T+ L E G ++KG W G I VK L +
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTR 49
Query: 123 --KEWLAEVNYLGQLYHPNLVKLVGYCLE--DDHRLLVYEFMPRGSLENHLFRRGSYFQP 178
+++ E L HPN++ ++G C H L+ +MP GSL N L ++
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--V 107
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD 238
+ + +K AL A+G+AFLH E + + ++++D + A++S +
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF------ 161
Query: 239 QSHVSTRVMGTYGYAAPEYL---ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295
S S M + APE L +D++SF V+L E+++
Sbjct: 162 -SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE------------ 208
Query: 296 NLVEWAKPY--LASKRKIFRIIDN--RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351
P+ L++ ++ R + + L C++ + RP
Sbjct: 209 ------VPFADLSNMEIGMKVALEGLRPTIPPGISPHV--SKLMKICMNEDPAKRPKFDM 260
Query: 352 VVTVLEQLQD 361
+V +LE++QD
Sbjct: 261 IVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 59/299 (19%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGH----KEWLAEVNYLG 133
++G GGFG V++ W G +AVK D + + E
Sbjct: 14 IIGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
L HPN++ L G CL++ + LV EF G L L + + ++ + A+ A+
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIAR 116
Query: 194 GVAFLHG-AETKVIYRDFKTSNILLD--------TNYNAKLSDFGLAKDGPTGDQSHVST 244
G+ +LH A +I+RD K+SNIL+ +N K++DFGLA++
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKM 172
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304
G Y + APE + + SDV+S+GV+L E+L+G P+
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------------------VPF 214
Query: 305 --LASKRKIFRIIDN--RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
+ + + N L T + A L C + + RP ++ L +
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPF--AKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-56
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 56/309 (18%)
Query: 64 FSDLKTATRNFRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGH 122
+ R +G G FG+V+KG W + +AVK LN
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQ 62
Query: 123 --KEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
+ + EV L + H N++ +GY +V ++ SL +HL +
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET---KFE 118
Query: 181 WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS 240
+ +A A+G+ +LH +I+RD K++NI L + K+ DFGLA + S
Sbjct: 119 MKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176
Query: 241 HVSTRVMGTYGYAAPE---YLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297
H ++ G+ + APE + + +SDVY+FG+VL E+++G+
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------- 223
Query: 298 VEWAKPY--LASKRKIFRIIDN---RLEGQYTLEGAYKA-ATLALRCLSTEGKFRPMMAE 351
PY + ++ +I ++ + K L CL + RP
Sbjct: 224 -----PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278
Query: 352 VVTVLEQLQ 360
++ +E+L
Sbjct: 279 ILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-55
Identities = 64/348 (18%), Positives = 124/348 (35%), Gaps = 68/348 (19%)
Query: 32 SSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG 91
S +S+ S P L+ ++ F L+ +G+G FG V+ G
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIP---FEQLEIGEL-------IGKGRFGQVYHG 52
Query: 92 -WIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLYHPNLVKLVGYCL 148
W E +A++ ++ + K + EV Q H N+V +G C+
Sbjct: 53 RWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYR 208
H ++ +L + + L N ++A KG+ +LH ++++
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA--KGILHK 154
Query: 209 DFKTSNILLDTNYNAKLSDFGLAK---DGPTGDQSHVSTRVMGTYGYAAPEYL------- 258
D K+ N+ D N ++DFGL G + G + APE +
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 259 --ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY--LASKRKIFRI 314
+ SDV++ G + E+ + P+ ++ I+++
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE------------------WPFKTQPAEAIIWQM 255
Query: 315 IDN--RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
Q + + L C + E + RP +++ +LE+L
Sbjct: 256 GTGMKPNLSQIGMGKEISD--ILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-52
Identities = 68/322 (21%), Positives = 114/322 (35%), Gaps = 55/322 (17%)
Query: 68 KTATRNFRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL 126
+T R+ +G+G +G V++G W E+ +AVK + + K W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 127 AE--VNYLGQLYHPNLVKLVGYCLEDDHR----LLVYEFMPRGSLENHLFRRGSYFQPLS 180
E + L H N++ + + H L+ + GSL ++L L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLD 103
Query: 181 WNLRLKVALGAAKGVAFLHGAET------KVIYRDFKTSNILLDTNYNAKLSDFGLA--K 232
L++ L A G+A LH + +RD K+ NIL+ N ++D GLA
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 233 DGPTGDQSHVSTRVMGTYGYAAPE------YLATGHLTAKSDVYSFGVVLLEMLSGRRAV 286
T + +GT Y APE + + D+++FG+VL E+ +
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
Query: 287 DKNRP--------SGEHNLVEWAKPYLASKRKIFR-IIDNRLEGQYTLEGAYKAATLALR 337
E + + ++ R I NR TL A L
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSDPTLT---SLAKLMKE 278
Query: 338 CLSTEGKFRPMMAEVVTVLEQL 359
C R + L ++
Sbjct: 279 CWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 6e-52
Identities = 78/355 (21%), Positives = 130/355 (36%), Gaps = 55/355 (15%)
Query: 42 SVPPTPRSEGEILR-----SPNLKSFSFSDL---KTATRNFRPDSVLGEGGFGSVFKG-W 92
S+ SEG L+ S S L +T R +G+G FG V++G W
Sbjct: 4 SLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 93 IDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAE--VNYLGQLYHPNLVKLVGYCLED 150
E +AVK + + + W E + L H N++ + +D
Sbjct: 64 RGEE------------VAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 151 D----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET--- 203
+ LV ++ GSL ++L R ++ +K+AL A G+A LH
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 204 ---KVIYRDFKTSNILLDTNYNAKLSDFGLA--KDGPTGDQSHVSTRVMGTYGYAAPEYL 258
+ +RD K+ NIL+ N ++D GLA D T +GT Y APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 259 ----ATGHLTA--KSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312
H + ++D+Y+ G+V E+ R ++ + + + +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 313 RIIDNRL-----EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362
+ + +L + E A + C G R + L QL
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 7e-52
Identities = 69/355 (19%), Positives = 122/355 (34%), Gaps = 50/355 (14%)
Query: 39 SSLSVPPTPRSEGEILRSPNLKSFSFSDL---KTATRNFRPDSVLGEGGFGSVFKG-WID 94
S +PP I +S + S S L +T + + +G+G +G V+ G W
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG 60
Query: 95 EHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL--AEVNYLGQLYHPNLVKLVGYCLEDDH 152
E +AVK W E+ + H N++ + ++
Sbjct: 61 EK------------VAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105
Query: 153 R----LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH------GAE 202
L+ ++ GSL ++L L LK+A + G+ LH +
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLA--KDGPTGDQSHVSTRVMGTYGYAAPEYLAT 260
+ +RD K+ NIL+ N ++D GLA T + +GT Y PE L
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 261 GHLTA------KSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314
+D+YSFG++L E+ R + + + + +
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 315 IDNRL-----EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364
+L + E + L C + R V L ++ +S +
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-43
Identities = 80/308 (25%), Positives = 128/308 (41%), Gaps = 38/308 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
R+ + LG+G FGSV D + TG V+AVK+L + +++ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 132 LGQLYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L L H N+VK G C R L+ E++P GSL ++L + + L L+
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KL-LQYTS 121
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG- 248
KG+ +L + I+RD T NIL++ K+ DFGL K P D+ + G
Sbjct: 122 QICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGE 178
Query: 249 -----TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303
APE L + SDV+SFGVVL E+ + P E +
Sbjct: 179 SPIFWY----APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDK 232
Query: 304 YLASKRKIFRIIDNRLEGQYTLE-------GAYKAATLALRCLSTEGKFRPMMAEVVTVL 356
+ +F +I+ L+ L Y + C + RP ++ +
Sbjct: 233 Q--GQMIVFHLIE-LLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRV 286
Query: 357 EQLQDSSE 364
+Q++D+
Sbjct: 287 DQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-43
Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 32/299 (10%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
LG+G FGSV D + TG V+AVK+L + +++ E+ L L H
Sbjct: 47 QQLGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 138 PNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
N+VK G C R L+ E++P GSL ++L + + L L+ KG+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KL-LQYTSQICKGM 158
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG------T 249
+L + I+RD T NIL++ K+ DFGL K P D+ + + G
Sbjct: 159 EYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWY 215
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL-ASK 308
APE L + SDV+SFGVVL E+ + P E +
Sbjct: 216 ----APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 309 RKIFRIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364
+ ++ N RL + Y + C + RP ++ ++Q++D
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 89/312 (28%), Positives = 128/312 (41%), Gaps = 46/312 (14%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVN 130
R + LGEG FG V D T GTG ++AVK L D G Q W E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 131 YLGQLYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L LYH +++K G C + LV E++P GSL ++L R + L A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFA 140
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST---- 244
+G+A+LH I+RD N+LLD + K+ DFGLAK P G + +
Sbjct: 141 QQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 245 ---RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEW 300
APE L SDV+SFGV L E+L+ D ++ L
Sbjct: 199 SPVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHC----DSSQSPPTKFLELI 248
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLE-------GAYKAATLALRCLSTEGKFRPMMAEVV 353
+ + R+ + LE L Y L C TE FRP ++
Sbjct: 249 GIAQ--GQMTVLRLTE-LLERGERLPRPDKCPAEVYH---LMKNCWETEASFRPTFENLI 302
Query: 354 TVLEQLQDSSET 365
+L+ + + +
Sbjct: 303 PILKTVHEKYQG 314
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 77/302 (25%), Positives = 122/302 (40%), Gaps = 36/302 (11%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVN 130
R + LGEG FG V D TG +AVK L + G + E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 131 YLGQLYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L LYH N+VK G C ED L+ EF+P GSL+ +L + ++ +LK A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYA 132
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+ KG+ +L + ++RD N+L+++ + K+ DFGL K T D+ + + +
Sbjct: 133 VQICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDR 189
Query: 249 ------TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWA 301
APE L SDV+SFGV L E+L+ + L
Sbjct: 190 DSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFLKMIG 241
Query: 302 KPYLA-SKRKIFRIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357
+ + ++ + RL + Y+ L +C + R ++ E
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGFE 298
Query: 358 QL 359
L
Sbjct: 299 AL 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-41
Identities = 75/310 (24%), Positives = 123/310 (39%), Gaps = 43/310 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
R+ + S LG+G FGSV D TG ++AVK+L G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 132 LGQLYHPNLVKLVGYCLEDDHR--LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L L+ +VK G + LV E++P G L + L R + L L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RL-LLYSS 134
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST----- 244
KG+ +L + ++RD NIL+++ + K++DFGLAK P +V
Sbjct: 135 QICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 245 --RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWA 301
APE L+ + +SDV+SFGVVL E+ + +
Sbjct: 193 PIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCD------KSCSPSAEFLRM 240
Query: 302 KPYLASKRKIFRIIDNRLEGQYTLE-------GAYKAATLALRCLSTEGKFRPMMAEVVT 354
+ R+++ LE L ++ L C + + RP + +
Sbjct: 241 MGCERDVPALSRLLE-LLEEGQRLPAPPACPAEVHE---LMKLCWAPSPQDRPSFSALGP 296
Query: 355 VLEQLQDSSE 364
L+ L S
Sbjct: 297 QLDMLWSGSR 306
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 43/289 (14%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
+G G FG VF G + +V AVK + ++L E L Q
Sbjct: 121 QIGRGNFGEVFSGRL---------RADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
HPN+V+L+G C + +V E + G L G L L++ AA G+
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGME 227
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+L I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 228 YLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SKRKIFRI 314
L G +++SDV+SFG++L E S G PY S ++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGAS------------------PYPNLSNQQTREF 327
Query: 315 IDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
++ RL + + ++ L +C + E RP + + L+ ++
Sbjct: 328 VEKGGRLPCPELCPDAVFR---LMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 41/294 (13%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
VLG G FG+V+KG WI E +A+K L + + +KE L E + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
+P++ +L+G CL L+ + MP G L +++ L L + AKG+
Sbjct: 76 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQ--YL-LNWCVQIAKGMN 131
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+L + ++++RD N+L+ T + K++DFGLAK ++ + + + A E
Sbjct: 132 YL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SKRKIFRI 314
+ T +SDV+S+GV + E+++ G + PY +I I
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSI 231
Query: 315 IDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL-QDSSE 364
++ RL Y + +C + RP E++ ++ +D
Sbjct: 232 LEKGERLPQPPICTIDVYM---IMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 70/267 (26%), Positives = 100/267 (37%), Gaps = 29/267 (10%)
Query: 25 SSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATR---NFRPDSVLG 81
S G D+ + S+ R S L+S + + + +F+ S LG
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLG 66
Query: 82 EGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLY-H 137
G +G VFK G + AVKR F+G K+ LAEV ++ H
Sbjct: 67 HGSYGEVFK---------VRSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEKVGQH 116
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQ-PLSWNLRLKVALGAAKGVA 196
P V+L E L E SL+ H G+ W L +A
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LA 171
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
LH +++ D K +NI L KL DFGL + T V G Y APE
Sbjct: 172 HLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE 226
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLSGR 283
L + +DV+S G+ +LE+
Sbjct: 227 LLQGSY-GTAADVFSLGLTILEVACNM 252
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 29/218 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLY 136
+LGEG FGSV +G + GT + +AVK + D + +E+L+E +
Sbjct: 41 ILGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 137 HPNLVKLVGYCLEDD-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR--LKVAL 189
HPN+++L+G C+E +++ FM G L +L P L+ LK +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QSHVSTRV- 246
A G+ +L + ++RD N +L + ++DFGL+K +GD + ++
Sbjct: 155 DIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 247 ---MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ A E LA T+KSDV++FGV + E+ +
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 65/313 (20%), Positives = 110/313 (35%), Gaps = 67/313 (21%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130
+F +VLG+G FG V K A A+K++ + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVK---------ARNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRL-------------LVYEFMPRGSLENHLFRRGSYFQ 177
L L H +V+ LE + + + E+ G+L + + Q
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 178 P-LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK---- 232
W L ++ ++++H +I+RD K NI +D + N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 233 ---------DGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSG 282
G ++++ + GT Y A E L TGH K D+YS G++ EM+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 283 RRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI---IDNRLEGQYTLEGAYKAATLALRCL 339
S V +K+ + + + +
Sbjct: 228 --------FSTGMERVN---IL----KKLRSVSIEFPPDFDDNKMKV----EKKIIRLLI 268
Query: 340 STEGKFRPMMAEV 352
+ RP +
Sbjct: 269 DHDPNKRPGARTL 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
VLG G FG+V KG WI E + +K + G Q + + +G L
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQP---LSWNLRLKVALGAAK 193
H ++V+L+G C LV +++P GSL +H+ + P L+W + AK
Sbjct: 74 HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAK 126
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ +L E +++R+ N+LL + +++DFG+A P D+ + + +
Sbjct: 127 GMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
A E + G T +SDV+S+GV + E+++ G
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 83/322 (25%), Positives = 132/322 (40%), Gaps = 58/322 (18%)
Query: 65 SDLKTATRNFRPD---------SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
+L A ++ V+G G FG V+ G G + AVK LN
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLN 62
Query: 116 QD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH-RLLVYEFMPRGSLENHLFRRG 173
+ ++L E + HPN++ L+G CL + L+V +M G L N + R
Sbjct: 63 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RN 120
Query: 174 SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233
P +L + L AKG+ +L A K ++RD N +LD + K++DFGLA+D
Sbjct: 121 ETHNPTVKDL-IGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 234 GPTGDQSHVSTRVMGTYGYA------APEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAV 286
+ V G A E L T T KSDV+SFGV+L E+++ G
Sbjct: 178 MYDKE----YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-- 231
Query: 287 DKNRPSGEHNLVEWAKPYLA-SKRKIFRIIDN--RLEG-QYTLEGAYKAATLALRCLSTE 342
PY + I + RL +Y + Y+ + L+C +
Sbjct: 232 ----------------PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE---VMLKCWHPK 272
Query: 343 GKFRPMMAEVVTVLEQLQDSSE 364
+ RP +E+V+ + + +
Sbjct: 273 AEMRPSFSELVSRISAIFSTFI 294
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
VLG G FG+V+KG WI E +A+K L + + +KE L E + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVD 75
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
+P++ +L+G CL L+ + MP G L +++ L L + AKG+
Sbjct: 76 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQ--YL-LNWCVQIAKGMN 131
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+L + ++++RD N+L+ T + K++DFGLAK ++ + + + A E
Sbjct: 132 YL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SKRKIFRI 314
+ T +SDV+S+GV + E+++ G + PY +I I
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSI 231
Query: 315 IDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364
++ RL Y + ++C + RP E++ ++ +
Sbjct: 232 LEKGERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-37
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLY 136
+LG+G FGSV + + G+ + +AVK L D +E+L E + +
Sbjct: 30 MLGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 137 HPNLVKLVGYCLEDDHR------LLVYEFMPRGSLENHLFRRGSYFQPLSWNLR--LKVA 188
HP++ KLVG L + +++ FM G L L P + L+ ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QSHVSTRV 246
+ A G+ +L + I+RD N +L + ++DFGL++ +GD + ++++
Sbjct: 144 VDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 247 ----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ A E LA T SDV++FGV + E+++
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 73/267 (27%), Positives = 109/267 (40%), Gaps = 33/267 (12%)
Query: 33 STGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATR-NFRPDSVLGEGGFGSVFKG 91
+GS +S + +G I+ +P FS + + R + LGEG FG VF
Sbjct: 4 GSGSSLSPTEGKGSG-LQGHIIENPQY--FSDACVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 92 WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151
M++AVK L + +++ E L L H ++V+ G C E
Sbjct: 61 ----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 152 HRLLVYEFMPRGSLENHLFRR-----------GSYFQPLSWNLRLKVALGAAKGVAFLHG 200
L+V+E+M G L L PL L VA A G+ +L
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-- 174
Query: 201 AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV------MGTYGYAA 254
A ++RD T N L+ K+ DFG+++D + D V R M
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------P 228
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLS 281
PE + T +SDV+SFGVVL E+ +
Sbjct: 229 PESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
LG+G FG V++G K +A+K +N+ + E+L E + + +
Sbjct: 32 ELGQGSFGMVYEGVAKG-----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 86
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL------FRRGSYFQPLSWNLRLKVALG 190
++V+L+G + L++ E M RG L+++L P S + +++A
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QSHVSTRV-- 246
A G+A+L K ++RD N ++ ++ K+ DFG+ +D D + +
Sbjct: 147 IADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 247 --MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
M +PE L G T SDV+SFGVVL E+ +
Sbjct: 205 RWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEV 129
R + D +G G F +V+KG +D T + +A L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKG-LDT--------ETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 130 NYLGQLYHPNLVKLVGYCL---EDDHRLLVY-EFMPRGSLENHLFRRGSYFQPLSWNLRL 185
L L HPN+V+ + +++ E M G+L+ +L R F+ + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLR 132
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKLSDFGLAKDGPTGDQSHVST 244
KG+ FLH +I+RD K NI + + K+ D GLA S
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT------LKRASF 186
Query: 245 R--VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
V+GT + APE + DVY+FG+ +LEM +
Sbjct: 187 AKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL-Y 136
V+GEG FG V K I K G M A+KR+ + H+++ E+ L +L +
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQPLSWNLR----------- 184
HPN++ L+G C + L E+ P G+L + L R P
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
L A A+G+ +L ++ + I+RD NIL+ NY AK++DFGL++ +
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MG 201
Query: 245 RV----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
R+ M A E L T SDV+S+GV+L E++S
Sbjct: 202 RLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 66/209 (31%), Positives = 106/209 (50%), Gaps = 26/209 (12%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
+G+G FG V G + G +AVK + D + +LAE + + QL H
Sbjct: 200 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 245
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
NLV+L+G +E+ L +V E+M +GSL ++L RG L + LK +L + +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAME 303
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE 256
+L ++RD N+L+ + AK+SDFGL K+ + + ++ + APE
Sbjct: 304 YL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKL--PVKWTAPE 356
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
L + KSDV+SFG++L E+ S GR
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---EWLAEVNYLGQ 134
LG+G FG V +G W G + +AVK L D + +++ EVN +
Sbjct: 25 KLGDGSFGVVRRGEW-------DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
L H NL++L G L +V E P GSL + L + +F + A+ A+G
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEG 133
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YG 251
+ +L + I+RD N+LL T K+ DFGL + P D +V +
Sbjct: 134 MGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
+ APE L T + SD + FGV L EM + G+
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 67/307 (21%), Positives = 112/307 (36%), Gaps = 66/307 (21%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
LG+G F +FKG + + + +K L++ + + + + +L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
+LV G C+ D +LV EF+ GSL+ +L + + L +L+VA A + F
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW---KLEVAKQLAAAMHF 128
Query: 198 LHGAETKVIYRDFKTSNILLDT--------NYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
L E +I+ + NILL KLSD G++ V+
Sbjct: 129 L--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174
Query: 250 YGY------AAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302
PE + +L +D +SFG L E+ SG G+ K
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG----------GD-------K 217
Query: 303 PYLA-SKRKIFRIIDNRLEGQYTLEG-----AYKAATLALRCLSTEGKFRPMMAEVVTVL 356
P A ++ + ++R + L L C+ E RP ++ L
Sbjct: 218 PLSALDSQRKLQFYEDR----HQLPAPKAAELAN---LINNCMDYEPDHRPSFRAIIRDL 270
Query: 357 EQLQDSS 363
L
Sbjct: 271 NSLFTPD 277
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 77/312 (24%), Positives = 137/312 (43%), Gaps = 44/312 (14%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLY 136
V+G G FG V+KG +A+K L + ++L E +GQ
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
H N+++L G + +++ E+M G+L+ L + S + + G A G+
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMK 161
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YGYA 253
+L A ++RD NIL+++N K+SDFGL++ D + G +
Sbjct: 162 YL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWT 217
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SKRKI 311
APE ++ T+ SDV+SFG+V+ E+++ G R PY S ++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSNHEV 259
Query: 312 FRIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNI 368
+ I++ RL Y+ L ++C E RP A++V++L++L + ++
Sbjct: 260 MKAINDGFRLPTPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316
Query: 369 RCNTHNRPKIRR 380
+ R IR
Sbjct: 317 LADFDPRVSIRL 328
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
LG G +G V++G W + +AVK L +D + +E+L E + ++ H
Sbjct: 227 KLGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKH 275
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PNLV+L+G C + ++ EFM G+L ++L Q +S + L +A + + +
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEY 333
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEY 257
L + I+R+ N L+ N+ K++DFGL++ TGD + APE
Sbjct: 334 L--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPES 390
Query: 258 LATGHLTAKSDVYSFGVVLLEMLS 281
LA + KSDV++FGV+L E+ +
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-36
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
+G G FG V G W+++ +A+K + +G ++++ E + +L H
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSH 62
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
P LV+L G CLE LV EFM G L ++L + F + L + L +G+A+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAY 119
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YGYAA 254
L E VI+RD N L+ N K+SDFG+ + T GT +A+
Sbjct: 120 L--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWAS 173
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
PE + ++KSDV+SFGV++ E+ S G+
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 49/299 (16%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
V+G G FG V+ G G + AVK LN+ ++L E + H
Sbjct: 96 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 138 PNLVKLVGYCLEDDH-RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
PN++ L+G CL + L+V +M G L N + R P +L + L AKG+
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDL-IGFGLQVAKGMK 206
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG------TY 250
FL A K ++RD N +LD + K++DFGLA+D + V +
Sbjct: 207 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM- 263
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SK 308
A E L T T KSDV+SFGV+L E+++ G PY +
Sbjct: 264 ---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP------------------PYPDVNT 302
Query: 309 RKIFRIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364
I + RL +Y + Y+ + L+C + + RP +E+V+ + + +
Sbjct: 303 FDITVYLLQGRRLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
LG G FG V G W ++ +AVK + +G E+ E + +L H
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD-----------VAVKMIK-EGSMSEDEFFQEAQTMMKLSH 62
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
P LVK G C ++ +V E++ G L N+L G +P L++ +G+AF
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAF 119
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YGYAA 254
L + I+RD N L+D + K+SDFG+ + +GT ++A
Sbjct: 120 L--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSA 173
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
PE ++KSDV++FG+++ E+ S G+
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 57/245 (23%), Positives = 104/245 (42%), Gaps = 31/245 (12%)
Query: 45 PTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG-WIDEHSFAATKP 103
P +P+ + + ++ LG G FG V G W ++
Sbjct: 2 PLGSKN-----APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD------ 50
Query: 104 GTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRG 163
+A+K + +G E++ E + L H LV+L G C + ++ E+M G
Sbjct: 51 -----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104
Query: 164 SLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223
L N+L FQ L L++ + + +L + ++RD N L++
Sbjct: 105 CLLNYLREMRHRFQTQ--QL-LEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVV 159
Query: 224 KLSDFGLAKDGPTGDQSHVSTRVMGT---YGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280
K+SDFGL++ T +G+ ++ PE L ++KSD+++FGV++ E+
Sbjct: 160 KVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 281 S-GRR 284
S G+
Sbjct: 216 SLGKM 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 28/217 (12%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQ 134
D LG G FG+V KG+ +AVK L + E LAE N + Q
Sbjct: 22 DKELGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
L +P +V+++G C + +LV E G L +L ++ + + N+ +++ + G
Sbjct: 75 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDK--NI-IELVHQVSMG 129
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG------ 248
+ +L E+ ++RD N+LL T + AK+SDFGL+K D+++ + G
Sbjct: 130 MKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKW 186
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
APE + ++KSDV+SFGV++ E S G++
Sbjct: 187 Y----APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 55/250 (22%), Positives = 104/250 (41%), Gaps = 23/250 (9%)
Query: 39 SSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSF 98
+ PP P+ + + P++ + ++ FR + +G G F V++
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLAN-------FRIEKKIGRGQFSEVYR-------- 50
Query: 99 AATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQLYHPNLVKLVGYCLEDDHRLL 155
A G+ +A+K++ K + E++ L QL HPN++K +ED+ +
Sbjct: 51 -AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109
Query: 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215
V E G L + + + K + + +H +V++RD K +N+
Sbjct: 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANV 167
Query: 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVV 275
+ KL D GL + + + + V GT Y +PE + KSD++S G +
Sbjct: 168 FITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 276 LLEMLSGRRA 285
L EM + +
Sbjct: 226 LYEMAALQSP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 60/241 (24%), Positives = 90/241 (37%), Gaps = 31/241 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
+++ LGEGGF V G A+KR+ Q +E E +
Sbjct: 29 KHYLFIQKLGEGGFSYVDL---------VEGLHDGHFYALKRILCHEQQDREEAQREADM 79
Query: 132 LGQLYHPNLVKLVGYCLEDDHR----LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
HPN+++LV YCL + L+ F RG+L N + R L+ + L +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
LG +G+ +H +RD K +NILL L D G + +
Sbjct: 140 LLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 248 -------GTYGYAAPE------YLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294
T Y APE + ++DV+S G VL M+ G D G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 295 H 295
Sbjct: 255 S 255
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 77 DSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQ 134
D LG G FGSV +G + + +A+K L Q +E + E + Q
Sbjct: 15 DIELGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
L +P +V+L+G C + +LV E G L L + N+ ++ + G
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPV--SNV-AELLHQVSMG 122
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG------ 248
+ +L E ++RD N+LL + AK+SDFGL+K D S+ + R G
Sbjct: 123 MKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKW 179
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
APE + +++SDV+S+GV + E LS G++
Sbjct: 180 Y----APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 76/316 (24%), Positives = 122/316 (38%), Gaps = 51/316 (16%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
LG G FG V++G + + +AVK L + Q ++L E + +
Sbjct: 78 GLGHGAFGEVYEGQVSG-----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQPLSWNLR--LKVALGAAK 193
H N+V+ +G L+ R ++ E M G L++ L R QP S + L VA A
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
G +L E I+RD N LL AK+ DFG+A+D G
Sbjct: 193 GCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGC 245
Query: 251 GY-----AAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPY 304
PE G T+K+D +SFGV+L E+ S G PY
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------PY 287
Query: 305 LA-SKRKIFRIID--NRLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
+ S +++ + R++ + Y+ + +C + + RP A ++ +E
Sbjct: 288 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEYCT 344
Query: 361 DSSETGNIRCNTHNRP 376
+ N P
Sbjct: 345 QDPDVINTALPIEYGP 360
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
+G+G FG V G + G +AVK + D + +LAE + + QL H
Sbjct: 28 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 73
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
NLV+L+G +E+ L +V E+M +GSL ++L R L + LK +L + +
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV----MGTYGY 252
+L ++RD N+L+ + AK+SDFGL K+ + + + ++
Sbjct: 132 YL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWT----- 181
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
APE L + KSDV+SFG++L E+ S GR
Sbjct: 182 -APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 41/311 (13%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
LG G FG V++G + + +AVK L + Q ++L E + +
Sbjct: 37 GLGHGAFGEVYEGQVSG-----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQPLSWNLR--LKVALGAAK 193
H N+V+ +G L+ R ++ E M G L++ L R QP S + L VA A
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
G +L E I+RD N LL AK+ DFG+A+D M
Sbjct: 152 GCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SK 308
+ PE G T+K+D +SFGV+L E+ S G PY + S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------------------PYPSKSN 251
Query: 309 RKIFRIID--NRLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365
+++ + R++ + Y+ + +C + + RP A ++ +E +
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
Query: 366 GNIRCNTHNRP 376
N P
Sbjct: 309 INTALPIEYGP 319
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
LGEG FG VF + + M++AVK L K++ E L L H +
Sbjct: 23 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF------------QPLSWNLRLKV 187
+VK G C + D ++V+E+M G L L G L + L +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QSHVSTR 245
A A G+ +L A ++RD T N L+ N K+ DFG+++D + D + T
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 246 V----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ M PE + T +SDV+SFGV+L E+ +
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 32/294 (10%)
Query: 8 RIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDL 67
++ P V+ SS + M+S V + + + +
Sbjct: 19 KLTKRIPLRRQVTVSAESS--SSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW 76
Query: 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWL 126
+ LGEG FG V KP + +AVK L D + + +
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 134
Query: 127 AEVNYLGQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR- 184
+E+ + + H N++ L+G C +D ++ E+ +G+L +L R S+++
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 185 -----------LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233
+ A+G+ +L A K I+RD N+L+ N K++DFGLA+D
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 234 GPTGD--QSHVSTRV----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
D + + R+ M APE L T +SDV+SFGV++ E+ +
Sbjct: 253 INNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
V+G+G FG V+ G + + A+K L++ Q + +L E + L H
Sbjct: 28 VIGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 138 PNLVKLVGYCLEDD-HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
PN++ L+G L + ++ +M G L + + + + L A+G+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGME 138
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD----GPTGDQSHVSTRV----MG 248
+L AE K ++RD N +LD ++ K++DFGLA+D Q H R+
Sbjct: 139 YL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
A E L T T KSDV+SFGV+L E+L+
Sbjct: 196 -----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-35
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL-Y 136
LGEG FG V KP + +AVK L D + + ++E+ + +
Sbjct: 42 PLGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR------------ 184
H N++ L+G C +D ++ E+ +G+L +L R S+++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QSHV 242
+ A+G+ +L A K I+RD N+L+ N K++DFGLA+D D +
Sbjct: 160 VSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 243 STRV----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ R+ M APE L T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG+G FG V+ G T GT V A+K L G + +L E + +L H
Sbjct: 191 KLGQGCFGEVWMG---------TWNGTTRV-AIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
LV+L E+ +V E+M +GSL + L + L + +A A G+A++
Sbjct: 240 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYV 296
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 297 --ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 353
Query: 259 ATGHLTAKSDVYSFGVVLLEMLS 281
G T KSDV+SFG++L E+ +
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTT 376
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-35
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 40/219 (18%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G +G V++G + +AVK L +D + +E+L E + ++ HP
Sbjct: 20 KLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
NLV+L+G C + ++ EFM G+L ++L R Q +S + L +A + + +L
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA----- 253
+ I+RD N L+ N+ K++DFGL+ R+M Y
Sbjct: 128 --EKKNFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGA 172
Query: 254 -------APEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
APE LA + KSDV++FGV+L E+ + G
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-35
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYH 137
++G G G V G + +A+K L + +++L+E + +GQ H
Sbjct: 56 IIGSGDSGEVCYGR------LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PN+++L G ++V E+M GSL+ L + + + G G+ +
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRY 166
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YGYAA 254
L ++ ++RD N+L+D+N K+SDFGL++ D + G + A
Sbjct: 167 L--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTA 222
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
PE +A ++ SDV+SFGVV+ E+L+ G R
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-35
Identities = 41/253 (16%), Positives = 76/253 (30%), Gaps = 19/253 (7%)
Query: 44 PPTPRSEGEILRSPNLKSFS-FSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATK 102
P L + ++ + ++ +LGEG F V++
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA---TQGDLNDA 92
Query: 103 PGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPR 162
+K + L +K L + +LV E
Sbjct: 93 K-NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 163 GSLENHLFRRGSY-FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---- 217
G+L N + + + + L + A+ + +H E +I+ D K N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209
Query: 218 -------DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVY 270
D + L D G + D + + T T G+ E L+ + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 271 SFGVVLLEMLSGR 283
+ ML G
Sbjct: 270 GVAATVYCMLFGT 282
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
+LGEG FG V++G + + G + +AVK +D +++++E + L
Sbjct: 19 ILGEGFFGEVYEGVYTN-------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
HP++VKL+G E+ ++ E P G L ++L R + + L+ + +L K +A
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMA 127
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV-------MGT 249
+L ++RD NIL+ + KL DFGL++ D+ + V M
Sbjct: 128 YL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWM-- 181
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
+PE + T SDV+ F V + E+LS G++
Sbjct: 182 ----SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 33/226 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNY 131
+ LG GGFG V + H TG +A+K+ Q+ ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---IHQD------TGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 132 LGQLYHPNLVKLV------GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
+ +L HPN+V +D LL E+ G L +L + + L+
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG-----LKE 120
Query: 186 KVALGA----AKGVAFLHGAETKVIYRDFKTSNILLDTNYNA---KLSDFGLAKDGPTGD 238
+ + +LH E ++I+RD K NI+L K+ D G AK+
Sbjct: 121 GPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQ 176
Query: 239 QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+ V GT Y APE L T D +SFG + E ++G R
Sbjct: 177 GELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 77/313 (24%), Positives = 137/313 (43%), Gaps = 43/313 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYH 137
V+G G FG V G + +A+K L + +++L E + +GQ H
Sbjct: 52 VVGAGEFGEVCSGR------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
PN+++L G + ++V E+M GSL++ L + + + + + G A G+ +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT---YGYAA 254
L ++ ++RD NIL+++N K+SDFGL + D + G + +
Sbjct: 163 L--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTS 218
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA-SKRKIF 312
PE +A T+ SDV+S+G+VL E++S G R PY S + +
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER------------------PYWEMSNQDVI 260
Query: 313 RIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNIR 369
+ +D RL Y+ L L C + RP ++V++L++L + + I
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQ---LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317
Query: 370 CNTHNRPKIRRHS 382
+ RP
Sbjct: 318 TSAAARPSNLLLD 330
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
LG G FG V+ G + +AVK L G +LAE N + QL H
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-----------VAVKSLK-QGSMSPDAFLAEANLMKQLQH 67
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
LV+L ++ ++ E+M GSL + L + L+ N L +A A+G+AF
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD-QSHVSTRVMGTYGYAAPE 256
+ E I+RD + +NIL+ + K++DFGLA+ + + + + APE
Sbjct: 125 I--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPE 180
Query: 257 YLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
+ G T KSDV+SFG++L E+++ GR
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
LGE FG V+KG H F +A+K L +E+ E +L H
Sbjct: 16 ELGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF------------QPLSWNLRL 185
PN+V L+G +D +++ + G L L R + L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST- 244
+ A G+ +L + V+++D T N+L+ N K+SD GL ++ D +
Sbjct: 132 HLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 245 -----RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
R M APE + G + SD++S+GVVL E+ S
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 4e-34
Identities = 74/379 (19%), Positives = 134/379 (35%), Gaps = 56/379 (14%)
Query: 2 GICLSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKS 61
G C +S + + K S + SE + +
Sbjct: 316 GYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSV-SETDDYAEIIDEE 374
Query: 62 FSFSDLKTATRNFRPDSV-----LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ 116
+++ T + + + +GEG FG V +G + M +A+K
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKN 428
Query: 117 D-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY 175
+++L E + Q HP++VKL+G E+ ++ E G L + L R
Sbjct: 429 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS 487
Query: 176 FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235
+L + A + +A+L + ++RD N+L+ +N KL DFGL++
Sbjct: 488 LDLA--SL-ILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-- 540
Query: 236 TGDQSHVSTR-----VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKN 289
D ++ + APE + T+ SDV+ FGV + E+L G +
Sbjct: 541 MEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVK----- 591
Query: 290 RPSGEHNLVEWAKPYLA-SKRKIFRIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKF 345
P+ + I+N RL Y L +C + +
Sbjct: 592 -------------PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS---LMTKCWAYDPSR 635
Query: 346 RPMMAEVVTVLEQLQDSSE 364
RP E+ L + + +
Sbjct: 636 RPRFTELKAQLSTILEEEK 654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL-Y 136
LG G FG V + +F K + +AVK L + ++E+ + L
Sbjct: 53 TLGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQ----------PLSWNLRLK 186
H N+V L+G C L++ E+ G L N L R+ + S L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST-- 244
+ A+G+AFL A I+RD N+LL + AK+ DFGLA+D V
Sbjct: 169 FSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 245 ----RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ M APE + T +SDV+S+G++L E+ S
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG+G FG V+ G T GT V A+K L G + +L E + +L H
Sbjct: 274 KLGQGCFGEVWMG---------TWNGTTRV-AIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
LV+L E+ +V E+M +GSL + L +G + L + +A A G+A++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 380 --ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 436
Query: 259 ATGHLTAKSDVYSFGVVLLEMLS 281
G T KSDV+SFG++L E+ +
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTT 459
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-34
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL-Y 136
LGEG FG V + KP +AVK L D + + ++E+ + +
Sbjct: 76 PLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR------------ 184
H N++ L+G C +D ++ E+ +G+L +L R S+N
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QSHV 242
+ A A+G+ +L A K I+RD N+L+ + K++DFGLA+D D +
Sbjct: 194 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 243 STRV----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
+ R+ M APE L T +SDV+SFGV+L E+ +
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-34
Identities = 65/226 (28%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL- 135
LG G FG V + K M +AVK L + ++E+ L L
Sbjct: 30 TLGAGAFGKVVEATAYG-----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL-FRRGSYFQPLSWNLR---------- 184
H N+V L+G C L++ E+ G L N L +R S+ +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 185 ---LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSH 241
L + AKG+AFL A I+RD NILL K+ DFGLA+D
Sbjct: 145 EDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 242 VST------RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
V + M APE + T +SDV+S+G+ L E+ S
Sbjct: 203 VKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
+GEG FG V +G + + +A+K +++L E + Q H
Sbjct: 22 CIGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
P++VKL+G E+ ++ E G L + L R +L + A + +A+
Sbjct: 76 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLA--SL-ILYAYQLSTALAY 131
Query: 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV-------MGTY 250
L + ++RD N+L+ +N KL DFGL++ D ++ M
Sbjct: 132 L--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWM--- 184
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
APE + T+ SDV+ FGV + E+L G +
Sbjct: 185 ---APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 70/297 (23%), Positives = 117/297 (39%), Gaps = 58/297 (19%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
+F+ ++G GGFG VFK A G +KR+ + +++ EV
Sbjct: 11 MDFKEIELIGSGGFGQVFK---------AKHRIDGKTYVIKRVKYN----NEKAEREVKA 57
Query: 132 LGQLYHPNLVKLVGYCLEDDHRL----------------LVYEFMPRGSLENHLFRRGSY 175
L +L H N+V G D+ + EF +G+LE + +R
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG- 116
Query: 176 FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235
+ L L L++ KGV ++H K+I RD K SNI L K+ DFGL
Sbjct: 117 -EKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--- 170
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295
+ TR GT Y +PE +++ + D+Y+ G++L E+L
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------- 217
Query: 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ + + D + + + TL + LS + + RP +E+
Sbjct: 218 -----CDTAFETSKFFTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEI 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYH 137
+GEG FG VF+ + ++AVK L ++ ++ E + + +
Sbjct: 54 DIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF--------------------Q 177
PN+VKL+G C L++E+M G L L +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 178 PLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237
PLS +L +A A G+A+L +E K ++RD T N L+ N K++DFGL+++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 238 DQSHVSTRV------MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
D M PE + T +SDV+++GVVL E+ S
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-33
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 34/233 (14%)
Query: 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WL 126
T+ + +LG+G +VF+ TG + A+K N F + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR---------GRHKKTGDLFAIKVFNNISFLRPVDVQM 55
Query: 127 AEVNYLGQLYHPNLVKLVGYCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWN 182
E L +L H N+VKL + +E++ H++L+ EF P GSL L + + L +
Sbjct: 56 REFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPES 112
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAKDGPTGD 238
L V G+ L E +++R+ K NI+ D KL+DFG A++ D
Sbjct: 113 EFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168
Query: 239 QSHVSTRVMGTYGYAAPEYLATGHL--------TAKSDVYSFGVVLLEMLSGR 283
+ GT Y P+ L A D++S GV +G
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 20/213 (9%)
Query: 77 DSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQ 134
D LG G FGSV +G + + +A+K L Q +E + E + Q
Sbjct: 341 DIELGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
L +P +V+L+G C + +LV E G L L + N+ ++ + G
Sbjct: 393 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPV--SNV-AELLHQVSMG 448
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA- 253
+ +L E ++R+ N+LL + AK+SDFGL+K D S+ + R G +
Sbjct: 449 MKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKW 505
Query: 254 -APEYLATGHLTAKSDVYSFGVVLLEMLS-GRR 284
APE + +++SDV+S+GV + E LS G++
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 34/233 (14%)
Query: 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WL 126
T+ + +LG+G +VF+ TG + A+K N F + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR---------GRHKKTGDLFAIKVFNNISFLRPVDVQM 55
Query: 127 AEVNYLGQLYHPNLVKLVGYCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWN 182
E L +L H N+VKL + +E++ H++L+ EF P GSL L + + L +
Sbjct: 56 REFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-GLPES 112
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAKDGPTGD 238
L V G+ L E +++R+ K NI+ D KL+DFG A++ D
Sbjct: 113 EFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168
Query: 239 QSHVSTRVMGTYGYAAPEYLATGHL--------TAKSDVYSFGVVLLEMLSGR 283
+ GT Y P+ L A D++S GV +G
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G FG V+ T V AVK + G + +LAE N + L H
Sbjct: 195 KLGAGQFGEVWMA---------TYNKHTKV-AVKTMK-PGSMSVEAFLAEANVMKTLQHD 243
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
LVKL ++ ++ EFM +GSL + L + + A+G+AF+
Sbjct: 244 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFI 300
Query: 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL 258
+ I+RD + +NIL+ + K++DFGLA+ ++ + APE +
Sbjct: 301 --EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI 357
Query: 259 ATGHLTAKSDVYSFGVVLLEMLS-GRR 284
G T KSDV+SFG++L+E+++ GR
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 23/233 (9%)
Query: 56 SPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
++ F ++ + +GEG FG G +K +N
Sbjct: 12 DLGTENLYFQSME----KYVRLQKIGEGSFGKAIL---------VKSTEDGRQYVIKEIN 58
Query: 116 QDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR 172
KE EV L + HPN+V+ E+ +V ++ G L + +
Sbjct: 59 ISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117
Query: 173 GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
+ L + + +H + K+++RD K+ NI L + +L DFG+A+
Sbjct: 118 K--GVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA 285
+ GT Y +PE KSD+++ G VL E+ + + A
Sbjct: 174 VL-NSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 35/231 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNY 131
+F P LG GGFG VF+ A A+KR+ + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFE---------AKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 132 LGQLYHPNLVKLVGYCLEDD---------HRLLVY---EFMPRGSLENHLFRRGSYFQPL 179
L +L HP +V+ LE + ++ +Y + + +L++ + R + +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEER 115
Query: 180 SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK------- 232
++ L + L A+ V FLH +++RD K SNI + K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 233 ---DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280
T +GT Y +PE + + K D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 41/231 (17%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLY 136
LGEG FG V K +AVK L ++ ++ L+E N L Q+
Sbjct: 30 TLGEGEFGKVVKATAFH-----LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF-------------------- 176
HP+++KL G C +D LL+ E+ GSL L
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
+ L+ + A ++G+ +L AE K+++RD NIL+ K+SDFGL++D
Sbjct: 145 RALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 237 GDQSHVST------RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS 281
D + + M A E L T +SDV+SFGV+L E+++
Sbjct: 203 EDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 82/314 (26%), Positives = 121/314 (38%), Gaps = 62/314 (19%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL- 135
LG G FG V + K T +AVK L + H+ ++E+ L +
Sbjct: 34 PLGRGAFGQVIEADAFG-----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 136 YHPNLVKLVGYCL-EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR---------- 184
+H N+V L+G C +++ EF G+L +L + + F P
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 185 --LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD--QS 240
+ + AKG+ FL A K I+RD NILL K+ DFGLA+D
Sbjct: 149 HLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 241 HVSTRV----MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295
R+ M APE + T +SDV+SFGV+L E+ S G
Sbjct: 207 KGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGA------------ 248
Query: 296 NLVEWAKPY--LASKRKIFRIIDN--RLEG-QYTLEGAYKAATLALRCLSTEGKFRPMMA 350
PY + + R + R+ YT Y+ L C E RP +
Sbjct: 249 ------SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFS 299
Query: 351 EVVTVLEQLQDSSE 364
E+V L L ++
Sbjct: 300 ELVEHLGNLLQANA 313
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 62/274 (22%), Positives = 103/274 (37%), Gaps = 26/274 (9%)
Query: 16 NTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFR 75
+ VSS S + + S + L + E + + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL 135
+G G FG V + D+ TG AVK++ + F+ + E+ L
Sbjct: 62 HQPRVGRGSFGEVHRM-KDK--------QTGFQCAVKKVRLEVFR-----VEELVACAGL 107
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
P +V L G E + E + GSL + + G L + L A +G+
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGL 163
Query: 196 AFLHGAETKVIYRDFKTSNILLDTN-YNAKLSDFGLAK---DGPTGDQSHVSTRVMGTYG 251
+LH ++++ D K N+LL ++ A L DFG A G + GT
Sbjct: 164 EYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 252 YAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+ APE + AK D++S ++L ML+G
Sbjct: 222 HMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 18/226 (7%)
Query: 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKE 124
+ + ++ +G G +G K + G ++ K L+ +
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 125 WLAEVNYLGQLYHPNLVKLVG-YCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWN 182
++EVN L +L HPN+V+ + L +V E+ G L + + + Q L
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 183 LRLKVALGAAKGVAFLH---GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
L+V + H V++RD K +N+ LD N KL DFGLA+ D
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDT 170
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA 285
S T V GT Y +PE + KSD++S G +L E+ +
Sbjct: 171 SFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 79/321 (24%), Positives = 123/321 (38%), Gaps = 69/321 (21%)
Query: 79 VLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL- 135
VLG G FG V +K G + +AVK L + + ++E+ + QL
Sbjct: 52 VLGSGAFGKVMNATAYGI-----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR----------- 184
H N+V L+G C L++E+ G L N+L + F
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 185 --------LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
L A AKG+ FL ++RD N+L+ K+ DFGLA+D +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 237 GDQSHVST------RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKN 289
V + M APE L G T KSDV+S+G++L E+ S G
Sbjct: 225 DSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVN----- 273
Query: 290 RPSGEHNLVEWAKPY--LASKRKIFRIID--NRLEG-QYTLEGAYKAATLALRCLSTEGK 344
PY + +++I +++ Y E Y + C + + +
Sbjct: 274 -------------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI---IMQSCWAFDSR 317
Query: 345 FRPMMAEVVTVLE-QLQDSSE 364
RP + + L QL D+ E
Sbjct: 318 KRPSFPNLTSFLGCQLADAEE 338
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 57/297 (19%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+F P VLG G G++ F +AVKR+ + F EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVY----RGMF------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 133 GQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+ HPN+++ + + + E +L+ ++ ++ L + +
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQT 127
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILL-----DTNYNAKLSDFGLAKDGPTGDQS-HVSTR 245
G+A LH +++RD K NIL+ A +SDFGL K G S +
Sbjct: 128 TSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 246 VMGTYGYAAPEYL---ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302
V GT G+ APE L + T D++S G V ++S G H
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE----------GSH------- 228
Query: 303 PYLASKRKIFRIIDNRLEGQYTLEGAYK-------AATLALRCLSTEGKFRPMMAEV 352
P+ S ++ I L G +L+ + A L + ++ + + RP V
Sbjct: 229 PFGKSLQRQANI----LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 42/218 (19%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---EWLAEVNYLGQL 135
LG+G FG+V+ A + + ++A+K L + + + EV L
Sbjct: 16 PLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLK 186
HPN+++L GY D R+ L+ E+ P G++ L + +Y L
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------- 118
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
A +++ H +VI+RD K N+LL + K++DFG + P
Sbjct: 119 -----ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTD 166
Query: 247 M-GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ GT Y PE + K D++S GV+ E L G+
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 46/265 (17%), Positives = 94/265 (35%), Gaps = 43/265 (16%)
Query: 45 PTPRSEGEILRSPNLKSFSFSDLKTATR--NFRPDSVLGEGGFGSVFKGWIDEHSFAATK 102
P + + NL + + ++R L +G F + E
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC---EK------ 52
Query: 103 PGTGMVIAVKRLNQDGFQGHKEWLA-----------------EVNYLGQLYHPNLVKLVG 145
A+K+ + + +++ E+ + + + + G
Sbjct: 53 --DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 146 YCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL----GAAKGVAFLHG 200
+ + + ++YE+M S+ + + + ++V +++H
Sbjct: 111 I-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH- 168
Query: 201 AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT 260
E + +RD K SNIL+D N KLSDFG ++ + GTY + PE+ +
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKG-SRGTYEFMPPEFFSN 224
Query: 261 --GHLTAKSDVYSFGVVLLEMLSGR 283
+ AK D++S G+ L M
Sbjct: 225 ESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 46/220 (20%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLAEVNYLG 133
LG+G FG+V+ A + ++A+K +L ++G + E+
Sbjct: 21 PLGKGKFGNVYL---------AREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQS 69
Query: 134 QLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRG--------SYFQPLSWNLR 184
L HPN++++ Y D R+ L+ EF PRG L L + G ++ + L
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----- 123
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
A + + H E KVI+RD K N+L+ K++DFG + P+
Sbjct: 124 -------ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RR 169
Query: 245 RVM-GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
R M GT Y PE + K D++ GV+ E L G
Sbjct: 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 52/243 (21%), Positives = 94/243 (38%), Gaps = 33/243 (13%)
Query: 56 SPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
++ F + R + +G GG VF+ ++E + A+K +N
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNE---------KKQIYAIKYVN 61
Query: 116 QDGFQGH--KEWLAEVNYLGQLYHPNL--VKLVGYCLEDDHRLLVYEFMPRGSLENHLFR 171
+ + E+ YL +L + ++L Y + D + +V E L + L +
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK 120
Query: 172 RGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
+ S + R + V +H + +++ D K +N L+ KL DFG+A
Sbjct: 121 KKS----IDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEYL-----------ATGHLTAKSDVYSFGVVLLEML 280
S V +GT Y PE + + ++ KSDV+S G +L M
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 281 SGR 283
G+
Sbjct: 234 YGK 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-31
Identities = 55/273 (20%), Positives = 98/273 (35%), Gaps = 38/273 (13%)
Query: 31 MSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTAT-----RNFRPDSVLGEGGF 85
+ GS + + R + S R + +G GG
Sbjct: 10 LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69
Query: 86 GSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNL--V 141
VF+ ++E + A+K +N + Q + E+ YL +L + +
Sbjct: 70 SKVFQV-LNE---------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA 201
+L Y + D + +V E L + L ++ S + R + V +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIH-- 172
Query: 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL--- 258
+ +++ D K +N L+ KL DFG+A S V +G Y PE +
Sbjct: 173 QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 259 --------ATGHLTAKSDVYSFGVVLLEMLSGR 283
+ ++ KSDV+S G +L M G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 64/218 (29%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
F VLG GGFG VF A TG + A K+LN+ + K + + E
Sbjct: 186 WFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L +++ +V L Y E L LV M G + H++ +
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAI 292
Query: 189 LGAAK---GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
A+ G+ LH + +IYRD K N+LLD + N ++SD GLA + G
Sbjct: 293 FYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGY 349
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
GT G+ APE L D ++ GV L EM++ R
Sbjct: 350 A-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 47/266 (17%)
Query: 32 SSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG 91
+ V ++ P P + P + + R + LG+GGF F+
Sbjct: 6 DPGKAGVPGVAAPGAPAA-----APPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFE- 59
Query: 92 WIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---EWLAEVNYLGQLYHPNLVKLVGYCL 148
+ T V A K + + + E++ L H ++V G+
Sbjct: 60 --------ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-F 110
Query: 149 EDDHRL-LVYEFMPRGSLENHLFRRGS--------YFQPLSWNLRLKVALGAAKGVAFLH 199
ED+ + +V E R SL RR + Y + + G +LH
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------------VLGCQYLH 158
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYL 258
+VI+RD K N+ L+ + K+ DFGLA + +V+ GT Y APE L
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVL 213
Query: 259 A-TGHLTAKSDVYSFGVVLLEMLSGR 283
+ GH + + DV+S G ++ +L G+
Sbjct: 214 SKKGH-SFEVDVWSIGCIMYTLLVGK 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
VLG+G +G V+ G + IA+K + + + + E+ L H
Sbjct: 29 VLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V+ +G E+ + E +P GSL L + + +G+ +L
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIGFYTKQILEGLKYL 138
Query: 199 HGAETKVIYRDFKTSNILLDT-NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPE- 256
H + ++++RD K N+L++T + K+SDFG +K + + GT Y APE
Sbjct: 139 H--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEI 194
Query: 257 --YLATGHLTAKSDVYSFGVVLLEMLSGRR 284
G+ +D++S G ++EM +G+
Sbjct: 195 IDKGPRGY-GKAADIWSLGCTIIEMATGKP 223
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---EWLAE 128
R + LG+GGF F+ + T V A K + + + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFE---------ISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGS--------YFQPL 179
++ L H ++V G+ ED+ + +V E R SL RR + Y + +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 180 SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
G +LH +VI+RD K N+ L+ + K+ DFGLA +
Sbjct: 125 ------------VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170
Query: 240 SHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
+V+ GT Y APE L+ GH + + DV+S G ++ +L G+
Sbjct: 171 RK---KVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 212
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 76/251 (30%), Positives = 107/251 (42%), Gaps = 27/251 (10%)
Query: 40 SLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFA 99
LSV P I + L+ FR VLG+GGFG V A
Sbjct: 152 YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC---------A 202
Query: 100 ATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRL-L 155
TG + A K+L + + K L E L ++ +V L Y E L L
Sbjct: 203 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCL 261
Query: 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK---GVAFLHGAETKVIYRDFKT 212
V M G L+ H++ G P + + AA+ G+ LH +++YRD K
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFYAAEICCGLEDLH--RERIVYRDLKP 314
Query: 213 SNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSF 272
NILLD + + ++SD GLA P G RV GT GY APE + T D ++
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 273 GVVLLEMLSGR 283
G +L EM++G+
Sbjct: 372 GCLLYEMIAGQ 382
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK- 123
+ + +F+ ++LG+G F V++ A TG+ +A+K +++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYR---------AESIHTGLEVAIKMIDKKAMYKAGM 54
Query: 124 --EWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRG------- 173
EV QL HP++++L Y ED + + LV E G + +L R
Sbjct: 55 VQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE 113
Query: 174 --SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
+ + G+ +LH +++RD SN+LL N N K++DFGLA
Sbjct: 114 ARHFMHQI------------ITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
+ H T + GT Y +PE + H +SDV+S G + +L GR
Sbjct: 160 TQLKMPHEKH-YT-LCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH--KEWLAEVNYLGQLY 136
+G GG VF+ ++E + A+K +N + + E+ YL +L
Sbjct: 16 QIGSGGSSKVFQV-LNE---------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 137 HPNL--VKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
+ ++L Y + D + +V E L + L ++ S + R +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEA 120
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
V +H + +++ D K +N L+ KL DFG+A S V +GT Y
Sbjct: 121 VHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 255 PEYL-----------ATGHLTAKSDVYSFGVVLLEMLSGR 283
PE + + ++ KSDV+S G +L M G+
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 40/263 (15%), Positives = 78/263 (29%), Gaps = 62/263 (23%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL---------- 114
S+L R +VLG+ + + AT TG V
Sbjct: 66 SELGERPRTLVRGTVLGQEDPYAYLE---------ATDQETGESFEVHVPYFTERPPSNA 116
Query: 115 ------------------NQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156
NQ + H ++ + + ++++ D L
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSR 175
Query: 157 YEFMPR-----GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFK 211
+ PR + L S + L + RL++ L + +A LH +++ +
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLR 233
Query: 212 TSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT----------- 260
+I+LD L+ F + + G+ PE A
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 261 GHLTAKSDVYSFGVVLLEMLSGR 283
+T D ++ G+V+ +
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCAD 310
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
+F ++G GGFG V+ K TG + A+K L++ + + L E
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 130 NYLGQL---YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
L + P +V + Y +L + + M G L HL + G + +
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------- 292
Query: 186 KVALGAAK---GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+ AA+ G+ +H V+YRD K +NILLD + + ++SD GLA D
Sbjct: 293 DMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 347
Query: 243 STRVMGTYGYAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGR 283
V GT+GY APE L G S D +S G +L ++L G
Sbjct: 348 HASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 31/233 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
R VL EGGF V++ A G+G A+KRL + + ++ + EV +
Sbjct: 28 LRLRVRRVLAEGGFAFVYE---------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 132 LGQL-YHPNLVKLVGYCLEDDHR-------LLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
+ +L HPN+V+ L+ + +G L L + S PLS +
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDT 137
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA---KDGPTGDQS 240
LK+ + V +H + +I+RD K N+LL KL DFG A P S
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 241 HVSTRVM-------GTYGYAAPE---YLATGHLTAKSDVYSFGVVLLEMLSGR 283
++ T Y PE + + K D+++ G +L + +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 29/252 (11%), Positives = 51/252 (20%), Gaps = 49/252 (19%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE 124
S L R + L G VF A+K E
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFL---------VRDVERLEDFALKVFTMGAENSRSE 105
Query: 125 W---LAEVNYLGQLYHPNLVKLVGYC-----------------------LEDDHRLLVYE 158
+L + + +D
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 159 FMPR-----GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTS 213
MP L + L + + + A L +++ F
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPD 223
Query: 214 NILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL--TAKSDVYS 271
N+ + + L D T YA E+L T + +
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 272 FGVVLLEMLSGR 283
G+ + +
Sbjct: 279 LGLSIYRVWCLF 290
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----EV 129
+R ++G GG G V++ A ++A+K +++ + E
Sbjct: 36 YRLRRLVGRGGMGDVYE---------AEDTVRERIVALKLMSET-LSSDPVFRTRMQREA 85
Query: 130 NYLGQLYHPNLVKL--VGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
G+L P++V + G E D +L + + L L R+G PL+ +
Sbjct: 86 RTAGRLQEPHVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVA 138
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+ + H A +RD K NIL+ + A L DFG+A + +
Sbjct: 139 IVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-T 195
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+GT Y APE + H T ++D+Y+ VL E L+G
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 60/236 (25%), Positives = 92/236 (38%), Gaps = 44/236 (18%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
+ +LG G G+V + SF G +AVKR+ D E+ L
Sbjct: 17 VVSEKILGYGSSGTVVF----QGSF------QGRPVAVKRMLIDFCDIALM---EIKLLT 63
Query: 134 QL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA---L 189
+ HPN+++ D + E +L++ + + + L
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDT-------------NYNAKLSDFGLAK---D 233
A GVA LH K+I+RD K NIL+ T N +SDFGL K
Sbjct: 123 QIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 234 GPTGDQSHVSTRVMGTYGYAAPEYL-------ATGHLTAKSDVYSFGVVLLEMLSG 282
G + +++++ GT G+ APE L LT D++S G V +LS
Sbjct: 181 GQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----EV 129
++ LG GG +V+ D + +A+K + + +E L EV
Sbjct: 13 YKIVDKLGGGGMSTVYLAE-DTI--------LNIKVAIKAIFIP-PREKEETLKRFEREV 62
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
+ QL H N+V ++ EDD LV E++ +L ++ G PLS + +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTN 118
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST-RVMG 248
G+ H ++++RD K NIL+D+N K+ DFG+AK + S T V+G
Sbjct: 119 QILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLG 174
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
T Y +PE +D+YS G+VL EML G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-28
Identities = 75/250 (30%), Positives = 117/250 (46%), Gaps = 24/250 (9%)
Query: 35 GSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWID 94
G K+ L + R E + K D +F S LG G G VFK
Sbjct: 1 GKKLEELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKV--- 52
Query: 95 EHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHR 153
H KP +G+V+A K ++ + + + E+ L + P +V G D
Sbjct: 53 SH-----KP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106
Query: 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTS 213
+ E M GSL+ L + G + + L KV++ KG+ +L + K+++RD K S
Sbjct: 107 SICMEHMDGGSLDQVLKKAGRIPEQI---LG-KVSIAVIKGLTYLR-EKHKIMHRDVKPS 161
Query: 214 NILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFG 273
NIL+++ KL DFG++ G D S ++ V GT Y +PE L H + +SD++S G
Sbjct: 162 NILVNSRGEIKLCDFGVS--GQLID-SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMG 217
Query: 274 VVLLEMLSGR 283
+ L+EM GR
Sbjct: 218 LSLVEMAVGR 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 51/237 (21%), Positives = 81/237 (34%), Gaps = 42/237 (17%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAE 128
T F +G G FGSVFK K G + A+KR + G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFK---------CVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 129 VNYLGQLY-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
V L H ++V+ EDDH L+ E+ GSL + + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-------------------YNAKLSDF 228
L +G+ ++H +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA--TGHLTAKSDVYSFGVVLLEMLSGR 283
G S G + A E L HL K+D+++ + ++
Sbjct: 179 GHVT-----RISSPQVEE-GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 58/255 (22%), Positives = 105/255 (41%), Gaps = 39/255 (15%)
Query: 39 SSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSF 98
++ P S P + D F+ +LGEG F +V
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVV--------- 47
Query: 99 AATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRL- 154
A + T A+K L + + E + + +L HP VKL + +DD +L
Sbjct: 48 LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLY 106
Query: 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLR-----LKVALGAAKGVAFLHGAETKVIYRD 209
+ G L ++ + GS+ + + R + AL +LH +I+RD
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCT---RFYTAEIVSALE------YLH--GKGIIHRD 155
Query: 210 FKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSD 268
K NILL+ + + +++DFG AK + + +GT Y +PE L + SD
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS-SD 214
Query: 269 VYSFGVVLLEMLSGR 283
+++ G ++ ++++G
Sbjct: 215 LWALGCIIYQLVAGL 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 43/261 (16%), Positives = 81/261 (31%), Gaps = 59/261 (22%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD------- 117
S+L R +VLG+ + + AT TG V
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLE---------ATDQETGESFEVHVPYFTERPPSNA 121
Query: 118 ---------------GFQGHKEWLAEVNYLGQ---LYHPNLVKLVGYCLEDDHRLLVYEF 159
G + K+ + ++ + P K++ L++ ++ F
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 181
Query: 160 --MPR-----GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKT 212
PR + L S + L + RL++ L + +A LH +++ +
Sbjct: 182 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRP 239
Query: 213 SNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA----------TGH 262
+I+LD L+ F G S G+A PE A
Sbjct: 240 VDIVLDQRGGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTL 293
Query: 263 LTAKSDVYSFGVVLLEMLSGR 283
+T D ++ G+ + +
Sbjct: 294 MTFAFDTWTLGLAIYWIWCAD 314
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 46/252 (18%)
Query: 42 SVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAAT 101
S+PP ++ N F L+ +G+G FG V
Sbjct: 1 SMPPVFDENEDV----NFDHFEI--LR----------AIGKGSFGKVCI---------VQ 35
Query: 102 KPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVY 157
K T + A+K +N+ E E+ + L HP LV L Y +D+ + +V
Sbjct: 36 KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVV 94
Query: 158 EFMPRGSLENHLFRRGSYFQPLSWNLRLKVA-LGAAKGVAFLHGAETKVIYRDFKTSNIL 216
+ + G L HL + + + +L + L A + +L ++I+RD K NIL
Sbjct: 95 DLLLGGDLRYHLQQNVHFKEETV---KLFICELVMA--LDYLQ--NQRIIHRDMKPDNIL 147
Query: 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA----TGHLTAKSDVYSF 272
LD + + ++DF +A P T + GT Y APE + G+ A D +S
Sbjct: 148 LDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSL 203
Query: 273 GVVLLEMLSGRR 284
GV E+L GRR
Sbjct: 204 GVTAYELLRGRR 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 43/255 (16%)
Query: 52 EI-LRSPNLKSFSFSDLKTATRNFRPDSV---------LGEGGFGSVFKGWIDEHSFAAT 101
EI L K F F DL ++ P ++ LG G G V A
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL---------AF 155
Query: 102 KPGTGMVIAVKRLNQDGFQGHKEWLA--------EVNYLGQLYHPNLVKLVGYCLEDDHR 153
+ T +A++ +++ F A E+ L +L HP ++K+ + + +
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214
Query: 154 LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTS 213
+V E M G L + + + ++ V +LH E +I+RD K
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM----LLAVQYLH--ENGIIHRDLKPE 268
Query: 214 NILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL---TAKS 267
N+LL + + K++DFG +K G+ S + T GT Y APE L +
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAV 325
Query: 268 DVYSFGVVLLEMLSG 282
D +S GV+L LSG
Sbjct: 326 DCWSLGVILFICLSG 340
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/337 (20%), Positives = 115/337 (34%), Gaps = 69/337 (20%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPD----SVLGEGGFGSVFKGWIDEHSFA 99
S E L + ++ LG G +G V
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLL--------- 54
Query: 100 ATKPGTGMVIAVKRLN------------QDGFQGHKEWLA-EVNYLGQLYHPNLVKLVGY 146
+ A+K + + E + E++ L L HPN++KL
Sbjct: 55 CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114
Query: 147 CLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKV 205
ED LV EF G L + R + + + N+ +K L + +LH + +
Sbjct: 115 F-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-MKQILSG---ICYLH--KHNI 167
Query: 206 IYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH 262
++RD K NILL+ N K+ DFGL+ + + +GT Y APE L
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYIAPEVL-KKK 223
Query: 263 LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP-YLASKRKIFRIIDNRLEG 321
K DV+S GV++ +L G P + + I + + +G
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYP------------------PFGGQNDQDIIKKV---EKG 262
Query: 322 QYTLEGAY------KAATLALRCLSTEGKFRPMMAEV 352
+Y + +A L L+ + R E
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 69/277 (24%), Positives = 102/277 (36%), Gaps = 58/277 (20%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-H 137
VLGEG V T AVK + + EV L Q H
Sbjct: 20 VLGEGAHARVQT---------CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY--------FQPLSWNLRLKVAL 189
N+++L+ + E+D LV+E M GS+ +H+ +R + Q +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV---------- 120
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKD-GPTGDQSHVSTR 245
A + FLH + +RD K NIL + K+ DF L GD S +ST
Sbjct: 121 --ASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 246 VM----GTYGYAAPEYLATGHLTAKS-----DVYSFGVVLLEMLSGRRAVDKNRP----S 292
+ G+ Y APE + A D++S GV+L +LSG P
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRC 230
Query: 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
G + + A + +F I EG+Y
Sbjct: 231 GSDCGWDRGEACPACQNMLFESI---QEGKYEFPDKD 264
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 59/304 (19%)
Query: 67 LKTATRNFRPD----SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH 122
++ +T F VLG+G FG V TG AVK +++ +
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVIL---------CKDKITGQECAVKVISKRQVKQK 67
Query: 123 KEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQP 178
+ L EV L QL HPN++KL + ED LV E G L + + R + +
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGP 235
+ + ++ L + ++H + K+++RD K N+LL++ + N ++ DFGL+
Sbjct: 127 DAARI-IRQVLSG---ITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST--- 177
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295
+ S +GT Y APE L G K DV+S GV+L +LSG
Sbjct: 178 HFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP----------- 225
Query: 296 NLVEWAKPYLA-SKRKIFRIIDNRLEGQYTLEGAY------KAATLALRCLSTEGKFRPM 348
P+ ++ I + + +G+YT E A L + L+ R
Sbjct: 226 -------PFNGANEYDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
Query: 349 MAEV 352
+
Sbjct: 276 ARDA 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 57/298 (19%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKP 103
P G IL + F D+ + V+G+G F V +
Sbjct: 3 PGISGGGGGILDMAD-DDVLFEDV------YELCEVIGKGPFSVVRR---------CINR 46
Query: 104 GTGMVIAVK-----RLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYE 158
TG AVK + ++ E + L HP++V+L+ D +V+E
Sbjct: 47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106
Query: 159 FMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK----GVAFLHGAETKVIYRDFKTSN 214
FM L + +R S VA + + + H + +I+RD K
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSE----AVASHYMRQILEALRYCH--DNNIIHRDVKPHC 160
Query: 215 ILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYS 271
+LL + + KL FG+A RV GT + APE + DV+
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWG 218
Query: 272 FGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
GV+L +LSG P+ +K ++F I ++G+Y +
Sbjct: 219 CGVILFILLSGCL------------------PFYGTKERLFEGI---IKGKYKMNPRQ 255
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 67/245 (27%), Positives = 99/245 (40%), Gaps = 30/245 (12%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKP 103
+ E E+ + + ++ F +LG+G FG V +
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNE-------FEYLKLLGKGTFGKVI---------LVKEK 170
Query: 104 GTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEF 159
TG A+K L ++ E L E L HP L L Y + RL V E+
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEY 229
Query: 160 MPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219
G L HL R + + + R A + +LH E V+YRD K N++LD
Sbjct: 230 ANGGELFFHLSRERVFSEDRA---RFYGA-EIVSALDYLHS-EKNVVYRDLKLENLMLDK 284
Query: 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLATGHLTAKSDVYSFGVVLLE 278
+ + K++DFGL K+G + + GT Y APE L D + GVV+ E
Sbjct: 285 DGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 279 MLSGR 283
M+ GR
Sbjct: 342 MMCGR 346
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 73/324 (22%), Positives = 125/324 (38%), Gaps = 56/324 (17%)
Query: 42 SVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAAT 101
S +G++ +P F S + ++ LG G +G V
Sbjct: 9 SGRENLYFQGDLQATPG--MFITSKKGHLSEMYQRVKKLGSGAYGEVLL---------CR 57
Query: 102 KPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYE 158
T + A+K + + + + L EV L L HPN++KL + ED LV E
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVME 116
Query: 159 FMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218
G L + + R + + + + +K L V +LH + +++RD K N+LL+
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVI-IKQVLSG---VTYLH--KHNIVHRDLKPENLLLE 170
Query: 219 T---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVV 275
+ + K+ DFGL+ + +GT Y APE L K DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVI 226
Query: 276 LLEMLSGRRAVDKNRPSGEHNLVEWAKP-YLASKRKIFRIIDNRLEGQYTLEGAY----- 329
L +L+G P + ++I R + +G+YT +
Sbjct: 227 LFILLAGYP------------------PFGGQTDQEILRKV---EKGKYTFDSPEWKNVS 265
Query: 330 -KAATLALRCLSTEGKFRPMMAEV 352
A L + L + + R +
Sbjct: 266 EGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
VLG G F VF + TG + A+K + + E+ L ++ H
Sbjct: 16 VLGSGAFSEVFL---------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFL 198
N+V L H LV + + G L + + RG Y + + + ++ L A V +L
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLSA---VKYL 122
Query: 199 HGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
H E +++RD K N+L T N ++DFGL+K +ST GT GY AP
Sbjct: 123 H--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC-GTPGYVAP 176
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSG 282
E LA + D +S GV+ +L G
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 74/348 (21%), Positives = 124/348 (35%), Gaps = 79/348 (22%)
Query: 6 SARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFS 65
R S + S + ++ ++ K + + E E+ K F
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--- 92
Query: 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW 125
+ + P V+G G V + TG AVK + + E
Sbjct: 93 -----YQKYDPKDVIGRGVSSVVRR---------CVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 126 LA--------EVNYLGQLY-HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSY 175
L E + L Q+ HP+++ L+ E + LV++ M +G L ++L + +
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVAL 197
Query: 176 --------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227
+ L + V+FLH +++RD K NILLD N +LSD
Sbjct: 198 SEKETRSIMRSL------------LEAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTA------KSDVYSFGVVLLEMLS 281
FG + + GT GY APE L + D+++ GV+L +L+
Sbjct: 244 FGFSCH--LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 282 GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
G P W + + + R+I +EGQY
Sbjct: 301 GS------PPF-------WHR----RQILMLRMI---MEGQYQFSSPE 328
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 34/279 (12%)
Query: 19 VSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDS 78
++ + + SS G+ +S + + + K NF
Sbjct: 1 MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW----LAEVNYLGQ 134
VLG G +G VF + TG + A+K L + + E L
Sbjct: 61 VLGTGAYGKVFLV---RKI---SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 135 LYH-PNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLR-----LKV 187
+ P LV L Y + + +L L+ +++ G L HL +R + + + + +
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV---QIYVGEIVL 170
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
AL LH + +IYRD K NILLD+N + L+DFGL+K+ +
Sbjct: 171 ALE------HLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC- 221
Query: 248 GTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGR 283
GT Y AP+ + +GH A D +S GV++ E+L+G
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 70/244 (28%), Positives = 105/244 (43%), Gaps = 32/244 (13%)
Query: 50 EGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVI 109
EG I K F VLG+G FG VF + + +
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLV---KKI---SGSDARQLY 55
Query: 110 AVKRLNQDGFQGHKEW--LAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLE 166
A+K L + + E + L ++ HP +VKL Y + + +L L+ +F+ G L
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLF 114
Query: 167 NHLFRRGSYFQPLSWNLR-----LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221
L + + + + L +AL LH +IYRD K NILLD
Sbjct: 115 TRLSKEVMFTEEDV---KFYLAELALALD------HLH--SLGIIYRDLKPENILLDEEG 163
Query: 222 NAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEM 279
+ KL+DFGL+K+ ++ GT Y APE + GH T +D +SFGV++ EM
Sbjct: 164 HIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEM 219
Query: 280 LSGR 283
L+G
Sbjct: 220 LTGT 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVN-Y 131
P LG G +G V K H P +G ++AVKR+ Q K L +++
Sbjct: 9 LEPIMELGRGAYGVVEKM---RH-----VP-SGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+ + P V G + + E M SL+ + Q + ++ K+A+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
K + LH ++ VI+RD K SN+L++ K+ DFG++ G
Sbjct: 119 VKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKP 174
Query: 252 YAAPE----YLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L + KSD++S G+ ++E+ R
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 72/260 (27%), Positives = 107/260 (41%), Gaps = 42/260 (16%)
Query: 41 LSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPD-----SVLGEGGFGSVFKGWIDE 95
+S P P P S + ++ + +P V+G+G FG V
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLL----- 56
Query: 96 HSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQ-LYHPNLVKLVGYCLEDD 151
A + AVK L + KE ++E N L + + HP LV L + +
Sbjct: 57 ----ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTA 111
Query: 152 HRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLR-----LKVALGAAKGVAFLHGAETKV 205
+L V +++ G L HL R + +P + R + ALG +LH +
Sbjct: 112 DKLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAAEIASALG------YLH--SLNI 160
Query: 206 IYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLA-TGHL 263
+YRD K NILLD+ + L+DFGL K+ + +T GT Y APE L +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTPEYLAPEVLHKQPY- 216
Query: 264 TAKSDVYSFGVVLLEMLSGR 283
D + G VL EML G
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
+F +LG+G FG V + TG A+K L ++ E + E
Sbjct: 6 DFDYLKLLGKGTFGKVIL---------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 57 RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM- 247
+ +LH V+YRD K N++LD + + K++DFGL K+G + + +
Sbjct: 116 SA----LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFC 166
Query: 248 GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
GT Y APE L + D + GVV+ EM+ GR
Sbjct: 167 GTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----EV 129
+ +LG GG V D +AVK L D + E
Sbjct: 14 YELGEILGFGGMSEVHLAR-DLR--------DHRDVAVKVLRAD-LARDPSFYLRFRREA 63
Query: 130 NYLGQLYHPNLVKL--VGYCLEDDHRL--LVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
L HP +V + G L +V E++ +L + + G P++ +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAI 119
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST- 244
+V A + + F H +I+RD K +NI++ K+ DFG+A+ S T
Sbjct: 120 EVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
V+GT Y +PE + A+SDVYS G VL E+L+G
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 58/284 (20%), Positives = 104/284 (36%), Gaps = 72/284 (25%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN---------QDGFQG 121
N+ P +LG G V + T AVK ++ ++ +
Sbjct: 16 YENYEPKEILGRGVSSVVRR---------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 122 HKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY----- 175
+ L EV+ L ++ HPN+++L + LV++ M +G L ++L + +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 176 ---FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
+ L + + LH + +++RD K NILLD + N KL+DFG +
Sbjct: 127 RKIMRAL------------LEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKS------DVYSFGVVLLEMLSGRRAV 286
+ GT Y APE + D++S GV++ +L+G
Sbjct: 173 Q--LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP-- 227
Query: 287 DKNRPSGEHNLVEWAKPYLA-SKRKIFRIIDNRLEGQYTLEGAY 329
P+ + + R+I + G Y
Sbjct: 228 ----------------PFWHRKQMLMLRMI---MSGNYQFGSPE 252
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK---EW-LAE 128
F VLG+GG+G VF+ T TG + A+K L + + AE
Sbjct: 18 CFELLRVLGKGGYGKVFQV---RKV---TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLR--- 184
N L ++ HP +V L+ Y + +L L+ E++ G L L R G + + +
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA---CFYL 127
Query: 185 --LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+ +ALG LH + +IYRD K NI+L+ + KL+DFGL K+
Sbjct: 128 AEISMALG------HLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--- 176
Query: 243 STRVM-GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
T GT Y APE L +GH D +S G ++ +ML+G
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130
+ + +G+G G+V+ A TG +A++++N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ + +PN+V + L D +V E++ GSL + + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET----CMDEGQIAAVCRE 124
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+ + FLH +VI+RD K+ NILL + + KL+DFG T +QS ST V GT
Sbjct: 125 CLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTP 180
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ APE + K D++S G++ +EM+ G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 65/277 (23%), Positives = 105/277 (37%), Gaps = 44/277 (15%)
Query: 59 LKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG 118
+K F + LGEG F K + AVK +++
Sbjct: 1 MKDSPFYQHYDLDLKDK---PLGEGSFSICRK---------CVHKKSNQAFAVKIISKRM 48
Query: 119 FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQ 177
++ E+ L HPN+VKL + H LV E + G L + ++ + +
Sbjct: 49 EANTQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE 105
Query: 178 PLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLSDFGLAKDG 234
+ + K+ V+ +H + V++RD K N+L + N K+ DFG A+
Sbjct: 106 TEASYIMRKLV----SAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159
Query: 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP--S 292
P +Q + T T YAAPE L D++S GV+L MLSG +
Sbjct: 160 PPDNQP-LKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-------QVPFQ 210
Query: 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
S +I + I +G ++ EG
Sbjct: 211 SHDR-----SLTCTSAVEIMKKI---KKGDFSFEGEA 239
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 40/233 (17%), Positives = 83/233 (35%), Gaps = 21/233 (9%)
Query: 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH 122
+ R + + L G F W++ + + + + +
Sbjct: 44 RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS 103
Query: 123 KEWLA--EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQP-- 178
++ + N V + + + + + +L++ + RR S
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 179 -LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD---- 233
+ ++ +++A V FLH +++RD K SNI + K+ DFGL
Sbjct: 164 GVCLHIFIQIAEA----VEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 234 ------GPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEML 280
T +GT Y +PE + + + K D++S G++L E+L
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 23/82 (28%), Positives = 34/82 (41%), Gaps = 10/82 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVN 130
+F P +G GGFG VF+ A A+KR+ + +E + EV
Sbjct: 6 TDFEPIQCMGRGGFGVVFE---------AKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 131 YLGQLYHPNLVKLVGYCLEDDH 152
L +L HP +V+ LE
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPP 78
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 64/280 (22%)
Query: 55 RSPNLKSFSFSDLKTA--TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK 112
S ++ F + + +G+G +G V A + T + A+K
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRV---------AIENQTRAIRAIK 57
Query: 113 -----RLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLE 166
++ Q + + EV + +L+HPN+ +L ED+ + LV E G L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLL 116
Query: 167 NHLFRRGSYFQPLSWNLRLKVALG-----------------------------AAK---- 193
+ L +K + +
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176
Query: 194 ---GVAFLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAK---DGPTGDQSHVSTR 245
+ +LH + +RD K N L TN + KL DFGL+K G+ ++T+
Sbjct: 177 IFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 246 VMGTYGYAAPEYLATGHL--TAKSDVYSFGVVLLEMLSGR 283
GT + APE L T + K D +S GV+L +L G
Sbjct: 235 A-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 30/217 (13%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNYL 132
+ + GG G ++ +D + G + +K L G + +AE +L
Sbjct: 82 YEVKGCIAHGGLGWIYLA-LDRNV-------NGRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 133 GQLYHPNLVKLVGYCLEDDHRL-----LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
++ HP++V++ + D +V E++ SL+ + L +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAY 187
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
L +++LH ++Y D K NI+L KL D G + +
Sbjct: 188 LLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVS---RINSFGY---LY 238
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
GT G+ APE + T +D+Y+ G L +
Sbjct: 239 GTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 70/287 (24%), Positives = 115/287 (40%), Gaps = 54/287 (18%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLY 136
+LG+G FG V K T AVK +N+ + L EV L +L
Sbjct: 29 MLGKGSFGEVLK---------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 137 HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
HPN++KL ED +V E G L + + +R + + + + +K +
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSG---I 134
Query: 196 AFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
++H + +++RD K NILL++ + + K+ DFGL+ Q+ +GT Y
Sbjct: 135 TYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYY 189
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA-SKRKI 311
APE L G K DV+S GV+L +LSG P+ ++ I
Sbjct: 190 IAPEVL-RGTYDEKCDVWSAGVILYILLSGTP------------------PFYGKNEYDI 230
Query: 312 FRIIDNRLEGQYTLEGAY------KAATLALRCLSTEGKFRPMMAEV 352
+ + G+Y + A L + L+ R +
Sbjct: 231 LKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130
+GEG G V A + +G +AVK ++ Q + EV
Sbjct: 44 RLLLDSYVKIGEGSTGIVCL---------AREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ H N+V++ L + ++ EF+ G+L + + + L+ V
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQV----RLNEEQIATVCEA 149
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+ +A+LH VI+RD K+ +ILL + KLSDFG + D + V GT
Sbjct: 150 VLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLV-GTP 205
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ APE ++ + D++S G++++EM+ G
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/217 (24%), Positives = 81/217 (37%), Gaps = 29/217 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAEVNYLGQL 135
V+G G F V TG V A+K +N+ E + E + L
Sbjct: 68 VIGRGAFSEVAV---------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA-LGAAK 193
+ +L + +D++ L LV E+ G L L + G P R +A + A
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEM-ARFYLAEIVMA- 174
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
+ +H ++RD K NILLD + +L+DFG V GT Y
Sbjct: 175 -IDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYL 230
Query: 254 APEYLATGHLTAKSDVY-------SFGVVLLEMLSGR 283
+PE L + Y + GV EM G+
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 33/224 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----- 127
+ LG G G V A + T +A+K +++ F A
Sbjct: 11 EYIMSKTLGSGACGEVKL---------AFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 128 ---EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR 184
E+ L +L HP ++K+ + + + +V E M G L + + +
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSH 241
++ V +LH E +I+RD K N+LL + + K++DFG +K G+ S
Sbjct: 121 YQM----LLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 172
Query: 242 VSTRVMGTYGYAAPEYLATGHL---TAKSDVYSFGVVLLEMLSG 282
+ T GT Y APE L + D +S GV+L LSG
Sbjct: 173 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
LGEG +G V A T +AVK ++ E + E+ L H
Sbjct: 15 LGEGAYGEVQL---------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLKVALG 190
N+VK G+ E + + L E+ G L + + +F L
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
GV +LHG + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 -MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 251 GYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L DV+S G+VL ML+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 31/245 (12%)
Query: 48 RSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGM 107
S G++ SP + + F+ + + +G G +GSV K H KP +G
Sbjct: 4 ESSGKLKISPE-QHWDFTA-----EDLKDLGEIGRGAYGSVNKM---VH-----KP-SGQ 48
Query: 108 VIAVKRLNQDGF-QGHKEWLAEVN-YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSL 165
++AVKR+ + K+ L +++ + P +V+ G + + E M S
Sbjct: 49 IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSF 107
Query: 166 ENHLFRRGSYF-QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224
+ S + + K+ L K + L K+I+RD K SNILLD + N K
Sbjct: 108 DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPSNILLDRSGNIK 166
Query: 225 LSDFGLAKDGPTG--DQSHVSTRVMGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLE 278
L DFG++ G S TR G Y APE + +SDV+S G+ L E
Sbjct: 167 LCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
Query: 279 MLSGR 283
+ +GR
Sbjct: 222 LATGR 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-24
Identities = 59/256 (23%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
+G G +G V A + GT + A K++ + + + E+ + L HP
Sbjct: 16 TIGRGSWGEVKI---------AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 139 NLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAF 197
N+++L ED+ + LV E G L + + + + + + +K L A VA+
Sbjct: 67 NIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAY 121
Query: 198 LHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
H + V +RD K N L T + KL DFGLA + +GT Y +
Sbjct: 122 CH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVS 176
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA-SKRKIFR 313
P+ L + + D +S GV++ +L G P+ A + ++
Sbjct: 177 PQVLEGLY-GPECDEWSAGVMMYVLLCGYP------------------PFSAPTDSEVML 217
Query: 314 IIDNRLEGQYTLEGAY 329
I EG +T
Sbjct: 218 KI---REGTFTFPEKD 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-24
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAE 128
+ N+ LG+G F V + TG+ A K +N ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRR---------CVHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
+L HPN+V+L E+ LV++ + G L + R Y + A
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADA 107
Query: 189 LGAAK----GVAFLHGAETKVIYRDFKTSNILLDTNYNA---KLSDFGLAKDGPTGDQSH 241
+ +A+ H +++R+ K N+LL + KL+DFGLA + D
Sbjct: 108 SHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEA 163
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
GT GY +PE L + D+++ GV+L +L G
Sbjct: 164 WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL-AEVNYL 132
F +G+G FG VFKG ID T V+A+K ++ + + E + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNR--------TQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
Q P + K G L+D ++ E++ GS L G PL +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG----PLDETQIATILREIL 129
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
KG+ +LH K I+RD K +N+LL + KL+DFG+A G D +GT +
Sbjct: 130 KGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFW 185
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
APE + +K+D++S G+ +E+ G
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 55/248 (22%), Positives = 94/248 (37%), Gaps = 34/248 (13%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKP 103
+ ++ R + + N+ LG+G F V +
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFS---DNYDVKEELGKGAFSVVRR---------CVHK 51
Query: 104 GTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMP 161
TG+ A K +N ++ E +L HPN+V+L E+ LV++ +
Sbjct: 52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111
Query: 162 RGSLENHLFRRGSYFQPLSWNLRLKVALGAAK----GVAFLHGAETKVIYRDFKTSNILL 217
G L + R Y + A + +A+ H +++R+ K N+LL
Sbjct: 112 GGELFEDIVAREFYSE--------ADASHCIQQILESIAYCH--SNGIVHRNLKPENLLL 161
Query: 218 DT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGV 274
+ KL+DFGLA + D GT GY +PE L + D+++ GV
Sbjct: 162 ASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 275 VLLEMLSG 282
+L +L G
Sbjct: 219 ILYILLVG 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-24
Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 46/281 (16%)
Query: 55 RSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL 114
+ + T + +LG+G FG V K T AVK +
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLK---------CKDRITQQEYAVKVI 55
Query: 115 NQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR 172
N+ + L EV L +L HPN++KL + +V E G L + + +R
Sbjct: 56 NKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 173 GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFG 229
+ + + + +K + ++H + +++RD K NILL++ + + K+ DFG
Sbjct: 116 KRFSEHDAARI-IKQVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKN 289
L+ + + R+ GT Y APE L G K DV+S GV+L +LSG
Sbjct: 170 LSTC--FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT------ 219
Query: 290 RP-SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
P G+ ++ I + + G+Y +
Sbjct: 220 PPFYGK------------NEYDILKRV---ETGKYAFDLPQ 245
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 34/252 (13%)
Query: 39 SSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSF 98
+ T + + + N +D F VLG+G FG V
Sbjct: 315 TKAPEEKTANTISKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVML-------- 359
Query: 99 AATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY-HPNLVKLVGYCLEDDHRL 154
+ + GT + AVK L +D + + E L P L +L C + RL
Sbjct: 360 -SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRL 417
Query: 155 -LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTS 213
V E++ G L H+ + G + +P + ++A+G + FL +IYRD K
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ--SKGIIYRDLKLD 471
Query: 214 NILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDVYS 271
N++LD+ + K++DFG+ K+ +T+ GT Y APE +A + D ++
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWA 527
Query: 272 FGVVLLEMLSGR 283
FGV+L EML+G+
Sbjct: 528 FGVLLYEMLAGQ 539
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 60/275 (21%), Positives = 103/275 (37%), Gaps = 54/275 (19%)
Query: 32 SSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG 91
SS S + P K + + ++ +LG GGFGSV
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSV--- 59
Query: 92 WIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLA-EVNYLGQLYH--PNLVKL 143
++ + + +A+K R++ G + + EV L ++ +++L
Sbjct: 60 ------YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113
Query: 144 VGYCLEDDHRLLVYEF-MPRGSLENHLFRRG--------SYFQPLSWNLRLKVALGAAKG 194
+ + D +L+ E P L + + RG S+F + +
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV------------LEA 161
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNY-NAKLSDFGLA---KDGPTGDQSHVSTRVMGTY 250
V H V++RD K NIL+D N KL DFG KD + GT
Sbjct: 162 VRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFD-GTR 212
Query: 251 GYAAPEYLATGHL--TAKSDVYSFGVVLLEMLSGR 283
Y+ PE++ H + V+S G++L +M+ G
Sbjct: 213 VYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 48/297 (16%)
Query: 6 SARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSP-NLKSFSF 64
+ + +S N+G + + + ++ + R+ + P F
Sbjct: 16 TENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDH 75
Query: 65 SDLKTATRNFR------PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG 118
+ +LG G FG V K + TG+ +A K + G
Sbjct: 76 RIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK---------CEETATGLKLAAKIIKTRG 126
Query: 119 FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYF- 176
+ +E E++ + QL H NL++L E + + LV E++ G L + +
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 177 ---------QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA--KL 225
Q G+ +H + +++ D K NIL K+
Sbjct: 186 ELDTILFMKQICE-------------GIRHMH--QMYILHLDLKPENILCVNRDAKQIKI 230
Query: 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
DFGLA+ GT + APE + ++ +D++S GV+ +LSG
Sbjct: 231 IDFGLAR---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 9e-24
Identities = 65/222 (29%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
+F +LG+G FG VF A T A+K L +D + + E
Sbjct: 18 DFILHKMLGKGSFGKVFL---------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 130 NYLGQ-LYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK- 186
L HP L + + L V E++ G L H+ + R
Sbjct: 69 RVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATF 122
Query: 187 ----VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+ LG + FLH ++YRD K NILLD + + K++DFG+ K+ GD
Sbjct: 123 YAAEIILG----LQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--- 173
Query: 243 STRVM-GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T GT Y APE L D +SFGV+L EML G+
Sbjct: 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
LGEG +G V A T +AVK ++ E + E+ L H
Sbjct: 15 LGEGAYGEVQL---------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLKVALG 190
N+VK G+ E + + L E+ G L + + +F L
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
GV +LHG + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 -MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 251 GYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
Y APE L DV+S G+VL ML+G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 57/233 (24%), Positives = 85/233 (36%), Gaps = 35/233 (15%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE 124
++ +F V+G G FG V V A+K LN+ E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAV---------VKLKNADKVFAMKILNKWEMLKRAE 117
Query: 125 ---WLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS 180
+ E + L + L Y +DD+ L LV ++ G L L + P
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL-PEE 175
Query: 181 WNLR-----LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235
R + +A+ +H + ++RD K NIL+D N + +L+DFG
Sbjct: 176 M-ARFYLAEMVIAID------SVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKS-----DVYSFGVVLLEMLSGR 283
S V GT Y +PE L D +S GV + EML G
Sbjct: 227 EDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 34/245 (13%)
Query: 46 TPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGT 105
T + + + N +D F VLG+G FG V + + GT
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVML---------SERKGT 44
Query: 106 GMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY-HPNLVKLVGYCLEDDHRL-LVYEFM 160
+ AVK L +D + + E L P L +L C + RL V E++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 103
Query: 161 PRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220
G L H+ + G + +P + ++A+G + FL +IYRD K N++LD+
Sbjct: 104 NGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ--SKGIIYRDLKLDNVMLDSE 157
Query: 221 YNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLE 278
+ K++DFG+ K+ +T+ GT Y APE +A + D ++FGV+L E
Sbjct: 158 GHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYE 213
Query: 279 MLSGR 283
ML+G+
Sbjct: 214 MLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 39/266 (14%)
Query: 25 SSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGG 84
+ + + GS + R G+ S L+ F L+ V+G G
Sbjct: 17 TENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL--LR----------VIGRGS 64
Query: 85 FGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY-HPNL 140
+ V T + A++ + ++ ++ E + Q HP L
Sbjct: 65 YAKVLL---------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 141 VKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
V L C + + RL V E++ G L H+ R+ + + +++L + +LH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 170
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYL 258
E +IYRD K N+LLD+ + KL+D+G+ K+G +T GT Y APE L
Sbjct: 171 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEIL 225
Query: 259 A-TGHLTAKSDVYSFGVVLLEMLSGR 283
+ D ++ GV++ EM++GR
Sbjct: 226 RGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYH 137
V+G G V A +A+KR+N + Q + L E+ + Q +H
Sbjct: 22 VIGSGATAVVQA---------AYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR-------LKVALG 190
PN+V + D LV + + GS+ + + + + S L L+ L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL- 131
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL-AKDGPTGDQSHVSTR--VM 247
+G+ +LH + I+RD K NILL + + +++DFG+ A GD + R +
Sbjct: 132 --EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 248 GTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGR 283
GT + APE + K+D++SFG+ +E+ +G
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 55/227 (24%), Positives = 85/227 (37%), Gaps = 50/227 (22%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA----EVNYLGQ 134
+LGEG +G V + S T AVK L + + A E+ L +
Sbjct: 12 LLGEGSYGKVKEV---LDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 135 LYHPNLVKL--VGYCLEDDHRLLVYEFMPRGSLENHLF-------------RRGSYFQPL 179
L H N+++L V Y E +V E+ G E + YF L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHG--YFCQL 118
Query: 180 SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
G+ +LH ++++D K N+LL T K+S G+A+
Sbjct: 119 ------------IDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLT---AKSDVYSFGVVLLEMLSGR 283
G+ + PE +A G T K D++S GV L + +G
Sbjct: 165 DDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 29/235 (12%)
Query: 57 PNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ 116
+ + T F LG G FG V + +G+ +K +N+
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHL---------VEERSSGLERVIKTINK 57
Query: 117 DGFQGHKEWLA-EVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSL----ENHLF 170
D Q E + E+ L L HPN++K+ ED H + +V E G L +
Sbjct: 58 DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 171 RRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSD 227
R + + L +K + A +A+ H V+++D K NIL + K+ D
Sbjct: 117 RGKALSEGYVAEL-MKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
FGLA+ ST GT Y APE +T K D++S GVV+ +L+G
Sbjct: 171 FGLAE---LFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 71/249 (28%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKP 103
P EG + + + F VLG+G FG V A
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVML---------ARVK 45
Query: 104 GTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLY-HPNLVKLVGYCLEDDHRL-LVYE 158
TG + AVK L +D + + E L HP L +L C + RL V E
Sbjct: 46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVME 104
Query: 159 FMPRGSLENHLFRRGSYFQPLS--WNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216
F+ G L H+ + + + + + + AL FLH + +IYRD K N+L
Sbjct: 105 FVNGGDLMFHIQKSRRFDEARARFYAAEIISALM------FLH--DKGIIYRDLKLDNVL 156
Query: 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLA-TGHLTAKSDVYSFGV 274
LD + KL+DFG+ K+G +T GT Y APE L + D ++ GV
Sbjct: 157 LDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGV 212
Query: 275 VLLEMLSGR 283
+L EML G
Sbjct: 213 LLYEMLCGH 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 66/260 (25%), Positives = 107/260 (41%), Gaps = 29/260 (11%)
Query: 32 SSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSD--LKTATRNFR----PDSVLGEGGF 85
S+G + + ++ S +P S + +S LG G
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66
Query: 86 GSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVG 145
V++ + GT A+K L + K E+ L +L HPN++KL
Sbjct: 67 SIVYR---------CKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKV 205
LV E + G L + + +G Y + + + +K L A VA+LH E +
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQILEA---VAYLH--ENGI 169
Query: 206 IYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH 262
++RD K N+L T + K++DFGL+K Q + T GT GY APE L
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCA 226
Query: 263 LTAKSDVYSFGVVLLEMLSG 282
+ D++S G++ +L G
Sbjct: 227 YGPEVDMWSVGIITYILLCG 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 57/268 (21%), Positives = 101/268 (37%), Gaps = 27/268 (10%)
Query: 18 GVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPD 77
G + G K++ + + + +K S D +
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYD------YYDIL 56
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
LG G FG V + + TG V K +N E++ + QL+H
Sbjct: 57 EELGSGAFGVVHR---------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 138 PNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA 196
P L+ L ED + + L+ EF+ G L + + ++ A G+
Sbjct: 108 PKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLK 163
Query: 197 FLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAA 254
+H E +++ D K NI+ +T + K+ DFGLA + + T +AA
Sbjct: 164 HMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAA 218
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSG 282
PE + + +D+++ GV+ +LSG
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 61/227 (26%), Positives = 90/227 (39%), Gaps = 46/227 (20%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-----LA 127
+ +GEG +G VFK + TG ++A+K+ + L
Sbjct: 4 KYEKIGKIGEGSYGVVFKC-RNRD--------TGQIVAIKKFLESED---DPVIKKIALR 51
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL---SWNLR 184
E+ L QL HPNLV L+ LV+E+ ++ + L R S +
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD--GPTGDQSH- 241
+ V F H I+RD K NIL+ + KL DFG A+ GP+
Sbjct: 111 T------LQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162
Query: 242 VSTRVMGTYGYAAPEYLATGHLTAKS-----DVYSFGVVLLEMLSGR 283
V+TR Y +PE L + DV++ G V E+LSG
Sbjct: 163 VATR-----WYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 38/265 (14%)
Query: 29 NDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTA---TRNFRPDSVLGEGGF 85
D+ +T + ++ P P R+ +LK ++L + F +G G F
Sbjct: 12 YDIPTTENLYFQGAMDPMPAGG----RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSF 67
Query: 86 GSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVK 142
G+V+ A V+A+K+++ G Q +++W + EV +L +L HPN ++
Sbjct: 68 GAVYF---------ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE 202
G L + LV E+ + + + PL V GA +G+A+LH
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH--S 172
Query: 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR--VMGTYGYAAPEYLAT 260
+I+RD K NILL KL DFG A S ++ +GT + APE +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILA 224
Query: 261 ---GHLTAKSDVYSFGVVLLEMLSG 282
G K DV+S G+ +E+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAER 249
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 51/285 (17%)
Query: 19 VSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDS 78
+S + ++ + + S+ R + + + + + ++
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
V+G G FG V++ A +G ++A+K++ QD + E+ + +L H
Sbjct: 61 VIGNGSFGVVYQ---------AKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHC 107
Query: 139 NLVKLVGYCLEDDHRL------LVYEFMPRGSLENHLFRRGSYFQPLSWN---------L 183
N+V+L + + LV +++P ++ Q L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA-KLSDFGLAKDGPTGDQ--S 240
R +A++H + +RD K N+LLD + KL DFG AK G+ S
Sbjct: 167 R---------SLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 241 HVSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
++ +R Y Y APE + AT T+ DV+S G VL E+L G+
Sbjct: 216 YICSR----Y-YRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 45/236 (19%)
Query: 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH 122
S +D + N+R +G+G F V H TG +A+K +++ Q +
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLA---RHIL------TGREVAIKIIDKT--QLN 54
Query: 123 KEWLA----EVNYLGQLYHPNLVKLVGY-CLEDDHRL-LVYEFMPRGSLENHLFRRG--- 173
L EV + L HPN+VKL + +E + L L+ E+ G + ++L G
Sbjct: 55 PTSLQKLFREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 112
Query: 174 -----SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228
S F+ + V + H + ++++RD K N+LLD + N K++DF
Sbjct: 113 EKEARSKFRQI------------VSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADF 158
Query: 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
G + + G + G YAAPE + + DV+S GV+L ++SG
Sbjct: 159 GFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
+F V+G G + V T + A+K + ++ ++ E
Sbjct: 10 DFDLLRVIGRGSYAKVLL---------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 130 NYLGQLY-HPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
+ Q HP LV L C + + RL V E++ G L H+ R+ + + ++
Sbjct: 61 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
+L + +LH E +IYRD K N+LLD+ + KL+D+G+ K+G +T
Sbjct: 120 SLA----LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 170
Query: 248 -GTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
GT Y APE L + D ++ GV++ EM++GR
Sbjct: 171 CGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 7e-23
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEVNYLGQL 135
LG G FG V G A+K L ++ K+ E L +
Sbjct: 13 TLGTGSFGRVHL---------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 136 YHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLR-----LKVAL 189
HP ++++ +D ++ ++ +++ G L + L + + P++ + + +AL
Sbjct: 64 THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---KFYAAEVCLAL 119
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM-G 248
+LH +IYRD K NILLD N + K++DFG AK P T + G
Sbjct: 120 E------YLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCG 165
Query: 249 TYGYAAPEYLA------TGHLTAKSDVYSFGVVLLEMLSGR 283
T P+Y+A + + D +SFG+++ EML+G
Sbjct: 166 T-----PDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGY 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-23
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130
F LGEG +GSV+K A TG ++A+K++ + +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYK---------AIHKETGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ Q P++VK G ++ +V E+ GS+ + + R L+ + +
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQS 133
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
KG+ +LH + I+RD K NILL+T +AKL+DFG+A T + +T + GT
Sbjct: 134 TLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ-LTDTMAKRNTVI-GTP 189
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ APE + +D++S G+ +EM G
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAE 128
T ++ LG+G F V + K G A +N H++ E
Sbjct: 10 TEEYQLFEELGKGAFSVVRR---------CVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L HPN+V+L E+ H L+++ + G L + R Y + + + ++
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-IQQI 119
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQSHVSTR 245
L A V H + V++R+ K N+LL + KL+DFGLA + G+Q
Sbjct: 120 LEA---VLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGF 173
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
GT GY +PE L D+++ GV+L +L G
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 48/248 (19%)
Query: 48 RSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGM 107
+ +P+ + F LG G FG V +G
Sbjct: 24 EDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVML---------VKHKESGN 67
Query: 108 VIAVKRLNQDGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRG 163
A+K L++ K+ L E L + P LVKL + +D+ L +V E++ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGG 126
Query: 164 SLENHLFRRGSYFQPLSWNLR-----LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218
+ +HL R G + +P + R + + +LH +IYRD K N+L+D
Sbjct: 127 EMFSHLRRIGRFSEPHA---RFYAAQIVLTFE------YLH--SLDLIYRDLKPENLLID 175
Query: 219 TNYNAKLSDFGLAKDGPTGDQSHVSTRVM-GTYGYAAPEYLAT-GHLTAKS-DVYSFGVV 275
+++DFG AK T + GT APE + + G+ K+ D ++ GV+
Sbjct: 176 QQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILSKGY--NKAVDWWALGVL 227
Query: 276 LLEMLSGR 283
+ EM +G
Sbjct: 228 IYEMAAGY 235
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 61/279 (21%), Positives = 98/279 (35%), Gaps = 25/279 (8%)
Query: 6 SARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFS 65
+A + V G + G+ S+ + + +K
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156
Query: 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW 125
D + LG G FG V + T+ TG A K + +
Sbjct: 157 DH------YDIHEELGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETV 201
Query: 126 LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
E+ + L HP LV L +D+ +++YEFM G L + + +
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAKDGPTGDQSHVS 243
+ KG+ +H E ++ D K NI+ T + KL DFGL V
Sbjct: 262 RQVC---KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
GT +AAPE + +D++S GV+ +LSG
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
+ LG+G FG V+K A TG + A K + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYK---------AKNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
HP +VKL+G D ++ EF P G+++ + + L+ V +
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLE 128
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR---VMGTY 250
+ FLH ++I+RD K N+L+ + +L+DFG++ + +GT
Sbjct: 129 ALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTP 181
Query: 251 GYAAPEYLATGHLT-----AKSDVYSFGVVLLEMLSG 282
+ APE + + K+D++S G+ L+EM
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 56/244 (22%), Positives = 91/244 (37%), Gaps = 48/244 (19%)
Query: 52 EILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAV 111
I++ + S F+D + +G G + + T M AV
Sbjct: 8 SIVQQLHRNSIQFTD------GYEVKEDIGVGSYSVCKR---------CIHKATNMEFAV 52
Query: 112 KRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLF 170
K +++ E E+ L + HPN++ L + + +V E M G L + +
Sbjct: 53 KIIDKSKRDP-TE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL 108
Query: 171 RRGSY--------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222
R+ + + K V +LH V++RD K SNIL
Sbjct: 109 RQKFFSEREASAVLFTI------------TKTVEYLH--AQGVVHRDLKPSNILYVDESG 154
Query: 223 A----KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLE 278
++ DFG AK + + T T + APE L A D++S GV+L
Sbjct: 155 NPESIRICDFGFAKQL-RAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYT 212
Query: 279 MLSG 282
ML+G
Sbjct: 213 MLTG 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLA-EVNYL 132
LG G F V K + TG+ A K + +E + EV+ L
Sbjct: 19 ELGSGQFAIVKK---------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 133 GQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
Q+ H N++ L E+ + L+ E + G L + L ++ S + + + +K L
Sbjct: 70 RQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD- 126
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
GV +LH K+ + D K NI+L + KL DFGLA + +
Sbjct: 127 --GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
GT + APE + L ++D++S GV+ +LSG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYL 132
+G G G V+K + TG VIAVK++ + G + +K L +++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMR---F-----RK-TGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 133 -GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
P +V+ G + + + E M + + +G P+ + K+ +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAI 133
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
K + +L + VI+RD K SNILLD KL DFG++ G D R G
Sbjct: 134 VKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVD-DKAKDRSAGCAA 189
Query: 252 YAAPEYLATGHL-----TAKSDVYSFGVVLLEMLSGR 283
Y APE + ++DV+S G+ L+E+ +G+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 28/214 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWL-AEVNYL 132
LG G F V K + TG+ A K + +E + EV+ L
Sbjct: 19 ELGSGQFAIVKK---------CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
Q+ HPN++ L +L+ E + G L + L ++ S + + + +K L
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-- 126
Query: 193 KGVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
GV +LH K+ + D K NI+L + KL DFGLA + + G
Sbjct: 127 -GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFG 180
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
T + APE + L ++D++S GV+ +LSG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 64/286 (22%), Positives = 105/286 (36%), Gaps = 53/286 (18%)
Query: 53 ILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK 112
+ + P K ++ +D ++ VLG G G V + TG A+K
Sbjct: 15 LFQGPEPKKYAVTDDYQLSKQ-----VLGLGVNGKVLE---------CFHRRTGQKCALK 60
Query: 113 RLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHR-----LLVYEFMPRGSLE 166
L + EV++ Q P++V ++ E+ H L++ E M G L
Sbjct: 61 LLYD-----SPKARQEVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELF 114
Query: 167 NHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNA 223
+ + RG Q + ++ + FLH + +RD K N+L + +
Sbjct: 115 SRIQERGD--QAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
KL+DFG AK+ + T T Y APE L D++S GV++ +L G
Sbjct: 171 KLTDFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 284 RAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
P ++ A + R I GQY
Sbjct: 227 ------PPF-------YSNTGQAISPGMKRRI---RLGQYGFPNPE 256
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 48/237 (20%), Positives = 86/237 (36%), Gaps = 24/237 (10%)
Query: 58 NLKSFSFSDLKTATRNFRPDSVLGEG--GFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
NL S + +V+G+G +V A TG + V+R+N
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNL---------ARYKPTGEYVTVRRIN 61
Query: 116 QDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG 173
+ E++ HPN+V + D+ +V FM GS ++ +
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CT 119
Query: 174 SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG-LAK 232
+ ++ + G K + ++H ++R K S+IL+ + LS
Sbjct: 120 HFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 233 DGPTGDQSHV----STRVMGTYGYAAPEYLATGHL--TAKSDVYSFGVVLLEMLSGR 283
G + V + + +PE L AKSD+YS G+ E+ +G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 42/218 (19%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA---EVNYLGQLY 136
LG G FG V G EH TG +AVK LN+ + E+ L
Sbjct: 19 LGVGTFGKVKIG---EHQL------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 137 HPNLVKLVGY-CLEDDHRL-LVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLK 186
HP+++KL Y + +V E++ G L +++ + G FQ +
Sbjct: 70 HPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------- 120
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
V + H V++RD K N+LLD + NAK++DFGL+ G+ S
Sbjct: 121 -----LSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 171
Query: 247 MGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
G+ YAAPE ++ + + D++S GV+L +L G
Sbjct: 172 -GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 47/249 (18%)
Query: 56 SPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
S N + + + F+ + + G+G FG+V + TGM +A+K++
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQL---------GKEKSTGMSVAIKKVI 57
Query: 116 QDGFQGHKEWLAEVNYLGQLYHPNLVKL------VGYCLEDDHRL-LVYEFMPRGSLENH 168
QD ++E L + L L+HPN+V+L +G D L +V E++P +L
Sbjct: 58 QDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115
Query: 169 LFRRGSYFQPLSWN---------LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD- 218
+R + LH V +RD K N+L++
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIR---------SIGCLHLPSVNVCHRDIKPHNVLVNE 166
Query: 219 TNYNAKLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGV 274
+ KL DFG AK + +++ +R Y Y APE + H T D++S G
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQ-HYTTAVDIWSVGC 220
Query: 275 VLLEMLSGR 283
+ EM+ G
Sbjct: 221 IFAEMMLGE 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 56/273 (20%)
Query: 31 MSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFK 90
+ + + ++ + + P I + + + V+G G FG VF+
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKV----LASDGKTGEQREIAYTNCKVIGNGSFGVVFQ 58
Query: 91 GWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150
+ E + V A+K++ QD + E+ + + HPN+V L + +
Sbjct: 59 AKLVE---------SDEV-AIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSN 104
Query: 151 DHRL------LVYEFMPRGSLENHLFRRGSYFQPLSWN---------LRLKVALGAAKGV 195
+ LV E++P ++ Q + LR +
Sbjct: 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR---------SL 154
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNA-KLSDFGLAKDGPTGDQ--SHVSTRVMGTYGY 252
A++H + +RD K N+LLD KL DFG AK G+ S++ +R Y Y
Sbjct: 155 AYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-Y 207
Query: 253 AAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
APE + AT + T D++S G V+ E++ G+
Sbjct: 208 RAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-22
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLA-EVNYL 132
LG G F V K + GTG A K RL+ +E + EVN L
Sbjct: 12 ELGSGQFAIVRK---------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 133 GQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
++ HPN++ L E+ + L+ E + G L + L + S + A
Sbjct: 63 REIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQF 113
Query: 192 AK----GVAFLHGAETKVIYRDFKTSNILL----DTNYNAKLSDFGLAKDGPTGDQSHVS 243
K GV +LH ++ + D K NI+L N KL DFG+A G++
Sbjct: 114 LKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN- 170
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ GT + APE + L ++D++S GV+ +LSG
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-22
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLA-EVNYL 132
LG G F V K + TG+ A K R +E + EV+ L
Sbjct: 18 ELGSGQFAVVKK---------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 133 GQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
++ HPN++ L E+ + L+ E + G L + L + S + + LK L
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILNG 126
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDT----NYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
V +LH ++ + D K NI+L K+ DFGLA D + +
Sbjct: 127 ---VYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIF 178
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
GT + APE + L ++D++S GV+ +LSG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 63/330 (19%), Positives = 103/330 (31%), Gaps = 74/330 (22%)
Query: 20 SSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSV 79
+ + PP + + +K + D T V
Sbjct: 15 PAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT-----SQV 69
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN--QDGFQGHKEWLAEVNYLGQLY- 136
LG G G V + T A+K L + EV +
Sbjct: 70 LGLGINGKVLQ---------IFNKRTQEKFALKMLQDCPKARR-------EVELHWRASQ 113
Query: 137 HPNLVKLVGYC----LEDDHRLLVYEFMPRGSLENHLFRRGS----------YFQPLSWN 182
P++V++V L+V E + G L + + RG + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI--- 170
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL-DTNYNA--KLSDFGLAKDGPTGDQ 239
+ + +LH + +RD K N+L NA KL+DFG AK+ + +
Sbjct: 171 ---------GEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299
++T T Y APE L D++S GV++ +L G P
Sbjct: 220 --LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF------- 263
Query: 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
++ LA + I GQY
Sbjct: 264 YSNHGLAISPGMKTRI---RMGQYEFPNPE 290
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 27/218 (12%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN 139
+G G +G V+K A+K++ G E+ L +L HPN
Sbjct: 29 VGRGTYGHVYKAK-------RKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 140 LVKLVGYCLED-DHRL-LVYEFMP---RGSLENHLFRRGSY-FQPLSWNLRLKVALGAAK 193
++ L L D ++ L++++ ++ H + + L + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNA----KLSDFGLAK--DGPTGDQSHVSTRVM 247
G+ +LH V++RD K +NIL+ K++D G A+ + P + + V+
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 248 GTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
T+ Y APE L A H T D+++ G + E+L+
Sbjct: 198 -TFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSE 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 51/230 (22%), Positives = 83/230 (36%), Gaps = 46/230 (20%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLA 127
+ S LG G FG V W + VK ++ +D + +
Sbjct: 25 KYSTMSPLGSGAFGFV---WTAVDKE------KNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 128 ---EVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGS-LENHLFRRG--------S 174
E+ L ++ H N++K++ E+ LV E G L + R
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 175 YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234
F+ L V +L +I+RD K NI++ ++ KL DFG A
Sbjct: 135 IFRQL------------VSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
Query: 235 PTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
G + GT Y APE L + + +++S GV L ++
Sbjct: 181 ERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL---NQDGFQGHKEWLAEV 129
+ LGEG + +V+KG T ++A+K + +++G + EV
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTA--IREV 51
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL---SWNLRLK 186
+ L L H N+V L + LV+E++ + L+ +L G+ + +L
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL- 109
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA--KDGPTGDQSHVST 244
+G+A+ H KV++RD K N+L++ KL+DFGLA K PT +
Sbjct: 110 -----LRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--- 159
Query: 245 RVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
V+ T Y P+ L +T + T D++ G + EM +GR
Sbjct: 160 EVV-TLWYRPPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 36/247 (14%)
Query: 46 TPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGT 105
++ F ++ + ++GEG +G V K + T
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSME----KYENLGLVGEGSYGMVMKCRNKD---------T 49
Query: 106 GMVIAVKRLNQDGFQGHKEW-----LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFM 160
G ++A+K+ + + + E+ L QL H NLV L+ C + LV+EF+
Sbjct: 50 GRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106
Query: 161 PRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220
++ + L + L + G+ F H +I+RD K NIL+ +
Sbjct: 107 DH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCH--SHNIIHRDIKPENILVSQS 160
Query: 221 YNAKLSDFGLAKD--GPTGDQSH-VSTRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVL 276
KL DFG A+ P V+TR Y APE L DV++ G ++
Sbjct: 161 GVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDVKYGKAVDVWAIGCLV 215
Query: 277 LEMLSGR 283
EM G
Sbjct: 216 TEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 37/231 (16%)
Query: 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE- 124
D+K+ + + LGEG F +V+K D++ T ++A+K++ K+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKA-RDKN--------TNQIVAIKKIKLGHRSEAKDG 54
Query: 125 ----WLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL- 179
L E+ L +L HPN++ L+ + LV++FM LE + P
Sbjct: 55 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSH 113
Query: 180 --SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGP 235
++ L +G+ +LH + +++RD K +N+LLD N KL+DFGLAK P
Sbjct: 114 IKAYMLMT------LQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 236 TGDQSH-VSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
+H V TR Y APE L A + D+++ G +L E+L
Sbjct: 166 NRAYTHQVVTR-----WYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 59/244 (24%), Positives = 94/244 (38%), Gaps = 67/244 (27%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA------------ 127
+G+G +G V A A+K L++ +
Sbjct: 21 IGKGSYGVVKL---------AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 128 --------------EVNYLGQLYHPNLVKL--VGYCLEDDHRLLVYEFMP---------R 162
E+ L +L HPN+VKL V +DH +V+E +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 163 GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222
L R YFQ L KG+ +LH K+I+RD K SN+L+ + +
Sbjct: 132 KPLSEDQARF--YFQDL------------IKGIEYLH--YQKIIHRDIKPSNLLVGEDGH 175
Query: 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLT---AKSDVYSFGVVLLEM 279
K++DFG++ + G + +S V GT + APE L+ DV++ GV L
Sbjct: 176 IKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 280 LSGR 283
+ G+
Sbjct: 234 VFGQ 237
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 34/243 (13%)
Query: 55 RSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL 114
+ +L S L+ F ++G G +G V+KG TG + A+K +
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVK--------TGQLAAIKVM 57
Query: 115 NQDGFQGHKEWLAEVNYLGQL-YHPNLVK-----LVGYCLEDDHRL-LVYEFMPRGSLEN 167
+ G +E E+N L + +H N+ + D +L LV EF GS+ +
Sbjct: 58 DVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 168 HLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227
+ + + L + +G++ LH + KVI+RD K N+LL N KL D
Sbjct: 117 LI--KNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVD 172
Query: 228 FGLAKDGPTGDQSHVSTR---VMGTYGYAAPEYLATGHLT-----AKSDVYSFGVVLLEM 279
FG++ R +GT + APE +A KSD++S G+ +EM
Sbjct: 173 FGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
Query: 280 LSG 282
G
Sbjct: 228 AEG 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE 124
DL+ ++ V+G G FG V T V A+K L++ +
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQL---------VRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 125 ---WLAEVNYLGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLS 180
+ E + + P +V+L Y +DD L +V E+MP G L N + + +
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWA 170
Query: 181 WNLRLKVA-LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
R A + A + +H I+RD K N+LLD + + KL+DFG
Sbjct: 171 ---RFYTAEVVLA--LDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 240 SHVSTRVMGTYGYAAPEYL----ATGHLTAKSDVYSFGVVLLEMLSGR 283
T V GT Y +PE L G+ + D +S GV L EML G
Sbjct: 224 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 39/217 (17%), Positives = 72/217 (33%), Gaps = 42/217 (19%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP 138
LG G FG V + + + K + G E++ L H
Sbjct: 12 DLGRGEFGIVHR---------CVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHR 61
Query: 139 NLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYF----------QPLSWNLRLKV 187
N++ L E L +++EF+ + + Q
Sbjct: 62 NILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------- 113
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAKDGPTGDQSHVSTR 245
+ FLH + + D + NI+ T ++ K+ +FG A+
Sbjct: 114 ------ALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRL 162
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ Y APE ++ +D++S G ++ +LSG
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-21
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 54/235 (22%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLA 127
+R +LG+GGFG+VF A + + +A+K R+
Sbjct: 32 EYRLGPLLGKGGFGTVF---------AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 128 -EVNYLGQL----YHPNLVKLVGYCLEDDHRLLVYEF-MPRGSLENHLFRRG-------- 173
EV L ++ HP +++L+ + + +LV E +P L +++ +G
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142
Query: 174 SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA-KLSDFGLA- 231
+F + + H V++RD K NIL+D KL DFG
Sbjct: 143 CFFGQV------------VAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSGA 188
Query: 232 --KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLT-AKSDVYSFGVVLLEMLSGR 283
D P + GT Y+ PE+++ + V+S G++L +M+ G
Sbjct: 189 LLHDEP------YTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-21
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-----WLAEVNYLGQ 134
+GEG +G+VFK + T ++A+KR+ D E L E+ L +
Sbjct: 10 IGEGTYGTVFKA-KNRE--------THEIVALKRVRLDDD---DEGVPSSALREICLLKE 57
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL---SWNLRLKVALGA 191
L H N+V+L D LV+EF + L+ + P S+ +L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL------ 110
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD--GPTGDQSHVSTRVMGT 249
KG+ F H V++RD K N+L++ N KL++FGLA+ P S V+ T
Sbjct: 111 LKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-T 164
Query: 250 YGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGRRA 285
Y P+ L A + T+ D++S G + E+ + R
Sbjct: 165 LWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL---NQDGFQGHKEWLAEVNYLGQLY 136
LG G + +V+K TG+ +A+K + +++G + E++ + +L
Sbjct: 13 LGNGTYATVYK---------GLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELK 61
Query: 137 HPNLVKLVGYCLEDDHRLLVYEFMP---RGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
H N+V+L ++ LV+EFM + +++ + L NL +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYFQWQLLQ 119
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA--KDGPTGDQSHVSTRVMGTYG 251
G+AF H E K+++RD K N+L++ KL DFGLA P S V+ T
Sbjct: 120 GLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 252 YAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
Y AP+ L + + T+ D++S G +L EM++G+
Sbjct: 174 YRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-----WLAEVNYLGQ 134
+GEG +G V+K + G A+K++ + E + E++ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKE---DEGIPSTTIREISILKE 56
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL---SWNLRLKVALGA 191
L H N+VKL +LV+E + + L+ L + + S+ L+L
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL------ 109
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD--GPTGDQSHVSTRVMGT 249
G+A+ H + +V++RD K N+L++ K++DFGLA+ P +H ++ T
Sbjct: 110 LNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-T 163
Query: 250 YGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
Y AP+ L + + T D++S G + EM++G
Sbjct: 164 LWYRAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 57/216 (26%), Positives = 83/216 (38%), Gaps = 40/216 (18%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-EVNYLGQLYHP 138
+G G FG T ++AVK + + E + E+ L HP
Sbjct: 28 IGSGNFGVARLM---RDKL------TKELVAVKYIERG--AAIDENVQREIINHRSLRHP 76
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLKVALG 190
N+V+ L H ++ E+ G L + G +FQ L
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL----------- 125
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNY--NAKLSDFGLAKDGPTGDQSHVSTRVMG 248
GV++ H ++ +RD K N LLD + K+ DFG +K Q + V G
Sbjct: 126 -LSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-G 179
Query: 249 TYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
T Y APE L + +DV+S GV L ML G
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 42/218 (19%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA---EVNYLGQLY 136
LG G FG V G +H TG +AVK LN+ + E+ L
Sbjct: 24 LGVGTFGKVKVG---KHEL------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 137 HPNLVKLVGY-CLEDDHRL-LVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLK 186
HP+++KL Y + + +V E++ G L +++ + G FQ +
Sbjct: 75 HPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------- 125
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
GV + H V++RD K N+LLD + NAK++DFGL+ G+ S
Sbjct: 126 -----LSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176
Query: 247 MGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
G+ YAAPE ++ + + D++S GV+L +L G
Sbjct: 177 -GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 35/214 (16%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-----WLAEVNYLGQ 134
+GEG +G V+K K G ++A+KR+ D E + E++ L +
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKE 75
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPL---SWNLRLKVALGA 191
L+HPN+V L+ + LV+EFM + L+ L + Q + +L
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQL------ 128
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+GVA H + ++++RD K N+L++++ KL+DFGLA+ G T + T
Sbjct: 129 LRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLW 184
Query: 252 YAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
Y AP+ L + + T+ D++S G + EM++G+
Sbjct: 185 YRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 53/233 (22%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+ ++ +G G G V AA +A+K+L+ FQ K
Sbjct: 61 LKRYQNLKPIGSGAQGIVC---------AAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYR 110
Query: 128 EVNYLGQLYHPNLVKLV-----GYCLEDDHRL-LVYEFMP-------RGSLENHLFRRGS 174
E+ + + H N++ L+ LE+ + LV E M + L++ R S
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMS 167
Query: 175 YF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
Y Q L G+ LH A +I+RD K SNI++ ++ K+ DFGLA+
Sbjct: 168 YLLYQML-------------CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 233 DGPTGDQS--HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T +V TR Y APE + D++S G ++ EM+ +
Sbjct: 213 TAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-20
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 43/218 (19%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA---EVNYLGQLY 136
LGEG FG V H T +A+K +++ + + E++YL L
Sbjct: 17 LGEGSFGKVKLA---THYK------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 137 HPNLVKLVGY-CLEDDHRL-LVYEFMPRGSLENHLFRRG--------SYFQPLSWNLRLK 186
HP+++KL Y + + +V E+ G L +++ + +FQ +
Sbjct: 68 HPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQI------- 117
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+ + H K+++RD K N+LLD N N K++DFGL+ G+ S
Sbjct: 118 -----ICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-- 168
Query: 247 MGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGR 283
G+ YAAPE + + + DV+S G+VL ML GR
Sbjct: 169 -GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 53/233 (22%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+ ++ +G G G V AA +A+K+L+ FQ K
Sbjct: 24 LKRYQNLKPIGSGAQGIVC---------AAYDAILERNVAIKKLS-RPFQNQTHAKRAYR 73
Query: 128 EVNYLGQLYHPNLVKLV-----GYCLEDDHRL-LVYEFMP-------RGSLENHLFRRGS 174
E+ + + H N++ L+ LE+ + +V E M + L++ R S
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH---ERMS 130
Query: 175 YF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232
Y Q L G+ LH A +I+RD K SNI++ ++ K+ DFGLA+
Sbjct: 131 YLLYQML-------------CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 233 DGPTGDQS--HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T +V TR Y APE + D++S G ++ EM+ G
Sbjct: 176 TAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 50/223 (22%), Positives = 82/223 (36%), Gaps = 48/223 (21%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK-----RLNQDGFQGHKEWLAEVNYLG 133
LG G F V + TG A K R QD E L E+ L
Sbjct: 36 ELGRGKFAVVRQ---------CISKSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLE 83
Query: 134 QLYH-PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR------GSYFQPLSWNLRLK 186
P ++ L +L+ E+ G E +F +
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSE--------N 131
Query: 187 VALGAAK----GVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQ 239
+ K GV +LH + +++ D K NILL + + K+ DFG+++ G
Sbjct: 132 DVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHA 187
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG 282
+ + GT Y APE L +T +D+++ G++ +L+
Sbjct: 188 CELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 54/233 (23%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+ + + +G G +GSV A +G +A+K+L+ FQ K
Sbjct: 23 PKTYVSPTHVGSGAYGSVCS---------AIDKRSGEKVAIKKLS-RPFQSEIFAKRAYR 72
Query: 128 EVNYLGQLYHPNLVKLV-----GYCLEDDHRL-LVYEFMP-------RGSL-ENHLFRRG 173
E+ L + H N++ L+ L + + LV FM E +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI---- 128
Query: 174 SYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
Y Q L KG+ ++H A V++RD K N+ ++ + K+ DFGLA
Sbjct: 129 QYLVYQML-------------KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ +V TR + Y APE L+ H D++S G ++ EML+G+
Sbjct: 174 RHADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 59/256 (23%), Positives = 106/256 (41%), Gaps = 42/256 (16%)
Query: 44 PPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKP 103
+ + P S S + T+ +R + LGEG +G V+K A
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYK---------AIDT 56
Query: 104 GTGMVIAVKRLNQDGFQGHKE-----WLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYE 158
T +A+KR+ + +E + EV+ L +L H N+++L + L++E
Sbjct: 57 VTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 159 FMPRGSLENHLFRRGSYFQPL--SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216
+ L+ ++ + + S+ +L GV F H + ++RD K N+L
Sbjct: 114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCH--SRRCLHRDLKPQNLL 164
Query: 217 LDTNYNA-----KLSDFGLAKD--GPTGDQSHVSTRVMGTYGYAAPEYL--ATGHLTAKS 267
L + + K+ DFGLA+ P +H ++ T Y PE L + + T+
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHYSTS-V 219
Query: 268 DVYSFGVVLLEMLSGR 283
D++S + EML
Sbjct: 220 DIWSIACIWAEMLMKT 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 57/244 (23%), Positives = 89/244 (36%), Gaps = 64/244 (26%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW----- 125
+ + G +G+V G +D G+ +A+KR+ G
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDS---------EGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 126 ------LAEVNYLGQLYHPNLVKL----VGYCLEDDHRL-LVYEFM----------PRGS 164
L E+ L +HPN++ L V + H+L LV E M R
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 165 LENHLFRRGSYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222
+ + YF L G+ LH A V++RD NILL N +
Sbjct: 131 ISPQHIQ---YFMYHIL-------------LGLHVLHEAG--VVHRDLHPGNILLADNND 172
Query: 223 AKLSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEY-LATGHLTAKSDVYSFGVVLLEM 279
+ DF LA++ +V+ R Y APE + T D++S G V+ EM
Sbjct: 173 ITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 280 LSGR 283
+ +
Sbjct: 228 FNRK 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-----LA 127
+ P + +G G +G+V+K D H +G +A+K + G +
Sbjct: 10 RYEPVAEIGVGAYGTVYKA-RDPH--------SGHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 128 EVNYLGQL---YHPNLVKL----VGYCLEDDHRL-LVYEFMP---RGSLENHLFRRGSYF 176
EV L +L HPN+V+L + + ++ LV+E + R L+
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGL 117
Query: 177 QP-----LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
L +G+ FLH +++RD K NIL+ + KL+DFGLA
Sbjct: 118 PAETIKDLMRQF--------LRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ Q ++ V+ T Y APE L D++S G + EM +
Sbjct: 168 R--IYSYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 58/237 (24%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL----NQDGF--QGHKEWL 126
+ + +GEG +G VFK D + G +A+KR+ ++G +
Sbjct: 12 QYECVAEIGEGAYGKVFKA-RDLKN-------GGRFVALKRVRVQTGEEGMPLST----I 59
Query: 127 AEVNYLGQL---YHPNLVKL----VGYCLEDDHRL-LVYEFM-----------PRGSLEN 167
EV L L HPN+V+L + + +L LV+E + P +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119
Query: 168 HLFRRGSY-FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226
+ FQ L +G+ FLH +V++RD K NIL+ ++ KL+
Sbjct: 120 ETIK--DMMFQLL-------------RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLA 162
Query: 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
DFGLA+ Q +++ V+ T Y APE L D++S G + EM +
Sbjct: 163 DFGLAR--IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 62/243 (25%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA--- 127
+ +F+ S+LGEG +G V AT TG ++A+K++ F K A
Sbjct: 10 SSDFQLKSLLGEGAYGVVCS---------ATHKPTGEIVAIKKIEP--FD--KPLFALRT 56
Query: 128 --EVNYLGQLYHPNLVKLV----GYCLEDDHRL-LVYEFMP--------RGSLEN-HLFR 171
E+ L H N++ + E+ + + ++ E M L + H+
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI-- 114
Query: 172 RGSYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229
YF Q L + V LHG+ VI+RD K SN+L+++N + K+ DFG
Sbjct: 115 --QYFIYQTL-------------RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFG 157
Query: 230 LA----KDGPTGDQSHVSTRVMGTY----GYAAPEY-LATGHLTAKSDVYSFGVVLLEML 280
LA + + M + Y APE L + + DV+S G +L E+
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
Query: 281 SGR 283
R
Sbjct: 218 LRR 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 52/229 (22%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-----WLAEVNYLGQ 134
+G+G FG VFK A TG +A+K++ + KE L E+ L
Sbjct: 25 IGQGTFGEVFK---------ARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 135 LYHPNLVKLVGYCLEDDHRL--------LVYEFMP---RGSLENHLFRRG-----SYFQP 178
L H N+V L+ C LV++F G L N L + Q
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPT 236
L G+ ++H K+++RD K +N+L+ + KL+DFGLA+
Sbjct: 133 L------------LNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 237 GDQSHVSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGR 283
Q + T + T Y PE L + D++ G ++ EM +
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 60/321 (18%), Positives = 105/321 (32%), Gaps = 78/321 (24%)
Query: 20 SSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSV 79
SS ++ S T VS R + + SD + R + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR-YEIRHL 60
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA-----EVNYLGQ 134
+G G +G V + A V+A+K++ F+ E+ L +
Sbjct: 61 IGTGSYGHVCE---------AYDKLEKRVVAIKKIL-RVFE--DLIDCKRILREIAILNR 108
Query: 135 LYHPNLVKLV----GYCLEDDHRL-LVYEFMP---------RGSLENHLFRRGSYF--QP 178
L H ++VK++ +E L +V E L +
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK---TLLYNL 165
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA------- 231
L GV ++H A +++RD K +N L++ + + K+ DFGLA
Sbjct: 166 L-------------VGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 232 --------------KDGPTGDQSHVSTRVMGTYG----YAAPE-YLATGHLTAKSDVYSF 272
+ T + R + + Y APE L + T DV+S
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270
Query: 273 GVVLLEMLSGRRAVDKNRPSG 293
G + E+L+ +
Sbjct: 271 GCIFAELLNMIKENVAYHADR 291
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 57/237 (24%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+ S +GEG +G V +A + +A+K+++ F+ + L
Sbjct: 26 GPRYTNLSYIGEGAYGMVC---------SAYDNLNKVRVAIKKISP--FEHQTYCQRTLR 74
Query: 128 EVNYLGQLYHPNLVKLVG----YCLEDDHRL-LVYEFMP--------RGSLEN-HLFRRG 173
E+ L + H N++ + +E + +V + M L N H+
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 130
Query: 174 SYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
YF Q L +G+ ++H A V++RD K SN+LL+T + K+ DFGLA
Sbjct: 131 CYFLYQIL-------------RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 232 KDGPTGDQSHVSTRVMGTY----GYAAPEY-LATGHLTAKSDVYSFGVVLLEMLSGR 283
+ D H T + Y Y APE L + T D++S G +L EMLS R
Sbjct: 176 R---VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 57/268 (21%), Positives = 100/268 (37%), Gaps = 81/268 (30%)
Query: 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL 126
L+T+++ + LG G FG V + + E +G A+K++ QD +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP----RYKN 48
Query: 127 AEVNYLGQLYHPNLVKL-------------------------------------VGYCLE 149
E++ + L H N++KL V
Sbjct: 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 150 DDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWN---------LRLKVALGAAKGVAFLH 199
+ L ++ E++P +L L + + N R V F+H
Sbjct: 109 QNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR---------AVGFIH 158
Query: 200 GAETKVIYRDFKTSNILLDTNYNA-KLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPE 256
+ +RD K N+L+++ N KL DFG AK + +++ +R + Y APE
Sbjct: 159 SL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE 211
Query: 257 -YLATGHLTAKSDVYSFGVVLLEMLSGR 283
L T D++S G V E++ G+
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 58/215 (26%), Positives = 82/215 (38%), Gaps = 30/215 (13%)
Query: 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216
E +E Y L+ + + AKG+ FL A K I+RD NIL
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNIL 225
Query: 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVL 276
L K+ DFGLA+D + APE + T +SDV+SFGV+L
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 277 LEMLS-GRRAVDKNRPSGEHNLVEWAKPY--LASKRKIFRIID--NRLEG-QYTLEGAYK 330
E+ S G A PY + + R + R+ YT Y+
Sbjct: 286 WEIFSLG------------------ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327
Query: 331 AATLALRCLSTEGKFRPMMAEVVTVLE-QLQDSSE 364
L C E RP +E+V L LQ +++
Sbjct: 328 ---TMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQL 135
LG G FG V + K T +AVK L + H+ ++E+ L +
Sbjct: 27 GKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 136 -YHPNLVKLVGYCLEDDHRLLV-YEFMPRGSLENHLFRRGSYFQPL 179
+H N+V L+G C + L+V EF G+L +L + + F P
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 53/233 (22%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
++ S +G G +GSV AA TG+ +AVK+L+ FQ K
Sbjct: 28 PERYQNLSPVGSGAYGSVC---------AAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYR 77
Query: 128 EVNYLGQLYHPNLVKLV-----GYCLEDDHRL-LVYEFMP--------RGSLENHLFRRG 173
E+ L + H N++ L+ LE+ + + LV M L + +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ-- 135
Query: 174 SYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
+ Q L +G+ ++H A+ +I+RD K SN+ ++ + K+ DFGLA
Sbjct: 136 -FLIYQIL-------------RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ +V+TR Y APE L H D++S G ++ E+L+GR
Sbjct: 180 RHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 53/233 (22%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+R +G G +G+V +A TG +A+K+L FQ K
Sbjct: 24 RAVYRDLQPVGSGAYGAVC---------SAVDGRTGAKVAIKKLY-RPFQSELFAKRAYR 73
Query: 128 EVNYLGQLYHPNLVKLV-----GYCLEDDHRL-LVYEFMP--------RGSLENHLFRRG 173
E+ L + H N++ L+ L+D LV FM L +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ-- 131
Query: 174 SYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
+ Q L KG+ ++H A +I+RD K N+ ++ + K+ DFGLA
Sbjct: 132 -FLVYQML-------------KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEY-LATGHLTAKSDVYSFGVVLLEMLSGR 283
+ + +V TR Y APE L T D++S G ++ EM++G+
Sbjct: 176 RQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 72/249 (28%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
+ LG GG G VF A +A+K++ K L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFS---------AVDNDCDKRVAIKKIV---LTDPQSVKHALR 57
Query: 128 EVNYLGQLYHPNLVKL-------------VGYCLEDDHRL-LVYEFMP--------RGSL 165
E+ + +L H N+VK+ L + + + +V E+M +G L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL 117
Query: 166 EN-HLFRRGSYF--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NY 221
H F Q L +G+ ++H A V++RD K +N+ ++T +
Sbjct: 118 LEEHA----RLFMYQLL-------------RGLKYIHSAN--VLHRDLKPANLFINTEDL 158
Query: 222 NAKLSDFGLAK--DGPTGDQSH----VSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGV 274
K+ DFGLA+ D + H + T+ Y +P L+ + T D+++ G
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 275 VLLEMLSGR 283
+ EML+G+
Sbjct: 214 IFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 47/219 (21%)
Query: 80 LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HP 138
LG G + VF+ + VK L K+ E+ L L P
Sbjct: 44 LGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGP 91
Query: 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWN---------LRLKVAL 189
N++ L + R F + N F++ +Q L+ L+
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQ--LYQTLTDYDIRFYMYEILK----- 141
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLD-TNYNAKLSDFGLAKDGPTGDQ--SHVSTRV 246
+ + H +++RD K N+++D + +L D+GLA+ G + V++R
Sbjct: 142 ----ALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 247 MGTYGYAAPEYLATGHLTAKS-DVYSFGVVLLEMLSGRR 284
+ PE L + S D++S G +L M+ +
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 53/250 (21%), Positives = 97/250 (38%), Gaps = 58/250 (23%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA--- 127
N+ ++G G +G V+ A T +A+K++N F+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYL---------AYDKNTEKNVAIKKVN-RMFE--DLIDCKRI 72
Query: 128 --EVNYLGQLYHPNLVKLV-----GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
E+ L +L +++L L+ D +V E S LF+ L+
Sbjct: 73 LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP---IFLT 127
Query: 181 WNLRLKV----ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA----- 231
+K L G F+H + +I+RD K +N LL+ + + K+ DFGLA
Sbjct: 128 -EEHIKTILYNLL---LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 232 -----------KDGPTGDQSHVSTRVMGTY----GYAAPEY-LATGHLTAKSDVYSFGVV 275
++ G + + + ++ Y APE L + T D++S G +
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241
Query: 276 LLEMLSGRRA 285
E+L+ ++
Sbjct: 242 FAELLNMLQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 66/250 (26%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH---KEWLA 127
R + LG+G +G V+K + TG V+AVK++ D FQ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWK---------SIDRRTGEVVAVKKIF-DAFQNSTDAQRTFR 57
Query: 128 EVNYLGQL-YHPNLVKLVGYCLEDDHR--LLVYEFMP-------RGSL--ENHLFRRGSY 175
E+ L +L H N+V L+ D+ R LV+++M R ++ H Y
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK----QY 113
Query: 176 F--QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA-- 231
Q + K + +LH +++RD K SNILL+ + K++DFGL+
Sbjct: 114 VVYQLI-------------KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRS 158
Query: 232 -------------KDGPTGDQSHVSTRVMGTY----GYAAPEY-LATGHLTAKSDVYSFG 273
+ ++ Y Y APE L + T D++S G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 274 VVLLEMLSGR 283
+L E+L G+
Sbjct: 219 CILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 50/269 (18%), Positives = 81/269 (30%), Gaps = 86/269 (31%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-H 137
VLG G G V + T A+K L + EV +
Sbjct: 25 VLGLGINGKVLQ---------IFNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 70
Query: 138 PNLVKLVGYC----LEDDHRLLVYEFMPRGSLENHLFRRG----------SYFQPLSWNL 183
P++V++V L+V E + G L + + RG + +
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI---- 126
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLSDFGLAKDGPTGDQS 240
+ + +LH + +RD K N+L + N KL+DFG
Sbjct: 127 --------GEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------- 166
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300
A E + D++S GV++ +L G P +
Sbjct: 167 -------------AKETTGEKY-DKSCDMWSLGVIMYILLCGY------PPF-------Y 199
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAY 329
+ LA + I GQY
Sbjct: 200 SNHGLAISPGMKTRI---RMGQYEFPNPE 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 27/214 (12%), Positives = 56/214 (26%), Gaps = 49/214 (22%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVN 130
+R G ++ D +A+ ++ G +E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQAL-DTA--------LDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
L ++ P + +++ L+V E++ GSL+ S ++
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQS 137
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
A H A V S + + + + L+
Sbjct: 138 LAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+ D+ G L +L R
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 41/223 (18%), Positives = 77/223 (34%), Gaps = 37/223 (16%)
Query: 26 SDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGF 85
S G D+ + S++ G +L + R ++ S
Sbjct: 8 SSGVDLGTENLYFQSMTTSLEALPTGTVLT------------DKSGRQWKLKSFQTRDNQ 55
Query: 86 GSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL--------AEVNYLGQLYH 137
G +++ + ++K +DG + E +VN +LY
Sbjct: 56 GILYEA-APTSTLTCDSGPQKQKFSLKLDAKDG-RLFNEQNFFQRAAKPLQVNKWKKLYS 113
Query: 138 PNLV---KLVGY-CLEDDHRLLVYEFMPR--GSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L+ +G+ +D +R LV +P SL+ LS L+VA
Sbjct: 114 TPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPK-HVLSERSVLQVACRL 168
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK--LSDFGLAK 232
+ FLH E + ++ + NI +D ++ L+ +G A
Sbjct: 169 LDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 37/228 (16%), Positives = 85/228 (37%), Gaps = 42/228 (18%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEVNYLGQL- 135
LG G F +V+ D +A+K + + + E+ L ++
Sbjct: 25 RKLGWGHFSTVWLAK-DMV--------NNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVN 73
Query: 136 ----------YHPNLVKLVGY----CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSW 181
+++KL+ + H ++V+E + +L + + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPL 130
Query: 182 NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD------TNYNAKLSDFGLAKDGP 235
+++ G+ ++H +I+ D K N+L++ K++D G A
Sbjct: 131 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ + TR Y +PE L +D++S ++ E+++G
Sbjct: 190 EHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEVNYLGQL- 135
S++G+G FG V K + D +A+K + N+ F + EV L +
Sbjct: 60 SLIGKGSFGQVVKAY-DRV--------EQEWVAIKIIKNKKAF--LNQAQIEVRLLELMN 108
Query: 136 -YHP----NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR--RGSYFQPLSWNLRLKVA 188
+ +V L + + +H LV+E L +L+ R + F+ +S NL K A
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILL--DTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+ FL E +I+ D K NILL K+ DFG + ++ +R
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 223
Query: 247 MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
Y +PE L D++S G +L+EM +G
Sbjct: 224 -----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEVNYLGQL 135
V+G+G FG V K + D +A+K + N+ F H++ E+ L L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHK--------VHQHVALKMVRNEKRF--HRQAAEEIRILEHL 150
Query: 136 --YHP----NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLF---RRGSYFQPLSWNLRLK 186
N++ ++ +H + +E L +L+ ++ FQ S L K
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNK-FQGFSLPLVRK 204
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAKDGPTGDQSHVST 244
A + + LH + ++I+ D K NILL + K+ DFG + +++ +
Sbjct: 205 FAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262
Query: 245 RVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSGR 283
R Y APE L + D++S G +L E+L+G
Sbjct: 263 RF-----YRAPEVILGARY-GMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 50/232 (21%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVN 130
+R +G G FG ++ G T G +A+K + Q H E
Sbjct: 10 RYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTKHPQLHIES----- 55
Query: 131 YLGQLYH-----PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
++Y + + E D+ ++V E + SLE LF S + S L
Sbjct: 56 ---KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCS--RKFSLKTVL 108
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK---LSDFGLAK---DGPTGDQ 239
+A + ++H I+RD K N L+ + DFGLAK D T
Sbjct: 109 LLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-- 164
Query: 240 SHVSTR----VMGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLEMLSGR 283
H+ R + GT YA+ + T HL + + D+ S G VL+ G
Sbjct: 165 QHIPYRENKNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 1e-08
Identities = 52/416 (12%), Positives = 111/416 (26%), Gaps = 114/416 (27%)
Query: 5 LSARIKAESPFNTGVSSKYVSSDGNDMSSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSF 64
L + IK E + ++ Y+ + + + + +V R + +
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQR-DRLYNDNQVFAKYNVS---RLQ------------PY 137
Query: 65 SDLKTATRNFRPDS---VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG 121
L+ A RP + G G G K W+ V ++ Q
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSG---KTWV-----------ALDVCLSYKV-QCKMDF 182
Query: 122 HKEWL---------AEVNYLGQLYH---PNLVKLVGYCLEDDH----RLLVYEFMPRGSL 165
WL + L +L + PN + DH +L ++
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPN------WTSRSDHSSNIKLRIHSIQAE--- 233
Query: 166 ENHLFRRGSYFQPL-----SWNLR-LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219
L + Y L N + AF + + R + ++ L
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWN---------AFNLSCKILLTTRFKQVTDFLSAA 284
Query: 220 NYNAKLSDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLE 278
D T D+ + + + P + T + L
Sbjct: 285 TTTHISLDH--HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP-----------RRLS 331
Query: 279 MLSGRRAVDKNRPSGEHNLVEWAKPYL-ASKRKIFRIIDNRLEGQYTLE--GAYKAATLA 335
+++ W + + K+ II++ L E + L+
Sbjct: 332 IIAESIRDGLAT---------W-DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR--LS 379
Query: 336 LRCLSTEGKFR---PMMAEVVTVLEQLQDSSETGNIRCNTHNRPKIRRHSADDARS 388
+ F + +++++ S+ + H + + + S
Sbjct: 380 V--------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 44/230 (19%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+++ +GEG FG +F+G T +A+K + + E
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 59
Query: 133 GQLYH-PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR--LKVAL 189
L + + + E H +LV + + SLE L ++++ A
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLD----LCGRKFSVKTVAMAAK 113
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK-----LSDFGLAK---DGPTGDQSH 241
V +H E ++YRD K N L+ + + DFG+ K D T H
Sbjct: 114 QMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QH 169
Query: 242 VSTR----VMGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLEMLSGR 283
+ R + GT Y + + T HL + + D+ + G V + L G
Sbjct: 170 IPYREKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 42/240 (17%), Positives = 88/240 (36%), Gaps = 44/240 (18%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-----L 126
++ +G+GGFG ++ ++ + VK D E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGPLFTELKFYQRA 90
Query: 127 AEVNYLGQLYHPNLVKLVG----------YCLEDDHRLLVYEFMPR-G-SLENHLFRRGS 174
A+ + + +K +G +R ++ M R G L+ ++ +
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDRFGSDLQ-KIYEANA 146
Query: 175 YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK--LSDFGLAK 232
+ S L+++L + ++H E + ++ D K SN+LL+ + L D+GLA
Sbjct: 147 --KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
Query: 233 D-GPTGDQSHVSTR----VMGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLEMLSGR 283
P G + GT + + + H + + D+ G +++ L+G
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 50/232 (21%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVN 130
FR +G G FG ++ G T T +A+K + Q E
Sbjct: 8 KFRLGRKIGSGSFGEIYLG---------TNIQTNEEVAIKLENVKTKHPQLLYES----- 53
Query: 131 YLGQLYH-----PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
++Y + + + +E D+ +LV + + SLE LF S + LS L
Sbjct: 54 ---KIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCS--RKLSLKTVL 106
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK---LSDFGLAK---DGPTGDQ 239
+A V F+H ++RD K N L+ A + DFGLAK D T
Sbjct: 107 MLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-- 162
Query: 240 SHVSTR----VMGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLEMLSGR 283
H+ R + GT YA+ + T HL + + D+ S G VL+ L G
Sbjct: 163 QHIPYRENKNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 46/231 (19%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK--RLNQDGFQGHKEWLAEVN 130
NFR +G G FG + G + + T +A+K + Q H E+
Sbjct: 10 NFRVGKKIGCGNFGELRLG-KNLY--------TNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR--LKVA 188
P ++ + + +V E + SLE LF +++L+ L +A
Sbjct: 61 LGSGDGIP---QVYYFGPCGKYNAMVLELLGP-SLE-DLFD----LCDRTFSLKTVLMIA 111
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK-----LSDFGLAK---DGPTGDQS 240
+ + ++H +IYRD K N L+ N + DF LAK D T
Sbjct: 112 IQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--K 167
Query: 241 HVSTR----VMGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLEMLSGR 283
H+ R + GT Y + + T HL + + D+ + G + + L G
Sbjct: 168 HIPYREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 8e-08
Identities = 47/265 (17%), Positives = 73/265 (27%), Gaps = 67/265 (25%)
Query: 62 FSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAV---KRLNQDG 118
FS T + +GEG FG VF+ I +H+ A K +IA+ +N
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIK-----IIAIEGPDLVNGSH 63
Query: 119 FQGHKEWLAEVNYLGQLY---------HPNLVKLVGYCL--------------------- 148
+ +E L E+ +L + L
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 149 ---------EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLH 199
+DD +V EF G + + S + +A
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAE 178
Query: 200 GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG---------PTGDQSHVSTRVMGTY 250
A + +RD N+LL KL K D + G
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 251 GYA---APEYLATGHLTAKSDVYSF 272
+ E L TG + D+Y
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 51/269 (18%), Positives = 83/269 (30%), Gaps = 86/269 (31%)
Query: 80 LGEGGFGSVFKGW-IDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL--- 135
LG G F +V+ W I F A K +V + + + L E+ L +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK----VVKSAEHYTETA-------LDEIRLLKSVRNS 93
Query: 136 --YHPNLVKLVGYCLEDD---------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR 184
PN +V L DD H +V+E + L + S +Q L
Sbjct: 94 DPNDPNREMVV--QLLDDFKISGVNGTHICMVFEVL-GHHL--LKWIIKSNYQGLPLPCV 148
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILL--------------------------- 217
K+ +G+ +LH + ++I+ D K NILL
Sbjct: 149 KKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 218 ----------------------DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAP 255
K++D G A + TR Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSL 262
Query: 256 EYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
E L +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 51/235 (21%), Positives = 81/235 (34%), Gaps = 54/235 (22%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEVNYLGQL- 135
LGEG FG V + D +A+K + N + + E+N L ++
Sbjct: 25 GNLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKY--REAARLEINVLKKIK 74
Query: 136 -YHP----NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
V + + H + +E + + L + + FQP +A
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFL--KENNFQPYPLPHVRHMAYQ 131
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA-------------------KLSDFGLA 231
+ FLH E ++ + D K NIL + +++DFG A
Sbjct: 132 LCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 232 KDGPTGDQSH---VSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSG 282
+ H V+TR Y PE L G DV+S G +L E G
Sbjct: 190 TF---DHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFEYYRG 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 50/281 (17%), Positives = 97/281 (34%), Gaps = 61/281 (21%)
Query: 32 SSTGSKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKG 91
S +L P EG++L D + + +G GGFG ++
Sbjct: 9 SGVDLGTENLYFQSMPFPEGKVL-----------DDMEGNQ-WVLGKKIGSGGFGLIYLA 56
Query: 92 W-IDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW-----LAEVNYLGQLYHPNLVKLVG 145
+ ++ A VK Q+ E +A+ + + + + +G
Sbjct: 57 FPTNKPEKDARH-------VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109
Query: 146 -----YC-----LEDDHRLLVYEFMPR--GSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
+R +V M R L+ + + F + L++ +
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNGTF---KKSTVLQLGIRMLD 162
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAK--LSDFGLAKD-GPTGDQSHVSTRV---- 246
+ ++H E + ++ D K +N+LL + L+D+GL+ P G+
Sbjct: 163 VLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 247 MGTYGYAAPEYLATGHL----TAKSDVYSFGVVLLEMLSGR 283
GT + + L H + +SDV G +L L G+
Sbjct: 221 NGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 55/242 (22%), Positives = 82/242 (33%), Gaps = 64/242 (26%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEVNYLGQL- 135
+G+G FG V AVK + N + + E + L ++
Sbjct: 41 RKMGDGTFGRVLLCQ-HID--------NKKYYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 136 -YHP---NLVKLVGYCLEDDHRLLVYEFMPRGSLENHL--FRRGSYFQPLSWNLRLKVAL 189
N+VK G + DH L++E L L + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCI 144
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA-------------------------K 224
K + +L + + + D K NILLD Y K
Sbjct: 145 EILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 225 LSDFGLAKDGPTGDQSH---VSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEML 280
L DFG A H ++TR Y APE L G + SD++SFG VL E+
Sbjct: 203 LIDFGCATF---KSDYHGSIINTRQ-----YRAPEVILNLGWDVS-SDMWSFGCVLAELY 253
Query: 281 SG 282
+G
Sbjct: 254 TG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 63/235 (26%), Positives = 92/235 (39%), Gaps = 54/235 (22%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRL-NQDGFQGHKEWLAEVNYLGQL- 135
LGEG FG V + D + G +AVK + N D + + +E+ L L
Sbjct: 20 DTLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLN 69
Query: 136 -YHP----NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
P V+++ + H +V+E + S + + + + F P + K+A
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFI--KENGFLPFRLDHIRKMAYQ 126
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA-------------------KLSDFGLA 231
K V FLH K+ + D K NIL + K+ DFG A
Sbjct: 127 ICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 232 KDGPTGDQSH---VSTRVMGTYGYAAPE-YLATGHLTAKSDVYSFGVVLLEMLSG 282
D+ H VSTR Y APE LA G DV+S G +L+E G
Sbjct: 185 TY---DDEHHSTLVSTRH-----YRAPEVILALGWSQP-CDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 404 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.08 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.79 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.76 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.25 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.33 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=437.53 Aligned_cols=271 Identities=28% Similarity=0.417 Sum_probs=219.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|.+.+.||+|+||+||+|.+.. .....++..||||+++.......+++.+|+++|++++|||||++++++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYN----LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECS----CC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC----cccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 568888999999999999997754 2344568899999998776666678999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 152 HRLLVYEFMPRGSLENHLFRRG---------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
.+|||||||++|+|.+++...+ .....+++..++.++.||+.||+||| +++|+||||||+||||+.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCCc
Confidence 9999999999999999997643 22356999999999999999999999 789999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~--- 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVI--- 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH---
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---
Confidence 99999999986543333223334569999999999999999999999999999999998 89999764321 111
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
. .+.. ......+..++.++.+|+.+||+.||++|||+.+|++.|+++.+.++.
T Consensus 241 ~----------~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 241 E----------CITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp H----------HHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred H----------HHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 1 1111 111233445567889999999999999999999999999998876553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=437.36 Aligned_cols=270 Identities=28% Similarity=0.402 Sum_probs=214.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|.+.+.||+|+||+||+|.++. .....++..||||+++.......++|.+|+++|++++|||||+++++|.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHN----LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESS----SCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECC----cccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467778899999999999998754 3345578899999998776666678999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSY-----------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
.+|||||||++|+|.+++...... ..++++..++.++.||+.||+||| +.+|+||||||+||||+.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCC
Confidence 999999999999999999765321 246899999999999999999999 7899999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~ 299 (404)
+.+||+|||+++.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||...... .
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------E 268 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------H
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------H
Confidence 9999999999987655444444456789999999999999999999999999999999999 89999764321 1
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
... .+.. ......+..++.++.+|+.+||+.||++|||+.||++.|+.+.+..+
T Consensus 269 ~~~----------~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 269 AID----------CITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp HHH----------HHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred HHH----------HHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 111 1111 11123344556788999999999999999999999999999877543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-59 Score=435.99 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=209.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.|++.+.||+|+||+||+| .+..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a---------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIA---------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEE---------EECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56999999999999999995 455678999999998766566677899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
.+|||||||+||+|.+++... .+++..++.++.||+.||+||| +++|+||||||+||||+.+|.+||+|||+|
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999999763 4899999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ......
T Consensus 218 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~------ 283 (346)
T 4fih_A 218 AQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIR------ 283 (346)
T ss_dssp EECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH------
T ss_pred eecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH------
Confidence 8654322 23445789999999999999999999999999999999999999997543211 000000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...... .......+.++.+||.+||+.||++|||+.|+++
T Consensus 284 -~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 284 -DNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -HSSCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cCCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000001 1122334567889999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-59 Score=435.34 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=202.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++++.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+++|+.|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEE---------EETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 58999999999999999995 4555789999999976533 234678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++.+|||||||+||+|.++|..... ..+++..++.++.||+.||+||| +++|+||||||+||||+.+|.+||+|||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999999976542 45789999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+|+..... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 171 la~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~------- 235 (350)
T 4b9d_A 171 IARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVL------- 235 (350)
T ss_dssp EESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH-------
T ss_pred cceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHH-------
Confidence 99865321 11234468999999999999999999999999999999999999999764321 1111
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..... ...+...+.++.+||.+||+.||++|||+.|+++
T Consensus 236 ---~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 236 ---KIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 1223344567889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=428.20 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=210.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||+||+ +.+..+++.||+|++.+.. ....+.+.+|+++|+.++|||||+++++|.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~---------a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVL---------ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEE---------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEE---------EEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4699999999999999999 4555678999999997532 234467899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++.+||||||++||+|.+++.+.+ .+++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEc
Confidence 9999999999999999999998764 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+|+..............+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~------ 244 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFA------ 244 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH------
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH------
Confidence 9998765444444455679999999999999999999999999999999999999999754321 1111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..... .++...+.++.+||.+||+.||++|||+.|++.
T Consensus 245 ----~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 245 ----KIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ----HHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ----HHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1111111 223334567889999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=427.65 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=213.6
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++++.+.||+|+||+||+|.+.. ..+..+++.||||+++.... ...++|.+|+.++++++|||||++++++.+++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFG----PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HCeEeeEeccCCCcEEEEEEEcC----CccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 45667899999999999998753 23445678999999975432 33467999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
.++||||||++|+|.++|..... ....+++..++.++.||+.||+||| +.+|+||||||+||||+.
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccccceEECC
Confidence 99999999999999999975432 1245899999999999999999999 789999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~ 298 (404)
++.+||+|||+++.....+.........||+.|||||++.+..|+.++|||||||++|||+| |..||...... ++.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~ 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 99999999999986544433334455689999999999999999999999999999999998 89999764321 111
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
. .+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 258 ~--------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 E--------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp H--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred H--------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 11111112344556778999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=419.27 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=205.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+++.+.+.||+|+||+||+|.++ ..||||+++... ....+.|.+|+.+|++++|||||++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 357788899999999999998653 248999987543 233467899999999999999999999875
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++.+|||||||++|+|.+++.... .++++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+||
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECCC
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEeec
Confidence 457899999999999999997654 46899999999999999999999 789999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc---CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|+|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... ......
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~ 250 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMV 250 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHH
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHH
Confidence 99987654443334456789999999999864 458999999999999999999999997543210 000000
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.. ....+.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.++...+
T Consensus 251 ~~-----~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 251 GR-----GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp HT-----TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred hc-----CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 00 0011111 12334456778999999999999999999999999999876554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=421.07 Aligned_cols=258 Identities=23% Similarity=0.240 Sum_probs=210.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.|++.+.||+|+||+||+| .+..+|+.||||+++.+... .+|+.+|+.++|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a---------~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEE---------EECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45778889999999999995 45567899999999765432 46999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEEecccC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKLSDFGL 230 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl~Dfg~ 230 (404)
.+|||||||+||+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||||+.+| .+||+|||+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999999998764 5899999999999999999999 89999999999999999988 699999999
Q ss_pred CCCCCCCCCC---cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQS---HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|+........ ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+ ...
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~ 271 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASE 271 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHS
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcC
Confidence 9865433211 1223467999999999999999999999999999999999999999765443221111 111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.. .....+...+..+.++|.+||+.||++|||+.|+++.|........
T Consensus 272 ~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 272 PP---------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CC---------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CC---------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 00 0112334456778899999999999999999999999988765443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=429.56 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.|++.+.||+|+||.||+| .+..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a---------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIA---------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEE---------EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 56999999999999999995 555678999999998776666778999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
.+|||||||+||+|.+++... .+++..+..++.||+.||+||| +++|+||||||+||||+.+|.+||+|||+|
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999999753 4899999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ....+
T Consensus 295 ~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i------- 359 (423)
T 4fie_A 295 AQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMI------- 359 (423)
T ss_dssp EECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-------
T ss_pred eECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHH-------
Confidence 8654322 23455789999999999999999999999999999999999999997543211 11100
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.......+ ......+.++.+||.+||+.||++|||+.|+++
T Consensus 360 ~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 360 RDNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HcCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000111 112234567889999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=425.65 Aligned_cols=280 Identities=26% Similarity=0.346 Sum_probs=224.7
Q ss_pred CHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCC-CCc
Q 046897 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYH-PNL 140 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-p~i 140 (404)
....+....++|++.+.||+|+||+||+|.+.. ..+..+++.||+|.+...... ..+.+.+|+++|.++.| |||
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~----~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEET----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcC----CCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence 344444556789999999999999999997754 233445678999999765433 34668999999999965 999
Q ss_pred ceEEEEEEeC-CeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCcee
Q 046897 141 VKLVGYCLED-DHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIY 207 (404)
Q Consensus 141 v~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H 207 (404)
|+++++|.++ +.+|||||||++|+|.++|..... ....+++..+..++.||+.||+||| +++|+|
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiH 208 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIH 208 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeec
Confidence 9999999765 568999999999999999976432 1245899999999999999999999 889999
Q ss_pred cCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCc
Q 046897 208 RDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAV 286 (404)
Q Consensus 208 ~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~ 286 (404)
|||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444334455679999999999999999999999999999999998 99999
Q ss_pred CCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 287 DKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
....... . +...+........+..++.++.+++.+||+.||++|||+.+|++.|+++.+...
T Consensus 289 ~~~~~~~--~--------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 289 PGVKIDE--E--------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp TTCCCSH--H--------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCHHH--H--------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 7643211 0 011111111223344456778999999999999999999999999999876544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=405.51 Aligned_cols=247 Identities=28% Similarity=0.365 Sum_probs=192.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||+||+ +.+..+|+.||+|++..... ...+.+.+|+++|+.++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~---------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKL---------AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEE---------EECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEE---------EEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 5799999999999999999 55566789999999976432 33457899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++.+|+||||+ +|+|.+++.... ++++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCS
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeec
Confidence 999999999999 789999998764 5999999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||...+. ......
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~---- 223 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKN---- 223 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH----
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHH----
Confidence 9998654322 2345789999999999988776 5799999999999999999999975321 111111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.+... .++...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 224 ------i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 224 ------ISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------HHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------HHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 2223345678899999999999999999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=407.32 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=195.8
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-- 149 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 149 (404)
|++.+.||+|+||+||+|+ +..++..||+|++.... ....+.+.+|+++|+.++|||||+++++|..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEE---------ECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 3667789999999999954 45578999999986542 2334668999999999999999999999875
Q ss_pred --CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEcC-CCcEE
Q 046897 150 --DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLDT-NYNAK 224 (404)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~~-~~~vk 224 (404)
+..+|||||||++|+|.+++.+.. .+++..+..++.||+.||+||| +++ |+||||||+||||+. +|.+|
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH--~~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCCCEEecccChhheeEECCCCCEE
Confidence 346899999999999999998763 6899999999999999999999 566 999999999999984 79999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...... ......
T Consensus 173 l~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~- 241 (290)
T 3fpq_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR- 241 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH-
T ss_pred EEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHH-
Confidence 9999999864321 2445789999999999865 6999999999999999999999999653221 010000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+.........+...+.++.+|+.+||+.||++|||+.++++
T Consensus 242 ---------i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 242 ---------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---------HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---------HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001111222346889999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=411.79 Aligned_cols=246 Identities=27% Similarity=0.323 Sum_probs=197.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||+||+|+. .....+++.||+|++..... .....+.+|+++|+.++|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~------~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKK------ISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEE------CSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEE------ccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 5799999999999999999764 23345688999999976432 223467889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++.+|||||||+||+|.+++.+.. .+++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999999999998764 5899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~------- 236 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMT------- 236 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-------
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHH-------
Confidence 998643322 1234578999999999999999999999999999999999999999754321 1111
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
.+..... .++...+.++.+|+.+||+.||++|||+
T Consensus 237 ---~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 237 ---MILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---HHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---HHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111111 2233455678899999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=400.96 Aligned_cols=273 Identities=24% Similarity=0.302 Sum_probs=200.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..... .......|+..+..++|||||++++++.++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~ 69 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence 35688889999999999999865 367899999975432 112234566666788999999999999876
Q ss_pred C----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCCceecCCCCCcEEEcCC
Q 046897 151 D----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA------ETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 151 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~i~H~Dlkp~NIll~~~ 220 (404)
+ .+||||||+++|+|.+++... ++++..+..++.|++.||+|||+. ..+|+||||||+||||+.+
T Consensus 70 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 70 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 4 579999999999999999764 489999999999999999999942 2389999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCC--cceeeccccccccCccccccC------CCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 221 YNAKLSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATG------HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
+.+||+|||+++........ ......+||+.|||||++.+. .|+.++|||||||++|||+||..||......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999864333221 122346799999999998654 3677999999999999999999888654322
Q ss_pred CCcchh-hhhhhhhhhccccchhhcccccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 293 GEHNLV-EWAKPYLASKRKIFRIIDNRLEGQ-----YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 293 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
...... ....+... .....+.+..+... ...+....+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 225 ~~p~~~~~~~~~~~~--~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCTTTTTSCSSCCHH--HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchhcccccchHH--HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 110000 00000000 00001111111111 2234667889999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=396.24 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=188.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|++.+.||+|+||+||+| .+..+|+.||+|++..... ...+.+.+|+++|+.++|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEE---------EETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEE---------EECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 46889999999999999995 4555789999999875443 2336689999999999999999999998764
Q ss_pred C------------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 151 D------------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 151 ~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
+ .+|+|||||++|+|.+++..... .....+..++.++.||+.||+||| +++|+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEEC
Confidence 4 37999999999999999986543 234567788999999999999999 88999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCC----------cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCC
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQS----------HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~ 288 (404)
.++.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999999999999865433211 11234579999999999999999999999999999999996 6643
Q ss_pred CCCCCCcchhhhhhhhhhhccccchhhcccccCCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYT---LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. +... .+..+. ...++ ......+.+|+.+||+.||++|||+.++++
T Consensus 230 ~~-----~~~~----------~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 230 QM-----ERVR----------TLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-----HHHH----------HHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-----HHHH----------HHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 0000 000111 11222 223345678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=398.65 Aligned_cols=269 Identities=22% Similarity=0.284 Sum_probs=201.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++++.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+++|+.++|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a---------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSA---------RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEE---------EECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 467999999999999999994 5556789999999975432 33456889999999999999999999976
Q ss_pred e------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 E------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
. .+.+|||||||+ |+|.+++... .++++..+..++.||+.||.||| +++|+||||||+|||++.+|.
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCC
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCC
Confidence 4 357899999995 6899999764 46999999999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCC--CCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 223 AKLSDFGLAKDGPTGD--QSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
+||+|||+++...... ........+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+.......+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~ 276 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 276 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999998653322 12234457899999999998765 56999999999999999999999997643221111110
Q ss_pred hhhhhhh-h------ccccchhhcccc-cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 300 WAKPYLA-S------KRKIFRIIDNRL-EGQYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 300 ~~~~~~~-~------~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....... . .......+.... ....+ ...+.++.+||.+||+.||++|||+.|+|+.
T Consensus 277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0 000000000000 00000 1224567899999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=387.25 Aligned_cols=204 Identities=27% Similarity=0.353 Sum_probs=172.4
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
...++|++.+.||+|+||+||+|+.+ .+..+++.||+|.+.... ...++.+|+++|+.+ +||||++++++|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 45678999999999999999997643 233467899999987653 346688999999988 699999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcEEEe
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLS 226 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~vkl~ 226 (404)
.+++++|+||||+++|+|.+++. .+++..+..++.||+.||+||| +++|+||||||+|||++.+ +.+||+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred EECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999999999983 3789999999999999999999 8999999999999999877 899999
Q ss_pred cccCCCCCCCCCC--------------------------CcceeeccccccccCccccccC-CCCcccchhhhhHHHHHH
Q 046897 227 DFGLAKDGPTGDQ--------------------------SHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEM 279 (404)
Q Consensus 227 Dfg~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~el 279 (404)
|||+|+....... .......+||+.|+|||++.+. .|+.++||||+||++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999975432211 0112345799999999998765 589999999999999999
Q ss_pred HhCCCCcCCC
Q 046897 280 LSGRRAVDKN 289 (404)
Q Consensus 280 l~g~~p~~~~ 289 (404)
++|+.||...
T Consensus 241 l~G~~Pf~~~ 250 (361)
T 4f9c_A 241 LSGRYPFYKA 250 (361)
T ss_dssp HHTCSSSSCC
T ss_pred HHCCCCCCCC
Confidence 9999999643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=378.32 Aligned_cols=283 Identities=40% Similarity=0.679 Sum_probs=240.1
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
+....++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3445689999999999999999997532 477899999887766666789999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+...+..++||||+++++|.+++.........+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCEEEC
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999765544456899999999999999999999 7899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++................||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|.....
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~- 260 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH- 260 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-
Confidence 9999986543333333344568999999999988899999999999999999999999998776666656555544322
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
....+..++++.+...........+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 23345556666666677888999999999999999999999999999999988654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=409.58 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=209.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||+|+||.||+ |.+..+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~---------~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEE---------EEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred cccEEEEEEeeccCeEEEE---------EEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 5799999999999999999 4555688999999998776666677899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC--CcEEEeccc
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN--YNAKLSDFG 229 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~--~~vkl~Dfg 229 (404)
.+|||||||+||+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeecc
Confidence 9999999999999999986543 36899999999999999999999 8999999999999999854 899999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+++...... .....+||+.|||||++.+..|+.++|||||||++|||++|..||........ ..
T Consensus 303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~------- 366 (573)
T 3uto_A 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LR------- 366 (573)
T ss_dssp SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HH-------
T ss_pred ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HH-------
Confidence 998764432 34557899999999999999999999999999999999999999976432110 00
Q ss_pred ccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 310 KIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.... +........+.++.+||.+||+.||++|||+.|+++
T Consensus 367 ---~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 367 ---NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ---HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 111111223556789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=404.98 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHH---HHHHHHHhcCCCCCcceEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEW---LAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~hp~iv~~~~ 145 (404)
++|++.++||+|+||+||+ |.+..+|+.||+|++.+... .....+ ..++.+++.++|||||++++
T Consensus 189 ddf~i~k~LG~G~fG~V~l---------a~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp GGEEEEEEEEECSSEEEEE---------EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HHeEEEEEEecccCeEEEE---------EEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 5799999999999999999 45566899999999965321 111223 34467778889999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
+|.+++.+||||||++||+|.++|.+.+ .+++..+..++.||+.||.||| +++|+||||||+||||+.+|.+||
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEe
Confidence 9999999999999999999999998764 5899999999999999999999 899999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
+|||+|+...... ....+||+.|||||++. +..|+.++|||||||++|||++|.+||..........+ ..
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~-- 404 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DR-- 404 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HH--
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HH--
Confidence 9999998654322 34468999999999996 46799999999999999999999999975433211111 11
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.+.... ..++...+.++.+||.+||+.||.+|++ +.||++
T Consensus 405 --------~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 405 --------MTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------HHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------hhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111 1233345567889999999999999998 577665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=367.36 Aligned_cols=289 Identities=42% Similarity=0.729 Sum_probs=238.9
Q ss_pred CCCCCccCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhc
Q 046897 56 SPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQ 134 (404)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~ 134 (404)
......++..++....++|.+.+.||+|+||.||+|.. .++..||+|++...... ....+.+|+.+++.
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~ 83 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL----------ADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC----------SSSCCEEEEECCC-----CCCHHHHHHHGGGT
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEe----------cCCCEEEEEEeccccCchHHHHHHHHHHHHHh
Confidence 34556788999999999999999999999999999642 24778999998765322 22468899999999
Q ss_pred CCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC---CceecCCC
Q 046897 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET---KVIYRDFK 211 (404)
Q Consensus 135 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~---~i~H~Dlk 211 (404)
++||||+++++++......++||||+.+++|.+++........++++..++.++.|++.||.||| +. +|+|||||
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlk 161 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--DHCDPKIIHRDVK 161 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--HSSSSCEECCCCS
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCc
Confidence 99999999999999999999999999999999999887665567999999999999999999999 67 99999999
Q ss_pred CCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCC-
Q 046897 212 TSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR- 290 (404)
Q Consensus 212 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~- 290 (404)
|+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred hhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence 9999999999999999999986543322 23344569999999999988889999999999999999999999996321
Q ss_pred -CCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 291 -PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 291 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
.........|..... ....+..+.+..+...........+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 241 ANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 122233334433322 2344556666667777888899999999999999999999999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=373.88 Aligned_cols=274 Identities=24% Similarity=0.363 Sum_probs=219.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+.... .....++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 467899999999999999998764211 11234577899999976532 2345789999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.++.+|+||||+++|+|.+++...... ...+++..++.++.||+.||.||| +.+|+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhEE
Confidence 999999999999999999999875421 235889999999999999999999 889999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986544333223334567889999999999999999999999999999999 999997543211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
.. ..+........+..++..+.+++.+||+.||++||++.++++.|+.+......
T Consensus 314 -~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 -LF--------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp -HH--------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -HH--------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 00 11111111233344566789999999999999999999999999998865443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=355.70 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=208.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++........+.+.+|+.+++.++||||+++++++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEE---------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEE---------EECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 468999999999999999994 45557899999999776666667889999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999764 4899999999999999999999 78999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~---- 230 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIAT---- 230 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH----
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh----
Confidence 876543322 2344679999999999999999999999999999999999999997543210 0000000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........+...+..+.+++.+||+.||++|||+.++++
T Consensus 231 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 231 -----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000111222334567889999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=357.72 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=215.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|. +..++..||+|.+........+.+.+|+++++.++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~---------~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVT---------HRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEE---------ETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEE---------ECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3578899999999999999954 4456889999998776666667899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred CeeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999999998754 46899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCc------------ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh
Q 046897 231 AKDGPTGDQSH------------VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 231 a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~ 298 (404)
+.......... ......||+.|+|||++.+..++.++||||||+++|||++|..||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh
Confidence 98643322111 111457999999999999999999999999999999999999998754332211111
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
. .....+. ..+...+..+.+++.+||+.||++|||+.++++.|++++....
T Consensus 235 ~-----------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 235 N-----------VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp C-----------HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred h-----------hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 0011111 1122334567899999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=360.26 Aligned_cols=274 Identities=25% Similarity=0.293 Sum_probs=209.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.+. +..||+|++.... ........|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 468999999999999999997542 5789999987543 2234456789999999999999999999875
Q ss_pred C----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC----------CceecCCCCCcEE
Q 046897 151 D----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET----------KVIYRDFKTSNIL 216 (404)
Q Consensus 151 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----------~i~H~Dlkp~NIl 216 (404)
. .+++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEE
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEE
Confidence 4 469999999999999999764 4899999999999999999999 77 9999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCC
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~ 291 (404)
++.++.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999999999976544333223334679999999999876 3456789999999999999999999986544
Q ss_pred CCCcchhhhhhhhhhhccccchhhcccccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 292 SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQ-----YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
............................... ........+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 3222221110000000000000111111111 12245567999999999999999999999999999987643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=359.09 Aligned_cols=267 Identities=25% Similarity=0.414 Sum_probs=212.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+.. ....+..||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRV------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECC------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEec------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4678999999999999999987642 22345679999997653 2334678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999999999997543 36899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------------- 262 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------------- 262 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------------
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------------
Confidence 99865433221 12223456788999999998899999999999999999999 999996543210
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
+...+........+...+..+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 263 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 263 ---VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ---HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 0011111111223334566788999999999999999999999999999876544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=346.22 Aligned_cols=286 Identities=38% Similarity=0.636 Sum_probs=229.9
Q ss_pred CCCccCHHHHHHHhcCCCCC------CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC----cccHHHHHH
Q 046897 58 NLKSFSFSDLKTATRNFRPD------SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG----FQGHKEWLA 127 (404)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~ 127 (404)
....|++.++...+++|... +.||+|+||.||+|.. ++..||+|++.... ....+.+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~ 79 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQ 79 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHH
Confidence 45678999999999888776 8999999999999753 36789999986532 223467889
Q ss_pred HHHHHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCcee
Q 046897 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIY 207 (404)
Q Consensus 128 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H 207 (404)
|+.+++.++||||+++++++...+..++||||+++++|.+++..... ..++++..++.++.|++.||.||| +.+|+|
T Consensus 80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H 156 (307)
T 2nru_A 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH--ENHHIH 156 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh--cCCeec
Confidence 99999999999999999999999999999999999999999975322 246899999999999999999999 889999
Q ss_pred cCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 208 RDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 208 ~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
|||||+||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986544333323344679999999998864 58899999999999999999999998
Q ss_pred CCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 288 KNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
....... ...+..........+...++..+ ..........+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 236 EHREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cCcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 6544322 11222222222233334444433 34567778899999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=365.37 Aligned_cols=280 Identities=26% Similarity=0.344 Sum_probs=222.2
Q ss_pred cCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCC
Q 046897 62 FSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPN 139 (404)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~ 139 (404)
+.........++|++.+.||+|+||.||+|.+.. ..+..+++.||+|++..... ...+.+.+|++++..+ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecc----ccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 3445555567899999999999999999987643 23556788999999976533 2335689999999999 7999
Q ss_pred cceEEEEEEeCCe-eEEEEeccCCCChHHHHhhcCCC-------------------------------------------
Q 046897 140 LVKLVGYCLEDDH-RLLVYEFMPRGSLENHLFRRGSY------------------------------------------- 175 (404)
Q Consensus 140 iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------- 175 (404)
|+++++++.+.+. .++||||+++|+|.+++......
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999987654 89999999999999999865421
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCC
Q 046897 176 -------------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236 (404)
Q Consensus 176 -------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~ 236 (404)
...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 122889999999999999999999 78999999999999999999999999999986544
Q ss_pred CCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
...........||+.|+|||++.+..++.++|||||||++|||++ |..||........ . ...+
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~--------------~~~~ 309 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F--------------CRRL 309 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H--------------HHHH
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--H--------------HHHH
Confidence 433333445678999999999999999999999999999999998 9999976432210 0 0111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 111111223334567889999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=353.91 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=203.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..+|++.+.||+|+||.||+|.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 56799999999999999999754 367899999876543 22356889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEcCCCcEEEe
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
.....++||||+++++|.+++..... ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 99999999999999999999976431 124899999999999999999999 778 9999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~----- 248 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VV----- 248 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HH-----
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-----
Confidence 999997543221 12334679999999999999999999999999999999999999997543210 00
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
..+.........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 249 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 249 -----AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -----HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -----HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0011111112333345567889999999999999999999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=366.68 Aligned_cols=271 Identities=25% Similarity=0.344 Sum_probs=213.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+.. ..+..++..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSG----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEcc----CCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4678999999999999999987643 2244568899999986542 2334568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---cE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGS---YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY---NA 223 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~---~v 223 (404)
....++||||+++|+|.+++..... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999987542 2235899999999999999999999 88999999999999999555 59
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~-- 295 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EV-- 295 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HH--
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HH--
Confidence 9999999974322222222334568999999999999999999999999999999998 99999754321 00
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
...+........+...+..+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 296 ---------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 296 ---------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ---------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 01111111112233445678899999999999999999999999999876544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.37 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=206.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..+|..||+|++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 468999999999999999995 455578999999986542 233466889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..|+||||+++++|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeec
Confidence 9999999999999999999997764 5899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCC-cccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLT-AKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...... ....
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~----- 224 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRE----- 224 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-----
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHH-----
Confidence 9997654332 23456799999999999887775 7999999999999999999999764311 1111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..... ..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 225 -----~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 225 -----RVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----HHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----HHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111 2222345678899999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=362.30 Aligned_cols=279 Identities=25% Similarity=0.357 Sum_probs=222.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+|...... ......+..||+|++..... ...+.+.+|+++++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 468999999999999999998764311 11234567899999976532 2336688999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.++..++||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+||||||+|||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL 223 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcceEE
Confidence 999999999999999999999875421 235899999999999999999999 789999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987654433333444567889999999999999999999999999999999 99999754311
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCccc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNIRC 370 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~~ 370 (404)
. +...+........+...+..+.+++.+||+.||++|||+.+|++.|+++...........
T Consensus 301 ---~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 301 ---E-----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp ---H-----------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred ---H-----------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 1 111111111122233445678899999999999999999999999999998777666543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=354.48 Aligned_cols=279 Identities=25% Similarity=0.370 Sum_probs=214.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|++. ..+..++..||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEC-----TTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEe-----cccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999999999998653 235567899999999877666667889999999999999999999998653
Q ss_pred --CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 151 --DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
...++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 56899999999999999998754 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh---
Q 046897 229 GLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY--- 304 (404)
Q Consensus 229 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~--- 304 (404)
|++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~ 234 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQG 234 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCT
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCcccc
Confidence 999865433221 1223345778899999999999999999999999999999999988642110 00000000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
......+...+........+...+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00000011111122222334455678899999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=352.82 Aligned_cols=268 Identities=28% Similarity=0.391 Sum_probs=216.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.... .....++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFH----LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEET----GGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEec----cCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 5689999999999999999987643 2234457899999997643 2334678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecC
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSY--------------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRD 209 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~D 209 (404)
++..++||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCcccc
Confidence 99999999999999999999875431 134889999999999999999999 78999999
Q ss_pred CCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCC
Q 046897 210 FKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDK 288 (404)
Q Consensus 210 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~ 288 (404)
|||+|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986544333222334567889999999988889999999999999999999 9999975
Q ss_pred CCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
...... ...+........+...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus 256 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 256 IPPERL-----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCGGGH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH-----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 432110 01111111122333445678899999999999999999999999998865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=358.80 Aligned_cols=255 Identities=25% Similarity=0.304 Sum_probs=202.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEE---------ECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4689999999999999999954 4457889999998654322 23567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..|+||||+++++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEee
Confidence 99999999999999999988654 35899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++................||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-------- 221 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-------- 221 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH--------
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH--------
Confidence 9976533332223345679999999999987665 7789999999999999999999976443211 00110
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
................+.+++.+||+.||++|||+.++++.
T Consensus 222 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 222 ------KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------hcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001001112234567899999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.54 Aligned_cols=272 Identities=26% Similarity=0.372 Sum_probs=220.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+.. ..+..++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEee----ccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 4679999999999999999987533 23456788999999976543 3346788999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY--------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
.++..++||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+||||||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~N 175 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARN 175 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccce
Confidence 999999999999999999999875421 125899999999999999999999 7899999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSG 293 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~ 293 (404)
|+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999987655443333344567889999999988899999999999999999999 999997543211
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
. ....+........+...+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 256 ~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 K----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp H----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred H----------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 0 001111111112223345678899999999999999999999999999887654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=353.71 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=205.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||+||++ .+..+++.||+|++.... ......+.+|+.+|+.++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 357899999999999999995 445578999999986531 23446688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
...+..|+||||+++|+|..++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+|
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEee
Confidence 99999999999999999999998753 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 149 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~----- 215 (337)
T 1o6l_A 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFE----- 215 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-----
T ss_pred ccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHH-----
Confidence 99998532221 1234568999999999999999999999999999999999999999753211 1111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
.+..... .++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 216 -----~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 216 -----LILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----HHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111111 22333456788999999999999999 88888764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.81 Aligned_cols=267 Identities=25% Similarity=0.448 Sum_probs=204.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|.+.+.||+|+||.||+|++.. ...++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 4689999999999999999975431 12457789999997653 2334678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....++||||+++++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 999999999999999999997653 46899999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~-------- 258 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------D-------- 258 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------H--------
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------H--------
Confidence 998654322111 1122345778999999998999999999999999999998 99999654311 0
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
+...+........+...+..+.+++.+||+.||++||++.+|++.|+++......
T Consensus 259 ---~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 259 ---VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp ---HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred ---HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 0111111111222334556788999999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=365.87 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=209.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ...+.+.+|+++|+.++||||+++++++..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLR---------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEe---------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 467888999999999999996543 3678999999875432 223457899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence 999999999999999999998653 35899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--------------- 323 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--------------- 323 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---------------
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------------
Confidence 9986433211111112335778999999988899999999999999999998 999997543210
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
+...+........+..++..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 324 --~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 324 --TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 001111111112333345678899999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=357.44 Aligned_cols=275 Identities=26% Similarity=0.400 Sum_probs=215.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
..++|.+.+.||+|+||.||+|.+.. .....++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYG----ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEES----CSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeec----cccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35789999999999999999987632 2344567899999997542 23346789999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSY-------------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYR 208 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~ 208 (404)
...+..++||||+++|+|.+++...... ...+++..++.++.||+.||.||| +.+|+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcccC
Confidence 9999999999999999999999865421 124789999999999999999999 8899999
Q ss_pred CCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcC
Q 046897 209 DFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVD 287 (404)
Q Consensus 209 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~ 287 (404)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986544333323344567889999999988899999999999999999998 999997
Q ss_pred CCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 288 KNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
....... +...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 277 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 277 GIPVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp TCCCSHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred cCCcHHH----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 6432210 01111111122233344567889999999999999999999999999987665543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=356.60 Aligned_cols=273 Identities=26% Similarity=0.361 Sum_probs=214.9
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
...++|++.+.||+|+||.||+|.... .....++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPG----LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEET----SSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecC----cCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345789999999999999999987643 11224568899999976532 2346688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCcee
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSY--------------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIY 207 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H 207 (404)
..++..++||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeec
Confidence 9999999999999999999999874321 146899999999999999999999 889999
Q ss_pred cCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCc
Q 046897 208 RDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAV 286 (404)
Q Consensus 208 ~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~ 286 (404)
|||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999975433222222334568899999999988899999999999999999999 99999
Q ss_pred CCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 287 DKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
...... .... .+.+.. ....+...+..+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 278 ~~~~~~------~~~~----------~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHE------EVIY----------YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHH------HHHH----------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChH------HHHH----------HHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 753311 0000 111111 112233445678899999999999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=346.40 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=208.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||++ .+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLA---------EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEE---------EETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEE---------EECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 468999999999999999995 4455788999999865432 2235688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..++..|+||||+++++|.+++.... ++++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998763 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~- 226 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQ- 226 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHS-
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhh-
Confidence 999986543221 1233457999999999999999999999999999999999999999754321 00000000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhHhccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-MMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~~ 364 (404)
.... ..........+..+.+++.+||+.||.+|| ++.++++.|+.+.....
T Consensus 227 -~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 227 -DSVP-----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp -SCCC-----CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred -ccCC-----CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 0000 000112223456788999999999999998 89999999998765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=353.09 Aligned_cols=265 Identities=24% Similarity=0.390 Sum_probs=206.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+... .......|++|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35789999999999999999765421 11223457888886432 2445678999999999999999999999987
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+. .++++||+.+|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEccCc
Confidence 54 788999999999999998754 46899999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------------- 227 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------- 227 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------------
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------------
Confidence 9986544333333334567889999999999999999999999999999999 999997643211
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
+...+........+......+.+++.+||+.||++||++.++++.|+.+....
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 228 --ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred --HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 11112112222233345567889999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=354.57 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=204.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
.++|++.+.||+|+||.||++ .+..+|..||+|++...... ..+.+.+|+.+|+.++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~---------~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEE---------EECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 467999999999999999995 45557899999999765332 346789999999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--- 221 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--- 221 (404)
+++.+....|+||||+++|+|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCc
Confidence 9999999999999999999999999764 35899999999999999999999 88999999999999998877
Q ss_pred -cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 -NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~ 226 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET 226 (361)
T ss_dssp CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH
T ss_pred cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HH
Confidence 79999999998654432 234467999999999999889999999999999999999999999754321 00
Q ss_pred hhhhhhhccccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. .+..... .++ ...+..+.++|.+||..||++|||+.++++
T Consensus 227 ~~----------~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 LA----------NITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HH----------HHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----------HHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 1111100 111 123456889999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=348.29 Aligned_cols=268 Identities=19% Similarity=0.178 Sum_probs=212.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..+++.||+|++..... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGK---------NLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEE---------ETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEE---------ECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4689999999999999999954 445789999999876532 34578999999999 89999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc-----EE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-----AK 224 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~-----vk 224 (404)
+...++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +|
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceEE
Confidence 99999999999 999999998653 46899999999999999999999 789999999999999998887 99
Q ss_pred EecccCCCCCCCCCCCc-----ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 225 LSDFGLAKDGPTGDQSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
|+|||++.......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 99999998643332211 1235679999999999999999999999999999999999999998754332211111
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
.... .... .... ......+ .+.+++.+||+.||.+||++.+|++.|+++.......
T Consensus 231 ~i~~---~~~~---~~~~----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 231 KIGD---TKRA---TPIE----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHHH---HHHH---SCHH----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHh---hhcc---CCHH----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1100 0000 0000 0001123 7889999999999999999999999999987755443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=342.36 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=210.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEec----------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 467889999999999999997643 35679999997654 3456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred CceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEeccccc
Confidence 99999999999999999997644 45899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+....... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~------- 218 (269)
T 4hcu_A 153 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVE------- 218 (269)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-------
T ss_pred cccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHH-------
Confidence 97543221 111223456788999999998899999999999999999999 99999754321 0000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+. .......+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 219 ---~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 219 ---DIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---HHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHh-cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 000 1111122223356788999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=349.93 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=206.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||++ .+..++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEE---------EECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 468999999999999999995 455578999999987653 3345688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC--CCcEEEecc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT--NYNAKLSDF 228 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~--~~~vkl~Df 228 (404)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 99999999999999999997543 36899999999999999999999 889999999999999987 789999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~------ 213 (321)
T 1tki_A 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIE------ 213 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH------
T ss_pred CCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHH------
Confidence 9998754432 344567999999999998888999999999999999999999999754321 1111
Q ss_pred cccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..... .++ ...+..+.+++.+||..||++|||+.++++.
T Consensus 214 ----~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 214 ----NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHcCCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 111 1234578899999999999999999999984
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=349.96 Aligned_cols=265 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+... .......|++|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 46799999999999999999765421 1112345688877543 33455778999999999999999999999987
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+. .+++++|+.+++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence 64 788999999999999998754 46899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------------- 227 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------- 227 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------------
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------------
Confidence 9987544333333334567889999999999999999999999999999999 999997643221
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
+...+........+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 228 --ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11111111222233345567889999999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=356.52 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=200.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
.++|++.+.||+|+||.||+|+ +..++..||+|++.... ....+.+.+|..+|..+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLAR---------VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEE---------EcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 4689999999999999999954 44578899999987542 23345678899999988 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+.+.+|+||||+++|+|..++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEEc
Confidence 999999999999999999999998763 5899999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ..
T Consensus 167 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~------ 232 (353)
T 3txo_A 167 DFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DL------ 232 (353)
T ss_dssp CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH------
T ss_pred cccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HH------
Confidence 999998533221 2344568999999999999889999999999999999999999999754321 11
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM------AEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~ 354 (404)
...+..... .++......+.+++.+||+.||++||++ .++++
T Consensus 233 ----~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 233 ----FEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----HHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111111111 2233345678899999999999999998 66665
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=340.01 Aligned_cols=254 Identities=28% Similarity=0.519 Sum_probs=204.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-------HHHHHHHHHHhcCCCCCcceE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-------KEWLAEVNYLGQLYHPNLVKL 143 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~hp~iv~~ 143 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++........ +.+.+|+.+++.++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGR---------LVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEE---------ETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEE---------EcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 3678899999999999999954 444688999999865433221 568899999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEcCCC
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLDTNY 221 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~~~~ 221 (404)
++++.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCC
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccC
Confidence 99986554 79999999999999887654 46899999999999999999999 778 99999999999998877
Q ss_pred c-----EEEecccCCCCCCCCCCCcceeeccccccccCcccc--ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 222 N-----AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL--ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 222 ~-----vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~ 294 (404)
. +||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||........
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 6 99999999975332 23446799999999998 345678899999999999999999999975433211
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
... ..+.........+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 237 ----~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 ----KFI----------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----HHH----------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----HHH----------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000 011111222233344566789999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=350.17 Aligned_cols=280 Identities=26% Similarity=0.336 Sum_probs=220.8
Q ss_pred CHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCc
Q 046897 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNL 140 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~i 140 (404)
.........++|++.+.||+|+||.||+|.+.. ..+..++..||+|++..... ...+.+.+|+.++..+ +||||
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEec----CCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 344444556889999999999999999986543 22445788999999976533 2335688999999999 79999
Q ss_pred ceEEEEEEeCC-eeEEEEeccCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCcee
Q 046897 141 VKLVGYCLEDD-HRLLVYEFMPRGSLENHLFRRGSY------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIY 207 (404)
Q Consensus 141 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H 207 (404)
+++++++...+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+|+|
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H 171 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIH 171 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCccc
Confidence 99999988755 589999999999999999875431 123889999999999999999999 789999
Q ss_pred cCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCc
Q 046897 208 RDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAV 286 (404)
Q Consensus 208 ~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~ 286 (404)
|||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987544333333344568899999999999999999999999999999998 99999
Q ss_pred CCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 287 DKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
....... ... ..+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 252 ~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 252 PGVKIDE--EFC--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TTCCCSH--HHH--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccchhH--HHH--------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 7543211 000 0000011112222345678899999999999999999999999999886543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=341.46 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=199.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+.. ....+..|++|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hHHeEEEeEeeecCCeeEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 4679999999999999999987532 223467899999876432 33456889999999999999999999984
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECccc
Confidence 567899999999999999998654 35899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||....... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~--------- 228 (281)
T 1mp8_A 162 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG--------- 228 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---------
T ss_pred cccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH---------
Confidence 9986543221 12233457789999999988899999999999999999996 999997543211 110
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+.. ......+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 229 ----~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 229 ----RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111 011123334556788999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=339.81 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=209.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+++.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 467999999999999999997543 35679999997654 3446789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred CceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCcc
Confidence 99999999999999999998753 35899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~------- 216 (268)
T 3sxs_A 151 TRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVL------- 216 (268)
T ss_dssp EEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH-------
T ss_pred ceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHH-------
Confidence 986543321 11223456778999999988899999999999999999999 999997543210 000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+.. ......+...+..+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus 217 ---~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 217 ---KVSQ-GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---HHHT-TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---HHHc-CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0000 001111222345788999999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=349.68 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=197.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|++.+.||+|+||.||+|.+... ......||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 356899999999999999999765321 1122479999987652 33456789999999999999999999999
Q ss_pred EeCCee------EEEEeccCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 148 LEDDHR------LLVYEFMPRGSLENHLFRRG--SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 148 ~~~~~~------~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
...... ++||||+.+++|.+++.... .....+++..++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECT
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEEcC
Confidence 877655 99999999999999997543 12235899999999999999999999 789999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~ 298 (404)
++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ .
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~ 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---Y 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---H
Confidence 99999999999986544433333334567889999999999999999999999999999999 9999976432110 0
Q ss_pred hhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
. .+.. ......+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 250 ~-------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 N-------------YLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp H-------------HHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H-------------HHhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 0000 1111223344567889999999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=346.98 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=204.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||++ .+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 357899999999999999995 445578999999987542 23346678899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+....|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+|
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEee
Confidence 99999999999999999999998753 5899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 150 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~------- 211 (318)
T 1fot_A 150 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KT------- 211 (318)
T ss_dssp CSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HH-------
T ss_pred cCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HH-------
Confidence 999986432 123467999999999999999999999999999999999999999753211 11
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
...++.... .++...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 212 ---~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 212 ---YEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111111111 22333456788999999999999999 78888753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=341.63 Aligned_cols=269 Identities=17% Similarity=0.163 Sum_probs=214.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ..+.+.+|+.+++.+ +|+|++++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEE---------ETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEE---------ECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 5689999999999999999954 44578899999986543 234578899999999 79999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc-----EE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-----AK 224 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~-----vk 224 (404)
+...++||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++. +|
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence 99999999999 999999998754 35899999999999999999999 899999999999999987776 99
Q ss_pred EecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 225 LSDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
|+|||++......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 9999999865433221 12344679999999999999899999999999999999999999998754332221111
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
....... ...........+..+.+++.+||+.||++||++.+|++.|+++.......
T Consensus 232 ~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 232 RIGEKKQ----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHH----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhhcc----------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 1100000 00000111123467889999999999999999999999999998765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=352.59 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=204.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCCcceEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-----FQGHKEWLAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~ 145 (404)
.++|++.+.||+|+||.||+| .+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 457999999999999999995 445578999999986421 124567899999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc---
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN--- 222 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~--- 222 (404)
++.+++..|+||||+++++|.+++.........+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCCc
Confidence 999999999999999999999888765433346899999999999999999999 889999999999999987655
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 172 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~ 242 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFE 242 (351)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHH
T ss_pred EEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHH
Confidence 9999999998654322 123446799999999999988999999999999999999999999975311 0000
Q ss_pred hhhhhccccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..... ... ...+..+.+++.+||+.||++|||+.++++
T Consensus 243 ----------~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 243 ----------GIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ----------HHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----------HHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111000 011 123457889999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=342.75 Aligned_cols=271 Identities=23% Similarity=0.278 Sum_probs=212.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGR---------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEE---------ECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 4679999999999999999954 444688999999875432 334677899999999999999999999987
Q ss_pred CC--eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE----cCCCcE
Q 046897 150 DD--HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNA 223 (404)
Q Consensus 150 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll----~~~~~v 223 (404)
.. ..++||||+++++|.+++..... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCceE
Confidence 65 77999999999999999986532 134899999999999999999999 8899999999999999 788889
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccc--------cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA--------TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
||+|||++....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.........
T Consensus 156 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 999999998654432 223457999999999885 578899999999999999999999999754332211
Q ss_pred chhhhhhhhhhhc--cc---cchhh--------cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 046897 296 NLVEWAKPYLASK--RK---IFRII--------DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358 (404)
Q Consensus 296 ~~~~~~~~~~~~~--~~---~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 358 (404)
. .......... .. +.... .......+.......+.+++.+||+.||++|||+.|+++....
T Consensus 233 ~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 233 K--EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp H--HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred H--HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 1 1111111100 00 00000 0011224567788899999999999999999999999998874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=343.96 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=211.0
Q ss_pred ccCHHHHHHHhcC----------CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHH
Q 046897 61 SFSFSDLKTATRN----------FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVN 130 (404)
Q Consensus 61 ~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~ 130 (404)
.+++.++..+.+. |...+.||+|+||.||+|. +..+|+.||+|++........+.+.+|+.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~---------~~~~g~~vavK~~~~~~~~~~~~~~~E~~ 94 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR---------EKHSGRQVAVKMMDLRKQQRRELLFNEVV 94 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEETTTCCSHHHHHHHHH
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEE---------ECCCCcEEEEEEEeccchhHHHHHHHHHH
Confidence 3556666655543 6667799999999999954 44468899999998776666778999999
Q ss_pred HHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCC
Q 046897 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDF 210 (404)
Q Consensus 131 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dl 210 (404)
+++.++||||+++++++...+..++||||+++++|.+++... .+++..++.++.|++.||.||| +.+|+||||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dl 167 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLH--AQGVIHRDI 167 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCC
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCC
Confidence 999999999999999999999999999999999999998643 5899999999999999999999 789999999
Q ss_pred CCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 211 KTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 211 kp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876543221 2344679999999999998899999999999999999999999997543
Q ss_pred CCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 291 PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.. ....... ....+.. ......+..+.+++.+||+.||++|||+.++++.
T Consensus 246 ~~------~~~~~~~-------~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 PV------QAMKRLR-------DSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH------HHHHHHH-------HSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH------HHHHHHh-------cCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21 1110000 0000001 1112234568899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=343.98 Aligned_cols=270 Identities=25% Similarity=0.391 Sum_probs=203.8
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|.+.+.||+|+||.||+|.+. .+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLK------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEE------CTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEe------ccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4578999999999999999998653 2334577899999876532 2335688999999999999999999999
Q ss_pred EeCC-----eeEEEEeccCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 148 LEDD-----HRLLVYEFMPRGSLENHLFRRG--SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 148 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
.... ..++||||+++++|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCC
Confidence 8765 3599999999999999986432 22356899999999999999999999 8899999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~ 299 (404)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH
Confidence 9999999999986544332223334567889999999999899999999999999999999 888987543211 000
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.+.. ......+...+..+.+++.+||..||.+|||+.++++.|+++....+
T Consensus 261 -------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 -------------YLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -------------HHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -------------HHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0000 11112233345678899999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=354.98 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=200.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
.++|++.++||+|+||+||+|+ +..+++.||+|++..... ...+.+..|..+|..+ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~---------~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVR---------LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 4579999999999999999954 445788999999976422 2234578899999877 89999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+++.+|+||||+++|+|..++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEEe
Confidence 999999999999999999999998763 5899999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc--hhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN--LVEWAKPY 304 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~--~~~~~~~~ 304 (404)
|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... ......
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-- 271 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-- 271 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--
Confidence 999998532222 23445789999999999999999999999999999999999999997543221110 011110
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
..+..... .++...+..+.+||.+||+.||++||++
T Consensus 272 -------~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 272 -------QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------HHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 01111111 2333445678899999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=348.61 Aligned_cols=275 Identities=24% Similarity=0.360 Sum_probs=215.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+.... .....++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 468999999999999999998764311 11234678899999976532 3346688999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
.++..++||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+||||||+|||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccceEE
Confidence 999999999999999999999865421 134889999999999999999999 889999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 99999999999999986544332222334567889999999988889999999999999999999 99999753211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
... ..+........+...+..+.+++.+||+.||.+|||+.++++.|+++.......
T Consensus 267 ---~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 267 ---ELF-----------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp ---HHH-----------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ---HHH-----------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 110 001111111223344567889999999999999999999999999998765543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=358.93 Aligned_cols=254 Identities=24% Similarity=0.277 Sum_probs=205.3
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
...++|++.+.||+|+||.||++ .+..+|..+|+|++...... ..+.+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~---------~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 78 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEE---------EETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEE---------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence 34578999999999999999994 55567899999998765432 33568899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc---CCCcE
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD---TNYNA 223 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~---~~~~v 223 (404)
+.+++..|+||||+.+|+|.+.+.... .+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+
T Consensus 79 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 79 ISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EECSSEEEEEECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEECCEEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcE
Confidence 999999999999999999999998763 5899999999999999999999 88999999999999998 56889
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||+|||++....... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||...... ....
T Consensus 153 kL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~- 223 (444)
T 3soa_A 153 KLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQ- 223 (444)
T ss_dssp EECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH-
T ss_pred EEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHH-
Confidence 999999998654322 1234467999999999999889999999999999999999999999653311 1111
Q ss_pred hhhhccccchhhcccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 304 YLASKRKIFRIIDNRL--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+..... ........+..+.+++.+||+.||++|||+.++++.
T Consensus 224 ---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 224 ---------QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---------HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111 011112335678899999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=354.42 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=203.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||++ .+..++..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIV---------QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 57999999999999999995 445578899999986532 233467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+.+..|+||||+.+|+|..++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEecc
Confidence 999999999999999999999765 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc---CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..............
T Consensus 160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----- 231 (384)
T 4fr4_A 160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----- 231 (384)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-----
T ss_pred ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-----
Confidence 9998654322 2345689999999999863 4689999999999999999999999975433221111110
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-MAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~ 354 (404)
+... ...++...+..+.+++.+||+.||.+||+ +.++++
T Consensus 232 --------~~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 --------FETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------Hhhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0000 11233344567889999999999999998 666654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=350.95 Aligned_cols=248 Identities=26% Similarity=0.317 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 367999999999999999995 445578899999986432 12235788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
......++||||+ +|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEECC
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEEE
Confidence 9999999999999 789999887763 5899999999999999999999 78999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+
T Consensus 152 FG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------- 220 (336)
T 3h4j_B 152 FGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------- 220 (336)
T ss_dssp SSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------
T ss_pred eccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------
Confidence 99998654332 2344679999999999988776 68999999999999999999999764332211110
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 221 --------~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 --------NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --------CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --------HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 012223345678899999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=344.79 Aligned_cols=276 Identities=26% Similarity=0.374 Sum_probs=212.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+. ..+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEC-----TTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEc-----cccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 356888999999999999998653 2355678999999987543 2344678999999999999999999999987
Q ss_pred C--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 150 D--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 150 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
. ...++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEEECc
Confidence 6 66899999999999999996654 35899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh--
Q 046897 228 FGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY-- 304 (404)
Q Consensus 228 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~-- 304 (404)
||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+...... ......+.
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~ 245 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHG 245 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCG
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCccc
Confidence 9999865443321 1233456888999999999889999999999999999999999987532100 00000000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
......+...+........+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00000111111122222334455678899999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=351.21 Aligned_cols=265 Identities=23% Similarity=0.386 Sum_probs=206.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+... .......|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 35788999999999999999765421 11223458888875443 223355678999999999999999999886
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++||||+.+|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCC
Confidence 457899999999999999997643 36888999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++................++..|+|||++.+..++.++|||||||++|+|++ |+.||..........
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------------ 228 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD------------ 228 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH------------
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH------------
Confidence 9987655444434455678889999999998899999999999999999999 999997644321111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
.+........+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 229 -----LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -----HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -----HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11111111122223445678999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=347.45 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=204.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
.++|.+.+.||+|+||.||++ .+..++..||+|++...... ..+.+.+|+.+|+.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEE---------EECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 356899999999999999995 44557889999998764322 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--- 221 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--- 221 (404)
+++......++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCC
Confidence 9999999999999999999999999754 35899999999999999999999 88999999999999999887
Q ss_pred -cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 -NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 155 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~ 225 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET 225 (326)
T ss_dssp CCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH
T ss_pred CCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HH
Confidence 79999999998654332 233467999999999998889999999999999999999999999653211 00
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
......... ..........+..+.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 LANVSAVNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCC--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 00000011224567899999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=340.56 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=207.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||++.+. ++..||+|++.... ...+++.+|+++++.++||||+++++++.++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 467899999999999999997543 35679999997654 3446789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred CCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEccccc
Confidence 99999999999999999997643 35899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~------- 232 (283)
T 3gen_A 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAE------- 232 (283)
T ss_dssp GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH-------
T ss_pred ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHH-------
Confidence 976432211 11222456788999999998899999999999999999998 999997543210 000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
. +........+...+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 233 ---~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 233 ---H-IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ---H-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---H-HhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0 011111122223346788999999999999999999999999988753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=359.47 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=208.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 467888999999999999997652 5689999998653 457899999999999999999999998776
Q ss_pred C-eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 D-HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
. ..|+||||+++|+|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 5 78999999999999999987642 34789999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||........ ..
T Consensus 335 ~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~--------- 397 (450)
T 1k9a_A 335 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP--------- 397 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH---------
T ss_pred Cccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---------
Confidence 99854321 122357889999999999999999999999999999998 9999976443211 11
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+........+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 398 -----~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 398 -----RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 0111111233344567889999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=347.16 Aligned_cols=280 Identities=30% Similarity=0.435 Sum_probs=216.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC-
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED- 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 150 (404)
.|++.+.||+|+||.||++.+. +.+..++..||+|++..... ...+.+.+|+++|+.++||||+++++++.+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEEC-----SCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEc-----cCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3488999999999999998654 56667899999999986532 3345688999999999999999999999884
Q ss_pred -CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 -DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
...++||||+++++|.+++... .+++..++.++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred CceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCcc
Confidence 5789999999999999999764 3899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+... ....
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~-~~~~ 257 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQG-QMTV 257 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCH-HHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhccccc-chhH
Confidence 99876443321 12334568889999999998899999999999999999999999996421100 000000000 0001
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
..+...+........+...+..+.+++.+||+.||++|||+.++++.|+.+.+....+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1122222222333344455678999999999999999999999999999998766543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=352.16 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=199.2
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 156 (404)
.+.||+|+||.||+|. +..+|..||+|++........+.+.+|+.+|+.++||||+++++++...+..++|
T Consensus 94 ~~~lG~G~~g~Vy~a~---------~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCE---------ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEE---------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEE---------EcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999954 4457889999999887666667899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE--cCCCcEEEecccCCCCC
Q 046897 157 YEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL--DTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll--~~~~~vkl~Dfg~a~~~ 234 (404)
|||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++...
T Consensus 165 ~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999887643 35899999999999999999999 8899999999999999 56789999999999865
Q ss_pred CCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchh
Q 046897 235 PTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314 (404)
Q Consensus 235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (404)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 240 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~---- 306 (373)
T 2x4f_A 240 KPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD---- 306 (373)
T ss_dssp CTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC----
T ss_pred CCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC----
Confidence 4432 223456999999999998889999999999999999999999999754321 111111110000
Q ss_pred hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 046897 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT--VLEQL 359 (404)
Q Consensus 315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~ 359 (404)
.........+..+.+++.+||+.||.+|||+.++++ .|...
T Consensus 307 ----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 ----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 000111223567889999999999999999999998 45543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.32 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=204.3
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
..++|++.+.||+|+||.||+| .+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEE---------EECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3567999999999999999995 4455788999999976533 2335688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---cEE
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY---NAK 224 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~---~vk 224 (404)
.+++..|+||||+.+++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+|
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEE
Confidence 9999999999999999999998765 35899999999999999999999 88999999999999997654 599
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 172 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i 242 (362)
T 2bdw_A 172 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQI 242 (362)
T ss_dssp ECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred EeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence 99999998754332 233467999999999999889999999999999999999999999753211 111100
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... .........+..+.+++.+||+.||++||++.++++.
T Consensus 243 ~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 243 KAGAYD--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHTCCC--------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhCCCC--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0001112234578899999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.69 Aligned_cols=254 Identities=24% Similarity=0.302 Sum_probs=195.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||++ .+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEE---------EETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEE---------EECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 467999999999999999995 455578899999997654 3336788999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc--EEEecc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN--AKLSDF 228 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~--vkl~Df 228 (404)
...++||||+.+++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEeec
Confidence 99999999999999999997653 5899999999999999999999 899999999999999987765 999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcc-cchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAK-SDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... .....
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~----- 232 (361)
T 3uc3_A 163 GYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQ----- 232 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHH-----
T ss_pred CccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHH-----
Confidence 9987432221 2334579999999999988777665 89999999999999999999764432211 11111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.............+..+.+|+.+||+.||++|||+.++++.
T Consensus 233 -----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 233 -----RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -----HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -----HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111111111111234567899999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.92 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=207.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEE---------EECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 467999999999999999995 44457889999999876555556789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC--CCcEEEecc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT--NYNAKLSDF 228 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~--~~~vkl~Df 228 (404)
...++||||+.+++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEec
Confidence 99999999999999999987543 35899999999999999999999 889999999999999974 577999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 196 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~ 266 (387)
T 1kob_A 196 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD 266 (387)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC
T ss_pred ccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence 9998754322 234457999999999999889999999999999999999999999754321 1111000000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...........+..+.+++.+||+.||++|||+.++++.
T Consensus 267 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 --------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 001111222345678899999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=345.03 Aligned_cols=268 Identities=25% Similarity=0.431 Sum_probs=206.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.+.. .....+..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEec-----CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3567788999999999999987643 1222356799999876532 233568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999997653 46899999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++......... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~------ 260 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVM------ 260 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH------
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHH------
Confidence 99865432211 11222456788999999988899999999999999999999 99999653211 000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
..+........+...+..+.+++.+||+.||++||++.++++.|+++......
T Consensus 261 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 261 -----KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -----HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -----HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 00111111122334456788999999999999999999999999998865443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.95 Aligned_cols=282 Identities=25% Similarity=0.338 Sum_probs=217.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEE--
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL-- 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 148 (404)
.++|++.+.||+|+||.||++.+. ..+..++..||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEC-----TTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEec-----cCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 467999999999999999997653 2355678999999998876666677999999999999999999999987
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEccc
Confidence 4457899999999999999998643 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ... .....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~-~~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCE-RDVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccc-ccccc
Confidence 9998654333211 22335688889999999988999999999999999999999999864221000000 000 00000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
...+...+........+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 011112222222233444556788999999999999999999999999998866554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=337.16 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=194.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.++|++.+.||+|+||.||+|.+ ++..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35788999999999999999754 267899999875432 224678899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC---ceecCCCCCcEEEcC----
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK---VIYRDFKTSNILLDT---- 219 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~---i~H~Dlkp~NIll~~---- 219 (404)
+..++..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEeccccc
Confidence 9999999999999999999999853 35899999999999999999999 677 999999999999986
Q ss_pred ----CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 220 ----NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 220 ----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
++.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 220 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--- 220 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---
T ss_pred ccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 7789999999997643322 22457999999999999889999999999999999999999999753311
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
. ..............+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 221 ---~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ---A----------VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---H----------HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---H----------HHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 01111111222233344556788999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=349.26 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=204.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||++ .+..++..||+|++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEE---------EECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 57899999999999999995 444578899999986532 233467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++...|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+||
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEccc
Confidence 9999999999999999999998764 4899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~------ 248 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYE------ 248 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH------
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHH------
Confidence 999865332 23467999999999999999999999999999999999999999754311 1111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.+..... .++...+..+.+++.+||+.||.+||+ +.+|++
T Consensus 249 ----~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 249 ----KIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111111 223334567889999999999999998 777765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=350.68 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=203.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVG 145 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~ 145 (404)
..++|.+.+.||+|+||.||+|. +..+++.||+|++.... ....+.+..|..++..+ +||||+++++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 45789999999999999999954 44578999999997542 23345678899999876 8999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
++.+.+..|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCCEEE
Confidence 9999999999999999999999998753 5899999999999999999999 789999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+|||++........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 160 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~--- 228 (345)
T 1xjd_A 160 ADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFH--- 228 (345)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---
T ss_pred eEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHH---
Confidence 99999986432221 234568999999999999999999999999999999999999999754321 1111
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA-EVV 353 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil 353 (404)
.+.... ..++...+..+.+++.+||+.||++||++. +|+
T Consensus 229 -------~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 229 -------SIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------HHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 122233456788999999999999999997 654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=340.72 Aligned_cols=263 Identities=26% Similarity=0.389 Sum_probs=216.3
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG---------GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEec---------CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3577999999999999999996543 457899999987653 345778999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999999999987543 56899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------------- 220 (288)
T 3kfa_A 157 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 220 (288)
T ss_dssp GGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------------
T ss_pred cceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------------
Confidence 998654322 122333457889999999998899999999999999999999 999997543211
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 221 --VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111111112222333445678899999999999999999999999998876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.45 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=195.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--------------------------cHHH
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--------------------------GHKE 124 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~ 124 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEE---------EETTTTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEE---------EECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 367999999999999999995 44457889999998754321 1256
Q ss_pred HHHHHHHHhcCCCCCcceEEEEEEe--CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 046897 125 WLAEVNYLGQLYHPNLVKLVGYCLE--DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE 202 (404)
Q Consensus 125 ~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 202 (404)
+.+|+.+|+.++||||+++++++.+ ....|+||||+++++|.+++.. .++++..++.++.||+.||.||| +
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~ 155 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLH--Y 155 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH--H
Confidence 8899999999999999999999987 5688999999999999875432 46899999999999999999999 7
Q ss_pred CCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCC---CCcccchhhhhHHHHHH
Q 046897 203 TKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH---LTAKSDVYSFGVVLLEM 279 (404)
Q Consensus 203 ~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~ll~el 279 (404)
.+|+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred CCeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 899999999999999999999999999998654322 1234467999999999987654 47789999999999999
Q ss_pred HhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 280 LSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 280 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
++|+.||..... ...... +.............+..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~g~~pf~~~~~------~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 234 VFGQCPFMDERI------MCLHSK----------IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHSSCSSCCSSH------HHHHHH----------HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHCCCCCCCccH------HHHHHH----------HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999975321 111110 11111111111233457889999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=366.13 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=213.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|.+.+.||+|+||.||+|.+. .++..||+|.+.... ...+.+.+|+.+|+.++||||+++++++..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEG---------GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEc---------CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456888999999999999997654 357889999997654 3467899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
...++||||+++|+|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 999999999999999999986542 46899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 365 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---------------- 427 (495)
T 1opk_A 365 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------- 427 (495)
T ss_dssp EECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------
T ss_pred ceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------
Confidence 98654322 111222346788999999988899999999999999999999 999997643211
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
+...+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 428 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 428 -VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 111111222223334456778899999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.18 Aligned_cols=283 Identities=17% Similarity=0.189 Sum_probs=213.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-----------HHHHHHHHHHhcCCCCC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-----------KEWLAEVNYLGQLYHPN 139 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hp~ 139 (404)
.++|++.+.||+|+||.||+|.+... .....++.||+|++........ ..+..|+..++.++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 46899999999999999999876542 2223467899999876542111 12345667778889999
Q ss_pred cceEEEEEEeC----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 140 LVKLVGYCLED----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 140 iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
|+++++++... ...|+||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNL 183 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCCHHHE
Confidence 99999998865 4589999999 999999998753 46899999999999999999999 78999999999999
Q ss_pred EEc--CCCcEEEecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCC
Q 046897 216 LLD--TNYNAKLSDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288 (404)
Q Consensus 216 ll~--~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~ 288 (404)
|++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999 8899999999999754322111 111335699999999999998999999999999999999999999985
Q ss_pred CCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCc
Q 046897 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNI 368 (404)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 368 (404)
..... ........ .....+..+++..+.. ...+..+.+++..||..||++||++.+|++.|+++.........
T Consensus 264 ~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 264 NLKDP--KYVRDSKI--RYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp GTTCH--HHHHHHHH--HHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred cccCH--HHHHHHHH--HhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 33221 11111111 0111223333332211 12245788999999999999999999999999999876655544
Q ss_pred cc
Q 046897 369 RC 370 (404)
Q Consensus 369 ~~ 370 (404)
..
T Consensus 337 ~~ 338 (364)
T 3op5_A 337 GK 338 (364)
T ss_dssp CC
T ss_pred Cc
Confidence 33
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.72 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=203.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
.++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+.+..|..+|..+ +||||++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSE---------RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEE---------ETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEE---------ECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 4689999999999999999954 44568899999987542 23346678899999988 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+
T Consensus 90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 90 FQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEEE
Confidence 999999999999999999999998753 5899999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 164 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~----- 230 (353)
T 2i0e_A 164 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELF----- 230 (353)
T ss_dssp CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-----
T ss_pred eCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHH-----
Confidence 999998633221 1234568999999999999999999999999999999999999999753311 111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
..+..... .++...+..+.+++.+||+.||.+||+ +.+|++
T Consensus 231 -----~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 231 -----QSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----HHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111111 233344567889999999999999996 455554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=349.80 Aligned_cols=270 Identities=25% Similarity=0.366 Sum_probs=213.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+|..... ........|++|.+..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 46899999999999999999876431 1223346899999876532 3346688999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS----------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
.++..++||||+++|+|.+++..... ....+++..++.++.||+.||.||| +.+|+||||||+|||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGCEEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccceEEEC
Confidence 99999999999999999999976421 1245799999999999999999999 78999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcch
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNL 297 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~ 297 (404)
.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--- 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--- 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---
Confidence 999999999999986543332223334567889999999988899999999999999999998 9999975432110
Q ss_pred hhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
+..+.........+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 276 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 -------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 0011111111122223356788999999999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=353.44 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=195.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHH-HhcCCCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNY-LGQLYHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hp~iv~~~~~ 146 (404)
.++|++.+.||+|+||+||+++ +..++..||+|++...... ....+..|..+ ++.++||||++++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLAR---------HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEE---------ETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEE---------EcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 4679999999999999999954 4557889999999765322 22445667766 467899999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+.+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEe
Confidence 999999999999999999999998753 5889999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...
T Consensus 182 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~----- 248 (373)
T 2r5t_A 182 DFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMY----- 248 (373)
T ss_dssp CCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHH-----
T ss_pred eCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHH-----
Confidence 999997532211 1234568999999999999999999999999999999999999999753211 111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
..++...+ .++...+..+.+++.+||+.||.+||++.+.++.+
T Consensus 249 -----~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 249 -----DNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -----HHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -----HHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11111111 22233456788999999999999999986544443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=348.69 Aligned_cols=270 Identities=23% Similarity=0.374 Sum_probs=213.7
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
...++|++.+.||+|+||.||+|.+.. .....++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecC----ccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345789999999999999999987642 22234578899999876432 2335688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRG------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
..++..++||||+++++|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+||+++.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEcCCC
Confidence 99999999999999999999997532 11245789999999999999999999 78999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~ 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HH
Confidence 999999999976433222222233457889999999988899999999999999999999 88998754211 10
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
.. .+.... ....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 250 ~~----------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LR----------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH----------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH----------HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00 001100 112223445678899999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=334.48 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=205.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 357889999999999999997652 67899999876532 33456899999999999999999999998
Q ss_pred eC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEcCCCcEE
Q 046897 149 ED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~~~~~vk 224 (404)
.. ...++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCccee
Confidence 77 788999999999999999986532 35899999999999999999999 677 99999999999999999999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCc---ccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTA---KSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
|+|||++..... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||...... ..
T Consensus 154 l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~- 219 (271)
T 3kmu_A 154 ISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EI- 219 (271)
T ss_dssp EEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HH-
T ss_pred EEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HH-
Confidence 999988764322 2346899999999998765554 799999999999999999999753311 00
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
...+.........+...+..+.+++.+||+.||++|||+.++++.|+++++
T Consensus 220 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 ---------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011111122223334456678899999999999999999999999998854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=342.72 Aligned_cols=268 Identities=22% Similarity=0.316 Sum_probs=201.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAA---------CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEE---------ETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEE---------EcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3579999999999999999954 44468899999987533 23345688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..++..++||||+++++|.+++.........+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEEEe
Confidence 9999999999999999999999764333356899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 180 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~---- 249 (310)
T 2wqm_A 180 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK---- 249 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHH----
T ss_pred ccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHH----
Confidence 99987643322 1223456899999999998889999999999999999999999999653211 1111110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
+.............+..+.+++.+||+.||++|||+.+|++.|+++......
T Consensus 250 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 250 ------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ------HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0000111111123355788999999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=342.35 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=198.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|... ++..||+|++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 467999999999999999996542 3788999998754322 2356889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.+...++||||++ ++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEccC
Confidence 9999999999996 58888887654 45899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ ......
T Consensus 164 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~ 238 (311)
T 3niz_A 164 GLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGT 238 (311)
T ss_dssp TTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCC
T ss_pred cCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCC
Confidence 9998653222 12334578999999999876 56899999999999999999999999765443221111 000000
Q ss_pred --------ccccchhh-------cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 --------KRKIFRII-------DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 --------~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...+.... ..............++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 000000011123457789999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=339.79 Aligned_cols=262 Identities=28% Similarity=0.435 Sum_probs=201.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.+. +..||+|.+... ...+.+.+|+++++.++||||+++++++.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 357888999999999999997542 567999998754 34467899999999999999999999876
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCc-EEEecc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYN-AKLSDF 228 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~-vkl~Df 228 (404)
+..++||||+++++|.+++..... ...++...++.++.|++.||+|||... .+|+||||||+|||++.++. +||+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 458999999999999999976432 234788999999999999999999311 78999999999999998887 799999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~---- 217 (307)
T 2eva_A 151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV---- 217 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH----
T ss_pred ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH----
Confidence 999754321 223468999999999998899999999999999999999999997533211 0000000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNI 368 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 368 (404)
............+..+.+++.+||+.||++|||+.++++.|+.+....+....
T Consensus 218 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 218 -------HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp -------HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred -------hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 00011122223455688999999999999999999999999999876655443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=345.50 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=200.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
++|++.+.||+|+||.||++. +..+++.||+|++..... ...+.+.+|..++..+ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVR---------LKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEE---------ECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 578899999999999999954 445789999999976532 2235578899999887 899999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+|
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998753 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc--hhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN--LVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~--~~~~~~~~~ 305 (404)
||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 154 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--- 228 (345)
T 3a8x_A 154 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--- 228 (345)
T ss_dssp GGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH---
T ss_pred ccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH---
Confidence 99998532222 12345689999999999999999999999999999999999999997532221110 001100
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
..+..... .++...+..+.+++.+||+.||++||++
T Consensus 229 ------~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 229 ------QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------HHHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 01111111 2333445678899999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=344.04 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=196.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.++|++.+.||+|+||.||+++.. ....++..||+|++..... .....+.+|+.+|+.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKV------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEC------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEe------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 467999999999999999997652 2345788999999976532 233457789999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+..++..|+||||+++++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEEEE
Confidence 999999999999999999999998753 5889999999999999999999 7899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~---- 231 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTID---- 231 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH----
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHH----
Confidence 999987532221 1233467999999999998889999999999999999999999999754311 1111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
.+..... .++...+..+.+++.+||+.||++|| ++.++++
T Consensus 232 ------~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 232 ------KILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------HHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------HHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111111 22333456788999999999999999 6667765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=336.69 Aligned_cols=262 Identities=25% Similarity=0.362 Sum_probs=207.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.+.. ...++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 4678999999999999999987532 23456679999987653 2344678899999999999999999999764
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCccC
Confidence 46789999999999999998754 35899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~-------- 226 (281)
T 3cc6_A 159 LSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV-------- 226 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH--------
T ss_pred CCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH--------
Confidence 9986543221 12233457889999999988899999999999999999998 999997533211 1100
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
+........+...+..+.+++.+||..||++|||+.++++.|+++...
T Consensus 227 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 227 ------LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000011112223456788999999999999999999999999988754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=338.41 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=199.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+|. +..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEE---------ECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 578999999999999999954 4457889999999765332 23668899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++ +|.+.+.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999965 6666665533 46899999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCC-CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS- 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (404)
++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .............
T Consensus 147 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 147 LARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTP 222 (292)
T ss_dssp TCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred cceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCC
Confidence 998653222 1233457899999999987655 899999999999999999998886432211 0111000000000
Q ss_pred -ccc---cchhhc---------ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 -KRK---IFRIID---------NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 -~~~---~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .....+ ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000000 00001122234567889999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.90 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=191.5
Q ss_pred cCCCCC-CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHh-cCCCCCcceEEEEEEe
Q 046897 72 RNFRPD-SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG-QLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~ 149 (404)
++|.+. ++||+|+||+||++ .+..++..||+|++... ..+.+|+.++. ..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~---------~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEE---------EECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 456665 78999999999995 44557899999998642 45678888874 4589999999999875
Q ss_pred ----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCc
Q 046897 150 ----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYN 222 (404)
Q Consensus 150 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~ 222 (404)
...+|+||||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCC
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCcc
Confidence 5678999999999999999976532 46899999999999999999999 789999999999999987 789
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc-hhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN-LVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~-~~~~~ 301 (404)
+||+|||++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... .....
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 9999999998643322 2345678999999999999999999999999999999999999997654322111 10000
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... ..........+..+.+||.+||+.||++|||+.++++.
T Consensus 280 ---~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 280 ---RMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---HHTCC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HcCcc--------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 00001112345678899999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=336.72 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=209.4
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
.|.+.+.||+|+||.||+|.+.. ...++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 45567899999999999986532 223456799999876433 33467889999999999999999999998766
Q ss_pred ee-EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 152 HR-LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 152 ~~-~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
.. +++|||+.+++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 55 99999999999999997643 46889999999999999999999 78999999999999999999999999999
Q ss_pred CCCCCCCCC--CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 231 AKDGPTGDQ--SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 231 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+........ ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~---------- 238 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLT---------- 238 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHH----------
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHH----------
Confidence 986433221 11223456889999999999989999999999999999999966554322111 0111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCC
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGN 367 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 367 (404)
..+........+...+..+.+++.+||+.||.+|||+.++++.|+++.+......
T Consensus 239 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 239 ----HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ----HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 1111111112233345678899999999999999999999999999988765443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.90 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=211.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred chHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 3567888999999999999998653 25679999998654 45678999999999999999999999986
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.+..++||||+.+|+|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 6678999999999999999975421 24788999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 330 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~------ 396 (454)
T 1qcf_A 330 LARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIR------ 396 (454)
T ss_dssp GGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHH------
T ss_pred CceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHH------
Confidence 998643211 111122346788999999988899999999999999999999 99999753311 1000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
.+........+..++..+.+++.+||+.||++|||+.+|++.|+.+......+
T Consensus 397 -----~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 397 -----ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp -----HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred -----HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 01111111223345667889999999999999999999999999886654433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=345.75 Aligned_cols=269 Identities=26% Similarity=0.327 Sum_probs=209.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE- 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 149 (404)
.++|++.+.||+|+||.||++. +..+++.||+|++........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVE---------GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEE---------ETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEE---------ecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4689999999999999999954 445688999999877665666788999999999999999999999873
Q ss_pred ---CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 150 ---DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 150 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
....++||||+.+++|.+++.........+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEEEE
Confidence 34789999999999999999875433457999999999999999999999 7899999999999999999999999
Q ss_pred cccCCCCCCCCCCCc-------ceeeccccccccCccccccCC---CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 227 DFGLAKDGPTGDQSH-------VSTRVMGTYGYAAPEYLATGH---LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-- 254 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-- 254 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--
Confidence 999987542211100 011245799999999987544 68899999999999999999999963211100
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
.+................+..+.+++.+||+.||.+|||+.++++.|+.+....+.
T Consensus 255 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 255 -------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp -------------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred -------------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00001111111122233456788999999999999999999999999988654444
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=338.34 Aligned_cols=268 Identities=26% Similarity=0.404 Sum_probs=207.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEE-
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL- 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~- 148 (404)
..+|++.+.||+|+||.||+|.+.. .......+++|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 3568889999999999999986532 22345678999987643 233467889999999999999999999865
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECcc
Confidence 4567899999999999999997543 45889999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCC--cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||........ ...
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~----- 244 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----- 244 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH-----
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH-----
Confidence 999865433211 12233567889999999998999999999999999999999 5556654332211 000
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
+.. ......+...+..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 245 --------~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 245 --------LLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp --------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred --------Hhc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 000 0011112223457889999999999999999999999999998866543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=343.37 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=197.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEE---------ETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEE---------EcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4678999999999999999954 445688999999875432 344678999999999999999999999866
Q ss_pred CC---------------------------------------------------------eeEEEEeccCCCChHHHHhhc
Q 046897 150 DD---------------------------------------------------------HRLLVYEFMPRGSLENHLFRR 172 (404)
Q Consensus 150 ~~---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~ 172 (404)
.. ..++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 379999999999999999875
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCC----------cc
Q 046897 173 GSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQS----------HV 242 (404)
Q Consensus 173 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~----------~~ 242 (404)
.. .....+..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++......... ..
T Consensus 156 ~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T 3qd2_B 156 CS-LEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232 (332)
T ss_dssp CS-GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred cC-ccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence 43 244677789999999999999999 889999999999999999999999999999865443211 12
Q ss_pred eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCC
Q 046897 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQ 322 (404)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (404)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+.... . ........ ....
T Consensus 233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~----------~~~~~~~~-~~~~ 293 (332)
T 3qd2_B 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------R----------IITDVRNL-KFPL 293 (332)
T ss_dssp CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------H----------HHHHHHTT-CCCH
T ss_pred ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------H----------HHHHhhcc-CCCc
Confidence 233579999999999999999999999999999999999877653110 0 00000000 0011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 323 YTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 323 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........+.+++.+||+.||++|||+.++++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11234456789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=344.68 Aligned_cols=271 Identities=25% Similarity=0.354 Sum_probs=207.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+.. ..+..++..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSG----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcC----CCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 4689999999999999999987542 1244568899999997543 2334568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCcE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSY---FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNA 223 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~v 223 (404)
....|+||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999875421 235889999999999999999999 889999999999999984 4469
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~--- 256 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE--- 256 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH---
Confidence 9999999874332222222334568899999999988899999999999999999998 99999753211 0000
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.+........+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 257 -----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 257 -----------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -----------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 000111112223345678899999999999999999999999998876443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=336.46 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=195.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+. ..+|+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 568999999999999999997542 2499999875432 3346688999999999999999999965
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEccc
Confidence 5567899999999999999996543 46899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++................||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .... ..
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~ 238 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MV 238 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HH
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----Hh
Confidence 9998654333333344567999999999986 5678889999999999999999999997543211 0000 00
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
... . .... ........+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 239 ~~~-~----~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 GRG-S----LSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHT-S----CCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccc-c----cCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000 0 0000 011223445678999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=360.89 Aligned_cols=258 Identities=21% Similarity=0.246 Sum_probs=204.8
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceE
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKL 143 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~ 143 (404)
+....++|++.++||+|+||+||+|+. ..+++.||+|++..... .....+.+|..++..++||||+++
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~---------~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKL---------KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEE---------cCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 334467899999999999999999544 45688999999865321 122347889999999999999999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
+++|.+++.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCCE
Confidence 999999999999999999999999997643 46899999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~ 298 (404)
||+|||++....... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...+...
T Consensus 215 kL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~----- 288 (437)
T 4aw2_A 215 RLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE----- 288 (437)
T ss_dssp EECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----
T ss_pred EEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-----
Confidence 999999997653322 12233468999999999986 4678999999999999999999999997543211
Q ss_pred hhhhhhhhhccccchhhccccc---CCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 299 EWAKPYLASKRKIFRIIDNRLE---GQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
... .++..... .......+..+.+||.+||+.+|++ ||++.++++.
T Consensus 289 -~~~----------~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 -TYG----------KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HHH----------HHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -HHH----------hhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111 11110000 0111124556889999999998888 9999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=357.93 Aligned_cols=253 Identities=23% Similarity=0.258 Sum_probs=203.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
..++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~---------~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVR---------HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEE---------ECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45789999999999999999954 455788999999865211 222447789999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.++..+|+||||+++|+|.+++... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEEEe
Confidence 99999999999999999999999764 4899999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCC----CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH----LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|||++....... .......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...... ...
T Consensus 211 DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~- 282 (410)
T 3v8s_A 211 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTY- 282 (410)
T ss_dssp CCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-
T ss_pred ccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHH-
Confidence 999997654322 11233568999999999997655 889999999999999999999999754321 111
Q ss_pred hhhhhccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKF--RPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~ 355 (404)
..++... +........+..+.+||.+||+.+|.+ ||++.+|++.
T Consensus 283 ---------~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 ---------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---------HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---------HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111111 000111123567889999999999988 9999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=361.70 Aligned_cols=195 Identities=24% Similarity=0.368 Sum_probs=153.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++... .....+++.+|+.+|+.++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEA---------YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEE---------EECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEE---------EECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 468999999999999999995 44557889999998653 2233467889999999999999999999995
Q ss_pred eC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 149 ED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
.. ..+|+||||+ +++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+||||+.++.+
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCE
Confidence 43 5689999998 67999998754 35899999999999999999999 7899999999999999999999
Q ss_pred EEecccCCCCCCCCCCC-------------------------cceeeccccccccCcccc-ccCCCCcccchhhhhHHHH
Q 046897 224 KLSDFGLAKDGPTGDQS-------------------------HVSTRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVLL 277 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~ll~ 277 (404)
||+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999865322111 123446789999999976 4667999999999999999
Q ss_pred HHHh
Q 046897 278 EMLS 281 (404)
Q Consensus 278 ell~ 281 (404)
||++
T Consensus 276 ellt 279 (458)
T 3rp9_A 276 ELLN 279 (458)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 9999
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=341.83 Aligned_cols=260 Identities=25% Similarity=0.320 Sum_probs=205.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|.+.+.||+|+||.||+|....... .....+..|++|++........+.+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4678899999999999999987653210 00112367999999776666667899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc--------
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-------- 222 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~-------- 222 (404)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999998753 34899999999999999999999 889999999999999998887
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||++..... .....|++.|+|||++.+ ..++.++||||||+++|||++|..|+...... ....
T Consensus 160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~ 228 (289)
T 4fvq_A 160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKL 228 (289)
T ss_dssp EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHH
T ss_pred eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHH
Confidence 99999999875422 223568899999999977 67899999999999999999965544322110 0000
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
...... ...+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 229 -~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 -QFYEDR------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHHHTT------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -HHhhcc------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000000 01111123457799999999999999999999999998765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.99 Aligned_cols=272 Identities=19% Similarity=0.198 Sum_probs=209.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEE-E
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYC-L 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~ 148 (404)
..++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+|+.+++.++|++++..+..+ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEE---------EcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 45789999999999999999954 445788999998765432 24578899999999887776666655 5
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKL 225 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vkl 225 (404)
..+..++||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEE
Confidence 677889999999 999999998643 45899999999999999999999 8899999999999999 78999999
Q ss_pred ecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 226 SDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence 999999865443221 122346799999999999998999999999999999999999999987554433332221
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCc
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNI 368 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 368 (404)
....... .... ......+..+.+++.+||+.||++|||+.++++.|+++.........
T Consensus 230 ~~~~~~~------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 4hgt_A 230 ISEKKMS------TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHHHHHH------SCHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred hhccccc------chhh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence 1110000 0000 00111245788999999999999999999999999999876655443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=332.68 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=209.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.+. ++..|++|++..... ..+.+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 467888999999999999997543 356799999987543 446789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccc
Confidence 99999999999999999997654 35899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+....... ........++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~------- 216 (267)
T 3t9t_A 151 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVE------- 216 (267)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-------
T ss_pred cccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHH-------
Confidence 97643211 111123457788999999988899999999999999999999 89999753311 0000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
.+.. ......+...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 217 ---~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 217 ---DIST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ---HHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhc-CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 01111222335678899999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=339.67 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=189.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEE---------ECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEE---------EECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 467999999999999999995 4455788999999875432 234678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRG--SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
++..++||||++ ++|.+++.... .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECc
Confidence 999999999996 69999987542 22245899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .........
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~ 226 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMG 226 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhC
Confidence 999986432211 2334578999999999876 4689999999999999999999999975432111 000000000
Q ss_pred h-----------------------ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 S-----------------------KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ...+...+.+. .....+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH----TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGG----CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCChhHhhhhhhhhhcccccccccchhHHHhhccc----ccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000011111 11123457889999999999999999999876
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=345.18 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=196.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCC--CCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYH--PNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--p~iv~~~~~ 146 (404)
.++|++.+.||+|+||.||++.. .++..||+|++..... ...+.+.+|+.+|+.++| +||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN----------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC----------TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe----------CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 56799999999999999999643 2477899999876532 233668899999999976 999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+..+...++|||+. +++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++ ++.+||+
T Consensus 78 ~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 78 EITDQYIYMVMECG-NIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp EECSSEEEEEECCC-SEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred EeeCCEEEEEEeCC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEEe
Confidence 99999999999954 88999999875 35899999999999999999999 88999999999999997 6789999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-----------CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 226 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 226 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence 9999987654433333445679999999999864 67889999999999999999999999643210
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. ..+..+++......++......+.+++.+||+.||.+|||+.++++.
T Consensus 227 --~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 --I----------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --H----------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --H----------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0 11112222222223333334578899999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=340.95 Aligned_cols=279 Identities=25% Similarity=0.367 Sum_probs=216.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||++.+. ..+..++..||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYD-----PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEEC-----TTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEec-----cccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 457889999999999999997653 234567899999999877666667899999999999999999999998765
Q ss_pred C--eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 151 D--HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 151 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+ ..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEecC
Confidence 4 7899999999999999998754 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh---
Q 046897 229 GLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY--- 304 (404)
Q Consensus 229 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~--- 304 (404)
|++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~ 265 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQG 265 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCT
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccch
Confidence 9998754432211 122345778899999998888999999999999999999999998632100 00000000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
......+...+........+...+..+.+++.+||+.||++|||+.+|++.|+++++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000011111111112233445677899999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=335.62 Aligned_cols=266 Identities=25% Similarity=0.349 Sum_probs=211.2
Q ss_pred cCCCCCC-cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDS-VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|.+.+ .||+|+||.||+|.+. ...++..||+|++..... ...+.+.+|+.+++.++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYR-------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEec-------cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566665 9999999999997643 233578899999977532 3446788999999999999999999999 5
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECccc
Confidence 567899999999999999997543 46899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~-------- 224 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA-------- 224 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH--------
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHH--------
Confidence 99865433221 11223456889999999988889999999999999999998 99999754321 1110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCC
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGN 367 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 367 (404)
.+........+...+..+.+++.+||+.||++||++.++++.|+++..+.....
T Consensus 225 ------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 225 ------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ------HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 011111122334456788999999999999999999999999999877655443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=335.20 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=199.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ--LYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+ ++..||+|++... ....+..|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 57899999999999999999754 3678999998654 33455666666665 79999999999876
Q ss_pred eC----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCCceecCCCCCcEEEc
Q 046897 149 ED----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA------ETKVIYRDFKTSNILLD 218 (404)
Q Consensus 149 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~i~H~Dlkp~NIll~ 218 (404)
.. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||.. +.+|+||||||+|||++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 53 458999999999999999954 3589999999999999999999932 57899999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCCc--ceeeccccccccCccccccC------CCCcccchhhhhHHHHHHHhC--------
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQSH--VSTRVMGTYGYAAPEYLATG------HLTAKSDVYSFGVVLLEMLSG-------- 282 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~ll~ell~g-------- 282 (404)
.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 99999999999997543322111 12234799999999998766 455799999999999999999
Q ss_pred --CCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 283 --RRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 283 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
..||........... . .......... ................+.+++.+||+.||++|||+.+|++.|+++
T Consensus 228 ~~~~pf~~~~~~~~~~~-~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFE-D-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCTTTTTSCSSCCHH-H-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCcchh-h-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 777755433221110 0 0000000000 000011122345677899999999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=345.30 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=189.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|. +..+++.||+|++.... ..+.+.+|+.+|+.++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCK---------QKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEE---------ECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 35689999999999999999954 44567899999997653 34567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~vkl~ 226 (404)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIA 193 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEc
Confidence 99999999999999999999764 35899999999999999999999 789999999999999975 8899999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....
T Consensus 194 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~---- 261 (349)
T 2w4o_A 194 DFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFR---- 261 (349)
T ss_dssp CCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHH----
T ss_pred cCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHH----
Confidence 999998643321 2334679999999999998899999999999999999999999996533210 0000
Q ss_pred hccccchhhcccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRL--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..... ........+..+.+++.+||+.||++|||+.++++
T Consensus 262 ------~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 262 ------RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ------HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110 01112234567889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=349.75 Aligned_cols=275 Identities=18% Similarity=0.233 Sum_probs=205.2
Q ss_pred hcCCCCCCccccc--CcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEG--GFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.++|++.+.||+| +||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLAR---------YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEE---------ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEE---------EcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 5689999999999 999999954 445789999999976432 233567889999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+..++..|+||||+++++|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEc
Confidence 9999999999999999999999987532 45899999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCCC-----CcceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 227 DFGLAKDGPTGDQ-----SHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 227 Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~ 248 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LE 248 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HH
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HH
Confidence 9998864322110 011222478999999999977 57999999999999999999999999764332111 00
Q ss_pred hhhhhhh---hc-----c-------------ccchhhc---------ccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 300 WAKPYLA---SK-----R-------------KIFRIID---------NRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 300 ~~~~~~~---~~-----~-------------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
....... +. . .+..... ...........+..+.+|+.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 0000000 00 0 0000000 000001222345678899999999999999999
Q ss_pred HHHHHH--HHhhH
Q 046897 350 AEVVTV--LEQLQ 360 (404)
Q Consensus 350 ~eil~~--L~~~~ 360 (404)
.++++. |+++.
T Consensus 329 ~ell~hp~f~~~~ 341 (389)
T 3gni_B 329 STLLNHSFFKQIK 341 (389)
T ss_dssp HHHTTSGGGGGC-
T ss_pred HHHhcCHHHHHHh
Confidence 999865 54443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=357.22 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=206.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 35678889999999999999976542 4569999997654 345789999999999999999999999866
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 678999999999999999975321 35899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~------- 391 (452)
T 1fmk_A 326 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVL------- 391 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHH-------
T ss_pred cceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHH-------
Confidence 9986543221 12223457789999999988899999999999999999999 99999753321 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
..+........+..++..+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 392 ----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 392 ----DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ----HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ----HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 01111111123344566788999999999999999999999999988655443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=347.47 Aligned_cols=267 Identities=27% Similarity=0.409 Sum_probs=201.2
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe-C
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-D 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 150 (404)
.|.+.+.||+|+||.||+|.+.. ....+..||+|.+... .....+.+.+|+.+++.++||||+++++++.. +
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred eeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 46677899999999999987632 2223457899998653 23345678999999999999999999998754 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeeccc
Confidence 57899999999999999997543 45789999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCC--cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 231 AKDGPTGDQS--HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 231 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
++........ .......+++.|+|||++.+..++.++|||||||++|||++ |.+||........ ....
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~------ 309 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL------ 309 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH------
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH------
Confidence 9865332211 11233457889999999999999999999999999999999 6777765433211 1100
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCC
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGN 367 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 367 (404)
.. ......+...+..+.+++.+||+.||++|||+.++++.|+++........
T Consensus 310 -------~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 310 -------LQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp -------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred -------Hc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 00 00111222345678899999999999999999999999999988776554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=342.23 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=207.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcE--EEEEEecCC-CcccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV--IAVKRLNQD-GFQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
++|++.+.||+|+||.||+|... .++.. +++|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIK---------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEE---------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEc---------cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 57889999999999999996543 34554 489988653 223346688999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRG------------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
...+..++||||+++++|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccceE
Confidence 99999999999999999999997653 22346899999999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGE 294 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~ 294 (404)
|++.++.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-- 248 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 248 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--
Confidence 99999999999999987432211 1223457889999999988889999999999999999998 99999754321
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
... ..+........+...+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 249 ----~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 ----ELY-----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ----HHH-----------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ----HHH-----------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 0011111112233445678899999999999999999999999999887544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.95 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=205.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|. +..++..+++|.+........+.+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAV---------QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEE---------eCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35679999999999999999954 445688999999987655667889999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vkl~ 226 (404)
+...++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999999999987753 5899999999999999999999 8899999999999999 788999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ....
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~---- 217 (277)
T 3f3z_A 152 DFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVML---- 217 (277)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH----
T ss_pred ecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHH----
Confidence 999997654332 2334579999999999865 4999999999999999999999999753321 0000
Q ss_pred hccccchhhcccccCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTL----EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+..... ..+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 218 ------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 218 ------KIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------HHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------HHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111100 1111 23457889999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=358.01 Aligned_cols=249 Identities=27% Similarity=0.352 Sum_probs=195.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD---GFQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEE---------EEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 467999999999999999995 45557899999998753 223335677899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCcEEEe
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
...+.+|+||||+++++|.+++.... .+++..+..++.||+.||+||| + .+|+||||||+|||++.++.+||+
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~giiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHh--hcCCEEECCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999997753 5899999999999999999999 6 899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 292 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~---- 359 (446)
T 4ejn_A 292 DFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFE---- 359 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH----
T ss_pred cCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHH----
Confidence 999998533222 1234578999999999999999999999999999999999999999753321 1111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
.+..... .++...+..+.++|.+||+.||.+|| ++.++++
T Consensus 360 ------~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 360 ------LILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------HHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------HHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111111 22333456788999999999999999 9999886
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=339.46 Aligned_cols=246 Identities=25% Similarity=0.281 Sum_probs=192.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||+||+|.. ..+++.||+|++..... ........|+..+..+ +||||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRS---------KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEE---------TTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEE---------CCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 46799999999999999999544 44688999998865432 2223455566555555 899999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEECC
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999 779999887764 46899999999999999999999 78999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....
T Consensus 201 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------------- 260 (311)
T 3p1a_A 201 FGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------------- 260 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------------
T ss_pred ceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------
Confidence 99987653322 2334569999999999875 799999999999999999999776643110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...+........+....+..+.+++.+||+.||++|||+.++++
T Consensus 261 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 ---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111111111111223467889999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=355.75 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=204.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|.+.+.||+|+||.||+| .+..+|..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEE---------EETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 367999999999999999995 4445789999999865421 2345788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
...+..|+||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEe
Confidence 9999999999999999999999754 35899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ....
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~---- 226 (476)
T 2y94_A 160 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFK---- 226 (476)
T ss_dssp CSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHH----
T ss_pred ccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHH----
Confidence 99998754432 2334679999999999987765 68999999999999999999999754321 1111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.+... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 227 ------~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 227 ------KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111111 112223456889999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=336.55 Aligned_cols=264 Identities=27% Similarity=0.368 Sum_probs=208.6
Q ss_pred hcCCCCCC-cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDS-VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|.+.+ .||+|+||.||+|.+. ...++..|++|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeec-------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45787777 9999999999997542 3345788999998765322 246789999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 5677899999999999999998753 5899999999999999999999 78999999999999999999999999
Q ss_pred ccCCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------ 228 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------------ 228 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------------
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------------
Confidence 99998654433211 1222446788999999988889999999999999999999 999997543210
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
+...+........+...+..+.+++.+||+.||++||++.++++.|+++......
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 229 -----VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp -----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 0011111111223334566788999999999999999999999999998765543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.46 Aligned_cols=265 Identities=17% Similarity=0.166 Sum_probs=209.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCcceEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY---HPNLVKLVGY 146 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 146 (404)
..++|.+.+.||+|+||.||+|++.. ..+..+++.||+|++.... ..++..|+++++.++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGD----LNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecC----CcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 35679999999999999999986533 2345678899999997653 456677777777776 9999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC------
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGS-YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT------ 219 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~------ 219 (404)
+..++..|+||||+++|+|.+++..... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGTCC-
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999976332 2356999999999999999999999 899999999999999998
Q ss_pred -----CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 220 -----NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 220 -----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~ 294 (404)
++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999975433233334455789999999999999999999999999999999999999996432210
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhHhcccc
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFR-PMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~~~~~~~~ 365 (404)
..+... +. .. .....+.+++..||+.+|.+| |++.++.+.|+.+......
T Consensus 293 --------------~~~~~~----~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 293 --------------CKPEGL----FR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp --------------EEECSC----CT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred --------------eeechh----cc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 000010 11 11 124567799999999999999 6899999999988765433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=334.06 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=202.9
Q ss_pred HHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCCcceE
Q 046897 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL--YHPNLVKL 143 (404)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~~ 143 (404)
......++|++.+.||+|+||.||+|.+ .+..||+|++... .......|.+++..+ +||||+++
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~ 96 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGF 96 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeE
Confidence 3344567899999999999999999754 2678999998653 223445566666554 89999999
Q ss_pred EEEEEeC----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--------CceecCCC
Q 046897 144 VGYCLED----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET--------KVIYRDFK 211 (404)
Q Consensus 144 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--------~i~H~Dlk 211 (404)
++++... ...++||||+++++|.+++... .+++..++.++.|++.||.||| .. +|+|||||
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLH--TEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp EEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHH--SCBCSTTCBCCEECSCCC
T ss_pred EEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH--HhhhhhccCCCEEecccc
Confidence 9999887 6889999999999999999764 4899999999999999999999 66 99999999
Q ss_pred CCcEEEcCCCcEEEecccCCCCCCCCCCCc--ceeeccccccccCccccccCCCCcc------cchhhhhHHHHHHHhC-
Q 046897 212 TSNILLDTNYNAKLSDFGLAKDGPTGDQSH--VSTRVMGTYGYAAPEYLATGHLTAK------SDVYSFGVVLLEMLSG- 282 (404)
Q Consensus 212 p~NIll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~ll~ell~g- 282 (404)
|+|||++.++.+||+|||++.......... ......||+.|+|||++.+..+... +|||||||++|||++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 999999999999999999997543322211 1124579999999999987666655 9999999999999999
Q ss_pred ---------CCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCC-----CHHHHHHHHHHHHHcccCCCCCCCC
Q 046897 283 ---------RRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQY-----TLEGAYKAATLALRCLSTEGKFRPM 348 (404)
Q Consensus 283 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs 348 (404)
..||.......... .. .... .......... ...+...+.+++.+||+.||.+|||
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~-~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 318 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSY-ED-MREI---------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCH-HH-HHHH---------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred CcccccccccccHhhhcCCCCch-hh-hHHH---------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC
Confidence 45554332221110 00 0000 0011111111 2367788999999999999999999
Q ss_pred HHHHHHHHHhhHhccc
Q 046897 349 MAEVVTVLEQLQDSSE 364 (404)
Q Consensus 349 ~~eil~~L~~~~~~~~ 364 (404)
+.+|++.|+++.+...
T Consensus 319 ~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 319 ALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHhhcc
Confidence 9999999999987643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.34 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=196.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC--CCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLY--HPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~~~~~ 146 (404)
.++|.+.+.||+|+||.||++.. . .+..||+|++..... ...+.+.+|+.+|+.+. ||||++++++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~---------~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLN---------E-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEC---------T-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEc---------C-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 35699999999999999999643 2 278899999876532 33467889999999996 5999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+..++.+|+|||+ .+++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++ ++.+||+
T Consensus 125 ~~~~~~~~lv~E~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 125 EITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EECSSEEEEEEEC-CSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EecCCEEEEEEec-CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 9999999999995 5889999998753 5889999999999999999999 88999999999999995 5899999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-----------CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
|||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--- 273 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 273 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---
Confidence 9999987644333323345679999999999864 36889999999999999999999999653211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.. .+..+++......++......+.+++.+||+.||++|||+.++++.
T Consensus 274 --~~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 --IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HH----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 1112222222222222234578899999999999999999999865
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=335.33 Aligned_cols=266 Identities=25% Similarity=0.273 Sum_probs=199.6
Q ss_pred hcCCCC-CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRP-DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++ .+.||+|+||.||+| .+..++..||+|++........+.+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEE---------ECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEE---------EEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 356877 478999999999995 45557889999999876656667889999999885 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc---EEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN---AKL 225 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~---vkl 225 (404)
+++..|+||||+++++|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+|||++.++. +||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEE
Confidence 9999999999999999999998753 5899999999999999999999 789999999999999988776 999
Q ss_pred ecccCCCCCCCCCC-----CcceeeccccccccCcccccc-----CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 226 SDFGLAKDGPTGDQ-----SHVSTRVMGTYGYAAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999875432211 111223569999999999864 56889999999999999999999999765433211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTL----EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.......... .......+..... .++. ..+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 236 WDRGEACPAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp C----CCHHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccchhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1000000000 0000001111111 1111 13457889999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=354.74 Aligned_cols=256 Identities=22% Similarity=0.222 Sum_probs=202.5
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
....++|++.+.||+|+||+||+++ +..+++.||+|++..... ...+.+.+|..++..++||||++++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~---------~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVK---------MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 3345789999999999999999954 445789999999865321 1223478899999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
+++.+++.+|+||||+++|+|.+++...+ ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCCEE
Confidence 99999999999999999999999998754 36899999999999999999999 89999999999999999999999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccc-------cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-------TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
|+|||++........ ......+||+.|+|||++. +..|+.++|||||||++|||++|+.||.......
T Consensus 203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---- 277 (412)
T 2vd5_A 203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---- 277 (412)
T ss_dssp ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----
T ss_pred EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH----
Confidence 999999986543221 1223468999999999986 3578999999999999999999999997543210
Q ss_pred hhhhhhhhhhccccchhhccc--c-cCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDNR--L-EGQYTLEGAYKAATLALRCLSTEGKFR---PMMAEVVTV 355 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~ 355 (404)
... .++... + ........+.++.++|.+||+ +|++| |++.+|++.
T Consensus 278 --~~~----------~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 278 --TYG----------KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --HHH----------HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --HHH----------HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000 111100 0 011112345678899999999 99998 588888654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.08 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=204.3
Q ss_pred cccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEEEE
Q 046897 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVY 157 (404)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 157 (404)
.||+|+||.||+|.+.. ..++..||||+++.... ...+.+.+|+++|+.++||||+++++++.. +..++||
T Consensus 343 ~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp EEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred EEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 79999999999986542 23467899999976532 345789999999999999999999999976 5689999
Q ss_pred eccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCC
Q 046897 158 EFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237 (404)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~ 237 (404)
||+.+|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999997543 46899999999999999999999 789999999999999999999999999999875433
Q ss_pred CCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccchhh
Q 046897 238 DQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII 315 (404)
Q Consensus 238 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (404)
... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... .. ..+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~--------------~~i 552 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM--------------AFI 552 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH--------------HHH
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH--------------HHH
Confidence 211 11222345688999999998999999999999999999998 999997643211 11 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 316 DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
........+..++..+.+++.+||+.||++||++.+|++.|+.+.......
T Consensus 553 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 111112333445678899999999999999999999999999987655443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.14 Aligned_cols=275 Identities=22% Similarity=0.275 Sum_probs=214.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|+ +..++..||+|++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGR---------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEE---------ECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 4679999999999999999954 445688999999976432 334667899999999999999999999987
Q ss_pred CC--eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE----cCCCcE
Q 046897 150 DD--HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DTNYNA 223 (404)
Q Consensus 150 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll----~~~~~v 223 (404)
.. ..++||||+++++|.+++..... ...+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCceeE
Confidence 65 77999999999999999976432 123899999999999999999999 8899999999999999 778889
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCcccccc--------CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999998654322 2334679999999998864 56788999999999999999999999754432221
Q ss_pred chhhhhhhhhhhc--cc---cchhh--------cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 296 NLVEWAKPYLASK--RK---IFRII--------DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 296 ~~~~~~~~~~~~~--~~---~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
. .......... .. +.... +......+.......+.+++.+||+.||++||++.++++.++.+.+.
T Consensus 233 ~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 233 K--EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp H--HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred H--HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1 1111111100 00 00000 00112245577888999999999999999999999999999988763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=345.88 Aligned_cols=262 Identities=23% Similarity=0.237 Sum_probs=201.4
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCCcc
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-----GFQGHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv 141 (404)
+....++|++.+.||+|+||.||+|. +..++..||+|++... .....+.+.+|+.+++.++||||+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAI---------ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhheeecceeeecCCeEEEEEE---------ECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 55667889999999999999999954 4457889999998643 223446789999999999999999
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCC------------------------------------CCCCCCHHHHH
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGS------------------------------------YFQPLSWNLRL 185 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~l~~~~~~ 185 (404)
++++++.+.+..++||||+++++|.+++..... ....+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 999999999999999999999999999852110 01124577888
Q ss_pred HHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC--cEEEecccCCCCCCCCCC--CcceeeccccccccCcccccc-
Q 046897 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--NAKLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPEYLAT- 260 (404)
Q Consensus 186 ~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~- 260 (404)
.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 172 NIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 99999999999999 78999999999999998776 899999999975422211 112344679999999999865
Q ss_pred -CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhccccc--CCCCHHHHHHHHHHHHH
Q 046897 261 -GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLE--GQYTLEGAYKAATLALR 337 (404)
Q Consensus 261 -~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 337 (404)
..++.++|||||||++|||++|+.||...... .. +..+...... .......+..+.+++.+
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DT----------ISQVLNKKLCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH----------HHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HH----------HHHHHhcccccCCcccccCCHHHHHHHHH
Confidence 67899999999999999999999999754321 11 1111111111 01111235678899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 046897 338 CLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 338 cl~~dP~~RPs~~eil~~ 355 (404)
||+.||.+||++.++++.
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=340.75 Aligned_cols=248 Identities=27% Similarity=0.336 Sum_probs=178.8
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 155 (404)
.+.||+|+||.||+|. +..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...|+
T Consensus 16 ~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCV---------HKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEE---------ETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEE---------ECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 4889999999999954 4457889999998653 3456788999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---cEEEecccCCC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY---NAKLSDFGLAK 232 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~---~vkl~Dfg~a~ 232 (404)
||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999999875 35899999999999999999999 88999999999999997766 89999999998
Q ss_pred CCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc-hhhhhhhhhhhcccc
Q 046897 233 DGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN-LVEWAKPYLASKRKI 311 (404)
Q Consensus 233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 311 (404)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ......
T Consensus 158 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 226 (325)
T 3kn6_A 158 LKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK--------- 226 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH---------
T ss_pred ecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH---------
Confidence 6433221 2344678999999999999999999999999999999999999997644321111 111111
Q ss_pred chhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+...... .......+..+.+++.+||+.||++|||+.++++
T Consensus 227 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 227 -KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111110 0111224567889999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=331.73 Aligned_cols=255 Identities=25% Similarity=0.310 Sum_probs=203.9
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||.||+|. +..++..|++|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEE---------ECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 35679999999999999999954 445688999999865432 33467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeC
Confidence 999999999999999999988654 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++................|++.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ....+.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~------ 222 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK------ 222 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH------
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh------
Confidence 99976433222222344679999999999987665 7799999999999999999999976443211 011110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
............+..+.+++.+||+.||++|||+.++++
T Consensus 223 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 --------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000000111223456789999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=331.26 Aligned_cols=269 Identities=20% Similarity=0.207 Sum_probs=211.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEE-Ee
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYC-LE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~ 149 (404)
.++|++.+.||+|+||.||+|. +..+++.||+|++..... .+.+.+|+.+++.++|++++..+.++ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEE---------ETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEE---------EcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 5789999999999999999954 445788999999876532 35688999999999988766666555 56
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vkl~ 226 (404)
....++||||+ +++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence 67889999999 999999997543 46899999999999999999999 8899999999999999 488999999
Q ss_pred cccCCCCCCCCCCCc-----ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 227 DFGLAKDGPTGDQSH-----VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 999998654432211 123467999999999999989999999999999999999999999875543333222211
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
...... .... ......+..+.+++.+||+.||++|||+.+|++.|+++.......
T Consensus 231 ~~~~~~------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 231 SEKKMS------TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHH------SCHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccccC------CchH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 110000 0000 011123456889999999999999999999999999988765544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=334.63 Aligned_cols=255 Identities=28% Similarity=0.406 Sum_probs=205.6
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
....+|++.+.||+|+||.||+|.. ..++..||+|.+.... +.+.+|+++++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKH---------RIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEE---------TTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEE---------cCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 3457799999999999999999544 4468899999997653 35678999999999999999999886
Q ss_pred e----------------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCC
Q 046897 149 E----------------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKT 212 (404)
Q Consensus 149 ~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp 212 (404)
. ....++||||+++++|.+++..... ..+++..++.++.||+.||.||| +.+|+|+||||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp 150 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIH--SKKLINRDLKP 150 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSG
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCH
Confidence 4 3457999999999999999976432 46899999999999999999999 78999999999
Q ss_pred CcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 213 SNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 213 ~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
+||+++.++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+....
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 225 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-- 225 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--
T ss_pred HHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--
Confidence 99999999999999999988654332 1234569999999999998899999999999999999999998874210
Q ss_pred CCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 293 GEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
.. ...+....+ +...+..+.+++.+||+.||++|||+.++++.|+.++.....
T Consensus 226 ------~~----------~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 226 ------KF----------FTDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp ------HH----------HHHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred ------HH----------HHHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 00 001111111 122345678999999999999999999999999988765443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=343.72 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=199.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ---GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
+.|.+.+.||+|+||.||+|. +..++..||+|++...... ..+.+.+|+++++.++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEE---------EccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458889999999999999954 4457889999998754322 2356889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..++||||+. |+|.+++.... .++++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeec
Confidence 9999999999996 68888886543 46899999999999999999999 789999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ....
T Consensus 199 G~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~--- 263 (348)
T 1u5q_A 199 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY--- 263 (348)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH---
T ss_pred cCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHH---
Confidence 99976533 22357999999999884 567899999999999999999999999653211 1111
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.............+..+.+++.+||+.||++|||+.++++.
T Consensus 264 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 264 -------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -------HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111111122335568899999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=361.33 Aligned_cols=255 Identities=28% Similarity=0.396 Sum_probs=207.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.++||+|+||.||+|. +..+|..||+|++.... ......+.+|+.+|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~---------~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQ---------VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEE---------ECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 4578899999999999999954 44578999999986532 12345678999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+.+.+|+||||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+|
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999976542 35899999999999999999999 78999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+ ...
T Consensus 330 FGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~---- 400 (576)
T 2acx_A 330 LGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERL---- 400 (576)
T ss_dssp CTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHH----
T ss_pred cccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHH----
Confidence 99998754332 234468999999999999889999999999999999999999999764432111110 000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
+.. ....++...+..+.+||.+||+.||.+|| ++.+|++.
T Consensus 401 ------i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 401 ------VKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------hhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 000 01122333456788999999999999999 67888753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=346.41 Aligned_cols=210 Identities=25% Similarity=0.301 Sum_probs=180.0
Q ss_pred ccCHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC----
Q 046897 61 SFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY---- 136 (404)
Q Consensus 61 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---- 136 (404)
.+++.+.....++|++.+.||+|+||.||+|. +..++..||+|++.... ...+.+..|+.+++.+.
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~ 93 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQ---------HIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDI 93 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCST
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEE---------ECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCC
Confidence 34555555667899999999999999999954 44568899999987532 33456778999999886
Q ss_pred -CCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 137 -HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 137 -hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
||||+++++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NI 168 (360)
T 3llt_A 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENI 168 (360)
T ss_dssp TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccE
Confidence 999999999999999999999999 9999999987543 35899999999999999999999 89999999999999
Q ss_pred EEcC-------------------------CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchh
Q 046897 216 LLDT-------------------------NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVY 270 (404)
Q Consensus 216 ll~~-------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 270 (404)
|++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchH
Confidence 9975 789999999999864332 2345789999999999999999999999
Q ss_pred hhhHHHHHHHhCCCCcCCCC
Q 046897 271 SFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 271 slG~ll~ell~g~~p~~~~~ 290 (404)
||||++|+|++|+.||....
T Consensus 244 slG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHHHCCCCCCCCc
Confidence 99999999999999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=337.95 Aligned_cols=265 Identities=25% Similarity=0.321 Sum_probs=198.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcC---CCCCcc
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-----QGHKEWLAEVNYLGQL---YHPNLV 141 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~hp~iv 141 (404)
..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.+ +||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEE---------ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 4678999999999999999994 4555789999999864321 1224566777777766 499999
Q ss_pred eEEEEEEeCC-----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 142 KLVGYCLEDD-----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 142 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
++++++.... ..++||||+. ++|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil 152 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENIL 152 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEE
Confidence 9999998765 5799999995 699999986543 34899999999999999999999 789999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
++.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-- 227 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-- 227 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999999999998654322 23446799999999999999999999999999999999999999975432111
Q ss_pred hhhhhhhhhhh--ccccch---hhccccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 297 LVEWAKPYLAS--KRKIFR---IIDNRLE-------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 297 ~~~~~~~~~~~--~~~~~~---~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.......... ...... +...... ..........+.+++.+||+.||++|||+.++++
T Consensus 228 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 228 -LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp -HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000000 000000 0000000 0011123457889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=332.60 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=200.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||++.. .+..||+|++.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 46799999999999999999654 26789999987653 456789999999999999999999997654
Q ss_pred -CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 151 -DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeecc
Confidence 478999999999999999976531 23788999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ..
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---------- 224 (278)
T 1byg_A 163 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---------- 224 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----------
T ss_pred cccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----------
Confidence 98754332 223457889999999988899999999999999999998 999997543211 00
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
..+........+...+..+.+++.+||+.||++|||+.++++.|++++..
T Consensus 225 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 225 ----PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ----HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 00111111123334456788999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.93 Aligned_cols=244 Identities=22% Similarity=0.284 Sum_probs=202.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCCcc
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--------GHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv 141 (404)
..++|++.+.||+|+||.||+| .+..++..||+|++...... ..+.+.+|+.+|+.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEE---------EETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEE---------EECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 4578999999999999999995 44557899999998765321 223567899999999999999
Q ss_pred eEEEEEEeCCeeEEEEeccCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRG-SLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
++++++.+.+..++||||+.+| +|.+++.... .+++..++.++.||+.||.||| ..+|+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAED 166 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCC
Confidence 9999999999999999999666 9999997653 5899999999999999999999 8899999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
+.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 236 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------- 236 (335)
T ss_dssp SCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred CcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence 999999999998654432 2334679999999999988776 78999999999999999999999642110
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ---------------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---------------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1111134568899999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=341.32 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=196.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||++ .+..+++.||+|++....... ...+.+|+.+++.++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLA---------RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEE---------EECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 468999999999999999995 445578999999997653332 34678999999999999999999998
Q ss_pred EeCCe----eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 148 LEDDH----RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 148 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
..... .|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSCE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCCE
Confidence 86653 399999999999999998653 5899999999999999999999 8899999999999999999999
Q ss_pred EEecccCCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~ 229 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAY 229 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHH
Confidence 99999999865433221 1223457999999999999999999999999999999999999999754321 1000
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHHHhhHh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE-VVTVLEQLQD 361 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-il~~L~~~~~ 361 (404)
......... ........+..+.+++.+||+.||++||+..+ +...|.++..
T Consensus 230 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 230 QHVREDPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHCCCCC--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHhcCCCCC--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000000000 00001123456889999999999999996554 5555665543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=341.63 Aligned_cols=280 Identities=19% Similarity=0.287 Sum_probs=200.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHH--HhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY--LGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.. ++..||+|++.... ...+..|.++ +..++||||+++++.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 46799999999999999999754 46789999986542 2334444444 45589999999998654
Q ss_pred e-----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC---------CceecCCCCCc
Q 046897 149 E-----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET---------KVIYRDFKTSN 214 (404)
Q Consensus 149 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~---------~i~H~Dlkp~N 214 (404)
. ....++||||+++|+|.+++.... .++..++.++.||+.||.||| +. +|+||||||+|
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~N 150 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSRN 150 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGGG
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccce
Confidence 3 235789999999999999997653 588999999999999999999 67 99999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCC------CcceeeccccccccCcccccc-------CCCCcccchhhhhHHHHHHHh
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQ------SHVSTRVMGTYGYAAPEYLAT-------GHLTAKSDVYSFGVVLLEMLS 281 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~ll~ell~ 281 (404)
||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 9999999999999999976433211 112234579999999999876 356678999999999999999
Q ss_pred CCCCcCCCCCCCCcchhhhh-hhhhhhccccchhh-cccccCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046897 282 GRRAVDKNRPSGEHNLVEWA-KPYLASKRKIFRII-DNRLEGQ------YTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353 (404)
Q Consensus 282 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 353 (404)
|..||............... .............. ....... .....+..+.+++.+||+.||++|||+.+++
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l 310 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence 98877543332211111000 00000000000000 0011111 1234667899999999999999999999999
Q ss_pred HHHHhhHhccccCCcccc
Q 046897 354 TVLEQLQDSSETGNIRCN 371 (404)
Q Consensus 354 ~~L~~~~~~~~~~~~~~~ 371 (404)
+.|+++.......+....
T Consensus 311 ~~L~~ll~~~~~~~~~~~ 328 (336)
T 3g2f_A 311 ERMAELMMIWERNKSVSP 328 (336)
T ss_dssp HHHHHHHHCCCC------
T ss_pred HHHHHHHHHHHhcccCCC
Confidence 999999988777665543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=335.48 Aligned_cols=266 Identities=27% Similarity=0.386 Sum_probs=200.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|.+.. ..+.+..|++|++.... ....+.+.+|+++++.++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEecc------CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 4679999999999999999986532 12234578999887542 23346788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..+. .++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCEEEcc
Confidence 8764 899999999999999998653 35899999999999999999999 78999999999999999999999999
Q ss_pred ccCCCCCCCCCCCc-ceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSH-VSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 228 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~--- 235 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILH--- 235 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH---
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHH---
Confidence 99998754433211 1223567888999999988889999999999999999999 99999754321 1111
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
.+.........+...+..+.+++.+||..||++|||+.++++.|+++.....
T Consensus 236 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 236 -------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -------HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 1111111112223445678899999999999999999999999998765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.80 Aligned_cols=254 Identities=25% Similarity=0.301 Sum_probs=197.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||++. +..++..+|+|++.... ....+.+.+|+++++.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVE---------ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEE---------EccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 3578999999999999999954 44568899999987643 2345778999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vkl~ 226 (404)
....++||||+++++|.+++.........+++..++.++.|++.||.||| +.+|+||||||+||++ +.++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 99999999999999999998654322356899999999999999999999 8899999999999999 556889999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||....... .......
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATY 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhcc
Confidence 999997643322 234467999999999885 578999999999999999999999997543110 0000000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ..... ......+..+.+++.+||+.||++|||+.++++
T Consensus 240 ~--------~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 240 K--------EPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C--------CCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred C--------Ccccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 000112456789999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=354.22 Aligned_cols=271 Identities=21% Similarity=0.212 Sum_probs=211.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH-PNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..++..||||++..... ...+.+|+++++.+.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~---------~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGT---------NIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEE---------ETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEE---------ECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 5789999999999999999954 444688999998876532 2457889999999976 566667777778
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vkl~ 226 (404)
.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||| +.++.+||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEE
Confidence 88999999999 999999998643 46899999999999999999999 8899999999999999 688999999
Q ss_pred cccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 227 DFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 227 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
|||++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 99999865443221 1123567999999999999999999999999999999999999999875443222221111
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCCc
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGNI 368 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 368 (404)
..... ...+.. +....+.++.+++.+||+.||++||++.+|++.|+++.........
T Consensus 229 ~~~~~-~~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~ 285 (483)
T 3sv0_A 229 SEKKV-ATSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFD 285 (483)
T ss_dssp HHHHH-HSCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred hhccc-cccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCcc
Confidence 10000 000000 0012245788999999999999999999999999998775554433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=334.66 Aligned_cols=262 Identities=28% Similarity=0.408 Sum_probs=208.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ...+.+.+|+++++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 3567899999999999999997543 35679999987654 34577899999999999999999999886
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 4568999999999999999965321 25899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
++........ .......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... .....
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~----- 222 (279)
T 1qpc_A 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQN----- 222 (279)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-----
T ss_pred ccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHH-----
Confidence 9986543221 11223456788999999988889999999999999999999 99999753321 00000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
+........+...+..+.+++.+||..||++|||+.++++.|+++......
T Consensus 223 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 223 ------LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ------HhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 000111122233456788999999999999999999999999998766544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=337.19 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++...... ..+.+.+|+.+++.++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEE---------EECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 467999999999999999995 44557889999998764322 346789999999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--- 221 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--- 221 (404)
+++......++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCc
Confidence 9999999999999999999999999764 35899999999999999999999 78999999999999999888
Q ss_pred -cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 -NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~ 226 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ET 226 (321)
T ss_dssp CCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HH
T ss_pred CCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HH
Confidence 79999999998654432 223457999999999999889999999999999999999999999753211 00
Q ss_pred hhhhhhhccccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. .+.... ...+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 227 ~~----------~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 227 LA----------NITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HH----------HHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HH----------HHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000000 0111 123456889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=335.15 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=196.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN----------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE----------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEc----------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 4788999999999999999643 3578899999865432 223678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..++||||++ ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 72 KKRLVLVFEHLD-QDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCeEEEEEEecC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECc
Confidence 999999999996 59999887643 45899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS- 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (404)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........
T Consensus 146 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~ 220 (288)
T 1ob3_A 146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTP 220 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred cccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCC
Confidence 987543211 12234578999999999865 4689999999999999999999999975432110 0000000000
Q ss_pred -cc---ccchh--hcccc-------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 -KR---KIFRI--IDNRL-------EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 -~~---~~~~~--~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. ..... .++.. ........+..+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000 00000 00111223557789999999999999999999976
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=358.02 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=204.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.++||+|+||.||++ .+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a---------~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFAC---------QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 57888999999999999995 4445789999999965422 23456889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
....+|+||||++||+|.+++.........+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEeec
Confidence 999999999999999999999876544457999999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++........ .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ......
T Consensus 334 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~----- 404 (543)
T 3c4z_A 334 GLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR----- 404 (543)
T ss_dssp TTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHH-----
T ss_pred ceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHH-----
Confidence 99986543321 223458999999999999999999999999999999999999999765332111 111111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
+.... ..++...+..+.+++.+||+.||++||++
T Consensus 405 -----i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 -----VLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -----HHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -----Hhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11111 12333445678899999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=348.26 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=191.5
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCC-CCCcceEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLY-HPNLVKLVG 145 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 145 (404)
...++|++.+.||+|+||.||+| .+..++..||+|++... .....+.+.+|+.+|+.+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEE---------EETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEE---------EECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 34678999999999999999995 45557899999998653 2333466789999999997 999999999
Q ss_pred EEEeCC--eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 146 YCLEDD--HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 146 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
++..++ .+|+||||++ ++|..++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~ 148 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHV 148 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCE
Confidence 998654 6899999995 6999988763 4899999999999999999999 7899999999999999999999
Q ss_pred EEecccCCCCCCCCC-------------------CCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCC
Q 046897 224 KLSDFGLAKDGPTGD-------------------QSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGR 283 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~ 283 (404)
||+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 228 (388)
T 3oz6_A 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228 (388)
T ss_dssp EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence 999999997542211 1112334689999999999876 67899999999999999999999
Q ss_pred CCcCCCCCCCCcchhhhhhhhhhhc--cccc------------hhh------cccccCC------------CCHHHHHHH
Q 046897 284 RAVDKNRPSGEHNLVEWAKPYLASK--RKIF------------RII------DNRLEGQ------------YTLEGAYKA 331 (404)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~------------~~~------~~~~~~~------------~~~~~~~~l 331 (404)
.||...........+ ....... ..+. .+. ....... .....+..+
T Consensus 229 ~pf~~~~~~~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (388)
T 3oz6_A 229 PIFPGSSTMNQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305 (388)
T ss_dssp CSCCCSSHHHHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred CCCCCCCHHHHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence 999764321110000 0000000 0000 000 0000000 000224568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 046897 332 ATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 332 ~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+|+.+||+.||++|||+.++++.
T Consensus 306 ~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 306 LDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhhccCcccCCCHHHHhCC
Confidence 899999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.57 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=201.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEE---------EccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 4679999999999999999954 44568899999986532 12235688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+....++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECS
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999998763 5899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~----- 217 (279)
T 3fdn_A 153 FGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYK----- 217 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-----
T ss_pred ccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHH-----
Confidence 9998654332 123457899999999999989999999999999999999999999753211 0000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.. .....+...+..+.+++.+||+.||++|||+.++++.
T Consensus 218 -----~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 218 -----RISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----HHHH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----HHHh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 1112223345678899999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.84 Aligned_cols=263 Identities=20% Similarity=0.265 Sum_probs=200.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++....... .+.+.+|+.+++.++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAE---------DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEE---------EcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 4689999999999999999954 44568899999987653222 36688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
..++..|+||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEec
Confidence 99999999999999999999998753 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 178 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~ 249 (309)
T 2h34_A 178 FGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ 249 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS
T ss_pred CccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc
Confidence 999876543221 1223457999999999999889999999999999999999999999753211 00000000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhHhccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-MMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~~~~ 364 (404)
. . ..........+..+.+++.+||+.||++|| ++.++++.|+++.....
T Consensus 250 ~--~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 250 A--I------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp C--C------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred C--C------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 0 000112233455788999999999999999 99999999998765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=329.44 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCV---------HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEE---------EcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 5789999999999999999954 445688999999865432 23356789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc---EEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN---AKL 225 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~---vkl 225 (404)
.++..++||||+.+++|.+.+.... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++. +||
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999999999887763 5899999999999999999999 889999999999999986655 999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 150 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~ 220 (284)
T 3kk8_A 150 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIK 220 (284)
T ss_dssp CCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH
T ss_pred eeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHH
Confidence 9999997654322 223467999999999999999999999999999999999999999653221 1000000
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.... . .........+..+.+++.+||+.||++|||+.++++.
T Consensus 221 ~~~~---~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 221 AGAY---D-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HTCC---C-----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hccc---c-----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 0 0001112234568899999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=332.17 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=183.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAE---------SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred cccceeeeeecCCCceEEEEEE---------EccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence 3579999999999999999954 444688999999865321 2236788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+.+..++||||+++++|.+++.... .++++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999999999997643 46899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------- 222 (278)
T 3cok_A 156 FGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------- 222 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred ecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----------
Confidence 999986533221 1234578999999999988889999999999999999999999997643321110
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 223 -----~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 223 -----KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000000 0122233457889999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.76 Aligned_cols=254 Identities=25% Similarity=0.309 Sum_probs=200.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||.||++ .+..++..||+|++...... ..+|++++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 3567999999999999999995 45557899999999765432 34678888877 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC----CcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN----YNAK 224 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~----~~vk 224 (404)
++...|+||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||+..+ +.+|
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEE
Confidence 9999999999999999999997653 5899999999999999999999 8899999999999998543 3599
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||............. ..
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i 235 (342)
T 2qr7_A 161 ICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RI 235 (342)
T ss_dssp ECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HH
T ss_pred EEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HH
Confidence 999999986533221 2344678999999999988889999999999999999999999997543221111111 10
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.... ...........+..+.+++.+||..||++||++.++++.
T Consensus 236 ~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 236 GSGK--------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHCC--------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCC--------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 001111223345678899999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.02 Aligned_cols=264 Identities=21% Similarity=0.248 Sum_probs=194.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..+++.||+|++... .....+++.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEE---------EECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 578999999999999999995 45557899999999754 2233467889999999999999999999997
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
... ..|+||||+++ +|.+.+.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSC
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCC
Confidence 553 56999999965 57666642 3889999999999999999999 789999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh---
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE--- 299 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~--- 299 (404)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l 279 (464)
T 3ttj_A 203 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279 (464)
T ss_dssp EEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999998654322 2345689999999999999999999999999999999999999997643211000000
Q ss_pred -------------hhhhhhhhcc-----ccchhhcccccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 300 -------------WAKPYLASKR-----KIFRIIDNRLEG---QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 300 -------------~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....+..... .........+.. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000000000000 0111225678999999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=337.88 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=205.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|.+.+.||+|+||.||++. +..++..+++|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEIS---------DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4689999999999999999954 44568899999986542 23345688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+.+..|+||||+++++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~D 184 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGD 184 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEee
Confidence 99999999999999999999987653 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 185 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~----- 251 (335)
T 2owb_A 185 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYL----- 251 (335)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-----
T ss_pred ccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHH-----
Confidence 999986533221 233467999999999999888999999999999999999999999753211 0000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.... ...+......+.+++.+||+.||++|||+.++++.
T Consensus 252 -----~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 252 -----RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----HHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----HHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001100 11222334567899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=333.08 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=203.1
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||++. +..+++.||+|++........+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVK---------QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEE---------ECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 35679999999999999999954 445788999999987654455678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vkl~ 226 (404)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+||++ +.++.+||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred CCEEEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEc
Confidence 999999999999999999997653 5899999999999999999999 8899999999999999 788999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~ 221 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKE 221 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc
Confidence 99998754322 223456999999999999889999999999999999999999999753311 10000000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... ..........+..+.+++.+||+.||++|||+.++++.
T Consensus 222 ~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 222 GYY--------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCC--------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCC--------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 01111222345678899999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.33 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=189.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 149 (404)
..+|++.+.||+|+||.||+|. +..++..||+|++........+.+.+|+.+++.+. ||||+++++++..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQ---------DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEE---------ETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEE---------ECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 4579999999999999999954 44578899999987766566677899999999996 9999999999953
Q ss_pred --------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEcC
Q 046897 150 --------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLDT 219 (404)
Q Consensus 150 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~~ 219 (404)
....+++|||+ +|+|.+++..... ..++++..++.++.||+.||.||| ..+ |+||||||+|||++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELC-KGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp CTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGCEECT
T ss_pred cccccccCCceEEEEEEec-CCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccEEECC
Confidence 33579999999 5799998875321 135899999999999999999999 777 999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCc----------ceeeccccccccCcccc---ccCCCCcccchhhhhHHHHHHHhCCCCc
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSH----------VSTRVMGTYGYAAPEYL---ATGHLTAKSDVYSFGVVLLEMLSGRRAV 286 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~ll~ell~g~~p~ 286 (404)
++.+||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 9999999999998654332111 11135689999999998 5667889999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 287 DKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
........ ................+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 254 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 254 EDGAKLRI--------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred cchhHHHh--------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 75332110 0001110111112234678999999999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=328.18 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=204.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
.++|++.+.||+|+||.||++. +..++..||+|++...... ..+.+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEE---------EcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 4578999999999999999954 4456889999998754322 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--- 221 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--- 221 (404)
+++......++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSS
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCC
Confidence 9999999999999999999999999765 35899999999999999999999 88999999999999998877
Q ss_pred -cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 -NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 149 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~ 219 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ET 219 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH
T ss_pred CceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HH
Confidence 89999999998654322 223456999999999998889999999999999999999999999754311 00
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhHhc
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT--VLEQLQDS 362 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~~~~ 362 (404)
........ ...........+..+.+++.+||+.||++|||+.++++ .++.+...
T Consensus 220 ~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 220 LTNISAVN--------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHTTC--------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHhHhcc--------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 00000000 00000001122456889999999999999999999997 46665443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.59 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=210.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+++|+.++||||+++++++.+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 35678889999999999999986542 4569999997654 345789999999999999999999999865
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..||||||+.+|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+||||+.++.+||+|||
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred -ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 678999999999999999975321 35889999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 409 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~------- 474 (535)
T 2h8h_A 409 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVL------- 474 (535)
T ss_dssp STTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHH-------
T ss_pred cceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-------
Confidence 998653211 111122456788999999988899999999999999999999 99999753211 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
..+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+......
T Consensus 475 ----~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 475 ----DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 01111111123334566788999999999999999999999999987655443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.46 Aligned_cols=271 Identities=19% Similarity=0.206 Sum_probs=199.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhcCCCCC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-----------GHKEWLAEVNYLGQLYHPN 139 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~ 139 (404)
.++|++.+.||+|+||.||+|.... ...++..+|+|++...... ....+.+|+..++.++|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTN------KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESS------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecC------CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 4679999999999999999976542 1125678999998765321 1133667889999999999
Q ss_pred cceEEEEEEe----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 140 LVKLVGYCLE----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 140 iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
|+++++++.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANL 182 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCcCHHHE
Confidence 9999999988 67899999999 999999997653 6899999999999999999999 78999999999999
Q ss_pred EEcCCC--cEEEecccCCCCCCCCCC-----CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCC
Q 046897 216 LLDTNY--NAKLSDFGLAKDGPTGDQ-----SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288 (404)
Q Consensus 216 ll~~~~--~vkl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~ 288 (404)
|++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998887 999999999975432211 1112345799999999999988999999999999999999999999964
Q ss_pred CCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
...... ......... ...+...+.... .....+..+.+++.+||+.||++||++.+|++.|+++.-
T Consensus 263 ~~~~~~--~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 263 NLKDPV--AVQTAKTNL--LDELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp GTTCHH--HHHHHHHHH--HHTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccccH--HHHHHHHhh--cccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 321110 000000000 000001000000 001234578899999999999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=332.71 Aligned_cols=268 Identities=24% Similarity=0.306 Sum_probs=197.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCR---------NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEE---------eCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence 3679999999999999999954 4456889999988665332 2356789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 73 RKRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeC
Confidence 999999999999999998887654 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh------
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA------ 301 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~------ 301 (404)
|++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...............
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 147 GFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 99986543221 2334578999999999875 67899999999999999999999999764322111110000
Q ss_pred --hhhhhhccccchhhcccccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 --KPYLASKRKIFRIIDNRLEGQYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 --~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...............+....... ...+..+.+++.+||+.||++|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000000000000 1234568899999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.49 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=197.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.+.|++.+.||+|+||.||+|. +..++..|++|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~---------~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeE---------ecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 3457888899999999999954 44568899999987543 233456889999999999999999999987
Q ss_pred e----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEc-CCC
Q 046897 149 E----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLD-TNY 221 (404)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~-~~~ 221 (404)
. ....++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+ |+|+||||+|||++ .++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTS
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCC
Confidence 5 35689999999999999999875 35899999999999999999999 677 99999999999997 789
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||...... ....
T Consensus 170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~ 239 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIY 239 (290)
T ss_dssp CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHH
T ss_pred CEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHH
Confidence 9999999999754332 234467999999999886 45999999999999999999999999653221 1100
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. .+.........+......+.+++.+||+.||.+|||+.++++
T Consensus 240 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 240 R----------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp H----------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H----------HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 000000001111122346889999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=328.20 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=204.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAR---------EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEE---------EcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3578999999999999999954 44568899999986532 12346788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEec
Confidence 99999999999999999999998763 5899999999999999999999 89999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~----- 222 (284)
T 2vgo_A 158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHR----- 222 (284)
T ss_dssp CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-----
T ss_pred ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHH-----
Confidence 99987543321 23457899999999999889999999999999999999999999753211 1000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.... ..++...+..+.+++.+||+.||.+||++.++++.
T Consensus 223 -----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 223 -----RIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----HHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----HHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111111 12223345678899999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=332.32 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=204.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||++. +..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEE---------ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 4679999999999999999954 445688999999976532 33456889999999999999999999886
Q ss_pred e--CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC-----ceecCCCCCcEEEcCCC
Q 046897 149 E--DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK-----VIYRDFKTSNILLDTNY 221 (404)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-----i~H~Dlkp~NIll~~~~ 221 (404)
. +...++||||+++++|.+++.........+++..++.++.|++.||.||| +.+ |+|+||||+||+++.++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSS
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCC
Confidence 4 56889999999999999999875443456899999999999999999999 677 99999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~ 225 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELA 225 (279)
T ss_dssp CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHH
Confidence 99999999987643321 1223457899999999998889999999999999999999999999754311 100
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
. .+... .....+...+..+.+++.+||+.||++|||+.+|++.+.
T Consensus 226 ~----------~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 226 G----------KIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp H----------HHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred H----------HHhhc-ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0 01110 011222334567889999999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=331.93 Aligned_cols=275 Identities=25% Similarity=0.369 Sum_probs=210.2
Q ss_pred CHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCCc
Q 046897 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ--LYHPNL 140 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~i 140 (404)
++.......++|.+.+.||+|+||.||+|.+ +++.||+|++... ....+.+|.+++.. ++||||
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni 98 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 98 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTB
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcE
Confidence 3444456678999999999999999999754 3678999998653 34567788888887 789999
Q ss_pred ceEEEEEEeCC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCCceecCC
Q 046897 141 VKLVGYCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA------ETKVIYRDF 210 (404)
Q Consensus 141 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~i~H~Dl 210 (404)
+++++++.... ..++||||+++++|.+++... .+++..++.++.|++.||.|||.. +.+|+||||
T Consensus 99 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp CCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred EEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 99999998876 789999999999999999764 489999999999999999999932 478999999
Q ss_pred CCCcEEEcCCCcEEEecccCCCCCCCCCCCc--ceeeccccccccCccccccC------CCCcccchhhhhHHHHHHHhC
Q 046897 211 KTSNILLDTNYNAKLSDFGLAKDGPTGDQSH--VSTRVMGTYGYAAPEYLATG------HLTAKSDVYSFGVVLLEMLSG 282 (404)
Q Consensus 211 kp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~ll~ell~g 282 (404)
||+|||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999999997543322111 12345799999999998765 234689999999999999999
Q ss_pred ----------CCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 046897 283 ----------RRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQ-YTLEGAYKAATLALRCLSTEGKFRPMMAE 351 (404)
Q Consensus 283 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~e 351 (404)
..||......... ...+.... . .....+.+... ........+.+++.+||+.||++|||+.+
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVV-C-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCC-HHHHHHHH-T-----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCcCCcccccccCccccCcCccc-HHHHHHHH-H-----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 6677554322111 11111100 0 00011111111 12356778999999999999999999999
Q ss_pred HHHHHHhhHhcc
Q 046897 352 VVTVLEQLQDSS 363 (404)
Q Consensus 352 il~~L~~~~~~~ 363 (404)
|++.|+++.+..
T Consensus 327 i~~~L~~i~~~~ 338 (342)
T 1b6c_B 327 IKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHHh
Confidence 999999987653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=329.51 Aligned_cols=247 Identities=21% Similarity=0.276 Sum_probs=198.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++.... ......+.+|+..+..+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCV---------KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEE---------EcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 4679999999999999999954 44568899999987643 23346688999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-------
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN------- 220 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~------- 220 (404)
.+++..++||||+++++|.+++.........+++..++.++.||+.||.||| +.+|+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC---------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCcccc
Confidence 9999999999999999999999875333346899999999999999999999 8899999999999999844
Q ss_pred ------------CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 221 ------------YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 221 ------------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++.
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998654322 23589999999998765 56689999999999999999998764
Q ss_pred CCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 288 KNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... . + ..+... .....+...+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~------~--~-----------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 233 NGD------Q--W-----------HEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SSH------H--H-----------HHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chh------H--H-----------HHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 321 0 0 001111 111222334567889999999999999999999976
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=361.97 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=202.1
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 155 (404)
+.||+|+||.||+|.+. ...++..||||+++.... ...+++.+|+.+|+.++||||+++++++.. +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~-------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEE-------CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEc-------CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 47999999999998653 234578899999976432 334779999999999999999999999864 56889
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
||||+++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++...
T Consensus 447 v~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 99999999999999765 35899999999999999999999 8899999999999999999999999999998654
Q ss_pred CCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 236 TGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 236 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~ 583 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTA 583 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHH
Confidence 33221 12233457789999999999999999999999999999998 999997643210 111
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+........+..++..+.+++.+||+.||++||++.+|++.|+++..+
T Consensus 584 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 584 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111122233444567889999999999999999999999999988654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=329.48 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=205.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|.+.+.||+|+||.||++. +..++..+++|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEIS---------DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEE---------ECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4679999999999999999954 445688999999865422 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999987653 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~----- 225 (294)
T 2rku_A 159 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYL----- 225 (294)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-----
T ss_pred ccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-----
Confidence 999986533221 233457899999999998888999999999999999999999999753311 0000
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+.... ...+......+.+++.+||+.||++|||+.++++.
T Consensus 226 -----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 226 -----RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----HHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011111 11222334568899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=337.31 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=198.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCR---------NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEE---------ETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEE---------ECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 3579999999999999999954 4456889999998654322 2345789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeC
Confidence 999999999999988888876544 35899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh--------
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE-------- 299 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~-------- 299 (404)
|++....... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.............
T Consensus 169 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 169 GFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 9997643322 123345789999999998765 78999999999999999999999997643211100000
Q ss_pred hhhhhhhhccccchhhcccccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQY-----TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.....+...........+...... ....+..+.+++.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000001111111111 11235678999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=339.02 Aligned_cols=264 Identities=21% Similarity=0.257 Sum_probs=191.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEE---------EECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 467999999999999999995 445578999999997653322 345779999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE-----cCCCcE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL-----DTNYNA 223 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll-----~~~~~v 223 (404)
.++..++||||++ ++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccceE
Confidence 9999999999996 59999998764 5899999999999999999999 7899999999999999 455569
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... ....
T Consensus 177 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~ 252 (329)
T 3gbz_A 177 KIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFE 252 (329)
T ss_dssp EECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred EECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHH
Confidence 999999997543221 123345689999999998764 58999999999999999999999997543211000 0000
Q ss_pred hhh-hhcc-------------ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 303 PYL-ASKR-------------KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 303 ~~~-~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .... .........+...........+.+|+.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000 000000000000011113457889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.90 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=201.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEE---------EETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEE---------EECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 467999999999999999995 445578899999986432 234567899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc---CCCcEEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD---TNYNAKL 225 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~---~~~~vkl 225 (404)
.....|+||||+.+++|.+.+.... .+++..++.++.||+.||.||| +.+|+||||||+|||++ .++.+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEE
Confidence 9999999999999999999987763 5899999999999999999999 88999999999999995 4567999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... ....
T Consensus 166 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~--- 232 (486)
T 3mwu_A 166 IDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILK--- 232 (486)
T ss_dssp CSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH---
T ss_pred EECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH---
Confidence 9999998643322 2344679999999999865 5999999999999999999999999754321 1011
Q ss_pred hhccccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+...... .......+..+.+++.+||+.||.+|||+.++++.
T Consensus 233 -------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 233 -------RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -------HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -------HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111100 01112235578899999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.33 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=199.1
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCe
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDH 152 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 152 (404)
+|....+||+|+||.||+|. +..++..||+|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGR---------DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEE---------ETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEE---------ECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 44555699999999999954 445688999999987765666788999999999999999999999999999
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-CCcEEEecccCC
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLSDFGLA 231 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~~~vkl~Dfg~a 231 (404)
.++||||+++++|.+++..... ...+++..++.++.|++.||.||| +.+|+|+||||+||+++. ++.+||+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999999976532 235678999999999999999999 789999999999999987 899999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCC--CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ....
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~-------- 236 (295)
T 2clq_A 171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMF-------- 236 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHH--------
T ss_pred cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHH--------
Confidence 76533221 223457899999999987643 8899999999999999999999996432110 0000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...........+...+..+.+++.+||+.||++||++.++++
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 237 ---KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---HHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---hhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000001111233344567889999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=327.49 Aligned_cols=254 Identities=20% Similarity=0.224 Sum_probs=199.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCCcceEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG----FQGHKEWLAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~ 145 (404)
..++|++.+.||+|+||.||++ .+..++..|++|++.... ....+.+.+|+.+++.++||||+++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEV---------LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEE---------EBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccceeEeeEEecCCCeEEEEE---------EECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 3578999999999999999995 455578899999987542 233467899999999999999999999
Q ss_pred EEE--eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 146 YCL--EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 146 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
++. +....++||||+.++ |.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 74 VLYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp EEECC---CEEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCE
T ss_pred EEEcCCCCeEEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcE
Confidence 985 445789999999765 7777766432 46899999999999999999999 8899999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCC--CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
||+|||++................|++.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ....
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~ 222 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLF 222 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHH
Confidence 999999998754433333344567999999999987643 47799999999999999999999975321 1111
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.. +.... ...+......+.+++.+||+.||.+|||+.++++.
T Consensus 223 ~~----------i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 223 EN----------IGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HH----------HHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HH----------HhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 11110 11222345678899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=349.87 Aligned_cols=251 Identities=18% Similarity=0.187 Sum_probs=192.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC---CcccHHHHHHHH---HHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD---GFQGHKEWLAEV---NYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hp~iv~~~ 144 (404)
.++|++.+.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+ ++|+.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEAT---------DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEE---------C-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEE---------ECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 3678889999999999999954 4456889999998743 223446788999 455556899999998
Q ss_pred -------EEEEeCC-----------------eeEEEEeccCCCChHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHH
Q 046897 145 -------GYCLEDD-----------------HRLLVYEFMPRGSLENHLFRRGSY---FQPLSWNLRLKVALGAAKGVAF 197 (404)
Q Consensus 145 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~l~~ 197 (404)
+++...+ ..|+||||+ +|+|.+++...... ...+++..++.++.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 7766553 278999999 68999999864321 1234458888999999999999
Q ss_pred hHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC-----------CCCcc
Q 046897 198 LHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-----------HLTAK 266 (404)
Q Consensus 198 LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 266 (404)
|| +.+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 222 LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HH--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99 78999999999999999999999999999985322 2344567 999999999877 89999
Q ss_pred cchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 046897 267 SDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFR 346 (404)
Q Consensus 267 ~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 346 (404)
+|||||||++|||++|+.||.......... .+... ....+..+.+++.+||+.||++|
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccchh----------------hhhhh------ccCCCHHHHHHHHHHcCCCchhC
Confidence 999999999999999999997544322111 11100 01224568899999999999999
Q ss_pred CCHHHHHH--HHHhhHh
Q 046897 347 PMMAEVVT--VLEQLQD 361 (404)
Q Consensus 347 Ps~~eil~--~L~~~~~ 361 (404)
||+.++++ .|+++.+
T Consensus 352 pt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 352 LLPLQAMETPEYEQLRT 368 (377)
T ss_dssp CCHHHHHTSHHHHHHHH
T ss_pred CCHHHHhhChHHHHHHH
Confidence 99999996 4555543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.38 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=205.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.+.|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGI---------DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEE---------ECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3568899999999999999954 445688999999876532 345778999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+...++||||+++++|.+++.. .++++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999999999864 35899999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~----- 231 (303)
T 3a7i_A 165 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLI----- 231 (303)
T ss_dssp TCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-----
T ss_pred cceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHh-----
Confidence 997643322 1223457899999999999889999999999999999999999999753221 000000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 356 (404)
. ...........+..+.+++.+||+.||++|||+.++++..
T Consensus 232 -----~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 232 -----P-KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -----H-HSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -----h-cCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 0 0001112223345688999999999999999999998853
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=337.16 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=193.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccH-HHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.+.||+|+||.||+|. +..++..||+|++........ ..+.+|+.+++.++||||+++++++..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGK---------SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEE---------ECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 578899999999999999954 445688999999875432211 2345799999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||++ ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred CEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCcc
Confidence 99999999995 69999988754 46899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh--
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS-- 307 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 307 (404)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..........
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~ 221 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPT 221 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 97543222 12334578999999999876 5689999999999999999999999976432111 1110000000
Q ss_pred ccccchhhc---------ccccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 308 KRKIFRIID---------NRLEG----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 308 ~~~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
......... +.... .........+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 00000 001123456789999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=348.56 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=167.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD--GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++... .....+++.+|+++|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEE---------EECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 468999999999999999995 44557899999999753 2233467899999999999999999999998
Q ss_pred eC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 149 ED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
.. ...|+||||+. ++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCE
Confidence 76 57899999994 6999999754 35899999999999999999999 7899999999999999999999
Q ss_pred EEecccCCCCCCCCCCC--------------------cceeeccccccccCcccc-ccCCCCcccchhhhhHHHHHHHhC
Q 046897 224 KLSDFGLAKDGPTGDQS--------------------HVSTRVMGTYGYAAPEYL-ATGHLTAKSDVYSFGVVLLEMLSG 282 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~ll~ell~g 282 (404)
||+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99999999865432211 123457899999999986 566799999999999999999986
Q ss_pred CCCcC
Q 046897 283 RRAVD 287 (404)
Q Consensus 283 ~~p~~ 287 (404)
..||.
T Consensus 249 ~~p~~ 253 (432)
T 3n9x_A 249 LQSHI 253 (432)
T ss_dssp CTTTC
T ss_pred ccccc
Confidence 65554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=363.56 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=202.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCCcceEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQL-YHPNLVKLVGY 146 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 146 (404)
..+|++.++||+|+||.||+|. +..+++.||+|++.... ....+.+..|..+|..+ +||||++++++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~---------~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSE---------RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEE---------ESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEE---------ECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 4679999999999999999954 44578899999987531 23345678899999988 79999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+.+.+||||||+++|+|.+++.... .+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+
T Consensus 411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 411 FQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp CBCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEEC
T ss_pred EEeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEe
Confidence 999999999999999999999998764 5899999999999999999999 8899999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||++....... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ..
T Consensus 485 DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~------ 550 (674)
T 3pfq_A 485 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------EL------ 550 (674)
T ss_dssp CCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH------
T ss_pred ecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HH------
Confidence 999998533222 1244578999999999999999999999999999999999999999764321 11
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 349 (404)
...++.... .++...+.++.+||.+||+.||++||++
T Consensus 551 ----~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 551 ----FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----HHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----HHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 111222111 2334456678899999999999999997
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=337.23 Aligned_cols=268 Identities=23% Similarity=0.295 Sum_probs=195.9
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhcCCCCCcce
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-----HKEWLAEVNYLGQLYHPNLVK 142 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~ 142 (404)
....++|++.+.||+|+||.||+| .+..+|..||+|++....... .+.+.+|+.+++.++||||++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 76 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76 (346)
T ss_dssp -------CEEEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCC
T ss_pred HHHhcccEEEeEEeecCCEEEEEE---------EECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCe
Confidence 344678999999999999999995 445578899999987542211 246789999999999999999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
+++++...+..++||||+++ +|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp EEEEECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCC
T ss_pred EEEEEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCC
Confidence 99999999999999999965 8988886543 45888899999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........ ....
T Consensus 151 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i 225 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRI 225 (346)
T ss_dssp EEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred EEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHH
Confidence 9999999998654322 12344678999999999865 4588999999999999999999999975432110 0000
Q ss_pred hhhhhh--ccccc---hhhcc---cccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLAS--KRKIF---RIIDN---RLEGQYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~--~~~~~---~~~~~---~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... ..... ...+. ......+ ...+..+.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00000 00000 0000011 2234678899999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=336.46 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=203.2
Q ss_pred HHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcC-C
Q 046897 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--------GHKEWLAEVNYLGQL-Y 136 (404)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~ 136 (404)
......++|.+.+.||+|+||.||+|. +..+|..||||++...... ..+.+.+|+.+++.+ +
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~---------~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 158 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCV---------HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEE---------ECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 344556789999999999999999954 4446889999998764321 124578899999999 7
Q ss_pred CCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 137 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
||||+++++++......|+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+|||
T Consensus 159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENIL 232 (365)
T ss_dssp CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence 999999999999999999999999999999999865 35899999999999999999999 789999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc------CCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999998654432 2344679999999998853 358889999999999999999999996532
Q ss_pred CCCCcchhhhhhhhhhhccccchhhcccccCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 291 PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTL----EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. ..... +..... .... ..+..+.+++.+||+.||++|||+.++++
T Consensus 310 ~~------~~~~~----------i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 QI------LMLRM----------IMEGQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH------HHHHH----------HHHTCC--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH------HHHHH----------HHhCCC--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 00000 000000 0010 12346889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=353.21 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=203.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEE---------EECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 467999999999999999995 455578899999986543 23456789999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE---cCCCcEE
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL---DTNYNAK 224 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll---~~~~~vk 224 (404)
......|+||||+.+++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~k 169 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIR 169 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999999999765 35899999999999999999999 7899999999999999 5678999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||++....... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||....... ...
T Consensus 170 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~-- 237 (484)
T 3nyv_A 170 IIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILK-- 237 (484)
T ss_dssp ECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH--
T ss_pred EEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHH--
Confidence 99999997654322 2334679999999999865 69999999999999999999999997643210 000
Q ss_pred hhhccccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 305 LASKRKIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+...... .......+..+.+++.+||+.||.+|||+.++++.
T Consensus 238 --------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 238 --------KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --------HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11111110 01112345678899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.42 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=202.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||++. +..++..||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEE---------ECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 3579999999999999999954 44578899999987653 2334668899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCcEEEcCCCcEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++..++||||+++++|.+++.... .+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HhCCEEcCCccHHHEEECCCCCEEEEEC
Confidence 999999999999999999998763 5899999999999999999999 64 8999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh--------
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW-------- 300 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~-------- 300 (404)
|++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 998643211 12345799999999999999999999999999999999999999975332110000000
Q ss_pred -----------hhhh---hhhccccch----hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 -----------AKPY---LASKRKIFR----IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 -----------~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...+ ......... +.............+..+.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 000000001 111111111112235578899999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=339.30 Aligned_cols=279 Identities=16% Similarity=0.176 Sum_probs=208.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcce--------
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVK-------- 142 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-------- 142 (404)
.++|++.+.||+|+||.||+|....... ......+..||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLT-CDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCcc-ccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4689999999999999999976543100 001114788999998754 45778999999999999887
Q ss_pred -------EEEEEEe-CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 143 -------LVGYCLE-DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 143 -------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
+++++.. +...|+||||+ +++|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHH
Confidence 6777776 67889999999 9999999986521 46899999999999999999999 7899999999999
Q ss_pred EEEcCCC--cEEEecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 215 ILLDTNY--NAKLSDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 215 Ill~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
||++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999764332211 11233579999999999998899999999999999999999999998
Q ss_pred CCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccCC
Q 046897 288 KNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETGN 367 (404)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 367 (404)
...... .........+... ...+..... .....+..+.+++.+||+.||++|||+.+|++.|+++........
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDK---PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHS---CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cCCcCH-HHHHHHHHhccCC---hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 654221 1111111111111 001111000 001124678899999999999999999999999999987665443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.58 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=198.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEE---------EETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEE---------EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 457999999999999999995 445578899999987643 233467899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC---CcEEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN---YNAKL 225 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~---~~vkl 225 (404)
+....|+||||+.+|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.. +.+||
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEE
Confidence 9999999999999999999887763 5899999999999999999999 8899999999999999764 45999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+|||++....... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||...... .......
T Consensus 181 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~ 250 (494)
T 3lij_A 181 VDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVE 250 (494)
T ss_dssp CCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH
T ss_pred EECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 9999998654322 234467999999999885 56999999999999999999999999764321 1111100
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... .........+..+.+++.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 251 KGKYT--------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HTCCC--------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hCCCC--------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00000 0001111234568899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=334.97 Aligned_cols=263 Identities=20% Similarity=0.243 Sum_probs=205.2
Q ss_pred CHHHHHHHhcCCCCC-CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCC
Q 046897 63 SFSDLKTATRNFRPD-SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQL-YHP 138 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hp 138 (404)
.+.......++|.+. +.||+|+||.||+|. +..++..||+|++.... ......+.+|+.++..+ +||
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCI---------SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEE---------ECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 344456667788887 899999999999954 44578899999987542 23356788999999999 479
Q ss_pred CcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 139 NLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 139 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
||+++++++......++||||+.+++|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLS 165 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEES
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEe
Confidence 99999999999999999999999999999886432 246899999999999999999999 88999999999999998
Q ss_pred C---CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 219 T---NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 219 ~---~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
. ++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 240 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-- 240 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--
Confidence 8 7899999999998654322 2234679999999999998999999999999999999999999997543210
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... . .............+..+.+++.+||+.||++|||+.++++.
T Consensus 241 ----~~~~i~-------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 ----TYLNIS-------Q-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----HHHHHH-------H-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----HHHHHH-------h-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000000 0 00011112222345678899999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=336.76 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=196.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..+|..||+|++.... ....+++.+|+++|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEE---------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEE---------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 468999999999999999995 445578999999986542 223456889999999999999999999998
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
... ..|+||||+ +++|.+++... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCC
Confidence 663 459999999 88999998763 4899999999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+
T Consensus 167 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i 238 (367)
T 1cm8_A 167 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEI 238 (367)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred EEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 999999999864321 234578999999999876 6799999999999999999999999976432110 0000
Q ss_pred hhhhhh-cc----------------ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 046897 302 KPYLAS-KR----------------KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQL 359 (404)
Q Consensus 302 ~~~~~~-~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 359 (404)
...... .. .+.......+ .......+..+.+|+.+||+.||++|||+.++++. |+.+
T Consensus 239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000 00 0000000000 01122345678899999999999999999999883 5444
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=329.67 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=187.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-H-HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-H-KEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||++ .+..+++.||+|++....... . +.+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKM---------RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEE---------EecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 468999999999999999995 444578999999987653222 2 22344555678889999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCcEEEcCCCcEEEec
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.++..++||||++ ++|.+++.........+++..++.++.|++.||.||| +. +|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999996 5888887653323357999999999999999999999 76 999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCcccc----ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL----ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...... ...
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~---- 222 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQ---- 222 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHH----
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHH----
Confidence 99997653322 22334799999999996 4567899999999999999999999999743211 000
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+................+..+.+++.+||+.||++|||+.++++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 -------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111111111112234567889999999999999999999988
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=328.70 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=199.8
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
...++|++.+.||+|+||.||+|. +..+|..||+|.+.... ..+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAI---------HKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp ----CEEEEEECC----CEEEEEE---------ETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEE---------ECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 345789999999999999999954 44468899999997653 3467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.++..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997543 46899999999999999999999 889999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 170 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-- 239 (314)
T 3com_A 170 GVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPT-- 239 (314)
T ss_dssp TTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH--
T ss_pred ccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhc--
Confidence 9997643321 1233457899999999998888999999999999999999999999753311 00000000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........+...+..+.+++.+||..||.+|||+.++++
T Consensus 240 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 240 -------NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -------SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000001112233567889999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=339.14 Aligned_cols=258 Identities=27% Similarity=0.338 Sum_probs=203.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCCcceEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGHKEWLAEVNYLGQL-YHPNLVKLVG 145 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~ 145 (404)
.++|++.+.||+|+||.||+++.. ....++..||+|++..... ...+.+.+|+.+|+.+ +||||+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEc------ccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 367999999999999999997652 2234688999999875321 2335567899999999 6999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
++..+...++||||+++++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEE
Confidence 9999999999999999999999998753 5899999999999999999999 789999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 201 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~ 277 (355)
T 1vzo_A 201 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRR 277 (355)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHH
T ss_pred eeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHH
Confidence 9999997643221 112334679999999999875 35788999999999999999999999754332211 111111
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
.. .. ...++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 278 ~~----------~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 278 IL----------KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HH----------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred Hh----------cc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 00 1123334456788999999999999999 88888775
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=342.79 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=191.6
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCCc
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--------QGHKEWLAEVNYLGQLYHPNL 140 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~i 140 (404)
...++|.+.+.||+|+||.||+|+ +..++..||+|++..... .....+.+|+.+|+.++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAF---------ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEE---------ETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEE---------ECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 456889999999999999999954 455788999999865321 112347899999999999999
Q ss_pred ceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 141 VKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 141 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+++++++. .+..|+||||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecC
Confidence 99999975 45689999999999999888654 35899999999999999999999 7899999999999999754
Q ss_pred C---cEEEecccCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 221 Y---NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 221 ~---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~ 294 (404)
+ .+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~ 352 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred CCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence 4 59999999998754322 234567999999999985 36788899999999999999999999975432211
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..... ..... ... ...+..+.+++.+||+.||++|||+.++++.
T Consensus 353 --~~~~i-------------~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 353 --LKDQI-------------TSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --HHHHH-------------HTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHH-------------hcCCC--CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11100 00000 111 1134578899999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=333.17 Aligned_cols=270 Identities=21% Similarity=0.277 Sum_probs=198.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEE---------ETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEEE---------ECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 3679999999999999999954 4457889999998654322 2356789999999999999999999998
Q ss_pred e--------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 149 E--------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 149 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
. .+..++||||++ ++|.+.+.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD 160 (351)
T ss_dssp EC--------CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTT
T ss_pred ccccccccCCceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCC
Confidence 7 346899999996 57877776543 45899999999999999999999 8899999999999999999
Q ss_pred CcEEEecccCCCCCCCCCC--CcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 221 YNAKLSDFGLAKDGPTGDQ--SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
+.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999976543221 112344678999999998875 5689999999999999999999999976432111110
Q ss_pred hhhhhh-h----hhh--ccccchhhcccccCCCCH--H-----HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 298 VEWAKP-Y----LAS--KRKIFRIIDNRLEGQYTL--E-----GAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 298 ~~~~~~-~----~~~--~~~~~~~~~~~~~~~~~~--~-----~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+..... . ... .......+.......... . ....+.+|+.+||+.||++|||+.++++.
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000 0 000 000000000000000000 0 13457899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.79 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=203.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--------CCCcce
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY--------HPNLVK 142 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~ 142 (404)
.++|++.+.||+|+||.||+|+ +..+++.||+|++... ....+.+.+|+++|+.++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSW---------DIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEE---------ecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 4789999999999999999954 4457899999999754 233466889999999885 788999
Q ss_pred EEEEEE----eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCcEEE
Q 046897 143 LVGYCL----EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSNILL 217 (404)
Q Consensus 143 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~NIll 217 (404)
+++++. .....++||||+ +++|.+++..... ..+++..++.++.||+.||.||| ++ +|+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCHHHeeE
Confidence 999988 455789999999 6677777765432 46899999999999999999999 77 99999999999999
Q ss_pred cCCC-------------------------------------------------cEEEecccCCCCCCCCCCCcceeeccc
Q 046897 218 DTNY-------------------------------------------------NAKLSDFGLAKDGPTGDQSHVSTRVMG 248 (404)
Q Consensus 218 ~~~~-------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~g 248 (404)
+.++ .+||+|||++...... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 9775 7999999999865332 233578
Q ss_pred cccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc------------------
Q 046897 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK------------------ 310 (404)
Q Consensus 249 t~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 310 (404)
|+.|+|||++.+..++.++|||||||++|||++|+.||......................+.
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999999989999999999999999999999999865544322211111111100000
Q ss_pred ---cchhhcc---------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 311 ---IFRIIDN---------RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 311 ---~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+..+.+. ......+......+.+|+.+||+.||++|||+.++++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000 0011345677888999999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.26 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=200.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCC
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-------------QGHKEWLAEVNYLGQLY 136 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 136 (404)
..++|++.+.||+|+||.||+| .+..++..||+|++..... ...+.+.+|+.+|+.++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEE---------EETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEE---------EECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999999995 4455788999999876432 22466889999999999
Q ss_pred CCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 137 HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 137 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
||||+++++++.+....|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENIL 178 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEE
Confidence 9999999999999999999999999999999997753 5899999999999999999999 789999999999999
Q ss_pred EcCCC---cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 217 LDTNY---NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 217 l~~~~---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
++.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.......
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 254 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 98776 69999999998654322 234467999999999986 469999999999999999999999997643211
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
... .+..... .++ ...+..+.+++.+||+.||.+|||+.++++.
T Consensus 255 ------~~~----------~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 255 ------IIK----------KVEKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ------HHH----------HHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHH----------HHHcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 1111110 011 1234578899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=359.23 Aligned_cols=263 Identities=23% Similarity=0.346 Sum_probs=207.7
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||.||+|.+.. ....+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECC------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEec------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 35678999999999999999987642 223467899999876432 33367899999999999999999999984
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++..|+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEEec
Confidence 567899999999999999998654 35899999999999999999999 789999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
|++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .. ..
T Consensus 536 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~---~~----- 603 (656)
T 2j0j_A 536 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DV---IG----- 603 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH---HH-----
T ss_pred CCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HH---HH-----
Confidence 99987543321 12233457789999999988899999999999999999997 99999754321 00 00
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+.. ......+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 604 -----~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 604 -----RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -----HHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0111 011123334556788999999999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=335.54 Aligned_cols=254 Identities=27% Similarity=0.369 Sum_probs=196.1
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
...++|++.+.||+|+||.||+|. +..++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGR---------HVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEE---------ECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 346789999999999999999954 44468899999987653 3446788999999998 799999999999
Q ss_pred Ee------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 148 LE------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 148 ~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
.. .+..++||||+++++|.+++.... ...+++..++.++.||+.||.||| +.+|+|+||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCCC
Confidence 87 467899999999999999998643 146899999999999999999999 78999999999999999999
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
.+||+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---- 240 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---- 240 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----
Confidence 99999999987643321 1223457999999999986 567889999999999999999999999653321
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.... .+.............+..+.+++.+||..||.+||++.++++
T Consensus 241 --~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 --RALF----------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HHHH----------HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHH----------HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 000000000111223457889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=340.27 Aligned_cols=272 Identities=23% Similarity=0.294 Sum_probs=200.3
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
....++|++.+.||+|+||.||+| .+..++..||+|++..+... ..+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEV---------FDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEE---------EETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEE---------EECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence 345678999999999999999995 44557899999998655322 23699999999999999999998
Q ss_pred EeC--------------------------------------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHH
Q 046897 148 LED--------------------------------------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189 (404)
Q Consensus 148 ~~~--------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~ 189 (404)
... ...++||||++ ++|.+.+.........+++..++.++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 543 34889999996 588887765332335799999999999
Q ss_pred HHHHHHHHhHcCCCCceecCCCCCcEEEc-CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCccc
Q 046897 190 GAAKGVAFLHGAETKVIYRDFKTSNILLD-TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKS 267 (404)
Q Consensus 190 qi~~~l~~LH~~~~~i~H~Dlkp~NIll~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 267 (404)
||+.||.||| +.+|+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++
T Consensus 149 qi~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 149 QLFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcch
Confidence 9999999999 89999999999999997 68999999999998654332 23345789999999998764 589999
Q ss_pred chhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh---------c-----cccchhhcccccCCCCHHHHHHHHH
Q 046897 268 DVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS---------K-----RKIFRIIDNRLEGQYTLEGAYKAAT 333 (404)
Q Consensus 268 DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~-----~~~~~~~~~~~~~~~~~~~~~~l~~ 333 (404)
|||||||++|||++|+.||........ ...... .... . .....+........++...+..+.+
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 999999999999999999976432111 000000 0000 0 0000000011111122334567889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH--HHhhHh
Q 046897 334 LALRCLSTEGKFRPMMAEVVTV--LEQLQD 361 (404)
Q Consensus 334 li~~cl~~dP~~RPs~~eil~~--L~~~~~ 361 (404)
|+.+||+.||++|||+.|+++. ++.+.+
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999999999999864 666554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=331.08 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=198.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|. +..++..|++|++........+.+.+|+.+++.++||||+++++++..+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAK---------NKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEE---------ETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEE---------EcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 5789999999999999999954 4446889999999877666778899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999999987643 45899999999999999999999 78999999999999999999999999998
Q ss_pred CCCCCCCCCCcceeeccccccccCcccc-----ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYL-----ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
+...... ........|++.|+|||++ .+..++.++||||||+++|+|++|..||...... .......
T Consensus 164 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~ 235 (302)
T 2j7t_A 164 SAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA 235 (302)
T ss_dssp HHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH
T ss_pred Ccccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHh
Confidence 7531110 0012235689999999988 3667899999999999999999999999754321 1000000
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. .......+...+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 236 KS---------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HS---------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cc---------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 00000112233557889999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.22 Aligned_cols=258 Identities=18% Similarity=0.229 Sum_probs=198.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++... ..+.+.+|+.+++.++ ||||+++++++..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEE---------ECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 4679999999999999999954 4456889999998753 3467889999999997 9999999999987
Q ss_pred --CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEEe
Q 046897 150 --DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKLS 226 (404)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl~ 226 (404)
....++||||+.+++|.+++. .+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 567899999999999999884 3789999999999999999999 88999999999999999777 89999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ..........
T Consensus 174 Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~ 248 (330)
T 3nsz_A 174 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVL 248 (330)
T ss_dssp CCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHH
T ss_pred eCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhc
Confidence 999998654332 2334578999999999876 678999999999999999999999995432210 0000000000
Q ss_pred hhc--------------cccchhh--------cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASK--------------RKIFRII--------DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~--------------~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .....+. ............+..+.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000000 000111111224567889999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=322.46 Aligned_cols=249 Identities=26% Similarity=0.341 Sum_probs=195.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|. +..+++.|++|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGE---------HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEE---------ECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4689999999999999999954 44468899999986532 23345788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
...+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEee
Confidence 99999999999999999999998763 5899999999999999999999 88999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...... .....
T Consensus 155 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~--- 222 (276)
T 2h6d_A 155 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKK--- 222 (276)
T ss_dssp CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH---
T ss_pred cccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHH---
Confidence 99998654322 2234568999999999987665 68999999999999999999999653211 10000
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.... ...+...+..+.+++.+||+.||++|||+.++++.
T Consensus 223 -------~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 223 -------IRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------hhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 01222234568899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=334.68 Aligned_cols=264 Identities=21% Similarity=0.253 Sum_probs=192.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEE---------EECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 468999999999999999995 445578899999987542 233456889999999999999999999998
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
... ..|+||||++ ++|.+++.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSC
T ss_pred cccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCC
Confidence 665 7899999995 578888752 4789999999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh----
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV---- 298 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~---- 298 (404)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 166 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 166 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred EEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999998643321 233467999999999999989999999999999999999999999764321100000
Q ss_pred ------------hhhhhhhhhcc-----ccchhhcccccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 ------------EWAKPYLASKR-----KIFRIIDNRLEG---QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ------------~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.....+..... ............ .........+.+|+.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 000000000000 0112336689999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=333.02 Aligned_cols=273 Identities=24% Similarity=0.307 Sum_probs=191.3
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
.....++|++.+.||+|+||.||+|. +..++..||+|++.... .......++++.+..++||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~ 87 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGK---------EKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSY 87 (360)
T ss_dssp HHHHHTTEEEC----------CEEEE---------ETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHh
Confidence 44556899999999999999999954 44568899999886543 233456778888899999999999999
Q ss_pred EEeCCe-------eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 147 CLEDDH-------RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 147 ~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
+..... .++||||+.+ +|...+.........+++..++.++.|++.||.|||.++.+|+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp EEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred hhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence 976433 7899999965 66655544322335689999999999999999999977789999999999999996
Q ss_pred -CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 220 -NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 220 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~- 242 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH- 242 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-
T ss_pred CCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH-
Confidence 8999999999998654432 22345789999999998654 48999999999999999999999997643211100
Q ss_pred hhhhhhhhhhccccchhhcc----------------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDN----------------RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.................++ .............+.+|+.+||+.||.+|||+.++++.
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 -EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp -HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000000000000 00011112245689999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=346.91 Aligned_cols=269 Identities=24% Similarity=0.303 Sum_probs=196.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|++.+.||+|+||.||+|.+ ..++..||+|++..... ...+|+++|+.++||||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKL---------CDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEE---------CCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 34688999999999999999654 44688999999865432 234699999999999999999998642
Q ss_pred ------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-CcE
Q 046897 151 ------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNA 223 (404)
Q Consensus 151 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~-~~v 223 (404)
..+++||||+++ +|.+.+.........+++..++.++.||+.||.||| +.+|+||||||+|||++.+ +.+
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeE
Confidence 236799999964 777766543222357999999999999999999999 8999999999999999965 578
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||....... .+.....
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK 271 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999986543321 2345789999999998764 79999999999999999999999997643211 1111110
Q ss_pred hhhh-hccccchh-------hcccc-----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhH
Q 046897 303 PYLA-SKRKIFRI-------IDNRL-----EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQ 360 (404)
Q Consensus 303 ~~~~-~~~~~~~~-------~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~ 360 (404)
..-. ....+..+ .-+.+ ...+....+.++.+|+.+||+.||.+||++.|+++. |+.+.
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000 00000000 00000 001122335678899999999999999999999863 54443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=323.77 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=202.4
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---------ccHHHHHHHHHHHhcCC-CCC
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---------QGHKEWLAEVNYLGQLY-HPN 139 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hp~ 139 (404)
..++|++.+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+.+++.+. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEE---------EcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 35789999999999999999954 445789999999876431 12345789999999995 999
Q ss_pred cceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 140 LVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 140 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
|+++++++..+...++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDD 159 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECT
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcC
Confidence 999999999999999999999999999999875 35899999999999999999999 889999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccc------cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA------TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
++.+||+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 235 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM- 235 (298)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-
Confidence 9999999999998654332 233457899999999874 456889999999999999999999999653211
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........... ..........+..+.+++.+||+.||++|||+.++++
T Consensus 236 -----~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 -----LMLRMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -----HHHHHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHhcCCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11110000000 0000111234567889999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=341.02 Aligned_cols=200 Identities=23% Similarity=0.325 Sum_probs=171.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC------CCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL------YHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~ 144 (404)
..+|++.+.||+|+||.||+|. +..++..||+|++.... ...+.+.+|+++++.+ +|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~---------~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAY---------DHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEE---------ETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEE---------ECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4679999999999999999954 44578899999997642 2335567788777766 578999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc--
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN-- 222 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~-- 222 (404)
+++......++||||+ +++|.+++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 166 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 166 ENFTFRNHICMTFELL-SMNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTSCC
T ss_pred eecccCCeEEEEEecc-CCCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCCcc
Confidence 9999999999999999 4699999987543 45899999999999999999999 789999999999999999887
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 241 vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999754322 234578999999999999899999999999999999999999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.28 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=185.3
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAY---------CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEE---------C----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeccccceEEEEEE---------ECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 35789999999999999999954 444678999998865432 33456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRG----SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
.++..++||||+++++|.+++.... .....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEE
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCEE
Confidence 9999999999999999999987421 11245899999999999999999999 78999999999999999999999
Q ss_pred EecccCCCCCCCCCC---CcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 225 LSDFGLAKDGPTGDQ---SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ..
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~- 237 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LM- 237 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH-
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HH-
Confidence 999999875433221 112234579999999999865 5689999999999999999999999976432210 00
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. .... ..................+..+.+++.+||+.||.+|||+.++++
T Consensus 238 -~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 238 -L-TLQN--DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -H-HHTS--SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H-Hhcc--CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0000 000000000001111223456889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.19 Aligned_cols=253 Identities=13% Similarity=0.015 Sum_probs=181.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHH---HHHHhcCCCCCcceEE-
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAE---VNYLGQLYHPNLVKLV- 144 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~hp~iv~~~- 144 (404)
.+|.+.+.||+|+||.||+|. +..++..||+|++..... ...+.+.+| +.+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVR---------DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEE---------ECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458889999999999999954 445688999999987543 223456677 455555 799988865
Q ss_pred ------EEEEeC-----------------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHH
Q 046897 145 ------GYCLED-----------------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR------LKVALGAAKGV 195 (404)
Q Consensus 145 ------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~l 195 (404)
+++..+ ...|+||||++ ++|.+++..... .+.+..+ +.++.||+.||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHH
Confidence 454433 23799999997 899999987532 2344455 67789999999
Q ss_pred HHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc--CCCCcccchhhhh
Q 046897 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFG 273 (404)
Q Consensus 196 ~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG 273 (404)
+||| +.+|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 208 ~~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 208 ANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp HHHH--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred HHHH--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 9999 88999999999999999999999999999986432 1224567799999999977 6799999999999
Q ss_pred HHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046897 274 VVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353 (404)
Q Consensus 274 ~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 353 (404)
|++|||++|+.||....+......... ..................+..+.+++.+||+.||++|||+.+++
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHHHHHHhCCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 999999999999987643321110000 00000011111111123456788999999999999999999997
Q ss_pred H
Q 046897 354 T 354 (404)
Q Consensus 354 ~ 354 (404)
+
T Consensus 352 ~ 352 (371)
T 3q60_A 352 E 352 (371)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=334.43 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=200.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..+|++.+.||+|+||.||+| .+..++..||+|++..... ...+.+.+|+++|+.++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEE---------EECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 568999999999999999995 4455788999999975432 233678899999999999999999999976
Q ss_pred C-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 150 D-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 150 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
. ...|+||||+. ++|.+++... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEE
Confidence 5 36899999995 6999998763 4899999999999999999999 88999999999999999999999
Q ss_pred EecccCCCCCCCCCCC-cceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 225 LSDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|+|||++......... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...........+ .
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~ 245 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---L 245 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---H
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---H
Confidence 9999999865432211 1123457999999999865 456899999999999999999999999765432211111 0
Q ss_pred hhhhhc--ccc--------chhhcccc-cCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLASK--RKI--------FRIIDNRL-EGQ-----YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~--~~~--------~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... ..+ ........ ... .....+..+.+|+.+||+.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000 00000000 000 111234578899999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=327.20 Aligned_cols=253 Identities=26% Similarity=0.328 Sum_probs=195.7
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCCcc
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--------QGHKEWLAEVNYLGQLYHPNLV 141 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv 141 (404)
..++|++.+.||+|+||.||+|. +..++..||+|++..... .....+.+|+.+|+.++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAF---------ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEE---------EcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 45679999999999999999954 445788999999875422 1123478999999999999999
Q ss_pred eEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC
Q 046897 142 KLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY 221 (404)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~ 221 (404)
++++++..+. .|+||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCC
Confidence 9999987654 89999999999999998754 35899999999999999999999 88999999999999998766
Q ss_pred c---EEEecccCCCCCCCCCCCcceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 222 N---AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 222 ~---vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
. +||+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 227 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS- 227 (322)
T ss_dssp SSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-
T ss_pred CCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-
Confidence 5 999999999865332 1223457999999999874 56789999999999999999999999975443211
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
...... ...... ........+..+.+++.+||+.||++||++.++++
T Consensus 228 -~~~~~~---~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 -LKDQIT---SGKYNF--------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHHHH---HTCCCC--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHH---hCcccc--------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111000 000000 00000123457889999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=334.32 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=183.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+| .+..+|..||+|++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEE---------EETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEE---------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 478999999999999999995 445578999999986542 233467889999999999999999999987
Q ss_pred eC------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 ED------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
.. ...|+|||++ +++|.+++.. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCC
Confidence 54 5679999999 7899988865 35899999999999999999999 889999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+
T Consensus 171 ~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i 242 (367)
T 2fst_X 171 LKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLI 242 (367)
T ss_dssp EEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH
T ss_pred EEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 99999999986432 1334679999999999876 6789999999999999999999999976432111 1100
Q ss_pred hhhhhhc----------cccchhhccccc-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASK----------RKIFRIIDNRLE-GQYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~----------~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....... ......+..... .... ......+.+|+.+||+.||++|||+.++++.
T Consensus 243 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 000000000000 0001 1224568899999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=333.42 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=197.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.+. ..+++|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~------------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWH------------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEES------------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEc------------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 578999999999999999997653 138999886542 223355778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.....++||||+++++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++ ++.+||+||
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred cCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEEEeec
Confidence 9999999999999999999997643 46889999999999999999999 78999999999999998 689999999
Q ss_pred cCCCCCCCCC---CCcceeeccccccccCcccccc---------CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcc
Q 046897 229 GLAKDGPTGD---QSHVSTRVMGTYGYAAPEYLAT---------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296 (404)
Q Consensus 229 g~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~ 296 (404)
|++....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 249 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---- 249 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 9987542211 1112233568999999999864 35788999999999999999999999754321
Q ss_pred hhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.... .+.............+..+.+++.+||..||++|||+.++++.|+++...
T Consensus 250 --~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 --AIIW----------QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp --HHHH----------HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred --HHHH----------HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 00000000011112334678999999999999999999999999988754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.84 Aligned_cols=271 Identities=21% Similarity=0.264 Sum_probs=196.6
Q ss_pred CHHHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-----------cHHHHHHHHHH
Q 046897 63 SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-----------GHKEWLAEVNY 131 (404)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~ 131 (404)
...++....++|++.+.||+|+||.||+|.. . .+..||+|++...... ..+.+.+|+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---------~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVD---------S-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEEC---------T-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEEC---------C-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 3566778889999999999999999999643 2 3788999988653221 12678999999
Q ss_pred HhcCCCCCcceEEEEEEeC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCce
Q 046897 132 LGQLYHPNLVKLVGYCLED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVI 206 (404)
Q Consensus 132 l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~ 206 (404)
++.++||||+++++++... ...|+||||+. ++|.+++.... ..+++..++.++.||+.||.||| +.+|+
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~iv 156 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLH--EAGVV 156 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCcCE
Confidence 9999999999999998543 36799999996 68888887543 46899999999999999999999 78999
Q ss_pred ecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCC
Q 046897 207 YRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRA 285 (404)
Q Consensus 207 H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p 285 (404)
||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999997543322 2334678999999999876 6789999999999999999999999
Q ss_pred cCCCCCCCCcchhhhhhhhhhh----------ccccchhhccccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 046897 286 VDKNRPSGEHNLVEWAKPYLAS----------KRKIFRIIDNRLE-------GQYTLEGAYKAATLALRCLSTEGKFRPM 348 (404)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs 348 (404)
|........ .......... .......+..... ..........+.+++.+||+.||++|||
T Consensus 234 f~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 234 FRGSTFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp CCCSSHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCHHHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 976432110 0000000000 0000000000000 0011123456889999999999999999
Q ss_pred HHHHHHH
Q 046897 349 MAEVVTV 355 (404)
Q Consensus 349 ~~eil~~ 355 (404)
+.++++.
T Consensus 311 ~~ell~h 317 (362)
T 3pg1_A 311 TEQALRH 317 (362)
T ss_dssp HHHHHTS
T ss_pred HHHHHcC
Confidence 9999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=327.45 Aligned_cols=204 Identities=25% Similarity=0.314 Sum_probs=172.5
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CC-----Ccce
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HP-----NLVK 142 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~ 142 (404)
...++|++.+.||+|+||.||+|. +..++..||+|++.... ...+.+..|+++++.++ |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAY---------DRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEE---------ETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEE---------EcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 345789999999999999999954 44578899999997542 23456677888888774 44 4999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc--CC
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD--TN 220 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~--~~ 220 (404)
+++++...+..++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+++.+|+||||||+|||++ .+
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 9999999999999999995 699999987542 458999999999999999999997668999999999999994 57
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 198 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 88999999999865332 234678999999999999899999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.78 Aligned_cols=251 Identities=26% Similarity=0.338 Sum_probs=201.4
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGY 146 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 146 (404)
...++|++.+.||+|+||.||+|. +..+++.|++|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~---------~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCK---------DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEE---------EcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence 345789999999999999999954 44568899999986542 2345678999999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC---CcE
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN---YNA 223 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~---~~v 223 (404)
+......++||||+.+++|.+++.... .+++..++.++.||+.||.||| +.+|+|+||||+||+++.+ +.+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred EeCCCeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcccE
Confidence 999999999999999999999887653 5899999999999999999999 7899999999999999764 469
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...... .....
T Consensus 164 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~ 233 (287)
T 2wei_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKR 233 (287)
T ss_dssp EECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH
T ss_pred EEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 999999987643322 1233568999999998865 5899999999999999999999999754321 11110
Q ss_pred hhhhccccchhhcccccCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQ--YTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+........ .....+..+.+++.+||+.||++|||+.++++
T Consensus 234 ----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 234 ----------VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----------HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000000 01123456889999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=323.90 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=196.4
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCC--CCCcce
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLY--HPNLVK 142 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~ 142 (404)
+....++|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|+.+++.++ |+||++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence 3445678999999999999999996432 377899999875432 33467889999999996 599999
Q ss_pred EEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 143 LVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
+++++..++..++|||+ .+++|.+++.... .+++..++.++.|++.||.||| +.+|+||||||+|||++. +.
T Consensus 93 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp EEEEEECSSEEEEEECC-CSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEET-TE
T ss_pred EEEEeecCCEEEEEEec-CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEEC-Ce
Confidence 99999999999999995 4889999998753 5899999999999999999999 789999999999999964 89
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-----------CCCCcccchhhhhHHHHHHHhCCCCcCCCCC
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-----------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~ll~ell~g~~p~~~~~~ 291 (404)
+||+|||++................|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 99999999987544333223344679999999999865 4688899999999999999999999965321
Q ss_pred CCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 292 SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. .. .+..+.+......++...+..+.+++.+||+.||++||++.++++.
T Consensus 245 ~-----~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 Q-----IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H-----HH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-----HH----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 00 1111222222222222335678899999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.37 Aligned_cols=268 Identities=23% Similarity=0.274 Sum_probs=194.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEE--
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL-- 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 148 (404)
.++|++.+.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAV---------DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEE---------ETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEE---------ECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4689999999999999999954 44568899999998776666678899999999999999999999873
Q ss_pred ------------eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 ------------EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
+....++||||+. ++|.+++.. .++++..++.++.|++.||+||| +.+|+||||||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLF 152 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEE
Confidence 3467899999996 699999864 35899999999999999999999 889999999999999
Q ss_pred Ec-CCCcEEEecccCCCCCCCCCC-CcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 217 LD-TNYNAKLSDFGLAKDGPTGDQ-SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 217 l~-~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
++ .++.+||+|||++........ ........++..|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 567999999999986533211 112234567899999998765 678999999999999999999999997643211
Q ss_pred Ccchhhhhhhhhh--hc----cccchhhccccc-C-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAKPYLA--SK----RKIFRIIDNRLE-G-----QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~~~~~--~~----~~~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....+....+... .. ..+......... . ......+..+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1000000000000 00 000000000000 0 0111235678899999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=333.73 Aligned_cols=207 Identities=23% Similarity=0.324 Sum_probs=157.0
Q ss_pred cCCCC-CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe-
Q 046897 72 RNFRP-DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE- 149 (404)
Q Consensus 72 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 149 (404)
+.|.+ .++||+|+||.||+|.+. +..++..||+|++.... ....+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~-------~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRK-------DGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEES-------SSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEc-------cCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 44665 568999999999997643 22457889999997653 23568899999999999999999999965
Q ss_pred -CCeeEEEEeccCCCChHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE----cC
Q 046897 150 -DDHRLLVYEFMPRGSLENHLFRRG-----SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL----DT 219 (404)
Q Consensus 150 -~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll----~~ 219 (404)
+...|+||||+. ++|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+|||| +.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCCC
Confidence 668999999995 58888876322 11234899999999999999999999 8899999999999999 77
Q ss_pred CCcEEEecccCCCCCCCCCC-CcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 220 NYNAKLSDFGLAKDGPTGDQ-SHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 88999999999986543211 122344679999999999877 458999999999999999999999997544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=332.29 Aligned_cols=262 Identities=16% Similarity=0.215 Sum_probs=199.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-----------HPN 139 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~ 139 (404)
.++|++.+.||+|+||.||+| .+..++..||+|++.... ...+.+.+|+.+++.+. |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLA---------KDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEE---------EecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 468999999999999999995 444578899999987542 33456788999988875 899
Q ss_pred cceEEEEEEeCC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCc
Q 046897 140 LVKLVGYCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSN 214 (404)
Q Consensus 140 iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~N 214 (404)
|+++++++...+ ..++||||+ +++|.+++..... ..+++..++.++.||+.||+||| +. +|+||||||+|
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPEN 162 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGG
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHH
Confidence 999999998654 789999999 8999999987543 45899999999999999999999 77 99999999999
Q ss_pred EEEc------CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCC
Q 046897 215 ILLD------TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288 (404)
Q Consensus 215 Ill~------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~ 288 (404)
||++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 4458999999999765332 2335789999999999999999999999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhhhhccc---------------------c-----------chhhcccccCCCCHHHHHHHHHHHH
Q 046897 289 NRPSGEHNLVEWAKPYLASKRK---------------------I-----------FRIIDNRLEGQYTLEGAYKAATLAL 336 (404)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~---------------------~-----------~~~~~~~~~~~~~~~~~~~l~~li~ 336 (404)
....................+. . ...+.. ...++......+.+||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLS 315 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHH
Confidence 5432211111111111000000 0 000000 12355677889999999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 046897 337 RCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 337 ~cl~~dP~~RPs~~eil~ 354 (404)
+||+.||++|||+.++++
T Consensus 316 ~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGGCSSTTTCBCHHHHHT
T ss_pred HHhccCccccCCHHHHhh
Confidence 999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.71 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=202.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC------CcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP------NLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~~~ 144 (404)
.++|++.+.||+|+||.||+|... ..++..||+|++.... ...+.+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 468999999999999999996432 3467899999987542 3346678899998888654 599999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-----
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT----- 219 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~----- 219 (404)
+++...+..++||||+ +++|.+++..... .++++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCCEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEecccccc
Confidence 9999999999999999 8899999987542 46889999999999999999999 789999999999999987
Q ss_pred --------------CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCC
Q 046897 220 --------------NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRA 285 (404)
Q Consensus 220 --------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p 285 (404)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 678999999999864322 2345789999999999988999999999999999999999999
Q ss_pred cCCCCCCCCcchhhhhhh-----hhhhccc--------------------cchhhcccc-cCCCCHHHHHHHHHHHHHcc
Q 046897 286 VDKNRPSGEHNLVEWAKP-----YLASKRK--------------------IFRIIDNRL-EGQYTLEGAYKAATLALRCL 339 (404)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~-----~~~~~~~--------------------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl 339 (404)
|................. ....... +........ ...........+.+++.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 975432211110000000 0000000 000000000 01123345678999999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 046897 340 STEGKFRPMMAEVVTV 355 (404)
Q Consensus 340 ~~dP~~RPs~~eil~~ 355 (404)
+.||.+|||+.|+++.
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999854
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=325.83 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=191.2
Q ss_pred HHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcC----C
Q 046897 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQL----Y 136 (404)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~ 136 (404)
.....++|++.+.||+|+||.||+| .+..++..||+|++...... ....+.+|+.++..+ +
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 96 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEE---------ECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCC
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEE---------EEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCC
Confidence 3445678999999999999999995 44557889999999765332 122345788888888 8
Q ss_pred CCCcceEEEEEEeCCeeEEEEec-cCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 137 HPNLVKLVGYCLEDDHRLLVYEF-MPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 137 hp~iv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
||||+++++++...+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 97 h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENI 170 (312)
T ss_dssp CSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGE
T ss_pred CCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhE
Confidence 99999999999999999999999 78899999998753 5899999999999999999999 78999999999999
Q ss_pred EEc-CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCC-cccchhhhhHHHHHHHhCCCCcCCCCCCC
Q 046897 216 LLD-TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLT-AKSDVYSFGVVLLEMLSGRRAVDKNRPSG 293 (404)
Q Consensus 216 ll~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~ll~ell~g~~p~~~~~~~~ 293 (404)
+++ .++.+||+|||++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-- 244 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-- 244 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--
Confidence 999 88999999999998654322 2345689999999998776664 589999999999999999999964210
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
+.... ..++......+.+++.+||+.||++|||+.++++.
T Consensus 245 --------------------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 --------------------ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --------------------HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------------------Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00101 11222345568899999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=330.75 Aligned_cols=260 Identities=17% Similarity=0.226 Sum_probs=201.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-----------------HHHHHHHHHHHh
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-----------------HKEWLAEVNYLG 133 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~ 133 (404)
.++|++.+.||+|+||.||+|.. ++..||+|++....... .+.+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999643 57899999986532211 177899999999
Q ss_pred cCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHH------HhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCce
Q 046897 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENH------LFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVI 206 (404)
Q Consensus 134 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~ 206 (404)
.++||||+++++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.||| + .+|+
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~ 174 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIH--NEKNIC 174 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHH--HTSCEE
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHh--ccCCEe
Confidence 99999999999999999999999999999999998 4432 1257999999999999999999999 7 8999
Q ss_pred ecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCc-ccchhhhhHHHHHHHhCCC
Q 046897 207 YRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTA-KSDVYSFGVVLLEMLSGRR 284 (404)
Q Consensus 207 H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~ll~ell~g~~ 284 (404)
|+||||+||+++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999864332 23446799999999999876 6666 9999999999999999999
Q ss_pred CcCCCCCCCCcchhhhhhhhhhhccccc----hhhcc---cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 285 AVDKNRPSGEHNLVEWAKPYLASKRKIF----RIIDN---RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
||...... ....... ........ ..... ..........+..+.+++.+||+.||.+|||+.++++
T Consensus 251 pf~~~~~~--~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 251 PFSLKISL--VELFNNI---RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCCSSCS--HHHHHHH---TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCcH--HHHHHHH---hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99764431 0111100 00000000 00000 0000011334567889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=338.06 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=192.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
..+|++.+.||+|+||.||+|... .++. +|+|++...... ..+|+.+++.++||||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~---------~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLV---------ESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET---------TTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEEC---------CCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 457999999999999999996543 2344 788877543222 23699999999999999999999654
Q ss_pred C------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc-CCCcE
Q 046897 151 D------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD-TNYNA 223 (404)
Q Consensus 151 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~-~~~~v 223 (404)
. .+++||||+++ ++...+.........+++..++.++.||+.||+||| +.+|+||||||+|||++ .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCcE
Confidence 3 37899999965 554444432222356899999999999999999999 88999999999999999 79999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......
T Consensus 182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~ 256 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK 256 (394)
T ss_dssp EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 9999999986533322 2345789999999998664 589999999999999999999999976432110 000000
Q ss_pred hh-------hh-hc-----cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 046897 303 PY-------LA-SK-----RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQL 359 (404)
Q Consensus 303 ~~-------~~-~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~ 359 (404)
.. +. .. .....+....+...+....+.++.+|+.+||+.||.+|||+.++++. |+.+
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00 00 00 00000000000111222345678999999999999999999999874 4444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=328.44 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=195.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+| .+..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEE---------EECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 578999999999999999995 4455789999999976432 22466889999999999999999999998
Q ss_pred eCCee------EEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDDHR------LLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
..+.. ++||||+. ++|.+++. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCC
Confidence 77654 99999995 68887773 34899999999999999999999 789999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus 183 ~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i 254 (371)
T 4exu_A 183 LKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQI 254 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH
T ss_pred EEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHH
Confidence 99999999986432 1334578999999999876 6889999999999999999999999975432110 0000
Q ss_pred hhhhhhc----------cccchhhcc---cccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASK----------RKIFRIIDN---RLEG---QYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~----------~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....... ......... .... ......+..+.+|+.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 000000000 0000 0111235678899999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=318.78 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=192.2
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
..++|++.+.||+|+||.||+|. +..++..||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKAR---------NALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEE---------EcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 35679999999999999999954 4456889999998653 2334678899999999999999999999865
Q ss_pred -------------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 150 -------------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 150 -------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
....|+||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+|+||||+|||
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil 148 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIF 148 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEE
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEE
Confidence 346799999999999999998653 45788999999999999999999 789999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCC------------CcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCC
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQ------------SHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGR 283 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~ 283 (404)
++.++.+||+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 99999999999999986532210 1122345789999999998754 68999999999999999998
Q ss_pred CCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 284 RAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 284 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
||.... .......... . ........+.......+.+++.+||+.||.+|||+.++++
T Consensus 227 -p~~~~~-----~~~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 227 -PFSTGM-----ERVNILKKLR-------S-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -CCSSHH-----HHHHHHHHHH-------S-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCCch-----hHHHHHHhcc-------c-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 443210 0000000000 0 0111122333444567889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.13 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=196.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|. +..+|..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSAT---------HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEE---------ECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999954 445688999999965432 233567899999999999999999998876
Q ss_pred C-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 150 D-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 150 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
+ ...++||||+. ++|.+++... .+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEE
Confidence 4 67899999995 6999998763 4899999999999999999999 78999999999999999999999
Q ss_pred EecccCCCCCCCCCCCc--------ceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCc
Q 046897 225 LSDFGLAKDGPTGDQSH--------VSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~ 295 (404)
|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 231 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ- 231 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 99999998654322110 1223578999999998754 6789999999999999999999999976432100
Q ss_pred chhhhhhhhhhhc-----------cccchhhccccc------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 296 NLVEWAKPYLASK-----------RKIFRIIDNRLE------GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 296 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........... ............ .......+..+.+++.+||+.||++|||+.++++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 232 --LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp --HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 000000000000 0011133567889999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=323.72 Aligned_cols=258 Identities=25% Similarity=0.340 Sum_probs=178.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHH-HHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVN-YLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|. +..++..||+|++..... .....+..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMV---------HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEE---------ETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEE---------EcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 4689999999999999999954 445688999999976532 22344556665 677789999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCcEEEcCCCcEEEe
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRG-SYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
.++..++||||+. ++|.+++.... .....+++..++.++.|++.||.||| .. +|+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCCEEEc
Confidence 9999999999996 58888776311 11256899999999999999999999 77 99999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCcccc----ccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL----ATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|||++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||......... .
T Consensus 169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~- 239 (327)
T 3aln_A 169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----L- 239 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----H-
Confidence 999997653322 22334699999999998 4567899999999999999999999999753221000 0
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+.......+........+..+.+++.+||+.||++|||+.++++.
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 ------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00000000111111112345578899999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.47 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=172.8
Q ss_pred hcCCCCC-CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPD-SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+. ++||+|+||.||+|+ +..+++.||+|++.... ....+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~---------~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECF---------HRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEE---------ECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 4678885 479999999999954 44578899999986531 222223334566789999999999976
Q ss_pred ----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCc
Q 046897 150 ----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYN 222 (404)
Q Consensus 150 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~ 222 (404)
+...++||||+++++|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCce
Confidence 4458999999999999999986542 46899999999999999999999 889999999999999976 455
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .
T Consensus 170 ~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~ 243 (336)
T 3fhr_A 170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--R 243 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--H
Confidence 999999999764322 2234578999999999988889999999999999999999999997543321100000 0
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
. + ...............+..+.+++.+||+.||++|||+.++++.
T Consensus 244 ~-------~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 244 R-------I-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred h-------h-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0 0000000111112345678899999999999999999999983
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=321.46 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=198.5
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCCcceEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQL---YHPNLVKLV 144 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hp~iv~~~ 144 (404)
..++|++.+.||+|+||.||+|... ..++..||+|++..... .....+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEec--------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 3578999999999999999996542 23578899998864321 1223456677766665 899999999
Q ss_pred EEEE-----eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC
Q 046897 145 GYCL-----EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT 219 (404)
Q Consensus 145 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~ 219 (404)
+++. .....++||||+. ++|.+++..... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTS 155 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcC
Confidence 9987 4567899999996 699999987543 35899999999999999999999 889999999999999999
Q ss_pred CCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 220 NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 220 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~ 229 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLG 229 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH
T ss_pred CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH
Confidence 9999999999997643221 2334678999999999988899999999999999999999999997543211 000
Q ss_pred hhhhhhhh--ccccch-------hh---cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 300 WAKPYLAS--KRKIFR-------II---DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 300 ~~~~~~~~--~~~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........ ...... .. .......+....+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000 00 000001122234567889999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.92 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCCc
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQLY--HPNL 140 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hp~i 140 (404)
...++|++.+.||+|+||.||+|. +..++..||+|++...... ..+.+.+|+.+++.+. |+||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEE---------ETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CccCceEEEEEEeeCCCeEEEEEE---------ECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 346789999999999999999954 4456899999998764322 1234667999999996 5999
Q ss_pred ceEEEEEEeCCeeEEEEeccCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc-
Q 046897 141 VKLVGYCLEDDHRLLVYEFMPR-GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD- 218 (404)
Q Consensus 141 v~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~- 218 (404)
+++++++..++..++|||++.+ ++|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDL 184 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEET
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEeC
Confidence 9999999999999999999975 89999998753 5899999999999999999999 88999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
.++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------ 254 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 254 (320)
T ss_dssp TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------
Confidence 78999999999998654322 234569999999999877665 6789999999999999999999964210
Q ss_pred hhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+..... ......+..+.+++.+||+.||++|||+.++++
T Consensus 255 ----------------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----------------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----------------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------------hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 111223456889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=323.41 Aligned_cols=264 Identities=21% Similarity=0.249 Sum_probs=198.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCC-cEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC------cceE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTG-MVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN------LVKL 143 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~~ 143 (404)
.++|++.+.||+|+||.||+|... .++ ..||+|++.... ...+.+.+|+.+++.++|++ ++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDH---------ARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred cccEEEEEEeeccCCeEEEEEEec---------CCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 578999999999999999996543 234 789999987542 33456788999998886655 9999
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE------
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL------ 217 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll------ 217 (404)
++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeccccc
Confidence 99999999999999999 6777777766432 46899999999999999999999 8899999999999999
Q ss_pred -------------cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCC
Q 046897 218 -------------DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284 (404)
Q Consensus 218 -------------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~ 284 (404)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 56789999999999764332 234579999999999999999999999999999999999999
Q ss_pred CcCCCCCCCCcchhhhhhh-----hhhhccc--------------------cchhhcc-cccCCCCHHHHHHHHHHHHHc
Q 046897 285 AVDKNRPSGEHNLVEWAKP-----YLASKRK--------------------IFRIIDN-RLEGQYTLEGAYKAATLALRC 338 (404)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~-----~~~~~~~--------------------~~~~~~~-~~~~~~~~~~~~~l~~li~~c 338 (404)
||................. ....... ....... .............+.+|+.+|
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 9975432111000000000 0000000 0000000 000112234456889999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 046897 339 LSTEGKFRPMMAEVVT 354 (404)
Q Consensus 339 l~~dP~~RPs~~eil~ 354 (404)
|+.||++|||+.++++
T Consensus 318 L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 318 LEFDPAQRITLAEALL 333 (355)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=324.38 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=195.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+| .+..+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEE---------EECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 468999999999999999995 4445789999999876432 22356889999999999999999999998
Q ss_pred eCCe------eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDDH------RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
.... .|+||||+. ++|.+++. ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCc
Confidence 7654 499999995 68877763 24899999999999999999999 789999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus 165 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i 236 (353)
T 3coi_A 165 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQI 236 (353)
T ss_dssp EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHH
T ss_pred EEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 999999999864321 234578999999999876 6789999999999999999999999976432110 0000
Q ss_pred hhhhhhc----------cccchhhc---cccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASK----------RKIFRIID---NRLE---GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~----------~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
....... ......+. .... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00000000 0000 11223446678999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.63 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=179.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-H-HHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-H-KEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|.. ..++..||+|++....... . +.+.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRF---------RKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEE---------TTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEE---------ecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 46788899999999999999544 4468899999997653322 2 23344556788889999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-CceecCCCCCcEEEcCCCcEEEec
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAET-KVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~-~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.++..++||||+ ++.+..+..... ..+++..++.++.|++.||.||| .. +|+|+||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEEEE
Confidence 999999999999 666666655432 46899999999999999999999 64 899999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
||++....... ......|++.|+|||++. +..++.++||||||+++|+|++|+.||...... .....
T Consensus 169 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~ 240 (318)
T 2dyl_A 169 FGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLT 240 (318)
T ss_dssp CTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH
T ss_pred CCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHH
Confidence 99997643322 223457999999999984 457889999999999999999999999753211 11111
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...... .... ......+..+.+++.+||+.||.+||++.++++.
T Consensus 241 ~~~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 241 KVLQEE-------PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHSC-------CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHhccC-------CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111000 0000 1111234568899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=328.86 Aligned_cols=254 Identities=25% Similarity=0.307 Sum_probs=185.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 150 (404)
+.|.+.++||+|+||+||.+ ...+|+.||||++..+ ..+.+.+|+.+|+.+ +||||+++++++.++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~----------~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ----------GSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE----------EESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEE----------EEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 45666789999999999853 1235789999998653 235678899999876 899999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCC---CCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC-------
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQP---LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN------- 220 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~------- 220 (404)
...|+||||+. |+|.+++......... ..+..++.++.||+.||+||| +.+|+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCccccccc
Confidence 99999999995 6999999865432111 123345789999999999999 7899999999999999754
Q ss_pred ------CcEEEecccCCCCCCCCCCCc--ceeeccccccccCcccccc-------CCCCcccchhhhhHHHHHHHh-CCC
Q 046897 221 ------YNAKLSDFGLAKDGPTGDQSH--VSTRVMGTYGYAAPEYLAT-------GHLTAKSDVYSFGVVLLEMLS-GRR 284 (404)
Q Consensus 221 ------~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~ll~ell~-g~~ 284 (404)
+.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 489999999998754432211 1234579999999999865 568999999999999999999 999
Q ss_pred CcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 285 AVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 285 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
||....... .. ........ ...........+..+.+++.+||+.||.+|||+.++++
T Consensus 239 Pf~~~~~~~----~~----i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 239 PFGDKYSRE----SN----IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTCSTTTHH----HH----HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCchhhH----HH----HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 996532210 00 00000000 01111234566788999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=336.82 Aligned_cols=273 Identities=25% Similarity=0.342 Sum_probs=205.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+ +.+..+|..||+|++... .....+.+.+|+++++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyl---------a~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~ 83 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLR---------WIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83 (676)
T ss_dssp ----CCCCCCCBCSSSBCCC---------CCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred CCCeEEEEEEeeCCCeEEEE---------EEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence 36899999999999999998 566667899999998764 22334668899999999999999999998765
Q ss_pred ------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc-
Q 046897 150 ------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN- 222 (404)
Q Consensus 150 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~- 222 (404)
++..++||||+++++|.+++..... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSSS
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCCc
Confidence 6678999999999999999986432 235888999999999999999999 789999999999999997765
Q ss_pred --EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 223 --AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 223 --vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|
T Consensus 161 ~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~ 232 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQW 232 (676)
T ss_dssp CEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHS
T ss_pred eeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhh
Confidence 9999999998754432 23446799999999999999999999999999999999999999965311 0111
Q ss_pred hhhhhhhc---cccchhhcc--------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHhhHhcc
Q 046897 301 AKPYLASK---RKIFRIIDN--------RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE-----VVTVLEQLQDSS 363 (404)
Q Consensus 301 ~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----il~~L~~~~~~~ 363 (404)
........ ......... ..........+..+.+++.+||..||++|||+.+ +.+.++.+.+..
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp STTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 10000000 000000000 0112344456788999999999999999999988 556666665533
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=326.18 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=183.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL-YHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 150 (404)
.+|.+.++||+|+||+|+.. ...+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~----------~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR----------GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE----------EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEE----------EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 46888899999999996532 2235788999999765432 345799999999 799999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-----CCcEEE
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-----NYNAKL 225 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-----~~~vkl 225 (404)
...|+||||+. |+|.+++..... .+.+..++.++.||+.||.||| +.+|+||||||+|||++. ...+||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999999995 699999976542 3444456789999999999999 789999999999999953 335889
Q ss_pred ecccCCCCCCCCCCC-cceeeccccccccCccccc---cCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhh
Q 046897 226 SDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLA---TGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~ 300 (404)
+|||++......... .......||+.|+|||++. ...++.++|||||||++|||++ |..||....... ..
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~- 239 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----AN- 239 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HH-
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HH-
Confidence 999999865433211 1233467999999999987 4567889999999999999999 999996432110 00
Q ss_pred hhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........ ............+.+++.+||+.||.+|||+.++++
T Consensus 240 ---~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 240 ---ILLGACSL-------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---HHTTCCCC-------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHhccCCc-------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000000 000112234556789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.97 Aligned_cols=233 Identities=14% Similarity=0.144 Sum_probs=184.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+|+ +..+++.||+|++....... .+.+.+|+.++..++||||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQAL---------DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEE---------ETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEE---------ecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 4679999999999999999954 44568999999997654332 36788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++..|+||||+++++|.+++... .....+..++.||+.||+||| +.+|+||||||+|||++.+|.+||++
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEECS
T ss_pred EECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEEEe
Confidence 9999999999999999999998532 355678889999999999999 88999999999999999999999985
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+| |++ .++.++|||||||++|||++|+.||.............
T Consensus 173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------- 215 (286)
T 3uqc_A 173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------- 215 (286)
T ss_dssp CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------
T ss_pred cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------
Confidence 43 232 36889999999999999999999998654322110000
Q ss_pred ccccchhhcccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 308 KRKIFRIIDNRL--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 308 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
....... ........+..+.+++.+||+.||++| |+.++++.|+++....
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 216 -----RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -----BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -----HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0000000 001112234568899999999999999 9999999999886543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=326.76 Aligned_cols=244 Identities=18% Similarity=0.165 Sum_probs=180.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCC-CCc-------
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEVNYLGQLYH-PNL------- 140 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-p~i------- 140 (404)
++|...++||+|+||.||+|. +..+|+.||||++..... ...+.+.+|+.+++.+.| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~---------~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEAT---------DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEE---------ecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457778899999999999954 445788999999874332 224678899999999977 221
Q ss_pred --ce------------EEEEEEe-----CCeeEEEEeccCCCChHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHHHHh
Q 046897 141 --VK------------LVGYCLE-----DDHRLLVYEFMPRGSLENHLFRR---GSYFQPLSWNLRLKVALGAAKGVAFL 198 (404)
Q Consensus 141 --v~------------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~l~~L 198 (404)
+. +..++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 11 1111111 22457788877 78999988522 22224578889999999999999999
Q ss_pred HcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccc----------ccCCCCcccc
Q 046897 199 HGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYL----------ATGHLTAKSD 268 (404)
Q Consensus 199 H~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 268 (404)
| +.+|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++ .+..++.++|
T Consensus 228 H--~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 228 H--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp H--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred H--hCCcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 9 89999999999999999999999999999876432 1344567 999999998 5556888999
Q ss_pred hhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 046897 269 VYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM 348 (404)
Q Consensus 269 iwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 348 (404)
||||||++|||++|+.||......... ..++... .. .+..+.+|+.+||+.||++||+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~----------------~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGS----------------EWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCS----------------GGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhH----------------HHHHhhc--cc----CCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999999754322111 1111100 11 2356889999999999999999
Q ss_pred HHHHHHH
Q 046897 349 MAEVVTV 355 (404)
Q Consensus 349 ~~eil~~ 355 (404)
+.++++.
T Consensus 358 ~~~~l~~ 364 (413)
T 3dzo_A 358 PLQAMET 364 (413)
T ss_dssp HHHHTTS
T ss_pred HHHHHhC
Confidence 8887653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=337.16 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=193.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 4789999999999999999975532 1578899999865432 334567899999999999999999999987
Q ss_pred CCe-----eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEE
Q 046897 150 DDH-----RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAK 224 (404)
Q Consensus 150 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vk 224 (404)
.+. .|+||||+++++|.+++.. .+++..++.++.||+.||.||| +.+|+||||||+|||++.+ .+|
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CEE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cEE
Confidence 665 6999999999999887643 5899999999999999999999 7899999999999999885 999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.........
T Consensus 222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------- 285 (681)
T 2pzi_A 222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------- 285 (681)
T ss_dssp ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------
T ss_pred EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---------
Confidence 9999999865432 345799999999998664 488999999999999999999988642211000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhHh
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-MMAEVVTVLEQLQD 361 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~ 361 (404)
...........+.+++.+||+.||++|| ++.++...|..+..
T Consensus 286 ---------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ---------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ---------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ---------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0011112345688999999999999999 56777777776643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=299.77 Aligned_cols=228 Identities=24% Similarity=0.301 Sum_probs=178.4
Q ss_pred cCCCCC-CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHH-hcCCCCCcceEEEEEEe
Q 046897 72 RNFRPD-SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL-GQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~ 149 (404)
++|.+. ++||+|+||.||++. +..++..||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIF---------NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEE---------EcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 456666 789999999999954 4457889999998643 5567888888 56689999999999987
Q ss_pred ----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCc
Q 046897 150 ----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYN 222 (404)
Q Consensus 150 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~ 222 (404)
....++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCc
Confidence 6678999999999999999987542 46899999999999999999999 889999999999999998 788
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+||+|||++.... +..++.++|||||||++|+|++|+.||............
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---- 210 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---- 210 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----
Confidence 9999999986421 245788999999999999999999999754322110000
Q ss_pred hhhhhccccchhhcccccCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 303 PYLASKRKIFRIIDNRLEGQYT----LEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
...+.... ...+ ...+..+.+++.+||+.||++|||+.++++.
T Consensus 211 --------~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 211 --------KTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --------CCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 0111 1235678899999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=300.90 Aligned_cols=238 Identities=16% Similarity=0.157 Sum_probs=182.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCC------
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--------QGHKEWLAEVNYLGQLY------ 136 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 136 (404)
.++|++.+.||+|+||.||+|+. ++..||+|++..... ...+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 46799999999999999999653 468999999976532 22367888988888875
Q ss_pred ---CCCcceEEEEEE------------------------------eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHH
Q 046897 137 ---HPNLVKLVGYCL------------------------------EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183 (404)
Q Consensus 137 ---hp~iv~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 183 (404)
||||+++.+++. .....|+||||+++|++.+.+.+ ..+++..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~ 162 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLAT 162 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHH
Confidence 888888877653 26789999999999976666643 3579999
Q ss_pred HHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC--------------------cEEEecccCCCCCCCCCCCcce
Q 046897 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--------------------NAKLSDFGLAKDGPTGDQSHVS 243 (404)
Q Consensus 184 ~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~ 243 (404)
++.++.||+.||.|||. +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus 163 ~~~i~~qi~~aL~~lH~-~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------- 234 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------- 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHH-HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------
T ss_pred HHHHHHHHHHHHHHHHH-hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------
Confidence 99999999999999992 37899999999999999887 899999999986432
Q ss_pred eeccccccccCccccccCCCCcccchhhhhHH-HHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccchhh-----cc
Q 046897 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVV-LLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRII-----DN 317 (404)
Q Consensus 244 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~l-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 317 (404)
....||+.|+|||++.+.. +.++||||||++ .++++.|..||... .|.... ...+. ..
T Consensus 235 ~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~------~~~~~~~~~~~~ 298 (336)
T 2vuw_A 235 GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYL------TDKMLKQMTFKT 298 (336)
T ss_dssp TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHH------HHHHHHTCCCSS
T ss_pred CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHH------HHhhhhhhccCc
Confidence 1347999999999998766 889999998777 78889999998431 110000 00111 00
Q ss_pred cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 046897 318 RLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353 (404)
Q Consensus 318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 353 (404)
..........+.++.+||.+||+.| |+.+++
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 1111223457788999999999977 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-33 Score=276.94 Aligned_cols=174 Identities=17% Similarity=0.109 Sum_probs=129.5
Q ss_pred ccCCCCcEEEEEEecCCCc----------ccHHHHHHHHHHHhcC-CCCCcceEEEEEEeCCeeEEEEeccCCCChHHHH
Q 046897 101 TKPGTGMVIAVKRLNQDGF----------QGHKEWLAEVNYLGQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHL 169 (404)
Q Consensus 101 ~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 169 (404)
+....|..+++|++..+.. ...+++.+|+++|+++ .|+||+++++++.+++..||||||++|++|.++|
T Consensus 254 rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i 333 (569)
T 4azs_A 254 RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDML 333 (569)
T ss_dssp EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHH
T ss_pred ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence 3334578899999976522 2224688999999999 6999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeecccc
Q 046897 170 FRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249 (404)
Q Consensus 170 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt 249 (404)
...+ +++.. .|+.||+.||+||| +++|+||||||+||||+.+|.+||+|||+|+...... ......+||
T Consensus 334 ~~~~----~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGT 402 (569)
T 4azs_A 334 AAGE----EIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQS 402 (569)
T ss_dssp HTTC----CCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHH
T ss_pred HhCC----CCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceec
Confidence 8764 45544 57899999999999 8999999999999999999999999999998654322 123457899
Q ss_pred ccccCccccccCCCCcccchhhhhHHHHHHHhCCCCc
Q 046897 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAV 286 (404)
Q Consensus 250 ~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~ 286 (404)
+.|||||++.+ .+..++|+|++|+++++|.++..++
T Consensus 403 p~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 403 FFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHC------------------CCCCTTHHHH
T ss_pred hhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 99999999865 4677899999999999887766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-29 Score=246.45 Aligned_cols=187 Identities=17% Similarity=0.233 Sum_probs=143.7
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc--------HHHHHHHHHHHhcCCCCCcceEEE
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--------HKEWLAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~ 145 (404)
+...++||+|+||.||+|.. .+..+++|......... .+++.+|+++|++++||||+++..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 406 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI 406 (540)
T ss_dssp ----------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred CCCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence 34567899999999999633 35678888765432211 234789999999999999996666
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
++...+..|+||||+++++|.+++.. +..++.|++.+|.||| +++|+||||||+|||++. .+||
T Consensus 407 ~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 407 FDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp EEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEE
T ss_pred EEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEE
Confidence 66677888999999999999999864 4689999999999999 889999999999999998 9999
Q ss_pred ecccCCCCCCCCCCCc-----ceeeccccccccCcccccc--CCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 226 SDFGLAKDGPTGDQSH-----VSTRVMGTYGYAAPEYLAT--GHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
+|||+++......... ......||+.|||||++.+ ..|+...|+|+..+-..+.+.++.+|.
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999998764422111 1235689999999999976 678888999999999999888877663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-24 Score=199.64 Aligned_cols=161 Identities=15% Similarity=0.052 Sum_probs=122.1
Q ss_pred HHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc------------------ccHHHHHHHH
Q 046897 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF------------------QGHKEWLAEV 129 (404)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~ 129 (404)
......|.+.+.||+|+||.||+|.+ .+|..||+|.+..... .....+.+|+
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~ 155 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 155 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH
T ss_pred HhCCeEEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHH
Confidence 33445667779999999999999644 4688999999864321 1234588999
Q ss_pred HHHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecC
Q 046897 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRD 209 (404)
Q Consensus 130 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~D 209 (404)
.+++.++| +++.+++.. +..|+||||+++++|.+ +.. .....++.|++.||.||| +.+|+|||
T Consensus 156 ~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH--~~giiHrD 218 (282)
T 1zar_A 156 RALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFY--HRGIVHGD 218 (282)
T ss_dssp HHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHH--HTTEECSC
T ss_pred HHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHH--HCCCEeCC
Confidence 99999984 555554433 56799999999999988 421 124469999999999999 89999999
Q ss_pred CCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc----------CCCCcccchhh
Q 046897 210 FKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT----------GHLTAKSDVYS 271 (404)
Q Consensus 210 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws 271 (404)
|||+|||++ ++.+||+|||+++.. ..++|||.+.. ..|+..+|+|.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999 999999999998642 33788887743 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-20 Score=167.68 Aligned_cols=138 Identities=18% Similarity=0.071 Sum_probs=103.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcE--EEEEEecCCCcc--c----------------------HHHHHH
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMV--IAVKRLNQDGFQ--G----------------------HKEWLA 127 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~--~----------------------~~~~~~ 127 (404)
|.+.+.||+|+||.||+|.. ..+|.. ||+|++...... . ...+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~---------~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADG---------VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEE---------EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEE---------cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 56788999999999999654 234778 999987543111 0 125788
Q ss_pred HHHHHhcCCCCCc--ceEEEEEEeCCeeEEEEeccCC-C----ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 046897 128 EVNYLGQLYHPNL--VKLVGYCLEDDHRLLVYEFMPR-G----SLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHG 200 (404)
Q Consensus 128 E~~~l~~l~hp~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 200 (404)
|+.+|..+.|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.|||.
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH
Confidence 9999999987754 444432 357899999932 3 67665432 2244577899999999999993
Q ss_pred CCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 201 AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 201 ~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
..+|+||||||+|||++. .++|+|||++...
T Consensus 189 -~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 -EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp -TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred -HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 368999999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=157.16 Aligned_cols=139 Identities=12% Similarity=0.072 Sum_probs=97.8
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-----c---------cHH--------HHHHHHH
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-----Q---------GHK--------EWLAEVN 130 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~---------~~~--------~~~~E~~ 130 (404)
-|.+.+.||.|+||.||+|.. .+|+.||||+++.... . ... ...+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d----------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD----------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC----------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEEC----------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 388899999999999999643 2488999998753210 0 000 1235677
Q ss_pred HHhcCCCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCC
Q 046897 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDF 210 (404)
Q Consensus 131 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dl 210 (404)
.|.++.+.++.-..-+... ..+|||||++|+.|..+.. . .....++.||+.+|.+|| ..+||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH--~~gIVHrDL 231 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLA--KHGLIHGDF 231 (397)
T ss_dssp HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHH--HTTEECSCC
T ss_pred HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHH--HCCCcCCCC
Confidence 7777754443221111112 2479999999888765431 1 124567899999999999 789999999
Q ss_pred CCCcEEEcCCC----------cEEEecccCCCCCC
Q 046897 211 KTSNILLDTNY----------NAKLSDFGLAKDGP 235 (404)
Q Consensus 211 kp~NIll~~~~----------~vkl~Dfg~a~~~~ 235 (404)
||.|||++.++ .+.|+||+.+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999998876 38999999887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.7e-13 Score=120.18 Aligned_cols=144 Identities=13% Similarity=-0.003 Sum_probs=109.1
Q ss_pred HHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEE
Q 046897 69 TATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYC 147 (404)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 147 (404)
.....|.+...++.|+++.||++. . .+..+++|+...........+.+|+.+++.+. +..+.++++++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~---------~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~ 79 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLV---------G--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEE---------C--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEE---------C--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 344578888889999999999843 2 25689999986532122345788999999884 67788999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-------------------------
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE------------------------- 202 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------- 202 (404)
...+..|+||||++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 80 ~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 80 RHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred ecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 988899999999999998775311 1123467788889999999410
Q ss_pred --------------------------------CCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 203 --------------------------------TKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 203 --------------------------------~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.4e-11 Score=110.69 Aligned_cols=134 Identities=17% Similarity=0.056 Sum_probs=93.5
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC--cceEEEEEEeCC
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN--LVKLVGYCLEDD 151 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~~ 151 (404)
+.+..+.+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++.+...++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~----------~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA----------QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC----------TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CceEecccCCCCceEEEEec----------CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 33333334566799998432 24567999987654 2245678888888885434 556888888777
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-----------------------------
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE----------------------------- 202 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------- 202 (404)
..++||||++|.+|. .. ... ...++.+++..|..||...
T Consensus 89 ~~~~v~e~i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp CEEEEEECCSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred CCEEEEEecCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 889999999998873 21 111 1255677777788888321
Q ss_pred ---------------------------CCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 203 ---------------------------TKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 203 ---------------------------~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
..++|+|++|.||+++.++.+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.1e-10 Score=108.29 Aligned_cols=141 Identities=14% Similarity=0.195 Sum_probs=102.3
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEec--CCC-cccHHHHHHHHHHHhcCC--CCCcceEEEEEEeC
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN--QDG-FQGHKEWLAEVNYLGQLY--HPNLVKLVGYCLED 150 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~ 150 (404)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567899999999985321 3568888775 322 122345778999999886 45578888888766
Q ss_pred ---CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC--------------------------
Q 046897 151 ---DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA-------------------------- 201 (404)
Q Consensus 151 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------- 201 (404)
+..|+||||++|..+.+.. ...++......++.+++..|..||..
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK 184 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence 3479999999987774311 13467888888999999999999942
Q ss_pred ------------------------------CCCceecCCCCCcEEEcCCCc--EEEecccCCCC
Q 046897 202 ------------------------------ETKVIYRDFKTSNILLDTNYN--AKLSDFGLAKD 233 (404)
Q Consensus 202 ------------------------------~~~i~H~Dlkp~NIll~~~~~--vkl~Dfg~a~~ 233 (404)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 146899999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.4e-10 Score=106.87 Aligned_cols=182 Identities=19% Similarity=0.207 Sum_probs=117.8
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCC--cceEEEEEEeCC--
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPN--LVKLVGYCLEDD-- 151 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~--iv~~~~~~~~~~-- 151 (404)
.+.++.|....||+ +. ..+++|+.... .....+.+|+++|+.+. +.. +..++......+
T Consensus 25 i~~~~~G~~n~v~~---------v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYE---------IN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEE---------ST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEE---------EC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 46689999999997 21 45888986533 33466889999998873 332 344554443333
Q ss_pred -eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC-----------------------------
Q 046897 152 -HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA----------------------------- 201 (404)
Q Consensus 152 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------------------------- 201 (404)
..|+||++++|.+|...... .++......++.+++..|..||..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 34889999999888654332 356667777777787777777731
Q ss_pred ---------------------------CCCceecCCCCCcEEEcC--CCcEEEecccCCCCCCCCCCCcceeeccccccc
Q 046897 202 ---------------------------ETKVIYRDFKTSNILLDT--NYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252 (404)
Q Consensus 202 ---------------------------~~~i~H~Dlkp~NIll~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 252 (404)
...++|+|++|.||+++. ++.+.|+||+.+........ ......+
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~ 236 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMED 236 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCT
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhh
Confidence 134799999999999988 45678999998865322100 0000011
Q ss_pred ---cCcccccc-----CC---------CCcccchhhhhHHHHHHHhCCCCc
Q 046897 253 ---AAPEYLAT-----GH---------LTAKSDVYSFGVVLLEMLSGRRAV 286 (404)
Q Consensus 253 ---~aPE~~~~-----~~---------~~~~~DiwslG~ll~ell~g~~p~ 286 (404)
..|+.... +. ...-.+.|++|.++|.+.+|..+|
T Consensus 237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 237 DEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221110 00 112258999999999999999876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=3.6e-07 Score=82.20 Aligned_cols=133 Identities=16% Similarity=0.094 Sum_probs=91.9
Q ss_pred ccccCcc-cEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEEEE
Q 046897 80 LGEGGFG-SVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLLVY 157 (404)
Q Consensus 80 lg~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 157 (404)
+..|..| .||+. .....+..+++|+-... ....+.+|...|+.+. +--+.+++.++.+++..|+||
T Consensus 32 ~~~G~S~~~v~rl---------~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRL---------YGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEE---------ECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEE---------EecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4445554 58873 33334667889976543 3456778999988874 334677888888889999999
Q ss_pred eccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------------------------------------
Q 046897 158 EFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA------------------------------------ 201 (404)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------------------ 201 (404)
|+++|.++.+...... .....+..++...|..||..
T Consensus 100 e~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp ECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 9999988877654321 12234455566666666621
Q ss_pred --------------------CCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 202 --------------------ETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 202 --------------------~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1126899999999999987777899998875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=5.1e-07 Score=82.94 Aligned_cols=135 Identities=20% Similarity=0.120 Sum_probs=89.3
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC---CcceEEEEEE-eCCe
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP---NLVKLVGYCL-EDDH 152 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~~~~~~~-~~~~ 152 (404)
.+.++.|....||+. +..+++|+... ......+.+|+++|+.+.+. .+.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 356788888899972 35588887532 22345688999999998642 3556666664 3456
Q ss_pred eEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHc--------------------------------
Q 046897 153 RLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHG-------------------------------- 200 (404)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-------------------------------- 200 (404)
.|+||||++|..|...... .++......++.++...|..||.
T Consensus 88 ~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~ 161 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF 161 (306)
T ss_dssp EEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred eEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence 7899999999888663211 12333444444444444444442
Q ss_pred --------------------------CCCCceecCCCCCcEEEcC---CCcE-EEecccCCCC
Q 046897 201 --------------------------AETKVIYRDFKTSNILLDT---NYNA-KLSDFGLAKD 233 (404)
Q Consensus 201 --------------------------~~~~i~H~Dlkp~NIll~~---~~~v-kl~Dfg~a~~ 233 (404)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 4554 8999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.8e-06 Score=80.90 Aligned_cols=84 Identities=4% Similarity=-0.104 Sum_probs=52.1
Q ss_pred Ccc-cccCcccEEEEEecCcccccccCC--CCcEEEEEEecCCC---cccHHHHHHHHHHHhcCC-C--CCcceEEEEEE
Q 046897 78 SVL-GEGGFGSVFKGWIDEHSFAATKPG--TGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLY-H--PNLVKLVGYCL 148 (404)
Q Consensus 78 ~~l-g~G~~g~Vy~~~~~~~~~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~ 148 (404)
+.| +.|....+|+..... ...+ .+..+++|+..... ......+.+|+.+++.+. + -.+.+++.++.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~-----~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARW-----QQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEECTTSSEEEEEEEEEEE-----EETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EECCCCCccceEEEEEEec-----ccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 456 788889999854320 0000 14678888765432 111245677888888774 2 34677787765
Q ss_pred eC---CeeEEEEeccCCCChH
Q 046897 149 ED---DHRLLVYEFMPRGSLE 166 (404)
Q Consensus 149 ~~---~~~~lv~e~~~~~~L~ 166 (404)
+. +..|+||||++|..+.
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCCC
T ss_pred CCCccCCceEEEEecCCCChh
Confidence 54 3468999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=5.4e-06 Score=78.95 Aligned_cols=76 Identities=13% Similarity=0.090 Sum_probs=47.9
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-------ccHHHHHHHHHHHhcCCC--CC-cceEEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-------QGHKEWLAEVNYLGQLYH--PN-LVKLVGY 146 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p~-iv~~~~~ 146 (404)
.+.||.|.++.||++... ..+..+++|....... ....++..|.++|+.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~---------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEEC---------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 457999999999995432 2356799997643211 123456778888887632 33 3455543
Q ss_pred EEeCCeeEEEEeccCCC
Q 046897 147 CLEDDHRLLVYEFMPRG 163 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~ 163 (404)
+.+..++|||++++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=4.6e-05 Score=70.60 Aligned_cols=31 Identities=23% Similarity=0.293 Sum_probs=27.9
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5779999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00017 Score=66.02 Aligned_cols=75 Identities=17% Similarity=0.120 Sum_probs=56.5
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCCcceEEEEEEeCCee
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY---HPNLVKLVGYCLEDDHR 153 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~ 153 (404)
.+.|+.|....+|+... .+..+++|+.... ....+..|...|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 35688999999998431 2467889987543 2456788988888873 35688888888877889
Q ss_pred EEEEeccCCCCh
Q 046897 154 LLVYEFMPRGSL 165 (404)
Q Consensus 154 ~lv~e~~~~~~L 165 (404)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.70 E-value=0.0002 Score=61.00 Aligned_cols=102 Identities=15% Similarity=0.044 Sum_probs=67.9
Q ss_pred CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcc
Q 046897 163 GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242 (404)
Q Consensus 163 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~ 242 (404)
-+|.+.|...+ .+++++++|.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 37999998776 689999999999999999877620 11112333457999999999998764 1111
Q ss_pred eeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCC
Q 046897 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284 (404)
Q Consensus 243 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~ 284 (404)
.....+.+||... ...+.+.=|||||+++|.-+--..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122366888763 345678899999999999886443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00015 Score=65.99 Aligned_cols=31 Identities=19% Similarity=0.078 Sum_probs=25.9
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5667889999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0006 Score=61.58 Aligned_cols=79 Identities=19% Similarity=0.167 Sum_probs=54.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC---CCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH---PNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~~~~~~~ 148 (404)
....-.+.+|.|..+.||+.... +|+.|++|+...........+..|++.|+.|.- -.+.+++++.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred CCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence 44445677899999999986543 478899998765544444567789998888742 2345555542
Q ss_pred eCCeeEEEEeccCCCC
Q 046897 149 EDDHRLLVYEFMPRGS 164 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~ 164 (404)
.-++||||++++.
T Consensus 84 ---~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 ---DRTLAMEWVDERP 96 (288)
T ss_dssp ---TTEEEEECCCCCC
T ss_pred ---CceEEEEeecccC
Confidence 3478999997654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00059 Score=65.29 Aligned_cols=78 Identities=15% Similarity=0.138 Sum_probs=47.7
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeecc--ccccccCccccccC---CCCcccchhhhhHHH
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM--GTYGYAAPEYLATG---HLTAKSDVYSFGVVL 276 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DiwslG~ll 276 (404)
...++|+|+++.|||++.++ ++|+||+.+........ ..... -...|.+|+..... ......++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 67899999999999998876 99999998875322110 00001 11345566544211 111234555777788
Q ss_pred HHHHhCC
Q 046897 277 LEMLSGR 283 (404)
Q Consensus 277 ~ell~g~ 283 (404)
|+.+.+.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0009 Score=62.92 Aligned_cols=149 Identities=14% Similarity=0.125 Sum_probs=81.4
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 155 (404)
.+.|..|-...+|+....+.. ......+..+++|+.... ........+|.++++.|. +.-..++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 456777888889986543210 001123568999986332 233456678999888874 3333566665532 28
Q ss_pred EEeccCCCChHH--------------HHh---hcC-CCCCCCC--HHHHHHHHHHHHH-------------------HHH
Q 046897 156 VYEFMPRGSLEN--------------HLF---RRG-SYFQPLS--WNLRLKVALGAAK-------------------GVA 196 (404)
Q Consensus 156 v~e~~~~~~L~~--------------~l~---~~~-~~~~~l~--~~~~~~i~~qi~~-------------------~l~ 196 (404)
||||++|.+|.. .+. ... ....+.. +..+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998755431 111 110 1111222 3445555544321 122
Q ss_pred H----hHc--CCCCceecCCCCCcEEEcCC----CcEEEecccCCC
Q 046897 197 F----LHG--AETKVIYRDFKTSNILLDTN----YNAKLSDFGLAK 232 (404)
Q Consensus 197 ~----LH~--~~~~i~H~Dlkp~NIll~~~----~~vkl~Dfg~a~ 232 (404)
. |.. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 221 13468999999999999876 789999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0061 Score=55.84 Aligned_cols=142 Identities=15% Similarity=0.116 Sum_probs=76.2
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--CcceEEEE-----EEeC
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHP--NLVKLVGY-----CLED 150 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~-----~~~~ 150 (404)
..|+ |....||+... .+|..+++|...... .....+..|..+++.+... .+.+++.. ...+
T Consensus 32 ~~l~-g~~n~~y~v~~----------~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD----------EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECC----------TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEc----------CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 3466 77788997321 235579999886432 2345566777777766311 13333332 1224
Q ss_pred CeeEEEEeccCCCChH-----HH---------HhhcC---CC--CCCCCHHHH----------------------HHHHH
Q 046897 151 DHRLLVYEFMPRGSLE-----NH---------LFRRG---SY--FQPLSWNLR----------------------LKVAL 189 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~-----~~---------l~~~~---~~--~~~l~~~~~----------------------~~i~~ 189 (404)
+..+++|++++|..+. .+ ++... .. ...++.... ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5667899999774331 11 11100 00 011221110 11112
Q ss_pred HHHHHHHHhHc--CCCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 190 GAAKGVAFLHG--AETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 190 qi~~~l~~LH~--~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
.++..+.-+-. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222222210 145689999999999998 4 899999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0031 Score=58.10 Aligned_cols=32 Identities=28% Similarity=0.330 Sum_probs=27.9
Q ss_pred CCCceecCCCCCcEEEcCC----CcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTN----YNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~----~~vkl~Dfg~a~~ 233 (404)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4679999999999999874 6799999998865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.006 Score=55.74 Aligned_cols=159 Identities=14% Similarity=0.134 Sum_probs=81.7
Q ss_pred ccCHHHHHHHhcCCCCC-----CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC
Q 046897 61 SFSFSDLKTATRNFRPD-----SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQL 135 (404)
Q Consensus 61 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l 135 (404)
.++..++.....+|.+. +.|+.|....+|+.... .+ .+++|+.... .....+..|+.+++.|
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~----------~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L 72 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT----------KD-PLILTLYEKR--VEKNDLPFFLGLMQHL 72 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES----------SC-CEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC----------Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHH
Confidence 34455566666667663 34566777889874321 23 5889988653 1223455677766665
Q ss_pred C-----CCCcceEE-E--EEEeCCeeEEEEeccCCCChHH--------------HHhhcC-CCCCC----CC---HHHHH
Q 046897 136 Y-----HPNLVKLV-G--YCLEDDHRLLVYEFMPRGSLEN--------------HLFRRG-SYFQP----LS---WNLRL 185 (404)
Q Consensus 136 ~-----hp~iv~~~-~--~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~-~~~~~----l~---~~~~~ 185 (404)
. -|.++... + +....+..+++|+|++|..+.. .++... ....+ .. |...+
T Consensus 73 ~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~ 152 (322)
T 2ppq_A 73 AAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLW 152 (322)
T ss_dssp HHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHH
T ss_pred HHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHH
Confidence 3 23333210 0 1122456789999998754311 111111 11001 11 11100
Q ss_pred H------------HHHHHHHHHHHhHc-----CCCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 186 K------------VALGAAKGVAFLHG-----AETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 186 ~------------i~~qi~~~l~~LH~-----~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
. +...+...++.+.. ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 153 DKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0 00112333444431 13568999999999999887666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0011 Score=63.60 Aligned_cols=80 Identities=15% Similarity=0.061 Sum_probs=47.6
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN-LVKLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 155 (404)
.+.|+.|....||+....... ......+..+++|+..... ....+..|+.+++.|...+ ..++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~--~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVY--PPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTS--CCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCc--cccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 356777888899986543210 0001235678999874321 2245667888888874333 356666543 2 38
Q ss_pred EEeccCCCC
Q 046897 156 VYEFMPRGS 164 (404)
Q Consensus 156 v~e~~~~~~ 164 (404)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999997633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.002 Score=62.17 Aligned_cols=74 Identities=15% Similarity=0.052 Sum_probs=42.9
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNL-VKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv 156 (404)
+.|+.|-...+|+.... ..+..+++|+........ -...+|+.+++.|...++ .++++.+ .+ .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~---------~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDM---------SKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEET---------TTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEE
T ss_pred EEcCCCeEeEEEEEEEC---------CCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEE
Confidence 45667777888885432 124678888875432111 112478888888864444 5666665 22 359
Q ss_pred EeccCCCCh
Q 046897 157 YEFMPRGSL 165 (404)
Q Consensus 157 ~e~~~~~~L 165 (404)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0024 Score=59.84 Aligned_cols=82 Identities=7% Similarity=0.007 Sum_probs=41.7
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-cceEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN-LVKLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 155 (404)
.+.|+.|....+|+........ ...+..+..+++|+..... ........|..+++.+...+ +.++++.+ . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 3457778888899864321000 0001123578888765432 11112356777777774223 44666544 2 368
Q ss_pred EEeccCCCC
Q 046897 156 VYEFMPRGS 164 (404)
Q Consensus 156 v~e~~~~~~ 164 (404)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.025 Score=52.12 Aligned_cols=32 Identities=13% Similarity=0.150 Sum_probs=27.8
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~ 233 (404)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35689999999999999888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.12 E-value=0.066 Score=50.90 Aligned_cols=81 Identities=12% Similarity=0.002 Sum_probs=44.9
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 156 (404)
+.|..|-...+|+........ .....+..+++++..... ...-...+|.++++.+. +.-..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 456667788899865432100 001125778999865432 11112346777777774 32345555533 2 3789
Q ss_pred EeccCCCCh
Q 046897 157 YEFMPRGSL 165 (404)
Q Consensus 157 ~e~~~~~~L 165 (404)
|+|++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.98 E-value=0.072 Score=50.30 Aligned_cols=29 Identities=28% Similarity=0.321 Sum_probs=24.6
Q ss_pred ceecCCCCCcEEE------cCCCcEEEecccCCCC
Q 046897 205 VIYRDFKTSNILL------DTNYNAKLSDFGLAKD 233 (404)
Q Consensus 205 i~H~Dlkp~NIll------~~~~~vkl~Dfg~a~~ 233 (404)
++|+|+.+.|||+ +.+..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.25 E-value=0.32 Score=41.26 Aligned_cols=116 Identities=9% Similarity=0.088 Sum_probs=79.4
Q ss_pred CCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 136 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
.||+++.. .+-..++.+.+.++.-..+.=...+ +.++....++++.+|+....+++ .-+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~----~r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNR----TRYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGG----SSEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhc----CceEEEEecceE
Confidence 68999877 5666667766666654322212223 23678899999999988775554 257888999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
+++.++.+++.--|+-... +|. .++...=.-.+=|++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987764332 121 11222234467789999999998885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.33 E-value=0.81 Score=38.88 Aligned_cols=115 Identities=10% Similarity=0.106 Sum_probs=77.8
Q ss_pred CCCCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HhHcCCCCceecCCCCCc
Q 046897 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVA-FLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 136 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~i~H~Dlkp~N 214 (404)
.||++ -..+-.+++.+.+.++.-+++.=...+. .++...+++++.+|+.... ++ ..-+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~----~~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHS----ARRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCC----SSSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhh----hCceeEEEeCce
Confidence 58888 4445566777777777654443333442 3678889999988877555 34 346788999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~ 287 (404)
|+++.++.++|.-.|+-.. ++|.- .+..-=+-.+=|++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998876433 22221 1222223367788899999988775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 404 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-71 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-66 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-71
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 31/293 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+G G FG+V+KG K + + + + Q + + EV L
Sbjct: 9 QITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+ H N++ +GY +V ++ SL +HL + + +A A
Sbjct: 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTA 114
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+G+ +LH +I+RD K++NI L + K+ DFGLA SH ++ G+ +
Sbjct: 115 QGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 253 AAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309
APE + + +SDVY+FG+VL E+++G+ + +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232
Query: 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362
K+ + L CL + RP+ +++ +E L S
Sbjct: 233 KVRSNCPKAM------------KRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 4e-66
Identities = 72/314 (22%), Positives = 132/314 (42%), Gaps = 32/314 (10%)
Query: 56 SPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
+ + S ++ + + LG G +G V++G + +AVK L
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLK 51
Query: 116 QDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSY 175
+D + +E+L E + ++ HPNLV+L+G C + ++ EFM G+L ++L
Sbjct: 52 EDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR- 109
Query: 176 FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235
Q +S + L +A + + +L + I+RD N L+ N+ K++DFGL++
Sbjct: 110 -QEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 236 TGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEH 295
GD + APE LA + KSDV++FGV+L E+ + + +
Sbjct: 167 -GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ- 224
Query: 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355
++ +++ + K L C RP AE+
Sbjct: 225 ---------------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269
Query: 356 LEQL-QDSSETGNI 368
E + Q+SS + +
Sbjct: 270 FETMFQESSISDEV 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 7e-66
Identities = 71/317 (22%), Positives = 132/317 (41%), Gaps = 40/317 (12%)
Query: 62 FSFSDLKTATRNF---------RPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVK 112
F+F D A R F + + V+G G FG V G + + +A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 113 RLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFR 171
L + +++L+E + +GQ HPN++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 172 RGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
+ + + G A G+ +L + ++RD NIL+++N K+SDFGL+
Sbjct: 121 N---DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 232 KDGPTGDQSHVSTRV---MGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDK 288
+ T + APE + T+ SDV+S+G+V+ E++S
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---- 231
Query: 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM 348
RP + + + I+ ++ L L C + RP
Sbjct: 232 -RPYWDMTNQD-----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 349 MAEVVTVLEQLQDSSET 365
++V L+++ + +
Sbjct: 280 FGQIVNTLDKMIRNPNS 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-65
Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 33/292 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ LG G FG V+ G+ + +AVK L Q +LAE N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQG-SMSPDAFLAEANLM 62
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
QL H LV+L + ++ E+M GSL + L L+ N L +A A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIA 119
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+G+AF+ E I+RD + +NIL+ + K++DFGLA+ ++ +
Sbjct: 120 EGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312
APE + G T KSDV+SFG++L E+++ R + E +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VI 220
Query: 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364
+ ++ + L C + RP + +VLE ++E
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-65
Identities = 75/308 (24%), Positives = 115/308 (37%), Gaps = 38/308 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNY 131
LG G FG V + ++ K M +AVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 132 LGQLY-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF-------------- 176
L L H N+V L+G C L++ E+ G L N L R+ F
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 177 QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPT 236
L L + AKG+AFL I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 237 GDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296
V + APE + T +SDV+S+G+ L E+ S + P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255
Query: 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVL 356
K +++I + + C + RP ++V ++
Sbjct: 256 -------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 357 E-QLQDSS 363
E Q+ +S+
Sbjct: 303 EKQISEST 310
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 8e-65
Identities = 80/294 (27%), Positives = 132/294 (44%), Gaps = 33/294 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNY 131
+F + V+G G FG V+ G + ++ G + AVK LN+ G ++L E
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 132 LGQLYHPNLVKLVGYCLEDD-HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ HPN++ L+G CL + L+V +M G L N + + + L
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQ 138
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD--GPTGDQSHVSTRVMG 248
AKG+ FL K ++RD N +LD + K++DFGLA+D D H T
Sbjct: 139 VAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308
+ A E L T T KSDV+SFGV+L E+++ P + N + L +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGR 251
Query: 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362
R L+ +Y + Y+ + L+C + + RP +E+V+ + + +
Sbjct: 252 R--------LLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-64
Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 39/290 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
+ + +G+G FG V G G +AVK + D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 132 LGQLYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
+ QL H NLV+L+G +E+ L +V E+M +GSL ++L RG L + LK +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLD 111
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+ + +L ++RD N+L+ + AK+SDFGL K+ S
Sbjct: 112 VCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPV 164
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
+ APE L + KSDV+SFG++L E+ S R P L + +
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYK- 218
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
D + C + RP ++ LE ++
Sbjct: 219 -MDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-64
Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 33/290 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+G G FG V G+ +A+K + + ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+L HP LV+L G CLE LV+EFM G L ++L + + L + L
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVC 111
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+G+A+L E VI+RD N L+ N K+SDFG+ + DQ ST +
Sbjct: 112 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 168
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312
A+PE + ++KSDV+SFGV++ E+ S + +NR + E +VE F
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGF 219
Query: 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362
R+ RL + C + RP + ++ L ++ +S
Sbjct: 220 RLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 2e-64
Identities = 75/327 (22%), Positives = 124/327 (37%), Gaps = 48/327 (14%)
Query: 56 SPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLN 115
+P L S + N +GEG FG VF+ + ++AVK L
Sbjct: 2 NPKLLSLEY-----PRNNIEYVRDIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLK 52
Query: 116 QDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGS 174
++ ++ E + + +PN+VKL+G C L++E+M G L L
Sbjct: 53 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSP 112
Query: 175 YF--------------------QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214
+ PLS +L +A A G+A+L E K ++RD T N
Sbjct: 113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRN 170
Query: 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGV 274
L+ N K++DFGL+++ + D + PE + T +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 275 VLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATL 334
VL E+ S +P E Y I +N + L
Sbjct: 231 VLWEIFSYGL-----QPYYGMAHEEVI--YYVRDGNILACPENCPL---------ELYNL 274
Query: 335 ALRCLSTEGKFRPMMAEVVTVLEQLQD 361
C S RP + +L+++ +
Sbjct: 275 MRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 4e-64
Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 43/309 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNY 131
N VLG G FG V ++ +K G + +AVK L + +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 132 LGQLY-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYF-------------- 176
+ QL H N+V L+G C L++E+ G L N+L + F
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 177 -----QPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231
L++ L A AKG+ FL ++RD N+L+ K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP 291
+D + V + APE L G T KSDV+S+G++L E+ S P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NP 266
Query: 292 SGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAE 351
+ +++I N + + + C + + + RP
Sbjct: 267 YPGIPVDAN----------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 352 VVTVLE-QL 359
+ + L QL
Sbjct: 317 LTSFLGCQL 325
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 7e-64
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 67 LKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEW 125
++ +F S LG G G VFK + +G+V+A K ++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 126 LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
+ E+ L + P +V G D + E M GSL+ L + G + +
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILG 107
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
KV++ KG+ +L + K+++RD K SNIL+++ KL DFG++ ++
Sbjct: 108 KVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 162
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
+GT Y +PE L H + +SD++S G+ L+EM GR
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 8e-64
Identities = 58/288 (20%), Positives = 106/288 (36%), Gaps = 33/288 (11%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
++ LG G FG V G +A+K + + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEG-SMSEDEFIEEAKV 52
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+ L H LV+L G C + ++ E+M G L N+L L++
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDV 109
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+ + +L + ++RD N L++ K+SDFGL++ D+ S
Sbjct: 110 CEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311
++ PE L ++KSD+++FGV++ E+ S + P E
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSE-----------T 210
Query: 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
I L + K T+ C + RP +++ + +
Sbjct: 211 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-63
Identities = 65/295 (22%), Positives = 133/295 (45%), Gaps = 28/295 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNY 131
V+G G FG V+KG + + + +A+K L + + ++L E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+GQ H N+++L G + +++ E+M G+L+ L + F S + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF---SVLQLVGMLRGI 119
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTRVMGTY 250
A G+ +L ++RD NIL+++N K+SDFGL++ + ++ ++
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
+ APE ++ T+ SDV+SFG+V+ E+++ + E
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------- 221
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365
+ + I++ ++ L ++C E RP A++V++L++L + ++
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-61
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 42/307 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNY 131
+ + V+GEG FG V K I K G M A+KR+ + H+++ E+
Sbjct: 11 DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 132 LGQLY-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRR------------GSYFQP 178
L +L HPN++ L+G C + L E+ P G+L + L + S
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD 238
LS L A A+G+ +L + + I+RD NIL+ NY AK++DFGL++
Sbjct: 124 LSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 239 QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298
+ T + A E L T SDV+S+GV+L E++S P
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCA 233
Query: 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358
E ++ + + L + L +C + RP A+++ L +
Sbjct: 234 E-----------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 359 LQDSSET 365
+ + +T
Sbjct: 283 MLEERKT 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-61
Identities = 68/314 (21%), Positives = 113/314 (35%), Gaps = 39/314 (12%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNY 131
R +G+G FG V++G G +AVK + + AE+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 132 LGQLYHPNLVKLVGYCLEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
L H N++ + +D+ LV ++ GSL ++L R ++ +K+
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKL 105
Query: 188 ALGAAKGVAFLH------GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAK--DGPTGDQ 239
AL A G+A LH + + +RD K+ NIL+ N ++D GLA D T
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 240 SHVSTRVMGTYGYAAPEYLAT------GHLTAKSDVYSFGVVLLEMLSGRR----AVDKN 289
+GT Y APE L ++D+Y+ G+V E+ D
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 290 RPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMM 349
P + + + + ++ N + E A + C G R
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 350 AEVVTVLEQLQDSS 363
+ L QL
Sbjct: 286 LRIKKTLSQLSQQE 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 7e-61
Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 31/293 (10%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAE 128
++ R LG+G FG V +G D S G + +AVK L D + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
VN + L H NL++L G L ++ V E P GSL + L + + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYA 117
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV-STRVM 247
+ A+G+ +L + I+RD N+LL T K+ DFGL + P D +V
Sbjct: 118 VQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 248 GTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307
+ + APE L T + SD + FGV L EM + + P N +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQI------- 223
Query: 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
+ +I + + ++C + + + RP + L + Q
Sbjct: 224 ---LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 31/288 (10%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNYLGQL 135
D LG G FGSV +G + +A+K L Q + +E + E + QL
Sbjct: 14 DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 136 YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGV 195
+P +V+L+G C + + +LV E G L L + + + + ++ + G+
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGM 122
Query: 196 AFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTRVMGTYGYAA 254
+L ++RD N+LL + AK+SDFGL+K G + + A
Sbjct: 123 KYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 255 PEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFRI 314
PE + +++SDV+S+GV + E LS + +P + E +
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE-----------VMAF 224
Query: 315 IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362
I+ + E + L C + + RP V + S
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-60
Identities = 65/288 (22%), Positives = 114/288 (39%), Gaps = 35/288 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVN 130
++ +G G +G K + G ++ K L+ + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQK---------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 131 YLGQLYHPNLVKLVGYCLE--DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L +L HPN+V+ ++ + +V E+ G L + + + Q L L+V
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 189 LGAAKGVAFLH---GAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
+ H V++RD K +N+ LD N KL DFGLA+ + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305
+GT Y +PE + KSD++S G +L E+ + P + E A
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAG--- 224
Query: 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353
KI R+ +Y+ E + R L+ + RP + E++
Sbjct: 225 ----KIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-60
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 30/288 (10%)
Query: 74 FRPDSVLGEGGFGSVFKG-WIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNY 131
F+ VLG G FG+V+KG WI E +A+K L + + +KE L E
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYV 64
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+ + +P++ +L+G CL +L + + MP G L +++ L +
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQI 120
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
AKG+ +L ++++RD N+L+ T + K++DFGLAK ++ + +
Sbjct: 121 AKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311
+ A E + T +SDV+S+GV + E+++ +P E I
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASE-----------I 222
Query: 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
I++ + ++C + RP E++ ++
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 9e-60
Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 33/285 (11%)
Query: 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVNYLGQ 134
D LG G FG+V KG+ +AVK L + E LAE N + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 135 LYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKG 194
L +P +V+++G C E + +LV E G L +L + + +++ + G
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMG 119
Query: 195 VAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG-DQSHVSTRVMGTYGYA 253
+ +L E+ ++RD N+LL T + AK+SDFGL+K + T +
Sbjct: 120 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 254 APEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313
APE + ++KSDV+SFGV++ E S + +P E +
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTA 221
Query: 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358
+++ + L C + + + RP A V L
Sbjct: 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-59
Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 33/292 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ R + LG+G FG V+ G T GT V A+K L + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMG---------TWNGTTRV-AIKTLKPG-TMSPEAFLQEAQVM 66
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
+L H LV+L ++ +V E+M +GSL + L + + +A A
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIA 123
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
G+A++ ++RD + +NIL+ N K++DFGLA+ ++ +
Sbjct: 124 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 180
Query: 253 AAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312
APE G T KSDV+SFG++L E+ + R + E +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VL 224
Query: 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364
++ E L +C E + RP + LE S+E
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-59
Identities = 60/289 (20%), Positives = 102/289 (35%), Gaps = 40/289 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEV 129
R + D +G G F +V+K T + +A L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYK---------GLDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 130 NYLGQLYHPNLVKLVGYCLE----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
L L HPN+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLR 115
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILL-DTNYNAKLSDFGLAKDGPTGDQSHVST 244
KG+ FLH +I+RD K NI + + K+ D GLA ++ +
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304
V+GT + APE DVY+FG+ +LEM + S N + +
Sbjct: 172 AVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYR-- 223
Query: 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353
R+ + + + C+ R + +++
Sbjct: 224 --------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-59
Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 36/285 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ LG+G FG V+K A T ++ A K ++ + ++++ E++ L
Sbjct: 13 FWEIIGELGDGAFGKVYK---------AQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
HPN+VKL+ +++ ++ EF G+++ + +PL+ + V
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTL 120
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGY 252
+ +LH + K+I+RD K NIL + + KL+DFG++ Q +GT +
Sbjct: 121 DALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYW 176
Query: 253 AAPEYLAT-----GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307
APE + K+DV+S G+ L+EM P E N + S
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKS 230
Query: 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ +CL R +++
Sbjct: 231 EPPTLAQPSRWSS---------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 7e-59
Identities = 66/282 (23%), Positives = 105/282 (37%), Gaps = 32/282 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNY 131
++ LGEG +G V A T +AVK ++ + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQL---------AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L H N+VK G+ E + + L E+ G L + + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQL 112
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
GV +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 113 MAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 252 YAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
Y APE L DV+S G+VL ML+G D+ S + K
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YLN 227
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
++ ID+ L + L R + ++
Sbjct: 228 PWKKIDS------------APLALLHKILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 7e-59
Identities = 72/303 (23%), Positives = 117/303 (38%), Gaps = 45/303 (14%)
Query: 57 PNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ 116
P++ F D + F +G G FG+V+ A V+A+K+++
Sbjct: 2 PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYF---------ARDVRNSEVVAIKKMSY 50
Query: 117 DGFQGHKEW---LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG 173
G Q +++W + EV +L +L HPN ++ G L + LV E+ + + +
Sbjct: 51 SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 110
Query: 174 SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233
PL V GA +G+A+LH +I+RD K NILL KL DFG A
Sbjct: 111 ----PLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 234 GPTGDQSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNR 290
+ +GT + APE + G K DV+S G+ +E+ +
Sbjct: 165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------P 212
Query: 291 PSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350
P N + I + L+ + E CL + RP
Sbjct: 213 PLFNMNAMSAL-------YHIAQNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSE 262
Query: 351 EVV 353
++
Sbjct: 263 VLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-58
Identities = 67/284 (23%), Positives = 108/284 (38%), Gaps = 40/284 (14%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEV 129
+F LG+G FG+V+ A + + ++A+K L + + EV
Sbjct: 7 DFEIGRPLGKGKFGNVYL---------AREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYIT 113
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
A +++ H +VI+RD K N+LL + K++DFG + P S T + GT
Sbjct: 114 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309
Y PE + K D++S GV+ E L G+ P + E K +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEF 221
Query: 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVV 353
+ A L R L RPM+ EV+
Sbjct: 222 TFPDFVTE------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-57
Identities = 65/296 (21%), Positives = 124/296 (41%), Gaps = 29/296 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHK-EWLAEVNY 131
LG+G FG V++G K +A+K +N+ + E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG------SYFQPLSWNLRL 185
+ + ++V+L+G + L++ E M RG L+++L P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTR 245
++A A G+A+L+ K ++RD N ++ ++ K+ DFG+ +D D +
Sbjct: 137 QMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305
+ + +PE L G T SDV+SFGVVL E+ + +P + + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLR--F 247
Query: 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361
+ + DN + L C K RP E+++ +++ +
Sbjct: 248 VMEGGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-56
Identities = 79/306 (25%), Positives = 118/306 (38%), Gaps = 36/306 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNY 131
+ LG G FG V + +F K T +AVK L + H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 132 LGQ-LYHPNLVKLVGYCLEDDHRL-LVYEFMPRGSLENHLFRRGSYFQP----------- 178
L +H N+V L+G C + L ++ EF G+L +L + + F P
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 179 -LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTG 237
L+ + + AKG+ FL K I+RD NILL K+ DFGLA+D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 238 DQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297
+ APE + T +SDV+SFGV+L E+ S P +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKI 242
Query: 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357
E L + R D + L C E RP +E+V L
Sbjct: 243 DEEFCRRLKEGTR-MRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 358 QLQDSS 363
L ++
Sbjct: 293 NLLQAN 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-55
Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 34/301 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEVNY 131
LGEG FG V KP +AVK L D + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 132 LGQLY-HPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRG------------SYFQP 178
+ + H N++ L+G C +D ++ E+ +G+L +L R + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 179 LSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGD 238
LS + A A+G+ +L K I+RD N+L+ + K++DFGLA+D D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 239 QSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV 298
+T + APE L T +SDV+SFGV+L E+ + + P E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQ 358
+F+++ + + C RP ++V L++
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 359 L 359
+
Sbjct: 294 I 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-55
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 30/290 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNY 131
+GEG FG V +G + + +A+K +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIY------MSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
+ Q HP++VKL+G ++ ++ E G L + L R L + A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQL 117
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
+ +A+L + ++RD N+L+ +N KL DFGL++ + +++
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIK 174
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311
+ APE + T+ SDV+ FGV + E+L +P + +R
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER-- 227
Query: 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361
+ N +L +C + + RP E+ L + +
Sbjct: 228 LPMPPNCPP---------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-54
Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 47/309 (15%)
Query: 49 SEGEILRSPNLKSF-SFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGM 107
S+ EIL L+S S D K + + +G+G G+V+ A TG
Sbjct: 1 SDEEILEK--LRSIVSVGDPK---KKYTRFEKIGQGASGTVYT---------AMDVATGQ 46
Query: 108 VIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLEN 167
+A++++N + + E+ + + +PN+V + L D +V E++ GSL +
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 168 HLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227
+ V + + FLH +VI+RD K+ NILL + + KL+D
Sbjct: 107 VVTETCM-----DEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVD 287
FG + + ++GT + APE + K D++S G++ +EM+ G
Sbjct: 160 FGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 288 KNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYK----AATLALRCLSTEG 343
P R ++ I N G L+ K RCL +
Sbjct: 218 NENP----------------LRALYLIATN---GTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 344 KFRPMMAEV 352
+ R E+
Sbjct: 259 EKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 59/298 (19%), Positives = 107/298 (35%), Gaps = 40/298 (13%)
Query: 68 KTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKE 124
K +F+ +LGEG F +V A + T A+K L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVL---------ARELATSREYAIKILEKRHIIKENKVPY 54
Query: 125 WLAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLR 184
E + + +L HP VKL +D+ + G L ++ + G
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCT 110
Query: 185 LKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVST 244
+ +LH +I+RD K NILL+ + + +++DFG AK + +
Sbjct: 111 RFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 245 RVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304
+GT Y +PE L SD+++ G ++ ++++G P+
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP------------------PF 210
Query: 305 LASKRKIFRIIDNRLEGQYTLEGAY--KAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360
A + I ++ +Y + KA L + L + R E+
Sbjct: 211 RAGNE--YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (437), Expect = 8e-51
Identities = 70/332 (21%), Positives = 113/332 (34%), Gaps = 40/332 (12%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
++ LG G FG V + T+ TG A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
L HP LV L +D+ +++YEFM G L + +S + ++
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVC 134
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYN--AKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
KG+ +H E ++ D K NI+ T + KL DFGL V GT
Sbjct: 135 KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 189
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
+AAPE + +D++S GV+ +LSG P G N E + +
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWN 243
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS-ETGNIR 369
+ + + + L + R + + L+ GN
Sbjct: 244 MDDSAFSGISED--------GKDFIRKLLLADPNTRMTIHQA------LEHPWLTPGNAP 289
Query: 370 CNTHNRPKIRRHSADDARSRSVTAYPRPSASP 401
P R D+ A+P P
Sbjct: 290 GRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPL 321
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 7e-49
Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 33/282 (11%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ LG G FG V + + TG V K +N E++ +
Sbjct: 30 YYDILEELGSGAFGVVHR---------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
QL+HP L+ L + +L+ EF+ G L + + +S + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQAC 137
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+G+ +H E +++ D K NI+ +T + K+ DFGLA + T
Sbjct: 138 EGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATA 192
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
+AAPE + + +D+++ GV+ +LSG P + +E + +
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWE 246
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ + + A L E + R + +
Sbjct: 247 FDEDAFSSVSPE--------AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (413), Expect = 3e-48
Identities = 65/297 (21%), Positives = 115/297 (38%), Gaps = 38/297 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVN 130
+ +LG GG V A +AVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHL---------ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRL----LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
L HP +V + + +V E++ +L + + G P++ ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIE 115
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTR 245
V A + + F H + +I+RD K +NI++ K+ DFG+A+ +G+ +
Sbjct: 116 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 246 VMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305
V+GT Y +PE + A+SDVYS G VL E+L+G P + V A ++
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHV 227
Query: 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-MMAEVVTVLEQLQD 361
L + L+ L+ + R AE+ L ++ +
Sbjct: 228 REDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (416), Expect = 9e-48
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 26/239 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEWLAEV 129
+F ++G GGFG V+ K TG + A+K L++ QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYG---------CRKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 130 N---YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLK 186
+ P +V + D + + M G L HL + G + + +
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 187 VALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRV 246
+ L G+ +H V+YRD K +NILLD + + ++SD GLA D
Sbjct: 116 IIL----GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHAS 165
Query: 247 MGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304
+GT+GY APE L G + +D +S G +L ++L G +++ +H +
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 1e-46
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 48/296 (16%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---------QGHK 123
N+ P +LG G V + T AVK ++ G + +
Sbjct: 4 NYEPKEILGRGVSSVVRR---------CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 124 EWLAEVNYLGQL-YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWN 182
L EV+ L ++ HPN+++L + LV++ M +G L ++L + LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEK 110
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
K+ + + LH + +++RD K NILLD + N KL+DFG + D
Sbjct: 111 ETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEK 165
Query: 243 STRVMGTYGYAAPEYLATGHL------TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHN 296
V GT Y APE + + D++S GV++ +L+G P
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRK 219
Query: 297 LVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ + ++ + + L R L + + R E
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-46
Identities = 63/237 (26%), Positives = 92/237 (38%), Gaps = 21/237 (8%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
+F +LG+G FG VF A T A+K L +D + + E
Sbjct: 3 DFILHKMLGKGSFGKVFL---------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 130 NYLG-QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L HP L + ++ V E++ G L H+ + A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYA 109
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
G+ FLH ++YRD K NILLD + + K++DFG+ K+ GD G
Sbjct: 110 AEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCG 165
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305
T Y APE L D +SFGV+L EML G+ + + P+
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 222
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-46
Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 46/288 (15%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+ LG G FG V + + + K + G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHR---------CVETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
H N++ L + ++++EF+ + + L+ +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVC 112
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLDTNYNA--KLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+ + FLH + + D + NI+ T ++ K+ +FG A+ GD + +
Sbjct: 113 EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
Y APE ++ +D++S G ++ +LSG P+LA +
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQ 209
Query: 311 IFRIIDNRLEGQYTLEGAY------KAATLALRCLSTEGKFRPMMAEV 352
+II+N + +YT + +A R L E K R +E
Sbjct: 210 --QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 1e-45
Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 36/283 (12%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-WLAEVNYL 132
+ VLG G F V A T ++A+K + + +G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVIL---------AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
++ HPN+V L H L+ + + G L + + +G + ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117
Query: 193 KGVAFLHGAETKVIYRDFKTSNILL---DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
V +LH + +++RD K N+L D + +SDFGL+K D V + GT
Sbjct: 118 DAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGT 172
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309
GY APE LA + D +S GV+ +L G P + N + + L ++
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEY 226
Query: 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ + + A + + + R +
Sbjct: 227 EFDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 63/290 (21%), Positives = 104/290 (35%), Gaps = 33/290 (11%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE-----WLAEVNYLG 133
LGEG F +V+K A T ++A+K++ K+ L E+ L
Sbjct: 5 FLGEGQFATVYK---------ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 134 QLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
+L HPN++ L+ + LV++FM L+ + L +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQ 111
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYA 253
G+ +LH + +++RD K +N+LLD N KL+DFGLAK G + T + T Y
Sbjct: 112 GLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYR 167
Query: 254 APEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPS----------GEHNLVEWAK 302
APE L + D+++ G +L E+L + + G +W
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227
Query: 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
F+ L R +
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-43
Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 28/298 (9%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGH-KEWLAEV 129
+ S +GEG +G V A + +A+K+++ Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCS---------AYDNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L + H N++ + + ++ + L++ Q LS +
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLY 116
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD-GPTGDQSHVSTRVMG 248
+G+ ++H V++RD K SN+LL+T + K+ DFGLA+ P D + T +
Sbjct: 117 QILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 249 TYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307
T Y APE + T D++S G +L EMLS R + N + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 308 KRKIFRIIDNRLEGQYTLEGAYK-------------AATLALRCLSTEGKFRPMMAEV 352
+ I +L K A L + L+ R + +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 3e-43
Identities = 54/302 (17%), Positives = 93/302 (30%), Gaps = 35/302 (11%)
Query: 66 DLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW 125
+L+ R +R +G G FG ++ T G +A+K H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYL---------GTDIAAGEEVAIKLECVK--TKHPQL 49
Query: 126 LAEVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
E + + + +C + ++ + SLE+ + S L
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVL 106
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNIL---LDTNYNAKLSDFGLAK-----DGPTG 237
+A + ++H I+RD K N L + DFGLAK
Sbjct: 107 LLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 238 DQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297
+ + GT YA+ + + D+ S G VL+ G + + +
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 298 VEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357
E K L Y E AT C S +P + + +
Sbjct: 225 YER------ISEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 358 QL 359
L
Sbjct: 275 NL 276
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 8e-43
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 28/293 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVN 130
NF+ +GEG +G V+K A TG V+A+K++ D + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYK---------ARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
L +L HPN+VKL+ ++ LV+EF+ + + F S + L
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQ 110
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+G+AF H +V++RD K N+L++T KL+DFGLA+ + V+ +
Sbjct: 111 LLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 167
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS----------GEHNLVEW 300
A L + + D++S G + EM++ R + G + V W
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 301 AKPY-LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ + F + + +L + L + R
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (377), Expect = 2e-42
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE---WLAE 128
++F+ LG G FG V G A+K L ++ K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHL---------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
L + HP ++++ G + ++ +++ LF Q + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+ +LH +IYRD K NILLD N + K++DFG AK P V+ + G
Sbjct: 111 AEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCG 163
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
T Y APE ++T D +SFG+++ EML+G
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-42
Identities = 61/295 (20%), Positives = 104/295 (35%), Gaps = 54/295 (18%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLA------ 127
+ LG G F V K + TG+ A K + + + + ++
Sbjct: 12 YDTGEELGSGQFAVVKK---------CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 128 EVNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
EV+ L ++ HPN++ L +L+ E + G L + L + L+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEF 118
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN----YNAKLSDFGLAKDGPTGDQSHVS 243
GV +LH ++ + D K NI+L K+ DFGLA G++
Sbjct: 119 LKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303
+ GT + APE + L ++D++S GV+ +LSG +
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------- 222
Query: 304 YLASKRKIFRIIDNRLEGQYTLEGAY------KAATLALRCLSTEGKFRPMMAEV 352
+ N Y E Y A R L + K R + +
Sbjct: 223 ---------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-41
Identities = 62/302 (20%), Positives = 108/302 (35%), Gaps = 35/302 (11%)
Query: 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---- 125
A + + + +GEG +G VFK G +A+KR+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPLSTIR 56
Query: 126 -LAEVNYLGQLYHPNLVKLVGYCL-----EDDHRLLVYEFMPRGSLENHLFRRGSYFQPL 179
+A + +L HPN+V+L C + LV+E + + +
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGV 113
Query: 180 SWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQ 239
+ +G+ FLH +V++RD K NIL+ ++ KL+DFGLA+
Sbjct: 114 PTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSF 168
Query: 240 SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299
T V+ T Y APE L D++S G + EM + + + +
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 300 WAKPY---------LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA 350
+A R+ F + ++ + L L+CL+ R
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 351 EV 352
Sbjct: 289 SA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (365), Expect = 3e-41
Identities = 55/293 (18%), Positives = 108/293 (36%), Gaps = 30/293 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVN 130
+ +GEG +G V+K + G A+K++ + + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
L +L H N+VKL +LV+E + + + G L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQ 108
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
G+A+ H + +V++RD K N+L++ K++DFGLA+ + + ++ +
Sbjct: 109 LLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLW 165
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS----------GEHNLVEW 300
A + + + D++S G + EM++G + G N W
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 301 AKPYLASKRKIFRIIDNRLEGQYTLEGAYKAAT-LALRCLSTEGKFRPMMAEV 352
K + L + L+G ++ L + L + R +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-41
Identities = 59/282 (20%), Positives = 97/282 (34%), Gaps = 39/282 (13%)
Query: 79 VLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-H 137
VLG G G V + T A+K L + EV +
Sbjct: 19 VLGLGINGKVLQ---------IFNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 138 PNLVKLVGYC----LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
P++V++V L+V E + G L + + RG Q + ++ +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGE 122
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYN---AKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
+ +LH + +RD K N+L + KL+DFG AK+ + + T
Sbjct: 123 AIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310
Y APE L D++S GV++ +L G P ++ + + R
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRM 231
Query: 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
N + + E L L TE R + E
Sbjct: 232 GQYEFPNPEWSEVSEE----VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 1e-40
Identities = 45/299 (15%), Positives = 85/299 (28%), Gaps = 40/299 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+++ +GEG FG +F+ T +A+K + + E
Sbjct: 6 HYKVGRRIGEGSFGVIFE---------GTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 133 GQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAA 192
L + V Y ++ ++ + SLE+ L G + S A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQML 111
Query: 193 KGVAFLHGAETKVIYRDFKTSNILLD-----TNYNAKLSDFGLAK-----DGPTGDQSHV 242
V +H E ++YRD K N L+ + DFG+ K
Sbjct: 112 ARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 243 STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA- 301
+ GT Y + + + D+ + G V + L G + + E
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 302 -KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359
K R++ + P + + ++
Sbjct: 230 EKKQSTPLRELCAGFPEEF------------YKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-40
Identities = 59/291 (20%), Positives = 98/291 (33%), Gaps = 56/291 (19%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKE------WLA 127
++ +LG GGFGSV+ + + +A+K + +D E
Sbjct: 6 YQVGPLLGSGGFGSVYS---------GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 128 EVNYLGQL--YHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRL 185
EV L ++ +++L+ + D +L+ E L L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELAR 113
Query: 186 KVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLSDFGLAKDGPTGDQSHVST 244
+ V H V++RD K NIL+D N KL DFG + V T
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 245 RVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303
GT Y+ PE++ + + V+S G++L +M+ G
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------------ 209
Query: 304 YLASKRKIFRIIDNRLEGQYTLEGAY--KAATLALRCLSTEGKFRPMMAEV 352
F + + GQ + L CL+ RP E+
Sbjct: 210 --------FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 6e-40
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 42/256 (16%)
Query: 36 SKVSSLSVPPTPRSEGEILRSPNLKSFSFSDLKTATRNFRPDSVLGEGGFGSVFKGWIDE 95
SKV+++ P + + S++D K V+G G FG V++
Sbjct: 1 SKVTTVVATPGQGPD-------RPQEVSYTDTK----------VIGNGSFGVVYQ----- 38
Query: 96 HSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD---- 151
A +G ++A+K++ QD + E+ + +L H N+V+L +
Sbjct: 39 ----AKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90
Query: 152 --HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRD 209
+ LV +++P Q L + +A++H + +RD
Sbjct: 91 EVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRD 147
Query: 210 FKTSNILLDTN-YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSD 268
K N+LLD + KL DFG AK G+ + + + Y A T+ D
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSID 205
Query: 269 VYSFGVVLLEMLSGRR 284
V+S G VL E+L G+
Sbjct: 206 VWSAGCVLAELLLGQP 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-39
Identities = 59/215 (27%), Positives = 85/215 (39%), Gaps = 20/215 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
+F +LG+G FG V + TG A+K L ++ E + E
Sbjct: 6 DFDYLKLLGKGTFGKVIL---------VREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L HP L L D V E+ G L HL R + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGA 112
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
+ +LH V+YRD K N++LD + + K++DFGL K+G + + GT
Sbjct: 113 EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR 284
Y APE L D + GVV+ EM+ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-37
Identities = 58/307 (18%), Positives = 110/307 (35%), Gaps = 42/307 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG--HKEWLAEVN 130
+ + +G+G FG VFK A TG +A+K++ + + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFK---------ARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 131 YLGQLYHPNLVKLVGYCLE--------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWN 182
L L H N+V L+ C LV++F + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLS 117
Query: 183 LRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHV 242
+V G+ ++H K+++RD K +N+L+ + KL+DFGLA+ S
Sbjct: 118 EIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 243 S--TRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299
+ T + T Y PE L D++ G ++ EM + + N + L+
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235
Query: 300 WAKPYL-------ASKRKIFRIIDNRLEGQYTLEGAYK-------AATLALRCLSTEGKF 345
+ +++ ++ + ++ K A L + L +
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295
Query: 346 RPMMAEV 352
R +
Sbjct: 296 RIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-37
Identities = 58/294 (19%), Positives = 98/294 (33%), Gaps = 30/294 (10%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVN 130
+ +GEG +G+VFK A T ++A+KR+ D L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFK---------AKNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 131 YLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALG 190
L +L H N+V+L D LV+EF + + G +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQ 109
Query: 191 AAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTY 250
KG+ F H V++RD K N+L++ N KL++FGLA+ + + S V+ +
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLW 166
Query: 251 GYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRP-----------SGEHNLVE 299
+ D++S G + E+ + R + G +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAAT-LALRCLSTEGKFRPMMAEV 352
W K + + + L L R E
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 2e-36
Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 23/239 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEW---LAEV 129
F LG G FG V +G A+K L++ K+ L E
Sbjct: 42 QFDRIKTLGTGSFGRVML---------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 130 NYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L + P LVKL ++ + +V E++ G + +HL R G S A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAA 148
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGT 249
+LH +IYRD K N+L+D +++DFG AK + + GT
Sbjct: 149 QIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGT 201
Query: 250 YGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308
APE + + D ++ GV++ EM +G ++P + + K S
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-36
Identities = 51/294 (17%), Positives = 102/294 (34%), Gaps = 30/294 (10%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNY 131
+R +G G +G+V A TG +A+K+L + K E+
Sbjct: 20 YRDLQPVGSGAYGAVCS---------AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 132 LGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGA 191
L + H N++ L+ D+ +F + + L + +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 192 AKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYG 251
KG+ ++H +I+RD K N+ ++ + K+ DFGLA+ S ++ V+ +
Sbjct: 131 LKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWY 184
Query: 252 YAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR-------------RAVDKNRPSGEHNLV 298
A L T D++S G ++ EM++G+ + +
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 299 EWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEV 352
+ K ++ + + A L + L + + R E
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 9e-33
Identities = 43/217 (19%), Positives = 79/217 (36%), Gaps = 29/217 (13%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYL 132
+++ LG G + VF+ A + VK L K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFE---------AINITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 133 GQL-YHPNLVKLVGYCLEDDHRL--LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVAL 189
L PN++ L + R LV+E + + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMY 136
Query: 190 GAAKGVAFLHGAETKVIYRDFKTSNILLDT-NYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
K + + H +++RD K N+++D + +L D+GLA+ G + +
Sbjct: 137 EILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVA 191
Query: 249 TYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRR 284
+ + PE L D++S G +L M+ +
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF----QGHKEWLAE 128
NF VLG G +G VF + TG + A+K L + + + E
Sbjct: 25 NFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 129 VNYLGQLYH-PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKV 187
L + P LV L + L+ +++ G L HL +R + + +
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIY 134
Query: 188 ALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVM 247
+ LH + +IYRD K NILLD+N + L+DFGL+K+ D++ +
Sbjct: 135 VGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFC 191
Query: 248 GTYGYAAPEYLATGH--LTAKSDVYSFGVVLLEMLSGRR 284
GT Y AP+ + G D +S GV++ E+L+G
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-30
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 17/215 (7%)
Query: 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAE 128
++ S +G G +GSV A TG+ +AVK+L++ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCA---------AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 129 VNYLGQLYHPNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVA 188
+ L + H N++ L+ + L Q L+ + +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 189 LGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMG 248
+G+ ++H +I+RD K SN+ ++ + K+ DFGLA+ ++ V
Sbjct: 128 YQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVAT 181
Query: 249 TYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
+ A L H D++S G ++ E+L+GR
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-29
Identities = 47/220 (21%), Positives = 82/220 (37%), Gaps = 29/220 (13%)
Query: 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEV 129
+ ++ +G G G V A +A+K+L++ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCA---------AYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 130 NYLGQLYHPNLVKLVGYCL------EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNL 183
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120
Query: 184 RLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVS 243
+ G+ LH +I+RD K SNI++ ++ K+ DFGLA+ T S +
Sbjct: 121 MSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 244 TRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T + T Y APE + D++S G ++ EM+ +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 9e-26
Identities = 34/223 (15%), Positives = 74/223 (33%), Gaps = 24/223 (10%)
Query: 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLG 133
+ LG G F +V+ A +A+K + D + E+ L
Sbjct: 15 YILVRKLGWGHFSTVWL---------AKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQ 64
Query: 134 QLYHPNLVKLVGYCLEDDHRLL-VYEFMPRGSLENHL-----------FRRGSYFQPLSW 181
++ + K +LL + + + + + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 182 NLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN-YNAKLSDFGLAKDGPTGDQS 240
+++ G+ ++H +I+ D K N+L++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 241 HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR 283
T + T Y +PE L +D++S ++ E+++G
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.0 bits (173), Expect = 4e-15
Identities = 21/160 (13%), Positives = 49/160 (30%), Gaps = 18/160 (11%)
Query: 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH 137
++GEG +VF + ++ K + K++ + G + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 138 PNLVKLVGYC----LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAK 193
L KL G + ++ E + + +V +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILE 114
Query: 194 GVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKD 233
VA + +++ D N+L+ + DF + +
Sbjct: 115 EVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 404 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.34 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-56 Score=405.79 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=209.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||+|+||+||+ |.+..+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~---------a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYT---------AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEE---------EEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEE---------EEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 5799999999999999999 4555678999999998766666678999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..|+||||+++|+|.+++... .+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhh
Confidence 999999999999999988753 4899999999999999999999 889999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKI 311 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (404)
+....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...... ........
T Consensus 164 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~----- 230 (293)
T d1yhwa1 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIAT----- 230 (293)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-----
T ss_pred eeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHh-----
Confidence 87543322 234567999999999999999999999999999999999999999754321 10000000
Q ss_pred chhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 312 FRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 ----NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ----HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111223344567889999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-57 Score=407.93 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=204.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||+||+| .+..+|+.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 457999999999999999995 45557899999998765332 33568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..|+||||+++|+|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG 148 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFG 148 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred CceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccch
Confidence 99999999999999999998654 36899999999999999999999 8899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+|+..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||......... ...
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~--------- 218 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD--------- 218 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH---------
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH---------
Confidence 9987644433334455789999999999988776 57899999999999999999999764432110 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+.............+.++.+|+.+||+.||++|||++|+++
T Consensus 219 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 219 -----WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111111111223456789999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=402.25 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=205.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||+||+|.++ ..||||+++... ....+.+.+|+.+|++++|||||++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 468999999999999999997542 249999987542 334467899999999999999999999875
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++.+++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEccc
Confidence 457899999999999999997654 35899999999999999999999 789999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc---CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|+++...............||+.|||||++.+ ..|+.++|||||||++|||++|+.||........ .....
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~ 222 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMV 222 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHH
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHH
Confidence 99987655444444556789999999999864 3588999999999999999999999976432110 00000
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
... ...+.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+.+
T Consensus 223 ~~~-----~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 223 GRG-----YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHT-----SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hcC-----CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 000 000110 12233445678899999999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=399.05 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=206.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||+||+| .+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEE---------EECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 46899999999999999995 455578999999986432 233467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..|+||||+++|+|.+++.... .+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeeccc
Confidence 9999999999999999999998763 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 151 G~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~------ 214 (263)
T d2j4za1 151 GWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYK------ 214 (263)
T ss_dssp CSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH------
T ss_pred ceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHH------
Confidence 999865432 234568999999999999999999999999999999999999999754321 1011
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.... ..++...+.++.+|+.+||+.||++|||++|+++
T Consensus 215 ----~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 ----RISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111111 1223334567889999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-55 Score=403.98 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=215.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||+||+|.+. .+++.||||+++.+. ...+++.+|+++|++++|||||++++++.++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEG---------GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEC---------CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 457888999999999999996553 467899999987654 4557899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||+||| +++|+||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccccc
Confidence 999999999999999999976543 56899999999999999999999 78999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
++...... ........|++.|+|||++.+..|+.++|||||||++|||++|..||...... ..
T Consensus 162 a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------------~~ 224 (287)
T d1opja_ 162 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQ 224 (287)
T ss_dssp TTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HH
T ss_pred eeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------HH
Confidence 98754322 22233356889999999999999999999999999999999987776432211 11
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
+.+.+........+...+..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 225 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122222223344445567889999999999999999999999999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=396.58 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=200.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||+|+||.||+|.+. ++..||||+++... ...+++.+|++++++++||||+++++++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 57888999999999999997653 35679999997654 44578999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred ceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchh
Confidence 9999999999999999987654 46889999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhC-CCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG-RRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
+........ ......||+.|+|||++.+..|+.++|||||||++|||+++ .+||..... ......
T Consensus 149 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~------- 214 (263)
T d1sm2a_ 149 RFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVED------- 214 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHH-------
T ss_pred eeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHH-------
Confidence 865433221 23345789999999999999999999999999999999995 545543211 111110
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
+........+..++..+.+++.+||+.||++|||+++|++.|+++.++
T Consensus 215 ----i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 215 ----ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111111122333456788999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-55 Score=402.77 Aligned_cols=263 Identities=24% Similarity=0.432 Sum_probs=202.6
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
++|++.++||+|+||+||+|++... ......||+|.+..... ...+++.+|+++|++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4677789999999999999876421 12334689998866433 3346789999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+||||+.++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCccc
Confidence 99999999999999999887643 36899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcc---eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 231 AKDGPTGDQSHV---STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 231 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
++.......... .....||+.|||||.+.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~-------- 243 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI-------- 243 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH--------
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH--------
Confidence 986543322111 122457899999999999999999999999999999998 89999764321 111
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
..+........+...+..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 244 ------~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 244 ------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111112233445567789999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=402.29 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=194.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ--GHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||+||+| .+..+|+.||+|++...... ..+.+.+|+++|++++||||+++++++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 73 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEE
T ss_pred chhCEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 357999999999999999995 45557899999999765432 2356889999999999999999999986
Q ss_pred e--CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC---CCceecCCCCCcEEEcCCCcE
Q 046897 149 E--DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE---TKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---~~i~H~Dlkp~NIll~~~~~v 223 (404)
+ ++.+|+||||+++|+|.+++.+.......+++..++.++.||+.||.|||+.. .+|+||||||+||||+.++.+
T Consensus 74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 5 45689999999999999999764433457999999999999999999999321 349999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 154 kl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~- 224 (269)
T d2java1 154 KLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAG- 224 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH-
T ss_pred EEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHH-
Confidence 999999998754322 1234568999999999999999999999999999999999999999753321 1111
Q ss_pred hhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.+... ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 ---------~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 ---------KIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111111 1223344567889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=400.84 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=207.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+.|++.+.||+|+||+||+| .+..++..||+|++........+.+.+|+++|+.++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEE---------EECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 46899999999999999995 445578899999998776667788999999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
..|+||||+++|+|.+++.... .++++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999999987654 46999999999999999999999 889999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCccccc-----cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLA-----TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
...... ........||+.|+|||++. +..|+.++|||||||++|||++|+.||........ .
T Consensus 158 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~-------- 224 (288)
T d2jfla1 158 AKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---L-------- 224 (288)
T ss_dssp EECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H--------
T ss_pred hccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---H--------
Confidence 753221 11233467999999999984 45689999999999999999999999976432211 0
Q ss_pred hccccchhhccc-ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNR-LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+.... .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 -----~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 -----LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----HHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111110 011222344567889999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=401.58 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=205.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||+||+| .+..+++.||||++.... ....+.+.+|+++|++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 56999999999999999995 455578999999986532 233467899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++.+|+||||+++|+|.+++...+ .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEeccc
Confidence 9999999999999999999988764 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+++..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ...
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~------- 219 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIF------- 219 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-------
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHH-------
Confidence 9998765444333445568999999999999999999999999999999999999999754321 000
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+..... .++...+.++.+||.+||+.||++|||++|+++.
T Consensus 220 ---~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 220 ---QKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---HHHHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---HHHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11111111 2233345678899999999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=406.28 Aligned_cols=265 Identities=27% Similarity=0.415 Sum_probs=213.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG-FQGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.++||+|+||+||+|++.. ..+......||+|.+.... ......+.+|+.+|.++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYG----ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEES----CSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcC----CCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 3678899999999999999987654 2233345679999886542 23346788999999998 8999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecC
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSY-------------------FQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRD 209 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~D 209 (404)
+.+..|+||||+++|+|.+++...... ...+++..++.++.||+.||+||| +++|+|||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecc
Confidence 999999999999999999999765321 235889999999999999999999 78999999
Q ss_pred CCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCC
Q 046897 210 FKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDK 288 (404)
Q Consensus 210 lkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~ 288 (404)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987554443333445678999999999999999999999999999999997 8999976
Q ss_pred CCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 046897 289 NRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLE 357 (404)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 357 (404)
..... .+..++........+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 270 ~~~~~----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHH----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43221 111222222223344455678999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=389.41 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=195.3
Q ss_pred CCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCCcceEEEEEEe--
Q 046897 74 FRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG--FQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-- 149 (404)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 149 (404)
|++.+.||+|+||+||+| .+..++..||+|.+.... ....+.+.+|+++|++++|||||++++++..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~---------~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEE---------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 366778999999999995 445578899999986543 2334568899999999999999999999875
Q ss_pred --CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCC--ceecCCCCCcEEEc-CCCcEE
Q 046897 150 --DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETK--VIYRDFKTSNILLD-TNYNAK 224 (404)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--i~H~Dlkp~NIll~-~~~~vk 224 (404)
+..+|+||||+++|+|.+++.... .+++..++.++.||+.||+||| +++ |+||||||+|||++ .++.+|
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH--~~~~~IiHrDiKp~NILl~~~~~~~K 155 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVK 155 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHH--HCCCCEEeCCcChhhceeeCCCCCEE
Confidence 346899999999999999998763 5899999999999999999999 666 99999999999996 578999
Q ss_pred EecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 225 LSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|+|||+++..... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||...... ......
T Consensus 156 l~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~- 224 (270)
T d1t4ha_ 156 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR- 224 (270)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH-
T ss_pred EeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHH-
Confidence 9999999864322 2345689999999999865 6999999999999999999999999653221 000000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+.........+.....++.+|+.+||+.||++|||+.|+++
T Consensus 225 ---------i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 225 ---------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---------HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---------HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00000001112223446789999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=384.80 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=211.6
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||+||+|+++ ++..||||+++... ...+++++|+.++++++||||+++++++.++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 368999999999999999997653 46789999998754 3457899999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+.+++||||+++|+|..++.... ..+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred CceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchh
Confidence 99999999999999999976654 46889999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .. .
T Consensus 147 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~---~------- 212 (258)
T d1k2pa_ 147 SRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA---E------- 212 (258)
T ss_dssp CCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH---H-------
T ss_pred heeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH---H-------
Confidence 9865443322 2334679999999999999999999999999999999998 899997643211 11 0
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
.+. .......+...+..+.+++.+||+.||++|||+++|++.|.+|
T Consensus 213 ---~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 213 ---HIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---HHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---HHH-hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 1111223334456789999999999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=391.71 Aligned_cols=266 Identities=24% Similarity=0.421 Sum_probs=206.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
+.|.+.++||+|+||.||+|.++.. .......||||++..... ....++.+|+.+|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4678889999999999999876532 122345799999875433 2335688999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+.++++.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999887654 46899999999999999999999 89999999999999999999999999999
Q ss_pred CCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~------------- 221 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE------------- 221 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH-------------
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH-------------
Confidence 9865433221 1233356899999999999999999999999999999999976665432211 01
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
+...+........+...+..+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 222 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 222 -VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 11112222223344455677899999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=393.45 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=207.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||.||+|.++ ++..||||++.... ...+.+.+|+.+|++++|||||++++++. +
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 467888999999999999997653 35689999997654 44577999999999999999999999875 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeeccccc
Confidence 568999999999999998765432 35899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
++....... .......||+.|+|||++.+..++.++|||||||++|||+||..|+...... .....
T Consensus 156 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~----------- 221 (272)
T d1qpca_ 156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQ----------- 221 (272)
T ss_dssp CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH-----------
T ss_pred eEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHH-----------
Confidence 987544321 2233457899999999999889999999999999999999966555332111 00000
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
.+........+...+..+.+|+.+||+.||++|||+++|++.|+.+-.++
T Consensus 222 ---~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 222 ---NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 01111112223345567889999999999999999999999999876543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=405.77 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=205.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||+||+| .+..+|+.||+|+++.... ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEE---------EETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 467999999999999999995 4455789999999976532 234678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CCceecCCCCCcEEEcCCCcEEEecc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAE-TKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
++++|+||||+++|+|.+++.+.. .+++..++.++.|++.||.||| + ++|+||||||+|||++.+|.+||+||
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH--~~~~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH--HhCCEEccccCHHHeeECCCCCEEEeeC
Confidence 999999999999999999998764 5899999999999999999999 5 48999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh---
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL--- 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~--- 305 (404)
|+|+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..... ..+.....
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~--~~~~~~~~~~~ 223 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDA 223 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH--HHC--------
T ss_pred CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhcCCc
Confidence 999854221 233468999999999999999999999999999999999999999754321100 00000000
Q ss_pred ------------------hh---ccccchh----hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHh
Q 046897 306 ------------------AS---KRKIFRI----IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQ 358 (404)
Q Consensus 306 ------------------~~---~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~ 358 (404)
.. .....+. .............+.++.+++.+||+.||++|||++|+++. |++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00 0000000 00000000011124568899999999999999999999883 554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=391.87 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=210.1
Q ss_pred cCCCCCCc-ccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSV-LGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|.+.+. ||+|+||.||+|.++. ..++..||||+++.... ...+++.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEec-------CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45566664 9999999999986542 23466899999976532 334678999999999999999999999864
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
+..|+||||+++|+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccch
Confidence 56899999999999999986543 46899999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 230 LAKDGPTGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~-------- 223 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA-------- 223 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH--------
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH--------
Confidence 99875443322 12234568999999999998999999999999999999998 89999764321 1111
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcccc
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSET 365 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 365 (404)
.+........+...+.++.+|+.+||+.||++|||+.+|++.|+.+..+..+
T Consensus 224 ------~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 224 ------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ------HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 1111111233445567889999999999999999999999999976654433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-54 Score=396.17 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=190.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.+.|++.+.||+|+||+||+| .+..+++.||+|++...... ....+.+|+.+|+.++||||+++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEE---------EETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 467999999999999999995 45557899999999765432 23457789999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc---CCCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD---TNYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~---~~~~vkl~ 226 (404)
++.+|+||||++||+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||+. .++.+||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEe
Confidence 99999999999999999999765 36999999999999999999999 89999999999999994 57899999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... ...
T Consensus 153 DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~---- 219 (307)
T d1a06a_ 153 DFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFE---- 219 (307)
T ss_dssp CC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHH----
T ss_pred ccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHH----
Confidence 999998654322 2345679999999999999999999999999999999999999997533210 000
Q ss_pred hccccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 SKRKIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.+.... .........+.++.+|+.+||+.||++|||+.|+++
T Consensus 220 ------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 220 ------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ------HHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------HHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111 111222344567889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-54 Score=397.03 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=201.3
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
+.|+..+.||+|+||+||+| .+..++..||||++....... .+.+.+|+.+|++++|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEE---------EECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 35889999999999999995 455578999999997654322 356889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++..|+|||||.+|+|..++... .++++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeec
Confidence 999999999999999887766554 36899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCcccccc---CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT---GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYL 305 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 305 (404)
|++..... .....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... ..
T Consensus 160 G~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~----- 222 (309)
T d1u5ra_ 160 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SA----- 222 (309)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-----
T ss_pred ccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HH-----
Confidence 99986433 234679999999999854 46899999999999999999999999753211 00
Q ss_pred hhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 306 ASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+..+.........+...+..+.+|+.+||+.||++|||+.++++
T Consensus 223 -----~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 223 -----LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111111111112234567889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.7e-54 Score=401.37 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=208.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||+|+||.||+| .+..+|..||+|++........+.+.+|+.+|+.++|||||++++++.+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~---------~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 57999999999999999995 455578999999998776666677899999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC--CCcEEEeccc
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT--NYNAKLSDFG 229 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~--~~~vkl~Dfg 229 (404)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence 9999999999999999986543 36999999999999999999999 899999999999999964 6889999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+++...... ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ...........
T Consensus 172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~ 242 (350)
T d1koaa2 172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW 242 (350)
T ss_dssp TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC
Confidence 998754332 344578999999999999999999999999999999999999999754321 11111111000
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..........+..+.+||.+||+.||++|||++|+++.
T Consensus 243 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 --------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111112334578899999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=387.57 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=201.3
Q ss_pred CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEeCCeeEE
Q 046897 78 SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 155 (404)
+.||+|+||+||+|.+.. ..+++.||||++..... ...+++.+|+++|++++|||||++++++.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 579999999999987542 23567899999865432 234678999999999999999999999864 46789
Q ss_pred EEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCCC
Q 046897 156 VYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGP 235 (404)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~~ 235 (404)
||||+++|+|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 vmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999999999999875 35899999999999999999999 7899999999999999999999999999998654
Q ss_pred CCCCC-cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhccccch
Q 046897 236 TGDQS-HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKRKIFR 313 (404)
Q Consensus 236 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (404)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .. ..
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~--------------~~ 221 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV--------------TA 221 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH--------------HH
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH--------------HH
Confidence 43322 12234578999999999999999999999999999999998 89999754321 11 11
Q ss_pred hhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 314 IIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
.+........+..++.++.+|+.+||+.||++|||+++|++.|+.+-
T Consensus 222 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 222 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11111122334445678899999999999999999999999988753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-53 Score=400.84 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=209.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
++|++.+.||+|+||.||+| .+..+|+.||+|++........+.+.+|+.+|++++|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 57999999999999999994 555678999999998776555677889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc--CCCcEEEeccc
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD--TNYNAKLSDFG 229 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~--~~~~vkl~Dfg 229 (404)
.+|+|||||++|+|.+++.... .++++..++.++.||+.||.||| +.+|+||||||+||||+ .++.+||+|||
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeecc
Confidence 9999999999999998876543 46999999999999999999999 89999999999999997 67899999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
+|....... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ..
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~-------- 237 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TL-------- 237 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH--------
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HH--------
Confidence 998764432 3455789999999999999999999999999999999999999997543211 00
Q ss_pred ccchhhccc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 310 KIFRIIDNR--LEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 310 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+.... .........+.++.+||.+||+.||++|||+.|+++.
T Consensus 238 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 238 --QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 1112223445678899999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=392.00 Aligned_cols=248 Identities=27% Similarity=0.337 Sum_probs=206.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++++.||+|+||+||+| .+..+|+.||+|++.+.. ....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 57999999999999999994 455578999999997532 234467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++.+|+||||+++|+|.+++.... .+++..++.++.||+.||+||| +++|+||||||+|||++.+|.+||+||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred cccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeec
Confidence 9999999999999999999998764 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 150 G~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~------ 215 (337)
T d1o6la_ 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFE------ 215 (337)
T ss_dssp TTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH------
T ss_pred ccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHH------
Confidence 9998653322 2344578999999999999999999999999999999999999999764321 1111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.+.... ..++...+.++.+||.+||+.||.+|++ +.++++
T Consensus 216 ----~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 ----LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----HHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111111 1233344567889999999999999995 777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=391.15 Aligned_cols=271 Identities=27% Similarity=0.338 Sum_probs=206.0
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
..++|++.+.||+|+||.||+|.+.. ..+..+++.||+|++..... ...+.+.+|..++.++ +|+||+.+++++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEES----TTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcC----CCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 34679999999999999999988754 33445678999999876433 3345677888888777 689999999998
Q ss_pred EeC-CeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 148 LED-DHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 148 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
..+ ..+++||||+++|+|.+++..... ....+++..++.++.||+.||.||| +++|+||||||+|
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDlKp~N 164 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARN 164 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcCCccc
Confidence 765 468999999999999999976432 1235889999999999999999999 8899999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCC-CCcCCCCCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR-RAVDKNRPSG 293 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~-~p~~~~~~~~ 293 (404)
|||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. .||.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998755444433444568999999999999999999999999999999999875 5776433211
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
. .. ..+........+...+.++.+++.+||+.||++|||+.+|++.|+++.++
T Consensus 245 --~----~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 --E----FC----------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp --H----HH----------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --H----HH----------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0 00 11111111223334456788999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=390.22 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=205.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCCcceEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF------QGHKEWLAEVNYLGQLYHPNLVKLV 144 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~ 144 (404)
.++|++.+.||+|+||+||+| .+..+|+.||+|++..... ...+.+.+|+.+|++++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467999999999999999995 4555789999999865322 2346789999999999999999999
Q ss_pred EEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC---
Q 046897 145 GYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY--- 221 (404)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~--- 221 (404)
+++.+++.+|+||||+++|+|.+++.... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcc
Confidence 99999999999999999999999998763 5899999999999999999999 89999999999999998776
Q ss_pred -cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 222 -NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 222 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .
T Consensus 154 ~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~ 224 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T 224 (293)
T ss_dssp CCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred cceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------H
Confidence 49999999998754433 2344679999999999999999999999999999999999999997543211 0
Q ss_pred hhhhhhhccccchhhcccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 301 AKPYLASKRKIFRIIDNRL--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. .+..... ........+..+.+||.+||+.||++|||++++++
T Consensus 225 ~~----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 225 LA----------NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HH----------HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HH----------HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1111000 00111123457889999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=383.90 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=201.5
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|++.+.||+|+||.||+|.+.. ....+..||+|.+...... ..+.+.+|+.+|++++||||+++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3578999999999999999987642 2234567999998654333 3356899999999999999999999985
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..|+||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccch
Confidence 567899999999999999887654 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
+++....... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||....... ...
T Consensus 154 ~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~--------- 220 (273)
T d1mp8a_ 154 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG--------- 220 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---------
T ss_pred hheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH---------
Confidence 9986543322 22344678999999999999999999999999999999998 899997654321 111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
.+.+ ......+...+..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 221 ----~i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 221 ----RIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 111133444567889999999999999999999999999988654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=390.10 Aligned_cols=264 Identities=24% Similarity=0.393 Sum_probs=207.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.+|++.++||+|+||+||+|.+... .......||+|.+... .....+++.+|+.++++++|||||++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999999999876431 1222447899988653 334457799999999999999999999999865
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
..+++|||+.+++|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred -CeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeecccc
Confidence 5678889999999999887754 46899999999999999999999 78999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.......
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---------------- 221 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------- 221 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------
Confidence 987655444434445678999999999999999999999999999999998 788887543211
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
+...+........+..++..+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 222 -~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 222 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 11111111222334445677889999999999999999999999999886543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=385.31 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=203.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++.+.||+|+||+||+|+++. +..||||++.... ...+.+.+|+.++++++|||||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 3579999999999999999976542 3579999997654 44578999999999999999999999985 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+..++||||+++|+|..++..... ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred CCeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccch
Confidence 568999999999999998875432 35899999999999999999999 88999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRK 310 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (404)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ...
T Consensus 160 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~------------- 223 (285)
T d1fmka3 160 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REV------------- 223 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH-------------
T ss_pred hhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHH-------------
Confidence 986543322 2234467999999999999999999999999999999999976665432211 001
Q ss_pred cchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhc
Q 046897 311 IFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDS 362 (404)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 362 (404)
...+........+...+..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 224 -~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 224 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp -HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -HHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 111111122234445567789999999999999999999999999976543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-53 Score=389.33 Aligned_cols=268 Identities=25% Similarity=0.354 Sum_probs=214.6
Q ss_pred HhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 70 ATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-HKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
..++|++.+.||+|+||+||+|++.. ..+..++..||||++....... .+++.+|+.+|+.++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPG----LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEET----SSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECC----CccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 35689999999999999999987653 2344567889999997654333 456899999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceec
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS--------------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYR 208 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~ 208 (404)
..+..+++|||+.+|+|.+++..... ....+++..++.++.|++.||+||| +.+|+||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeEee
Confidence 99999999999999999999975431 1235889999999999999999999 8999999
Q ss_pred CCCCCcEEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCC-CCcC
Q 046897 209 DFKTSNILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR-RAVD 287 (404)
Q Consensus 209 Dlkp~NIll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~-~p~~ 287 (404)
||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999997544433333344567899999999999999999999999999999999986 5676
Q ss_pred CCCCCCCcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhH
Q 046897 288 KNRPSGEHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQ 360 (404)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 360 (404)
...... ... .+.+.. ....+...+.++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 245 ~~~~~e---~~~-------------~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEE---VIY-------------YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHH---HHH-------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHH---HHH-------------HHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 533211 111 111111 11233344567889999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-52 Score=387.20 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=205.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD---GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||+||+| .+..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEE---------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 56999999999999999995 45557899999998653 2234567889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+++.+|+||||+.||+|..++.... .+++..+..++.||+.||+||| +++|+||||||+||||+.+|.+||+||
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecC
Confidence 9999999999999999999988764 5788999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.. ...
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~------- 210 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY------- 210 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-------
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHH-------
Confidence 999875432 33468999999999999999999999999999999999999999754321 111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVTV 355 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~ 355 (404)
..+.... ..++...+.++.+++.+||+.||.+|+ |++++++.
T Consensus 211 ---~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 211 ---EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111111 123333456788999999999999996 88898763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=378.50 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=200.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEe-C
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-D 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 150 (404)
++|++.+.||+|+||.||+|.++ |..||||+++.+ ...+.+.+|++++++++||||+++++++.+ +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56788899999999999997652 567999999765 344779999999999999999999999865 4
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccC
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGL 230 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~ 230 (404)
+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeeccccc
Confidence 568999999999999999976432 35899999999999999999999 78999999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhhhcc
Q 046897 231 AKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLASKR 309 (404)
Q Consensus 231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 309 (404)
++.... ......++..|+|||++.+..++.++|||||||++|||++ |++||...... +....
T Consensus 150 s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~--------- 212 (262)
T d1byga_ 150 TKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR--------- 212 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH---------
T ss_pred ceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH---------
Confidence 986433 2233568899999999999999999999999999999998 68777653321 11111
Q ss_pred ccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 310 KIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
+........+...+..+.+|+.+||+.||++|||+.+|++.|++++.
T Consensus 213 -----i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 -----VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11112223444455788999999999999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=381.18 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=200.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++.+.||+|+||.||+|.+.. ..+....||||++.... ....+++.+|+.+|++++||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 578999999999999999987642 22345579999887542 233467899999999999999999999996
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
+ ...++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred e-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeeccc
Confidence 5 57789999999999999887654 46899999999999999999999 789999999999999999999999999
Q ss_pred cCCCCCCCCCCCcc-eeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 229 GLAKDGPTGDQSHV-STRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 229 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
|+++.......... .....|+..|+|||++.+..++.++|||||||++|||++ |+.||...+.. ..
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~------ 223 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QI------ 223 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH------
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HH------
Confidence 99997644433222 233567889999999999999999999999999999998 89999754321 11
Q ss_pred hccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 046897 307 SKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQL 359 (404)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 359 (404)
+..+.........+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 224 ----~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 ----LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111122222233344556788999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=385.39 Aligned_cols=271 Identities=26% Similarity=0.361 Sum_probs=220.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.++||+|+||.||+|.+.. ..+..++..||||+++.... .....+.+|+.++..+ +|||||++++++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~----~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYG----LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEES----SSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCeEEEEEEEec----cccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3678889999999999999998753 34456788999999976543 3345688999999999 6999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS--------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSN 214 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~N 214 (404)
++...++||||+++|+|.+++..... ....+++..+..++.||+.||+||| +++++||||||+|
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp~N 175 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARN 175 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccccc
Confidence 99999999999999999999986532 2235889999999999999999999 8899999999999
Q ss_pred EEEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhC-CCCcCCCCCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSG-RRAVDKNRPSG 293 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g-~~p~~~~~~~~ 293 (404)
|+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+++ .+||......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~- 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999999976655444444557899999999999999999999999999999999995 5555443221
Q ss_pred CcchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 294 EHNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
..+..+++.......+...+..+.+|+.+||+.||++|||+.+|++.|+++.+.+
T Consensus 255 ---------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 255 ---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp ---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 1111222222222333445677899999999999999999999999999876654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-52 Score=381.84 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=203.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCCcceEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---HKEWLAEVNYLGQLYHPNLVKLVGYC 147 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 147 (404)
.++|++.+.||+|+||.||+| .+..+|+.||+|++....... ...+.+|+++|+.++||||+++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEE---------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 467999999999999999994 455578999999997654332 35688999999999999999999999
Q ss_pred EeCC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 148 LEDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 148 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
..++ ..|+||||++|++|.+++.... ++++..++.++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccc
Confidence 8654 3789999999999999987764 5899999999999999999999 8999999999999999999999
Q ss_pred EEecccCCCCCCCCCC-CcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQ-SHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
+|+|||.+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~ 224 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAY 224 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHH
Confidence 9999999875433222 22334568999999999999999999999999999999999999999754321 1111
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhHh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-MMAEVVTVLEQLQD 361 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~~ 361 (404)
........ .........+..+.+++.+||+.||.+|| |++++++.|.++++
T Consensus 225 ~~~~~~~~--------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 225 QHVREDPI--------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHCCCC--------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHhcCCC--------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11111000 00112223456788999999999999999 89999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=382.93 Aligned_cols=272 Identities=25% Similarity=0.361 Sum_probs=213.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ-GHKEWLAEVNYLGQL-YHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||.||+|+..... -....++..||||++..+... ...++.+|...+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 467889999999999999998764321 112234568999999775432 336688899888888 7999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEE
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGS------------YFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNIL 216 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIl 216 (404)
++...++||||+++|+|.+++..... ....+++..++.++.||+.||+||| +.+|+||||||+|||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL 167 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeeccccee
Confidence 99999999999999999999976532 1246899999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHh-CCCCcCCCCCCCCc
Q 046897 217 LDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLS-GRRAVDKNRPSGEH 295 (404)
Q Consensus 217 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~-g~~p~~~~~~~~~~ 295 (404)
++.++.+||+|||+++...............|++.|+|||.+.++.|+.++|||||||++|||++ |.+||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999987655444444455679999999999999999999999999999999998 68888653321
Q ss_pred chhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 296 NLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
. +...+........+...+..+.+|+.+||+.||++|||+.||++.|+++...+
T Consensus 245 ~--------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 245 E--------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp H--------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred H--------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 0 11111111222333344567899999999999999999999999999987543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=383.76 Aligned_cols=248 Identities=19% Similarity=0.253 Sum_probs=205.8
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED 150 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 150 (404)
.++|++++.||+|+||+||+| .+..+++.||+|+++.... ....+.+|+++|+.++||||++++++|.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~---------~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 467999999999999999994 5555789999999987643 335678999999999999999999999999
Q ss_pred CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC--CcEEEecc
Q 046897 151 DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN--YNAKLSDF 228 (404)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~--~~vkl~Df 228 (404)
+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.+ +.+||+||
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEccc
Confidence 99999999999999999997653 35899999999999999999999 8999999999999999854 57999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|++....... ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||...... ...
T Consensus 149 G~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~------- 212 (321)
T d1tkia_ 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QII------- 212 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-------
T ss_pred chhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHH-------
Confidence 9998754332 344567999999999999999999999999999999999999999764321 111
Q ss_pred cccchhhcccccCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTL----EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..+..... .++. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 213 ---~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 213 ---ENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111 1111 23456889999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=387.69 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=205.2
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
++|++++.||+|+||.||+| .+..+|+.||+|++.... ....+.+.+|+++|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a---------~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEE---------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 47999999999999999995 455578999999986432 233467889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecc
Q 046897 149 EDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDF 228 (404)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Df 228 (404)
.....++||||+.+|+|..++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeec
Confidence 9999999999999999999998764 5899999999999999999999 899999999999999999999999999
Q ss_pred cCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 229 GLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 229 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
|+++..... .....||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ....
T Consensus 186 G~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~------ 248 (350)
T d1rdqe_ 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYE------ 248 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH------
T ss_pred eeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHH------
Confidence 999875432 23467999999999999999999999999999999999999999754311 1111
Q ss_pred cccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 046897 309 RKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRP-----MMAEVVT 354 (404)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~ 354 (404)
.+..... ..+...+.++.++|.+||+.||.+|+ |++++++
T Consensus 249 ----~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 249 ----KIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1111111 22233456788999999999999994 8888876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-51 Score=387.47 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=199.4
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc---ccHHHH---HHHHHHHhcCCCCCcceEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF---QGHKEW---LAEVNYLGQLYHPNLVKLVG 145 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~hp~iv~~~~ 145 (404)
++|++.++||+|+||.||+| .+..+|+.||+|++..... .....+ ..|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~---------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEE---------EECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 57999999999999999995 4555789999999864321 111223 34577888889999999999
Q ss_pred EEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 146 YCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
++.+++.+|+||||+++|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEE
Confidence 9999999999999999999999998764 5789999999999999999999 899999999999999999999999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
+|||+|+...... .....||+.|+|||++. +..|+.++|||||||++|||++|+.||.............
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----- 219 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----- 219 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 9999998654332 33467999999999986 4568999999999999999999999997644322111000
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
..... ....+...+.++.+||.+||+.||++||| ++++++
T Consensus 220 --------~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 --------MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --------HSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --------hcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00000 11222234567889999999999999999 577775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-51 Score=371.83 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=204.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc---------HHHHHHHHHHHhcCC-CCCc
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG---------HKEWLAEVNYLGQLY-HPNL 140 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hp~i 140 (404)
.++|++.+.||+|+||+||+| .+..+|+.||+|++....... .+.+.+|+.++++++ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~---------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEE---------EECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 368999999999999999995 445578999999987653221 135789999999997 9999
Q ss_pred ceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 141 VKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 141 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+++++++.++++.||||||+++|+|.+++.... ++++..++.++.||+.||+||| +++|+||||||+|||++.+
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~ 146 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDD 146 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCC
Confidence 999999999999999999999999999998764 5899999999999999999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCcccccc------CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCC
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT------GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGE 294 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~ 294 (404)
+.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......
T Consensus 147 ~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~- 222 (277)
T d1phka_ 147 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML- 222 (277)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred CCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-
Confidence 999999999998754432 2344679999999998853 457889999999999999999999997643211
Q ss_pred cchhhhhhhhhhhccccchhhcccc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRL--EGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
... .+..... ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 223 -----~~~----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 -----MLR----------MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----HHH----------HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----HHH----------HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 1111111 11122244567889999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=381.73 Aligned_cols=252 Identities=25% Similarity=0.281 Sum_probs=199.1
Q ss_pred hcCCCCC-CcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhc-CCCCCcceEEEEEE
Q 046897 71 TRNFRPD-SVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQ-LYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~ 148 (404)
.++|.+. ++||+|+||+||+| .+..+++.||+|++... ..+.+|+.++.+ ++|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEE---------EECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3578776 56999999999995 45557899999998643 567789988654 58999999999987
Q ss_pred e----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CC
Q 046897 149 E----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NY 221 (404)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~ 221 (404)
+ +..+|+|||||+||+|.+++..++. ..+++..++.++.||+.||+||| +.+|+||||||+|||++. ++
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHH--HcCCccccccccccccccccccc
Confidence 5 4578999999999999999976532 46999999999999999999999 899999999999999975 56
Q ss_pred cEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 222 NAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 222 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
.+||+|||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.............
T Consensus 152 ~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-- 226 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-- 226 (335)
T ss_dssp CEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred cccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH--
Confidence 79999999998654433 2345679999999999999999999999999999999999999997654322111000
Q ss_pred hhhhhhccccchhhccccc--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 302 KPYLASKRKIFRIIDNRLE--GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
..+...... .......+.++.+|+.+||+.||++|||+.++++.
T Consensus 227 ----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 ----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000111110 01112345678999999999999999999999873
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=373.95 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=206.4
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCCcceEEEEEEe-CCeeE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQD-GFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLE-DDHRL 154 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~ 154 (404)
.++||+|+||+||+|++.. ..++...||||+++.. .....+++.+|+++|++++||||+++++++.. +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEEC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 4689999999999987643 1223457899998753 33445779999999999999999999999876 45889
Q ss_pred EEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCCCCC
Q 046897 155 LVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLAKDG 234 (404)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~~~ 234 (404)
+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999999987654 45778899999999999999999 889999999999999999999999999999875
Q ss_pred CCCCCC--cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhccccc
Q 046897 235 PTGDQS--HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASKRKIF 312 (404)
Q Consensus 235 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (404)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+...+. ..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~------ 249 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQ------ 249 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HT------
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---Hc------
Confidence 443322 1223356899999999999999999999999999999999988887643211 1111111 00
Q ss_pred hhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccccC
Q 046897 313 RIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSETG 366 (404)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~ 366 (404)
......+...+..+.+|+.+||+.||++|||+.||++.|+++.+.....
T Consensus 250 -----g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 250 -----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 0111222334567889999999999999999999999999998764443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=382.84 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=203.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC---cccHHHHHHHHHHHh-cCCCCCcceEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG---FQGHKEWLAEVNYLG-QLYHPNLVKLVGYC 147 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~ 147 (404)
++|++.+.||+|+||+||+| .+..+++.||+|++.... ....+.+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~---------~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEE---------EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 57999999999999999995 455678999999996532 123355667777665 68999999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEec
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSD 227 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~D 227 (404)
.+++.+|+||||+++|+|.+++.... .+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccc
Confidence 99999999999999999999998764 5899999999999999999999 78999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS 307 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 307 (404)
||+++....... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+... ...
T Consensus 147 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~----- 213 (320)
T d1xjda_ 147 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFH----- 213 (320)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-----
T ss_pred cchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHH-----
Confidence 999986543322 2344689999999999999999999999999999999999999997643211 010
Q ss_pred ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 046897 308 KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMA-EVVT 354 (404)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~ 354 (404)
.+.... ..++...+.++.+|+.+||+.||++||++. ++++
T Consensus 214 -----~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 214 -----SIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----HHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----HHHcCC--CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111111 122333456788999999999999999995 6754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=377.55 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=206.5
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCc--EEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCCcceEEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGM--VIAVKRLNQD-GFQGHKEWLAEVNYLGQL-YHPNLVKLVGYC 147 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 147 (404)
++|++.++||+|+||.||+|.++. ++. .||||.+... .....+.+.+|+++|.++ +|||||++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 578889999999999999976543 333 5778887543 223446789999999998 799999999999
Q ss_pred EeCCeeEEEEeccCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcE
Q 046897 148 LEDDHRLLVYEFMPRGSLENHLFRRG------------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNI 215 (404)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NI 215 (404)
.+++.+++||||+++|+|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNI 158 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceE
Confidence 99999999999999999999997542 23357999999999999999999999 88999999999999
Q ss_pred EEcCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCC-CcCCCCCCCC
Q 046897 216 LLDTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRR-AVDKNRPSGE 294 (404)
Q Consensus 216 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~-p~~~~~~~~~ 294 (404)
|++.++.+||+|||+++...... ......||..|+|||.+.+..|+.++|||||||++|||++|.. ||...+..
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-- 233 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 233 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred EEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--
Confidence 99999999999999997643322 1234568999999999999999999999999999999999765 56543211
Q ss_pred cchhhhhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 295 HNLVEWAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
... ..+........+...+..+.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus 234 -~~~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 234 -ELY--------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -HHH--------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHH--------------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 000 111111112333445678899999999999999999999999999987643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=376.32 Aligned_cols=268 Identities=23% Similarity=0.359 Sum_probs=213.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
.++|.+.+.||+|+||.||+|.+.. ..+...+..||||+++.... .....+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~----~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEE----EETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC----cccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4678889999999999999987753 22333467899999976432 333458899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRG------SYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
++..++||||+++|+|.+++.... .....+++..+..++.|++.||.||| .++|+||||||+|||++.++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCceE
Confidence 999999999999999999987532 22245789999999999999999999 7899999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCC-CCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGR-RAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~-~p~~~~~~~~~~~~~~~~~ 302 (404)
||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. .||...... ...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~- 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL- 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHH-
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHH-
Confidence 999999998654433333344457899999999999999999999999999999999985 667543211 111
Q ss_pred hhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 303 PYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
..+.+.. ....+...+..+.+++.+||+.||++|||+.+|++.|++..+
T Consensus 246 ---------~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 ---------RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---------HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---------HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 112233445679999999999999999999999999987643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=370.76 Aligned_cols=273 Identities=23% Similarity=0.325 Sum_probs=201.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHH--HHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWL--AEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|.+.+.||+|+||.||+|++ +|..||||++..+. .+.+. .|+..+..++||||+++++++.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~ 67 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEE
Confidence 45788889999999999999764 36789999986543 23333 4555556789999999999998
Q ss_pred eCC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCCceecCCCCCcEEEc
Q 046897 149 EDD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA------ETKVIYRDFKTSNILLD 218 (404)
Q Consensus 149 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~------~~~i~H~Dlkp~NIll~ 218 (404)
+++ .+|+||||+++|+|.+++++. ++++..++.++.|++.||+|||+. +++|+||||||+||||+
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~ 142 (303)
T d1vjya_ 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred eCCCcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence 754 579999999999999999864 489999999999999999999942 36999999999999999
Q ss_pred CCCcEEEecccCCCCCCCCCCC--cceeeccccccccCccccccCC------CCcccchhhhhHHHHHHHhCCCCcCCCC
Q 046897 219 TNYNAKLSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATGH------LTAKSDVYSFGVVLLEMLSGRRAVDKNR 290 (404)
Q Consensus 219 ~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~ll~ell~g~~p~~~~~ 290 (404)
.++.+||+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||....
T Consensus 143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 9999999999999865333221 1233467999999999986543 5678999999999999999999886543
Q ss_pred CCCCcchh--h--hhhhhhhhccccchhhcccccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhcc
Q 046897 291 PSGEHNLV--E--WAKPYLASKRKIFRIIDNRLEGQ-YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSS 363 (404)
Q Consensus 291 ~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 363 (404)
........ . ........ .......++.+... ........+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 223 DYQLPYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCCCTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccccchHHHHHH-HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 32111100 0 00000000 00001111111111 12345567999999999999999999999999999988654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=376.38 Aligned_cols=258 Identities=22% Similarity=0.253 Sum_probs=191.9
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCccc-----HHHHHHHHHHHhcCCCCCcceEEEEEEeCC
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQG-----HKEWLAEVNYLGQLYHPNLVKLVGYCLEDD 151 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 151 (404)
+++||+|+||+||+| .+..+|+.||+|+++...... .+.+.+|+.+|+.++|||||++++++..++
T Consensus 3 l~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEE---------EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 578999999999994 555678999999987543222 246889999999999999999999999999
Q ss_pred eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEecccCC
Q 046897 152 HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFGLA 231 (404)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a 231 (404)
+.|+||||+.++++..++... ..+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCccc
Confidence 999999999877666554332 46888999999999999999999 899999999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh--c
Q 046897 232 KDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS--K 308 (404)
Q Consensus 232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 308 (404)
........ .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||....... ....+...... .
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTE 222 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence 86543322 2334679999999998864 468999999999999999999999997543211 11000000000 0
Q ss_pred cccch---h---hcccccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 RKIFR---I---IDNRLEGQY-----TLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 ~~~~~---~---~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
..... . ......... ....+.++.+|+.+||+.||++|||++|+|+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 0 000000001 1123457889999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=370.99 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=197.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||+||+| .+..+|+.||+|++..... ...+.+.+|+++|++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 47999999999999999994 5555789999999965432 234678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++++|+||||+.+ .+..++..... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ccceeEEEeecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCC
Confidence 9999999999954 55555544322 46999999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCC-CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhh-
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLAS- 307 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~- 307 (404)
+++...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.... ..........
T Consensus 148 ~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~ 222 (298)
T d1gz8a_ 148 LARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTP 222 (298)
T ss_dssp HHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred cceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCC
Confidence 997643322 2233457999999999876655 57899999999999999999999975432110 0000000000
Q ss_pred cc----ccchhhcc------cccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 308 KR----KIFRIIDN------RLEGQ---YTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 308 ~~----~~~~~~~~------~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.. ......+. ..... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000000 00000 011234578899999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=368.70 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=196.2
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCCcce
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------GHKEWLAEVNYLGQLY--HPNLVK 142 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hp~iv~ 142 (404)
.++|++.+.||+|+||+||+| .+..+|+.||+|++...... ...++.+|+.+|++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 468999999999999999995 45557899999998754221 1233568999999986 899999
Q ss_pred EEEEEEeCCeeEEEEeccCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-C
Q 046897 143 LVGYCLEDDHRLLVYEFMPR-GSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-N 220 (404)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-~ 220 (404)
+++++.+++..++||||+.+ +++.+++.... .+++..++.++.||+.||+||| +.+|+||||||+|||++. +
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCC
Confidence 99999999999999999975 57888887653 5899999999999999999999 899999999999999985 4
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCC-CcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHL-TAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
+.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+.
T Consensus 148 ~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------- 215 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 215 (273)
T ss_dssp TEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------
Confidence 79999999999864332 2345679999999999987665 5679999999999999999999964210
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ..... .++...+.++.+++.+||+.||++|||++|+++
T Consensus 216 ----i----------~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 ----I----------IRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----H----------HHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----H----------hhccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 00000 112223467889999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=367.03 Aligned_cols=269 Identities=23% Similarity=0.276 Sum_probs=195.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCCcceEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQL---YHPNLVKLVG 145 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hp~iv~~~~ 145 (404)
.++|++++.||+|+||+||+|+... .+++.||||++..... .....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 4789999999999999999964321 2367799999865321 2223456777776655 7999999999
Q ss_pred EEEe-----CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 146 YCLE-----DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 146 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
+|.. ....+++|||+.++.+........ ..+++..++.++.|++.||+||| +++|+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTT
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCC
Confidence 9863 246899999998766654444332 46899999999999999999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh
Q 046897 221 YNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW 300 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~ 300 (404)
+.+||+|||++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......+..
T Consensus 153 ~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99999999998764322 234457899999999999999999999999999999999999999976432111000000
Q ss_pred hh-h----hhhhccccch-h---hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 301 AK-P----YLASKRKIFR-I---IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 301 ~~-~----~~~~~~~~~~-~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.. . .......... . ........+....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0 0000000000 0 00000111222334567899999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.1e-49 Score=359.71 Aligned_cols=265 Identities=20% Similarity=0.242 Sum_probs=196.0
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++.+.||+|+||+||+|.+. +|+.||+|++..... ...+.+.+|+.+|++++||||+++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999996542 578899999976532 224678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
++..+++|||+.++.+..+.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccc
Confidence 99999999999766665554433 46999999999999999999999 7899999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh-----h
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK-----P 303 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~-----~ 303 (404)
.+........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... .
T Consensus 146 ~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence 9976433221 2334568999999999865 457899999999999999999999997543211100000000 0
Q ss_pred hhhhccccchh------hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 304 YLASKRKIFRI------IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 304 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
........... .............+..+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 0000001112233457889999999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-47 Score=352.43 Aligned_cols=267 Identities=17% Similarity=0.175 Sum_probs=209.9
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYH-PNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 149 (404)
+++|++.+.||+|+||+||+| .+..+|+.||+|++.... ....+.+|+++++.+.| +|++.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 568999999999999999995 445578999999886543 23456788999999865 899999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC-----CCcEE
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT-----NYNAK 224 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~-----~~~vk 224 (404)
+...++||||+ +++|.+++.... ..++...+..++.|++.||+||| +.+|+||||||+|||++. ++.+|
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceE
Confidence 99999999999 789999987654 46899999999999999999999 899999999999999964 57899
Q ss_pred EecccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhh
Q 046897 225 LSDFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVE 299 (404)
Q Consensus 225 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~ 299 (404)
|+|||+++........ .......||+.|||||++.+..++.++|||||||++|||++|+.||.............
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 9999999865332211 12334679999999999999999999999999999999999999998654433222111
Q ss_pred hhhhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHhccc
Q 046897 300 WAKPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQDSSE 364 (404)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 364 (404)
...... ...... ......+.++.+++..|+..+|++||+++.+.+.|+++.....
T Consensus 227 ~i~~~~-~~~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 227 RIGEKK-QSTPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHH-HHSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhcc-CCCChH---------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 111000 000000 1111234568899999999999999999999999998765443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=363.48 Aligned_cols=270 Identities=23% Similarity=0.277 Sum_probs=195.7
Q ss_pred CCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCcceEEEEEEeC--
Q 046897 73 NFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNLVKLVGYCLED-- 150 (404)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 150 (404)
+|...++||+|+||+||+| .+..+|+.||||++..+... ..+|+++|++++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEE---------EECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 5777899999999999995 45557899999999765322 23799999999999999999998643
Q ss_pred ----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEE
Q 046897 151 ----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKL 225 (404)
Q Consensus 151 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl 225 (404)
.++|+||||++++ +...+.........+++..++.++.||+.||+||| +++|+||||||+|||++.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeE
Confidence 3578999999655 44444322222257999999999999999999999 89999999999999999775 8999
Q ss_pred ecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhh----
Q 046897 226 SDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEW---- 300 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~---- 300 (404)
+|||++....... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...........+..
T Consensus 165 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 165 CDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp CCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999998654433 2334679999999998764 5789999999999999999999999975432111000000
Q ss_pred -----hhhhhhh--ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhHh
Q 046897 301 -----AKPYLAS--KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQD 361 (404)
Q Consensus 301 -----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~~ 361 (404)
....... ....................+.++.+|+.+||+.||++|||+.|+++. |+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000 000000000001111122345578899999999999999999999863 655543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-48 Score=354.89 Aligned_cols=264 Identities=19% Similarity=0.184 Sum_probs=200.7
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCC-cceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPN-LVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~ 149 (404)
+++|++.+.||+|+||.||+|+ +..+|+.||||++..... .+++..|+++++.++|+| |+.+..++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~---------~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEE---------ECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 4679999999999999999954 445788999999876532 345788999999998665 5555666677
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcC---CCcEEEe
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDT---NYNAKLS 226 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~---~~~vkl~ 226 (404)
++..++||||+ +++|...+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++. +..+||+
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeee
Confidence 88899999999 667777766544 46899999999999999999999 899999999999999864 5579999
Q ss_pred cccCCCCCCCCCCC-----cceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 227 DFGLAKDGPTGDQS-----HVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 227 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999865443321 1234467999999999999999999999999999999999999999765443322221111
Q ss_pred hhhhhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhHh
Q 046897 302 KPYLASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTVLEQLQD 361 (404)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 361 (404)
..... ....+ ......+.++.+++..||+.||++||+++++.+.|+.+..
T Consensus 229 ~~~~~------~~~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 229 SEKKM------STPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHH------HSCHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hcccC------CCChh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000 00000 1111234568899999999999999999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=360.40 Aligned_cols=267 Identities=21% Similarity=0.311 Sum_probs=196.1
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++++.||+|+||+||+| .+..+|+.||+|++..... ...+.+.+|+++|+.++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEE---------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 468999999999999999994 4556789999999976432 22456889999999999999999999998
Q ss_pred eCC------eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCc
Q 046897 149 EDD------HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYN 222 (404)
Q Consensus 149 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~ 222 (404)
..+ ++|+||||+ +.+|..++... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhcccccc
Confidence 654 579999999 67888777543 5899999999999999999999 899999999999999999999
Q ss_pred EEEecccCCCCCCCCCCCcceeeccccccccCcccccc-CCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhh
Q 046897 223 AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLAT-GHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWA 301 (404)
Q Consensus 223 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~ 301 (404)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+...........
T Consensus 160 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 160 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 999999999865332 344679999999999876 45789999999999999999999999764321110000000
Q ss_pred hh-----hhhh---------ccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhH
Q 046897 302 KP-----YLAS---------KRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV--LEQLQ 360 (404)
Q Consensus 302 ~~-----~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~--L~~~~ 360 (404)
.. +... ...+.......+ ..........+.+||.+||+.||.+|||+.|+|+. |+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 0000 000000000000 01112234567899999999999999999999985 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=359.87 Aligned_cols=269 Identities=21% Similarity=0.240 Sum_probs=195.0
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF-QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
+.+|++++.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSA---------YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEE---------EETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEE---------EECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 457999999999999999995 4556789999999976432 334578899999999999999999999876
Q ss_pred CC----eeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEE
Q 046897 150 DD----HRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKL 225 (404)
Q Consensus 150 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl 225 (404)
.. ..+++++|+.+|+|.+++... .+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEE
Confidence 53 234445556699999999754 4899999999999999999999 899999999999999999999999
Q ss_pred ecccCCCCCCCCCCC-cceeeccccccccCccccc-cCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhh
Q 046897 226 SDFGLAKDGPTGDQS-HVSTRVMGTYGYAAPEYLA-TGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKP 303 (404)
Q Consensus 226 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~ 303 (404)
+|||++......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.................
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 999999864333221 1234467999999999984 55678999999999999999999999975432111000000000
Q ss_pred hhhh----cc---ccchhhccc-ccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 304 YLAS----KR---KIFRIIDNR-LEGQY-----TLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 304 ~~~~----~~---~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.... .. ......... ..... ....+.++.+|+.+||+.||++|||+.++|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00 000000000 00001 11123468899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=357.23 Aligned_cols=256 Identities=27% Similarity=0.349 Sum_probs=203.9
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCC-CCcceEEEE
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDG----FQGHKEWLAEVNYLGQLYH-PNLVKLVGY 146 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-p~iv~~~~~ 146 (404)
++|++.+.||+|+||+||+|+. .....+|+.||+|+++... ....+.+.+|+++|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~------~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRK------ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEE------CSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEE------CccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 5699999999999999999764 2345578999999986532 2234567889999999966 899999999
Q ss_pred EEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEe
Q 046897 147 CLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLS 226 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~ 226 (404)
+.+....+++|||+.+|+|.+++.... .+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred eccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEe
Confidence 999999999999999999999998774 4788999999999999999999 8999999999999999999999999
Q ss_pred cccCCCCCCCCCCCcceeeccccccccCccccccC--CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhh
Q 046897 227 DFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG--HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPY 304 (404)
Q Consensus 227 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~ 304 (404)
|||+++...... ........|++.|++||.+.+. .++.++|||||||++|+|++|+.||...........+...
T Consensus 172 DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--- 247 (322)
T d1vzoa_ 172 DFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--- 247 (322)
T ss_dssp CSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---
T ss_pred eccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---
Confidence 999997653322 2223446799999999998654 4678999999999999999999999765543322111100
Q ss_pred hhhccccchhhcccccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 046897 305 LASKRKIFRIIDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPM-----MAEVVT 354 (404)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~ 354 (404)
.... ....+...+..+.+++.+||+.||++||| ++|+++
T Consensus 248 ---------~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 ---------ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 11233345678889999999999999995 677765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=354.32 Aligned_cols=269 Identities=21% Similarity=0.264 Sum_probs=192.3
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 468999999999999999995 4455789999999865432 23467889999999999999999999986
Q ss_pred e--------CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCC
Q 046897 149 E--------DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTN 220 (404)
Q Consensus 149 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~ 220 (404)
. +.+.|+||||+.++.+....... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRD 153 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTT
T ss_pred cccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCC
Confidence 5 34689999999766555443322 46899999999999999999999 8999999999999999999
Q ss_pred CcEEEecccCCCCCCCCCCC--cceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcch
Q 046897 221 YNAKLSDFGLAKDGPTGDQS--HVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNL 297 (404)
Q Consensus 221 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~ 297 (404)
+.+||+|||++......... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence 99999999999765432221 122335799999999998764 689999999999999999999999975432111111
Q ss_pred hhhhhhhhh-h------ccccchhhcccccCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 298 VEWAKPYLA-S------KRKIFRIIDNRLEGQYTL-------EGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 298 ~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
+........ . .................. .....+.+|+.+||+.||++|||++|+++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000000000 0 000000000000000111 11346778999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.2e-47 Score=353.10 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=196.1
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeC
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLED 150 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 150 (404)
++|++++.||+|+||+||+| .+..+|+.||+|+++.. ..+++.+|+.+|+.+. ||||++++++|...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 57999999999999999995 55567899999998754 3467889999999995 99999999999854
Q ss_pred --CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCC-cEEEec
Q 046897 151 --DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNY-NAKLSD 227 (404)
Q Consensus 151 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~-~vkl~D 227 (404)
..+++||||+.+++|..+. +.+++..++.++.||+.||+||| +++|+||||||+||||+.++ .+||+|
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeecc
Confidence 5689999999999987653 35899999999999999999999 89999999999999998655 699999
Q ss_pred ccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhh
Q 046897 228 FGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLA 306 (404)
Q Consensus 228 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 306 (404)
||+++...... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 174 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g 248 (328)
T d3bqca1 174 WGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLG 248 (328)
T ss_dssp GGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHC
T ss_pred cccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHC
Confidence 99998654432 23446799999999998764 5799999999999999999999999754332110 000000000
Q ss_pred --------h------ccccchhh--------cccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 307 --------S------KRKIFRII--------DNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 307 --------~------~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
. ........ ............+.++.+||.+||+.||++|||++|+|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000 000111111223457889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=344.39 Aligned_cols=264 Identities=22% Similarity=0.266 Sum_probs=201.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|++++.||+|+||+||+| ++..+++.||||+++.... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEE---------EECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 47999999999999999995 5556789999999865432 334678999999999999999999999999
Q ss_pred CCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcEEEeccc
Q 046897 150 DDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNAKLSDFG 229 (404)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~vkl~Dfg 229 (404)
....+++++++.+++|..++... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecc
Confidence 99999999999888888877654 45889999999999999999999 8999999999999999999999999999
Q ss_pred CCCCCCCCCCCcceeeccccccccCccccccCC-CCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhhhhhhhc
Q 046897 230 LAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGH-LTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAKPYLASK 308 (404)
Q Consensus 230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 308 (404)
.+........ ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... +............
T Consensus 147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~ 222 (292)
T d1unla_ 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTP 222 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred hhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCC
Confidence 9987544332 233346788999999887654 6899999999999999999999975322111 1011000000000
Q ss_pred --cc---cchh---------hcccccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 046897 309 --RK---IFRI---------IDNRLEGQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVT 354 (404)
Q Consensus 309 --~~---~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 354 (404)
.. .... ................+.+|+.+||+.||++|||++|+|+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 0000011122233457889999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=353.83 Aligned_cols=263 Identities=21% Similarity=0.262 Sum_probs=189.7
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEEe
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCLE 149 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 149 (404)
++|+++++||+|+||+||+| .+..+|+.||||++..... ....++.+|+.+|+.++||||++++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~---------~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEE---------EETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEE---------EECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 67999999999999999995 4555789999999976532 233568899999999999999999999964
Q ss_pred C------CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 150 D------DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 150 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
. .++|+||||+.+ ++.+.+. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCE
T ss_pred ccccccCceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccce
Confidence 3 678999999965 4545443 34799999999999999999999 8899999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchh-----
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLV----- 298 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~----- 298 (404)
|++|||+++...... ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+.......+
T Consensus 159 kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999988654322 334567999999999999999999999999999999999999999754321100000
Q ss_pred ----hhh-------hhhhhhc-----cccchhhccccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 046897 299 ----EWA-------KPYLASK-----RKIFRIIDNRLE---GQYTLEGAYKAATLALRCLSTEGKFRPMMAEVVTV 355 (404)
Q Consensus 299 ----~~~-------~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 355 (404)
.+. ..+.... ............ .........++.+|+.+||..||++|||++|+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000000 000011111111 11123456788999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=347.15 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=195.4
Q ss_pred hcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCCcceEEEEEE
Q 046897 71 TRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGF--QGHKEWLAEVNYLGQLYHPNLVKLVGYCL 148 (404)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 148 (404)
.++|++.+.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEE---------EETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 468999999999999999994 4556789999999976532 33356889999999999999999999986
Q ss_pred eC-----CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEcCCCcE
Q 046897 149 ED-----DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLDTNYNA 223 (404)
Q Consensus 149 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~~~~~v 223 (404)
.. ...+++|+|+.+|+|.+++... .+++..++.++.||+.||+||| +++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCE
T ss_pred eccccccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCccccccccccc
Confidence 43 3346667777899999998643 5899999999999999999999 8899999999999999999999
Q ss_pred EEecccCCCCCCCCCCCcceeeccccccccCccccccC-CCCcccchhhhhHHHHHHHhCCCCcCCCCCCCCcchhhhhh
Q 046897 224 KLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATG-HLTAKSDVYSFGVVLLEMLSGRRAVDKNRPSGEHNLVEWAK 302 (404)
Q Consensus 224 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ll~ell~g~~p~~~~~~~~~~~~~~~~~ 302 (404)
|++|||++..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+....
T Consensus 161 kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 161 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp EECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432 23446799999999987665 46889999999999999999999997543211111000000
Q ss_pred h-----hhhh--ccccchhhccccc-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 046897 303 P-----YLAS--KRKIFRIIDNRLE-GQYT-----LEGAYKAATLALRCLSTEGKFRPMMAEVVT--VLEQL 359 (404)
Q Consensus 303 ~-----~~~~--~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~~ 359 (404)
. .... ............. .... ...+..+.+||.+||+.||++|||+.|+++ .|.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0 0000 0000000000000 0000 123456789999999999999999999987 35544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-41 Score=319.68 Aligned_cols=266 Identities=16% Similarity=0.184 Sum_probs=189.8
Q ss_pred cCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCCc
Q 046897 72 RNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-----------HPNL 140 (404)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~i 140 (404)
.+|+++++||+|+||+||+| .+..+|+.||||+++.+. ...+.+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~---------~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLA---------KDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 45999999999999999995 455578999999998653 23456778888888774 5789
Q ss_pred ceEEEEEEeC--CeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEEc
Q 046897 141 VKLVGYCLED--DHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILLD 218 (404)
Q Consensus 141 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll~ 218 (404)
+++++++... ...+++|+++..+.......... ....+++..++.++.||+.||+|||+ ..+|+||||||+||||+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLME 160 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeee
Confidence 9999888643 45667777665544333322221 22568899999999999999999993 38899999999999998
Q ss_pred CCCc------EEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHHHHHHhCCCCcCCCCCC
Q 046897 219 TNYN------AKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVLLEMLSGRRAVDKNRPS 292 (404)
Q Consensus 219 ~~~~------vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll~ell~g~~p~~~~~~~ 292 (404)
.++. ++++|||.+..... ......||+.|+|||++.+..++.++|||||||++++|++|+.||......
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 6653 99999999875432 223467999999999999999999999999999999999999999754432
Q ss_pred CCcchhhhhhhhhhhcc--------------------ccchhhcc----------cccCCCCHHHHHHHHHHHHHcccCC
Q 046897 293 GEHNLVEWAKPYLASKR--------------------KIFRIIDN----------RLEGQYTLEGAYKAATLALRCLSTE 342 (404)
Q Consensus 293 ~~~~~~~~~~~~~~~~~--------------------~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~d 342 (404)
...............-+ ........ .............+.+|+.+||+.|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 22211111110000000 00000000 0112345667788999999999999
Q ss_pred CCCCCCHHHHHH
Q 046897 343 GKFRPMMAEVVT 354 (404)
Q Consensus 343 P~~RPs~~eil~ 354 (404)
|++|||++|+|+
T Consensus 316 P~~Rpta~e~L~ 327 (362)
T d1q8ya_ 316 PRKRADAGGLVN 327 (362)
T ss_dssp TTTCBCHHHHHT
T ss_pred hhHCcCHHHHhc
Confidence 999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.1e-24 Score=185.84 Aligned_cols=168 Identities=15% Similarity=0.094 Sum_probs=116.2
Q ss_pred CCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcc------------------cHHHHHHHHHHHhcCCC
Q 046897 76 PDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQ------------------GHKEWLAEVNYLGQLYH 137 (404)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h 137 (404)
+.+.||+|+||+||+|... +|..||||+++..... .......|...+.++.|
T Consensus 4 vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 73 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73 (191)
T ss_dssp EEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred hCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC
Confidence 5678999999999996532 4788999987532110 01223568889999999
Q ss_pred CCcceEEEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcCCCCceecCCCCCcEEE
Q 046897 138 PNLVKLVGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGAETKVIYRDFKTSNILL 217 (404)
Q Consensus 138 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~i~H~Dlkp~NIll 217 (404)
.+++..+++. ..+++|||+++..+.. ++......++.|++.+|.||| ..+|+||||||+|||+
T Consensus 74 ~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv 136 (191)
T d1zara2 74 LAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLV 136 (191)
T ss_dssp SSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEE
T ss_pred CCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheee
Confidence 9999888653 2379999997754422 334446788999999999999 8899999999999999
Q ss_pred cCCCcEEEecccCCCCCCCCCCCcceeeccccccccCccccccCCCCcccchhhhhHHH
Q 046897 218 DTNYNAKLSDFGLAKDGPTGDQSHVSTRVMGTYGYAAPEYLATGHLTAKSDVYSFGVVL 276 (404)
Q Consensus 218 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ll 276 (404)
+.+ .++|+|||+|....+..........+.. -.+. ....|+.++|+||+.--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHHH
Confidence 865 5899999999765432211000000000 0011 145788999999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=2.4e-08 Score=87.33 Aligned_cols=148 Identities=15% Similarity=0.030 Sum_probs=98.6
Q ss_pred HHHHHHhcCCCCCCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceE
Q 046897 65 SDLKTATRNFRPDSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKL 143 (404)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~ 143 (404)
.++......|++.+..+.++.+.||+... .+..+++|+...........+.+|...++.+. +--+.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~v 75 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcE
Confidence 34566667888777766666788998432 34567888876554344445677888877763 3336677
Q ss_pred EEEEEeCCeeEEEEeccCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------
Q 046897 144 VGYCLEDDHRLLVYEFMPRGSLENHLFRRGSYFQPLSWNLRLKVALGAAKGVAFLHGA---------------------- 201 (404)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------------------- 201 (404)
+.+...++..++||++++|.++....... .. ...++.++...+..||..
T Consensus 76 l~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 76 LHFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 88888888999999999887775543211 11 122333444444444410
Q ss_pred -----------------------------------CCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 202 -----------------------------------ETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 202 -----------------------------------~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
...++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1226899999999999987667799998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=1.1e-05 Score=74.30 Aligned_cols=78 Identities=13% Similarity=0.078 Sum_probs=47.7
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecC------CC-cccHHHHHHHHHHHhcCC-C--CCcceEEEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQ------DG-FQGHKEWLAEVNYLGQLY-H--PNLVKLVGY 146 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~ 146 (404)
.+.||.|....||+. ....+++.+++|.-.. +. .....+...|.+.|+.+. + ..+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV---------~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHI---------YDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEE---------EC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEE---------EeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 346899999999984 3344567899996432 11 123345667888887662 2 345555544
Q ss_pred EEeCCeeEEEEeccCCCCh
Q 046897 147 CLEDDHRLLVYEFMPRGSL 165 (404)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L 165 (404)
+++..++|||++.+..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 45567899999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=2.2e-05 Score=67.46 Aligned_cols=73 Identities=19% Similarity=0.092 Sum_probs=47.7
Q ss_pred ccccC-cccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--CCCcceEEEEEEeCCeeEEE
Q 046897 80 LGEGG-FGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY--HPNLVKLVGYCLEDDHRLLV 156 (404)
Q Consensus 80 lg~G~-~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv 156 (404)
+..|. .+.||+... ..+..+++|....... ..+..|...|+.+. .-.+.+++.+..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~----------~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA----------QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEEC----------TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEe----------CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 34444 367887432 2355688887655432 23556777777663 23366778888888888999
Q ss_pred EeccCCCCh
Q 046897 157 YEFMPRGSL 165 (404)
Q Consensus 157 ~e~~~~~~L 165 (404)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999987654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.00045 Score=63.26 Aligned_cols=81 Identities=16% Similarity=0.049 Sum_probs=50.9
Q ss_pred CCcccccCcccEEEEEecCcccccccCCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCCcceEEEEEEeCCeeEE
Q 046897 77 DSVLGEGGFGSVFKGWIDEHSFAATKPGTGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLY-HPNLVKLVGYCLEDDHRLL 155 (404)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 155 (404)
++.|+.|-.-.+|++...+... ........|++++.... .......+|..+++.+. +.-..++++++.+ ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3567778888899987665332 12234456777776532 22344567888888874 4334567776632 58
Q ss_pred EEeccCCCCh
Q 046897 156 VYEFMPRGSL 165 (404)
Q Consensus 156 v~e~~~~~~L 165 (404)
|+||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999976433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.35 E-value=0.012 Score=51.46 Aligned_cols=31 Identities=26% Similarity=0.231 Sum_probs=27.6
Q ss_pred CCCceecCCCCCcEEEcCCCcEEEecccCCC
Q 046897 202 ETKVIYRDFKTSNILLDTNYNAKLSDFGLAK 232 (404)
Q Consensus 202 ~~~i~H~Dlkp~NIll~~~~~vkl~Dfg~a~ 232 (404)
..++||+|+.++||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5679999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.34 E-value=0.012 Score=51.85 Aligned_cols=126 Identities=13% Similarity=0.054 Sum_probs=67.0
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCCc-----ceE--EEEEEeCCeeEEEEeccCCCCh-----HHHHh--
Q 046897 105 TGMVIAVKRLNQDGFQGHKEWLAEVNYLGQLYHPNL-----VKL--VGYCLEDDHRLLVYEFMPRGSL-----ENHLF-- 170 (404)
Q Consensus 105 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~--~~~~~~~~~~~lv~e~~~~~~L-----~~~l~-- 170 (404)
+|..|++|+.... ....+++..|...+..|....| +.. -..+..+...+.+++++.|..+ ..+..
T Consensus 45 dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG 123 (325)
T d1zyla1 45 DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVG 123 (325)
T ss_dssp TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHH
T ss_pred CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHH
Confidence 5778999987654 3345667788888877742111 111 0122345667889999865322 11110
Q ss_pred -------h----cC-CCCCCCCH----------------------HHHHHHHHHHHHHHHHhH--cCCCCceecCCCCCc
Q 046897 171 -------R----RG-SYFQPLSW----------------------NLRLKVALGAAKGVAFLH--GAETKVIYRDFKTSN 214 (404)
Q Consensus 171 -------~----~~-~~~~~l~~----------------------~~~~~i~~qi~~~l~~LH--~~~~~i~H~Dlkp~N 214 (404)
. .. .....++. ......+.++...+.-+- ....+++|+|+.+.|
T Consensus 124 ~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~N 203 (325)
T d1zyla1 124 RYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGN 203 (325)
T ss_dssp HHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGG
T ss_pred HHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCccc
Confidence 0 00 00011111 112222333333332221 123568999999999
Q ss_pred EEEcCCCcEEEecccCCCC
Q 046897 215 ILLDTNYNAKLSDFGLAKD 233 (404)
Q Consensus 215 Ill~~~~~vkl~Dfg~a~~ 233 (404)
||++.+ ..++||+-+..
T Consensus 204 vL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 204 ILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EEESSS--EEECCCTTCCE
T ss_pred EEEeCC--ceEEechhccc
Confidence 999743 45899998764
|